
<html lang="en"     class="pb-page"  data-request-id="35e06b17-17f2-48c0-a196-38af94c9a153"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.8b01596;issue:issue:10.1021/jmcmar.2019.62.issue-12"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications" /></meta><meta name="dc.Creator" content="Zhihong  Li" /></meta><meta name="dc.Creator" content="Qidong  You" /></meta><meta name="dc.Creator" content="Xiaojin  Zhang" /></meta><meta name="dc.Description" content="Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaption to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythro..." /></meta><meta name="Description" content="Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaption to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 25, 2019" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01596" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01596" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01596" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01596" /></link>
        
    
    

<title>Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01596" /></meta><meta property="og:title" content="Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0026.jpeg" /></meta><meta property="og:description" content="Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaption to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythropoiesis, and metabolism. The HIF pathway is involved in many diseases. On one hand, overexpression of the HIF pathway is associated with solid tumors such as renal cell carcinoma (RCC). On the other hand, suppression of the HIF pathway is correlated with inflammatory, anemia, and other hypoxic–ischemic diseases. Therefore, modulation of the HIF pathway has been perceived as a promising strategy for treating HIF-related diseases. Recent advances in understanding of the biochemistry underlying the HIF pathway have stimulated small-molecule drugs development, and therapeutically, manipulation of the HIF-mediated response has been shown to have considerable medicinal potential. This review will summarize and provide insight into recent advances in research that have expanded our knowledge of the HIF pathway, including its structural basis and biology, small-molecule modulators of the pathway, including inhibitors and activators, and the potential therapeutic applications of these modulators." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01596"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01596">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01596&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01596&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01596&amp;href=/doi/10.1021/acs.jmedchem.8b01596" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 5725-5749</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01153" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01668" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhihong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhihong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing 211198, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhihong++Li">Zhihong Li</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1548-8996" title="Orcid link">http://orcid.org/0000-0003-1548-8996</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qidong You</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qidong You</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>Q.Y.: phone and fax, +86-25-83271351; e-mail, <a href="/cdn-cgi/l/email-protection#1f66706a6e7b5f2e292c317c7072"><span class="__cf_email__" data-cfemail="d6afb9a3a7b296e7e0e5f8b5b9bb">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qidong++You">Qidong You</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Xiaojin Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaojin Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China</div><div class="loa-info-affiliations-info">Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing 211198, China</div></div><span class="conrtib-corresp"><strong>*</strong>X.Z.: phone, +86-13913007140; e-mail, <a href="/cdn-cgi/l/email-protection#39434153795a494c175c5d4c175a57"><span class="__cf_email__" data-cfemail="d6acaebc96b5a6a3f8b3b2a3f8b5b8">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojin++Zhang">Xiaojin Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1898-3071" title="Orcid link">http://orcid.org/0000-0002-1898-3071</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01596&amp;href=/doi/10.1021%2Facs.jmedchem.8b01596" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 5725–5749</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 25, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 October 2018</li><li><span class="item_label"><b>Published</b> online</span>25 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 June 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01596" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01596</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5725%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhihong%2BLi%252C%2BQidong%2BYou%252C%2BXiaojin%2BZhang%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D12%26contentID%3Dacs.jmedchem.8b01596%26title%3DSmall-Molecule%2BModulators%2Bof%2Bthe%2BHypoxia-Inducible%2BFactor%2BPathway%253A%2BDevelopment%2Band%2BTherapeutic%2BApplications%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5749%26publicationDate%3DJune%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01596"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3526</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01596" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhihong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Qidong&quot;,&quot;last_name&quot;:&quot;You&quot;},{&quot;first_name&quot;:&quot;Xiaojin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;5725-5749&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01596&quot;},&quot;abstract&quot;:&quot;Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaption to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythropoiesis, and metabolism. The HIF pathway is involved in many diseases. On one hand, overexpression of the HIF pathway is associated with solid tumors such as renal cell carcinoma (RCC). On the other hand, suppression of the HIF pathway is correlated with inflammatory, anemia, and other hypoxic–ischemic diseases. Therefore, modulation of the HIF pathway has been perceived as a promising strategy for treating HIF-related diseases. Recent advances in understanding of the biochemistry underlying the HIF pathway have stimulated small-molecule drugs development, and therapeutically, manipulation of the HIF-mediated response has been shown to have considerable medicinal potential. This review will summarize and provide insight into recent advances in research that have expanded our knowledge of the HIF pathway, including i&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01596&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01596" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01596&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01596" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01596&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01596" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01596&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01596&amp;href=/doi/10.1021/acs.jmedchem.8b01596" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01596" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01596" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (14 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01596%26sid%3Dliteratum%253Aachs%26pmid%3D30682255%26genre%3Darticle%26aulast%3DLi%26date%3D2019%26atitle%3DSmall-Molecule%2BModulators%2Bof%2Bthe%2BHypoxia-Inducible%2BFactor%2BPathway%253A%2BDevelopment%2Band%2BTherapeutic%2BApplications%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D12%26spage%3D5725%26epage%3D5749%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/jmcmar.2019.62.issue-12/20190627/jmcmar.2019.62.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Hypoxia-inducible factor (HIF) is a central regulator involved in detection and adaption to cellular oxygen stress through regulation of the hypoxic transcriptional program in angiogenesis, erythropoiesis, and metabolism. The HIF pathway is involved in many diseases. On one hand, overexpression of the HIF pathway is associated with solid tumors such as renal cell carcinoma (RCC). On the other hand, suppression of the HIF pathway is correlated with inflammatory, anemia, and other hypoxic–ischemic diseases. Therefore, modulation of the HIF pathway has been perceived as a promising strategy for treating HIF-related diseases. Recent advances in understanding of the biochemistry underlying the HIF pathway have stimulated small-molecule drugs development, and therapeutically, manipulation of the HIF-mediated response has been shown to have considerable medicinal potential. This review will summarize and provide insight into recent advances in research that have expanded our knowledge of the HIF pathway, including its structural basis and biology, small-molecule modulators of the pathway, including inhibitors and activators, and the potential therapeutic applications of these modulators.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32835" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32835" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The response to hypoxia is thought to be related to the α,β-heterodimeric hypoxia inducible factor (HIF).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Under hypoxia, the oxygen-sensitive HIF-α subunit accumulates, enabling heterodimer complex formation between HIF-α and HIF-β. The HIF-α,β dimer further interacts with the transcriptional coactivator (p300) protein and binds to the hypoxia responsive element (HRE), which is part of the DNA nucleus, thereby regulating the expression of multiple genes, especially those related to hypoxic effects. HIF is a crucial oxygen-sensitive transcription factor that coordinates cellular adaptation to oxygen stress by regulating orchestrated transcriptional programs, such as mitochondrial metabolism, cell viability, proliferation, erythropoiesis, and angiogenesis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> The coordination of all these programs is generally associated with human disease processes related to anemia, ischemia, most tumors, and other hypoxic–ischemic diseases, making HIF an attractive target for therapeutic application.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a></div><div class="NLM_p">On one hand, according to a published report, a considerable proportion of solid tumors, which are induced by hypoxia, can exist in the low concentration of oxygen if the HIF pathway is stabilized.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Overexpression of the HIF pathway has been correlated with poor patient prognosis, aggressive tumor growth, and resistance to radiation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Therefore, the inhibition of HIF activity by small-molecule inhibitors has been identified as an effective and attractive therapeutic strategy for various solid tumors, such as breast cancer, lung cancer, multiple myeloma, and renal cell carcinoma (RCC). To date, an increasing number of HIF inhibitors with small-molecules have displayed obvious anticancer potency. For many of these, the mode of action has been developed on the basis of the HIF signaling pathway, mainly including the promotion of the HIF-1α protein degradation, disruption of the HIF-α/ HIF-β interaction, and the blockade of the HIF-α/p300 interaction. Recently, blockade of the HIF-α/p300 interaction has been demonstrated as a superior strategy for the inhibition of the HIF target.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">On the other hand, hypoxia occurs in ischemia reperfusion, inflammation, and neurodegenerative diseases; this has prompted researchers to pay significant attention to HIF activation. HIF activation is now considered as an innovative means to treat HIF-related diseases, such as anemia, ischemia, and Parkinson’s disease.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8,9)</a> On the basis of the HIF biological pathway, the current small-molecule activators of the HIF pathway can be classified into three main types: prolyl hydroxylase domain (PHD) inhibitors, von Hippel–Lindau (VHL) inhibitors, and factor inhibiting HIF (FIH) inhibitors. Among these activators of HIF, PHD inhibitors play the dominant role in up-regulating the transcription genes expression of the HIF signaling pathway, resulting in the recognition of the PHD inhibitors as a unique and rational approach for the treatment of anemia.</div><div class="NLM_p last">Consequently, manipulation of the HIF pathway by small-molecule modulators has been widely perceived as a very promising strategy for treating numerous diseases closely associated with HIF dysfunction. Substantial research efforts to date have investigated HIF transcriptional inhibition for the treatment of solid tumors and HIF pathway activation as an effective antianemia therapy.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This review will summarize and provide insights into the recent research advances with respect to the HIF pathway, including the structural basis and biology of the pathway, the crucial factors involved in its down- and up-regulation, small-molecule modulators of the pathway and their potential therapeutic applications.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  HIF Structure and Biology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The transcription factor HIF was first discovered by Semenza et al. in 1992; it is a multimeric factor that binds directly to a hypoxia-inducible enhancer with 50-base-pair sequence 3′ to the erythropoietin (EPO) gene. Further, it has been reported that HIF is a heterodimeric transcription factor, which consists of a highly oxygen-regulated subunit, HIF-α, and a constitutively expressed subunit, HIF-β. HIF-α contains three isoforms, HIF-1α, HIF-2α, and HIF-3α,<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11,12)</a> while HIF-β is the only subtype of the β subunit. HIF-1, consisting of HIF-1α and HIF-β subunits, is the most extensively investigated HIF isoform. HIF-β is a 91–94 kDa subunit identical to the known aryl hydrocarbon receptor nuclear translocator (ARNT); it is capable of forming a heterodimer together with the aryl hydrocarbon receptor (AhR), thereby modulating genes associated with the transcriptional response to oxidant stress and various environmental xenobiotics.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> HIF-1α is a 120–130 kDa protein; it is the most widely expressed HIF-α subunit in mammalian tissues and is also highly conserved in many other species. The other HIF-α subunits, HIF-2α and HIF-3α, appear to have more specialized and tissue-specific functions. Among the three known HIF-α subunits, HIF-1α and HIF-2α share high sequence identity. HIF-1α and HIF-2α both contain a basic helix–loop–helix (b-HLH) domain, two PAS domains, a PAC domain, an oxygen-dependent degradation (ODD) domain, an N-terminal transactivation domain (N-TAD), and a C-terminal TAD (C-TAD) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> It has been revealed that both the C-TAD and N-TAD are essential for the transcriptional activity of HIF-1α. Interestingly, the C-TAD domain interacts with CREB-binding protein (CBP)/p300, a coactivator, to modulate transcriptional activity of downstream gene under hypoxia, and N-TAD contributes to HIF-1α stabilization against proteasomal degradation.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> However, in the case of the HIF-3α subunit, no intrinsic transactivation activity has been observed. This may be because HIF-3α is missing the C-TAD region, as compared to the structures of HIF-1α and HIF-2α (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In addition, it has been found that HIF-3α can suppress HIF-1α, HIF-2α, and HIF-β-mediated transcription by interfering with the interaction between HIF-1α/2α and DNA.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional domains of the HIF subunits. HIF-1α and HIF-2α share high amino acid sequence similarities, while C-TAD is missing in HIF-3α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">HIF-1α is critical in vascular and metabolic responses to hypoxia, whereas HIF-2α is mainly related to erythropoiesis and vascular systems.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Recent studies have revealed that HIF-2α rather than HIF-1α might be of greater importance for hypoxia-induced expression of EPO in the kidneys.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> It has also been found that HIF-2α plays a critical role in the development of RCC and is a potentially effective novel target for the RCC treatment.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compared to HIF-1α and HIF-2α, HIF-3α has received much less research attention due to the existence of multiple HIF-3α variants.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_p">Although all of the HIF subunits are involved in generating diverse transcriptional responses under a hypoxic atmosphere, the key components are the HIF-1α and HIF-β subunits. Under the condition of normoxia, HIF-1α has a transient half-life because of content ubiquitination-dependent proteasomal degradation through the VHL E3 ligase protein. The VHL protein specifically recognizes the proline hydroxylated (Pro402-OH/Pro564-OH) HIF-1α on two independent sites: a carboxyl terminal oxygen-dependent degradation domain (CODD) and an amino terminal oxygen-dependent degradation domain (NODD).<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20,21)</a> The oxygen-sensitive PHD is an indispensable activator for catalyzing these hydroxylation reactions, establishing hydroxyl action as a novel functional post-translational modification in the HIF signaling pathways.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Additionally, K532 residue acetylation is achieved by ARD1 acetyltransferase for the binding of VHL inside normoxic cells; this contributes to ubiquitination of the HIF protein for degradation.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Moreover, HIF-1α can also be controlled by the oxygen-sensitive asparaginyl hydroxylase, factor inhibiting HIF (FIH). FIH is able to hydroxylate the Asn803 residue in the C-TAD domain of the HIF-1α subunit, affecting the interaction between the C-TAD domain and the transcriptional coactivators p300/CBP, thereby inhibiting various HIF transcriptional activities.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">For a better understanding of the progress in the HIF research field to date, we have compiled a historical timeline of core experimental results and key components of the HIF network (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). A tight interactive relationship has been found between hypoxia and chemoresistance, radioresistance, invasiveness, angiogenesis, and so forth. Overexpression of HIF pathway is associated with solid tumors such as RCC and triple-negative breast cancer (TNBC).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> On the other hand, the deficient expression of HIF is mainly correlated with inflammatory, anemia, and other hypoxic–ischemic diseases. Therefore, HIF modulation is recognized as a rather effective means to treat diseases related to HIF. HIF activators have shown therapeutic potential in treating ischemia, such as chronic kidney disease (CKD) related anemia.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Meanwhile, HIF inhibitors have been considered as therapies for treating all kinds of diseases related to overactivation of the HIF pathway, including solid tumors. Thus, it can be seen that the progress in HIF structure and biology over the past decades has contributed significantly to the development of HIF modulators for treating various diseases.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Profile of the main findings related to the critical components of the HIF pathway and the major modeled behaviors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Small-Molecule Inhibitors of the HIF Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Almost all solid tumors have a common feature, that is, hypoxia, resulting in overexpression of the HIF pathway in the tumor microenvironment.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In the case of tumor patients, overexpression of HIF usually results in poor prognosis and invasive tumor growth. Therefore, HIF inhibition has been suggested to be an attractive and promising strategy to treat cancer. In this section, we will summarize the recently described small-molecule inhibitors that down-regulate the HIF pathway. These small-molecule inhibitors have been classified and elucidated as follows according to their different mechanisms of action related to the HIF signaling pathway (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>): (1) inhibitors of the HIF-1α/p300 protein–protein interaction; (2) inhibitors of HIF-α/HIF-β dimerization; (3) inhibitors of HIF-1 DNA binding; (4) inhibitors that down-regulate the expression of HIF-1α mRNA; (5) small molecules that reduce the HIF-1α protein level; (6) small molecules that inhibit HIF at multiple pathways.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Small-molecule inhibitors of the HIF pathway targeting different sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">3.1.  Inhibitors of the HIF-1α/p300 Protein–Protein Interaction</h3><div class="NLM_p">When oxygen concentration is low enough, HIF-1α could escape the degradation and subsequently accumulates in the nucleus, thereby dimerizing with the HIF-β subunit. This allows the recruitment and binding of a transcriptional coactivator, p300, a multidomain protein that plays a key part in the activation of HIF-1.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> It is worth noting that HIF-1α overexpression has been found in many cancers and is correlated with NF-kB pathway, aberrant p53 accumulation, and tumor progression.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The NMR structure of the HIF-1α C-terminal activation domain (CAD) when complexed with the cysteine/histidine-rich region (CH1) domain of CBP/p300 was identified by Eck’s group (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The elucidated interactions demonstrate that disrupting the HIF-1α/p300 protein–protein interaction with α-helix mimetics is one strategy for blocking HIF-1 activation and could potentially be beneficial for tumor treatment.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Moreover, Wright et al. have also examined the complex structure of CBP/p300 and the CAD of HIF-1α; their study revealed the molecular interface between the CBP/p300 CH1 domain and HIF-1α in detail.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Further, it has demonstrated that hydroxylation of the Asn803 residue by FIH in the C-TAD of HIF-1α hampers the interaction between HIF-1α and p300.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33,34)</a> Inhibition of the HIF-1α pathway by disrupting its interaction with the transcriptional coactivator p300 hinders tumor angiogenesis, tumor growth, and resistance to radiation therapy.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, the compound YC-1 (<b>1</b>), which is an activator of platelet guanylate cyclase, has been found to exert HIF-1 inhibitory activity by enhancing FIH binding to HIF-α C-TAD and subsequent hydroxylation of Asn803.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> It has been revealed that <b>1</b> and its derivatives (compounds <b>2</b> and <b>3</b>)<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> interrupt the HIF-α and p300 interaction, thus inhibiting the transcriptional activity of HIF-1. Cell-based HIF-responsive-luciferase (HRE-Luc) assay in HeLa cell lines revealed that compound <b>1</b>, with an IC<sub>50</sub> value of 2.0 μM, is a representative member of this type of HIF-1 inhibitors; it suppresses the HIF target genes such as <i>VEGF</i> and <i>EPO</i>. However, most of these derivatives showed similar activity to both HIF-1α and HIF-2α; no selectivity between HIF-1α and HIF-2α isoforms was observed.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NMR structure of CH1domain of p300 (red) in complex with the HIF-1α CAD peptide (yellow) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L3E">1L3E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Natural products as inhibitors of the HIF-1α/p300 protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Subsequently, researchers have devoted their efforts to searching for selective HIF-1α inhibitors. HIF-1α transcriptional activity mainly relies on the protein–protein interaction between HIF-1α C-TAD and the co-transcription factor p300/CBP, which can act on the HRE sequence of the promoter of the target gene, subsequently initiating transcription of the target gene. Thus, inhibition of the HIF-1α and p300/CBP protein–protein interaction can directly inhibit HIF-1α-dependent transcriptional activity; this mechanism is a potential and frequently investigated drug target in current medicinal research.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> Initially, with a high-throughput screening (HTS) assay, De Munari et al. discovered that the natural product chaetocin (<b>4</b>) hampers the HIF-1α/p300 complex in some cancer cells and the expression of HIF-1α target genes was selectively down-regulated.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> Time resolved fluoroimmunoassay (TRFIA) revealed that compound <b>4</b> is able to inhibit the HIF-1α/p300 interaction with an IC<sub>50</sub> value of 12.50 μM, while enzyme linked immunosorbent assay (ELISA) showed that it interferes with the secretion of downstream VEGF protein in Hep3B with an IC<sub>50</sub> value of 0.10 μM; this resulted in remarkable and specific inhibition of tumor growth. Further, it was determined that the important factors for the HIF-1α/p300 interaction include the C-TAD of HIF-1α and CH1 of p300.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Thus, targeted blockade of HIF-1a C-TAD binding to the CBP/p300 CH1 domain would constitute a novel and specific approach for cancer treatment via the suppression of tumor angiogenesis and metastasis.</div><div class="NLM_p">Kung et al. reported that the natural product chetomin (<b>5</b>)<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> and its derivatives are capable of inhibiting the coactivator CBP/p300 and HIF-1α C-TAD interaction and then effectively reducing HIF-1 target proteins such as EPO, VEGF, and Glut1. However, further clinical application of these HIF-1α inhibitors was limited due to their high toxicity in normal tissues. Furthermore, Figg’s group identified heterocyclic alkaloids eudistidine A (<b>6</b>) and eudistidine B (<b>7</b>), which were isolated from the marine ascidian <i>Eudistoma</i> sp., as novel HIF-1α/p300 inhibitors.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Homogeneous time-resolved fluorescence (HTRF) assay revealed that eudistidine A (<b>6</b>) is a modest inhibitor of the HIF-1α/p300 interaction through effectively blocking the binding of p300-CH1 to immobilized HIF-1α C-TAD with an IC<sub>50</sub> of approximately 75 μM; this effect occurred in a dose–response manner. In addition, this research group performed a high-throughput screen from 170 298 crude natural product extracts and identified that pyrroloiminoquinone alkaloids <b>8</b>–<b>13</b> are HIF-1α/p300 inhibitors with comparable inhibitory activity to positive control <b>5</b>. These natural alkaloids belong to a novel potential of HIF-1α inhibitors which interfere with the HIF-1α and p300 protein–protein interaction, thereby decreasing HIF-1α-related transcription.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">Consequently, inspired by the intriguing structures of the natural products chaetocin (<b>4</b>) and chetomin (<b>5</b>), Block et al. reported on a chetomin analogue, ETP 3 (<b>14</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), which uses a benzene ring as the linker to connect two dithiopiperazine pharmacophoric moieties.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Fluorescence polarization (FP) assay revealed that ETP3 can bind to the p300-CH1 protein and is able to selectively disrupt the interaction of the p300/CBP coactivator, with an IC<sub>50</sub> value of 1.50 μM; this leads to down-regulation of the HIF-related genes critical for cancer progression. Encouraged by the success of <b>14</b>, this research group further designed and synthesized a novel dimeric chetomin analogue, ETP2 (<b>15</b>), with an extended linker, which was found to exert a higher FP affinity with an IC<sub>50</sub> value of 0.6 μM.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> It is worth noting that the designed natural-product-like compound <b>15</b> was found to be less toxic to normal cells than natural lead chetomin (<b>5</b>). Verified by the in vivo intravital microscopy (IVM) imaging model of breast cancer, ETP2 was found to effectively inhibit tumor growth with no damage or acute toxicity in mouse models.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Small-molecule inhibitors involved in the HIF-1α/p300 protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Additionally, indandione compound (<b>16</b>) and quinone compound (<b>17</b>) have been shown to possess the ability to break the tight interaction between HIF-1α CAD and p300.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Further mechanism studies have revealed that these compounds inhibit the binding of p300 to HIF-1α by inducing Zn<sup>2+</sup> ejection from the p300 protein. This mode of action results in a lack of specific-target selectivity for their potential interaction with other Zn<sup>2+</sup> containing proteins. <i>Ortho</i>-quinone compound (<b>18</b>) and thiazolidinone compound (<b>19</b>) have shown a superior inhibitory activity for HIF-1α/p300 interaction.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> These two types of compounds have been found to restrain the expression of VEGF with IC<sub>50</sub> values ranging from 0.10 to 100 μM in a hypoxic cell model. Moreover, Kwon et al. reported that KST012174 (<b>20</b>) with a novel chemical type could interrupt the HIF-1α/p300 interaction with an IC<sub>50</sub> value of 107.0 μM in an affinity-based FP assay.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Wang et al. found that the interaction of HIF-1α with cofactors p300/CBP was efficiently interrupted by arylsulfonamide KCN1 (<b>21</b>) in vitro using a surface plasmon resonance (SPR) assay.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Of note, it was observed that KCN1 inhibits the hypoxia-induced transcriptional activation of HIF-1 in LN229HRE-luc/LacZ cells with an IC<sub>50</sub> value of 590 nM. Studies have shown that <b>21</b> inhibits cell growth and leads to cell cycle arrest in human pancreatic cancer cells in a dose-dependent manner in vitro; it also possesses promising anticancer efficacy in mice bearing Panc-1 or Mia Paca-2 tumor xenografts in vivo. Notably, <b>21</b> has good pharmacological properties and bioavailability, which lays a good foundation for the treatment of human tumors displaying overexpression of HIF.<a onclick="showRef(event, 'ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref52 ref53">(52,53)</a></div><div class="NLM_p">With research advances in the clinical application of drugs, new drug indications are often revealed. Thus, there are many conventional drugs that find new clinical applications. Bortezomib (<b>22</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), which is clinically used to treat solid tumors and multiple myeloma, has been reported to break tumor adaption in a hypoxia atmosphere by functionally stimulating the FIH-mediated inhibition of HIF-1α<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> by means of inhibiting the association between HIF-1α and the p300 coactivator, thereby down-regulating HIF-1α dependent gene transcription. It has been reported that bortezomib blocks the hypoxic induction of EPO and VEGF in both drug-sensitive U299 cell lines and a resistant Hep3B cell line with a subnanomolar concentration.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Menadione (<b>23</b>) has a significant curative effect in hemostasis and detoxification, while ethacrynic acid (<b>24</b>) is regarded as a diuretic. Interestingly, recent research has revealed that these compounds could interfere with the HIF pathway by disrupting the interaction between HIF-1α and p300, thereby down-regulating the expression of VEGF.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> In addition, Wu et al. reported that novobiocin (<b>25</b>), a coumarin antibiotic, directly hinders the interaction between the CH1 region of p300/CBP and HIF-1α C-TAD.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Meanwhile, another study has shown that, by regulating the m-TOR signaling pathway, <b>25</b> is capable of restraining the function of HIF-1α and its corresponding downstream target protein</div><div class="NLM_p">Further, several peptoid inhibitors have been designed, based on the structure of HIF-1α, to be HIF-1α/p300 inhibitors with high selectivity and less cytotoxic side effects. Arora et al. revealed that the HIF residues Leu818, Leu822, Asp823, and Gln824 play a significant role in the binding of HIF-1α to p300.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> On the basis of this, a peptidomimetic HBS1 (<b>26</b>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) was designed. Peptoid <b>26</b> showed a preferable affinity with p300-CH1 and blocked its binding to the HIF-1α C-TAD. The dissociation constant (<i>K</i><sub>d</sub>) between peptoid <b>26</b> and p300 was 690 nM.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> Peptoid <b>26</b> inhibits HIF-1 target genes, including <i>VEGF</i> and <i>GLUT1</i>, in HeLa cells under hypoxic conditions. Furthermore, <b>26</b> has shown remarkable efficacy in reducing tumor growth in an RCC xenograft mouse model. Importantly, it provides a reasonable approach for discovery of HIF-1α/p300 inhibitors through topographical mimics of residues on the secondary structures of proteins that are energetically important. Computational and structural analyses of the HIF-1α/p300 complex have revealed that the CH1 domain of p300/CBP interacts with the helical residues of HIF-1α helix814–824. On the basis of these results, peptoid OHM1 (<b>27</b>), simulating the key amino acids Leu818, Leu822, and Gln824, was found to exert a highly selective inhibition of the HIF-1α/p300 interaction both in vitro and in vivo.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The intrinsic tryptophan fluorescence spectroscopy assay revealed that OHM1 targets the p300 CH1 domain with an affinity <i>K</i><sub>d</sub> = 530 nM.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative peptoid inhibitors of the HIF-1α/p300 protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">3.2.  Inhibitors of HIF-α/HIF-β Dimerization</h3><div class="NLM_p">Interrupting HIF-α/HIF-β dimerization has recently been considered as an attractive strategy to down-regulate the HIF pathway. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, acriflavine (<b>28</b>), initially reported to possess antiviral, antibacterial, and trypanocidal activities, is considered as a HIF dimerization inhibitor that interacts with both HIF-1α and HIF-2α in their PAS-B subdomain.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> It was discovered that <b>28</b> can suppress HIF transcriptional activity, which further inhibits vascularization and the growth of tumors. However, compound <b>28</b>, similar to most HIF inhibitors, targets both HIF-1 and HIF-2 without clear selectively between the two subunits. A high-throughput screening from a large library of over three million cyclic peptides using genetically encoded technology has led to the discovery of a cyclopeptide cyclo-CLLFVY (<b>29</b>), which is considered to be an effective inhibitor of the HIF-1α/HIF-β interaction.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Notably, compound <b>29</b> has indicated a high selectivity to the PAS-B domain of HIF-1α, thus inhibiting HIF-1 dimerization and transcription activity without interfering with HIF-2α. HIF-2α has long been considered as nontargetable and undruggable.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> However, recent studies have revealed that the PAS-B domain of HIF-2α possesses a large cavity that carries a hydrophobic core and it is quite different from the corresponding PAS-B region of HIF-1α; this provides potential opportunities to selectively target-specific small-molecule regulation of HIF-2α (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>).<a onclick="showRef(event, 'ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref62 ref63 ref64">(62−64)</a> Achiral compound (<b>30</b>) antagonizes endogenous HIF-2 heterodimerization and DNA-binding activity in vitro in Hep3B cells, significantly down-regulating HIF-2 target gene expression. Further, Tambar et al. have developed a series of chiral inhibitors of the HIF-2α PAS-B domain, exemplified by compound <b>31</b>, which can trigger greater changes in protein conformation than the achiral HIF-2 inhibitors reported previously.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Moreover, selective small-molecule antagonists of HIF-2α have been reported, establishing a novel approach to treating RCC with HIF-2α overexpression. PT2385 (<b>32</b>) and PT2399 (<b>33</b>) are the most active and representative inhibitors of HIF-2α/HIF-β dimerization for the treatment of RCC.<a onclick="showRef(event, 'ref65 ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref65 ref66 ref67">(65−67)</a> PT2399 can directly bind to the PAS-B domain of HIF-2α (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), crippling the ability of HIF-2α to bind to HIF-β. PT2385 (<b>32</b>) and PT2399 (<b>33</b>) represent a new class of therapeutic candidates for treating RCC and VHL disease; they have good preclinical efficacy, and their tolerability and safety are improved relative to the existing agents.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Of particular note is that PT2385 (<b>32</b>) exhibited no adverse effects on the cardiovascular system. A phase I clinical study for the treatment of RCC is currently underway.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> In addition, treatment with PT2385 (<b>32</b>) was able to markedly reduce the ceramide levels in the intestine and serum. Further experiments have shown that PT2385 has a positive effect on nonalcoholic fatty liver disease by increasing the expression of the neuraminidase 3 (<i>Neu3</i>) gene.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Small-molecule inhibitors interrupting HIF-α/HIF-β dimerization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Binding of the HIF-2α PAS-B and HIF-β PAS-B domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TBM">5TBM</a>) and the binding mode of PT2385 (<b>30</b>) with HIF-2α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">3.3.  Inhibitors of HIF-1 DNA Binding</h3><div class="NLM_p">The binding of HIF to DNA is the final step in the mechanism of HIF’s function as a transcription factor. Inhibition of HIF binding to HRE-DNA sequence is a promising target for small-molecule inhibitors. Dervan’s group has revealed that sequence-specific DNA-binding molecules (<b>34</b> and <b>35</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) can disrupt the connection between the HIF-1α/HIF-β heterodimer and the corresponding cognate DNA sequence, thus inhibiting the expression of VEGF and other genes related to hypoxia in the HIF pathway.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition, it has been illustrated that echinomycin (<b>36</b>), a cyclic octapeptide, can affect the interaction between HIF-1 and DNA with a high affinity, thereby influencing expression of almost every gene that is induced by hypoxia.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Additionally, Melillo et al. reported that NSC-50532 (<b>37</b>, <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), a semisynthetic pyrrolidone methyltetracycline natural product, selectively breaks HIF-1 and DNA binding.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Similarly, adriamycin (<b>38</b>) and daunorubicin (<b>39</b>) were able to inhibit HIF-1 bioactivity by blocking its binding to the downstream HRE-DNA sequence.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In human prostate cancer xenografted mouse models, both <b>38</b> and <b>39</b> showed significant inhibitory activity on tumor growth and vascularization. In addition, DJ12 (<b>40</b>) was initially reported to be an inhibitor of HIF function via blockade of HIF-1α and HRE-DNA binding, resulting in down-regulation of the downstream target mRNA of HIF. However, recent research has shown that DJ12 does not directly interrupt the association between the HIF-DNA complex; rather, it likely inhibits the tight complex formation between HIF and p300/CBP transcription.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Recently, the binding mode of the HIF-1/2 and HRE DNA sequences has been resolved with the use of X-ray diffraction crystallography (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> It was shown that the binding between HIF and DNA is mediated by the b-HLH and PAS-A domain; these corresponding structural binding details will be beneficial for future design of novel small inhibitors of HIF-1 or HIF-2 DNA binding.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Small-molecule inhibitors of HIF-1 DNA binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Architecture of HIF bHLH-PAS heterodimers: (A) X-ray crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPR">4ZPR</a>) of the HIF-1α/HIF-β bHLH-PAS heterodimer bound to DNA; (B) crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPK">4ZPK</a>) of the HIF-2α/HIF-β bHLH-PAS heterodimer bound to DNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">3.4.  Inhibitors That Down-Regulate the Expression of HIF-1α mRNA</h3><div class="NLM_p">Aminoflavone (<b>41</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>), a ligand of AhR that is currently under investigation in a phase II clinical trial, was reported to be an inhibitor of HIF-1α mRNA expression.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> In addition, GL331 (<b>42</b>), a podophyllotoxin derivative, has been found to exhibit strong cell proliferation inhibition to many tumor cells in phase II clinical trials. GL331 was found to inhibit the expression of HIF-1α mRNA but did not cause substantial changes in HIF-1α protein.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> EZN-2968, a 16-mer locked nucleic acid (LNA) antisense oligonucleotide, is another agent that was found to selectively reduce HIF-1α mRNA expression.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> In human prostate (15PC3, PC3, and DU145) and glioblastoma (U373) cells, inhibition of HIF-1α by EZN-2968 was found to successfully attenuate HIF-1α mRNA and protein level in an oxygen concentration independent fashion, which was associated with inhibition of tumor cell growth with an IC<sub>50</sub> value of approximately 1–5 nM. Beyond this, the endogenous expression of HIF-1α mRNA in the livers of mice was found to be continuously inhibited by EZN-2968 in the nanomolar range. However, the comprehensive utilization of EZN-2968 in tumor models needs further study because of its long half-life in the liver and kidneys.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Small-molecule inhibitors that down-regulate HIF-1α mRNA expression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">3.5.  Small-Molecules That Reduce HIF-1α Protein Levels</h3><div class="NLM_p">The endogenous expression of the HIF-1α protein can be modulated by its upstream signaling pathways. For instance, the acceleration of the rate of HIF-1α protein biosynthesis induced by the PI3K-Akt-mTOR signaling pathway makes a significant difference in up-regulation of the expression of HIF-1 in human cancer cell lines. Thus, suppressing specific proteins in the PI3K-Akt-mTOR signaling pathway can indirectly inhibit the biosynthesis of HIF-1α protein. It has been reported that the HIF-1α protein synthesis process is inhibited by wortmannin (<b>43</b>, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), a PI3K-specific inhibitor, in a dose-dependent manner in the prostate cancer cells PC-3, P19, and DU145.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Further, it has been revealed that inhibition of HIF-1α by suppression of the PI3K-Akt pathway can hinder the proliferation, migration, and invasion of gastric cancer.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Additionally, KC7F2 (<b>44</b>) and rapamycin (<b>45</b>), specific mTOR1 inhibitors, have been shown to reduce both the accumulation of HIF-1α and HIF-1 dependent transcription in PC-3 prostate cancer cells.<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80−82)</a> Moreover, KC7F2 (<b>44</b>) has been shown to inhibit the proliferation of many cancer cells, an effect that is increased in hypoxic conditions, whereas nontumor cells are less sensitive.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Besides the PI3K-Akt-mTOR signaling pathway, other pathways have also been found to be capable of reducing HIF-1α protein levels. LY-294002 (<b>46</b>) has been shown to regulate the expression of the functionally BCR/ABL-induced VEGF gene by inhibiting BCR/ABL-dependent HIF-1α expression.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> This may be of benefit for treating chronic myelogenous leukemia and for developing new treatment strategies. Gefitinib (<b>47</b>), an EGFR inhibitor, was revealed to increase the proteasomal degradation and reduce the protein biosynthesis of HIF-1α; thus, it may overcome the hypoxia-induced drug resistance.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Genistein (<b>48</b>), a nonspecific kinase inhibitor, was found to completely block the biosynthesis of the HIF-1α subunit and the binding of the HIF-1 dimer to DNA in A549 lung cancer cells; this implicated <b>48</b> as a promising candidate for the treatment of lung cancer.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> PD-98059 (<b>49</b>), an inhibitor of the MEK pathway, inhibits HIF-1-mediated target gene activation.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Additionally, NS-398 (<b>50</b>), a COX-2 inhibitor, seems to facilitate to the inhibition of HIF-1α expression in both COX-2-negative HCT116 cells and COX-2-positive PC-3 cells.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Recent research has indicated that flavopiridol (<b>51</b>) down-regulates HIF-1α expression in combination with a proteasome inhibitor, a substance that causes the accumulation of HIF-1α under normal conditions. If flavopiridol treatment is combined with a proteasome inhibitor, the down-regulation of HIF-1α expression may be very promising for the treatment of cancers.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> 2ME2 (<b>52</b>) and ENMD-1198 (<b>53</b>) have been confirmed to possess potent inhibitory effects on HIF-1α translation, nuclear translocation, and downstream elements responsible for microtubule disruption; this effect was related to antiangiogenic activity.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89−91)</a> NSC-609699 (<b>54</b>), a Topo I inhibitor, has been clinically used to treat small-cell lung cancer and ovarian cancer. This study indicated that <b>54</b> decreases the expression of HIF-1α and suppresses angiogenesis and the growth of tumors in a human glioma xenograft model.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a> Representative small-molecule inhibitors that decrease the cellular levels of HIF-1α protein are summarized and listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Small Molecules That Suppress HIF-1α Expression</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">agent name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">indications<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">current status<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">wortmannin (<b>43</b>)</td><td class="colsep0 rowsep0" align="left">PI3K/Akt inhibitor</td><td class="colsep0 rowsep0" align="left">inflammatory bowel disease</td><td class="colsep0 rowsep0" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KC7F2 (<b>44</b>)</td><td class="colsep0 rowsep0" rowspan="2" align="left">mTOR complex 1 inhibitor</td><td class="colsep0 rowsep0" align="left">solid tumors</td><td class="colsep0 rowsep0" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rapamycin (<b>45</b>)</td><td class="colsep0 rowsep0" align="left">renal diseases</td><td class="colsep0 rowsep0" align="left">approved</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LY-294002 (<b>46</b>)</td><td class="colsep0 rowsep0" align="left">BCR-ABL inhibitor</td><td class="colsep0 rowsep0" align="left">leukemia</td><td class="colsep0 rowsep0" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gefitinib (<b>47</b>)</td><td class="colsep0 rowsep0" align="left">EGFR inhibitor</td><td class="colsep0 rowsep0" align="left">non-small-cell lung cancer</td><td class="colsep0 rowsep0" align="left">approved</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">genistein (<b>48</b>)</td><td class="colsep0 rowsep0" align="left">nonspecific kinase inhibitor</td><td class="colsep0 rowsep0" align="left">prostate cancer</td><td class="colsep0 rowsep0" align="left">phase II</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PD-98059 (<b>49</b>)</td><td class="colsep0 rowsep0" align="left">MEK inhibitor</td><td class="colsep0 rowsep0" align="left">stroke</td><td class="colsep0 rowsep0" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NS-398 (<b>50</b>)</td><td class="colsep0 rowsep0" align="left">COX-2 inhibitor</td><td class="colsep0 rowsep0" align="left">thrombosis and stroke</td><td class="colsep0 rowsep0" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">flavopiridol (<b>51</b>)</td><td class="colsep0 rowsep0" align="left">CDK inhibitor</td><td class="colsep0 rowsep0" align="left">multiple myeloma</td><td class="colsep0 rowsep0" align="left">phase II</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2ME2 (<b>52</b>)</td><td class="colsep0 rowsep0" rowspan="2" align="left">microtubules inhibitor</td><td class="colsep0 rowsep0" align="left">prostate cancer</td><td class="colsep0 rowsep0" align="left">discontinued</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ENMD-1198 (<b>53</b>)</td><td class="colsep0 rowsep0" align="left">solid tumors</td><td class="colsep0 rowsep0" align="left">phase I</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NSC-609699 (<b>54</b>)</td><td class="colsep0 rowsep0" align="left">Topo-I inhibitor</td><td class="colsep0 rowsep0" align="left">lung cancer</td><td class="colsep0 rowsep0" align="left">approved</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Indications and current status registered at <a href="http://integrity.thomson-pharma.com" class="ext-link">integrity.thomson-pharma.com</a>.</p></div></div></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Representative small-molecules that suppress HIF-1α expression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Decreasing HIF-1α protein stability by promoting the degradation of HIF-1α protein is also an important strategy for down-regulating the HIF-1α pathway. These kinds of small molecules increase the ubiquitination level of HIF-1α via specific pathways, thereby facilitating its subsequent degradation by proteasomes. In the upstream regulatory signaling pathway of HIF-1α, extensive research has revealed that the stability of HIF-1α is regulated by heat-shock protein 90 (Hsp90), p53-MDM2 proteins, PHDs, and so forth. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, inhibitors of the HIF-1α protein via its decreasing stability primarily included Hsp90 inhibitors, p53-MDM2 inhibitors, and PHD2 activators. Geldanamycin (GA, <b>55</b>, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) and its corresponding analogues 17-AAG (<b>56</b>) and 17-DMAG (<b>57</b>), representative Hsp90 inhibitors, can promote ubiquitination of HIF-1α independent from VHL; the subsequent degradation of HIF-1α is mediated by proteasomes in renal cell carcinoma.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94,95)</a> Furthermore, STA-9090 (<b>58</b>), a second-generation Hsp90 inhibitor, blocked HIF-1 activity and inhibits TNBC orthotopic tumor growth, invasion, and metastasis.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> In addition, the p53 tumor suppressor protein is a potent negative regulator of HIF-1α and VEGF in hypoxic conditions. RITA (<b>59</b>) was found to induce p53-dependent phosphorylation of eIF-2, and this was related to its ability to block HIF-1α induction in hypoxia.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Further, KRH102053 (<b>60</b>) and KRH102140 (<b>61</b>), potent activators of the PHD2 enzyme, have been found to efficiently suppress HIF-1α in human osteosarcoma cells under hypoxia.<a onclick="showRef(event, 'ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref97 ref98">(97,98)</a> Moreover, R59949 <b>(62</b>), an activator of HIF prolyl hydroxylases that increases the affinity of the PHD enzyme with oxygen and stimulated PHD activity,<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> is capable of inhibiting the accumulation of the HIF protein, leading to suppression of the neovascular response and prevention of glial degeneration.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitors of the HIF-1α Protein by Decreasing Its Stability</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">agent name</th><th class="colsep0 rowsep0" align="center">target</th><th class="colsep0 rowsep0" align="center">indications<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">current status<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GA (<b>55</b>)</td><td class="colsep0 rowsep0" rowspan="4" align="left">Hsp90 inhibitor</td><td class="colsep0 rowsep0" align="left">multiple myeloma</td><td class="colsep0 rowsep0" align="left">discontinued</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">17-AAG (<b>56</b>)</td><td class="colsep0 rowsep0" align="left">multiple myeloma</td><td class="colsep0 rowsep0" align="left">phase III</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">17-DMAG (<b>57</b>)</td><td class="colsep0 rowsep0" align="left">breast cancer</td><td class="colsep0 rowsep0" align="left">discontinued</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STA-9090 (<b>58</b>)</td><td class="colsep0 rowsep0" align="left">multiple myeloma</td><td class="colsep0 rowsep0" align="left">phase II</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RITA (<b>59</b>)</td><td class="colsep0 rowsep0" align="left">p53-MDM2 inhibitor</td><td class="colsep0 rowsep0" align="left">solid tumors</td><td class="colsep0 rowsep0" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KRH102053 (<b>60</b>)</td><td class="colsep0 rowsep0" rowspan="3" align="left">PHD activator</td><td class="colsep0 rowsep0" rowspan="3" align="left">solid tumors</td><td class="colsep0 rowsep0" rowspan="3" align="left">preclinical</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KRH102140 (<b>61</b>)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">R59949 (<b>62</b>)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Indications and current status registered at <a href="http://integrity.thomson-pharma.com" class="ext-link">integrity.thomson-pharma.com</a>.</p></div></div></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Representative small molecules that decrease the stability of the HIF-1α protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition, some inhibitors can probably bind to HIF-1α, thus facilitating its degradation. LW6 (<b>63</b>, <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), a novel small-molecule inhibitor of HIF-1α with an IC<sub>50</sub> value of 2.6 μM in an HRE-Luc assay in Hep3B cell lines which bears the unique adamantyl group, has been shown to decrease the stability of HIF-1α and then suppress the expression of HIF-1α target genes <i>VEGF</i> and <i>EPO</i> in a dose-dependent manner.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> Further, according to a detailed structure–activity relationship (SAR) investigation, the unique adamantyl group functions as the pharmacophoric motif responsible for the activity of <b>63</b>. On the basis of lead compound <b>63</b>, several derivatives such as isoniccotinic acid derivatives <b>64</b>–<b>66</b>, benzimidazole derivative <b>67</b>, and (<i>E</i>)-phenoxyacrylic amide derivative <b>68</b> were designed and synthesized to exert satisfactory bioactivity for directly decreasing the stability of the HIF-1α protein.<a onclick="showRef(event, 'ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref102 ref103">(102,103)</a> Further, our group reported a series of <i>N</i>-(benzofuran-5-yl)-aromatic-sulfonamide derivatives as novel HIF-1α inhibitors.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> For instance, compound <b>69</b> was shown to facilitate HIF-1α degradation and hinder the accumulation of HIF-1α protein in MCF-7 and HUVEC cells. Of particular note was that <b>69</b> could effectively suppress angiogenesis in chicken chorioallantoic membrane (CAM) model in vivo.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Later, Moreno-Manzano et al. reported that FM19G11 (<b>70</b>) down-regulates the HIF-1α protein in several tumor cells and in embryonic and adult stem cells. HRE-Luc assay in HeLa cells revealed that compound <b>70</b> exhibits significant inhibitory activity against HIF-1α with an IC<sub>50</sub> value of 2.6 μM.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Representative small molecules that facilitate HIF-1α degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12">3.6.  Small Molecules That Inhibit HIF at Multiple Pathways</h3><div class="NLM_p">PX-478 (<b>71</b>, <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>), a phase I clinical agent against advanced solid tumors, was shown to decrease the mRNA level, protein stability, translation, and transactivation activity of HIF-1α in various cancer cells under hypoxic conditions.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Compound <b>71</b> was found to be highly selective for HIF-1α when compared with HIF-2α and is considered to be a promising drug to target the chemotherapy resistance of tumors by inducing cell cycle arrest in G2 stage, promoting apoptosis, and reducing COX-2 and PD-L1 expression of esophageal squamous cell cancer cells.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a></div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Small molecule that inhibits HIF at multiple pathways.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4.  Small-Molecule Activators of HIF Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51111" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51111" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Under normoxic conditions, VHL Cullin RING E3 ubiquitin ligase complex poly-ubiquitinates the HIF-α subunit efficiently, resulting in proteasomal degradation of HIF-α.<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a> The hydroxylation of HIF-α proline residues by PHD enzymes is critical for the recognition of HIF-α by VHL. There is another process of HIF regulation that involves hydroxylation of asparagine in HIF-α CAD by FIH. The hydroxylation of asparagine prevents HIF from recruiting the transcriptional coactivator p300/CBP to the HIF-α CAD. On the basis of the HIF biological pathway, the up-regulation of the HIF pathway can be categorized as follows (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>): (1) PHD inhibitors; (2) inhibitors of the VHL:HIF-α protein–protein interaction; (3) FIH inhibitors.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Oxygen-dependent regulation process of HIF-α and the potential strategies for activating the HIF pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.1.  PHD Inhibitors</h3><div class="NLM_p">PHD enzymes primarily contain three isozymes in mammalian cells: 407-amino-acid PHD1, 426-amino-acid PHD2, and 239-amino-acid PHD3.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> Since the genes coding PHD1, PHD2, and PHD3 are isogenous with the Egl-9 gene of the nematode, these three isoforms were respectively named EGLN2, EGLN1, EGLN3.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> A fourth isoform, PHD4, has been reported; however its function is much less elucidated.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> PHDs show a clear intracellular distribution pattern: PHD1 is primarily distributed in the nucleus, PHD2 is mainly distributed in the cytoplasm, and PHD3 is found both in the nucleus and cytoplasm.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> PHDs belong to the non-heme Fe(II)-containing dioxygenase family; 2-oxoglutarate (2-OG) and oxygen are adopted as substrates, and ascorbate and iron are used as cofactors. Under normoxia, PHDs hydroxylate certain proline residues of HIF-α (Pro402 and Pro564 of HIF-1α, Pro531 of HIF-2α, and Pro490 of HIF-3α) in the ODD region. Subsequently, p-VHL, which is critical in the process of recognizing the ubiquitin ligase complex, will bind to the hydroxylated HIF-α to initiate the proteasomal degradation of HIF-α. It is worth noting that all three isoforms of the PHD1–3 subunits can hydroxylate residue Pro564 of HIF-1α, but residue Pro402 can only be hydroxylated by PHD1 and PHD2. In addition, the <i>K</i><sub>m</sub> values of PHD1 and PHD2 for residue Pro402 are much higher than for Pro564, indicating that Pro564 plays a significant role in HIF regulation by PHDs, as compared to residue Pro402.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> More importantly, the <i>K</i><sub>m</sub> values of HIF PHDs for oxygen ranged from 230 μM to 250 μM, as reported. This is only little higher than the concentration of oxygen which is physiologically dissolved at atmospheric pressure (nearly 200 μM),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> suggesting that PHDs are effective and sensitive oxygen sensors.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Therefore, PHD inhibitors can efficiently up-regulate HIF levels.</div><div class="NLM_p">It has been revealed that PHD1/3 exhibits tissue-specific expression, while PHD2 is the most widely distributed subtype and of the most significance in preserving steady-state levels of HIF-α.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117,118)</a> Moreover, researchers have revealed that hypoxia affects PHD1 expression probably via a non-HRE-mediated manner, while two PHD1 isoforms have been identified in the nucleus, each showing a different function in cell proliferation.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Since PHD2 plays a crucial role in controlling the HIF-α content in mammalian cells, it has been considered as a promising target for treating numerous conditions related to HIF, including ischemia, stroke, and inflammation. The complex structure of PHD2 with HIF-1α CODD and endogenous 2-OG has been determined (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>), this provides a structural biology foundation for the exploration of target small-molecule inhibitors. PHD2 forms a stable complex with HIF-1α CODD, which is composed of a ligand 2-OG and a cofactor ferrous ion; the Pro564 residue that is close to the carboxyl of 2-OG of HIF-1α can recognize the catalytic pocket of PHD2 (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>A).<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. (A) Crystal structures of the PHD2 (red) and HIF-1α peptide substrate (green) complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR">3HQR</a>). (B) Crystal structure of PHD2 and 2-OG complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ">3OUJ</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mechanically, PHDs require 2-oxoglutarate,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Fe(II), and O<sub>2</sub> for their catalytic activities to hydroxylate HIF-α. On the basis of this, compounds that affect the concentration of O<sub>2</sub>, Fe(II), and 2-OG or their binding to PHD2<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> can obviously inhibit the hydroxylation function of PHD2, thereby up-regulating HIF levels. PHD2 has been identified as a promising therapeutic target in erythropoiesis and iron metabolism. Up to now, many small-molecule PHD2 inhibitors have been explored, and these mainly fall into two categories: (1) noncompetitive and nonselective iron chelators and (2) competitive and selective 2-OG mimetics. Representative examples of iron chelators include deferoxamine (DFO, <b>72</b>), 3,4-dihydroxybenzoic acid (DHB, <b>73</b>), and 1,10-phenanthroline (<b>74</b>). These iron chelators can chelate with Fe(II), reduce the concentration of ferrous iron, hinder PHD catalytic activity, stabilize the HIF-α, and up-regulate of the expression of EPO, VEGF, and transferrin receptor.<a onclick="showRef(event, 'ref122 ref123'); return false;" href="javascript:void(0);" class="ref ref122 ref123">(122,123)</a> However, iron chelators lack selectivity as they can interact with all iron-containing proteins; this may cause toxic side effects such as heart failure, liver cirrhosis, and fibrosis. Consequently, competitive and selective PHD inhibitors have been developed. Almost all of the reported PHD2 inhibitors are 2-OG derivatives or mimetics, sharing key pharmacophores similar to the binding mode of 2-OG with the PHD2 enzyme (<a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>B).<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a> and <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a></a>, with the example of FG-2216 (<b>75</b>),<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> a ferrous iron (Fe<sup>2+</sup>) coordination fragment and a fragment that forms ionic bonds with Arg383 are both essential for FG-2216’s inhibitory activity against PHDs.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Recently, IOX-2 (<b>76</b>) was developed; this potent PHD2 up-regulates endogenous EPO with high affinity (IC<sub>50</sub> = 22.0 nM).<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Further studies revealed that IOX-4 (<b>77</b>), a promising PHD2 inhibitor, induces HIF-α in human cells (HeLa, Hep3B, and RCC4) and in the brain tissue of wild-type mice, thereby stabilizing HIF for treating cerebral diseases such as stroke.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> To date, at least six PHD2 inhibitors have been examined in clinical studies in humans (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and have shown clinically meaningful effects for the up-regulation of erythropoietin via stabilization of HIF-α, thereby providing a promising strategy for treating anemia induced by CKD.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> The reported structures are shown in <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>, including FG-2216 (<b>75</b>), FG-4592 (roxadustat) (<b>78</b>), AKB-6548 (vadadustat) (<b>79</b>), GSK-1278863 (daprodustat) (<b>80</b>), BAY-85-3934 (molidustat) (<b>81</b>),<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> and JTZ-951 (<b>82</b>).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> Clinical trial of FG-4592 has just been completed in China to explore the safety and efficacy of this compound in patients with anemia associated with CKD, including patients who were dialysis-dependent (DD) and those who were not dialysis-dependent (NDD). The clinical data indicated that FG-4592 is an orally active PHD inhibitor that can be used therapeutically for the treatment of anemia in CKD patients. Recent studies indicated that FG-4592 could potentially correct anemia with an acceptable safety profile, regardless of inflammation or initial iron repletion status. Besides, it can reduce hepcidin and cholesterol levels in patients with NDD-CKD.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Clinical trials of representative small-molecule inhibitors of PHD are summarized and listed in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of representative small-molecule inhibitors of PHD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Crystal structure of the PHD2 and FG-2216 (<b>75</b>) complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT">2HBT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Clinical Trial Information of Small-Molecule PHD Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">molecule</th><th class="colsep0 rowsep0" align="center">phase</th><th class="colsep0 rowsep0" align="center">NCT ref</th><th class="colsep0 rowsep0" align="center">study design</th><th class="colsep0 rowsep0" align="center">treatment duration</th><th class="colsep0 rowsep0" align="center">renal disease category<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FG-4592 roxadustat (ASP-1517)</td><td class="colsep0 rowsep0" align="left">approved 12/2018</td><td class="colsep0 rowsep0" align="left">02278341</td><td class="colsep0 rowsep0" align="left">randomized open label verus epoetin α and darbepoetin α, 838 patients</td><td class="colsep0 rowsep0" align="left">4 years (11/2014–7/2018)</td><td class="colsep0 rowsep0" align="left">stable HD or PD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">03303066</td><td class="colsep0 rowsep0" align="left">randomized quadruple verus placebo 175 patients</td><td class="colsep0 rowsep0" align="left">3 years (11/2017–12/2020)</td><td class="colsep0 rowsep0" align="left">MDS or risk with <5% blasts</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">03263091</td><td class="colsep0 rowsep0" align="left">randomized quadruple verus placebo 184 patients</td><td class="colsep0 rowsep0" align="left">1–3 years (9/2017–3/2019)</td><td class="colsep0 rowsep0" align="left">MDS or IPSS-R with <5% blasts</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKB-6548 vadadustat</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">02865850</td><td class="colsep0 rowsep0" align="left">randomized open label verus dabepoetin α, 400 patients</td><td class="colsep0 rowsep0" align="left">3 years (7/2016–9/2019)</td><td class="colsep0 rowsep0" align="left">DD-CKD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">02892149</td><td class="colsep0 rowsep0" align="left">randomized open label verus dabepoetin α, 90 patients</td><td class="colsep0 rowsep0" align="left">3 years (8/2016–8/2019)</td><td class="colsep0 rowsep0" align="left">DD-CKD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">03329196</td><td class="colsep0 rowsep0" align="left">randomized open label verus MT-6548 and darbepoetin α, 300 patients</td><td class="colsep0 rowsep0" align="left">3 years (10/2017–5/2020)</td><td class="colsep0 rowsep0" align="left">NDD-CKD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK1278863 daprodustat</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">02829320</td><td class="colsep0 rowsep0" align="left">randomized single-blind verus iron, 252 patients</td><td class="colsep0 rowsep0" align="left">24 weeks (8/2016–1/2018)</td><td class="colsep0 rowsep0" align="left">stable HD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">02879305</td><td class="colsep0 rowsep0" align="left">randomized double verus placebo and iron therapy, placebo, rhEPO 3000 patients</td><td class="colsep0 rowsep0" align="left">4 years (9/2016–5/2020)</td><td class="colsep0 rowsep0" align="left">anemia</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BAY-85-3934 molidustat</td><td class="colsep0 rowsep0" align="left">III</td><td class="colsep0 rowsep0" align="left">02064426</td><td class="colsep0 rowsep0" align="left">long-term extension of NCT 01975818</td><td class="colsep0 rowsep0" align="left">≤3 years (6/2014–11/2018)</td><td class="colsep0 rowsep0" align="left">stable HD</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">03350321</td><td class="colsep0 rowsep0" align="left">randomized open label verus molidustat and darbepoetin α, 150 patients</td><td class="colsep0 rowsep0" align="left">≤3 years (2/2017–10/2019)</td><td class="colsep0 rowsep0" align="left">anemia and renal insufficiency</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">03543657</td><td class="colsep0 rowsep0" align="left">randomized quadruple verus darbepoetin α, placebo of darbepoetin α, 225patients</td><td class="colsep0 rowsep0" align="left">1 years (6/2018–11/2019)</td><td class="colsep0 rowsep0" align="left">anemia and renal insufficiency</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">CKD, chronic kidney disease; Hb, hemoglobin; HD, hemodialysis; PD, peritoneal dialysis; DD, dialysis-dependent; NDD, non-dialysis-dependent; NA, no active studies registered at <a href="http://ClinicalTrials.gov" class="ext-link">ClinicalTrials.gov</a>.</p></div></div></div><div class="NLM_p">In addition, several new potent PHD inhibitors have been reported in recent years. On the basis of AS-MS screening methodology, Hale et al. reported a series of triazaspiro[4.5]decanones as potent PHD inhibitors; these compounds have great clinical potential due to their short-acting PHD inhibition, leading to great downstream in vivo efficacy.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Most recently, our group reported a series of triazole-containing picolinoylglycines as new PHD2 inhibitors using a click-chemistry based strategy. Notably, the orally active inhibitor <b>83</b> has an IC<sub>50</sub> of 62.3 nM, as determined by an FP assay, which is almost 10 times more potent in vitro than the recently approved drug FG-4592.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Compound <b>83</b> can stabilize HIF-α to stimulate EPO formation, thereby up-regulating hemoglobin to normal levels in cisplatin-induced anemic mice; this was associated with favorable safety profiles for treating anemia.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a></div><div class="NLM_p">Further, Merck recently used a high throughput screen method to report on a novel class of PHD pan inhibitors with promising pharmacokinetics and pharmacodynamics. The representative example was MK-8617 (<b>84</b>) with an encouraging IC<sub>50</sub> value of 1.0 nM for PHD2 inhibition, as measured in time-resolved fluorescence (TRF) assay;<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> the structure of this compound is totally different from the above-mentioned inhibitors as it is missing the carbonyl acid moiety. Molecular modeling studies revealed that the heterobiaryl moieties of <b>84</b> chelate Fe<sup>2+</sup> and one of the methoxy substituted aryl rings stacking over Arg322 attributed to cation−π interaction with the Arg322 residue of PHD2 (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Moreover, MK-8617 has shown improved potency and bioavailability in rats and its <i>t</i><sub>1/2</sub> determined in monkeys is 10–19 h, suggesting that it has preferable pharmacological and pharmacokinetic properties for targeting PHD in vivo.</div><div class="NLM_p">In comparison to PHD2 inhibitors, PHD1 inhibitors have been less studied. Recently, Ahmed et al. reported a series of 1,2,4-triazolo[1,5-<i>a</i>]pyridines, exemplified by compound <b>85</b> with an IC<sub>50</sub> value of 34 nM, to be PHD1 enzyme inhibitors.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> X-ray crystallography revealed that these PHD1 inhibitors can chelate with Fe<sup>2+</sup> ion by the triazole N1 atom in a previously undiscovered monodentate mode (<a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>); the benzonitrile group then interacts and binds with hydrogen from the Asn315 residue. Notably, compared with most of the reported PHD inhibitors, this PHD1 inhibitor has superior bioactivity with preferable oral exposure both in the CNS and peripherally, making it a promising potent candidate for the in vivo study of the pharmacological influence of PHD inhibition.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Crystal structure of the PHD1 and <b>85</b> complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5%2520V1B">5 V1B</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.2.  Inhibitors of the VHL:HIF-α Protein–Protein Interaction</h3><div class="NLM_p">Under normoxia, HIF-1α and HIF-2α are efficiently polyubiquitinated by VHL E3 ubiquitin ligase, subsequently undergoing proteasomal degradation.<a onclick="showRef(event, 'ref137 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref137 ref138 ref139">(137−139)</a> The hydroxylation of catalytically essential proline residues in the ODD of HIF-α (such as Pro<sup>402</sup> and Pro<sup>564</sup>) by oxygen-dependent PHD enzymes is critical to the highly specific HIF-α recognition by pVHL. Thus, disruption of the HIF-α/VHL interaction results in elevation of HIF gene expression and increases in the concentration of endogenous EPO for treating CKD anemia.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> The blockade of HIF-α degradation by small-molecule inhibitors via disruption of the HIF-α/VHL interaction has proved a feasible method in recent research.<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Compared with PHD inhibitors, these inhibitors may effectively prevent the off-target effects independent of HIF. Further, studies indicate that the HyP-564 residue on HIF-1α exhibits a key interaction with VHL which is pivotal for HIF-1α binding.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Both molecular growing and docking strategies have been explored to guide the choice of optimal hydroxyproline analogues.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Ciulli et al. performed a fluorescent probe-based analysis and revealed that compound <b>86</b> (<a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>) possesses a considerable ability to bind to the VHL protein.<a onclick="showRef(event, 'ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref144 ref145">(144,145)</a> Encouraged by the preliminary results, they set out to increase the binding affinity of <b>86</b> through structure–activity relationship studies and structural modifications. As a result, the methylthiazolyl compound <b>87</b> turned out to be the optimal compound in vitro; it was demonstrated to target the VHL protein with an IC<sub>50</sub> of 0.9 μM in the FP assay.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Small-molecule inhibitors of the VHL:HIF-α protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">However, these molecules that were found to bind to p-VHL with moderate potency had very low log <i>P</i> values because their HyP cores is quite hydrophilic; this is detrimental to cell functioning. Small-molecules should bind to VHL very tightly so that they can compete with great affinity for hydroxylated HIF-α in cultured cells, thereby up-regulating HIF-related responses in cells. Recently, Ciulli et al. reported a series of VHL ligands based on isothermal titration calorimetry (ITC) assay and X-ray crystal structures.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> The potent VHL:HIF-α inhibitor <b>88</b> displayed binding affinities at the nanomolar level and increased potency of lipophilicity, which provided a good starting point to verify the inhibition of VHL as a target of drug.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Further, a highly potent and selective VHL inhibitor, VH298 (<b>89</b>), has been described by Ciullis’s group to trigger an effective HIF-α hydroxylation response in the signaling cascade related to hypoxia in various cell lines, including HeLa, U2OS, and CTL.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> The ITC assay was applied to quantify the binding of VH298 to VHL, and the resulting <i>K</i><sub>d</sub> value was 90 nM. This is the most potent inhibitor of the VHL:HIF-α interaction reported to date. VH298 is a first-class compound that selectively stabilizes hydroxylated HIF-α. It exhibits great affinity and specificity with VHL as its special cellular target; this leads to the accumulation of hydroxylated HIF-α inside cells in a time- and concentration-dependent manner. Subsequently, up-regulation of HIF-target genes at both the protein and mRNA level occurs.</div><div class="NLM_p">Importantly, the VHL:HIF-α inhibitors represented by VH298 could be regarded as promising chemical probes for therapeutic application against diseases associated with a hypoxic response.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Recently, structural biological studies have revealed the crystal structure of pVHL and hydroxylated HIF-1α CODD peptide complex (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>A)<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> as well as the crystal structure of VH298 (<b>89</b>) in complex with VHL:ElonginB:ElonginC (VBC) (<a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>B).<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> This has motivated the development of the next-generation of inhibitors that can interrupt the VHL:HIF-α protein–protein interaction.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Moreover, researchers have recently suggested that bifunctional proteolysis targeting chimeras (PROTACs) bearing a potent VHL ligand can induce degradation of target proteins by hijacking E3 ligase activity. Considering both the structure–activity relationship and the cellular permeability of VH298 analogues, researchers have recently developed new chemical strategies for probing the VHL-HIF signaling pathways and optimized VHL ligands for the next-generation PROTACs.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> CM11 (<b>90</b>) has been identified as the most active compound in vitro, exhibiting high avidity to dimerize VHL; it also triggers prominent, efficient, and self-degradation of VHL mediated by proteasomes in various cells. This occurs in a highly isoform-selective manner without inducing a hypoxic response.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> These findings expand our understanding of the currently available PROTAC-type scaffolds that could be beneficial for targeted degradation of various other therapeutically proteins.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. (A) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LQB">1LQB</a>) of the pVHL and hydroxylated HIF-1α CODD peptide complex. (B) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LLI">5LLI</a>) of the VBC and VH298 (<b>89</b>) complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.3.  FIH Inhibitors</h3><div class="NLM_p">In addition to the aforementioned PHD enzymes, FIH is another important 2-OG oxygenase involved in HIF hydroxylation. FIH hydroxylates a certain asparagine residue (Asn803 for HIF-1α) in the C-TAD of HIF-α isoforms. This asparaginyl hydroxylation has clearly been shown to hamper the interaction between p300 and HIF-1α.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Recent studies have revealed that FIH is much more sensitive to HIF-1α than PHDs under hypoxic conditions; thus FIH inhibitors can be regarded as chemotherapeutic agents in treating ischemic disease by targeting normal cells that are stressed by hypoxia.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Furthermore, PHDs may be able to stimulate unwanted angiogenesis and glycolysis in normoxia cells, whereas FIH-specific inhibition will not lead to these problems because FIH only hydroxylates the hypoxia-stabilized HIF-1α.</div><div class="NLM_p">The crystal structure of the FIH and HIF-1α peptide complex has already been reported (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>A).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Similar to PHD enzymes, the active site of FIH contains the substrate 2-OG and a Fe(II) that is coordinated by three protein side chains: His199, Asp201, and His279 (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>B).<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Initially, Fe(II) chelators, including pyridines (<b>91</b>, <b>92</b>), catechols (<b>93</b>, <b>94</b>), and hydroxypyrones/hydroxypyridines (<b>95</b>–<b>98</b>) (<a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>), were identified as nonselective FIH inhibitors.<a onclick="showRef(event, 'ref154 ref155'); return false;" href="javascript:void(0);" class="ref ref154 ref155">(154,155)</a> Further, based on the crystal structure of the FIH-Fe(II)-2OG complex (<a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>B), <i>N</i>-oxalylamino acids with hydrophobic side chain, such as <i>N</i>-oxalyl-<span class="smallcaps smallerCapital">d</span>-phenylalanine (<b>99</b>) and dimethyl-<i>N</i>-oxalyl-<span class="smallcaps smallerCapital">d</span>-phenylalanine (<b>100</b>), appear be a class of selective inhibitors for FIH.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> The apparent <i>K</i><sub>i</sub> of FIH for <b>99</b> is about 83 μM, as determined with an assay using the HIF-1R786-826 peptide fused with glutathione <i>S</i>-transferase (GST) as the substrate. In addition, compound <b>99</b> was found to be a competitive FIH inhibitor related to the structure of <i>N</i>-oxalylglycine (NOG), an analogue of 2-OG. These structures may be promising for further discovery of selective inhibitors of FIH, enabling up-regulation of specific genes that are responsive to the hypoxic condition.</div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. (A) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JWP">5JWP</a>) of the FIH (yellow), HIF-1α peptide (green), and 2-OG complex. (B) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MZF">1MZF</a>) of the FIH and 2-OG complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of small-molecule inhibitors of FIH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">5.  Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The close relationship between HIFs and angiogenesis, erythropoiesis, and tumor growth has been clearly demonstrated; thus, modulation of the HIF pathway is an attractive and effective therapeutic strategy for a variety of diseases. The past 20 years have witnessed the discovery of a large number of HIF small-molecule modulators; these can be classified into small-molecule inhibitors and small-molecule activators. Due to the complexity of the HIF regulatory mechanism, there are many different reported strategies for suppressing the HIF pathway. Inhibition of HIF-1 and inhibition of HIF-2 are the principal methods for HIF down-regulation. Indirect regulators, such as LW6 derivatives and PX-478 (<b>71</b>, <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>), suppress hypoxia-induced transcriptional activity by reducing the level of HIF protein through modulation of HIF-α translation or through affecting its stabilization. However, the indirect inhibition of HIF-1 influences critical physical processes and the normal activity of tissue. During the past decade, there has been significant efforts directed toward the search for potent direct HIF-1 inhibitors. Chetomin derivatives and KCN (<b>21</b>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) directly inhibit the HIF-1α/p300 interaction without affecting intracellular HIF-1α levels. They are able to minimize in vivo toxicity, indicating their potential utility for the treatment of vascular disease and cancers. Additionally, it has been confirmed that HIF-1 inhibitors regulate cancer metabolism, but only a few studies involving detailed function of HIF-1 in cancer metabolism have been reported. Therefore, further studies in the field of HIF inhibitors in cancer metabolism are necessary in order to understand their exact mode of action as for cancer therapy.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><div class="NLM_p">Furthermore, direct and selective targeting of HIF-α proteins, HIF-1α and HIF-2α, by small molecules is another promising field for therapeutic applications given that the HIF-1α and HIF-2α subtypes have been found to exhibit different biological functions. For example, HIF-2α, but not HIF-1α, is considered as a crucial factor involved in the development and progression of clear cell RCC, which is quite common in renal cancer. However, the HIF-1α and HIF-2α subtypes share 48% amino acid homology, which hinders the potential for developing subtype-selective small-molecule inhibitors. Recently, PT2385 (<b>32</b>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>), a potent and selective HIF-2α inhibitor, has exhibited promising results in phase I clinical studies; this compound shows promise for the development of HIF-2α targeting anticancer agent. All in all, with the development of HIF inhibitors, most of them exhibited off-target effects by interfering with other cell signaling, such as DNA replication and cell division. To address these critical issues, it is crucial to explicate whether these small-molecule inhibitors work against HIF-1α or HIF-2α or whether they have particular selectivity in tumor cells; this would assist in achieving an optimal therapeutic effect.</div><div class="NLM_p">On the other hand, with regard to HIF up-regulation, inhibition of PHD and inhibition of VHL are considered to be the most attractive strategies for up-regulating the HIF pathway. These strategies have significant potential for treating a variety of ischemic diseases in specific tissues, including renal anemia and stroke. Recently, several PHD inhibitors have been developed based on the endogenous 2-OG mimetic approach. These have been developed for treating CKD anemia. Evidence from clinical practice has demonstrated that these compounds have promising treatment effects for CKD patients via stimulation of EPO production. FG-4592 (<b>78</b>, <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>) is a first-in-class pan PHD inhibitor developed by FibroGen for the treatment of CKD anemia. More pleasingly still, FG-4592 (roxadustat) was approved in China in December 2018 by the National Medical Products Administration (NMPA) for the treatment of CKD anemia. Besides its role in treating CKD anemia, FG-4592 could also be applied for the treatment of acute kidney injury (AKI) and Parkinson’s diseases via regulation of redox biology and mitochondrial function.<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158,159)</a> Huang et al. demonstrated that epidermal stem cell proliferation and motility can be promoted by FG-4592 via HIF-1α stabilization, and wound healing can be meanwhile accelerated in vivo. Thus it is identified as a promising new candidate for wound care.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> However, most current PHD inhibitors lack selectivity for PHD subtypes and have broad-spectrum HIF activating activities on the body; this may complicate their role in cancer promotion.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Interestingly, recent studies have revealed that global selective haplodeficient inactivation of PHD2 in endothelial cells does not contribute to primary tumor growth, but it rather suppresses cancer cell invasion and metastasis by impairing activation of cancer-associated fibroblasts (CAFs) both in vitro and in vivo.<a onclick="showRef(event, 'ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref162 ref163">(162,163)</a> Considering that patients with CKD anemia may be medicated long-term with pan PHD inhibitors such as FG-4592, the development of selective PHD2 inhibitors may be a promising direction in future for anemia treatment with low risk of cancer promotion, especially for chemotherapy-associated anemia in cancer patients.</div><div class="NLM_p last">With respect to HIF-α degradation, which is dependent on ubiquitination through the VHL E3 ligase protein, inhibition of the VHL and HIF-α interaction could result in selective accumulation of HIF-α, leading to up-regulation of HIF target genes. VH298 (<b>89</b>, <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>), a potent VHL inhibitor, is a high-quality chemical probe for suppressing the HIF signaling cascade. Recent studies have illustrated that VH298 can accelerate healing of entheses in rats by inhibiting the ubiquitination of hydroxy-HIF-1α.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Hence, it is usually used as a starting point for developing potential novel therapeutics targeting hypoxia via inhibition of the VHL/HIF-α interaction. Recently, homo-PROTACs of VHL have been reported using two ligands of VHL inhibitors; one such compound is compound <b>90</b>. This compound exhibits high binding affinity and triggers prominent and efficient self-degradation of VHL in specific cells. This evidence suggests that homo-PROTACs will be a promising new strategy for up-regulating the HIF system, especially due to their HIF-independent roles. We supposed that small-molecule ligands of VHL for targeting specific-protein degradation will be of worthy of much more attention by medicinal chemists, chemical biologists, and drug developers alike. FIH, another 2OG-dependent non-heme iron enzyme, acts in concert with the PHD/VHL pathway to facilitate the metabolic response to hypoxia medidated by HIF.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Further studies related to the effects of FIH on oxidative metabolism are necessary in order to understand their exact mode of action for application in cancer therapy. It is clear that the functions of HIFs and their subtype regulatory mode of action are complicated, and further biological and pharmacologic research is required to improve our understanding. Future work is warranted to uncover more specific and subtype-selective small-molecule modulators of HIF, known as HIF inhibitors and activators, in order to promote the development of specific targeted therapies.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01596" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qidong You</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8587-0122" title="Orcid link">http://orcid.org/0000-0002-8587-0122</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1d8ced4d0c5e19097928fc2cecc"><span class="__cf_email__" data-cfemail="740d1b010510344542475a171b19">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojin Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, School of Science, China Pharmaceutical
University, Nanjing 211198, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1898-3071" title="Orcid link">http://orcid.org/0000-0002-1898-3071</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89f3f1e3c9eaf9fca7ecedfca7eae7"><span class="__cf_email__" data-cfemail="c9b3b1a389aab9bce7acadbce7aaa7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhihong Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of
Drug Design and Optimization, China Pharmaceutical
University, Nanjing 210009, China</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Chemistry, School of Science, China Pharmaceutical
University, Nanjing 211198, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1548-8996" title="Orcid link">http://orcid.org/0000-0003-1548-8996</a></span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32754" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32754" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Zhihong Li</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=BIO-d7e2228-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhihong Li</b> received his Bachelor’s degree from China Pharmaceutical University. Currently, he is a Master student majoring in Medicinal Chemistry under the supervision of Associate Professor Xiaojin Zhang, Department of Chemistry, China Pharmaceutical University. His research topic focuses on rational design of HIF activators by inhibiting the 2-OG oxygenases including PHDs and FIH.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Qidong You</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=BIO-d7e2233-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Qidong You</b> received his Bachelor’s degree from the Nanjing College of Pharmacy in 1982 and his Ph.D. in Medicinal Chemistry from Shanghai Institute of Pharmaceutical Industry in 1989. Currently, he is a Professor of Medicinal Chemistry and the Director of Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University. His current research interests focus on structure-based and natural product-based new drug design and discovery.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Xiaojin Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=BIO-d7e2238-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiaojin Zhang</b> received his Bachelor’s degree from China Pharmaceutical University, where he also earned his Ph.D. in Medicinal Chemistry under the supervision of professor Qidong You. Currently, he is an Associate Professor of Medicinal Chemistry and the Deputy Director of the Department of Chemistry, China Pharmaceutical University. His main research interests lie in the rational design, discovery, and chemical biology studies of small-molecule modulators that target cell redox system and oxygen-sensing system.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by grants from the National Natural Science Foundation of China (Grant 81773571), Jiangsu Province Funds for Excellent Young Scientists (Grant BK20170088), the Fundamental Research Funds for the Central Universities (Grant 2632017ZD03), and the Jiangsu Qing Lan Project and 333 Project.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AhR</td><td class="NLM_def"><p class="first last">aryl hydrocarbon receptor</p></td></tr><tr><td class="NLM_term">ARNT</td><td class="NLM_def"><p class="first last">aryl hydrocarbon receptor nuclear translocator</p></td></tr><tr><td class="NLM_term">AKI</td><td class="NLM_def"><p class="first last">acute kidney injury</p></td></tr><tr><td class="NLM_term">b-HLH</td><td class="NLM_def"><p class="first last">basic helix–loop–helix domain</p></td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">coactivator protein CREB binding protein</p></td></tr><tr><td class="NLM_term">CODD</td><td class="NLM_def"><p class="first last">carboxyl terminal oxygen-dependent degradation domain</p></td></tr><tr><td class="NLM_term">CKD</td><td class="NLM_def"><p class="first last">chronic kidney disease</p></td></tr><tr><td class="NLM_term">C-TAD</td><td class="NLM_def"><p class="first last">C-terminal transactivation domain</p></td></tr><tr><td class="NLM_term">CH1</td><td class="NLM_def"><p class="first last">cysteine histidine-rich domain</p></td></tr><tr><td class="NLM_term">DD</td><td class="NLM_def"><p class="first last">dialysis-dependent</p></td></tr><tr><td class="NLM_term">EPO</td><td class="NLM_def"><p class="first last">erythropoietin</p></td></tr><tr><td class="NLM_term">HIF</td><td class="NLM_def"><p class="first last">hypoxia-inducible factor</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat-shock protein 90</p></td></tr><tr><td class="NLM_term">FIH</td><td class="NLM_def"><p class="first last">factor inhibiting HIF</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">Hb</td><td class="NLM_def"><p class="first last">hemoglobin</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">Hyp</td><td class="NLM_def"><p class="first last">hydroxyproline</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">hemodialysis</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">HRE</td><td class="NLM_def"><p class="first last">hypoxic response element</p></td></tr><tr><td class="NLM_term">NMPA</td><td class="NLM_def"><p class="first last">National Medical Products Administration</p></td></tr><tr><td class="NLM_term">ODD</td><td class="NLM_def"><p class="first last">oxygen-dependent degradation domain</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">peritoneal dialysis</p></td></tr><tr><td class="NLM_term">PHD</td><td class="NLM_def"><p class="first last">prolyl hydroxylase domain</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">Per-ARNT-Sim</p></td></tr><tr><td class="NLM_term">NODD</td><td class="NLM_def"><p class="first last">amino terminal oxygen-dependent degradation domain</p></td></tr><tr><td class="NLM_term">NDD</td><td class="NLM_def"><p class="first last">nondialysis-dependent</p></td></tr><tr><td class="NLM_term">N-TAD</td><td class="NLM_def"><p class="first last">N-terminal transactivation domain</p></td></tr><tr><td class="NLM_term">RCC</td><td class="NLM_def"><p class="first last">renal cell carcinoma</p></td></tr><tr><td class="NLM_term">RACK</td><td class="NLM_def"><p class="first last">activated protein kinase</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">TNBC</td><td class="NLM_def"><p class="first last">triple-negative breast cancer</p></td></tr><tr><td class="NLM_term">2-OG</td><td class="NLM_def"><p class="first last">2-oxoglutarate</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">no active studies registered at <a href="http://ClinicalTrials.gov" class="ext-link">ClinicalTrials.gov</a></p></td></tr><tr><td class="NLM_term">VHL</td><td class="NLM_def"><p class="first last">the Von Hippel–Landau E3 ligase</p></td></tr><tr><td class="NLM_term">VBC complex</td><td class="NLM_def"><p class="first last">VHL:ElonginB:ElonginC complex</p></td></tr><tr><td class="NLM_term">USP9X</td><td class="NLM_def"><p class="first last">ubiquitin-specific protease 9X</p></td></tr><tr><td class="NLM_term">VEGF</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor</p></td></tr><tr><td class="NLM_term">CAF</td><td class="NLM_def"><p class="first last">cancer-associated fibroblast</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22888" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22888" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 165 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">The human oxygen sensing machinery and its manipulation</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1039/b701676j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2Fb701676j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18568157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFejsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=1308-1319&issue=7&author=R.+Chowdhuryauthor=A.+Hardyauthor=C.+J.+Schofield&title=The+human+oxygen+sensing+machinery+and+its+manipulation&doi=10.1039%2Fb701676j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The human oxygen sensing machinery and its manipulation</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; Hardy, Adam; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1308-1319</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Animals respond to the challenge of limited oxygen availability by a coordinated response that works to increase oxygen supply and minimize tissue damage.  The chronic hypoxic response is mediated by the α,β-hypoxia inducible transcription factor (HIF) that enables the expression of a gene array.  Because this array includes genes encoding for proteins that regulate processes including red blood cell and blood vessel formation, manipulation of the HIF system has potential for the treatment of ischemic diseases, anemia and tumors.  Hydroxylase enzymes act as oxygen sensors by regulating both the lifetime of HIF-α and its transcriptional activity.  This tutorial review aims to provide a non-expert introduction to the HIF field by providing a background to current work, summarizing mol. knowledge on the HIF system, and outlining opportunities for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ryJk6Dq22LVg90H21EOLACvtfcHk0lg2P_rVUxxl2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFejsLg%253D&md5=0065a2e7f0c71d834cda758fd6bb3437</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1039%2Fb701676j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb701676j%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DHardy%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520human%2520oxygen%2520sensing%2520machinery%2520and%2520its%2520manipulation%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26issue%3D7%26spage%3D1308%26epage%3D1319%26doi%3D10.1039%2Fb701676j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B.Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klco, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickols, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervan, P. B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">16768</span>– <span class="NLM_lpage">16773</span>, <span class="refDoi"> DOI: 10.1073/pnas.0407617101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0407617101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15556999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16768-16773&issue=48&author=B.Z.+Olenyukauthor=G.+J.+Zhangauthor=J.+M.+Klcoauthor=N.+G.+Nickolsauthor=W.+G.+Kaelinauthor=P.+B.+Dervan&title=Inhibition+of+vascular+endothelial+growth+factor+with+a+sequence-specific+hypoxia+response+element+antagonist&doi=10.1073%2Fpnas.0407617101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist</span></div><div class="casAuthors">Olenyuk, Bogdan Z.; Zhang, Guo-Jun; Klco, Jeffery M.; Nickols, Nicholas G.; Kaelin, William G., Jr.; Dervan, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16768-16773</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) and its receptors have been implicated as key factors in tumor angiogenesis that are up-regulated by hypoxia.  We evaluated the effects of DNA-binding small mols. on hypoxia-inducible transcription of VEGF.  A synthetic pyrrole-imidazole polyamide designed to bind the hypoxia response element (HRE) was found to disrupt hypoxia-inducible factor (HIF) binding to HRE.  In cultured HeLa cells, this resulted in a redn. of VEGF mRNA and secreted protein levels.  The obsd. effects were polyamide-specific and dose-dependent.  Anal. of genome-wide effects of the HRE-specific polyamide revealed that a no. of hypoxia-inducible genes were downregulated.  Pathway-based regulation of hypoxia-inducible gene expression with DNA-binding small mols. may represent a new approach for targeting angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHMJXCJLFfbVg90H21EOLACvtfcHk0lg2P_rVUxxl2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansrzF&md5=771a32718ed7b951effab51bd04565b6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407617101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407617101%26sid%3Dliteratum%253Aachs%26aulast%3DOlenyuk%26aufirst%3DB.Z.%26aulast%3DZhang%26aufirst%3DG.%2BJ.%26aulast%3DKlco%26aufirst%3DJ.%2BM.%26aulast%3DNickols%26aufirst%3DN.%2BG.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26aulast%3DDervan%26aufirst%3DP.%2BB.%26atitle%3DInhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520with%2520a%2520sequence-specific%2520hypoxia%2520response%2520element%2520antagonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D48%26spage%3D16768%26epage%3D16773%26doi%3D10.1073%2Fpnas.0407617101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span> <span> </span><span class="NLM_article-title">Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1517/17460441.2013.796358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1517%2F17460441.2013.796358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23642028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOitL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=965-976&issue=8&author=Y.+Higashijimaauthor=T.+Tanakaauthor=M.+Nangaku&title=Structure-based+drug+design+for+hypoxia-inducible+factor+prolyl-hydroxylase+inhibitors+and+its+therapeutic+potential+for+the+treatment+of+erythropoiesis-stimulating+agent-resistant+anemia%3A+raising+expectations+for+exploratory+clinical+trials&doi=10.1517%2F17460441.2013.796358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials</span></div><div class="casAuthors">Higashijima, Yoshiki; Tanaka, Tetsuhiro; Nangaku, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">965-976</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Anemia occurs in various chronic diseases and its treatment is dramatically improved after the appearance of erythropoiesis-stimulating agents (ESA).  However, there are several problems regarding the use of ESA including: (i) invasiveness, (ii) high cost and (iii) ESA resistance.  Therefore, there is a need to develop small mol. drugs which can improve these problems.  Hypoxia-inducible factor (HIF) plays a key role in regulating erythropoietin prodn.  HIF stabilizers, particularly, prolyl hydroxylase domain-contg. protein (PHD) inhibitors, have emerged as small mol.-based anti-anemia medicine.  Areas covered: This article discusses the current status of PHD inhibitors and the pros and cons of currently tested methods.  Specifically, the article reviews the advantages of structure-based drug design in the development of PHD inhibitors and looks at future perspectives within the field.  Expert opinion: Despite the fact that structure-based drug design has dramatically improved drug discovery, testing on humans is still one of the most time-consuming parts of drug discovery and one that is not accelerated by structural approaches.  Exploratory clin. trials, first-in-man studies have emerged as a new strategy for preclin. and clin. development of drugs.  Exploratory clin. trials will not only reduce the time and cost in preclin. trials but also provide important information on candidate drug's pharmacol. effects in humans.  Exploratory clin. trials may be a potential alternative strategy for the drug discovery in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-cXHk00oTjLVg90H21EOLACvtfcHk0lg2P_rVUxxl2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOitL7K&md5=e91fa9d462817c59affc775b48911b1b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.796358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.796358%26sid%3Dliteratum%253Aachs%26aulast%3DHigashijima%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DNangaku%26aufirst%3DM.%26atitle%3DStructure-based%2520drug%2520design%2520for%2520hypoxia-inducible%2520factor%2520prolyl-hydroxylase%2520inhibitors%2520and%2520its%2520therapeutic%2520potential%2520for%2520the%2520treatment%2520of%2520erythropoiesis-stimulating%2520agent-resistant%2520anemia%253A%2520raising%2520expectations%2520for%2520exploratory%2520clinical%2520trials%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D965%26epage%3D976%26doi%3D10.1517%2F17460441.2013.796358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, A.</span></span> <span> </span><span class="NLM_article-title">Hypoxia inducible factor as a therapeutic target for atherosclerosis</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.pharmthera.2017.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28942242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOrt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2018&pages=22-33&author=T.+Jainauthor=E.+A.+Nikolopoulouauthor=Q.+Xuauthor=A.+Qu&title=Hypoxia+inducible+factor+as+a+therapeutic+target+for+atherosclerosis&doi=10.1016%2Fj.pharmthera.2017.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia inducible factor as a therapeutic target for atherosclerosis</span></div><div class="casAuthors">Jain, Tanmay; Nikolopoulou, Eleni Aliki; Xu, Qingbo; Qu, Aijuan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-33</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Atherosclerosis is a highly prevalent disease that can significantly increase the risk of major vascular events, such as myocardial or cerebral infarctions.  The anoxemia theory states that a disparity between oxygen supply and demand contributes to atherosclerosis.  Hypoxia inducible factor-1 (HIF-1) is a heterodimeric protein, part of the basic helix-loop-helix family and one of the main regulators of cellular responses in a low-oxygen environment.  It plays a key role in the development of atherosclerosis through cell-specific responses, acting on endothelial cells, vascular smooth muscle cells (SMCs) and macrophages.  Through the upregulation of VEGF, NO, ROS and PDGF, HIF-1 is able to cause endothelial cell dysfunction, proliferation, angiogenesis and inflammation.  Activation of the NF-kB pathway in endothelial cells is an important contributor to inflammation and pos. feedbacks to HIF-1.  HIF-1 also plays a significant role in both the proliferation and migration of smooth muscle cells - two important features of atherosclerosis, while the formation of foam cells (lipid-laden macrophages) is also a crit. step in atherosclerosis and mediated by HIF-1 through various mechanisms such as dysfunctional efflux pathways in macrophages.  Overall, HIF-1 exerts its effect on the pathogenesis of atherosclerosis via a variety of mol. and cellular events in the process.  In this review article, we examine the effects HIF-1 on vascular cells and macrophages in the development of atherosclerosis, highlighting the environmental cues and signalling pathways that control HIF-1 expression/activation within the vasculature.  We will highlight the potential of HIF-1 as a therapeutic target on the disease development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQEXMxI2rIlrVg90H21EOLACvtfcHk0lhTtLYZNDrJnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOrt7%252FF&md5=8b320f6bbdee92a45abc7de260707810</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DT.%26aulast%3DNikolopoulou%26aufirst%3DE.%2BA.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DQu%26aufirst%3DA.%26atitle%3DHypoxia%2520inducible%2520factor%2520as%2520a%2520therapeutic%2520target%2520for%2520atherosclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D183%26spage%3D22%26epage%3D33%26doi%3D10.1016%2Fj.pharmthera.2017.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warfel, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span> <span> </span><span class="NLM_article-title">HIF-1 signaling in drug resistance to chemotherapy</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">3021</span>– <span class="NLM_lpage">3028</span>, <span class="refDoi"> DOI: 10.2174/0929867321666140414101056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.2174%2F0929867321666140414101056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24735366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKgsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=3021-3028&issue=26&author=N.+A.+Warfelauthor=W.+S.+El-Deiry&title=HIF-1+signaling+in+drug+resistance+to+chemotherapy&doi=10.2174%2F0929867321666140414101056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 Signaling in Drug Resistance to Chemotherapy</span></div><div class="casAuthors">Warfel, N. A.; El-Deiry, W. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3021-3028</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Activation of hypoxia-inducible factor 1 (HIF-1) signaling is obsd. in a broad range of human cancers due to tumor hypoxia and epigenetic mechanisms.  HIF-1 activation leads to the transcription of a plethora of target genes that promote physiol. changes assocd. with therapeutic resistance, including the inhibition of apoptosis and senescence and the activation of drug efflux and cellular metab.  As a result, targeting HIF-1 represents an attractive strategy to enhance the efficacy of current therapies as well as reduce resistance to chemotherapy in tumors.  Approaches to inhibit HIF-1 signaling have primarily focused on reducing HIF-1α protein levels, by inducing its degrdn. or inhibiting its transcription, inhibiting HIF-1-mediated transcription, or disrupting the formation of the HIF-1 transcription factor complex.  To date, multiple preclin. and clin. agents have been identified that effectively inhibit HIF-1 activity through various mechanisms, likely accounting for a portion of their anti-tumor efficacy.  This review aims to provide an overview of our current understanding of the role of HIF-1 in therapeutic resistance and discuss the ongoing effort to develop HIF-1 inhibitors as an anti-cancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosCs3z--5GYLVg90H21EOLACvtfcHk0lhTtLYZNDrJnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKgsrnN&md5=c8648648e198f8e4d880e455b706b41b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140414101056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140414101056%26sid%3Dliteratum%253Aachs%26aulast%3DWarfel%26aufirst%3DN.%2BA.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26atitle%3DHIF-1%2520signaling%2520in%2520drug%2520resistance%2520to%2520chemotherapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26issue%3D26%26spage%3D3021%26epage%3D3028%26doi%3D10.2174%2F0929867321666140414101056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masoud, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">HIF-1α pathway: role, regulation and intervention for cancer therapy</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.apsb.2015.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26579469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=378-389&issue=5&author=G.+N.+Masoudauthor=W.+Li&title=HIF-1%CE%B1+pathway%3A+role%2C+regulation+and+intervention+for+cancer+therapy&doi=10.1016%2Fj.apsb.2015.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1α pathway: role, regulation and intervention for cancer therapy</span></div><div class="casAuthors">Masoud Georgina N; Li Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">378-89</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer drug target.  Many recent studies have provided convincing evidences of strong correlation between elevated levels of HIF-1 and tumor metastasis, angiogenesis, poor patient prognosis as well as tumor resistance therapy.  It was found that hypoxia (low O2 levels) is a common character in many types of solid tumors.  As an adaptive response to hypoxic stress, hypoxic tumor cells activate several survival pathways to carry out their essential biological processes in different ways compared with normal cells.  Recent advances in cancer biology at the cellular and molecular levels highlighted the HIF-1α pathway as a crucial survival pathway for which novel strategies of cancer therapy could be developed.  However, targeting the HIF-1α pathway has been a challenging but promising progresses have been made in the past twenty years.  This review summarizes the role and regulation of the HIF-1α in cancer, and recent therapeutic approaches targeting this important pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl5ggzHGM8X5CfW6udTcc2eaSJbyMlfr5Sbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOqsg%253D%253D&md5=807f3c1d149d6f93137dac071e13d1d5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DMasoud%26aufirst%3DG.%2BN.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DHIF-1%25CE%25B1%2520pathway%253A%2520role%252C%2520regulation%2520and%2520intervention%2520for%2520cancer%2520therapy%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26issue%3D5%26spage%3D378%26epage%3D389%26doi%3D10.1016%2Fj.apsb.2015.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of HIF-1alpha-p300/CBP inhibitors as anti-cancer agents</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.2174/1389557516666160630124938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.2174%2F1389557516666160630124938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27484627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1amu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=296-309&issue=4&author=J.+Weiauthor=Y.+Yangauthor=M.+Luauthor=Y.+Leiauthor=L.+Xuauthor=Z.+Jiangauthor=X.+Xuauthor=X.+Guoauthor=X.+Zhangauthor=H.+Sunauthor=Q.+You&title=Recent+advances+in+the+discovery+of+HIF-1alpha-p300%2FCBP+inhibitors+as+anti-cancer+agents&doi=10.2174%2F1389557516666160630124938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents</span></div><div class="casAuthors">Wei, Jinlian; Yang, Yingrui; Lu, Mengchen; Lei, Yonghua; Xu, Lili; Jiang, Zhengyu; Xu, Xiaoli; Guo, Xiaoke; Zhang, Xiaojin; Sun, Haopeng; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">296-309</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1), a heterodimeric (contg. &#945; and &#946; subunits) transcription factor, is involved in hypoxia response pathway that regulates the expression of many tumorrelated genes.  The stabilized HIF-1 heterodimer couples to the general co-activators p300/CBP (CREB binding protein), forming an active transcription factor to initiate hypoxic responses.  Inhibiting the transcription factor-coactivator HIF-1&#945;-p300/CBP interaction represents an attractive approach for blocking hypoxia pathway in tumors.  Recently, diverse HIF-1&#945;-p300/CBP inhibitors have been designed and their anti-tumor activities have been evaluated.  The developments of inhibitors of HIF-1&#945;- p300/CBP are discussed in this review.  An outline of structures and biol. activities of these inhibitors can be traced, along with the approaches for inhibitors discovery.  The challenges in identifying novel and selective potent inhibitors of HIF-1&#945;-p300/CBP are also put forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEyyag59FsKLVg90H21EOLACvtfcHk0lgZ2Z3IQoky7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1amu7w%253D&md5=b73708d2cc6a9cd34375efbbc6b60e66</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1389557516666160630124938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666160630124938%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520HIF-1alpha-p300%252FCBP%2520inhibitors%2520as%2520anti-cancer%2520agents%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26issue%3D4%26spage%3D296%26epage%3D309%26doi%3D10.2174%2F1389557516666160630124938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson’s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">121</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2018.00121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.3389%2Ffnagi.2018.00121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29755339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=121&author=X.+Liauthor=X.+X.+Cuiauthor=Y.+J.+Chenauthor=T.+T.+Wuauthor=H.+Xuauthor=H.+Yinauthor=Y.+C.+Wu&title=Therapeutic+potential+of+a+prolyl+hydroxylase+inhibitor+FG-4592+for+Parkinson%E2%80%99s+diseases+in+vitro+and+in+vivo%3A+regulation+of+redox+biology+and+mitochondrial+function&doi=10.3389%2Ffnagi.2018.00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for parkinson's diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span></div><div class="casAuthors">Li, Xuan; Cui, Xin-Xin; Chen, Ya-Jing; Wu, Ting-Ting; Xu, Huaxi; Yin, Huiyong; Wu, Yun-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">121/1-121/16</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">As the main transcription factor that regulates the cellular responses to hypoxia, Hypoxia-inducible factor-1α (HIF-1α) plays an important role in the pathogenesis of Parkinson's disease (PD).  HIF-1α is normally degraded through ubiquitination after hydroxylation by prolyl hydroxylases (PHD).  Emerging evidence has suggested that HIF PHD inhibitors (HIF-PHI) may have neuroprotective effects on PD through increasing HIF-1α levels.  However, the therapeutic benefit of HIF-PHI for PD remains poorly explored due to the lack of proper clin. compds. and understanding of the underlying mol. mechanisms.  In this study, we examd. the therapeutic benefit of a new HIF-PHI, FG-4592, which is currently in phase 3 clin. trials to treat anemia in patients with chronic kidney diseases (CKD) in PD models.  FG-4592 attenuates MPP+-induced apoptosis and loss of tyrosine hydroxylase (TH) in SHSY5Y cells.  Pretreatment with FG-4592 mitigates MPP+-induced loss of mitochondrial membrane potential (MMP), mitochondrial oxygen consumption rate (OCR), prodn. of reactive oxygen species (ROS) and ATP.  Furthermore, FG-4592 counterbalances the oxidative stress through up-regulating nuclear factor erythroid 2 p45-related factor 2 (Nrf-2), heme oxygenase-1 (HO-1) and superoxide dismutase 2 (SOD2).  FG-4592 treatment also induces the expression of Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) through increasing the phosphorylation of AMP-activated protein kinase (AMPK).  In MPTP-treated mice, FG-4592 protects against MPTP-induced loss of TH-pos. neurons of substantia nigra and attenuates behavioral impairments.  Collectively, our study demonstrates that FG-4592 is a promising therapeutic strategy for PD through improving the mitochondrial function under oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQ__V5ZZmvrVg90H21EOLACvtfcHk0lgZ2Z3IQoky7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN&md5=6de27ad23eb1b16c4384ff23d385b38e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2018.00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2018.00121%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DX.%2BX.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DWu%26aufirst%3DT.%2BT.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%2BC.%26atitle%3DTherapeutic%2520potential%2520of%2520a%2520prolyl%2520hydroxylase%2520inhibitor%2520FG-4592%2520for%2520Parkinson%25E2%2580%2599s%2520diseases%2520in%2520vitro%2520and%2520in%2520vivo%253A%2520regulation%2520of%2520redox%2520biology%2520and%2520mitochondrial%2520function%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2018%26volume%3D10%26spage%3D121%26doi%3D10.3389%2Ffnagi.2018.00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colgan, S. P.</span></span> <span> </span><span class="NLM_article-title">Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">852</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1038/nrd4422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnrd4422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25359381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCmsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=852-869&issue=11&author=H.+K.+Eltzschigauthor=D.+L.+Brattonauthor=S.+P.+Colgan&title=Targeting+hypoxia+signalling+for+the+treatment+of+ischaemic+and+inflammatory+diseases&doi=10.1038%2Fnrd4422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting hypoxia signalling for the treatment of ischemic and inflammatory diseases</span></div><div class="casAuthors">Eltzschig, Holger K.; Bratton, Donna L.; Colgan, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">852-869</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIFs) are stabilized during adverse inflammatory processes assocd. with disorders such as inflammatory bowel disease, pathogen infection and acute lung injury, as well as during ischemia-reperfusion injury.  HIF stabilization and hypoxia-induced changes in gene expression have a profound impact on the inflamed tissue microenvironment and on disease outcomes.  Although the mechanism that initiates HIF stabilization may vary, the final mol. steps that control HIF stabilization converge on a set of oxygen-sensing prolyl hydroxylases (PHDs) that mark HIFs for proteasomal degrdn.  PHDs are therefore promising therapeutic targets.  In this Review, we discuss the emerging potential and assocd. challenges of targeting the PHD-HIF pathway for the treatment of inflammatory and ischemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx3QDAep7Kn7Vg90H21EOLACvtfcHk0lgZ2Z3IQoky7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCmsrrP&md5=df291f8754ab0cb25ef5c9abdfb09c24</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd4422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4422%26sid%3Dliteratum%253Aachs%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DBratton%26aufirst%3DD.%2BL.%26aulast%3DColgan%26aufirst%3DS.%2BP.%26atitle%3DTargeting%2520hypoxia%2520signalling%2520for%2520the%2520treatment%2520of%2520ischaemic%2520and%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D11%26spage%3D852%26epage%3D869%26doi%3D10.1038%2Fnrd4422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors in physiology and medicine</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cell.2012.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22304911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFaqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=399-408&issue=3&author=G.+L.+Semenza&title=Hypoxia-inducible+factors+in+physiology+and+medicine&doi=10.1016%2Fj.cell.2012.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factors in physiology and medicine</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-408</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxygen homeostasis represents an organizing principle for understanding metazoan evolution, development, physiol., and pathobiol.  The hypoxia-inducible factors (HIFs) are transcriptional activators that function as master regulators of oxygen homeostasis in all metazoan species.  Rapid progress is being made in elucidating homeostatic roles of HIFs in many physiol. systems, detg. pathol. consequences of HIF dysregulation in chronic diseases, and investigating potential targeting of HIFs for therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeggwDZ0i657Vg90H21EOLACvtfcHk0lgZ2Z3IQoky7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFaqsrY%253D&md5=f43f8e5c556c8aa7a5596176ecf31af5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factors%2520in%2520physiology%2520and%2520medicine%26jtitle%3DCell%26date%3D2012%26volume%3D148%26issue%3D3%26spage%3D399%26epage%3D408%26doi%3D10.1016%2Fj.cell.2012.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokotani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii-Kuriyama, Y.</span></span> <span> </span><span class="NLM_article-title">A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4273</span>– <span class="NLM_lpage">4278</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.9.4273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.94.9.4273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=9113979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK2sXjtVyitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4273-4278&issue=9&author=M.+Emaauthor=S.+Tayaauthor=N.+Yokotaniauthor=K.+Sogawaauthor=Y.+Matsudaauthor=Y.+Fujii-Kuriyama&title=A+novel+bHLH-PAS+factor+with+close+sequence+similarity+to+hypoxia-inducible+factor+1alpha+regulates+the+VEGF+expression+and+is+potentially+involved+in+lung+and+vascular+development&doi=10.1073%2Fpnas.94.9.4273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development</span></div><div class="casAuthors">Ema, Masatsugu; Taya, Shinichiro; Yokotani, Noboru; Sogawa, Kazuhiro; Matsuda, Youichi; Fujii-Kuriyama, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4273-4278</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors have isolated and characterized a cDNA for a novel Per-Arnt/AhR-Sim basic helix-loop-helix (bHLH-PAS) factor that interacts with the Ah receptor nuclear translocator (Arnt), and its predicted amino acid sequence exhibits significant similarity to the hypoxia-inducible factor 1α (HIF1α) and Drosophila trachealess (dTrh) gene product.  The HIF1α-like factor (HLF) encoded by the isolated cDNA bound the hypoxia-response element (HRE) found in enhancers of genes for erythropoietin, vascular endothelial growth factor (VEGF), and various glycolytic enzymes, and activated transcription of a reporter gene harboring the HRE.  Although transcription-activating properties of HLF were very similar to those reported for HIFA1α, their expression patterns were quite different between the two factors; HLF mRNA was most abundantly expressed in lung, followed by heart, liver, and other various organs under normoxic conditions, whereas HIF1α mRNA was ubiquitously expressed at much lower levels.  In lung development around parturition, HLF mRNA expression was markedly enhanced, whereas that of HIF1α mRNA remained apparently unchanged at a much lower level.  Moreover, HLF mRNA expression was closely correlated with that of VEGF mRNA.  Whole mount in situ hybridization expts. demonstrated that HLF mRNA was expressed in vascular endothelial cells at the middle stages (9.5 and 10.5 days postcoitus) of mouse embryo development, where HIF1α mRNA was almost undetectable.  The high expression level of HLF mRNA in the O2 delivery system of developing embryos and adult organs suggests that in a normoxic state, HLF regulates gene expression of VEGF, various glycolytic enzymes, and others driven by the HRE sequence, and may be involved in development of blood vessels and the tubular system of lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Z3HBze-7drVg90H21EOLACvtfcHk0lhxu4WQwAsUUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtVyitbY%253D&md5=b847e32f117f6adc37ec975252d64275</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.9.4273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.9.4273%26sid%3Dliteratum%253Aachs%26aulast%3DEma%26aufirst%3DM.%26aulast%3DTaya%26aufirst%3DS.%26aulast%3DYokotani%26aufirst%3DN.%26aulast%3DSogawa%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DFujii-Kuriyama%26aufirst%3DY.%26atitle%3DA%2520novel%2520bHLH-PAS%2520factor%2520with%2520close%2520sequence%2520similarity%2520to%2520hypoxia-inducible%2520factor%25201alpha%2520regulates%2520the%2520VEGF%2520expression%2520and%2520is%2520potentially%2520involved%2520in%2520lung%2520and%2520vascular%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D9%26spage%3D4273%26epage%3D4278%26doi%3D10.1073%2Fpnas.94.9.4273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogenesch, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradfield, C. A.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α</span>. <i>Gene Expression</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=9840812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1cXnslKhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=205-213&issue=3&author=Y.+Z.+Guauthor=S.+M.+Moranauthor=J.+B.+Hogeneschauthor=L.+Wartmanauthor=C.+A.+Bradfield&title=Molecular+characterization+and+chromosomal+localization+of+a+third+%CE%B1-class+hypoxia+inducible+factor+subunit%2C+HIF3%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α</span></div><div class="casAuthors">Gu, Yi-Zhong; Moran, Susan M.; Hogenesch, John B.; Wartman, Lukas; Bradfield, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Expression</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-213</span>CODEN:
                <span class="NLM_cas:coden">GEEXEJ</span>;
        ISSN:<span class="NLM_cas:issn">1052-2166</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors that regulate a no. of adaptive responses to low oxygen tension.  They are composed of α- and β-subunits that belong to the basic helix-loop-helix-PAS (bHLH-PAS) superfamily.  In these efforts to identify new bHLH-PAS proteins, the authors cloned a cDNA encoding a novel α-class hypoxia inducible factor, HIF3α.  The HIF3α open reading frame encodes a 662-amino acid protein with a predicted mol. wt. of 73 kDa and is expressed in adult thymus, lung, brain, heart, and kidney.  The N-terminal bHLH-PAS domain of this protein shares amino acid sequence identity with that of HIF1α and HIF2α (57% and 53% identity, resp.).  The C-terminus of HIF3α contains a 36-amino acid sequence that shares 61% identity with the hypoxia responsive domain-1 (HRD1) of HIF1α.  In transient transfections, this domain confers hypoxia responsiveness when linked to a heterologous transactivation domain.  In vitro studies reveal that HIF3α dimerizes with a prototype β-class subunit, ARNT, and that the resultant heterodimer recognizes the hypoxia responsive element (HRE) core sequence, TACGTG.  Transient transfection expts. demonstrate that the HIF3α-ARNT interaction can occur in vivo, and that the activity of HIF3α is upregulated in response to cobalt chloride or low oxygen tension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUZOh7jJT1eLVg90H21EOLACvtfcHk0lhxu4WQwAsUUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslKhsLg%253D&md5=6f6f960ed1aa4bf35618b8a022791d1c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DY.%2BZ.%26aulast%3DMoran%26aufirst%3DS.%2BM.%26aulast%3DHogenesch%26aufirst%3DJ.%2BB.%26aulast%3DWartman%26aufirst%3DL.%26aulast%3DBradfield%26aufirst%3DC.%2BA.%26atitle%3DMolecular%2520characterization%2520and%2520chromosomal%2520localization%2520of%2520a%2520third%2520%25CE%25B1-class%2520hypoxia%2520inducible%2520factor%2520subunit%252C%2520HIF3%25CE%25B1%26jtitle%3DGene%2520Expression%26date%3D1998%26volume%3D7%26issue%3D3%26spage%3D205%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hankinson, O.</span></span> <span> </span><span class="NLM_article-title">Cloning of a factor required for activity of the Ah (dioxin) receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>252</i></span> (<span class="NLM_issue">5008</span>),  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1126/science.1852076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1852076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1852076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK38XjsFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1991&pages=954-958&issue=5008&author=E.+C.+Hoffmanauthor=H.+Reyesauthor=F.+F.+Chuauthor=F.+Sanderauthor=L.+H.+Conleyauthor=B.+A.+Brooksauthor=O.+Hankinson&title=Cloning+of+a+factor+required+for+activity+of+the+Ah+%28dioxin%29+receptor&doi=10.1126%2Fscience.1852076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a factor required for activity of the Ah (dioxin) receptor</span></div><div class="casAuthors">Hoffman, Emily C.; Reyes, Herminio; Chu, Fong Fong; Sander, Fred; Conley, Linda H.; Brooks, Barbara A.; Hankinson, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">5008</span>),
    <span class="NLM_cas:pages">954-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The aryl hydrocarbon (Ah) receptor binds various environmental pollutants, such as polycyclic arom. hydrocarbons, heterocyclic amines, and polychlorinated arom. compds. (dioxins, dibenzofurans, and biphenyls), and mediates the carcinogenic effects of these agents.  The cDNA and part of the gene for an 87-kilodalton human protein that is necessary for Ah receptor function have been cloned.  The protein is not the ligand-binding subunit of the receptor but is a factor that is required for the ligand-binding subunit to translocate from the cytosol to the nucleus after binding ligand.  The requirement for this factor distinguishes the Ah receptor from the glucocorticoid receptor, to which the Ah receptor has been presumed to be similar.  Two portions of the 87-kilodalton protein share sequence similarities with 2 Drosophila proteins, Per and Sim.  Another segment of the protein shows conformity to the consensus sequence for the basic helix-loop-helix motif found in proteins that bind DNA as homodimers or heterodimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Y4LQODfhXrVg90H21EOLACvtfcHk0lhxu4WQwAsUUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XjsFeitQ%253D%253D&md5=9b50f6894e5bb7a148d6ed9f0e653ee3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1852076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1852076%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DE.%2BC.%26aulast%3DReyes%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DF.%2BF.%26aulast%3DSander%26aufirst%3DF.%26aulast%3DConley%26aufirst%3DL.%2BH.%26aulast%3DBrooks%26aufirst%3DB.%2BA.%26aulast%3DHankinson%26aufirst%3DO.%26atitle%3DCloning%2520of%2520a%2520factor%2520required%2520for%2520activity%2520of%2520the%2520Ah%2520%2528dioxin%2529%2520receptor%26jtitle%3DScience%26date%3D1991%26volume%3D252%26issue%3D5008%26spage%3D954%26epage%3D958%26doi%3D10.1126%2Fscience.1852076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rue, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">17771</span>– <span class="NLM_lpage">17778</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.30.17771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.271.30.17771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=8663540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK28XksFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=17771-17778&issue=30&author=B.+H.+Jiangauthor=E.+G.+Rueauthor=L.+Wangauthor=R.+Roeauthor=G.+L.+Semenza&title=Dimerization%2C+DNA+binding%2C+and+transactivation+properties+of+hypoxia-inducible+factor+1&doi=10.1074%2Fjbc.271.30.17771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1</span></div><div class="casAuthors">Jiang, Bing-Hua; Rue, Elizabeth; Wang, Guang L.; Roe, Rick; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">17771-17778</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix transcription factor that regulates hypoxia-inducible genes including the human erythropoietin (EPO) gene.  This study reports structural features of the HIF-1α subunit that are required for heterodimerization, DNA binding, and transactivation.  The HIF-1α and HIF-1β (ARNT; aryl hydrocarbon receptor nuclear translocator) subunits were coimmunopptd. from nuclear exts., indicating that these proteins heterodimerize in the absence of DNA.  In vitro-translated HIF-1α and HIF-1β generated a HIF-1/DNA complex with similar electrophoretic mobility and sequence specificity as HIF-1 present in nuclear exts. from hypoxic cells.  Compared to 826-amino acid, full-length HIF-1α, amino acids 1-166 mediated heterodimerization with HIF-1β (ARNT), but amino acids 1-390 were required for optimal DNA binding.  A deletion involving the basic domain of HIF-1α eliminated DNA binding without affecting heterodimerization.  In cotransfection assays, forced expression of recombinant HIF-1α and HIF-1β (ARNT) activated transcription of reporter genes contg. EPO enhancer sequences with intact, but not mutant, HIF-1 binding sites.  Deletion of the C-terminus of HIF-1α (amino acids 391-826) markedly decreased the ability of recombinant HIF-1 to activate transcription.  Overexpression of a HIF-1α construct with deletions of the basic domain and C-terminus blocked reporter gene activation by endogenous HIF-1 in hypoxic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIAZXegFaPK7Vg90H21EOLACvtfcHk0lgrOR0wFjqJsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFyit70%253D&md5=e97f21eebd815ff821bdfeda72b96c87</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.30.17771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.30.17771%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DRue%26aufirst%3DE.%2BG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRoe%26aufirst%3DR.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDimerization%252C%2520DNA%2520binding%252C%2520and%2520transactivation%2520properties%2520of%2520hypoxia-inducible%2520factor%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D30%26spage%3D17771%26epage%3D17778%26doi%3D10.1074%2Fjbc.271.30.17771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishopric, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. A.</span></span> <span> </span><span class="NLM_article-title">Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">12645</span>– <span class="NLM_lpage">12653</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011344200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M011344200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11278891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFynt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=12645-12653&issue=16&author=K.+D.+Yamashitaauthor=J.+Discherauthor=J.+Huauthor=N.+H.+Bishopricauthor=K.+A.+Webster&title=Molecular+regulation+of+the+endothelin-1+gene+by+hypoxia.+Contributions+of+hypoxia-inducible+factor-1%2C+activator+protein-1%2C+GATA-2%2C+and+p300%2FCBP&doi=10.1074%2Fjbc.M011344200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP</span></div><div class="casAuthors">Yamashita, Kazuhito; Discher, Daryl J.; Hu, Jing; Bishopric, Nanette H.; Webster, Keith A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">12645-12653</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Endothelin-1 (ET-1) is a peptide hormone with potent vasoconstrictor properties which is synthesized and secreted predominantly by vascular endothelial cells.  Its prodn. is regulated by numerous stimuli including ischemia and hypoxia, and the enhanced levels that occur during myocardial ischemia may contribute to the progression of heart failure.  We reported previously a preliminary characterization of a hypoxia-inducible factor-1 (HIF-1) binding site in the human ET-1 promoter which contributed to the activation of ET-1 expression in endothelial cells.  We report here that the HIF-1 binding site alone is not sufficient for the response to hypoxia but requires an addnl. 50 base pairs of flanking sequence that includes binding sites for the factors activator protein-1 (AP-1), GATA-2, and CAAT-binding factor (NF-1).  Mutation of any one of these sites or the HIF-1 site eliminated induction by hypoxia.  Mutations of the AP-1 and GATA-2 sites, but not the HIF-1 site, were complemented by overexpressing AP-1, GATA-2, HIF-1α, or the activator protein p300/CBP, restoring the response to hypoxia.  Binding studies in vitro confirmed phys. assocns. among GATA-2, AP-1, and HIF-1 factors.  Overexpression or depletion of p300/CBP modulated the level of ET-1 promoter expression as well as the endogenous ET-1 transcript but did not change the fold induction by hypoxia in either case.  Regulation of the ET-1 promoter by hypoxia in non-endothelial cells required overexpression of GATA-2 and HIF-1α.  The results support essential roles for AP-1, GATA-2, and NF-1 in stabilizing the binding of HIF-1 and promoting recruitment of p300/CBP to the ET-1 hypoxia response complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx1xkLdtgQRrVg90H21EOLACvtfcHk0lgrOR0wFjqJsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFynt7c%253D&md5=0306ca6413b77d0845bb7b2bdc3f71bc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011344200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011344200%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DK.%2BD.%26aulast%3DDischer%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DBishopric%26aufirst%3DN.%2BH.%26aulast%3DWebster%26aufirst%3DK.%2BA.%26atitle%3DMolecular%2520regulation%2520of%2520the%2520endothelin-1%2520gene%2520by%2520hypoxia.%2520Contributions%2520of%2520hypoxia-inducible%2520factor-1%252C%2520activator%2520protein-1%252C%2520GATA-2%252C%2520and%2520p300%252FCBP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D16%26spage%3D12645%26epage%3D12653%26doi%3D10.1074%2Fjbc.M011344200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imura, N.</span></span> <span> </span><span class="NLM_article-title">Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: suppression of HIF-mediated gene expression by HIF-3α</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.5659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1006%2Fbbrc.2001.5659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11573933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntV2gu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=808-813&issue=4&author=S.+Haraauthor=J.+Hamadaauthor=C.+Kobayashiauthor=Y.+Kondoauthor=N.+Imura&title=Expression+and+characterization+of+hypoxia-inducible+factor+%28HIF%29-3%CE%B1+in+human+kidney%3A+suppression+of+HIF-mediated+gene+expression+by+HIF-3%CE%B1&doi=10.1006%2Fbbrc.2001.5659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: suppression of HIF-mediated gene expression by HIF-3α</span></div><div class="casAuthors">Hara, Shuntaro; Hamada, Junko; Kobayashi, Chie; Kondo, Yukihiro; Imura, Nobumasa</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors that regulate a no. of adaptive responses to low oxygen tension.  They are composed of α- and β-subunits that belong to the basic helix-loop-helix-PAS superfamily.  Here we examd. the expression of HIF-α subunit proteins in the human kidney and found that, in addn. to HIF-1α and -2α, HIF-3α was also expressed.  The sequence anal. revealed that, like mouse HIF-3α, human HIF-3α has high similarity with HIF-1α and -2α in the bHLH and PAS domains, but lacks structures for transactivation found in the C-terminus of HIF-1α and -2α.  Furthermore, we performed reporter gene anal. and showed that HIF-3α suppresses hypoxia-inducible HIF-mediated gene expression.  HIF-3α might be a neg. regulator of hypoxia-inducible gene expression in the human kidney.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3L1bSRQlGLVg90H21EOLACvtfcHk0lgrOR0wFjqJsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntV2gu7g%253D&md5=9f3175506948605be257f28c8a395527</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.5659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.5659%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DS.%26aulast%3DHamada%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DC.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DImura%26aufirst%3DN.%26atitle%3DExpression%2520and%2520characterization%2520of%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-3%25CE%25B1%2520in%2520human%2520kidney%253A%2520suppression%2520of%2520HIF-mediated%2520gene%2520expression%2520by%2520HIF-3%25CE%25B1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26issue%3D4%26spage%3D808%26epage%3D813%26doi%3D10.1006%2Fbbrc.2001.5659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title">HIF-1 and HIF-2: working alone or together in hypoxia?</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1172/JCI31750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1172%2FJCI31750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17404612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=862-865&issue=4&author=P.+J.+Ratcliffe&title=HIF-1+and+HIF-2%3A+working+alone+or+together+in+hypoxia%3F&doi=10.1172%2FJCI31750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 and HIF-2: working alone or together in hypoxia?</span></div><div class="casAuthors">Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">862-865</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Erythropoietin (EPO) is the hormonal regulator of red cell prodn. and provided the paradigm for oxygen-regulated gene expression that led to the discovery of hypoxia-inducible factor (HIF).  In this issue of the JCI, Rankin and colleagues show, using targeted gene inactivation, that induction of Epo expression in murine liver is dependent on the integrity of HIF-2α, and not HIF-1α (see the related article beginning on page 1068).  These results demonstrate distinct functions for different HIF-α isoforms that could potentially be exploited in therapeutic approaches to anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpge5O8T1sFDbVg90H21EOLACvtfcHk0lisv0_2MmV71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOisLc%253D&md5=729bd7e4db61a2d25a4245b2fc184482</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1172%2FJCI31750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI31750%26sid%3Dliteratum%253Aachs%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DHIF-1%2520and%2520HIF-2%253A%2520working%2520alone%2520or%2520together%2520in%2520hypoxia%253F%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26issue%3D4%26spage%3D862%26epage%3D865%26doi%3D10.1172%2FJCI31750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biju, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, V. H.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1068</span>– <span class="NLM_lpage">1077</span>, <span class="refDoi"> DOI: 10.1172/JCI30117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1172%2FJCI30117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17404621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=1068-1077&issue=4&author=E.+B.+Rankinauthor=M.+P.+Bijuauthor=Q.+Liuauthor=T.+L.+Ungerauthor=J.+Rhaauthor=R.+S.+Johnsonauthor=M.+C.+Simonauthor=B.+Keithauthor=V.+H.+Haase&title=Hypoxia-inducible+factor-2+%28HIF-2%29+regulates+hepatic+erythropoietin+in+vivo&doi=10.1172%2FJCI30117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo</span></div><div class="casAuthors">Rankin, Erinn B.; Biju, Mangatt P.; Liu, Qingdu; Unger, Travis L.; Rha, Jennifer; Johnson, Randall S.; Simon, M. Celeste; Keith, Brian; Haase, Volker H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1068-1077</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Erythropoiesis is critically dependent on erythropoietin (EPO), a glycoprotein hormone that is regulated by hypoxia-inducible factor (HIF).  Hepatocytes are the primary source of extrarenal EPO in the adult and express HIF-1 and HIF-2, whose roles in the hypoxic induction of EPO remain controversial.  In order to define the role of HIF-1 and HIF-2 in the regulation of hepatic EPO expression, we have generated mice with conditional inactivation of Hif-1α and/or Hif-2α (Epas1) in hepatocytes.  We have previously shown that inactivation of the von Hippel-Lindau tumor suppressor pVHL, which targets both HIFs for proteasomal degrdn., results in increased hepatic Epo prodn. and polycythemia independent of Hif-1α.  Here we show that conditional inactivation of Hif-2α in pVHL-deficient mice suppressed hepatic Epo and the development of polycythemia.  Furthermore, we found that physiol. Epo expression in infant livers required Hif-2α but not Hif-1α and that the hypoxic induction of liver Epo in anemic adults was Hif-2α dependent.  Since other Hif target genes such phosphoglycerate kinase 1 (Pgk) were Hif-1α dependent, we provide genetic evidence that HIF-1 and HIF-2 have distinct roles in the regulation of hypoxia-inducible genes and that EPO is preferentially regulated by HIF-2 in the liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRmkJgWNuXdrVg90H21EOLACvtfcHk0lisv0_2MmV71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOit70%253D&md5=8e741a8ead316dbc00dbf5da438f3440</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1172%2FJCI30117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI30117%26sid%3Dliteratum%253Aachs%26aulast%3DRankin%26aufirst%3DE.%2BB.%26aulast%3DBiju%26aufirst%3DM.%2BP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DUnger%26aufirst%3DT.%2BL.%26aulast%3DRha%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DHaase%26aufirst%3DV.%2BH.%26atitle%3DHypoxia-inducible%2520factor-2%2520%2528HIF-2%2529%2520regulates%2520hepatic%2520erythropoietin%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26issue%3D4%26spage%3D1068%26epage%3D1077%26doi%3D10.1172%2FJCI30117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavia-Jimenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homayoun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousuf, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedrosa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zojwalla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugarolas, J.</span></span> <span> </span><span class="NLM_article-title">Targeting renal cell carcinoma with a HIF-2 antagonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>539</i></span> (<span class="NLM_issue">7627</span>),  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1038/nature19796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature19796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27595394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslyis7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=539&publication_year=2016&pages=112-117&issue=7627&author=W.+Chenauthor=H.+Hillauthor=A.+Christieauthor=M.+S.+Kimauthor=E.+Hollomanauthor=A.+Pavia-Jimenezauthor=F.+Homayounauthor=Y.+Maauthor=N.+Patelauthor=P.+Yellauthor=G.+Haoauthor=Q.+Yousufauthor=A.+Joyceauthor=I.+Pedrosaauthor=H.+Geigerauthor=H.+Zhangauthor=J.+Changauthor=K.+H.+Gardnerauthor=R.+K.+Bruickauthor=C.+Reevesauthor=T.+H.+Hwangauthor=K.+Courtneyauthor=E.+Frenkelauthor=X.+Sunauthor=N.+Zojwallaauthor=T.+Wongauthor=J.+P.+Rizziauthor=E.+M.+Wallaceauthor=J.+A.+Joseyauthor=Y.+Xieauthor=X.+J.+Xieauthor=P.+Kapurauthor=R.+M.+McKayauthor=J.+Brugarolas&title=Targeting+renal+cell+carcinoma+with+a+HIF-2+antagonist&doi=10.1038%2Fnature19796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting renal cell carcinoma with a HIF-2 antagonist</span></div><div class="casAuthors">Chen, Wenfang; Hill, Haley; Christie, Alana; Kim, Min Soo; Holloman, Eboni; Pavia-Jimenez, Andrea; Homayoun, Farrah; Ma, Yuanqing; Patel, Nirav; Yell, Paul; Hao, Guiyang; Yousuf, Qurratulain; Joyce, Allison; Pedrosa, Ivan; Geiger, Heather; Zhang, He; Chang, Jenny; Gardner, Kevin H.; Bruick, Richard K.; Reeves, Catherine; Hwang, Tae Hyun; Courtney, Kevin; Frenkel, Eugene; Sun, Xiankai; Zojwalla, Naseem; Wong, Tai; Rizzi, James P.; Wallace, Eli M.; Josey, John A.; Xie, Yang; Xie, Xian-Jin; Kapur, Payal; McKay, Renee M.; Brugarolas, James</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">539</span>
        (<span class="NLM_cas:issue">7627</span>),
    <span class="NLM_cas:pages">112-117</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumor suppressor gene (VHL).  Because no other gene is mutated as frequently in ccRCC and VHL mutations are truncal, VHL inactivation is regarded as the governing event.  VHL loss activates the HIF-2 transcription factor, and constitutive HIF-2 activity restores tumorigenesis in VHL-reconstituted ccRCC cells.  HIF-2 has been implicated in angiogenesis and multiple other processes, but angiogenesis is the main target of drugs such as the tyrosine kinase inhibitor sunitinib.  HIF-2 has been regarded as undruggable.  Here we use a tumorgraft/patient-derived xenograft platform to evaluate PT2399, a selective HIF-2 antagonist that was identified using a structure-based design approach.  PT2399 dissocd. HIF-2 (an obligatory heterodimer of HIF-2α-HIF-1β) in human ccRCC cells and suppressed tumorigenesis in 56% (10 out of 18) of such lines.  PT2399 had greater activity than sunitinib, was active in sunitinib-progressing tumors, and was better tolerated.  Unexpectedly, some VHL-mutant ccRCCs were resistant to PT2399.  Resistance occurred despite HIF-2 dissocn. in tumors and evidence of Hif-2 inhibition in the mouse, as detd. by suppression of circulating erythropoietin, a HIF-2 target and possible pharmacodynamic marker.  We identified a HIF-2-dependent gene signature in sensitive tumors.  Gene expression was largely unaffected by PT2399 in resistant tumors, illustrating the specificity of the drug.  Sensitive tumors exhibited a distinguishing gene expression signature and generally higher levels of HIF-2α.  Prolonged PT2399 treatment led to resistance.  We identified binding site and second site suppressor mutations in HIF-2α and HIF-1β, resp.  Both mutations preserved HIF-2 dimers despite treatment with PT2399.  Finally, an extensively pretreated patient whose tumor had given rise to a sensitive tumorgraft showed disease control for more than 11 mo when treated with a close analog of PT2399, PT2385.  We validate HIF-2 as a target in ccRCC, show that some ccRCCs are HIF-2 independent, and set the stage for biomarker-driven clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnxhUY1OeFy7Vg90H21EOLACvtfcHk0lisv0_2MmV71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslyis7rL&md5=006f9c774419f6226e22681286f43b6e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature19796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19796%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHill%26aufirst%3DH.%26aulast%3DChristie%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DHolloman%26aufirst%3DE.%26aulast%3DPavia-Jimenez%26aufirst%3DA.%26aulast%3DHomayoun%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DYell%26aufirst%3DP.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DYousuf%26aufirst%3DQ.%26aulast%3DJoyce%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DI.%26aulast%3DGeiger%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DReeves%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DT.%2BH.%26aulast%3DCourtney%26aufirst%3DK.%26aulast%3DFrenkel%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZojwalla%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DKapur%26aufirst%3DP.%26aulast%3DMcKay%26aufirst%3DR.%2BM.%26aulast%3DBrugarolas%26aufirst%3DJ.%26atitle%3DTargeting%2520renal%2520cell%2520carcinoma%2520with%2520a%2520HIF-2%2520antagonist%26jtitle%3DNature%26date%3D2016%26volume%3D539%26issue%3D7627%26spage%3D112%26epage%3D117%26doi%3D10.1038%2Fnature19796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordgren, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, A.</span></span> <span> </span><span class="NLM_article-title">Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4307</span>– <span class="NLM_lpage">4317</span>, <span class="refDoi"> DOI: 10.1039/c1cs15032d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2Fc1cs15032d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=21483947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=4307-4317&issue=8&author=I.+K.+Nordgrenauthor=A.+Tavassoli&title=Targeting+tumour+angiogenesis+with+small+molecule+inhibitors+of+hypoxia+inducible+factor&doi=10.1039%2Fc1cs15032d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor</span></div><div class="casAuthors">Nordgren, Ida Karin; Tavassoli, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4307-4317</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The adaptation of tumors to hypoxia is crit. for their survival and growth.  The high proliferation rate of solid tumors causes the continuous outstripping of the oxygen supply provided by the local vasculature, resulting in hypoxic regions within the tumor.  Hypoxia inducible factor (HIF) is the key mediator of cellular response to hypoxia, activating the expression of multiple genes that participate in angiogenesis, iron metab., glycolysis, glucose transport and cell proliferation and survival.  The crit. role of the hypoxia response network and HIF in cancer has resulted in it being viewed as an ideal target for small mol. intervention.  In this tutorial review we discuss the central role of HIF in the adaptation of tumors to a hypoxic environment, going on to describe recent attempts at developing small mols. that disrupt this pathway and their potential for use as the next generation anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqss09KS6Sw3rVg90H21EOLACvtfcHk0ljMP-DCe8Je4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVemurk%253D&md5=47759f99f7fe35b1d45748086c14d8bc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc1cs15032d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cs15032d%26sid%3Dliteratum%253Aachs%26aulast%3DNordgren%26aufirst%3DI.%2BK.%26aulast%3DTavassoli%26aufirst%3DA.%26atitle%3DTargeting%2520tumour%2520angiogenesis%2520with%2520small%2520molecule%2520inhibitors%2520of%2520hypoxia%2520inducible%2520factor%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26issue%3D8%26spage%3D4307%26epage%3D4317%26doi%3D10.1039%2Fc1cs15032d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1038/nrc3183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnrc3183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aisbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=9-22&issue=1&author=B.+Keithauthor=R.+S.+Johnsonauthor=M.+C.+Simon&title=HIF1%CE%B1+and+HIF2%CE%B1%3A+sibling+rivalry+in+hypoxic+tumour+growth+and+progression&doi=10.1038%2Fnrc3183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression</span></div><div class="casAuthors">Keith, Brian; Johnson, Randall S.; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-22</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factors (HIFs) are broadly expressed in human cancers, and HIF1α and HIF2α were previously suspected to promote tumor progression through largely overlapping functions.  However, this relatively simple model has now been challenged in light of recent data from various approaches that reveal unique and sometimes opposing activities of these HIFα isoforms in both normal physiol. and disease.  These effects are mediated in part through the regulation of unique target genes, as well as through direct and indirect interactions with important oncoproteins and tumor suppressors, including MYC and p53.  As HIF inhibitors are currently undergoing clin. evaluation as cancer therapeutics, a more thorough understanding of the unique roles performed by HIF1α and HIF2α in human neoplasia is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5DWqO5HSWFrVg90H21EOLACvtfcHk0ljMP-DCe8Je4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aisbzM&md5=c306992e7ffe972c98a351a9b8217c57</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrc3183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3183%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DHIF1%25CE%25B1%2520and%2520HIF2%25CE%25B1%253A%2520sibling%2520rivalry%2520in%2520hypoxic%2520tumour%2520growth%2520and%2520progression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26issue%3D1%26spage%3D9%26epage%3D22%26doi%3D10.1038%2Fnrc3183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleadle, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mole, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakkola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barstead, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title"><i>C. elegans</i> EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(01)00507-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS0092-8674%2801%2900507-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11595184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFOntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2001&pages=43-54&issue=1&author=A.+C.+Epsteinauthor=R.+J.+M.+Gleadleauthor=L.+A.+McNeillauthor=K.+S.+Hewitsonauthor=J.+O%E2%80%99Rourkeauthor=D.+R.+Moleauthor=M.+Mukherjiauthor=E.+Metzenauthor=M.+I.+Wilsonauthor=A.+Dhandaauthor=Y.+M.+Tianauthor=N.+Massonauthor=D.+L.+Hamiltonauthor=P.+Jaakkolaauthor=R.+Barsteadauthor=J.+Hodgkinauthor=P.+H.+Maxwellauthor=C.+W.+Pughauthor=C.+J.+Schofieldauthor=P.+J.+Ratcliffe&title=C.+elegans+EGL-9+and+mammalian+homologs+define+a+family+of+dioxygenases+that+regulate+HIF+by+prolyl+hydroxylation&doi=10.1016%2FS0092-8674%2801%2900507-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation</span></div><div class="casAuthors">Epstein, Andrew C. R.; Gleadle, Jonathan M.; McNeill, Luke A.; Hewitson, Kirsty S.; O'Rourke, John; Mole, David R.; Mukherji, Mridul; Metzen, Eric; Wilson, Michael I.; Dhanda, Anu; Tian, Ya-Min; Masson, Norma; Hamilton, Donald L.; Jaakkola, Panu; Barstead, Robert; Hodgkin, Jonathan; Maxwell, Patrick H.; Pugh, Christopher W.; Schofield, Christopher J.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-54</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis.  Recent studies have defined posttranslational modification by prolyl hydroxylation as a key regulatory event that targets HIF-α subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex.  Here, we define a conserved HIF-VHL-prolyl hydroxylase pathway in C. elegans, and use a genetic approach to identify EGL-9 as a dioxygenase that regulates HIF by prolyl hydroxylation.  In mammalian cells, we show that the HIF-prolyl hydroxylases are represented by a series of isoforms bearing a conserved 2-histidine-1-carboxylate iron coordination motif at the catalytic site.  Direct modulation of recombinant enzyme activity by graded hypoxia, iron chelation, and cobaltous ions mirrors the characteristics of HIF induction in vivo, fulfilling requirements for these enzymes being oxygen sensors that regulate HIF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWz1IWEpVokbVg90H21EOLACvtfcHk0lhnvO8X1a4Ybw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFOntL0%253D&md5=a23d16c40ee5b3fa12c8e616e85ce771</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900507-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900507-4%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DA.%2BC.%26aulast%3DGleadle%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DJ.%26aulast%3DMole%26aufirst%3DD.%2BR.%26aulast%3DMukherji%26aufirst%3DM.%26aulast%3DMetzen%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DM.%2BI.%26aulast%3DDhanda%26aufirst%3DA.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DMasson%26aufirst%3DN.%26aulast%3DHamilton%26aufirst%3DD.%2BL.%26aulast%3DJaakkola%26aufirst%3DP.%26aulast%3DBarstead%26aufirst%3DR.%26aulast%3DHodgkin%26aufirst%3DJ.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DC.%2520elegans%2520EGL-9%2520and%2520mammalian%2520homologs%2520define%2520a%2520family%2520of%2520dioxygenases%2520that%2520regulate%2520HIF%2520by%2520prolyl%2520hydroxylation%26jtitle%3DCell%26date%3D2001%26volume%3D107%26issue%3D1%26spage%3D43%26epage%3D54%26doi%3D10.1016%2FS0092-8674%2801%2900507-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czyzyk-Krzeska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, J. W.</span></span> <span> </span><span class="NLM_article-title">Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">10430</span>– <span class="NLM_lpage">10435</span>, <span class="refDoi"> DOI: 10.1073/pnas.190332597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.190332597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10973499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10430-10435&issue=19&author=T.+Kamuraauthor=S.+Satoauthor=K.+Iwaiauthor=M.+Czyzyk-Krzeskaauthor=R.+C.+Conawayauthor=J.+W.+Conaway&title=Activation+of+HIF1alpha+ubiquitination+by+a+reconstituted+von+Hippel-Lindau+%28VHL%29+tumor+suppressor+complex&doi=10.1073%2Fpnas.190332597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span></div><div class="casAuthors">Kamura, Takumi; Sato, Shigeo; Iwai, Kazuhiro; Czyzyk-Krzeska, Maria; Conaway, Ronald C.; Conaway, Joan Weliky</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10430-10435</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the VHL tumor suppressor gene result in constitutive expression of many hypoxia-inducible genes, at least in part because of increases in the cellular level of hypoxia-inducible transcription factor HIF1α, which in normal cells is rapidly ubiquitinated and degraded by the proteasome under normoxic conditions.  The recent observation that the VHL protein is a subunit of an Skp1-Cul1/Cdc53-F-box (SCF)-like E3 ubiquitin ligase raised the possibility that VHL may be directly responsible for regulating cellular levels of HIF1α by targeting it for ubiquitination and proteolysis.  In this report, we test this hypothesis directly.  We report development of methods for prodn. of the purified recombinant VHL complex and present direct biochem. evidence that it can function with an E1 ubiquitin-activating enzyme and E2 ubiquitin-conjugating enzyme to activate HIF1α ubiquitination in vitro.  Our findings provide new insight into the function of the VHL tumor suppressor protein, and they provide a foundation for future investigations of the mechanisms underlying VHL regulation of oxygen-dependent gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjwQDn-YYjRLVg90H21EOLACvtfcHk0lhnvO8X1a4Ybw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D&md5=5ba458b01d352b6350e61c2dbdc074ca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.190332597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.190332597%26sid%3Dliteratum%253Aachs%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIwai%26aufirst%3DK.%26aulast%3DCzyzyk-Krzeska%26aufirst%3DM.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26atitle%3DActivation%2520of%2520HIF1alpha%2520ubiquitination%2520by%2520a%2520reconstituted%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520tumor%2520suppressor%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26issue%3D19%26spage%3D10430%26epage%3D10435%26doi%3D10.1073%2Fpnas.190332597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lando, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitelaw, M. L.</span></span> <span> </span><span class="NLM_article-title">Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">5556</span>),  <span class="NLM_fpage">858</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1126/science.1068592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1068592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11823643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFemtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=858-861&issue=5556&author=D.+Landoauthor=D.+J.+Peetauthor=D.+A.+Whelanauthor=J.+J.+Gormanauthor=M.+L.+Whitelaw&title=Asparagine+hydroxylation+of+the+HIF+transactivation+domain%3A+A+hypoxic+switch&doi=10.1126%2Fscience.1068592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch</span></div><div class="casAuthors">Lando, David; Peet, Daniel J.; Whelan, Dean A.; Gorman, Jeffrey J.; Whitelaw, Murray L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5556</span>),
    <span class="NLM_cas:pages">858-861</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The hypoxia-inducible factors (HIFs) 1α and 2α are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress.  This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel-Lindau (VHL tumor suppressor) ubiquitin ligase.  We now show that hypoxic induction of the C-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD.  Inhibitors of Fe(II)- and 2-oxoglutarate-dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator.  Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity.  Full induction of HIF-1α and 2α, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degrdn. and C-terminal transactivation domains, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpfguxNUc4bVg90H21EOLACvtfcHk0lhnvO8X1a4Ybw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFemtrs%253D&md5=45b32c44aa081c620c436ca246a640c9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1068592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1068592%26sid%3Dliteratum%253Aachs%26aulast%3DLando%26aufirst%3DD.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26aulast%3DWhelan%26aufirst%3DD.%2BA.%26aulast%3DGorman%26aufirst%3DJ.%2BJ.%26aulast%3DWhitelaw%26aufirst%3DM.%2BL.%26atitle%3DAsparagine%2520hydroxylation%2520of%2520the%2520HIF%2520transactivation%2520domain%253A%2520A%2520hypoxic%2520switch%26jtitle%3DScience%26date%3D2002%26volume%3D295%26issue%3D5556%26spage%3D858%26epage%3D861%26doi%3D10.1126%2Fscience.1068592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenchock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerfen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkiewicz, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>166</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cell.2016.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27368101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaitLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2016&pages=126-139&issue=1&author=K.+J.+Briggsauthor=P.+Koivunenauthor=S.+Caoauthor=K.+M.+Backusauthor=B.+A.+Olenchockauthor=H.+Patelauthor=Q.+Zhangauthor=S.+Signorettiauthor=G.+J.+Gerfenauthor=A.+L.+Richardsonauthor=A.+K.+Witkiewiczauthor=B.+F.+Cravattauthor=J.+Clardyauthor=W.+G.+Kaelin&title=Paracrine+induction+of+HIF+by+glutamate+in+breast+cancer%3A+EglN1+senses+cysteine&doi=10.1016%2Fj.cell.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine</span></div><div class="casAuthors">Briggs, Kimberly J.; Koivunen, Peppi; Cao, Shugeng; Backus, Keriann M.; Olenchock, Benjamin A.; Patel, Hetalben; Zhang, Qing; Signoretti, Sabina; Gerfen, Gary J.; Richardson, Andrea L.; Witkiewicz, Agnieszka K.; Cravatt, Benjamin F.; Clardy, Jon; Kaelin, William G. Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-139</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The HIF transcription factor promotes adaptation to hypoxia and stimulates the growth of certain cancers, including triple-neg. breast cancer (TNBC).  The HIFα subunit is usually prolyl-hydroxylated by EglN family members under normoxic conditions, causing its rapid degrdn.  We confirmed that TNBC cells secrete glutamate, which we found is both necessary and sufficient for the paracrine induction of HIF1α in such cells under normoxic conditions.  Glutamate inhibits the xCT glutamate-cystine antiporter, leading to intracellular cysteine depletion.  EglN1, the main HIFα prolyl-hydroxylase, undergoes oxidative self-inactivation in the absence of cysteine both in biochem. assays and in cells, resulting in HIF1α accumulation.  Therefore, EglN1 senses both oxygen and cysteine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpixbsM2Fx-erVg90H21EOLACvtfcHk0li99DDAN5vaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaitLbJ&md5=c73e36d306dfb7bcebb3b897c79c94fa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DBriggs%26aufirst%3DK.%2BJ.%26aulast%3DKoivunen%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DOlenchock%26aufirst%3DB.%2BA.%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DGerfen%26aufirst%3DG.%2BJ.%26aulast%3DRichardson%26aufirst%3DA.%2BL.%26aulast%3DWitkiewicz%26aufirst%3DA.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DClardy%26aufirst%3DJ.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DParacrine%2520induction%2520of%2520HIF%2520by%2520glutamate%2520in%2520breast%2520cancer%253A%2520EglN1%2520senses%2520cysteine%26jtitle%3DCell%26date%3D2016%26volume%3D166%26issue%3D1%26spage%3D126%26epage%3D139%26doi%3D10.1016%2Fj.cell.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishbane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, I. C.</span></span> <span> </span><span class="NLM_article-title">Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1159/000455166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1159%2F000455166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28118622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvF2jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=187-199&issue=3&author=F.+Locatelliauthor=S.+Fishbaneauthor=G.+A.+Blockauthor=I.+C.+Macdougall&title=Targeting+hypoxia-inducible+factors+for+the+treatment+of+anemia+in+chronic+kidney+disease+patients&doi=10.1159%2F000455166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients</span></div><div class="casAuthors">Locatelli, Francesco; Fishbane, Steven; Block, Geoffrey A.; MacDougall, Iain C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Anemia, a common complication of chronic kidney disease (CKD), has previously been attributed primarily to decreased prodn. of erythropoietin.  More recently, it has become apparent that the etiol. of anemia involves several other factors, most notably dysfunctional iron metab., mediated via increased hepcidin activity and reduced clearance.  Current management of anemia in patients with advanced CKD is based on erythropoiesis-stimulating agents and iron supplementation, along with red blood cell transfusions when necessary; however, safety considerations assocd. with these therapies highlight the need to pursue alternative treatment options targeting other mechanisms such as hypoxia-inducible factors (HIFs) that act as central regulators of erythropoiesis by coordinating a series of graded hypoxic responses.  Summary: This review discusses the discovery of the HIF pathway and its regulation via HIF prolyl hydroxylase enzymes in the context of erythropoiesis and iron metab.  The rationale for targeting this pathway and the clin. development of HIF prolyl hydroxylase inhibitors are reviewed, with a commentary on the potential implications of this class of agents in CKD anemia management.  Key Messages: Pharmacol. activation of the HIF pathway results in a transient pseudo-hypoxic state that stimulates erythropoiesis in CKD patients with anemia.  Results from clin. studies of a no. of HIF prolyl hydroxylase inhibitors are increasingly available and provide support for the continued evaluation of the risk-benefit ratio of this novel therapeutic approach to the treatment of anemia in CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjrGsm4Prr1LVg90H21EOLACvtfcHk0li99DDAN5vaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvF2jsr8%253D&md5=1ebf14b1fea55a5ce5834517ef75ca69</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1159%2F000455166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000455166%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DFishbane%26aufirst%3DS.%26aulast%3DBlock%26aufirst%3DG.%2BA.%26aulast%3DMacdougall%26aufirst%3DI.%2BC.%26atitle%3DTargeting%2520hypoxia-inducible%2520factors%2520for%2520the%2520treatment%2520of%2520anemia%2520in%2520chronic%2520kidney%2520disease%2520patients%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2017%26volume%3D45%26issue%3D3%26spage%3D187%26epage%3D199%26doi%3D10.1159%2F000455166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spivak-Kroizman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeure, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hingorani, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palculict, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiriakova, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmelek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeusz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span> <span> </span><span class="NLM_article-title">Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3235</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-11-1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23633488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFSqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3235-3247&issue=11&author=T.+R.+Spivak-Kroizmanauthor=G.+Hostetterauthor=R.+Posnerauthor=M.+Azizauthor=C.+Huauthor=M.+J.+Demeureauthor=D.+Von+Hoffauthor=S.+R.+Hingoraniauthor=T.+B.+Palculictauthor=J.+Izzoauthor=G.+M.+Kiriakovaauthor=M.+Abdelmelekauthor=G.+Bartholomeuszauthor=B.+P.+Jamesauthor=G.+Powis&title=Hypoxia+triggers+hedgehog-mediated+tumor-stromal+interactions+in+pancreatic+cancer&doi=10.1158%2F0008-5472.CAN-11-1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer</span></div><div class="casAuthors">Spivak-Kroizman, Taly R.; Hostetter, Galen; Posner, Richard; Aziz, Meraj; Hu, Chengcheng; Demeure, Michael J.; Von Hoff, Daniel; Hingorani, Sunil R.; Palculict, Timothy B.; Izzo, Julie; Kiriakova, Galina M.; Abdelmelek, Mena; Bartholomeusz, Geoffrey; James, Brian P.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3235-3247</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is characterized by a desmoplastic reaction that creates a dense fibroinflammatory microenvironment, promoting hypoxia and limiting cancer drug delivery due to decreased blood perfusion.  Here, we describe a novel tumor-stroma interaction that may help explain the prevalence of desmoplasia in this cancer.  Specifically, we found that activation of hypoxia-inducible factor-α (HIF-1α) by tumor hypoxia strongly activates secretion of the sonic hedgehog (SHH) ligand by cancer cells, which in turn causes stromal fibroblasts to increase fibrous tissue deposition.  In support of this finding, elevated levels of HIF-1α and SHH in pancreatic tumors were detd. to be markers of decreased patient survival.  Repeated cycles of hypoxia and desmoplasia amplified each other in a feed forward loop that made tumors more aggressive and resistant to therapy.  This loop could be blocked by HIF-1α inhibition, which was sufficient to block SHH prodn. and hedgehog signaling.  Taken together, our findings suggest that increased HIF-1α produced by hypoxic tumors triggers the desmoplasic reaction in pancreatic cancer, which is then amplified by a feed forward loop involving cycles of decreased blood flow and increased hypoxia.  Our findings strengthen the rationale for testing HIF inhibitors and may therefore represent a novel therapeutic option for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEC-EkRE3eA7Vg90H21EOLACvtfcHk0li99DDAN5vaRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFSqsrc%253D&md5=619e19ddd9ccfe02924ce2a65f6cbb82</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1433%26sid%3Dliteratum%253Aachs%26aulast%3DSpivak-Kroizman%26aufirst%3DT.%2BR.%26aulast%3DHostetter%26aufirst%3DG.%26aulast%3DPosner%26aufirst%3DR.%26aulast%3DAziz%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DDemeure%26aufirst%3DM.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%26aulast%3DHingorani%26aufirst%3DS.%2BR.%26aulast%3DPalculict%26aufirst%3DT.%2BB.%26aulast%3DIzzo%26aufirst%3DJ.%26aulast%3DKiriakova%26aufirst%3DG.%2BM.%26aulast%3DAbdelmelek%26aufirst%3DM.%26aulast%3DBartholomeusz%26aufirst%3DG.%26aulast%3DJames%26aufirst%3DB.%2BP.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DHypoxia%2520triggers%2520hedgehog-mediated%2520tumor-stromal%2520interactions%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26issue%3D11%26spage%3D3235%26epage%3D3247%26doi%3D10.1158%2F0008-5472.CAN-11-1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">11570</span>– <span class="NLM_lpage">11572</span>, <span class="refDoi"> DOI: 10.1073/pnas.192442299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.192442299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12186981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11570-11572&issue=18&author=G.+L.+Semenza&title=Physiology+meets+biophysics%3A+visualizing+the+interaction+of+hypoxia-inducible+factor+1%CE%B1+with+p300+and+CBP&doi=10.1073%2Fpnas.192442299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11570-11572</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review on the mol. mechanism for the oxygen-dependent regulation of the expression and transcriptional activity of hypoxia-inducible factor 1α (HIF-1α).  The binding of the coactivators CBP (CREB-binding protein) and p300 to the carboxyl-terminal transactivation domain (TAD-C) is crit. for HIF-1 transcriptional activity.  Oxygen-dependent hydroxylation of Asn-803 in TAD-C domain of HIF-1 can disrupt this interaction.  HIF-1α TAD-C binds to a domain in p300 and CBP that is known as the cysteine/histidine-rich 1 (CH1) or transcriptional adapter zinc-binding 1 (TAZ1) domain.  The recent NMR spectroscopic analyses of the structural interaction of HIF-1α TAD-C with the CH1/TAZ1 domain of either p300 or CBP are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN2MSfZhL27LVg90H21EOLACvtfcHk0lhH0z-axs2S1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqs7s%253D&md5=409271e316a744734f8272a771f9bcfd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192442299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192442299%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DPhysiology%2520meets%2520biophysics%253A%2520visualizing%2520the%2520interaction%2520of%2520hypoxia-inducible%2520factor%25201%25CE%25B1%2520with%2520p300%2520and%2520CBP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D18%26spage%3D11570%26epage%3D11572%26doi%3D10.1073%2Fpnas.192442299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leshchinsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caro, J.</span></span> <span> </span><span class="NLM_article-title">Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2984</span>– <span class="NLM_lpage">2992</span>, <span class="refDoi"> DOI: 10.1128/MCB.22.9.2984-2992.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1128%2FMCB.22.9.2984-2992.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11940656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFylsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2984-2992&issue=9&author=N.+Sangauthor=J.+Fangauthor=V.+Srinivasauthor=I.+Leshchinskyauthor=J.+Caro&title=Carboxyl-terminal+transactivation+activity+of+hypoxia-inducible+factor+1+alpha+is+governed+by+a+von+Hippel-Lindau+protein-independent%2C+hydroxylation-regulated+association+with+p300%2FCBP&doi=10.1128%2FMCB.22.9.2984-2992.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP</span></div><div class="casAuthors">Sang, Nianli; Fang, Jie; Srinivas, Vickram; Leshchinsky, Irene; Caro, Jaime</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2984-2992</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 complex (HIF-1) plays a pivotal role in oxygen homeostasis and adaptation to hypoxia.  Its function is controlled by both the protein stability and the transactivation activity of its alpha subunit, HIF-1α.  Hydroxylation of at least two prolyl residues in the oxygen-dependent degrdn. domain of HIF-1α regulates its interaction with the von Hippel-Lindau protein (VHL) that targets HIF-1α for ubiquitination and proteasomal degrdn.  Several prolyl hydroxylases have been found to specifically hydroxylate HIF-1α.  In this report, we investigated possible roles of VHL and hydroxylases in the regulation of the transactivation activity of the C-terminal activating domain (CAD) of HIF-1α.  We demonstrate that regulation of the transactivation activity of HIF-1α CAD also involves hydroxylase activity but does not require functional VHL.  In addn., stimulation of the CAD activity by a hydroxylase inhibitor, hypoxia, and desferrioxamine was severely blocked by the adenoviral oncoprotein E1A but not by an E1A mutant defective in targeting p300/CBP.  We further demonstrate that a hydroxylase inhibitor, hypoxia, and desferrioxamine promote the functional and phys. interaction between HIF-1α CAD and p300/CBP in vivo.  Taken together, our data provide evidence that hypoxia-regulated stabilization and transcriptional stimulation of HIF-1α function are regulated through partially overlapping but distinguishable pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4aoLCyMGskLVg90H21EOLACvtfcHk0lhH0z-axs2S1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFylsbw%253D&md5=46844a10eddfd9275179cbf646677d05</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.9.2984-2992.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.9.2984-2992.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DSrinivas%26aufirst%3DV.%26aulast%3DLeshchinsky%26aufirst%3DI.%26aulast%3DCaro%26aufirst%3DJ.%26atitle%3DCarboxyl-terminal%2520transactivation%2520activity%2520of%2520hypoxia-inducible%2520factor%25201%2520alpha%2520is%2520governed%2520by%2520a%2520von%2520Hippel-Lindau%2520protein-independent%252C%2520hydroxylation-regulated%2520association%2520with%2520p300%252FCBP%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26issue%3D9%26spage%3D2984%26epage%3D2992%26doi%3D10.1128%2FMCB.22.9.2984-2992.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poy, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5367</span>– <span class="NLM_lpage">5372</span>, <span class="refDoi"> DOI: 10.1073/pnas.082117899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.082117899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11959990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=5367-5372&issue=8&author=S.+J.+Freedmanauthor=Z.+Y.+Sunauthor=J.+F.+Poyauthor=A.+L.+Kungauthor=D.+M.+Livingstonauthor=G.+Wagnerauthor=M.+J.+Eck&title=Structural+basis+for+recruitment+of+CBP%2Fp300+by+hypoxia-inducible+factor-1%CE%B1&doi=10.1073%2Fpnas.082117899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α</span></div><div class="casAuthors">Freedman, Steven J.; Sun, Zhen-Yu J.; Poy, Florence; Kung, Andrew L.; Livingston, David M.; Wagner, Gerhard; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5367-5372</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Adaptation to hypoxia is mediated by transactivation of hypoxia-responsive genes by hypoxia-inducible factor-1 (HIF-1) in complex with the CBP and p300 transcriptional coactivators.  We report the soln. structure of the cysteine/histidine-rich 1 (CH1) domain of p300 bound to the C-terminal transactivation domain of HIF-1α.  CH1 has a triangular geometry composed of four α-helixes with three intervening Zn2+-coordinating centers.  CH1 serves as a scaffold for folding of the HIF-1α C-terminal transactivation domain, which forms a vise-like clamp on the CH1 domain that is stabilized by extensive hydrophobic and polar interactions.  The structure reveals the mechanism of specific recognition of p300 by HIF-1α, and shows how HIF-1α transactivation is regulated by asparagine hydroxylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrILX4VebplX7Vg90H21EOLACvtfcHk0lhH0z-axs2S1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFKlsL4%253D&md5=89e6f7a3be011184c0d2fc7cd7c80d80</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.082117899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.082117899%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DPoy%26aufirst%3DJ.%2BF.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520recruitment%2520of%2520CBP%252Fp300%2520by%2520hypoxia-inducible%2520factor-1%25CE%25B1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D8%26spage%3D5367%26epage%3D5372%26doi%3D10.1073%2Fpnas.082117899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henchey, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hypoxia inducible factor 1 transcription coactivator interaction by a hydrogen bond surrogate α-helix</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1021/ja9082864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9082864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=941-943&issue=3&author=L.+K.+Hencheyauthor=S.+Kushalauthor=R.+Dubeyauthor=R.+N.+Chapmanauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=Inhibition+of+hypoxia+inducible+factor+1+transcription+coactivator+interaction+by+a+hydrogen+bond+surrogate+%CE%B1-helix&doi=10.1021%2Fja9082864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxia Inducible Factor 1 - Transcription Coactivator Interaction by a Hydrogen Bond Surrogate α-Helix</span></div><div class="casAuthors">Henchey, Laura K.; Kushal, Swati; Dubey, Ramin; Chapman, Ross N.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">941-943</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers.  We report a stabilized α-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1α (HIF-1α) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300.  The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZknynNJEK87Vg90H21EOLACvtfcHk0lgQnVupXuUDDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alur%252FF&md5=1914debf74c9001d2c0ed6087d7081ea</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja9082864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9082864%26sid%3Dliteratum%253Aachs%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DChapman%26aufirst%3DR.%2BN.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DInhibition%2520of%2520hypoxia%2520inducible%2520factor%25201%2520transcription%2520coactivator%2520interaction%2520by%2520a%2520hydrogen%2520bond%2520surrogate%2520%25CE%25B1-helix%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26issue%3D3%26spage%3D941%26epage%3D943%26doi%3D10.1021%2Fja9082864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burslem, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warriner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule proteomimetic inhibitors of the HIF-1α-p300 protein-protein interaction</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1083</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.1002/cbic.201400009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fcbic.201400009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24782431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVSntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1083-1087&issue=8&author=G.+M.+Burslemauthor=H.+F.+Kyleauthor=A.+L.+Breezeauthor=T.+A.+Edwardsauthor=A.+Nelsonauthor=S.+L.+Warrinerauthor=A.+J.+Wilson&title=Small-molecule+proteomimetic+inhibitors+of+the+HIF-1%CE%B1-p300+protein-protein+interaction&doi=10.1002%2Fcbic.201400009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Proteomimetic Inhibitors of the HIF-1α-p300 Protein-Protein Interaction</span></div><div class="casAuthors">Burslem, George M.; Kyle, Hannah F.; Breeze, Alexander L.; Edwards, Thomas A.; Nelson, Adam; Warriner, Stuart L.; Wilson, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-1087</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The therapeutically relevant hypoxia inducible factor HIF-1α-p300 protein-protein interaction can be orthosterically inhibited with α-helix mimetics based on an oligoamide scaffold that recapitulates essential features of the C-terminal helix of the HIF-1α C-TAD (C-terminal transactivation domain).  Preliminary SAR studies demonstrated the important role of side-chain size and hydrophobicity/hydrophilicity in detg. potency.  These small mols. represent the first biophys. characterized HIF-1α-p300 PPI inhibitors and the first examples of small-mol. arom. oligoamide helix mimetics to be shown to have a selective binding profile.  Although the compds. were less potent than HIF-1α, the result is still remarkable in that the mimetic reproduces only three residues from the 42-residue HIF-1α C-TAD from which it is derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPBNsroQkON7Vg90H21EOLACvtfcHk0lgQnVupXuUDDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVSntrg%253D&md5=b687264154fe266515f9400b21f1a391</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201400009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201400009%26sid%3Dliteratum%253Aachs%26aulast%3DBurslem%26aufirst%3DG.%2BM.%26aulast%3DKyle%26aufirst%3DH.%2BF.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DEdwards%26aufirst%3DT.%2BA.%26aulast%3DNelson%26aufirst%3DA.%26aulast%3DWarriner%26aufirst%3DS.%2BL.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26atitle%3DSmall-molecule%2520proteomimetic%2520inhibitors%2520of%2520the%2520HIF-1%25CE%25B1-p300%2520protein-protein%2520interaction%26jtitle%3DChemBioChem%26date%3D2014%26volume%3D15%26issue%3D8%26spage%3D1083%26epage%3D1087%26doi%3D10.1002%2Fcbic.201400009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dames, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Yamout, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Guzman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5271</span>– <span class="NLM_lpage">5276</span>, <span class="refDoi"> DOI: 10.1073/pnas.082121399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.082121399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11959977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=5271-5276&issue=8&author=S.+A.+Damesauthor=M.+Martinez-Yamoutauthor=R.+N.+De-Guzmanauthor=H.+J.+Dysonauthor=P.+E.+Wright&title=Structural+basis+for+Hif-1+alpha+%2FCBP+recognition+in+the+cellular+hypoxic+response&doi=10.1073%2Fpnas.082121399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response</span></div><div class="casAuthors">Dames, Sonja A.; Martinez-Yamout, Maria; De Guzman, Roberto N.; Dyson, H. Jane; Wright, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5271-5276</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The cellular response to low tissue oxygen concns. is mediated by the hypoxia-inducible transcription factor HIF-1.  Under hypoxic conditions, HIF-1 activates transcription of crit. adaptive genes by recruitment of the general coactivators CBP/p300 through interactions with its α-subunit (Hif-1α).  Disruption of the Hif-1α/p300 interaction has been linked to attenuation of tumor growth.  To delineate the structural basis for this interaction, we have detd. the soln. structure of the complex between the carboxy-terminal activation domain (CAD) of Hif-1α and the zinc-binding TAZ1 (CH1) motif of cAMP response element binding protein (CREB) binding protein (CBP).  Despite the overall similarity of the TAZ1 structure to that of the TAZ2 (part of the CH3) domain of CBP, differences occur in the packing of helixes that can account for differences in specificity.  The unbound CAD is intrinsically disordered and remains relatively extended upon binding, wrapping almost entirely around the TAZ1 domain in a groove through much of its surface.  Three short helixes are formed upon binding, stabilized by intermol. interactions.  The Asn-803 side chain, which functions as a hypoxic switch, is located on the second of these helixes and is buried in the mol. interface.  The third helix of the Hif-1α CAD docks in a deep hydrophobic groove in TAZ1, providing extensive intermol. hydrophobic interactions that contribute to the stability of the complex.  The structure of this complex provides new insights into the mechanism through which Hif-1α recruits CBP/p300 in response to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmGZTdgpkoWrVg90H21EOLACvtfcHk0lgQnVupXuUDDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFKlsro%253D&md5=acda89a699984ab91f03c0968c416f2a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.082121399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.082121399%26sid%3Dliteratum%253Aachs%26aulast%3DDames%26aufirst%3DS.%2BA.%26aulast%3DMartinez-Yamout%26aufirst%3DM.%26aulast%3DDe-Guzman%26aufirst%3DR.%2BN.%26aulast%3DDyson%26aufirst%3DH.%2BJ.%26aulast%3DWright%26aufirst%3DP.%2BE.%26atitle%3DStructural%2520basis%2520for%2520Hif-1%2520alpha%2520%252FCBP%2520recognition%2520in%2520the%2520cellular%2520hypoxic%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D8%26spage%3D5271%26epage%3D5276%26doi%3D10.1073%2Fpnas.082121399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. E.</span></span> <span> </span><span class="NLM_article-title">Role of intrinsic protein disorder in the function and interactions of the transcriptional coactivators CREB-binding Protein (CBP) and p300</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6714</span>– <span class="NLM_lpage">6122</span>, <span class="refDoi"> DOI: 10.1074/jbc.R115.692020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.R115.692020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26851278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVyntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=6714-6122&issue=13&author=H.+J.+Dysonauthor=P.+E.+Wright&title=Role+of+intrinsic+protein+disorder+in+the+function+and+interactions+of+the+transcriptional+coactivators+CREB-binding+Protein+%28CBP%29+and+p300&doi=10.1074%2Fjbc.R115.692020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of intrinsic protein disorder in the function and interactions of the transcriptional coactivators CREB-binding protein (CBP) and p300</span></div><div class="casAuthors">Dyson, H. Jane; Wright, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6714-6722</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Transcriptional coactivators CREB-binding protein (CBP) and p300 undergo a particularly rich set of interactions with disordered and partly ordered partners, as a part of their ubiquitous role in facilitating transcription of genes.  CBP and p300 contain a no. of small structured domains that provide scaffolds for the interaction of disordered transactivation domains from a wide variety of partners, including p53, hypoxia-inducible factor 1α (HIF-1α), NF-κB, and STAT proteins, and are the targets for the interactions of disordered viral proteins that compete with cellular factors to disrupt signaling and subvert the cell cycle.  The functional diversity of the CBP/p300 interactome provides an excellent example of the power of intrinsic disorder to facilitate the complexity of living systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6SVRTjy0OFbVg90H21EOLACvtfcHk0ljEO5vaLEtgsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVyntr4%253D&md5=b42a41e633abe38f5072d058fd946334</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.692020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.692020%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DH.%2BJ.%26aulast%3DWright%26aufirst%3DP.%2BE.%26atitle%3DRole%2520of%2520intrinsic%2520protein%2520disorder%2520in%2520the%2520function%2520and%2520interactions%2520of%2520the%2520transcriptional%2520coactivators%2520CREB-binding%2520Protein%2520%2528CBP%2529%2520and%2520p300%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D13%26spage%3D6714%26epage%3D6122%26doi%3D10.1074%2Fjbc.R115.692020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poellinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span> <span> </span><span class="NLM_article-title">The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cmet.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20399150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtleis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=364-378&issue=5&author=N.+Zhangauthor=Z.+Fuauthor=S.+Linkeauthor=J.+Chicherauthor=J.+J.+Gormanauthor=D.+Viskauthor=G.+G.+Haddadauthor=L.+Poellingerauthor=D.+J.+Peetauthor=F.+Powellauthor=R.+S.+Johnson&title=The+asparaginyl+hydroxylase+factor+inhibiting+HIF-1alpha+is+an+essential+regulator+of+metabolism&doi=10.1016%2Fj.cmet.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The asparaginyl hydroxylase factor inhibiting HIF-1α is an essential regulator of metabolism</span></div><div class="casAuthors">Zhang, Na; Fu, Zhenxing; Linke, Sarah; Chicher, Johana; Gorman, Jeffrey J.; Visk, DeeAnn; Haddad, Gabriel G.; Poellinger, Lorenz; Peet, Daniel J.; Powell, Frank; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-378</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Factor inhibiting HIF-1α (FIH) is an asparaginyl hydroxylase.  Hydroxylation of HIF-α proteins by FIH blocks assocn. of HIFs with the transcriptional coactivators CBP/p300, thus inhibiting transcriptional activation.  We have created mice with a null mutation in the FIH gene and found that it has little or no discernable role in mice in altering classical aspects of HIF function, e.g., angiogenesis, erythropoiesis, or development.  Rather, it is an essential regulator of metab.: mice lacking FIH exhibit reduced body wt., elevated metabolic rate, hyperventilation, and improved glucose and lipid homeostasis and are resistant to high-fat-diet-induced wt. gain and hepatic steatosis.  Neuron-specific loss of FIH phenocopied some of the major metabolic phenotypes of the global null animals: those mice have reduced body wt., increased metabolic rate, and enhanced insulin sensitivity and are also protected against high-fat-diet-induced wt. gain.  These results demonstrate that FIH acts to a significant degree through the nervous system to regulate metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3n8qeyuQXk7Vg90H21EOLACvtfcHk0ljEO5vaLEtgsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtleis7g%253D&md5=9a0248ccf3984d8d257e9e1bdae308b2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DLinke%26aufirst%3DS.%26aulast%3DChicher%26aufirst%3DJ.%26aulast%3DGorman%26aufirst%3DJ.%2BJ.%26aulast%3DVisk%26aufirst%3DD.%26aulast%3DHaddad%26aufirst%3DG.%2BG.%26aulast%3DPoellinger%26aufirst%3DL.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26aulast%3DPowell%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DThe%2520asparaginyl%2520hydroxylase%2520factor%2520inhibiting%2520HIF-1alpha%2520is%2520an%2520essential%2520regulator%2520of%2520metabolism%26jtitle%3DCell%2520Metab.%26date%3D2010%26volume%3D11%26issue%3D5%26spage%3D364%26epage%3D378%26doi%3D10.1016%2Fj.cmet.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span> <span> </span><span class="NLM_article-title">YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1093/jnci/95.7.516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1093%2Fjnci%2F95.7.516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12671019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislyjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=516-525&issue=7&author=E.+J.+Yeoauthor=Y.+S.+Chunauthor=Y.+S.+Choauthor=J.+Kimauthor=J.+C.+Leeauthor=M.+S.+Kimauthor=J.+W.+Park&title=YC-1%3A+A+potential+anticancer+drug+targeting+hypoxia-inducible+factor+1&doi=10.1093%2Fjnci%2F95.7.516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1</span></div><div class="casAuthors">Yeo, Eun-Jin; Chun, Yang-Sook; Cho, Young-Suk; Kim, Jinho; Lee, June-Chul; Kim, Myung-Suk; Park, Jong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 alpha (HIF-1α), a component of HIF-1, is expressed in human tumors and renders cells able to survive and grow under hypoxic (low-oxygen) conditions.  YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, an agent developed for circulatory disorders that inhibits platelet aggregation and vascular contraction, inhibits HIF-1 activity in vitro.  We tested whether YC-1 inhibits HIF-1 and tumor growth in vivo.  Hep3B hepatoma, NCI-H87 stomach carcinoma, Caki-1 renal carcinoma, SiHa cervical carcinoma, and SK-N-MC neuroblastoma cells were grown as xenografts in immunodeficient mice (69 mice total).  After the tumors were 100-150 mm3, mice received daily i.p. injections of vehicle or YC-1 (30 μg/g) for 2 wk.  HIF-1α protein levels and vascularity in tumors were assessed by immunohistochem., and the expression of HIF-1-inducible genes (vascular endothelial growth factor, aldolase, and enolase) was assessed by reverse transcription-polymerase chain reaction.  All statistical tests were two-sided.  Compared with tumors from vehicle-treated mice, tumors from YC-1-treated mice were statistically significantly smaller (P<.01 for all comparisons), expressed lower levels of HIF-1α (P<.01 for all comparisons), were less vascularized (P<.01 for all comparisons), and expressed lower levels of HIF-1-inducible genes, regardless of tumor type.  The inhibition of HIF-1α activity in tumors from YC-1-treated mice is assocd. with blocked angiogenesis and an inhibition of tumor growth.  YC-1 has the potential to become the first antiangiogenic anticancer agent to target HIF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kqeoaq7INLVg90H21EOLACvtfcHk0ljEO5vaLEtgsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislyjs74%253D&md5=8b2370cf3dce9a7528cdcac7b2a93250</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.7.516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.7.516%26sid%3Dliteratum%253Aachs%26aulast%3DYeo%26aufirst%3DE.%2BJ.%26aulast%3DChun%26aufirst%3DY.%2BS.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26atitle%3DYC-1%253A%2520A%2520potential%2520anticancer%2520drug%2520targeting%2520hypoxia-inducible%2520factor%25201%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2003%26volume%3D95%26issue%3D7%26spage%3D516%26epage%3D525%26doi%3D10.1093%2Fjnci%2F95.7.516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchimaru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizaka-Kondoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1461</span>, <span class="refDoi"> DOI: 10.1039/c2md20134h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2Fc2md20134h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1455-1461&issue=11&author=A.+Takeuchiauthor=M.+Horiauthor=S.+Satoauthor=H.+S.+Banauthor=T.+Kuchimaruauthor=S.+Kizaka-Kondohauthor=T.+Yamoriauthor=H.+Nakamura&title=Synthesis+and+biological+activity+of+furanylindazoles+as+inhibitors+of+hypoxia+inducible+factor+%28HIF%29-1+transcriptional+activity&doi=10.1039%2Fc2md20134h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity</span></div><div class="casAuthors">Takeuchi, Ayano; Hori, Makihito; Sato, Shinichi; Ban, Hyun Seung; Kuchimaru, Takahiro; Kizaka-Kondoh, Shinae; Yamori, Takao; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1455-1461</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New YC-1 derivs. were synthesized and evaluated with HIF-1 transcriptional activity, and a potent deriv. shows activity in vivo.  Furthermore, for the mechanistic study of the YC-1 deriv., we evaluate the antiproliferative activity against 39 human cancer cell lines and the localization of active probes in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU6JkW56vrPLVg90H21EOLACvtfcHk0li23IcFbGhs3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrnK&md5=acd688d8471a74a2a044a1957fb43e2d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2Fc2md20134h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20134h%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DA.%26aulast%3DHori%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DKuchimaru%26aufirst%3DT.%26aulast%3DKizaka-Kondoh%26aufirst%3DS.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520furanylindazoles%2520as%2520inhibitors%2520of%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529-1%2520transcriptional%2520activity%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D1455%26epage%3D1461%26doi%3D10.1039%2Fc2md20134h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span> <span> </span><span class="NLM_article-title">Anti-angiogenesis Compounds</span>. <span class="NLM_patent">WO2007065010A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+W.+Park&title=Anti-angiogenesis+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BW.%26atitle%3DAnti-angiogenesis%2520Compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, T. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9308</span>– <span class="NLM_lpage">9319</span>, <span class="refDoi"> DOI: 10.1021/ja412434f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&issue=26&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+C.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+Mullerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+optimization+of+small-molecule+ligands+for+the+CBP%2Fp300+bromodomains&doi=10.1021%2Fja412434f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0li23IcFbGhs3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520small-molecule%2520ligands%2520for%2520the%2520CBP%252Fp300%2520bromodomains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D26%26spage%3D9308%26epage%3D9319%26doi%3D10.1021%2Fja412434f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arany, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunn, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span> <span> </span><span class="NLM_article-title">An essential role for p300/CBP in the cellular response to hypoxia</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">12969</span>– <span class="NLM_lpage">12973</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.23.12969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.93.23.12969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=8917528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK28XmvV2ksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=12969-12973&issue=23&author=Z.+Aranyauthor=L.+E.+Huangauthor=R.+Ecknerauthor=S.+Bhattacharyaauthor=C.+Jiangauthor=M.+A.+Goldbergauthor=H.+F.+Bunnauthor=D.+M.+Livingston&title=An+essential+role+for+p300%2FCBP+in+the+cellular+response+to+hypoxia&doi=10.1073%2Fpnas.93.23.12969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An essential role for p300/CBP in the cellular response to hypoxia</span></div><div class="casAuthors">Arany, Zoltan; Huang, L. Eric; Eckner, Richard; Bhattacharya, Shoumo; Jiang, Chian; Goldberg, Mark A.; Bunn, H. Franklin; Livingston, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12969-12973</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">P300 and CBP are homologous transcription adapters targeted by the E1A oncoprotein.  They participate in numerous biol. processes, including cell cycle arrest, differentiation, and transcription activation.  P300 and/or CBP (p300/CBP) also coactivate CREB.  How they participate in these processes is not yet known.  In a search for specific p300 binding proteins, the authors have cloned the intact cDNA for HIF-1α.  This transcription factor mediates hypoxic induction of genes encoding certain glycolytic enzymes, erythropoietin (Epo), and vascular endothelial growth factor.  Hypoxic conditions lead to the formation of a DNA binding complex contg. both HIF-1α and p300/CBP.  Hypoxia-induced transcription from the Epo promoter was specifically enhanced by ectopic p300 and inhibited by E1A binding to p300/CBP.  Hypoxia-induced VEGF and Epo mRNA synthesis were similarly inhibited by E1A.  Hence, p300/CBP-HIF complexes participate in the induction of hypoxia-responsive genes, including one (vascular endothelial growth factor) that plays a major role in tumor angiogenesis.  Paradoxically, these data, to the authors knowledge for the first time, suggest that p300/CBP are active in both transformation suppression and tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM-e4qQzJO8LVg90H21EOLACvtfcHk0li23IcFbGhs3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvV2ksL0%253D&md5=9e4664e6abbe36f1ab5112cd8601ceb5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.23.12969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.23.12969%26sid%3Dliteratum%253Aachs%26aulast%3DArany%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%2BE.%26aulast%3DEckner%26aufirst%3DR.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DM.%2BA.%26aulast%3DBunn%26aufirst%3DH.%2BF.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DAn%2520essential%2520role%2520for%2520p300%252FCBP%2520in%2520the%2520cellular%2520response%2520to%2520hypoxia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26issue%3D23%26spage%3D12969%26epage%3D12973%26doi%3D10.1073%2Fpnas.93.23.12969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabludoff, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornell-Kennon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memmert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naegeli, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span> <span> </span><span class="NLM_article-title">Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.ccr.2004.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15261140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlKnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=33-43&issue=1&author=A.+L.+Kungauthor=S.+D.+Zabludoffauthor=D.+S.+Franceauthor=S.+J.+Freedmanauthor=E.+A.+Tannerauthor=A.+Vieiraauthor=S.+Cornell-Kennonauthor=J.+Leeauthor=B.+Wangauthor=J.+Wangauthor=K.+Memmertauthor=H.+U.+Naegeliauthor=F.+Petersenauthor=M.+J.+Eckauthor=K.+W.+Bairauthor=A.+W.+Woodauthor=D.+M.+Livingston&title=Small+molecule+blockade+of+transcriptional+coactivation+of+the+hypoxia-inducible+factor+pathway&doi=10.1016%2Fj.ccr.2004.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway</span></div><div class="casAuthors">Kung, Andrew L.; Zabludoff, Sonya D.; France, Dennis S.; Freedman, Steven J.; Tanner, Elizabeth A.; Vieira, Annelisa; Cornell-Kennon, Susan; Lee, Jennifer; Wang, Beqing; Wang, Jamin; Memmert, Klaus; Naegeli, Hans-Ulrich; Petersen, Frank; Eck, Michael J.; Bair, Kenneth W.; Wood, Alexander W.; Livingston, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-43</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Homeostasis under hypoxic conditions is maintained through a coordinated transcriptional response mediated by the hypoxia-inducible factor (HIF) pathway and requires coactivation by the CBP and p300 transcriptional coactivators.  Through a target-based high-throughput screen, the authors identified chetomin as a disrupter of HIF binding to p300.  At a mol. level, chetomin disrupts the structure of the CH1 domain of p300 and precludes its interaction with HIF, thereby attenuating hypoxia-inducible transcription.  Systemic administration of chetomin inhibited hypoxia-inducible transcription within tumors and inhibited tumor growth.  These results demonstrate a therapeutic window for pharmacol. attenuation of HIF activity and further establish the feasibility of disrupting a signal transduction pathway by targeting the function of a transcriptional coactivator with a small mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKTy3mUgy2bbVg90H21EOLACvtfcHk0lhCbcWVm_qDVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlKnt7s%253D&md5=3caa81703ea36d0be098ba295ade1748</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26aulast%3DTanner%26aufirst%3DE.%2BA.%26aulast%3DVieira%26aufirst%3DA.%26aulast%3DCornell-Kennon%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMemmert%26aufirst%3DK.%26aulast%3DNaegeli%26aufirst%3DH.%2BU.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DWood%26aufirst%3DA.%2BW.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DSmall%2520molecule%2520blockade%2520of%2520transcriptional%2520coactivation%2520of%2520the%2520hypoxia-inducible%2520factor%2520pathway%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26issue%3D1%26spage%3D33%26epage%3D43%26doi%3D10.1016%2Fj.ccr.2004.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Munari, S.</span>; <span class="NLM_string-name">Grugni, M.</span>; <span class="NLM_string-name">Menta, E.</span>; <span class="NLM_string-name">Cassin, M.</span>; <span class="NLM_string-name">Colella, G.</span></span> <span> </span><span class="NLM_article-title">Use of diketodithiopiperazine Antibiotics for the Preparation of Antiangiogenic Pharmaceutical Compositions</span>. <span class="NLM_patent">WO2006066775A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+De+Munari&author=M.+Grugni&author=E.+Menta&author=M.+Cassin&author=G.+Colella&title=Use+of+diketodithiopiperazine+Antibiotics+for+the+Preparation+of+Antiangiogenic+Pharmaceutical+Compositions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMunari%26aufirst%3DS.%26atitle%3DUse%2520of%2520diketodithiopiperazine%2520Antibiotics%2520for%2520the%2520Preparation%2520of%2520Antiangiogenic%2520Pharmaceutical%2520Compositions%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dial, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. J.</span></span> <span> </span><span class="NLM_article-title">Three conformational states of the p300 CH1 domain define its functional properties</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">9937</span>– <span class="NLM_lpage">9945</span>, <span class="refDoi"> DOI: 10.1021/bi034989o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi034989o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=9937-9945&issue=33&author=R.+Dialauthor=Z.+Y.+J.+Sunauthor=S.+J.+Freedman&title=Three+conformational+states+of+the+p300+CH1+domain+define+its+functional+properties&doi=10.1021%2Fbi034989o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Three Conformational States of the p300 CH1 Domain Define Its Functional Properties</span></div><div class="casAuthors">Dial, Ravina; Sun, Zhen-Yu J.; Freedman, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">9937-9945</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Numerous transcription factors interact with the basal transcriptional machinery through the transcriptional co-activators p300 and CREB-binding protein (CBP).  The Zn2+-binding cysteine/histidine-rich 1 (CH1) domain of p300/CBP binds many of these transcription factors, including hypoxia-inducible factor (HIF).  The authors studied the structural and biophys. properties of the p300 CH1 domain alone and bound to the HIF-1α C-terminal transactivation domain (TAD) to understand the diverse binding properties of CH1.  The Zn2+-bound CH1 domain (CH1-Zn2+) and the HIF-1α TAD-CH1 complex (CH1-Zn2+-HIF-1α) are similarly helical, whereas metal-free CH1 is mostly random coil.  CH1-Zn2+ undergoes noncooperative thermal denaturation, does not have a near-UV elliptical signal, and binds the hydrophobic fluorophore ANS.  In contrast, the CH1-Zn2+-HIF-1α complex undergoes cooperative thermal denaturation, does produce a near-UV signal, and does not bind ANS.  Addn. of Zn2+ ions to metal-free CH1 produced one conformational change, and subsequent addn. of a HIF-1α TAD peptide induced a second conformational change as detected by intrinsic tryptophan fluorescence spectroscopy.  The NMR 1H-15N HSQC spectrum of CH1-Zn2+ exhibits few poorly dispersed peaks with broad line widths.  Removal of metal ions produces more poorly dispersed peaks with sharper line widths.  Addn. of a HIF-1α TAD peptide to CH1-Zn2+ produces many well-dispersed peaks with sharp line widths.  Taken together, these data support three conformational states for CH1, including an unstructured metal-free domain, a partially structured Zn2+-bound domain with molten globule characteristics, and a stable, well-ordered HIF-1α TAD-CH1 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8FPKW355mwrVg90H21EOLACvtfcHk0lhCbcWVm_qDVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVSjs70%253D&md5=1ef2323f606e713aca4e1ef6dc6303e2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi034989o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi034989o%26sid%3Dliteratum%253Aachs%26aulast%3DDial%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DZ.%2BY.%2BJ.%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26atitle%3DThree%2520conformational%2520states%2520of%2520the%2520p300%2520CH1%2520domain%2520define%2520its%2520functional%2520properties%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26issue%3D33%26spage%3D9937%26epage%3D9945%26doi%3D10.1021%2Fbi034989o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goey, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnermann, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, K. R.</span></span> <span> </span><span class="NLM_article-title">Structural elucidation and synthesis of eudistidine A: an unusual polycyclic marine alkaloid that blocks interaction of the protein binding domains of p300 and HIF-1alpha</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5569</span>– <span class="NLM_lpage">5575</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b02156</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b02156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=5569-5575&issue=16&author=S.+T.+Chanauthor=P.+R.+Patelauthor=T.+R.+Ransomauthor=C.+J.+Henrichauthor=T.+C.+McKeeauthor=A.+K.+Goeyauthor=K.+M.+Cookauthor=W.+D.+Figgauthor=J.+B.+McMahonauthor=M.+J.+Schnermannauthor=K.+R.+Gustafson&title=Structural+elucidation+and+synthesis+of+eudistidine+A%3A+an+unusual+polycyclic+marine+alkaloid+that+blocks+interaction+of+the+protein+binding+domains+of+p300+and+HIF-1alpha&doi=10.1021%2Fjacs.5b02156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α</span></div><div class="casAuthors">Chan, Susanna T. S.; Patel, Paresma R.; Ransom, Tanya R.; Henrich, Curtis J.; McKee, Tawnya C.; Goey, Andrew K. L.; Cook, Kristina M.; Figg, William D.; McMahon, James B.; Schnermann, Martin J.; Gustafson, Kirk R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5569-5575</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Low oxygen environments are a hallmark of solid tumors, and transcription of many hypoxia-responsive genes needed for survival under these conditions is regulated by the transcription factor HIF-1 (hypoxia-inducible factor 1).  Activation of HIF-1 requires binding of its α-subunit (HIF-1α) to the transcriptional coactivator protein p300.  Inhibition of the p300/HIF-1α interaction can suppress HIF-1 activity.  A screen for inhibitors of the protein binding domains of p300 (CH1) and HIF-1α (C-TAD) identified an ext. of the marine ascidian Eudistoma sp. as active.  Novel heterocyclic alkaloids eudistidines A (1, I) and B (2, II) were isolated from the ext., and their structures assigned by spectroscopic analyses.  They contain an unprecedented tetracyclic core composed of two pyrimidine rings fused with an imidazole ring.  Eudistidine A (1) was synthesized in a concise four-step sequence featuring a condensation/cyclization reaction cascade between 4-(2-aminophenyl)pyrimidin-2-amine and (4-methoxyphenyl)glyoxal, while eudistidine B (2) was synthesized in a similar fashion with glyoxylic acid in place of (4-methoxyphenyl)glyoxal.  Naturally occurring eudistidine A (1) effectively inhibited CH1/C-TAD binding with an IC50 of 75 μM, and synthetic 1 had similar activity.  The eudistidine A (1) scaffold, which can be synthesized in a concise, scalable manner, may provide potential therapeutic lead compds. or mol. probes to study p300/HIF-1α interactions and the role these proteins play in tumor response to low oxygen conditions.  The unique structural scaffolds and functional group arrays often found in natural products make these secondary metabolites a rich source of new compds. that can disrupt crit. protein-protein binding events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtuQlTDBBMprVg90H21EOLACvtfcHk0lhCbcWVm_qDVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOisLw%253D&md5=6d8a4aa6c942772992b638c88f87702d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b02156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b02156%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BT.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DRansom%26aufirst%3DT.%2BR.%26aulast%3DHenrich%26aufirst%3DC.%2BJ.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DGoey%26aufirst%3DA.%2BK.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DSchnermann%26aufirst%3DM.%2BJ.%26aulast%3DGustafson%26aufirst%3DK.%2BR.%26atitle%3DStructural%2520elucidation%2520and%2520synthesis%2520of%2520eudistidine%2520A%253A%2520an%2520unusual%2520polycyclic%2520marine%2520alkaloid%2520that%2520blocks%2520interaction%2520of%2520the%2520protein%2520binding%2520domains%2520of%2520p300%2520and%2520HIF-1alpha%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26issue%3D16%26spage%3D5569%26epage%3D5575%26doi%3D10.1021%2Fjacs.5b02156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goey, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sissung, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venzon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grkovic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadelis, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span> <span> </span><span class="NLM_article-title">Screening and biological effects of marine pyrroloiminoquinone alkaloids:potential inhibitors of the HIF-1alpha/p300 interaction</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1275</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00846</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00846" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVShsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=1267-1275&issue=5&author=A.+K.+Goeyauthor=C.+H.+Chauauthor=T.+M.+Sissungauthor=K.+M.+Cookauthor=D.+J.+Venzonauthor=A.+Castroauthor=T.+R.+Ransomauthor=C.+J.+Henrichauthor=T.+C.+McKeeauthor=J.+B.+McMahonauthor=T.+Grkovicauthor=M.+M.+Cadelisauthor=B.+R.+Coppauthor=K.+R.+Gustafsonauthor=W.+D.+Figg&title=Screening+and+biological+effects+of+marine+pyrroloiminoquinone+alkaloids%3Apotential+inhibitors+of+the+HIF-1alpha%2Fp300+interaction&doi=10.1021%2Facs.jnatprod.5b00846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction</span></div><div class="casAuthors">Goey, Andrew K. L.; Chau, Cindy H.; Sissung, Tristan M.; Cook, Kristina M.; Venzon, David J.; Castro, Amaya; Ransom, Tanya R.; Henrich, Curtis J.; McKee, Tawnya C.; McMahon, James B.; Grkovic, Tanja; Cadelis, Melissa M.; Copp, Brent R.; Gustafson, Kirk R.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1267-1275</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Inhibition of the hypoxia-inducible factor 1α (HIF-1α) pathway by disrupting its assocn. with the transcriptional coactivator p300 inhibits angiogenesis and tumor development.  Development of HIF-1α/p300 inhibitors has been hampered by preclin. toxicity; therefore, we aimed to identify novel HIF-1α/p300 inhibitors.  Using a cell-free assay designed to test compds. that block HIF-1α/p300 binding, 170,298 crude natural product exts. and prefractionated samples were screened, identifying 25 active exts.  One of these exts., originating from the marine sponge Latrunculia sp., afforded six pyrroloiminoquinone alkaloids that were identified as pos. hits (IC50 values: 1-35 μM).  Luciferase assays confirmed inhibition of HIF-1α transcriptional activity by discorhabdin B (1) and its dimer (2), 3-dihydrodiscorhabdin C (3), makaluvamine F (5), discorhabdin H (8), discorhabdin L (9), and discorhabdin W (11) in HCT 116 colon cancer cells (0.1-10 μM, p < 0.05).  Except for 11, all of these compds. also reduced HIF-1α transcriptional activity in LNCaP prostate cancer cells (0.1-10 μM, p < 0.05).  These effects occurred at noncytotoxic concns. (<50% cell death) under hypoxic conditions.  At the downstream HIF-1α target level, compd. 8 (0.5 μM) significantly decreased VEGF secretion in LNCaP cells (p < 0.05).  In COLO 205 colon cancer cells no activity was shown in the luciferase or cytotoxicity assays.  Pyrroloiminoquinone alkaloids are a novel class of HIF-1α inhibitors, which interrupt the protein-protein interaction between HIF-1α and p300 and consequently reduce HIF-related transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUXDw3T75ifrVg90H21EOLACvtfcHk0lgT1PBLuEDXlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVShsr0%253D&md5=e5a0fbd3511e8b5d47fc26d947e8beb4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00846%26sid%3Dliteratum%253Aachs%26aulast%3DGoey%26aufirst%3DA.%2BK.%26aulast%3DChau%26aufirst%3DC.%2BH.%26aulast%3DSissung%26aufirst%3DT.%2BM.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DVenzon%26aufirst%3DD.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DRansom%26aufirst%3DT.%2BR.%26aulast%3DHenrich%26aufirst%3DC.%2BJ.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DGrkovic%26aufirst%3DT.%26aulast%3DCadelis%26aufirst%3DM.%2BM.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DGustafson%26aufirst%3DK.%2BR.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DScreening%2520and%2520biological%2520effects%2520of%2520marine%2520pyrroloiminoquinone%2520alkaloids%253Apotential%2520inhibitors%2520of%2520the%2520HIF-1alpha%252Fp300%2520interaction%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26issue%3D5%26spage%3D1267%26epage%3D1275%26doi%3D10.1021%2Facs.jnatprod.5b00846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Block, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polaske, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henchey, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makhoul, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meuillet, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span> <span> </span><span class="NLM_article-title">Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">18078</span>– <span class="NLM_lpage">18088</span>, <span class="refDoi"> DOI: 10.1021/ja807601b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja807601b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVWhuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=18078-18088&issue=50&author=K.+M.+Blockauthor=H.+Wangauthor=L.+Z.+Szaboauthor=N.+W.+Polaskeauthor=L.+K.+Hencheyauthor=R.+Dubeyauthor=S.+Kushalauthor=C.+F.+Laszloauthor=J.+Makhoulauthor=Z.+Songauthor=E.+J.+Meuilletauthor=B.+Z.+Olenyuk&title=Direct+inhibition+of+hypoxia-inducible+transcription+factor+complex+with+designed+dimeric+epidithiodiketopiperazine&doi=10.1021%2Fja807601b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Inhibition of Hypoxia-Inducible Transcription Factor Complex with Designed Dimeric Epidithiodiketopiperazine</span></div><div class="casAuthors">Block, Katherine M.; Wang, Hui; Szabo, Lajos Z.; Polaske, Nathan W.; Henchey, Laura K.; Dubey, Ramin; Kushal, Swati; Laszlo, Csaba F.; Makhoul, Joshua; Song, Zuohe; Meuillet, Emmanuelle J.; Olenyuk, Bogdan Z.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">18078-18088</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective blockade of hypoxia-inducible gene expression by designed small mols. would prove valuable in suppressing tumor angiogenesis, metastasis and altered energy metab.  The design, synthesis, and biol. evaluation of a dimeric epidithiodiketopiperazine (ETP) small mol. transcriptional antagonist targeting the interaction of the p300/CBP coactivator with the transcription factor HIF-1α is reported.  The results indicate that disrupting this interaction results in rapid down-regulation of hypoxia-inducible genes crit. for cancer progression.  The obsd. effects are compd.-specific and dose-dependent.  Controlling gene expression with designed small mols. targeting the transcription factor-coactivator interface may represent a new approach for arresting tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCjFazOhjGcbVg90H21EOLACvtfcHk0lgT1PBLuEDXlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVWhuro%253D&md5=426c5b85378abc54f86fbd31279fd21f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja807601b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja807601b%26sid%3Dliteratum%253Aachs%26aulast%3DBlock%26aufirst%3DK.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSzabo%26aufirst%3DL.%2BZ.%26aulast%3DPolaske%26aufirst%3DN.%2BW.%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DLaszlo%26aufirst%3DC.%2BF.%26aulast%3DMakhoul%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26atitle%3DDirect%2520inhibition%2520of%2520hypoxia-inducible%2520transcription%2520factor%2520complex%2520with%2520designed%2520dimeric%2520epidithiodiketopiperazine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D50%26spage%3D18078%26epage%3D18088%26doi%3D10.1021%2Fja807601b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzer, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span> <span> </span><span class="NLM_article-title">Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-Inducible transcription factor complex</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4537</span>– <span class="NLM_lpage">4549</span>, <span class="refDoi"> DOI: 10.1021/ja400805b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja400805b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=4537-4549&issue=11&author=R.+Dubeyauthor=M.+D.+Levinauthor=L.+Z.+Szaboauthor=C.+F.+Laszloauthor=S.+Kushalauthor=J.+B.+Singhauthor=P.+Ohauthor=J.+E.+Schnitzerauthor=B.+Z.+Olenyuk&title=Suppression+of+tumor+growth+by+designed+dimeric+epidithiodiketopiperazine+targeting+hypoxia-Inducible+transcription+factor+complex&doi=10.1021%2Fja400805b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of Tumor Growth by Designed Dimeric Epidithiodiketopiperazine Targeting Hypoxia-Inducible Transcription Factor Complex</span></div><div class="casAuthors">Dubey, Ramin; Levin, Michael D.; Szabo, Lajos Z.; Laszlo, Csaba F.; Kushal, Swati; Singh, Jason B.; Oh, Philip; Schnitzer, Jan E.; Olenyuk, Bogdan Z.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4537-4549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia is a hallmark of solid tumors, is assocd. with local invasion, metastatic spread, resistance to chemo- and radiotherapy, and is an independent, neg. prognostic factor for a diverse range of malignant neoplasms.  The cellular response to hypoxia is primarily mediated by a family of transcription factors, among which hypoxia-inducible factor 1 (HIF1) plays a major role.  Under normoxia, the oxygen-sensitive α subunit of HIF1 is rapidly and constitutively degraded but is stabilized and accumulates under hypoxia.  Upon nuclear translocation, HIF1 controls the expression of over 100 genes involved in angiogenesis, altered energy metab., antiapoptotic, and pro-proliferative mechanisms that promote tumor growth.  A designed transcriptional antagonist, dimeric epidithiodiketopiperazine (ETP 2), selectively disrupts the interaction of HIF1α with p300/CBP coactivators and downregulates the expression of hypoxia-inducible genes.  ETP 2 was synthesized via a novel homo-oxidative coupling of the aliph. primary carbons of the dithioacetal precursor.  It effectively inhibits HIF1-induced activation of VEGFA, LOX, Glut1, and c-Met genes in a panel of cell lines representing breast and lung cancers.  We obsd. an outstanding antitumor efficacy of both (±)-ETP 2 and meso-ETP 2 in a fully established breast carcinoma model by intravital microscopy.  Treatment with either form of ETP 2 (1 mg/kg) resulted in a rapid regression of tumor growth that lasted for up to 14 days.  These results suggest that inhibition of HIF1 transcriptional activity by designed dimeric ETPs could offer an innovative approach to cancer therapy with the potential to overcome hypoxia-induced tumor growth and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXlsOJ0fCSKLVg90H21EOLACvtfcHk0ljiH8lldHJyqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgtbs%253D&md5=c92889f1e42c63eb55680b9700fe327f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja400805b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja400805b%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DLevin%26aufirst%3DM.%2BD.%26aulast%3DSzabo%26aufirst%3DL.%2BZ.%26aulast%3DLaszlo%26aufirst%3DC.%2BF.%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%2BB.%26aulast%3DOh%26aufirst%3DP.%26aulast%3DSchnitzer%26aufirst%3DJ.%2BE.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26atitle%3DSuppression%2520of%2520tumor%2520growth%2520by%2520designed%2520dimeric%2520epidithiodiketopiperazine%2520targeting%2520hypoxia-Inducible%2520transcription%2520factor%2520complex%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D11%26spage%3D4537%26epage%3D4549%26doi%3D10.1021%2Fja400805b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jayatunga, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reece, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekirnik, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seden, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.ejmech.2014.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25023609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=509-516&author=M.+K.+Jayatungaauthor=P.+S.+Thompsonauthor=T.+C.+McKeeauthor=M.+C.+Chanauthor=K.+M.+Reeceauthor=A.+P.+Hardyauthor=R.+Sekirnikauthor=P.+T.+Sedenauthor=K.+M.+Cookauthor=J.+B.+McMahonauthor=W.+D.+Figgauthor=C.+J.+Schofieldauthor=A.+D.+Hamilton&title=Inhibition+of+the+HIF1%CE%B1-p300+interaction+by+quinone-+and+indandione-mediated+ejection+of+structural+Zn%28II%29&doi=10.1016%2Fj.ejmech.2014.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)</span></div><div class="casAuthors">Jayatunga, Madura K. P.; Thompson, Sam; McKee, Tawnya C.; Chan, Mun Chiang; Reece, Kelie M.; Hardy, Adam P.; Sekirnik, Rok; Seden, Peter T.; Cook, Kristina M.; McMahon, James B.; Figg, William D.; Schofield, Christopher J.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Protein-protein interactions between the hypoxia inducible factor (HIF) and the transcriptional coactivators p300/CBP are potential cancer targets due to their role in the hypoxic response.  A natural product based screen led to the identification of indandione and benzoquinone derivs. that reduce the tight interaction between a HIF-1α fragment and the CH1 domain of p300.  The indandione derivs. were shown to fragment to give ninhydrin, which was identified as the active species.  Both the naphthoquinones and ninhydrin were obsd. to induce Zn(II) ejection from p300 and the catalytic domain of the histone demethylase KDM4A.  Together with previous reports on the effects of related compds. on HIF-1α and other systems, the results suggest that care should be taken in interpreting biol. results obtained with highly electrophilic/thiol modifying compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDr1pjG22OaLVg90H21EOLACvtfcHk0ljiH8lldHJyqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtLnF&md5=5e6b8137d90072e24936c1321d16995f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DJayatunga%26aufirst%3DM.%2BK.%26aulast%3DThompson%26aufirst%3DP.%2BS.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DReece%26aufirst%3DK.%2BM.%26aulast%3DHardy%26aufirst%3DA.%2BP.%26aulast%3DSekirnik%26aufirst%3DR.%26aulast%3DSeden%26aufirst%3DP.%2BT.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DInhibition%2520of%2520the%2520HIF1%25CE%25B1-p300%2520interaction%2520by%2520quinone-%2520and%2520indandione-mediated%2520ejection%2520of%2520structural%2520Zn%2528II%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D509%26epage%3D516%26doi%3D10.1016%2Fj.ejmech.2014.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassin, M. M.</span>; <span class="NLM_string-name">Colella, G.</span>; <span class="NLM_string-name">De Munari, S. M.</span>; <span class="NLM_string-name">Grugni, M.</span></span> <span> </span><span class="NLM_article-title">Use of Thiazolidinone Derivatives as Antiangiogenic Agents</span>. <span class="NLM_patent">WO2006066846A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+M.+Cassin&author=G.+Colella&author=S.+M.+De+Munari&author=M.+Grugni&title=Use+of+Thiazolidinone+Derivatives+as+Antiangiogenic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCassin%26aufirst%3DM.%2BM.%26atitle%3DUse%2520of%2520Thiazolidinone%2520Derivatives%2520as%2520Antiangiogenic%2520Agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, D. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5249</span>– <span class="NLM_lpage">5252</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bmcl.2012.06.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22789427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVamtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5249-5252&issue=16&author=H.+S.+Kwonauthor=D.+R.+Kimauthor=E.+G.+Yangauthor=Y.+K.+Parkauthor=H.+C.+Ahnauthor=S.+J.+Minauthor=D.+R.+Ahn&title=Inhibition+of+VEGF+transcription+through+blockade+of+the+hypoxia+inducible+factor-1%CE%B1-p300+interaction+by+a+small+molecule&doi=10.1016%2Fj.bmcl.2012.06.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule</span></div><div class="casAuthors">Kwon, Hyuk Sung; Kim, Da-Rae; Yang, Eun Gyeong; Park, Yong Keun; Ahn, Hee-Chul; Min, Sun-Joon; Ahn, Dae-Ro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5249-5252</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) plays a pro-angiogenic role in tumor progression.  Stabilization of a key regulator termed the hypoxia inducible factor (HIF)-1α under oxygen deficient environment around tumor is known to elicit expression of VEGF through binding to p300.  Thus, inhibition of the HIF-1α-p300 interaction would lead to down-regulation of VEGF expression, thereby providing potential cancer therapeutics.  Here, we have screened a chem. library against the interaction of the HIF-1α-derived peptide with p300 employing a fluorescence polarization-based assay.  We have identified a compd. as the most prominent inhibitor against the protein-protein interaction.  Further, we have obsd. suppression of the mRNA level of VEGF upon treatment of HeLa cells with the compd., demonstrating its inhibitory effect at the cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9yvc4cCB0rVg90H21EOLACvtfcHk0ljiH8lldHJyqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVamtbvE&md5=413fc3103d82c2a5c6f1ba5b4f918465</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BR.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DPark%26aufirst%3DY.%2BK.%26aulast%3DAhn%26aufirst%3DH.%2BC.%26aulast%3DMin%26aufirst%3DS.%2BJ.%26aulast%3DAhn%26aufirst%3DD.%2BR.%26atitle%3DInhibition%2520of%2520VEGF%2520transcription%2520through%2520blockade%2520of%2520the%2520hypoxia%2520inducible%2520factor-1%25CE%25B1-p300%2520interaction%2520by%2520a%2520small%2520molecule%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D16%26spage%3D5249%26epage%3D5252%26doi%3D10.1016%2Fj.bmcl.2012.06.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Noronha, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boreddy, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruscato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van-Meir, E. G.</span></span> <span> </span><span class="NLM_article-title">Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6623</span>– <span class="NLM_lpage">6633</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1078-0432.CCR-12-0861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22923450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFSiurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6623-6633&issue=24&author=S.+Yinauthor=S.+Kaluzauthor=N.+S.+Deviauthor=A.+A.+Jabbarauthor=R.+G.+de+Noronhaauthor=J.+Munauthor=Z.+Zhangauthor=P.+R.+Boreddyauthor=W.+Wangauthor=Z.+Wangauthor=T.+Abbruscatoauthor=Z.+Chenauthor=J.+J.+Olsonauthor=R.+Zhangauthor=M.+M.+Goodmanauthor=K.+C.+Nicolaouauthor=E.+G.+Van-Meir&title=Arylsulfonamide+KCN1+inhibits+in+vivo+glioma+growth+and+interferes+with+HIF+signaling+by+disrupting+HIF-1%CE%B1+interaction+with+cofactors+p300%2FCBP&doi=10.1158%2F1078-0432.CCR-12-0861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP</span></div><div class="casAuthors">Yin, Shaoman; Kaluz, Stefan; Devi, Narra S.; Jabbar, Adnan A.; de Noronha, Rita G.; Mun, Jiyoung; Zhang, Zhaobin; Boreddy, Purushotham R.; Wang, Wei; Wang, Zhibo; Abbruscato, Thomas; Chen, Zhengjia; Olson, Jeffrey J.; Zhang, Ruiwen; Goodman, Mark M.; Nicolaou, K. C.; Van Meir, Erwin G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6623-6633</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The hypoxia-inducible factor-1 (HIF-1) plays a crit. role in tumor adaptation to hypoxia, and its elevated expression correlates with poor prognosis and treatment failure in patients with cancer.  In this study, we detd. whether 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, KCN1, the lead inhibitor in a novel class of arylsulfonamide inhibitors of the HIF-1 pathway, had antitumorigenic properties in vivo and further defined its mechanism of action.  Exptl. Design: We studied the inhibitory effect of systemic KCN1 delivery on the growth of human brain tumors in mice.  To define mechanisms of KCN1 anti-HIF activities, we examd. its influence on the assembly of a functional HIF-1α/HIF-1β/p300 transcription complex.  Results: KCN1 specifically inhibited HIF reporter gene activity in several glioma cell lines at the nanomolar level.  KCN1 also downregulated transcription of endogenous HIF-1 target genes, such as VEGF, Glut-1, and carbonic anhydrase 9, in a hypoxia-responsive element (HRE)-dependent manner.  KCN1 potently inhibited the growth of s.c. malignant glioma tumor xenografts with minimal adverse effects on the host.  It also induced a temporary survival benefit in an intracranial model of glioma but had no effect in a model of melanoma metastasis to the brain.  Mechanistically, KCN1 did not downregulate the levels of HIF-1α or other components of the HIF transcriptional complex; rather, it antagonized hypoxia-inducible transcription by disrupting the interaction of HIF-1α with transcriptional coactivators p300/CBP.  Conclusions: Our results suggest that the new HIF pathway inhibitor KCN1 has antitumor activity in mouse models, supporting its further translation for the treatment of human tumors displaying hypoxia or HIF overexpression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjeEvHIu4G37Vg90H21EOLACvtfcHk0lhJqjKbSbFPYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFSiurfN&md5=5c755fea0b065156cf5dd489b5014062</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0861%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DS.%26aulast%3DKaluz%26aufirst%3DS.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3Dde%2BNoronha%26aufirst%3DR.%2BG.%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBoreddy%26aufirst%3DP.%2BR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAbbruscato%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DVan-Meir%26aufirst%3DE.%2BG.%26atitle%3DArylsulfonamide%2520KCN1%2520inhibits%2520in%2520vivo%2520glioma%2520growth%2520and%2520interferes%2520with%2520HIF%2520signaling%2520by%2520disrupting%2520HIF-1%25CE%25B1%2520interaction%2520with%2520cofactors%2520p300%252FCBP%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26issue%3D24%26spage%3D6623%26epage%3D6633%26doi%3D10.1158%2F1078-0432.CCR-12-0861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mooring, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van-Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8471</span>– <span class="NLM_lpage">8489</span>, <span class="refDoi"> DOI: 10.1021/jm201018g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201018g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8471-8489&issue=24&author=S.+R.+Mooringauthor=H.+Jinauthor=N.+S.+Deviauthor=A.+A.+Jabbarauthor=S.+Kaluzauthor=Y.+Liuauthor=E.+G.+Van-Meirauthor=B.+Wang&title=Design+and+synthesis+of+novel+small-molecule+inhibitors+of+the+hypoxia+inducible+factor+pathway&doi=10.1021%2Fjm201018g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway</span></div><div class="casAuthors">Mooring, Suazette Reid; Jin, Hui; Devi, Narra S.; Jabbar, Adnan A.; Kaluz, Stefan; Liu, Yuan; Van Meir, Erwin G.; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8471-8489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia, a redn. in partial oxygen pressure, is a salient property of solid tumors.  Hypoxia drives malignant progression and metastasis in tumors and participates in tumor resistance to radio- and chemotherapies.  Hypoxia activates the hypoxia-inducible factor (HIF) family of transcription factors, which induce target genes that regulate adaptive biol. processes such as anaerobic metab., cell motility, and angiogenesis.  Clin. evidence has demonstrated that expression of HIF-1 is strongly assocd. with poor patient prognosis and activation of HIF-1 contributes to malignant behavior and therapeutic resistance.  Consequently, HIF-1 has become an important therapeutic target for inhibition by small mols.  Herein, we describe the design and synthesis of small mols. that inhibit the HIF-1 signaling pathway.  Many of these compds. exhibit inhibitory activity in the nanomolar range.  Sep. mechanistic studies indicate that these inhibitors do not alter HIF-1 levels but interfere with the ability of HIF-1α/HIF-1β to interact with cofactors p300/CBP to form an active transcriptional complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC3eSwxgvkCLVg90H21EOLACvtfcHk0lhJqjKbSbFPYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO&md5=c21a16d41bf75cb886dc72753a880de9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm201018g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201018g%26sid%3Dliteratum%253Aachs%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DKaluz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DVan-Meir%26aufirst%3DE.%2BG.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520the%2520hypoxia%2520inducible%2520factor%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D24%26spage%3D8471%26epage%3D8489%26doi%3D10.1021%2Fjm201018g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Design and in vitro activities of N-Alkyl-N-((8-R-2,2-dimethyl-2H-chromen-6-yl)methyl)heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6738</span>– <span class="NLM_lpage">6750</span>, <span class="refDoi"> DOI: 10.1021/jm300752n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300752n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6738-6750&issue=15&author=J.+Munauthor=A.+A.+Jabbarauthor=N.+S.+Deviauthor=S.+Yinauthor=Y.+Wangauthor=C.+Tanauthor=D.+Culverauthor=J.+P.+Snyderauthor=E.+G.+Van+Meirauthor=M.+M.+Goodman&title=Design+and+in+vitro+activities+of+N-Alkyl-N-%28%288-R-2%2C2-dimethyl-2H-chromen-6-yl%29methyl%29heteroarylsulfonamides%2C+novel%2C+small-molecule+hypoxia+inducible+factor-1+pathway+inhibitors+and+anticancer+agents&doi=10.1021%2Fjm300752n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents</span></div><div class="casAuthors">Mun, Jiyoung; Jabbar, Adnan Abdul; Devi, Narra Sarojini; Yin, Shaoman; Wang, Yingzhe; Tan, Chalet; Culver, Deborah; Snyder, James P.; Van Meir, Erwin G.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6738-6750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypoxia inducible factor (HIF) pathway is an attractive target for cancer, as it controls tumor adaptation to growth under hypoxia and mediates chemotherapy and radiation resistance.  We previously discovered 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide as a novel, small-mol. HIF-1 pathway inhibitor in a high-throughput cell-based assay, but its in vivo delivery is hampered by poor aq. soly. (0.009 μM in water; log P7.4 = 3.7).  Here we describe the synthesis of 12 N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, which were designed to possess optimal lipophilicities and aq. solubilities by in silico calcns.  Exptl. log P7.4 values of 8 of the 12 new analogs ranged from 1.2-3.1.  Aq. solubilities of three analogs were measured, among which the most sol. N-[(8-methoxy-2,2-dimethyl-2H-chromen-6-yl)methyl]-N-(propan-2-yl)pyridine-2-sulfonamide had an aq. soly. of 80 μM, e.g., a soly. improvement of ∼9000-fold.  The pharmacol. optimization had limited impact on drug efficacy as the compds. retained IC50 values at or below 5 μM in our HIF-dependent reporter assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVawJDxwPEs7Vg90H21EOLACvtfcHk0lhJqjKbSbFPYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D&md5=8598c06dcaf2dfa4faec14fb3820299e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm300752n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300752n%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DDesign%2520and%2520in%2520vitro%2520activities%2520of%2520N-Alkyl-N-%2528%25288-R-2%252C2-dimethyl-2H-chromen-6-yl%2529methyl%2529heteroarylsulfonamides%252C%2520novel%252C%2520small-molecule%2520hypoxia%2520inducible%2520factor-1%2520pathway%2520inhibitors%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D15%26spage%3D6738%26epage%3D6750%26doi%3D10.1021%2Fjm300752n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span> <span> </span><span class="NLM_article-title">Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3136</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-11-120576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1182%2Fblood-2007-11-120576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18174379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvVamtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=3131-3136&issue=6&author=D.+H.+Shinauthor=Y.+S.+Chunauthor=D.+S.+Leeauthor=L.+E.+Huangauthor=J.+W.+Park&title=Bortezomib+inhibits+tumor+adaptation+to+hypoxia+by+stimulating+the+FIH-mediated+repression+of+hypoxia-inducible+factor-1&doi=10.1182%2Fblood-2007-11-120576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1</span></div><div class="casAuthors">Shin, Dong Hoon; Chun, Yang-Sook; Lee, Dong Soon; Huang, L. Eric; Park, Jong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3131-3136</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">B ortezomib (PS-341), a proteasome inhibitor, was examd. clin. for the treatment of multiple myeloma and several solid tumors.  Bortezomib directly induces tumor cell death and was also reported to inhibit tumor adaptation to hypoxia by functionally inhibiting hypoxia-inducible factor-1α (HIF-1α).  However, the mechanism underlying HIF-1 inhibition by bortezomib remains obscure.  In the present study, we demonstrated that bortezomib attenuated the hypoxic induction of erythropoietin and vascular endothelial growth factor at subnanomolar concns. in multiple myeloma and liver cancer cell lines, regardless of cytotoxic concns. of bortezomib.  Bortezomib repressed HIF-1α activity by inhibiting the recruitment of p300 coactivator.  Specifically, bortezomib targeted HIF-1α C-terminal transactivation domain (CAD) but not the CAD lacking Asn803, which is a hydroxylation site by the factor inhibiting HIF-1 (FIH).  Accordingly, this effect of bortezomib on CAD was augmented by FIH expression and abolished by FIH knock-down.  Furthermore, bortezomib stimulated the interaction between CAD and FIH under hypoxic conditions, and FIH inhibition reversed the suppressions of erythropoietin and vascular endothelial growth factor by bortezomib.  We propose that the mechanism underlying the inhibitory effects of bortezomib on tumor angiogenesis and hypoxic adaptation involves the repression of HIF-1α transcriptional activity by reinforcing the FIH-mediated inhibition of p300 recruitment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoH9RkSejPUrVg90H21EOLACvtfcHk0lghNZ3au9kMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvVamtbw%253D&md5=f24d6df8d498087281c30f8915d65347</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-11-120576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-11-120576%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DChun%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DHuang%26aufirst%3DL.%2BE.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26atitle%3DBortezomib%2520inhibits%2520tumor%2520adaptation%2520to%2520hypoxia%2520by%2520stimulating%2520the%2520FIH-mediated%2520repression%2520of%2520hypoxia-inducible%2520factor-1%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26issue%3D6%26spage%3D3131%26epage%3D3136%26doi%3D10.1182%2Fblood-2007-11-120576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span> <span> </span><span class="NLM_article-title">Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>434</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2013.04.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2013.04.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23618863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2013&pages=879-884&issue=4&author=Y.+R.+Naauthor=K.+C.+Hanauthor=H.+Parkauthor=E.+G.+Yang&title=Menadione+and+ethacrynic+acid+inhibit+the+hypoxia-inducible+factor+%28HIF%29+pathway+by+disrupting+HIF-1%CE%B1+interaction+with+p300&doi=10.1016%2Fj.bbrc.2013.04.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300</span></div><div class="casAuthors">Na, Yu-Ran; Han, Ki-Cheol; Park, Hyunsung; Yang, Eun Gyeong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-884</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia is a general characteristic of most solid malignancies and intimately related to neoplastic diseases and cancer progression.  Homeostatic response to hypoxia is primarily mediated by hypoxia inducible factor (HIF)-1α that elicits transcriptional activity through recruitment of the CREB binding protein (CBP)/p300 coactivator.  Targeted blockade of HIF-1α binding to CBP/p300 would thus constitute a novel approach for cancer treatment by suppressing tumor angiogenesis and metastasis.  Here, we identified inhibitors against the interaction between HIF-1α and p300 by a fluorescence polarization-based assay employing a fluorescently-labeled peptide contg. the C-terminal activation domain of HIF-1α.  Two small mol. inhibitors, menadione (MD) and ethacrynic acid (EA), were found to decrease expression of luciferase under the control of hypoxia-responsive elements in hypoxic cells as well as to efficiently block the interaction between the full-length HIF-1α and p300.  While these compds. did not alter the expression level of HIF-1α, they down-regulated expression of a HIF-1α target vascular endothelial growth factor (VEGF) gene.  Considering hypoxia-induced VEGF expression leading to highly aggressive tumor growth, MD and EA may provide new scaffolds for development of tumor therapeutic reagents as well as tools for a better understanding of HIF-1α-mediated hypoxic regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Qy17dyErErVg90H21EOLACvtfcHk0lghNZ3au9kMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlWjurk%253D&md5=db88e1fec232934d68dcc7587623b61e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.04.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.04.044%26sid%3Dliteratum%253Aachs%26aulast%3DNa%26aufirst%3DY.%2BR.%26aulast%3DHan%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DE.%2BG.%26atitle%3DMenadione%2520and%2520ethacrynic%2520acid%2520inhibit%2520the%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%2520pathway%2520by%2520disrupting%2520HIF-1%25CE%25B1%2520interaction%2520with%2520p300%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D434%26issue%3D4%26spage%3D879%26epage%3D884%26doi%3D10.1016%2Fj.bbrc.2013.04.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e62014</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0062014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1371%2Fjournal.pone.0062014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23671581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Orsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=5&author=D.+Wuauthor=R.+Zhangauthor=R.+Zhaoauthor=G.+Chenauthor=Y.+Caiauthor=J.+Jin&title=A+novel+function+of+novobiocin%3A+disrupting+the+interaction+of+HIF+1%CE%B1+and+p300%2FCBP+through+direct+binding+to+the+HIF1%CE%B1+C-terminal+activation+domain&doi=10.1371%2Fjournal.pone.0062014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain</span></div><div class="casAuthors">Wu, Donglu; Zhang, Rui; Zhao, Rui; Chen, Guang; Cai, Yong; Jin, Jingji</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e62014</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1α (HIF1α) is an important cellular survival protein under hypoxic conditions, regulating the cellular response to low oxygen tension via recruitment of a transcriptional co-activator, p300/CBP.  P300/CBP induces expression of multiple genes involved in cell survival, proliferation, angiogenesis, and tumor development.  Thus, a strategy to inhibit hypoxic responses in tumors may be to target the protein-protein interaction between HIF1α and p300/CBP.  Here, we document, for the first time, that the aminocoumarin antibiotic, novobiocin, directly blocks the protein-protein interaction between the HIF1α C-terminal activation domain (CTAD) and the cysteine-histidine rich (CH1) region of p300/CBP.  Also, novobiocin down-regulated HIF1α-controlled gene expression, specifically CA9, which is related to tumorigenesis.  In a monolayer cell culture, novobiocin inhibited cell proliferation and colony formation in the MCF-7 human breast adenocarcinoma cell line and the A549 human lung cancer cell line.  Rescue expts. revealed that the recombinant CTAD fragment of HIF1α partially reversed novobiocin's inhibitory effects on cell proliferation and colony formation in MCF-7 cells.  These findings suggest a novel mechanism of action for novobiocin which has the potential for innovative therapeutic use in tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqF65Ed7qzYbVg90H21EOLACvtfcHk0lghNZ3au9kMbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Orsbg%253D&md5=7173700dd540ccab47c71d5ab3974ef9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0062014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0062014%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DA%2520novel%2520function%2520of%2520novobiocin%253A%2520disrupting%2520the%2520interaction%2520of%2520HIF%25201%25CE%25B1%2520and%2520p300%252FCBP%2520through%2520direct%2520binding%2520to%2520the%2520HIF1%25CE%25B1%2520C-terminal%2520activation%2520domain%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D5%26doi%3D10.1371%2Fjournal.pone.0062014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henchey, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesallati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traaseth, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">15602</span>– <span class="NLM_lpage">15607</span>, <span class="refDoi"> DOI: 10.1073/pnas.1312473110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.1312473110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24019500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15602-15607&issue=39&author=S.+Kushalauthor=B.+B.+Laoauthor=L.+K.+Hencheyauthor=R.+Dubeyauthor=H.+Mesallatiauthor=N.+J.+Traasethauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=Protein+domain+mimetics+as+in+vivo+modulators+of+hypoxia-inducible+factor+signaling&doi=10.1073%2Fpnas.1312473110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span></div><div class="casAuthors">Kushal, Swati; Lao, Brooke Bullock; Henchey, Laura K.; Dubey, Ramin; Mesallati, Hanah; Traaseth, Nathaniel J.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15602-15607,S15602/1-S15602/29</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Selective blockade of gene expression by designed small mols. is a fundamental challenge at the interface of chem., biol., and medicine.  Transcription factors have been among the most elusive targets in genetics and drug discovery, but the fields of chem. biol. and genetics have evolved to a point where this task can be addressed.  Herein we report the design, synthesis, and in vivo efficacy evaluation of a protein domain mimetic targeting the interaction of the p300/CBP coactivator with the transcription factor hypoxia-inducible factor-1α.  Our results indicate that disrupting this interaction results in a rapid down-regulation of hypoxia-inducible genes crit. for cancer progression.  The obsd. effects were compd.-specific and dose-dependent.  Gene expression profiling with oligonucleotide microarrays revealed effective inhibition of hypoxia-inducible genes with relatively minimal perturbation of nontargeted signaling pathways.  We obsd. remarkable efficacy of the compd. HBS 1 in suppressing tumor growth in the fully established murine xenograft models of renal cell carcinoma of the clear cell type.  Our results suggest that rationally designed synthetic mimics of protein subdomains that target the transcription factor-coactivator interfaces represent a unique approach for in vivo modulation of oncogenic signaling and arresting tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM3XHm6lQqWrVg90H21EOLACvtfcHk0lhMC6eTppvh8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK&md5=230a70f6e32b3abc3c10abd7fb8df533</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312473110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312473110%26sid%3Dliteratum%253Aachs%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DTraaseth%26aufirst%3DN.%2BJ.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DProtein%2520domain%2520mimetics%2520as%2520in%2520vivo%2520modulators%2520of%2520hypoxia-inducible%2520factor%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D39%26spage%3D15602%26epage%3D15607%26doi%3D10.1073%2Fpnas.1312473110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishagin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesallati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7536</span>, <span class="refDoi"> DOI: 10.1073/pnas.1402393111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.1402393111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24821806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=7531-7536&issue=21&author=B.+B.+Laoauthor=I.+Grishaginauthor=H.+Mesallatiauthor=T.+F.+Brewerauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=In+vivo+modulation+of+hypoxia-inducible+signaling+by+topographical+helix+mimetics&doi=10.1073%2Fpnas.1402393111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span></div><div class="casAuthors">Lao, Brooke Bullock; Grishagin, Ivan; Mesallati, Hanah; Brewer, Thomas F.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Development of small-mol. inhibitors of protein-protein interactions is a fundamental challenge at the interface of chem. and cancer biol.  Successful methods for design of protein-protein interaction inhibitors include computational and exptl. high-throughput and fragment-based screening strategies to locate small-mol. fragments that bind protein surfaces.  An alternative rational design approach seeks to mimic the orientation and disposition of crit. binding residues at protein interfaces.  The authors describe the design, synthesis, biochem., and in vivo evaluation of a small-mol. scaffold that captures the topog. of α-helixes.  The authors designed mimics of a key α-helical domain at the interface of hypoxia-inducible factor 1α and p300 to develop inhibitors of hypoxia-inducible signaling.  The hypoxia-inducible factor/p300 interaction regulates the transcription of key genes, whose expression contributes to angiogenesis, metastasis, and altered energy metab. in cancer.  The designed compds. target the desired protein with high affinity and in a predetd. manner, with the optimal ligand providing effective redn. of tumor burden in exptl. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7DvqFbX-7prVg90H21EOLACvtfcHk0lhMC6eTppvh8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D&md5=34b4289424a570528a22e6eca0fb502e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1402393111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1402393111%26sid%3Dliteratum%253Aachs%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DGrishagin%26aufirst%3DI.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DBrewer%26aufirst%3DT.%2BF.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DIn%2520vivo%2520modulation%2520of%2520hypoxia-inducible%2520signaling%2520by%2520topographical%2520helix%2520mimetics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D21%26spage%3D7531%26epage%3D7536%26doi%3D10.1073%2Fpnas.1402393111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">17910</span>– <span class="NLM_lpage">17915</span>, <span class="refDoi"> DOI: 10.1073/pnas.0909353106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0909353106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19805192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2ru77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=17910-17915&issue=42&author=K.+Leeauthor=H.+Zhangauthor=D.+Z.+Qianauthor=S.+Reyauthor=J.+O.+Liuauthor=G.+L.+Semenza&title=Acriflavine+inhibits+HIF-1+dimerization%2C+tumor+growth%2C+and+vascularization&doi=10.1073%2Fpnas.0909353106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization</span></div><div class="casAuthors">Lee, KangAe; Zhang, Huafeng; Qian, David Z.; Rey, Sergio; Liu, Jun O.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">17910-17915, S17910/1-S17910/32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">HIF-1 is a heterodimeric transcription factor that mediates adaptive responses to hypoxia and plays crit. roles in cancer progression.  Using a cell-based screening assay we have identified acriflavine as a drug that binds directly to HIF-1α and HIF-2α and inhibits HIF-1 dimerization and transcriptional activity.  Pretreatment of mice bearing prostate cancer xenografts with acriflavine prevented tumor growth and treatment of mice bearing established tumors resulted in growth arrest.  Acriflavine treatment inhibited intratumoral expression of angiogenic cytokines, mobilization of angiogenic cells into peripheral blood, and tumor vascularization.  These results provide proof of principle that small mols. can inhibit dimerization of HIF-1 and have potent inhibitory effects on tumor growth and vascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpboBSToFYTvLVg90H21EOLACvtfcHk0lhMC6eTppvh8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2ru77O&md5=eab265a9166fff5d2a3fbf22fb0a7a41</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909353106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909353106%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DD.%2BZ.%26aulast%3DRey%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DAcriflavine%2520inhibits%2520HIF-1%2520dimerization%252C%2520tumor%2520growth%252C%2520and%2520vascularization%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D42%26spage%3D17910%26epage%3D17915%26doi%3D10.1073%2Fpnas.0909353106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordgren, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Male, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoakwie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Court, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, A.</span></span> <span> </span><span class="NLM_article-title">A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">10418</span>– <span class="NLM_lpage">10425</span>, <span class="refDoi"> DOI: 10.1021/ja402993u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja402993u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvFaksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=10418-10425&issue=28&author=E.+Mirandaauthor=I.+K.+Nordgrenauthor=A.+L.+Maleauthor=C.+E.+Lawrenceauthor=F.+Hoakwieauthor=F.+Cudaauthor=W.+Courtauthor=K.+R.+Foxauthor=P.+A.+Townsendauthor=G.+K.+Packhamauthor=S.+A.+Ecclesauthor=A.+Tavassoli&title=A+cyclic+peptide+inhibitor+of+HIF-1+heterodimerization+that+inhibits+hypoxia+signaling+in+cancer+cells&doi=10.1021%2Fja402993u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells</span></div><div class="casAuthors">Miranda, Elena; Nordgren, Ida K.; Male, Abigail L.; Lawrence, Charlotte E.; Hoakwie, Franciane; Cuda, Francesco; Court, William; Fox, Keith R.; Townsend, Paul A.; Packham, Graham K.; Eccles, Suzanne A.; Tavassoli, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10418-10425</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia inducible factor-1 (HIF-1) is a heterodimeric transcription factor that acts as the master regulator of cellular response to reduced oxygen levels, thus playing a key role in the adaptation, survival, and progression of tumors.  Here we report cyclo-CLLFVY, identified from a library of 3.2 million cyclic hexapeptides using a genetically encoded high-throughput screening platform, as an inhibitor of the HIF-1α/HIF-1β protein-protein interaction in vitro and in cells.  The identified compd. inhibits HIF-1 dimerization and transcription activity by binding to the PAS-B domain of HIF-1α, reducing HIF-1-mediated hypoxia response signaling in a variety of cell lines, without affecting the function of the closely related HIF-2 isoform.  The reported cyclic peptide demonstrates the utility of our high-throughput screening platform for the identification of protein-protein interaction inhibitors, and forms the starting point for the development of HIF-1 targeted cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodwKA_rNEr2LVg90H21EOLACvtfcHk0lhFS7gp5Ggatg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvFaksro%253D&md5=3f44683ebfa19a9dbb6f505d50bb6032</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja402993u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja402993u%26sid%3Dliteratum%253Aachs%26aulast%3DMiranda%26aufirst%3DE.%26aulast%3DNordgren%26aufirst%3DI.%2BK.%26aulast%3DMale%26aufirst%3DA.%2BL.%26aulast%3DLawrence%26aufirst%3DC.%2BE.%26aulast%3DHoakwie%26aufirst%3DF.%26aulast%3DCuda%26aufirst%3DF.%26aulast%3DCourt%26aufirst%3DW.%26aulast%3DFox%26aufirst%3DK.%2BR.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPackham%26aufirst%3DG.%2BK.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DTavassoli%26aufirst%3DA.%26atitle%3DA%2520cyclic%2520peptide%2520inhibitor%2520of%2520HIF-1%2520heterodimerization%2520that%2520inhibits%2520hypoxia%2520signaling%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D28%26spage%3D10418%26epage%3D10425%26doi%3D10.1021%2Fja402993u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Card, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakuzu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for PAS domain heterodimerization in the basic helix--loop--helix-PAS transcription factor hypoxia-inducible factor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">15504</span>– <span class="NLM_lpage">15509</span>, <span class="refDoi"> DOI: 10.1073/pnas.2533374100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.2533374100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=14668441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=15504-15509&issue=26&author=P.+J.+Erbelauthor=P.+B.+Cardauthor=O.+Karakuzuauthor=R.+K.+Bruickauthor=K.+H.+Gardner&title=Structural+basis+for+PAS+domain+heterodimerization+in+the+basic+helix%2D%2Dloop%2D%2Dhelix-PAS+transcription+factor+hypoxia-inducible+factor&doi=10.1073%2Fpnas.2533374100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor</span></div><div class="casAuthors">Erbel, Paul J. A.; Card, Paul B.; Karakuzu, Ozgur; Bruick, Richard K.; Gardner, Kevin H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15504-15509</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Biol. responses to oxygen availability play important roles in development, physiol. homeostasis, and many disease processes.  In mammalian cells, this adaptation is mediated in part by a conserved pathway centered on the hypoxia-inducible factor (HIF).  HIF is a heterodimeric protein complex composed of two members of the basic helix-loop-helix Per-ARNT-Sim (PAS) (ARNT, aryl hydrocarbon receptor nuclear translocator) domain family of transcriptional activators, HIFα and ARNT.  Although this complex involves protein-protein interactions mediated by basic helix-loop-helix and PAS domains in both proteins, the role played by the PAS domains is poorly understood.  To address this issue, we have studied the structure and interactions of the C-terminal PAS domain of human HIF-2α by NMR spectroscopy.  We demonstrate that HIF-2α PAS-B binds the analogous ARNT domain in vitro, showing that residues involved in this interaction are located on the solvent-exposed side of the HIF-2α central β-sheet.  Mutating residues at this surface not only disrupts the interaction between isolated PAS domains in vitro but also interferes with the ability of full-length HIF to respond to hypoxia in living cells.  Extending our findings to other PAS domains, we find that this β-sheet interface is widely used for both intra- and intermol. interactions, suggesting a basis of specificity and regulation of many types of PAS-contg. signaling proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokgBRHCUjRa7Vg90H21EOLACvtfcHk0lhFS7gp5Ggatg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCjtA%253D%253D&md5=5c1a92df60db24fba6af0e4b50ca1540</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2533374100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2533374100%26sid%3Dliteratum%253Aachs%26aulast%3DErbel%26aufirst%3DP.%2BJ.%26aulast%3DCard%26aufirst%3DP.%2BB.%26aulast%3DKarakuzu%26aufirst%3DO.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26atitle%3DStructural%2520basis%2520for%2520PAS%2520domain%2520heterodimerization%2520in%2520the%2520basic%2520helix--loop--helix-PAS%2520transcription%2520factor%2520hypoxia-inducible%2520factor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D26%26spage%3D15504%26epage%3D15509%26doi%3D10.1073%2Fpnas.2533374100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Key, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longgood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambar, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of hypoxia inducible factor-2 with small molecules</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnchembio.1185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23434853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFygtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=271-276&issue=4&author=T.+H.+Scheuermannauthor=Q.+Liauthor=H.+W.+Maauthor=J.+Keyauthor=L.+Zhangauthor=R.+Chenauthor=J.+A.+Garciaauthor=J.+Naidooauthor=J.+Longgoodauthor=D.+E.+Frantzauthor=U.+K.+Tambarauthor=K.+H.+Gardnerauthor=R.+K.+Bruick&title=Allosteric+inhibition+of+hypoxia+inducible+factor-2+with+small+molecules&doi=10.1038%2Fnchembio.1185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of hypoxia inducible factor-2 with small molecules</span></div><div class="casAuthors">Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; Key, Jason; Zhang, Lei; Chen, Rui; Garcia, Joseph A.; Naidoo, Jacinth; Longgood, Jamie; Frantz, Doug E.; Tambar, Uttam K.; Gardner, Kevin H.; Bruick, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in many cancers where they frequently promote the expression of protumorigenic pathways.  Though transcription factors are typically considered 'undruggable', the PAS-B domain of the HIF-2α subunit contains a large cavity within its hydrophobic core that offers a unique foothold for small-mol. regulation.  Here we identify artificial ligands that bind within this pocket and characterize the resulting structural and functional changes caused by binding.  Notably, these ligands antagonize HIF-2 heterodimerization and DNA-binding activity in vitro and in cultured cells, reducing HIF-2 target gene expression.  Despite the high sequence identity between HIF-2α and HIF-1α, these ligands are highly selective and do not affect HIF-1 function.  These chem. tools establish the mol. basis for selective regulation of HIF-2, providing potential therapeutic opportunities to intervene in HIF-2-driven tumors, such as renal cell carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBimby6zSuR7Vg90H21EOLACvtfcHk0lhFS7gp5Ggatg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFygtLc%253D&md5=e2e58842b3fe6472248c10012de365fb</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1185%26sid%3Dliteratum%253Aachs%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DH.%2BW.%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DJ.%2BA.%26aulast%3DNaidoo%26aufirst%3DJ.%26aulast%3DLonggood%26aufirst%3DJ.%26aulast%3DFrantz%26aufirst%3DD.%2BE.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26atitle%3DAllosteric%2520inhibition%2520of%2520hypoxia%2520inducible%2520factor-2%2520with%2520small%2520molecules%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26issue%3D4%26spage%3D271%26epage%3D276%26doi%3D10.1038%2Fnchembio.1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Key, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daggett, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span> <span> </span><span class="NLM_article-title">Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">17647</span>– <span class="NLM_lpage">17654</span>, <span class="refDoi"> DOI: 10.1021/ja9073062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9073062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17647-17654&issue=48&author=J.+Keyauthor=T.+H.+Scheuermannauthor=P.+C.+Andersonauthor=V.+Daggettauthor=K.+H.+Gardner&title=Principles+of+ligand+binding+within+a+completely+buried+cavity+in+HIF2alpha+PAS-B&doi=10.1021%2Fja9073062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of Ligand Binding within a Completely Buried Cavity in HIF2α PAS-B</span></div><div class="casAuthors">Key, Jason; Scheuermann, Thomas H.; Anderson, Peter C.; Daggett, Valerie; Gardner, Kevin H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">17647-17654</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIFs) are heterodimeric transcription factors responsible for the metazoan hypoxia response and promote tumor growth, metastases, and resistance to cancer treatment.  The C-terminal Per-ARNT-Sim (PAS) domain of HIF2α (HIF2α PAS-B) contains a preformed solvent-inaccessible cavity that binds artificial ligands that allosterically perturb the formation of the HIF heterodimer.  To better understand how small mols. bind within this domain, we examd. the structures and equil. and transition-state thermodn. of HIF2α PAS-B with several artificial ligands using isothermal titrn. calorimetry, NMR exchange spectroscopy, and x-ray crystallog.  Rapid assocn. rates reveal that ligand binding is not dependent upon a slow conformational change in the protein to permit ligand access, despite the closed conformation obsd. in the NMR and crystal structures.  Compensating enthalpic and entropic contributions to the thermodn. barrier for ligand binding suggest a binding-competent transition state characterized by increased structural disorder.  Finally, mol. dynamics simulations reveal conversion between open and closed conformations of the protein and pathways of ligand entry into the binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFEKzsVY8QgLVg90H21EOLACvtfcHk0ljscMqbYJ1DkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FL&md5=d34456db2763c4e586844a7d5c04aa89</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fja9073062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9073062%26sid%3Dliteratum%253Aachs%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DDaggett%26aufirst%3DV.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26atitle%3DPrinciples%2520of%2520ligand%2520binding%2520within%2520a%2520completely%2520buried%2520cavity%2520in%2520HIF2alpha%2520PAS-B%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D48%26spage%3D17647%26epage%3D17654%26doi%3D10.1021%2Fja9073062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleet, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayeh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longgood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambar, U. K.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective and stereoselective inhibition of hypoxia inducible factor-2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5930</span>– <span class="NLM_lpage">5941</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5930-5941&issue=15&author=T.+H.+Scheuermannauthor=D.+Stroudauthor=C.+E.+Sleetauthor=L.+Bayehauthor=C.+Shokriauthor=H.+Wangauthor=C.+G.+Caldwellauthor=J.+Longgoodauthor=J.+B.+MacMillanauthor=R.+K.+Bruickauthor=K.+H.+Gardnerauthor=U.+K.+Tambar&title=Isoform-selective+and+stereoselective+inhibition+of+hypoxia+inducible+factor-2&doi=10.1021%2Facs.jmedchem.5b00529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2</span></div><div class="casAuthors">Scheuermann, Thomas H.; Stroud, Daniel; Sleet, Christopher E.; Bayeh, Liela; Shokri, Cameron; Wang, Hanzhi; Caldwell, Charles G.; Longgood, Jamie; MacMillan, John B.; Bruick, Richard K.; Gardner, Kevin H.; Tambar, Uttam K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5930-5941</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia inducible factor (HIF) transcription factors reside at the center of signaling pathways used by mammalian cells to sense and respond to low oxygen levels.  While essential to maintain oxygen homeostasis, misregulation of HIF protein activity correlates with tumor development and metastasis.  To provide artificial routes to target misregulated HIF activity, the authors identified small mol. antagonists of the HIF-2 transcription factor that bind an internal cavity within the C-terminal PAS domain of the HIF-2α subunit.  Here the authors describe a new class of chiral small mol. ligands that provide the highest affinity binding, the most effective, isoform-selective inhibition of HIF-2 in cells, and trigger the largest protein conformation changes reported to date.  The current results further illuminate the mol. mechanism of HIF-2 antagonism and suggest addnl. routes to develop higher affinity and potency HIF-2 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe0ABJGYcks7Vg90H21EOLACvtfcHk0ljscMqbYJ1DkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmsbnP&md5=495125fa479708ae2ae60e64b52eadc4</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00529%26sid%3Dliteratum%253Aachs%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DStroud%26aufirst%3DD.%26aulast%3DSleet%26aufirst%3DC.%2BE.%26aulast%3DBayeh%26aufirst%3DL.%26aulast%3DShokri%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DLonggood%26aufirst%3DJ.%26aulast%3DMacMillan%26aufirst%3DJ.%2BB.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26atitle%3DIsoform-selective%2520and%2520stereoselective%2520inhibition%2520of%2520hypoxia%2520inducible%2520factor-2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D15%26spage%3D5930%26epage%3D5941%26doi%3D10.1021%2Facs.jmedchem.5b00529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wehn, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlachter, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halfmann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddie, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span> <span> </span><span class="NLM_article-title">Design and activity of specific hypoxia-inducible factor 2alpha (HIF-2alpha) inhibitors for the treatment of clear cell renal cell carcinoma: discovery of clinical candidate (S)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9691</span>– <span class="NLM_lpage">9721</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01196</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01196" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKqt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9691-9721&issue=21&author=P.+M.+Wehnauthor=J.+P.+Rizziauthor=D.+D.+Dixonauthor=J.+Grinaauthor=S.+T.+Schlachterauthor=B.+Wangauthor=R.+Xuauthor=H.+Yangauthor=X.+Duauthor=G.+Hanauthor=K.+Wangauthor=Z.+Caoauthor=T.+Chengauthor=R.+M.+Czerwinskiauthor=B.+S.+Gogginauthor=H.+Huangauthor=M.+M.+Halfmannauthor=M.+A.+Maddieauthor=E.+L.+Mortonauthor=S.+R.+Oliveauthor=H.+Tanauthor=S.+Xieauthor=T.+Wongauthor=J.+A.+Joseyauthor=E.+M.+Wallace&title=Design+and+activity+of+specific+hypoxia-inducible+factor+2alpha+%28HIF-2alpha%29+inhibitors+for+the+treatment+of+clear+cell+renal+cell+carcinoma%3A+discovery+of+clinical+candidate+%28S%29-3-%28%282%2C2-difluoro-1-hydroxy-7-%28methylsulfonyl%29-2%2C3-dihydro-1H-inden-4-yl%29oxy%29-5-fluorobenzonitrile+%28PT2385%29&doi=10.1021%2Facs.jmedchem.8b01196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)</span></div><div class="casAuthors">Wehn, Paul M.; Rizzi, James P.; Dixon, Darryl D.; Grina, Jonas A.; Schlachter, Stephen T.; Wang, Bin; Xu, Rui; Yang, Hanbiao; Du, Xinlin; Han, Guangzhou; Wang, Keshi; Cao, Zhaodan; Cheng, Tzuling; Czerwinski, Robert M.; Goggin, Barry S.; Huang, Heli; Halfmann, Megan M.; Maddie, Melissa A.; Morton, Emily L.; Olive, Sarah R.; Tan, Huiling; Xie, Shanhai; Wong, Tai; Josey, John A.; Wallace, Eli M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9691-9721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIF-2α, a member of the HIF family of transcription factors, is a key oncogenic driver in cancers such as clear cell renal cell carcinoma (ccRCC).  A signature feature of these cancers is the overaccumulation of HIF-2α protein, often by inactivation of the E3 ligase VHL (von Hippel-Lindau).  Herein the authors disclose their structure based drug design (SBDD) approach that culminated in the identification of PT2385, the first HIF-2α antagonist to enter clin. trials.  Highlights include the use of a putative n → π*Ar interaction to guide early analog design, the conformational restriction of an essential hydroxyl moiety, and the remarkable impact of fluorination near the hydroxyl group.  Evaluation of select compds. from two structural classes in a sequence of PK/PD, efficacy, PK, and metabolite profiling identified I (PT2385, luciferase EC50 = 27 nM) as the clin. candidate.  Finally, a retrospective crystallog. anal. describes the structural perturbations necessary for efficient antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwG1t-5Van7rVg90H21EOLACvtfcHk0ljscMqbYJ1DkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKqt7%252FN&md5=fcbb754286f47e1b1df3edb62bd2381e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01196%26sid%3Dliteratum%253Aachs%26aulast%3DWehn%26aufirst%3DP.%2BM.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DDixon%26aufirst%3DD.%2BD.%26aulast%3DGrina%26aufirst%3DJ.%26aulast%3DSchlachter%26aufirst%3DS.%2BT.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DGoggin%26aufirst%3DB.%2BS.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHalfmann%26aufirst%3DM.%2BM.%26aulast%3DMaddie%26aufirst%3DM.%2BA.%26aulast%3DMorton%26aufirst%3DE.%2BL.%26aulast%3DOlive%26aufirst%3DS.%2BR.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26atitle%3DDesign%2520and%2520activity%2520of%2520specific%2520hypoxia-inducible%2520factor%25202alpha%2520%2528HIF-2alpha%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520clear%2520cell%2520renal%2520cell%2520carcinoma%253A%2520discovery%2520of%2520clinical%2520candidate%2520%2528S%2529-3-%2528%25282%252C2-difluoro-1-hydroxy-7-%2528methylsulfonyl%2529-2%252C3-dihydro-1H-inden-4-yl%2529oxy%2529-5-fluorobenzonitrile%2520%2528PT2385%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D21%26spage%3D9691%26epage%3D9721%26doi%3D10.1021%2Facs.jmedchem.8b01196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">On-target efficacy of a HIF-2alpha antagonist in preclinical kidney cancer models</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>539</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1038/nature19795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature19795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27595393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslyis73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=539&publication_year=2016&pages=107-111&author=H.+Choauthor=X.+Duauthor=J.+P.+Rizziauthor=E.+Liberzonauthor=A.+A.+Chakrabortyauthor=W.+Gaoauthor=I.+Carvoauthor=S.+Signorettiauthor=R.+K.+Bruickauthor=J.+A.+Joseyauthor=E.+M.+Wallaceauthor=W.+G.+Kaelin&title=On-target+efficacy+of+a+HIF-2alpha+antagonist+in+preclinical+kidney+cancer+models&doi=10.1038%2Fnature19795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models</span></div><div class="casAuthors">Cho, Hyejin; Du, Xinlin; Rizzi, James P.; Liberzon, Ella; Chakraborty, Abhishek A.; Gao, Wenhua; Carvo, Ingrid; Signoretti, Sabina; Bruick, Richard K.; Josey, John A.; Wallace, Eli M.; Kaelin, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">539</span>
        (<span class="NLM_cas:issue">7627</span>),
    <span class="NLM_cas:pages">107-111</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma, the most common form of kidney cancer, is usually linked to inactivation of the pVHL tumor suppressor protein and consequent accumulation of the HIF-2α transcription factor (also known as EPAS1).  Here we show that a small mol. (PT2399) (I) that directly inhibits HIF-2α causes tumor regression in preclin. mouse models of primary and metastatic pVHL-defective clear cell renal cell carcinoma in an on-target fashion. pVHL-defective clear cell renal cell carcinoma cell lines display unexpectedly variable sensitivity to PT2399, however, suggesting the need for predictive biomarkers to be developed to use this approach optimally in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXNjIx5YKNerVg90H21EOLACvtfcHk0limGKsrgLkZFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslyis73F&md5=f8dc173e758b6a6a17630b791c0c318c</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnature19795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19795%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DLiberzon%26aufirst%3DE.%26aulast%3DChakraborty%26aufirst%3DA.%2BA.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DCarvo%26aufirst%3DI.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DOn-target%2520efficacy%2520of%2520a%2520HIF-2alpha%2520antagonist%2520in%2520preclinical%2520kidney%2520cancer%2520models%26jtitle%3DNature%26date%3D2016%26volume%3D539%26spage%3D107%26epage%3D111%26doi%3D10.1038%2Fnature19795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehn, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grina, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halfmann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddie, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlachter, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of HIF2alpha is efficacious in preclinical models of renal cell carcinoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5491</span>– <span class="NLM_lpage">5500</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-16-0473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27635045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=5491-5500&issue=18&author=E.+M.+Wallaceauthor=J.+P.+Rizziauthor=G.+Hanauthor=P.+M.+Wehnauthor=Z.+Caoauthor=X.+Duauthor=T.+Chengauthor=R.+M.+Czerwinskiauthor=D.+D.+Dixonauthor=B.+S.+Gogginauthor=J.+A.+Grinaauthor=M.+M.+Halfmannauthor=M.+A.+Maddieauthor=S.+R.+Oliveauthor=S.+T.+Schlachterauthor=H.+Tanauthor=B.+Wangauthor=K.+Wangauthor=S.+Xieauthor=R.+Xuauthor=H.+Yangauthor=J.+A.+Josey&title=A+small-molecule+antagonist+of+HIF2alpha+is+efficacious+in+preclinical+models+of+renal+cell+carcinoma&doi=10.1158%2F0008-5472.CAN-16-0473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma</span></div><div class="casAuthors">Wallace, Eli M.; Rizzi, James P.; Han, Guangzhou; Wehn, Paul M.; Cao, Zhaodan; Du, Xinlin; Cheng, Tzuling; Czerwinski, Robert M.; Dixon, Darryl D.; Goggin, Barry S.; Grina, Jonas A.; Halfmann, Megan M.; Maddie, Melissa A.; Olive, Sarah R.; Schlachter, Stephen T.; Tan, Huiling; Wang, Bin; Wang, Keshi; Xie, Shanhai; Xu, Rui; Yang, Hanbiao; Josey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5491-5500</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">More than 90% of clear cell renal cell carcinomas (ccRCC) exhibit inactivation of the von Hippel-Lindau (pVHL) tumor suppressor, establishing it as the major underlying cause of this malignancy.  PVHL inactivation results in stabilization of the hypoxia-inducible transcription factors, HIF1α and HIF2α, leading to expression of a genetic program essential for the initiation and progression of ccRCC.  Herein, we describe the potent, selective, and orally active small-mol. inhibitor PT2385 as a specific antagonist of HIF2α that allosterically blocks its dimerization with the HIF1α/2α transcriptional dimerization partner ARNT/HIF1β.  PT2385 inhibited the expression of HIF2α-dependent genes, including VEGF-A, PAI-1, and cyclin D1 in ccRCC cell lines and tumor xenografts.  Treatment of tumor-bearing mice with PT2385 caused dramatic tumor regressions, validating HIF2α as a pivotal oncogenic driver in ccRCC.  Notably, unlike other anticancer agents that inhibit VEGF receptor signaling, PT2385 exhibited no adverse effect on cardiovascular performance.  Thus, PT2385 represents a novel class of therapeutics for the treatment of RCC with potent preclincal efficacy as well as improved tolerability relative to current agents that target the VEGF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCMg5jKD7j2bVg90H21EOLACvtfcHk0lhpAehGYUJpJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbjP&md5=502bf54f4767817787adc05471d631eb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0473%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWehn%26aufirst%3DP.%2BM.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DDixon%26aufirst%3DD.%2BD.%26aulast%3DGoggin%26aufirst%3DB.%2BS.%26aulast%3DGrina%26aufirst%3DJ.%2BA.%26aulast%3DHalfmann%26aufirst%3DM.%2BM.%26aulast%3DMaddie%26aufirst%3DM.%2BA.%26aulast%3DOlive%26aufirst%3DS.%2BR.%26aulast%3DSchlachter%26aufirst%3DS.%2BT.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520HIF2alpha%2520is%2520efficacious%2520in%2520preclinical%2520models%2520of%2520renal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26issue%3D18%26spage%3D5491%26epage%3D5500%26doi%3D10.1158%2F0008-5472.CAN-16-0473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figlin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugarolas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zojwalla, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choueiri, T. K.</span></span> <span> </span><span class="NLM_article-title">Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2alpha antagonist in patients with previously treated advanced clear cell renal cell carcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1200/JCO.2017.74.2627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1200%2FJCO.2017.74.2627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29257710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1amsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=867-874&issue=9&author=K.+D.+Courtneyauthor=J.+R.+Infanteauthor=E.+T.+Lamauthor=R.+A.+Figlinauthor=B.+I.+Riniauthor=J.+Brugarolasauthor=N.+J.+Zojwallaauthor=A.+M.+Loweauthor=K.+Wangauthor=E.+M.+Wallaceauthor=J.+A.+Joseyauthor=T.+K.+Choueiri&title=Phase+I+dose-escalation+trial+of+PT2385%2C+a+first-in-class+hypoxia-inducible+factor-2alpha+antagonist+in+patients+with+previously+treated+advanced+clear+cell+renal+cell+carcinoma&doi=10.1200%2FJCO.2017.74.2627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Phase i dose-escalation trial of pt2385, a first-in-class hypoxia-inducible factor-2α antagonist in patients with previously treated advanced clear cell renal cell carcinoma</span></div><div class="casAuthors">Courtney, Kevin D.; Infante, Jeffrey R.; Lam, Elaine T.; Figlin, Robert A.; Rini, Brian I.; Brugarolas, James; Zojwalla, Naseem J.; Lowe, Ann M.; Wang, Keshi; Wallace, Eli M.; Josey, John A.; Choueiri, Toni K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">867-874,S1-S3</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose The von Hippel-Lindau tumor suppressor is inactivated in the majority of clear cell renal cell carcinomas (ccRCCs), leading to inappropriate stabilization of hypoxia-inducible factor-2α (HIF-2α).  PT2385 is a first-in-class HIF-2α antagonist.  Objectives of this first-in-human study were to characterize the safety, pharmacokinetics, pharmacodynamics, and efficacy, and to identify the recommended phase II dose (RP2D) of PT2385.  Patients and Methods Eligible patients had locally advanced or metastatic ccRCC that had progressed during one or more prior regimens that included a vascular endothelial growth factor inhibitor.  PT2385 was administered orally at twice-per-day doses of 100 to 1,800 mg, according to a 3 + 3 dose-escalation design, followed by an expansion phase at the RP2D.  Results The dose-escalation and expansion phases enrolled 26 and 25 patients, resp.  Patients were heavily pretreated, with a median of four (range, one to seven) prior therapies.  No dose-limiting toxicity was obsd. at any dose.  On the basis of safety, pharmacokinetic, and pharmacodynamic profiling, the RP2D was defined as 800 mg twice per day.  PT2385 was well tolerated, with anemia (grade 1 to 2, 35%; grade 3, 10%), peripheral edema (grade 1 to 2, 37%; grade 3, 2%), and fatigue (grade 1 to 2, 37%; no grade 3 or 4) being the most common treatment-emergent adverse events.  No patients discontinued treatment because of adverse events.  Complete response, partial response, and stable disease as best response were achieved by 2%, 12%, and 52% of patients, resp.  At data cutoff, eight patients remained in the study, with 13 patients in the study for ≥ 1 yr.  Conclusion PT2385 has a favorable safety profile and is active in patients with heavily pretreated ccRCC, validating direct HIF-2a antagonism for the treatment of patients with ccRCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgJGjefWSjx7Vg90H21EOLACvtfcHk0lhpAehGYUJpJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1amsbbL&md5=81997f4afc2c2f229cf057bbf3c94904</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1200%2FJCO.2017.74.2627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2017.74.2627%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DLam%26aufirst%3DE.%2BT.%26aulast%3DFiglin%26aufirst%3DR.%2BA.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DBrugarolas%26aufirst%3DJ.%26aulast%3DZojwalla%26aufirst%3DN.%2BJ.%26aulast%3DLowe%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DChoueiri%26aufirst%3DT.%2BK.%26atitle%3DPhase%2520I%2520dose-escalation%2520trial%2520of%2520PT2385%252C%2520a%2520first-in-class%2520hypoxia-inducible%2520factor-2alpha%2520antagonist%2520in%2520patients%2520with%2520previously%2520treated%2520advanced%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D36%26issue%3D9%26spage%3D867%26epage%3D874%26doi%3D10.1200%2FJCO.2017.74.2627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krausz, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1298</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1038/nm.4412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnm.4412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29035368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1aisrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1298-1308&issue=11&author=C.+Xieauthor=T.+Yagaiauthor=Y.+Luoauthor=X.+Liangauthor=T.+Chenauthor=Q.+Wangauthor=D.+Sunauthor=J.+Zhaoauthor=S.+K.+Ramakrishnanauthor=L.+Sunauthor=C.+Jiangauthor=X.+Xueauthor=Y.+Tianauthor=K.+W.+Krauszauthor=A.+D.+Pattersonauthor=Y.+M.+Shahauthor=Y.+Wuauthor=C.+Jiangauthor=F.+J.+Gonzalez&title=Activation+of+intestinal+hypoxia-inducible+factor+2alpha+during+obesity+contributes+to+hepatic+steatosis&doi=10.1038%2Fnm.4412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis</span></div><div class="casAuthors">Xie, Cen; Yagai, Tomoki; Luo, Yuhong; Liang, Xianyi; Chen, Tao; Wang, Qiong; Sun, Dongxue; Zhao, Jie; Ramakrishnan, Sadeesh K.; Sun, Lulu; Jiang, Chunmei; Xue, Xiang; Tian, Yuan; Krausz, Kristopher W.; Patterson, Andrew D.; Shah, Yatrik M.; Wu, Yue; Jiang, Changtao; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1298-1308</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Nonalcoholic fatty liver disease is becoming the most common chronic liver disease in Western countries, and limited therapeutic options are available.  Here we uncovered a role for intestinal hypoxia-inducible factor (HIF) in hepatic steatosis.  Human-intestine biopsies from individuals with or without obesity revealed that intestinal HIF-2α signaling was pos. correlated with body-mass index and hepatic toxicity.  The causality of this correlation was verified in mice with an intestine-specific disruption of Hif2a, in which high-fat-diet-induced hepatic steatosis and obesity were substantially lower as compared to control mice.  PT2385, a HIF-2α-specific inhibitor, had preventive and therapeutic effects on metabolic disorders that were dependent on intestine HIF-2α.  Intestine HIF-2α inhibition markedly reduced intestine and serum ceramide levels.  Mechanistically, intestine HIF-2α regulates ceramide metab. mainly from the salvage pathway, by pos. regulating the expression of Neu3, the gene encoding neuraminidase 3.  These results suggest that intestinal HIF-2α could be a viable target for hepatic steatosis therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_IFx6kul697Vg90H21EOLACvtfcHk0lgRL8OAkz1x7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1aisrzP&md5=1fb1444f6f986d84bb5baf905664d95b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnm.4412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4412%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DC.%26aulast%3DYagai%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DRamakrishnan%26aufirst%3DS.%2BK.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DKrausz%26aufirst%3DK.%2BW.%26aulast%3DPatterson%26aufirst%3DA.%2BD.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DActivation%2520of%2520intestinal%2520hypoxia-inducible%2520factor%25202alpha%2520during%2520obesity%2520contributes%2520to%2520hepatic%2520steatosis%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26issue%3D11%26spage%3D1298%26epage%3D1308%26doi%3D10.1038%2Fnm.4412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickols, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervan, P. B.</span></span> <span> </span><span class="NLM_article-title">Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1021/cb700110z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb700110z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVOht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=561-571&issue=8&author=N.+G.+Nickolsauthor=C.+S.+Jacobsauthor=M.+E.+Farkasauthor=P.+B.+Dervan&title=Modulating+hypoxia-inducible+transcription+by+disrupting+the+HIF-1-DNA+interface&doi=10.1021%2Fcb700110z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface</span></div><div class="casAuthors">Nickols, Nicholas G.; Jacobs, Claire S.; Farkas, Michelle E.; Dervan, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-571</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transcription mediated by hypoxia-inducible factor (HIF-1) contributes to tumor angiogenesis and metastasis but is also involved in activation of cell death pathways and normal physiol. processes.  Given the complexity of HIF-1 signaling, it could be advantageous to target a subset of HIF-1 effectors rather than the entire pathway.  We compare the genome-wide effects of three mols. that each interfere with the HIF-1-DNA interaction: a polyamide targeted to the hypoxia response element, small interfering RNA targeted to HIF-1α, and echinomycin, a DNA-binding natural product with a similar but less specific sequence preference than the polyamide.  The polyamide affects a subset of hypoxia induced genes consistent with its binding site preferences.  For comparison, HIF-1α siRNA and echinomycin each affect the expression of nearly every gene induced by hypoxia.  Remarkably, the total no. of genes affected by either polyamide or HIF-1α siRNA over a range of thresholds is comparable.  The data show that polyamides can be used to affect a subset of a pathway regulated by a transcription factor.  In addn., this study offers a unique comparison of three complementary approaches towards exogenous control of endogenous gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBCofzE4gRZLVg90H21EOLACvtfcHk0lgRL8OAkz1x7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVOht78%253D&md5=3494c59563db58e5a7ca26fac767c3e5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcb700110z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb700110z%26sid%3Dliteratum%253Aachs%26aulast%3DNickols%26aufirst%3DN.%2BG.%26aulast%3DJacobs%26aufirst%3DC.%2BS.%26aulast%3DFarkas%26aufirst%3DM.%2BE.%26aulast%3DDervan%26aufirst%3DP.%2BB.%26atitle%3DModulating%2520hypoxia-inducible%2520transcription%2520by%2520disrupting%2520the%2520HIF-1-DNA%2520interface%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26issue%3D8%26spage%3D561%26epage%3D571%26doi%3D10.1021%2Fcb700110z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardellina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.4161/cc.5.16.3019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.4161%2Fcc.5.16.3019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16861921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1847-1853&issue=16&author=E.+J.+Parkauthor=D.+Kongauthor=R.+Fisherauthor=J.+Cardellinaauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Targeting+the+PAS-A+domain+of+HIF-1alpha+for+development+of+small+molecule+inhibitors+of+HIF-1&doi=10.4161%2Fcc.5.16.3019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1</span></div><div class="casAuthors">Park, Eun Jung; Kong, Dehe; Fisher, Robert; Cardellina, John; Shoemaker, Robert H.; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1847-1853</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Hypoxia inducible factor-1 (HIF-1) is a master regulator of cellular adaptation to oxygen deprivation and activates transcription of genes involved in tumor metab., angiogenesis, invasion and metastasis, all of which are implicated in cancer progression.  Several domains of HIF-1α mediate protein-protein interaction, which is essential for the formation of the active heterodimer with HIF-1β.  Targeting specific domains of HIF-1α might lead to the identification of more selective inhibitors.  HIF-1α and HIF-1β contain two Per-Arnt-Sim (PAS) domains, A and B, both of which appear to be important for heterodimer formation.  In an attempt to identify small mol. inhibitors of the PAS-A domain of HIF-1 we expressed proteins contg. amino acids 86-165 of HIF-1α and amino acids 159-240 of HIF-1β fused to a His or FLAG tag, resp.  Expressed proteins retained functional activity as indicated by in vitro immunopptn. expts. and activation of luciferase expression in a mammalian two-hybrid system.  Interestingly, over-expression of HIF-1α-PAS-A domain was sufficient to abrogate hypoxic induction of HIF-1-dependent luciferase expression, supporting its potential role as drug target.  An ELISA based on the interaction between FLAG-HIF-1β-PAS-A and HIF-1α-PAS-A-His was developed and used to screen libraries of synthetic compds.  NSC 50352 specifically inhibited PAS-A-dependent interaction between HIF-1α and HIF-1β, but not the interaction mediated by unrelated domains.  However, NSC 50352 was devoid of activity in cell-based assays.  Our results provide proof-of-principle that the PAS-A domain of HIF-1α is a valid target for development of small mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0IlreWLKvPrVg90H21EOLACvtfcHk0lgRL8OAkz1x7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7vL&md5=82829de97c89d4149821338a16001f71</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.4161%2Fcc.5.16.3019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.5.16.3019%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DCardellina%26aufirst%3DJ.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DTargeting%2520the%2520PAS-A%2520domain%2520of%2520HIF-1alpha%2520for%2520development%2520of%2520small%2520molecule%2520inhibitors%2520of%2520HIF-1%26jtitle%3DCell%2520Cycle%26date%3D2006%26volume%3D5%26issue%3D16%26spage%3D1847%26epage%3D1853%26doi%3D10.4161%2Fcc.5.16.3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2353</span>– <span class="NLM_lpage">2358</span>, <span class="refDoi"> DOI: 10.1073/pnas.0812801106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0812801106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19168635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1yqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=2353-2358&issue=7&author=K.+Leeauthor=D.+Z.+Qianauthor=S.+Reyauthor=H.+Weiauthor=J.+O.+Liuauthor=G.+L.+Semenza&title=Anthracycline+chemotherapy+inhibits+HIF-1+transcriptional+activity+and+tumor-induced+mobilization+of+circulating+angiogenic+cells&doi=10.1073%2Fpnas.0812801106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells</span></div><div class="casAuthors">Lee, KangAe; Qian, David Z.; Rey, Sergio; Wei, Hong; Liu, Jun O.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2353-2358</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using a cell-based reporter gene assay, we screened a library of drugs in clin. use and identified the anthracycline chemotherapeutic agents doxorubicin and daunorubicin as potent inhibitors of hypoxia-inducible factor 1 (HIF-1)-mediated gene transcription.  These drugs inhibited HIF-1 by blocking its binding to DNA.  Daily administration of doxorubicin or daunorubicin potently inhibited the transcription of a HIF-1-dependent reporter gene as well as endogenous HIF-1 target genes encoding vascular endothelial growth factor, stromal-derived factor 1, and stem cell factor in tumor xenografts.  CXCR4+/sca1+, VEGFR2+/CD34+, and VEGFR2+/CD117+ bone-marrow derived cells were increased in the peripheral blood of SCID mice bearing prostate cancer xenografts but not in tumor-bearing mice treated for 5 days with doxorubicin or daunorubicin, which dramatically reduced tumor vascularization.  These results provide a mol. basis for the antiangiogenic effect of anthracycline therapy and have important implications for refining the use of these drugs to treat human cancer more effectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowjoJ93KjlVrVg90H21EOLACvtfcHk0lgRL8OAkz1x7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1yqtLg%253D&md5=0cc1320e9fb96bf3b35e63b06a771e15</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812801106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812801106%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DQian%26aufirst%3DD.%2BZ.%26aulast%3DRey%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DAnthracycline%2520chemotherapy%2520inhibits%2520HIF-1%2520transcriptional%2520activity%2520and%2520tumor-induced%2520mobilization%2520of%2520circulating%2520angiogenic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D7%26spage%3D2353%26epage%3D2358%26doi%3D10.1073%2Fpnas.0812801106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2202</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-05-0443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1535-7163.MCT-05-0443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16985052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1yns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2193-2202&issue=9&author=D.+T.+Jonesauthor=A.+L.+Harris&title=Identification+of+novel+small-molecule+inhibitors+of+hypoxia-inducible+factor-1+transactivation+and+DNA+binding&doi=10.1158%2F1535-7163.MCT-05-0443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding</span></div><div class="casAuthors">Jones, Dylan T.; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2193-2202</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-α (Hif-α) plays an important role in tumor growth by increasing resistance to apoptosis and the prodn. of angiogenic factors, such as vascular endothelial growth factor (VEGF).  Therefore, Hif-α is an attractive target for development of novel cancer therapeutics.  We have generated Chinese hamster ovary cells, which stably express luciferase reporter construct under the control of a hypoxia response element to screen 15,000 compds.  We identified 40 compds. that inhibited hypoxic up-regulation of luciferase, and the top 30 compds. were further screened in a secondary assay using MDA-468 breast cancer cell line.  Eight compds. were shown to inhibit VEGF expression in hypoxic cells at subtoxic concns.  Three top putative Hif inhibitors, DJ12, DJ15, and DJ30, were chosen for further anal.  Transient transfection of cells with hypoxia-regulated luciferase reporter plasmids further validated that these compds. inhibit hypoxia up-regulated genes.  All three compds. failed to inhibit Hif-1α protein levels but they did inhibit induction of downstream targets of Hif-α under hypoxia.  Two of the three compds. were cell type specific, whereas compd. DJ12 inhibited VEGF at subtoxic levels in breast cancer cell lines MDA-468 and ZR-75, melanoma cell line MDA-435, and pVHL mutant renal cancer cell lines RCC4 and 786-0.  Compd. DJ12 down-regulated mRNA of downstream targets of Hif-α, and significantly inhibited Hif-1α transactivation activity by blocking Hif-1α hypoxia response element-DNA binding.  Our cell-based approach and deconvolution of the inhibitory effect of DJ12 has identified a novel compd. that targets the hypoxia pathway by inhibiting Hif-α-inducible transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0jdC1W9Mx7Vg90H21EOLACvtfcHk0ljqvldVN5b6kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1yns7o%253D&md5=c996f44eb74d9cad0e343089a81ae809</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0443%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DIdentification%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520hypoxia-inducible%2520factor-1%2520transactivation%2520and%2520DNA%2520binding%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D9%26spage%3D2193%26epage%3D2202%26doi%3D10.1158%2F1535-7163.MCT-05-0443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potluri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span> <span> </span><span class="NLM_article-title">Structural integration in hypoxia-inducible factors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span> (<span class="NLM_issue">7565</span>),  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1038/nature14883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature14883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26245371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=303-308&issue=7565&author=D.+Wuauthor=N.+Potluriauthor=J.+Luauthor=Y.+Kimauthor=F.+Rastinejad&title=Structural+integration+in+hypoxia-inducible+factors&doi=10.1038%2Fnature14883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Structural integration in hypoxia-inducible factors</span></div><div class="casAuthors">Wu, Dalei; Potluri, Nalini; Lu, Jingping; Kim, Youngchang; Rastinejad, Fraydoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">303-308</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The hypoxia-inducible factors (HIFs) coordinate cellular adaptations to low oxygen stress by regulating transcriptional programs in erythropoiesis, angiogenesis and metab.  These programs promote the growth and progression of many tumors, making HIFs attractive anticancer targets.  Transcriptionally active HIFs consist of HIF-α and ARNT (also called HIF-1β) subunits.  Here we describe crystal structures for each of mouse HIF-2α-ARNT and HIF-1α-ARNT heterodimers in states that include bound small mols. and their hypoxia response element.  A highly integrated quaternary architecture is shared by HIF-2α-ARNT and HIF-1α-ARNT, wherein ARNT spirals around the outside of each HIF-α subunit.  Five distinct pockets are obsd. that permit small-mol. binding, including PAS domain encapsulated sites and an interfacial cavity formed through subunit heterodimerization.  The DNA-reading head rotates, extends and cooperates with a distal PAS domain to bind hypoxia response elements.  HIF-α mutations linked to human cancers map to sensitive sites that establish DNA binding and the stability of PAS domains and pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzlNDlRsluLVg90H21EOLACvtfcHk0ljqvldVN5b6kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzL&md5=6f61623f717e8344460b5e81e161c77c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature14883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14883%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DPotluri%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DRastinejad%26aufirst%3DF.%26atitle%3DStructural%2520integration%2520in%2520hypoxia-inducible%2520factors%26jtitle%3DNature%26date%3D2015%26volume%3D524%26issue%3D7565%26spage%3D303%26epage%3D308%26doi%3D10.1038%2Fnature14883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terzuoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puppo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapisarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranchimeg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6837</span>– <span class="NLM_lpage">6848</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-10-1075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20736373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2rsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=6837-6848&issue=17&author=E.+Terzuoliauthor=M.+Puppoauthor=A.+Rapisardaauthor=B.+Uranchimegauthor=L.+Caoauthor=A.+M.+Burgerauthor=M.+Zicheauthor=G.+Melillo&title=Aminoflavone%2C+a+ligand+of+the+aryl+hydrocarbon+receptor%2C+inhibits+HIF-1alpha+expression+in+an+AhR-independent+fashion&doi=10.1158%2F0008-5472.CAN-10-1075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion</span></div><div class="casAuthors">Terzuoli, Erika; Puppo, Maura; Rapisarda, Annamaria; Uranchimeg, Badarch; Cao, Liang; Burger, Angelika M.; Ziche, Marina; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6837-6848</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aminoflavone (AF), the active component of a novel anticancer agent (AFP464) in phase I clin. trials, is a ligand of the aryl hydrocarbon receptor (AhR).  AhR dimerizes with HIF-1β/AhR, which is shared with HIF-1α, a transcription factor crit. for the response of cells to oxygen deprivation.  To address whether pharmacol. activation of the AhR pathway might be a potential mechanism for inhibition of HIF-1, we tested the effects of AF on HIF-1 expression.  AF inhibited HIF-1α transcriptional activity and protein accumulation in MCF-7 cells.  However, inhibition of HIF-1α by AF was independent from a functional AhR pathway.  Indeed, AF inhibited HIF-1α expression in AhR100 cells, in which the AhR pathway is functionally impaired, yet did not induce cytotoxicity, providing evidence that these effects are mediated by distinct signaling pathways.  Moreover, AF was inactive in MDA-MB-231 cells, yet inhibited HIF-1α in MDA-MB-231 cells transfected with the SULT1A1 gene.  AF inhibited HIF-1α mRNA expression by ∼50%.  Notably, actinomycin-D completely abrogated the ability of AF to downregulate HIF-1α mRNA, indicating that active transcription was required for the inhibition of HIF-1α expression.  Finally, AF inhibited HIF-1α protein accumulation and the expression of HIF-1 target genes in MCF-7 xenografts.  These results show that AF inhibits HIF-1α in an AhR-independent fashion, and they unveil addnl. activities of AF that may be relevant for its further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoheAp_548Yt7Vg90H21EOLACvtfcHk0ljqvldVN5b6kA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2rsLfN&md5=fe37237b3f1778a7916a32bc2ddde427</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1075%26sid%3Dliteratum%253Aachs%26aulast%3DTerzuoli%26aufirst%3DE.%26aulast%3DPuppo%26aufirst%3DM.%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DBurger%26aufirst%3DA.%2BM.%26aulast%3DZiche%26aufirst%3DM.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DAminoflavone%252C%2520a%2520ligand%2520of%2520the%2520aryl%2520hydrocarbon%2520receptor%252C%2520inhibits%2520HIF-1alpha%2520expression%2520in%2520an%2520AhR-independent%2520fashion%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D17%26spage%3D6837%26epage%3D6848%26doi%3D10.1158%2F0008-5472.CAN-10-1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyu, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsien Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span> <span> </span><span class="NLM_article-title">GL331 inhibits HIF-1alpha expression in a lung cancer model</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00111-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS0006-291X%2803%2900111-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12593853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Cqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=95-100&issue=1&author=H.+Changauthor=K.+G.+Shyuauthor=C.+C.+Leeauthor=S.+C.+Tsaiauthor=B.+W.+Wangauthor=Y.+Hsien+Leeauthor=S.+Lin&title=GL331+inhibits+HIF-1alpha+expression+in+a+lung+cancer+model&doi=10.1016%2FS0006-291X%2803%2900111-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">GL331 inhibits HIF-1α expression in a lung cancer model</span></div><div class="casAuthors">Chang, Hang; Shyu, Kou-Gi; Lee, Chun-Chung; Tsai, Shiow-Chwen; Wang, Bao-Wei; Lee, Yu Hsien; Lin, Shankung</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">We have studied GL331's anti-cancer mechanisms by studying their effect on the tumor-induced angiogenesis.  Human lung adenocarcinoma CL1-5 cells were treated with GL331 and then maintained in serum-reduced, GL331-free medium for the prepn. of condition media.  These condition media were tested for their capability to induce in vitro angiogenesis, i.e., HUVEC tube formation and migration.  We found that media generated from GL331-treated CL1-5 cells presented reduced ability of inducing in vitro angiogenesis.  Western blot analyses showed that both VEGF and HIF-1α were down-regulated in GL331-treated CL1-5 cells.  Northern blot and EMSA analyses showed that GL331 down-regulated HIF-1α expression without decreasing the stability of HIF-1α mRNA, and that GL331 decreased the binding of CL1-5-derived nuclear components to the promoter of HIF-1α gene.  Therefore, our data showed that GL331 is a potent inhibitor of tumor-induced angiogenesis.  The underlying mechanisms might involve at least the inhibition of HIF-1α expression, probably through transcriptional repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLQ5c434gW2LVg90H21EOLACvtfcHk0liTY70jCzdEog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Cqt7s%253D&md5=fec10a894a4a3b90b15affc6a8518e50</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900111-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900111-6%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.%26aulast%3DShyu%26aufirst%3DK.%2BG.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DTsai%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DB.%2BW.%26aulast%3DHsien%2BLee%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DS.%26atitle%3DGL331%2520inhibits%2520HIF-1alpha%2520expression%2520in%2520a%2520lung%2520cancer%2520model%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D302%26issue%3D1%26spage%3D95%26epage%3D100%26doi%3D10.1016%2FS0006-291X%2803%2900111-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horak, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filpula, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westergaard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydenlund, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orum, H.</span></span> <span> </span><span class="NLM_article-title">A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3598</span>– <span class="NLM_lpage">3608</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1535-7163.MCT-08-0510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18974394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGgs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3598-3608&issue=11&author=L.+M.+Greenbergerauthor=I.+D.+Horakauthor=D.+Filpulaauthor=P.+Sapraauthor=M.+Westergaardauthor=H.+F.+Frydenlundauthor=C.+Albaekauthor=H.+Schroderauthor=H.+Orum&title=A+RNA+antagonist+of+hypoxia-inducible+factor-1alpha%2C+EZN-2968%2C+inhibits+tumor+cell+growth&doi=10.1158%2F1535-7163.MCT-08-0510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth</span></div><div class="casAuthors">Greenberger, Lee M.; Horak, Ivan D.; Filpula, David; Sapra, Puja; Westergaard, Majken; Frydenlund, Henrik F.; Albaek, Charlotte; Schroder, Henrik; Orum, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3598-3608</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that plays a crit. role in angiogenesis, survival, metastasis, drug resistance, and glucose metab.  Elevated expression of the α-subunit of HIF-1 (HIF-1α), which occurs in response to hypoxia or activation of growth factor pathways, is assocd. with poor prognosis in many types of cancer.  Therefore, down-regulation of HIF-1α protein by RNA antagonists may control cancer growth.  EZN-2968 is a RNA antagonist composed of third-generation oligonucleotide, locked nucleic acid, technol. that specifically binds and inhibits the expression of HIF-1α mRNA.  In vitro, in human prostate (15PC3, PC3, and DU145) and glioblastoma (U373) cells, EZN-2968 induced a potent, selective, and durable antagonism of HIF-1 mRNA and protein expression (IC50, 1-5 nmol/L) under normoxic and hypoxic conditions assocd. with inhibition of tumor cell growth.  Addnl., down-regulation of HIF-1α protein by EZN-2968 led to redn. of its transcriptional targets and of human umbilical vein endothelial cell tube formation.  In vivo, administration of EZN-2968 to normal mice led to specific, dose-dependent, and highly potent down-regulation of endogenous HIF-1α and vascular endothelial growth factor in the liver.  The effect can last for days after administration of single dose of EZN-2968 and is assocd. with long residence time of locked nucleic acid in certain tissues.  In efficacy studies, tumor redn. was found in nude mice implanted with DU145 cells treated with EZN-2968.  Ongoing phase I studies of EZN-2968 in patients with advanced malignancies will det. optimal dose and schedule for the phase II program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXfvxx_ooHjrVg90H21EOLACvtfcHk0liTY70jCzdEog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGgs77K&md5=4be42a347a2a1ff6873e610a7246f67c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0510%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DHorak%26aufirst%3DI.%2BD.%26aulast%3DFilpula%26aufirst%3DD.%26aulast%3DSapra%26aufirst%3DP.%26aulast%3DWestergaard%26aufirst%3DM.%26aulast%3DFrydenlund%26aufirst%3DH.%2BF.%26aulast%3DAlbaek%26aufirst%3DC.%26aulast%3DSchroder%26aufirst%3DH.%26aulast%3DOrum%26aufirst%3DH.%26atitle%3DA%2520RNA%2520antagonist%2520of%2520hypoxia-inducible%2520factor-1alpha%252C%2520EZN-2968%252C%2520inhibits%2520tumor%2520cell%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D11%26spage%3D3598%26epage%3D3608%26doi%3D10.1158%2F1535-7163.MCT-08-0510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, P. K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1</span>. <i>Cell Growth Differ.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11457733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVCgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=363-369&issue=7&author=B.+H.+Jiangauthor=G.+Jiangauthor=J.+Z.+Zhengauthor=Z.+Luauthor=T.+Hunterauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-kinase+signaling+controls+levels+of+hypoxia-inducible+factor+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1</span></div><div class="casAuthors">Jiang, Bing-Hua; Jiang, Guoqiang; Zheng, Jenny Z.; Lu, Zhimin; Hunter, Tony; Vogt, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">363-369</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K) signaling pathway has inherent oncogenic potential.  It is up-regulated in diverse human cancers by either a gain of function in PI3K itself or in its downstream target Akt or by a loss of function in the neg. regulator PTEN.  However, the complete consequences of this up-regulation are not known.  Here we show that insulin and epidermal growth factor or an inactivating mutation in the tumor suppressor PTEN specifically increase the protein levels of hypoxia-inducible factor (HIF) 1α but not of HIF-1β in human cancer cell lines.  This specific elevation of HIF-1α protein expression requires PI3K signaling.  In the prostate carcinoma-derived cell lines PC-3 and DU145, insulin- and epidermal growth factor-induced expression of HIF-1α was inhibited by the PI3K-specific inhibitors LY294002 and wortmannin in a dose-dependent manner.  HIF-1β expression was not affected by these inhibitors.  Introduction of wild-type PTEN into the PTEN-neg. PC-3 cell line specifically inhibited the expression of HIF-1α but not that of HIF-1β.  In contrast to the HIF-1α protein, the level of HIF-1α mRNA was not significantly affected by PI3K signaling.  Vascular endothelial growth factor reporter gene activity was induced by insulin in PC-3 cells and was inhibited by the PI3K inhibitor LY294002 and by the coexpression of a HIF-1 dominant neg. construct.  Vascular endothelial growth factor reporter gene activity was also inhibited by expression of a dominant neg. PI3K construct and by the tumor suppressor PTEN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0uJULeOiwrVg90H21EOLACvtfcHk0liTY70jCzdEog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVCgur8%253D&md5=6bee4f00d84c646821d278bece852eac</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DZheng%26aufirst%3DJ.%2BZ.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520signaling%2520controls%2520levels%2520of%2520hypoxia-inducible%2520factor%25201%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D2001%26volume%3D12%26issue%3D7%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span> <span> </span><span class="NLM_article-title">Downregulation of HIF-1α inhibits the proliferation, migration and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">BSR20180741</span>, <span class="refDoi"> DOI: 10.1042/BSR20180741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1042%2FBSR20180741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29899167" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=BSR20180741&author=J.+Zhangauthor=J.+Xuauthor=Y.+Dongauthor=B.+Huang&title=Downregulation+of+HIF-1%CE%B1+inhibits+the+proliferation%2C+migration+and+invasion+of+gastric+cancer+by+inhibiting+PI3K%2FAKT+pathway+and+VEGF+expression&doi=10.1042%2FBSR20180741"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1042%2FBSR20180741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20180741%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26atitle%3DDownregulation%2520of%2520HIF-1%25CE%25B1%2520inhibits%2520the%2520proliferation%252C%2520migration%2520and%2520invasion%2520of%2520gastric%2520cancer%2520by%2520inhibiting%2520PI3K%252FAKT%2520pathway%2520and%2520VEGF%2520expression%26jtitle%3DBiosci.%2520Rep.%26date%3D2018%26volume%3D38%26spage%3DBSR20180741%26doi%3D10.1042%2FBSR20180741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otterness, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomis, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaper, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R. T.</span></span> <span> </span><span class="NLM_article-title">Regulation of hypoxia-inducible factor 1 expression and function by the mammalian target of rapamycin</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">7004</span>– <span class="NLM_lpage">7014</span>, <span class="refDoi"> DOI: 10.1128/MCB.22.20.7004-7014.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1128%2FMCB.22.20.7004-7014.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12242281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=7004-7014&issue=20&author=C.+C.+Hudsonauthor=M.+Liuauthor=G.+G.+Chiangauthor=D.+M.+Otternessauthor=D.+C.+Loomisauthor=F.+Kaperauthor=A.+J.+Giacciaauthor=R.+T.+Abraham&title=Regulation+of+hypoxia-inducible+factor+1+expression+and+function+by+the+mammalian+target+of+rapamycin&doi=10.1128%2FMCB.22.20.7004-7014.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin</span></div><div class="casAuthors">Hudson, Christine C.; Liu, Mei; Chiang, Gary G.; Otterness, Diane M.; Loomis, Dawn C.; Kaper, Fiona; Giaccia, Amato J.; Abraham, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7004-7014</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric transcription factor contg. an inducibly expressed HIF-1α subunit and a constitutively expressed HIF-1β subunit.  Under hypoxic conditions, the HIF-1α subunit accumulates due to a decrease in the rate of proteolytic degrdn., and the resulting HIF-1α-HIF-1β heterodimers undergo posttranslational modifications that promote transactivation.  Recent studies suggest that amplified signaling through phosphoinositide 3-kinase, and its downstream target, mTOR, enhances HIF-1-dependent gene expression in certain cell types.  In the present study, we have explored further the linkage between mTOR and HIF-1 in PC-3 prostate cancer cells treated with hypoxia or the hypoxia mimetic agent, CoCl2.  Pretreatment of PC-3 cells with the mTOR inhibitor, rapamycin, inhibited both the accumulation of HIF-1α and HIF-1-dependent transcription induced by hypoxia or CoCl2.  Transfection of these cells with wild-type mTOR enhanced HIF-1 activation by hypoxia or CoCl2, while expression of a rapamycin-resistant mTOR mutant rendered both HIF-1α stabilization and HIF-1 transactivating function refractory to inhibition by rapamycin.  Studies with GAL4-HIF-1α fusion proteins pinpointed the oxygen-dependent degrdn. domain as a crit. target for the rapamycin-sensitive, mTOR-dependent signaling pathway leading to HIF-1α stabilization by CoCl2.  These studies position mTOR as an upstream activator of HIF-1 function in cancer cells and suggest that the antitumor activity of rapamycin is mediated, in part, through the inhibition of cellular responses to hypoxic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrELk511LwaKLVg90H21EOLACvtfcHk0ljVpQRUcg51-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKitrk%253D&md5=7f74629f6aacee66bf4289fdd3f16b85</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.20.7004-7014.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.20.7004-7014.2002%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DC.%2BC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DOtterness%26aufirst%3DD.%2BM.%26aulast%3DLoomis%26aufirst%3DD.%2BC.%26aulast%3DKaper%26aufirst%3DF.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DRegulation%2520of%2520hypoxia-inducible%2520factor%25201%2520expression%2520and%2520function%2520by%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26issue%3D20%26spage%3D7004%26epage%3D7014%26doi%3D10.1128%2FMCB.22.20.7004-7014.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spivak-Kroizman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the hypoxia response for cancer therapy: the new kid on the block</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5945</span>– <span class="NLM_lpage">5946</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-1650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1078-0432.CCR-09-1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19789327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=5945-5946&issue=19&author=M.+Y.+Kohauthor=T.+R.+Spivak-Kroizmanauthor=G.+Powis&title=Inhibiting+the+hypoxia+response+for+cancer+therapy%3A+the+new+kid+on+the+block&doi=10.1158%2F1078-0432.CCR-09-1650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block</span></div><div class="casAuthors">Koh, Mei Yee; Spivak-Kroizman, Taly R.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5945-5946</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hypoxia-inducible transcription factor (HIF)-1α inhibitor KC7F2 described in this issue of Clin. Cancer Research is the newest addn. to an emerging class of antitumor agents targeting the hypoxia response.  Here, we discuss the proposed mechanism of action of KC7F2 and its potential strengths and limitations in comparison with other promising HIF-1α inhibitors. (Clin Cancer Res 2009;15(19):5945-6).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkhgl0HOsZ7Vg90H21EOLACvtfcHk0ljVpQRUcg51-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbjL&md5=0ab7dd009b91465b6c872b1df34f46a8</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1650%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DM.%2BY.%26aulast%3DSpivak-Kroizman%26aufirst%3DT.%2BR.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DInhibiting%2520the%2520hypoxia%2520response%2520for%2520cancer%2520therapy%253A%2520the%2520new%2520kid%2520on%2520the%2520block%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D19%26spage%3D5945%26epage%3D5946%26doi%3D10.1158%2F1078-0432.CCR-09-1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shackelford, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbeil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R. J.</span></span> <span> </span><span class="NLM_article-title">mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">11137</span>– <span class="NLM_lpage">11142</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900465106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0900465106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19541609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVWgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=11137-11142&issue=27&author=D.+B.+Shackelfordauthor=D.+S.+Vasquezauthor=J.+Corbeilauthor=S.+Wuauthor=M.+Leblancauthor=C.+L.+Wuauthor=D.+R.+Veraauthor=R.+J.+Shaw&title=mTOR+and+HIF-1alpha-mediated+tumor+metabolism+in+an+LKB1+mouse+model+of+Peutz-Jeghers+syndrome&doi=10.1073%2Fpnas.0900465106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome</span></div><div class="casAuthors">Shackelford, David B.; Vasquez, Debbie S.; Corbeil, Jacqueline; Wu, Shulin; Leblanc, Mathias; Wu, Chin-Lee; Vera, David R.; Shaw, Reuben J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">11137-11142, S11137/1-S11137/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peutz-Jeghers syndrome (PJS) is a familial cancer disorder due to inherited loss of function mutations in the LKB1/STK11 serine/threonine kinase.  PJS patients develop gastrointestinal hamartomas with 100% penetrance often in the second decade of life, and demonstrate an increased predisposition toward the development of a no. of addnl. malignancies.  Among mitogenic signaling pathways, the mammalian-target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in tissues and tumors derived from LKB1-deficient mice.  Consistent with a central role for mTORC1 in these tumors, rapamycin as a single agent results in a dramatic suppression of preexisting GI polyps in LKB1+/- mice.  However, the key targets of mTORC1 in LKB1-deficient tumors remain unknown.  We demonstrate here that these polyps, and LKB1- and AMPK-deficient mouse embryonic fibroblasts, show dramatic up-regulation of the HIF-1α transcription factor and its downstream transcriptional targets in an rapamycin-suppressible manner.  The HIF-1α targets hexokinase II and Glut1 are up-regulated in these polyps, and using FDG-PET, we demonstrate that LKB1+/- mice show increased glucose utilization in focal regions of their GI tract corresponding to these gastrointestinal hamartomas.  Importantly, we demonstrate that polyps from human Peutz-Jeghers patients similarly exhibit up-regulated mTORC1 signaling, HIF-1α, and GLUT1 levels.  Furthermore, like HIF-1α and its target genes, the FDG-PET signal in the GI tract of these mice is abolished by rapamycin treatment.  These findings suggest a no. of therapeutic modalities for the treatment and detection of hamartomas in PJS patients, and potential for the screening and treatment of the 30% of sporadic human lung cancers bearing LKB1 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ-GDKsOxgbbVg90H21EOLACvtfcHk0ljVpQRUcg51-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVWgu78%253D&md5=323798fa0e664b1022918aa5f8a9f256</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900465106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900465106%26sid%3Dliteratum%253Aachs%26aulast%3DShackelford%26aufirst%3DD.%2BB.%26aulast%3DVasquez%26aufirst%3DD.%2BS.%26aulast%3DCorbeil%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DC.%2BL.%26aulast%3DVera%26aufirst%3DD.%2BR.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26atitle%3DmTOR%2520and%2520HIF-1alpha-mediated%2520tumor%2520metabolism%2520in%2520an%2520LKB1%2520mouse%2520model%2520of%2520Peutz-Jeghers%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D27%26spage%3D11137%26epage%3D11142%26doi%3D10.1073%2Fpnas.0900465106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayerhofer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valent, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperr, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillaber, C.</span></span> <span> </span><span class="NLM_article-title">BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3767</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1182/blood-2002-01-0109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1182%2Fblood-2002-01-0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12393646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=3767-3775&issue=10&author=M.+Mayerhoferauthor=P.+Valentauthor=W.+R.+Sperrauthor=J.+D.+Griffinauthor=C.+Sillaber&title=BCR%2FABL+induces+expression+of+vascular+endothelial+growth+factor+and+its+transcriptional+activator%2C+hypoxia+inducible+factor-1alpha%2C+through+a+pathway+involving+phosphoinositide+3-kinase+and+the+mammalian+target+of+rapamycin&doi=10.1182%2Fblood-2002-01-0109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin</span></div><div class="casAuthors">Mayerhofer, Matthias; Valent, Peter; Sperr, Wolfgang R.; Griffin, James D.; Sillaber, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3767-3775</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Recent data suggest that vascular endothelial growth factor (VEGF), a cytokine involved in autocrine growth of tumor cells and tumor angiogenesis, is up-regulated and plays a potential role in myelogenous leukemias.  In chronic myelogenous leukemia (CML), VEGF is expressed at high levels in the bone marrow and peripheral blood.  We show here that the CML-assocd. oncogene BCR/ABL induces VEGF gene expression in growth factor-dependent Ba/F3 cells.  Whereas starved cells were found to contain only baseline levels of VEGF mRNA, Ba/F3 cells induced to express BCR/ABL exhibited substantial amts. of VEGF mRNA.  BCR/ABL also induced VEGF promoter activity and increased VEGF protein levels in Ba/F3 cells.  Moreover, BCR/ABL was found to promote the expression of functionally active hypoxia-inducible factor-1 (HIF-1), a major transcriptional regulator of VEGF gene expression.  BCR/ABL-induced VEGF gene expression was counteracted by the phosphoinositide 3-kinase (PI3-kinase) inhibitor LY294002 and rapamycin, an antagonist of mammalian target of rapamycin (mTOR), but not by inhibition of the mitogen-activated protein kinase pathway.  Similarly, BCR/ABL-dependent HIF-1α expression was inhibited by the addn. of LY294002 and rapamycin.  Together, our data show that BCR/ABL induces VEGF- and HIF-1α gene expression through a pathway involving PI3-kinase and mTOR.  BCR/ABL-induced VEGF expression may contribute to the pathogenesis and increased angiogenesis in CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNo-4bbqnn47Vg90H21EOLACvtfcHk0ljIzZ39-Yeq8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslKlsro%253D&md5=8a9f8bcb0781b7d12a401a64ebb2aa66</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-01-0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-01-0109%26sid%3Dliteratum%253Aachs%26aulast%3DMayerhofer%26aufirst%3DM.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DSperr%26aufirst%3DW.%2BR.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DSillaber%26aufirst%3DC.%26atitle%3DBCR%252FABL%2520induces%2520expression%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520its%2520transcriptional%2520activator%252C%2520hypoxia%2520inducible%2520factor-1alpha%252C%2520through%2520a%2520pathway%2520involving%2520phosphoinositide%25203-kinase%2520and%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DBlood%26date%3D2002%26volume%3D100%26issue%3D10%26spage%3D3767%26epage%3D3775%26doi%3D10.1182%2Fblood-2002-01-0109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rho, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na,  II.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span> <span> </span><span class="NLM_article-title">Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19212642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=801-807&issue=3&author=J.+K.+Rhoauthor=Y.+J.+Choiauthor=J.+K.+Leeauthor=B.+Y.+Ryooauthor=+Naauthor=S.+H.+Yangauthor=C.+H.+Kimauthor=Y.+D.+Yooauthor=J.+C.+Lee&title=Gefitinib+circumvents+hypoxia-induced+drug+resistance+by+the+modulation+of+HIF-1alpha"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1α</span></div><div class="casAuthors">Rho, Jin Kyung; Choi, Yun Jung; Lee, Jin Kyung; Ryoo, Baek-yeol; Na, Im Ii; Yang, Sung Hyun; Kim, Cheol Hyeon; Yoo, Young Do; Lee, Jae Cheol</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">801-807</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1α (HIF-1α) is a transcriptional factor which is activated by hypoxia and assocd. with cell survival, proliferation and drug resistance.  Recent studies have shown that the down-stream mols. of the epidermal growth factor receptor (EGFR) signal are involved in the hypoxia-dependent or -independent HIF-1α protein accumulation.  Thus, we hypothesized that an EGFR-TK inhibitor, gefitinib, might circumvent the hypoxia-induced drug resistance via the regulation of HIF-1α expression.  In our data, treatment of gefitinib suppressed induced HIF-1α by hypoxia.  This action of gefitinib was caused by reduced protein stability without any change in the level of HIF-1α mRNA.  The effect of gefitinib on downregulation of HIF-1α was reversed by transfection of constitutively active form of Akt.  The cellular response to gefitinib was similar in both normoxia and hypoxia condition.  However, the response to conventional chemotherapeutic drugs decreased >50% under hypoxia condition and they did not change HIF-1α expression.  In addn., the suppression of HIF-1α using siRNA overcame partially hypoxia-induced drug resistance.  In conclusion, gefitinib was able to circumvent hypoxia-induced drug resistance suggesting that the effective suppression of HIF-1α by the inhibition of EGFR-Akt pathway may overcome the hypoxia-induced drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnMtTuGdQTdrVg90H21EOLACvtfcHk0ljIzZ39-Yeq8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWhtLo%253D&md5=e906e5f8f24ad622937ab651a6db9278</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRho%26aufirst%3DJ.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DRyoo%26aufirst%3DB.%2BY.%26aulast%3DNa%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DYoo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DGefitinib%2520circumvents%2520hypoxia-induced%2520drug%2520resistance%2520by%2520the%2520modulation%2520of%2520HIF-1alpha%26jtitle%3DOncol.%2520Rep.%26date%3D2009%26volume%3D21%26issue%3D3%26spage%3D801%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span> <span> </span><span class="NLM_article-title">Genistein decreases A549 cell viability via inhibition of the PI3K/AKT/HIF1alpha/VEGF and NF-kB/COX-2 signaling pathways</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2302</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.6260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.3892%2Fmmr.2017.6260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28259980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFWkt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=2296-2302&issue=4&author=J.+Zhangauthor=H.+Suauthor=Q.+Liauthor=J.+Liauthor=Q.+Zhao&title=Genistein+decreases+A549+cell+viability+via+inhibition+of+the+PI3K%2FAKT%2FHIF1alpha%2FVEGF+and+NF-kB%2FCOX-2+signaling+pathways&doi=10.3892%2Fmmr.2017.6260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Genistein decreases A549 cell viability via inhibition of the PI3K/AKT/HIF-1α/VEGF and NF-κB/COX-2 signaling pathways</span></div><div class="casAuthors">Zhang, Juan; Su, Hongzheng; Li, Qingfeng; Li, Jing; Zhao, Qianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2296-2302</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Genistein is an important chemopreventive agent against atherosclerosis and cancer.  However, whether genistein is effective in the treatment of lung cancer, and its underlying mechanism, remains to be detd.  The present study demonstrated that genistein treatment of A549 lung cancer cells decreased viability in a dose- and time-dependent manner, and induced apoptosis.  Addnl., A549 cells exhibited significantly increased reactive oxygen species formation and cytochrome-c leakage, and activated caspase-3, B-cell lymphoma 2-assocd. X protein and apoptosis inducing factor expression levels, which are involved in the mitochondrial apoptosis pathway.  Furthermore, the phosphatidylinositol-4,5-biphosphate 3-kinase (PI3K)/protein kinase B (AKT)/hypoxia-inducible factor-1α (HIF-1α) and nuclear factor-κB (NF-κB)/cyclooxygenase-2 (COX-2) signaling pathways were significantly downregulated by genistein treatment.  In conclusion, reduced proliferation and increased apoptosis in A549 lung cancer cells was assocd. with inhibition of the PI3K/AKT/HIF-1α/ and NF-κB/COX-2 signaling pathways, which implicates genistein as a potential chemotherapeutic agent for the treatment of lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxBvC1gPhJrVg90H21EOLACvtfcHk0ljIzZ39-Yeq8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFWkt7zJ&md5=0310a174a3b2bc38503079d0407a4f0c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.6260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.6260%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26atitle%3DGenistein%2520decreases%2520A549%2520cell%2520viability%2520via%2520inhibition%2520of%2520the%2520PI3K%252FAKT%252FHIF1alpha%252FVEGF%2520and%2520NF-kB%252FCOX-2%2520signaling%2520pathways%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D15%26issue%3D4%26spage%3D2296%26epage%3D2302%26doi%3D10.3892%2Fmmr.2017.6260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richard, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gothie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span> <span> </span><span class="NLM_article-title">P42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">32631</span>– <span class="NLM_lpage">32637</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.46.32631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.274.46.32631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10551817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1MXntlygsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=32631-32637&issue=46&author=D.+E.+Richardauthor=E.+Berraauthor=E.+Gothieauthor=D.+Rouxauthor=J.+Pouyssegur&title=P42%2Fp44+mitogen-activated+protein+kinases+phosphorylate+hypoxia-inducible+factor+1alpha+%28HIF-1alpha%29+and+enhance+the+transcriptional+activity+of+HIF-1&doi=10.1074%2Fjbc.274.46.32631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1</span></div><div class="casAuthors">Richard, Darren E.; Berra, Edurne; Gothie, Emmanuel; Roux, Daniele; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">32631-32637</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) controls the expression of a no. of genes such as vascular endothelial growth factor and erythropoietin in low oxygen conditions.  However, the mol. mechanisms that underlie the activation of the limiting subunit, HIF-1α, are still poorly resolved.  Results showing that endogenous HIF-1α migrated 12 kDa higher than in vitro translated protein led the authors to evaluate the possible role of phosphorylation on this phenomenon.  The authors report that HIF-1α is strongly phosphorylated in vivo and that phosphorylation is responsible for the marked differences in the migration pattern of HIF-1α.  In vitro, HIF-1α is phosphorylated by p42 and p44 mitogen-activated protein kinases (MAPKs) and not by p38 MAPK or c-Jun N-terminal kinase.  Interestingly, p42/p44 MAPK stoichiometrically phosphorylate HIF-1α in vitro, as judged by a complete upper shift of HIF-1α.  More importantly, the authors demonstrate that activation of the p42/p44 MAPK pathway in quiescent cells induced the phosphorylation and shift of HIF-1α, which was abrogated in presence of the MEK inhibitor, PD 98059.  Finally, the authors found that in a vascular endothelial growth factor promoter mutated at sites previously shown to be MAPK-sensitive (SP1/AP2-88-66 site), p42/p44 MAPK activation is sufficient to promote the transcriptional activity of HIF-1.  This interaction between HIF-1α and p42/p44 MAPK suggests a cooperation between hypoxic and growth factor signals that ultimately leads to the increase in HIF-1-mediated gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuwlVSit0_rVg90H21EOLACvtfcHk0liyelR9094JLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlygsbs%253D&md5=c8509171d0c8a0493625b87277e87726</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.46.32631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.46.32631%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DD.%2BE.%26aulast%3DBerra%26aufirst%3DE.%26aulast%3DGothie%26aufirst%3DE.%26aulast%3DRoux%26aufirst%3DD.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DP42%252Fp44%2520mitogen-activated%2520protein%2520kinases%2520phosphorylate%2520hypoxia-inducible%2520factor%25201alpha%2520%2528HIF-1alpha%2529%2520and%2520enhance%2520the%2520transcriptional%2520activity%2520of%2520HIF-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D46%26spage%3D32631%26epage%3D32637%26doi%3D10.1074%2Fjbc.274.46.32631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, J.</span></span> <span> </span><span class="NLM_article-title">NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1002/ijc.20438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fijc.20438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15382039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlGjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=585-595&issue=4&author=H.+Zhongauthor=M.+Willardauthor=J.+Simons&title=NS398+reduces+hypoxia-inducible+factor+%28HIF%29-1alpha+and+HIF-1+activity%3A+multiple-level+effects+involving+cyclooxygenase-2+dependent+and+independent+mechanisms&doi=10.1002%2Fijc.20438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">NS398 reduces hypoxia-inducible factor (HIF)-1α and HIF-1 activity: Multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms</span></div><div class="casAuthors">Zhong, Hua; Willard, Margaret; Simons, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">585-595</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Tissue hypoxia is a common feature in solid tumors.  Hypoxia-inducible factor 1 (HIF-1) is a crit. transcription factor that regulates the expression of genes encoding factors that influence tumor growth including vascular endothelial growth factor.  Previous studies have demonstrated that post-transcriptional modification events are important for regulation of HIF-1α protein expression and HIF-1 transcriptional activity.  Prostaglandin E2 (PGE2), a major end product of the cyclooxygenase-2 (COX-2) enzyme, induces the basal and hypoxia-induced nuclear relocalization of HIF-1α.  This is suppressed by NS398, a COX-2 selective inhibitor.  NS398 also inhibits hypoxia-induced angiogenesis, which may be mediated by the inhibition of HIF-1 function in a COX-2-dependent manner.  Here, we show that NS398 reduces HIF-1α and HIF-1 transcriptional function in both COX-2 pos. PC-3 cells and COX-2 neg. HCT116 cells under normoxic and hypoxic conditions.  On the one hand, NS398 decreases the expression of HIF-1α mRNA and reduces HIF-1α synthesis in a COX-2/PGE2 dependent way, which can be restored by addn. of exogenous PGE2 that activates the phosphatidylinositol 3-kinase/AKT/p7056k signaling pathway.  On the other hand, NS398 accelerates HIF-1α degrdn. by moderately increasing ubiquitination and remarkably promoting the clearance of ubiquitylated protein, an effect most likely independent of COX-2/PGE2 since exogenous PGE2 fails to reverse it.  Finally, NS398 decreases hypoxia-induced shifted form of HIF-1α and attenuates HIF-1 activation in greater extent under hypoxic than normoxic conditions.  These data not only confirm the inhibitory effect of NS398 on HIF-1α and HIF-1 transcriptional activity but also demonstrate that such an effect occurs at multiple levels involving both COX-2 dependent and independent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJMAYISQ-cWrVg90H21EOLACvtfcHk0liyelR9094JLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlGjsbs%253D&md5=5f2ead5d9d5d0e40e08ae4bbc9fc2314</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fijc.20438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20438%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DWillard%26aufirst%3DM.%26aulast%3DSimons%26aufirst%3DJ.%26atitle%3DNS398%2520reduces%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1alpha%2520and%2520HIF-1%2520activity%253A%2520multiple-level%2520effects%2520involving%2520cyclooxygenase-2%2520dependent%2520and%2520independent%2520mechanisms%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D112%26issue%3D4%26spage%3D585%26epage%3D595%26doi%3D10.1002%2Fijc.20438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukyanov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagzag, D.</span></span> <span> </span><span class="NLM_article-title">Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1215/S1152851704000997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1215%2FS1152851704000997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16053697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=225-235&issue=3&author=E.+W.+Newcombauthor=M.+A.+Aliauthor=T.+Schneeauthor=L.+Lanauthor=Y.+Lukyanovauthor=M.+Fowkesauthor=D.+C.+Millerauthor=D.+Zagzag&title=Flavopiridol+downregulates+hypoxia-mediated+hypoxia-inducible+factor-1alpha+expression+in+human+glioma+cells+by+a+proteasome-independent+pathway%3A+implications+for+in+vivo+therapy&doi=10.1215%2FS1152851704000997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1α expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy</span></div><div class="casAuthors">Newcomb, Elizabeth W.; Ali, M. Aktar; Schnee, Tona; Lan, Li; Lukyanov, Yevgeniy; Fowkes, Mary; Miller, Douglas C.; Zagzag, David</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Durham, NC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-235</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Duke University Press</span>)
        </div><div class="casAbstract">Angiogenesis is a crit. step required for sustained tumor growth and tumor progression.  The stimulation of endothelial cells by cytokines secreted by tumor cells such as vascular endothelial growth factor (VEGF) induces their proliferation and migration.  This is a prominent feature of high-grade gliomas.  The secretion of VEGF is greatly upregulated under conditions of hypoxia because of the transcription factor hypoxia-inducible factor (HIF)-1α, which controls the expression of many genes, allowing rapid adaptation of cells to their hypoxic microenvironment.  Flavopiridol, a novel cyclin-dependent kinase inhibitor, has been attributed with antiangiogenic properties in some cancer cell lines by its ability to inhibit VEGF prodn.  Here, we show that flavopiridol treatment of human U87MG and T98G glioma cell lines decreases hypoxia-mediated HIF-1α expression, VEGF secretion, and tumor cell migration.  These in vitro results correlate with reduced vascularity of intracranial syngeneic GL261 gliomas from animals treated with flavopiridol.  In addn., we show that flavopiridol downregulates HIF-1α expression in the presence of a proteasome inhibitor, an agent that normally results in the accumulation and overexpression of HIF-1α.  The potential to downregulate HIF-1α expression with flavopiridol treatment in combination with a proteasome inhibitor makes this an extremely attractive anticancer treatment strategy for tumors with high angiogenic activity, such as gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKisEISOYnrVg90H21EOLACvtfcHk0liyelR9094JLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cmtr4%253D&md5=e7aa7442a4d1fd1ae3e403bee8d86892</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1215%2FS1152851704000997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1215%252FS1152851704000997%26sid%3Dliteratum%253Aachs%26aulast%3DNewcomb%26aufirst%3DE.%2BW.%26aulast%3DAli%26aufirst%3DM.%2BA.%26aulast%3DSchnee%26aufirst%3DT.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLukyanov%26aufirst%3DY.%26aulast%3DFowkes%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DD.%2BC.%26aulast%3DZagzag%26aufirst%3DD.%26atitle%3DFlavopiridol%2520downregulates%2520hypoxia-mediated%2520hypoxia-inducible%2520factor-1alpha%2520expression%2520in%2520human%2520glioma%2520cells%2520by%2520a%2520proteasome-independent%2520pathway%253A%2520implications%2520for%2520in%2520vivo%2520therapy%26jtitle%3DNeuro%2520Oncol%26date%3D2005%26volume%3D7%26issue%3D3%26spage%3D225%26epage%3D235%26doi%3D10.1215%2FS1152851704000997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carbonaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span> <span> </span><span class="NLM_article-title">Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1083/jcb.201004145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1083%2Fjcb.201004145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=21220510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsl2htQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2011&pages=83-99&issue=1&author=M.+Carbonaroauthor=A.+O%E2%80%99Brateauthor=P.+Giannakakou&title=Microtubule+disruption+targets+HIF-1alpha+mRNA+to+cytoplasmic+P-bodies+for+translational+repression&doi=10.1083%2Fjcb.201004145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression</span></div><div class="casAuthors">Carbonaro, Marisa; O'Brate, Aurora; Giannakakou, Paraskevi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-99</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The hypoxia inducible factor 1α (HIF-1α) is overexpressed in solid tumors, driving tumor angiogenesis and survival.  However, the mechanisms regulating HIF-1α expression in solid tumors are not fully understood.  In this study, we find that microtubule integrity and dynamics are intricately involved in orchestrating HIF-1α translation.  HIF-1α mRNA traffics on dynamic microtubules when it is actively translated.  Microtubule perturbation by taxol (TX) and other microtubule-targeting drugs stalls HIF-1α mRNA transport and releases it from polysomes, suppressing its translation.  Immunopptn. of the P-body component Argonaute 2 (Ago2) after microtubule disruption shows significant enrichment of HIF-1α mRNAs and HIF-targeting microRNAs (miRNAs).  Inhibition of HIF-repressing miRNAs or Ago2 knockdown abrogates TX's ability to suppress HIF-1α translation.  Interestingly, microtubule repolymn. after nocodazole washout allows HIF-1α mRNA to reenter active translation, suggesting that microtubule dynamics exert tight yet reversible control over HIF-1α translation.  Collectively, we provide evidence for a new mechanism of microtubule-dependent HIF-1α translation with important implications for cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDT8LLNXs8bVg90H21EOLACvtfcHk0liyelR9094JLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsl2htQ%253D%253D&md5=3297aa4f3a6b7ecf0b2ac5ba7d6e9748</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201004145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201004145%26sid%3Dliteratum%253Aachs%26aulast%3DCarbonaro%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brate%26aufirst%3DA.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3DMicrotubule%2520disruption%2520targets%2520HIF-1alpha%2520mRNA%2520to%2520cytoplasmic%2520P-bodies%2520for%2520translational%2520repression%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D192%26issue%3D1%26spage%3D83%26epage%3D99%26doi%3D10.1083%2Fjcb.201004145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mabjeesh, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escuin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVallee, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribluda, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span> <span> </span><span class="NLM_article-title">2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00077-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS1535-6108%2803%2900077-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12726862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=363-375&issue=4&author=N.+J.+Mabjeeshauthor=D.+Escuinauthor=T.+M.+LaValleeauthor=V.+S.+Pribludaauthor=G.+M.+Swartzauthor=M.+S.+Johnsonauthor=M.+T.+Willardauthor=H.+Zhongauthor=J.+W.+Simonsauthor=P.+Giannakakou&title=2ME2+inhibits+tumor+growth+and+angiogenesis+by+disrupting+microtubules+and+dysregulating+HIF&doi=10.1016%2FS1535-6108%2803%2900077-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF</span></div><div class="casAuthors">Mabjeesh, Nicola J.; Escuin, Daniel; LaVallee, Theresa M.; Pribluda, Victor S.; Swartz, Glenn M.; Johnson, Michelle S.; Willard, Margaret T.; Zhong, Hua; Simons, Jonathan W.; Giannakakou, Paraskevi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">363-375</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">2-Methoxyestradiol (2ME2) is a novel antitumor and antiangiogenic agent, currently in clin. trials, whose mol. mechanism of action remains unclear.  It is reported here that 2ME2 inhibited the growth and angiogenesis of various tumors in vitro at concns. equiv. to those that efficiently disrupted tumor microtubules (MTs) in mice in vivo.  2ME2 downregulated hypoxia-inducible factor-1 (HIF) at the post-transcriptional level and inhibited HIF-1-induced transcriptional activation of vascular endothelial growth factor expression.  Inhibition of HIF-1 occurred downstream from the 2ME2/tubulin interaction, as disruption of interphase MTs is required for HIF-α downregulation.  These data establish 2ME2 as a low-mol.-wt. inhibitor of HIF-1 and provide a mechanistic link between the disruption of the MT cytoskeleton and inhibition of angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-DOdEq9rf-bVg90H21EOLACvtfcHk0ljYAJb-_dOYhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFGgsrY%253D&md5=6cf0acac54e7778ccb1f3fd72cf92831</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900077-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900077-1%26sid%3Dliteratum%253Aachs%26aulast%3DMabjeesh%26aufirst%3DN.%2BJ.%26aulast%3DEscuin%26aufirst%3DD.%26aulast%3DLaVallee%26aufirst%3DT.%2BM.%26aulast%3DPribluda%26aufirst%3DV.%2BS.%26aulast%3DSwartz%26aufirst%3DG.%2BM.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DWillard%26aufirst%3DM.%2BT.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DSimons%26aufirst%3DJ.%2BW.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3D2ME2%2520inhibits%2520tumor%2520growth%2520and%2520angiogenesis%2520by%2520disrupting%2520microtubules%2520and%2520dysregulating%2520HIF%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26issue%3D4%26spage%3D363%26epage%3D375%26doi%3D10.1016%2FS1535-6108%2803%2900077-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerbrand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlitt, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogler, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeltzing, O.</span></span> <span> </span><span class="NLM_article-title">ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">206</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-8-206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1186%2F1471-2407-8-206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18651980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A280%3ADC%252BD1cvpvFaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=206&author=C.+Moserauthor=S.+A.+Langauthor=A.+Moriauthor=C.+Hellerbrandauthor=H.+J.+Schlittauthor=E.+K.+Geisslerauthor=W.+E.+Foglerauthor=O.+Stoeltzing&title=ENMD-1198%2C+a+novel+tubulin-binding+agent+reduces+HIF-1alpha+and+STAT3+activity+in+human+hepatocellular+carcinoma%28HCC%29+cells%2C+and+inhibits+growth+and+vascularization+in+vivo&doi=10.1186%2F1471-2407-8-206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo</span></div><div class="casAuthors">Moser Christian; Lang Sven A; Mori Akira; Hellerbrand Claus; Schlitt Hans J; Geissler Edward K; Fogler William E; Stoeltzing Oliver</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">206</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Hepatocellular carcinoma (HCC) represents a highly vascularized tumor entity and the process of angiogenesis is essential for the growth of HCC.  Importantly, the pro-angiogenic transcription factors HIF-1alpha and STAT3 have been implicated in HCC progression, thus representing interesting targets for molecular targeted therapy.  We hypothesized that therapeutic inhibition of HIF-1alpha could be achieved by using a novel tubulin-binding agent (ENMD-1198).  ENMD-1198 is an analog of 2-methoxyestradiol (2ME2) with antiproliferative and antiangiogenic activity.  METHODS:  The human HCC cell lines HUH-7 and HepG2 were used for experiments.  Effects of ENMD-1198 on constitutive and inducible (hypoxia, growth factors) activation of signaling cascades, including HIF-1alpha and STAT3, were investigated by Western blotting.  Changes in VEGF expression were determined by real-time PCR.  Effects of ENMD-1198 on cancer cell migration and invasion were evaluated in in vitro-assays.  The growth-inhibitory effects of ENMD-1198 (200 mg/kg/day) were determined in a subcutaneous tumor model (HUH-7).  RESULTS:  ENMD-1198 inhibited the phosphorylation of MAPK/Erk, PI-3K/Akt and FAK.  Moreover, activation of HIF-1alpha and STAT3 was dramatically reduced by ENMD-1198, which resulted in lower VEGF mRNA expression (P < 0.05).  In addition, tumor cell migratory and invasive properties were significantly inhibited (P < 0.05, for both).  In vivo, treatment with ENMD-1198 led to a significant reduction in tumor growth, tumor vascularization, and numbers of proliferating tumor cells (P < 0.05 for all).  CONCLUSION:  The novel microtubule destabilizing agent ENMD-1198 is suitable for inhibiting HIF-1alpha and STAT3 in human HCC cells and leads to reduced tumor growth and vascularization in vivo.  Hence, inhibition of HIF-1alpha and STAT3 could prove valuable for therapy of hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ66w6qDcPMQWGmni0r9GoKfW6udTcc2ebjYESFizytzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvpvFaiug%253D%253D&md5=fdb3186794e06c9475b05c5a761f3577</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-8-206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-8-206%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DC.%26aulast%3DLang%26aufirst%3DS.%2BA.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DHellerbrand%26aufirst%3DC.%26aulast%3DSchlitt%26aufirst%3DH.%2BJ.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DFogler%26aufirst%3DW.%2BE.%26aulast%3DStoeltzing%26aufirst%3DO.%26atitle%3DENMD-1198%252C%2520a%2520novel%2520tubulin-binding%2520agent%2520reduces%2520HIF-1alpha%2520and%2520STAT3%2520activity%2520in%2520human%2520hepatocellular%2520carcinoma%2528HCC%2529%2520cells%252C%2520and%2520inhibits%2520growth%2520and%2520vascularization%2520in%2520vivo%26jtitle%3DBMC%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D206%26doi%3D10.1186%2F1471-2407-8-206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapisarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braunschweig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranchimeg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomi, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgel, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6845</span>– <span class="NLM_lpage">6848</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-04-2116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15466170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFalsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6845-6848&issue=19&author=A.+Rapisardaauthor=J.+Zalekauthor=M.+Hollingsheadauthor=T.+Braunschweigauthor=B.+Uranchimegauthor=C.+A.+Bonomiauthor=S.+D.+Borgelauthor=J.+P.+Carterauthor=S.+M.+Hewittauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Schedule-dependent+inhibition+of+hypoxia-inducible+factor-1alpha+protein+accumulation%2C+angiogenesis%2C+and+tumor+growth+by+topotecan+in+U251-HRE+glioblastoma+xenografts&doi=10.1158%2F0008-5472.CAN-04-2116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts</span></div><div class="casAuthors">Rapisarda, Annamaria; Zalek, Jessica; Hollingshead, Melinda; Braunschweig, Till; Uranchimeg, Badarch; Bonomi, Carrie A.; Borgel, Suzanne D.; Carter, John P.; Hewitt, Stephen M.; Shoemaker, Robert H.; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6845-6848</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have previously shown that topotecan, a topoisomerase I poison, inhibits hypoxia-inducible factor (HIF)-1α protein accumulation by a DNA damage-independent mechanism.  Here, we report that daily administration of topotecan inhibits HIF-1α protein expression in U251-HRE glioblastoma xenografts.  Concomitant with HIF-1α inhibition, topotecan caused a significant tumor growth inhibition assocd. with a marked decrease of angiogenesis and expression of HIF-1 target genes in tumor tissue.  These results provide a compelling rationale for testing topotecan in clin. trials to target HIF-1 in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OgB-vdXGNLVg90H21EOLACvtfcHk0ljYAJb-_dOYhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFalsr8%253D&md5=999f21239d31db046eff4f99b375bdfb</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2116%26sid%3Dliteratum%253Aachs%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DZalek%26aufirst%3DJ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DBraunschweig%26aufirst%3DT.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DBonomi%26aufirst%3DC.%2BA.%26aulast%3DBorgel%26aufirst%3DS.%2BD.%26aulast%3DCarter%26aufirst%3DJ.%2BP.%26aulast%3DHewitt%26aufirst%3DS.%2BM.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DSchedule-dependent%2520inhibition%2520of%2520hypoxia-inducible%2520factor-1alpha%2520protein%2520accumulation%252C%2520angiogenesis%252C%2520and%2520tumor%2520growth%2520by%2520topotecan%2520in%2520U251-HRE%2520glioblastoma%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D19%26spage%3D6845%26epage%3D6848%26doi%3D10.1158%2F0008-5472.CAN-04-2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creighton-Gutteridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardellina, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapisarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranchimeg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hite, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1010</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1078-0432.CCR-06-2301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17289897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1010-1018&issue=3&author=M.+Creighton-Gutteridgeauthor=J.+H.+Cardellinaauthor=A.+G.+Stephenauthor=A.+Rapisardaauthor=B.+Uranchimegauthor=K.+Hiteauthor=W.+A.+Dennyauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Cell+type-specific%2C+topoisomerase+II-dependent+inhibition+of+hypoxia-inducible+factor-1alpha+protein+accumulation+by+NSC+644221&doi=10.1158%2F1078-0432.CCR-06-2301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Cell Type-Specific, Topoisomerase II-Dependent Inhibition of Hypoxia-Inducible Factor-1α Protein Accumulation by NSC 644221</span></div><div class="casAuthors">Creighton-Gutteridge, Mark; Cardellina, John H., II; Stephen, Andrew G.; Rapisarda, Annamaria; Uranchimeg, Badarch; Hite, Karen; Denny, William A.; Shoemaker, Robert H.; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The discovery and development of small-mol. inhibitors of hypoxia-inducible factor-1 (HIF-1) is an attractive, yet challenging, strategy for the development of new cancer therapeutic agents.  Here, we report on a novel tricyclic carboxamide inhibitor of HIF-1α, NSC 644221.  Exptl. Design: We investigated the mechanism by which the novel compd. NSC 644221 inhibited HIF-1α.  RESULTS: NSC 644221 inhibited HIF-1-dependent, but not constitutive, luciferase expression in U251-HRE and U251-pGL3 cells, resp., as well as hypoxic induction of vascular endothelial growth factor mRNA expression in U251 cells.  HIF-1α, but not HIF-1{szligbeta}, protein expression was inhibited by NSC 644221 in a time- and dose-dependent fashion.  Interestingly, NSC 644221 was unable to inhibit HIF-1α protein accumulation in the presence of the proteasome inhibitors MG132 or PS341, yet it did not directly affect the degrdn. of HIF-1α as shown by expts. done in the presence of cyclohexamide or pulse-chase labeling using [35S]methionine.  In contrast, NSC 644221 decreased the rate of HIF-1α translation relative to untreated controls.  Silencing of topoisomerase (topo) IIα, but not topo I, by specific small interfering RNA completely blocked the ability of NSC 644221 to inhibit HIF-1α.  The data presented show that topo II is required for the inhibition of HIF-1α by NSC 644221.  Furthermore, although NSC 644221 induced p21 expression, γH2A.X, and G2-M arrest in the majority of cell lines tested, it only inhibited HIF-1α in a distinct subset of cells, raising the possibility of pathway-specific "resistance" to HIF-1 inhibition in cancer cells.  CONCLUSIONS: NSC 644221 is a novel HIF-1 inhibitor with potential for use as both an analytic tool and a therapeutic agent.  Our data provide a strong rationale for pursuing the preclin. development of NSC 644221 as a HIF-1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRfBXMVRyUF7Vg90H21EOLACvtfcHk0li9M_oOLTKe3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7Y%253D&md5=b593b6a25511f58ccb88404b0c583108</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2301%26sid%3Dliteratum%253Aachs%26aulast%3DCreighton-Gutteridge%26aufirst%3DM.%26aulast%3DCardellina%26aufirst%3DJ.%2BH.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DHite%26aufirst%3DK.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DCell%2520type-specific%252C%2520topoisomerase%2520II-dependent%2520inhibition%2520of%2520hypoxia-inducible%2520factor-1alpha%2520protein%2520accumulation%2520by%2520NSC%2520644221%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D3%26spage%3D1010%26epage%3D1018%26doi%3D10.1158%2F1078-0432.CCR-06-2301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimnaugh, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuttitta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L. M.</span></span> <span> </span><span class="NLM_article-title">Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1alpha degradative pathway</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">29936</span>– <span class="NLM_lpage">29944</span>, <span class="refDoi"> DOI: 10.1074/jbc.M204733200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M204733200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12052835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVKhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=29936-29944&issue=33&author=J.+S.+Isaacsauthor=Y.+J.+Jungauthor=E.+G.+Mimnaughauthor=A.+Martinezauthor=F.+Cuttittaauthor=L.+M.+Neckers&title=Hsp90+regulates+a+von+Hippel+Lindau-independent+hypoxia-inducible+factor-1alpha+degradative+pathway&doi=10.1074%2Fjbc.M204733200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway</span></div><div class="casAuthors">Isaacs, Jennifer S.; Jung, Yun-Jin; Mimnaugh, Edward G.; Martinez, Alfredo; Cuttitta, Frank; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29936-29944</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">HIF-1α is a normally labile proangiogenic transcription factor that is stabilized and activated in hypoxia.  Although the von Hippel Lindau (VHL) gene product, the ubiquitin ligase responsible for regulating HIF-1α protein levels, efficiently targets HIF-1α for rapid proteasome-dependent degrdn. under normoxia, HIF-1α is resistant to the destabilizing effects of VHL under hypoxia.  HIF-1α also assocs. with the mol. chaperone Hsp90.  To examine the role of Hsp90 in HIF-1α function, we used renal carcinoma cell (RCC) lines that lack functional VHL and express stable HIF-1α protein under normoxia.  Geldanamycin (GA), an Hsp90 antagonist, promoted efficient ubiquitination and proteasome-mediated degrdn. of HIF-1α in RCC in both normoxia and hypoxia.  Furthermore, HIF-1α point mutations that block VHL assocn. did not protect HIF-1α from GA-induced destabilization.  Hsp90 antagonists also inhibited HIF-1α transcriptional activity and dramatically reduced both hypoxia-induced accumulation of VEGF mRNA and hypoxia-dependent angiogenic activity.  These findings demonstrate that disruption of Hsp90 function (1) promotes HIF-1α degrdn. via a novel, oxygen-independent E3 ubiquitin ligase and (2) diminishes HIF-1α transcriptional activity.  Existence of an Hsp90-dependent pathway for elimination of HIF-1α predicts that Hsp90 antagonists may be hypoxic cell sensitizers and possess antiangiogenic activity in vivo, thus extending the utility of these drugs as therapeutic anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5TGTCyrzbcLVg90H21EOLACvtfcHk0li9M_oOLTKe3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVKhsrg%253D&md5=6e9204fb56624b5b5904debc46797b5d</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M204733200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M204733200%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DJ.%2BS.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCuttitta%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DHsp90%2520regulates%2520a%2520von%2520Hippel%2520Lindau-independent%2520hypoxia-inducible%2520factor-1alpha%2520degradative%2520pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D33%26spage%3D29936%26epage%3D29944%26doi%3D10.1074%2Fjbc.M204733200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilkes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1007/s00109-013-1102-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1007%2Fs00109-013-1102-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24248265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=151-164&issue=2&author=L.+Xiangauthor=D.+M.+Gilkesauthor=P.+Chaturvediauthor=W.+Luoauthor=H.+Huauthor=N.+Takanoauthor=H.+Liangauthor=G.+L.+Semenza&title=Ganetespib+blocks+HIF-1+activity+and+inhibits+tumor+growth%2C+vascularization%2C+stem+cell+maintenance%2C+invasion%2C+and+metastasis+in+orthotopic+mouse+models+of+triple-negative+breast+cancer&doi=10.1007%2Fs00109-013-1102-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer</span></div><div class="casAuthors">Xiang, Lisha; Gilkes, Daniele M.; Chaturvedi, Pallavi; Luo, Weibo; Hu, Hongxia; Takano, Naoharu; Liang, Houjie; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-164</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Targeted therapy against triple-neg. breast cancers, which lack expression of the estrogen, progesterone, and HER2 receptors, is not available and the overall response to cytotoxic chemotherapy is poor.  One of the mol. hallmarks of triple-neg. breast cancers is increased expression of genes that are transcriptionally activated by hypoxia-inducible factors (HIFs), which are implicated in many crit. aspects of cancer progression including metab., angiogenesis, invasion, metastasis, and stem cell maintenance.  Ganetespib is a second-generation inhibitor of heat shock protein 90 (HSP90), a mol. chaperone that is essential for the stability and function of multiple client proteins in cancer cells including HIF-1α.  In this study, human MDA-MB-231 and MDA-MB-435 triple-neg. breast cancer cells were injected into the mammary fat pad of immunodeficient mice that received weekly i.v. injections of ganetespib or vehicle following the development of palpable tumors.  Ganetespib treatment markedly impaired primary tumor growth and vascularization, and eliminated local tissue invasion and distant metastasis to regional lymph nodes and lungs.  Ganetespib treatment also significantly reduced the no. of Aldefluor-pos. cancer stem cells in the primary tumor.  Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1α (but not HIF-2α) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metab., invasion, and metastasis, thereby providing a mol. basis for obsd. effects of the drug on the growth and metastasis of triple-neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdTtl_GUyxwLVg90H21EOLACvtfcHk0li9M_oOLTKe3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2gs7fI&md5=85da4e780ed43a1f8b0fa1a93ff1aeec</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs00109-013-1102-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-013-1102-5%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DGilkes%26aufirst%3DD.%2BM.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DGanetespib%2520blocks%2520HIF-1%2520activity%2520and%2520inhibits%2520tumor%2520growth%252C%2520vascularization%252C%2520stem%2520cell%2520maintenance%252C%2520invasion%252C%2520and%2520metastasis%2520in%2520orthotopic%2520mouse%2520models%2520of%2520triple-negative%2520breast%2520cancer%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2014%26volume%3D92%26issue%3D2%26spage%3D151%26epage%3D164%26doi%3D10.1007%2Fs00109-013-1102-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perusinghe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouschop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashcroft, M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2243</span>– <span class="NLM_lpage">2253</span>, <span class="refDoi"> DOI: 10.1128/MCB.00959-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1128%2FMCB.00959-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19223463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Srs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=2243-2253&issue=8&author=J.+Yangauthor=A.+Ahmedauthor=E.+Poonauthor=N.+Perusingheauthor=A.+de+Haven+Brandonauthor=G.+Boxauthor=M.+Valentiauthor=S.+Ecclesauthor=K.+Rouschopauthor=B.+Woutersauthor=M.+Ashcroft&title=Small-molecule+activation+of+p53+blocks+hypoxia-inducible+factor+1alpha+and+vascular+endothelial+growth+factor+expression+in+vivo+and+leads+to+tumor+cell+apoptosis+in+normoxia+and+hypoxia&doi=10.1128%2FMCB.00959-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule activation of p53 blocks hypoxia-inducible factor 1α and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia</span></div><div class="casAuthors">Yang, Jun; Ahmed, Afshan; Poon, Evon; Perusinghe, Nina; de Haven Brandon, Alexis; Box, Gary; Valenti, Melanie; Eccles, Suzanne; Rouschop, Kasper; Wouters, Brad; Ashcroft, Margaret</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2243-2253</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The p53 tumor suppressor protein neg. regulates hypoxia-inducible factor 1α (HIF-1α).  Here, we show that induction of p53 by the small-mol. RITA (reactivation of p53 and induction of tumor cell apoptosis) [2,5-bis(5-hydroxymethyl-2-thienyl) furan] (NSC-652287) inhibits HIF-1α and vascular endothelial growth factor expression in vivo and induces significant tumor cell apoptosis in normoxia and hypoxia in p53-pos. cells.  RITA has been proposed to stabilize p53 by inhibiting the p53-HDM2 interaction.  However, induction of p53 alone was insufficient to block HIF-1α induced in hypoxia and has previously been shown to require addnl. stimuli, such as DNA damage.  Here, we identify a new mechanism of action for RITA: RITA activates a DNA damage response, resulting in phosphorylation of p53 and γH2AX in vivo.  Unlike other DNA damage response-inducing agents, RITA treatment of cells induced a p53-dependent increase in phosphorylation of the α subunit of eukaryotic initiation factor 2, requiring PKR-like endoplasmic reticulum kinase activity, and led to the subsequent downregulation of HIF-1α and p53 target proteins, including HDM2 and p21.  Through the identification of a new mechanism of action for RITA, our study uncovers a novel link between the DNA damage response-p53 pathway and the protein translational machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmqQO2vitL1bVg90H21EOLACvtfcHk0lj3yomViZWLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Srs7Y%253D&md5=e70685a058b8e9f4524ff8b8c7522222</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FMCB.00959-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00959-08%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DPoon%26aufirst%3DE.%26aulast%3DPerusinghe%26aufirst%3DN.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DRouschop%26aufirst%3DK.%26aulast%3DWouters%26aufirst%3DB.%26aulast%3DAshcroft%26aufirst%3DM.%26atitle%3DSmall-molecule%2520activation%2520of%2520p53%2520blocks%2520hypoxia-inducible%2520factor%25201alpha%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520expression%2520in%2520vivo%2520and%2520leads%2520to%2520tumor%2520cell%2520apoptosis%2520in%2520normoxia%2520and%2520hypoxia%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26issue%3D8%26spage%3D2243%26epage%3D2253%26doi%3D10.1128%2FMCB.00959-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nepal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, Y.</span></span> <span> </span><span class="NLM_article-title">An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1alpha</span>. <i>Cell. Biochem. Funct.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1002/cbf.1732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fcbf.1732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=21287578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktl2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=126-134&issue=2&author=M.+Nepalauthor=Y.+D.+Gongauthor=Y.+R.+Parkauthor=Y.+Soh&title=An+activator+of+PHD2%2C+KRH102140%2C+decreases+angiogenesis+via+inhibition+of+HIF-1alpha&doi=10.1002%2Fcbf.1732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α</span></div><div class="casAuthors">Nepal, Manoj; Gong, Young-Dae; Park, Young Ran; Soh, Yunjo</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Function</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-134</span>CODEN:
                <span class="NLM_cas:coden">CBFUDH</span>;
        ISSN:<span class="NLM_cas:issn">1099-0844</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hypoxia-inducible transcription factors (HIFs) play a pivotal role in the response of cells to hypoxia.  HIFs are dimers of an oxygen-sensitive α-subunit (HIF-1α or HIF-2α), and a constitutively expressed β-subunit.  In normoxia, HIF-1α is destabilized by post-translational hydroxylation of Pro-564 and Pro-402 by a family of oxygen-sensitive dioxygenases.  Prolyl hydroxylation leads to von Hippel-Lindau protein-dependent ubiquitination and rapid degrdn. of HIF-.perp.α.  We previously reported that KRH102053, an activator of PHD2, rapidly decreased HIF-1α and eventually inhibited angiogenesis.  Here, we report a potent activator of PHD2, KRH102140, which has a structure similar to KRH102053 KRH102140 more efficiently suppressed HIF-1α than KRH102053 in human osteosarcoma cells under hypoxia.  Furthermore, KRH102140 decreased the mRNA levels of HIF-regulated downstream target genes assocd. with angiogenesis and energy metab. such as vascular endothelial growth factor, adrenomedullin, Glut1, aldolase A, enolase 1 and monocarbosylate transporter 4.  KRH102140 also inhibited tube formation in human umbilical vein endothelium cells.  The results suggest that KRH102140 has potential therapeutic effects in alleviating various diseases assocd. with HIFs.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqADFjAMZmNULVg90H21EOLACvtfcHk0lj3yomViZWLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktl2hs78%253D&md5=27fa7b29d4864654ce1e6b3c3af4a526</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fcbf.1732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbf.1732%26sid%3Dliteratum%253Aachs%26aulast%3DNepal%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DY.%2BD.%26aulast%3DPark%26aufirst%3DY.%2BR.%26aulast%3DSoh%26aufirst%3DY.%26atitle%3DAn%2520activator%2520of%2520PHD2%252C%2520KRH102140%252C%2520decreases%2520angiogenesis%2520via%2520inhibition%2520of%2520HIF-1alpha%26jtitle%3DCell.%2520Biochem.%2520Funct.%26date%3D2011%26volume%3D29%26issue%3D2%26spage%3D126%26epage%3D134%26doi%3D10.1002%2Fcbf.1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwak, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, Y.</span></span> <span> </span><span class="NLM_article-title">Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fbjp.2008.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18332861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFOqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=114-125&issue=1&author=H.+J.+Choiauthor=B.+J.+Songauthor=Y.+D.+Gongauthor=W.+J.+Gwakauthor=Y.+Soh&title=Rapid+degradation+of+hypoxia-inducible+factor-1alpha+by+KRH102053%2C+a+new+activator+of+prolyl+hydroxylase+2&doi=10.1038%2Fbjp.2008.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2</span></div><div class="casAuthors">Choi, H. J.; Song, B.-J.; Gong, Y.-D.; Gwak, W. J.; Soh, Y.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-125</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF) is a transcription factor induced by hypoxia and degraded by ubiquitin-dependent proteasomes in normoxic conditions.  Under hypoxic conditions, hydroxylation of HIF-1α subunit by prolyl hydroxylase (PHD) is suppressed, thus leading to increased levels of HIF.  Although PHD2 plays a key role in regulating the levels of HIF, chem. activators of PHD2 are relatively unknown.  The aim of this study was to identify small mol. activators of PHD2 that could be used, eventually, to suppress the level of HIF-1α.  By using the overproduced PHD2 as a target, a mol. library consisting of more than 600 small mols. with a benzopyran structure was screened with an HPLC assay method.  We found a potent activator of PHD2, KRH102053 (2-amino-4-methylsulphanyl-butylic acid-4-methoxy-6-(4-methoxy-benzylamino)-2,2-dimethyl-chroman-3-yl ester).  The effects of KRH102053 on controlling HIF were studied in human HOS osteosarcoma, rat PC12 phaeochromocytoma and human HepG2 hepatoma cells.  Under our exptl. conditions, KRH102053 decreased the protein level of HIF-1α and the mRNA levels of HIF-regulated downstream target genes, such as vascular endothelial growth factor, aldolase A, enolase 1 and monocarboxylate transporter 4.  Consistent with these results, KRH102053 also inhibited the rates of HIF-related migration and invasion of HOS cells as well as the degree of tube formation in human umbilical vein endothelium cells.  These results suggest that KRH102053 and its structural analogs have the potential for use as therapeutic agents against various diseases assocd. with HIF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2esLBTkfJBrVg90H21EOLACvtfcHk0lj3yomViZWLVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFOqsrg%253D&md5=973fdcb897eb5e04954693281f282ad3</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.70%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DSong%26aufirst%3DB.%2BJ.%26aulast%3DGong%26aufirst%3DY.%2BD.%26aulast%3DGwak%26aufirst%3DW.%2BJ.%26aulast%3DSoh%26aufirst%3DY.%26atitle%3DRapid%2520degradation%2520of%2520hypoxia-inducible%2520factor-1alpha%2520by%2520KRH102053%252C%2520a%2520new%2520activator%2520of%2520prolyl%2520hydroxylase%25202%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26issue%3D1%26spage%3D114%26epage%3D125%26doi%3D10.1038%2Fbjp.2008.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Temes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Puig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta-Iborra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellanos, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feijoo-Cuaresma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landazuri, M. O.</span></span> <span> </span><span class="NLM_article-title">Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">24238</span>– <span class="NLM_lpage">24244</span>, <span class="refDoi"> DOI: 10.1074/jbc.M414694200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M414694200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15849364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlKgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=24238-24244&issue=25&author=E.+Temesauthor=S.+Martin-Puigauthor=B.+Acosta-Iborraauthor=M.+C.+Castellanosauthor=M.+Feijoo-Cuaresmaauthor=G.+Olmosauthor=J.+Aragonesauthor=M.+O.+Landazuri&title=Activation+of+HIF-prolyl+hydroxylases+by+R59949%2C+an+inhibitor+of+the+diacylglycerol+kinase&doi=10.1074%2Fjbc.M414694200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of HIF-prolyl Hydroxylases by R59949, an Inhibitor of the Diacylglycerol Kinase</span></div><div class="casAuthors">Temes, Elisa; Martin-Puig, Silvia; Acosta-Iborra, Barbara; Castellanos, Maria C.; Feijoo-Cuaresma, Monica; Olmos, Gemma; Aragones, Julian; Landazuri, Manuel O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">24238-24244</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIF) are heterodimeric (α/β) transcription factors that play a fundamental role in cellular adaptation to low oxygen tension.  In the presence of oxygen, the HIF-α subunit becomes hydroxylated at specific prolyl residues by prolyl hydroxylases.  This post-translational modification is recognized by the von Hippel-Lindau (VHL) protein, which targets HIF-α for degrdn.  In the absence of oxygen, HIF-α hydroxylation is compromised and this subunit is stabilized.  We have previously shown that the hypoxia-induced accumulation of HIF-α protein is strongly impaired by the inhibitor of diacylglycerol kinase, R59949.  Here, we have investigated the mechanisms through which this inhibitor exerts its effect.  We found that R59949 inhibits the accumulation of HIF-1/2α protein without affecting the expression of their mRNAs.  We also detd. that R59949 could only block the accumulation of HIF-α in the presence of VHL protein.  In agreement with this, the binding of VHL to endogenous HIF-α was significantly enhanced after R59949 treatment, even under hypoxic conditions.  In addn., we found that R59949 could stimulate prolyl hydroxylase both at 21% O2 as well as at 1% O2.  Taken together, these results reveal that R59949 is an activator of HIF prolyl hydroxylases.  This is of particular interest when we consider that to date mainly inhibitors of these enzymes have been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0GtOs6umRbVg90H21EOLACvtfcHk0lhHyNRx6ez5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlKgs7s%253D&md5=0b8ae54b1d0edb0607762461f1dbdc91</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M414694200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M414694200%26sid%3Dliteratum%253Aachs%26aulast%3DTemes%26aufirst%3DE.%26aulast%3DMartin-Puig%26aufirst%3DS.%26aulast%3DAcosta-Iborra%26aufirst%3DB.%26aulast%3DCastellanos%26aufirst%3DM.%2BC.%26aulast%3DFeijoo-Cuaresma%26aufirst%3DM.%26aulast%3DOlmos%26aufirst%3DG.%26aulast%3DAragones%26aufirst%3DJ.%26aulast%3DLandazuri%26aufirst%3DM.%2BO.%26atitle%3DActivation%2520of%2520HIF-prolyl%2520hydroxylases%2520by%2520R59949%252C%2520an%2520inhibitor%2520of%2520the%2520diacylglycerol%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D25%26spage%3D24238%26epage%3D24244%26doi%3D10.1074%2Fjbc.M414694200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span> <span> </span><span class="NLM_article-title">Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1007/s12031-014-0469-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1007%2Fs12031-014-0469-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25451596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=78-88&issue=1&author=L.+Yangauthor=Y.+Xuauthor=W.+Liauthor=B.+Yangauthor=S.+Yuauthor=H.+Zhouauthor=C.+Yangauthor=F.+Xuauthor=J.+Wangauthor=Y.+Gaoauthor=Y.+Huangauthor=L.+Luauthor=X.+Liang&title=Diacylglycerol+kinase+%28DGK%29+inhibitor+II+%28R59949%29+could+suppress+retinal+neovascularization+and+protect+retinal+astrocytes+in+an+oxygen-induced+retinopathy+model&doi=10.1007%2Fs12031-014-0469-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Diacylglycerol Kinase (DGK) Inhibitor II (R59949) Could Suppress Retinal Neovascularization and Protect Retinal Astrocytes in an Oxygen-Induced Retinopathy Model</span></div><div class="casAuthors">Yang, Lu; Xu, Yue; Li, Weihua; Yang, Boyu; Yu, Shanshan; Zhou, Huanjiao; Yang, Cheng; Xu, Fan; Wang, Jun; Gao, Yi; Huang, Yongsheng; Lu, Lin; Liang, Xiaoling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-88</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIF) play a fundamental role in retinal neovascularization (NV) induced by low oxygen tension.  In the presence of oxygen, the HIF-α subunit becomes hydroxylated at specific prolyl residues by prolyl hydroxylases (PHD), which triggers HIF-α for degrdn.  In our present study, we examd. the effect of R59949, the diacylglycerol kinase (DGK) inhibitor II, on the retinal NV and its potential mechanism in an oxygen-induced retinopathy (OIR) model.  OIR model was induced by exposure of hyperoxia (75 % oxygen) to C57BL/6J mice from postnatal day 7 (P7) to P12 and then returned to room air.  By i.p. injection once a day (10 μg/g/day) from P12 to P17, R59949 not only effectively prevented pathol. NV but also preserved the astrocyte morphol.  Furthermore, the expression of PHD-2 was upregulated and HIF-1α and vascular endothelial growth factor (VEGF) were downregulated in the retina of OIR mice following R59949 treatment.  These findings suggested a potential possibility that R59949 suppressed retinal neovascular pathophysiol. via PHD2/HIF-1α/VEGF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIVrvSo3P8s7Vg90H21EOLACvtfcHk0lhHyNRx6ez5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgtL3O&md5=0c43efc88d787076b8b73fd4980c8fd9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1007%2Fs12031-014-0469-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-014-0469-2%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DX.%26atitle%3DDiacylglycerol%2520kinase%2520%2528DGK%2529%2520inhibitor%2520II%2520%2528R59949%2529%2520could%2520suppress%2520retinal%2520neovascularization%2520and%2520protect%2520retinal%2520astrocytes%2520in%2520an%2520oxygen-induced%2520retinopathy%2520model%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2015%26volume%3D56%26issue%3D1%26spage%3D78%26epage%3D88%26doi%3D10.1007%2Fs12031-014-0469-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boovanahalli, S.K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6305</span>– <span class="NLM_lpage">6310</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bmcl.2007.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17884495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6305-6310&issue=22&author=S.K.+Boovanahalliauthor=X.+Jinauthor=Y.+Jinauthor=J.+H.+Kimauthor=N.+T.+Datauthor=Y.+S.+Hongauthor=J.+H.+Leeauthor=S.+H.+Jungauthor=K.+Leeauthor=J.+J.+Lee&title=Synthesis+of+%28aryloxyacetylamino%29-isonicotinic%2Fnicotinic+acid+analogues+as+potent+hypoxia-inducible+factor+%28HIF%29-1alpha+inhibitors&doi=10.1016%2Fj.bmcl.2007.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1α inhibitors</span></div><div class="casAuthors">Boovanahalli, Shanthaveerappa K.; Jin, Xuejun; Jin, Yinglan; Kim, Jin Hwan; Dat, Nguyen Tien; Hong, Young-Soo; Lee, Jeong Hyung; Jung, Sang-Hun; Lee, Kyeong; Lee, Jung Joon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6305-6310</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We report a new series of HIF-1α inhibitors which were obtained through structural modifications of previously reported lead compd. I.  The in vitro inhibitory potencies of newly synthesized compds. were evaluated against hypoxia-induced HIF-1 activation using cell-based reporter assay in three human cancer cell lines including SK-Hep-1, Hep3B, and AGS cells.  Several compds. displayed significant inhibitory activity in all the three tested cell lines.  In particular, analog II displayed potent inhibition of hypoxia-induced accumulation of HIF-1α protein in Hep3B cell line, in addn. to the dose-dependent inhibition of HIF-1 target genes VEGF and EPO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19KpOefEl1bVg90H21EOLACvtfcHk0lhHyNRx6ez5zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7rJ&md5=d55848ea7e16ad40d25566ad9f0e3e4a</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DBoovanahalli%26aufirst%3DS.K.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520%2528aryloxyacetylamino%2529-isonicotinic%252Fnicotinic%2520acid%2520analogues%2520as%2520potent%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1alpha%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D22%26spage%3D6305%26epage%3D6310%26doi%3D10.1016%2Fj.bmcl.2007.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship of (<i>E</i>)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1alpha inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10564</span>– <span class="NLM_lpage">10571</span>, <span class="refDoi"> DOI: 10.1021/jm301419d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301419d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10564-10571&issue=23&author=R.+Naikauthor=M.+Wonauthor=B.+K.+Kimauthor=Y.+Xiaauthor=H.+K.+Choiauthor=G.+Jinauthor=Y.+Jungauthor=H.+M.+Kimauthor=K.+Lee&title=Synthesis+and+structure-activity+relationship+of+%28E%29-phenoxyacrylic+amide+derivatives+as+hypoxia-inducible+factor+%28HIF%29+1alpha+inhibitors&doi=10.1021%2Fjm301419d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship of (E)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors</span></div><div class="casAuthors">Naik, Ravi; Won, Misun; Kim, Bo-Kyung; Xia, Yan; Choi, Hyun Kyung; Jin, Guanghai; Jung, Youngjin; Kim, Hwan Mook; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10564-10571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(E)-phenoxyacrylamides such as I were prepd. and tested as inhibitors of the transcription factor hypoxia inducible factor-1α (HIF-1α) for potential use as antitumor agents; their toxicities to human cells and the aq. solubilities of selected compds. were detd.  I was a potent inhibitor of HIF-1α under hypoxic conditions (IC50 = 0.12 μM) in HCT116 cells.  I suppressed both hypoxia-induced HIF-1α accumulation and the expression of mRNAs for the genes for vascular endothelial growth factor, erythropoietin, and matrix metalloproteinase-9 in a dose-dependent manner.  I also inhibited tube formation (angiogenesis) and cell migration in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzPCB8XH7HLrVg90H21EOLACvtfcHk0ljwwHDZeaIriQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI&md5=cc1c0da351a3e7d6b9ef0a97d8b2fcc6</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm301419d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301419d%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520of%2520%2528E%2529-phenoxyacrylic%2520amide%2520derivatives%2520as%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%25201alpha%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10564%26epage%3D10571%26doi%3D10.1021%2Fjm301419d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boovanahalli, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2009.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2009.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19433063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVGnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=16-21&issue=1&author=M.+S.+Wonauthor=N.+Imauthor=S.+Parkauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=X.+Jinauthor=K.+S.+Chungauthor=M.+Kangauthor=K.+Leeauthor=S.+K.+Parkauthor=H.+M.+Kimauthor=B.+M.+Kwonauthor=J.+J.+Leeauthor=K.+Lee&title=A+novel+benzimidazole+analogue+inhibits+the+hypoxia-inducible+factor+%28HIF%29-1+pathway&doi=10.1016%2Fj.bbrc.2009.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway</span></div><div class="casAuthors">Won, Mi-Sun; Im, Namhui; Park, Soohyun; Boovanahalli, Shanthaveerappa K.; Jin, Yinglan; Jin, Xuejun; Chung, Kyung-Sook; Kang, Moorim; Lee, Kiho; Park, Song-Kyu; Kim, Hwan Mook; Kwon, Byoung Mog; Lee, Jung Joon; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-21</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF)-1 is a therapeutic target in solid tumors.  We report the novel benzimidazole analog AC1-004, obtained from a chem. library using an HRE-dependent cell-based assay in colorectal carcinoma HCT-116 cells.  The accumulation of hypoxia-induced HIF-1α was inhibited by compd. AC1-004 in various cancer cells, including HCT-116, MDA-MB435, SK-HEP1, and Caki-1.  Further, AC1-004 down-regulated VEGF and EPO, target genes of HIF-1, and inhibited in vitro tube formation of HUVEC, suggesting its potential inhibitory activity on angiogenesis.  Importantly, AC1-004 was found to regulate the stability of HIF-1α through the Hsp90-Akt pathway, leading to the degrdn. of HIF-1α.  An in vivo antitumor study demonstrated that AC1-004 reduced tumor size significantly (i.e., by 58.6%), without severe side effects.  These results suggest the benzimidazole analog AC1-004 is a novel HIF inhibitor that targets HIF-1α via the Hsp90-Akt pathway, and that it can be used as a new lead in developing anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-ymiDLQODIbVg90H21EOLACvtfcHk0ljwwHDZeaIriQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVGnur0%253D&md5=698a8dde07240e37a946e6db3d84129b</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DM.%2BS.%26aulast%3DIm%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DChung%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKwon%26aufirst%3DB.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DA%2520novel%2520benzimidazole%2520analogue%2520inhibits%2520the%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1%2520pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D385%26issue%3D1%26spage%3D16%26epage%3D21%26doi%3D10.1016%2Fj.bbrc.2009.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1746</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bmc.2016.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28209257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1Wgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1737-1746&issue=6&author=J.+Weiauthor=Y.+Yangauthor=Y.+Liauthor=X.+Moauthor=X.+Guoauthor=X.+Zhangauthor=X.+Xuauthor=Z.+Jiangauthor=Q.+You&title=Synthesis+and+evaluation+of+N-%28benzofuran-5-yl%29aromaticsulfonamide+derivatives+as+novel+HIF-1+inhibitors+that+possess+anti-angiogenic+potential&doi=10.1016%2Fj.bmc.2016.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential</span></div><div class="casAuthors">Wei, Jinlian; Yang, Yingrui; Li, Yali; Mo, Xiaofei; Guo, Xiaoke; Zhang, Xiaojin; Xu, Xiaoli; Jiang, Zhengyu; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1737-1746</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) as a key mediator in tumor metastasis, angiogenesis, and poor patient prognosis has been recognized as an important cancer drug target.  A novel series of N-(benzofuran-5-yl)aromaticsulfonamide derivs. were synthesized and evaluated as HIF-1 inhibitor.  Among these compds., 7q exhibited specific inhibitory effects on HIF-1 by downregulating the expression of HIF-1α under hypoxic conditions.  It inhibited the HIF-1 transcriptional activity (IC50 = 12.5 ± 0.7 μM) and secretion of VEGF (IC50 = 18.8 μM) in MCF-7 cells.  Meanwhile, it also significantly suppressed hypoxia-induced migration of HUVEC cells in nontoxic concns.  Addnl., tube formation assay demonstrated its anti-angiogenesis activity.  Finally, the in vivo study indicated that compd. 7q could retard angiogenesis in CAM model.  These findings supported the HIF-1 inhibitory effect and anti-angiogenic potential of this class of compds. as HIF-1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg1WrIaxBW8bVg90H21EOLACvtfcHk0ljwwHDZeaIriQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1Wgt7s%253D&md5=39ec1334c309af5bcce7cfad25e8943f</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMo%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520N-%2528benzofuran-5-yl%2529aromaticsulfonamide%2520derivatives%2520as%2520novel%2520HIF-1%2520inhibitors%2520that%2520possess%2520anti-angiogenic%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D6%26spage%3D1737%26epage%3D1746%26doi%3D10.1016%2Fj.bmc.2016.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Manzano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Jimenez, F.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acena-Bonilla, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fustero-Lardies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erceg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dopazo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojkovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Puelles, J. M.</span></span> <span> </span><span class="NLM_article-title">FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1342</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.008326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M109.008326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19897487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFar" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=1333-1342&issue=2&author=V.+Moreno-Manzanoauthor=F.%0AJ.+Rodriguez-Jimenezauthor=J.+L.+Acena-Bonillaauthor=S.+Fustero-Lardiesauthor=S.+Ercegauthor=J.+Dopazoauthor=D.+Montanerauthor=M.+Stojkovicauthor=J.+M.+Sanchez-Puelles&title=FM19G11%2C+a+new+hypoxia-inducible+factor+%28HIF%29+modulator%2C+affects+stem+cell+differentiation+status&doi=10.1074%2Fjbc.M109.008326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status</span></div><div class="casAuthors">Moreno-Manzano, Victoria; Rodriguez-Jimenez, Francisco J.; Acena-Bonilla, Jose L.; Fustero-Lardies, Santos; Erceg, Slaven; Dopazo, Joaquin; Montaner, David; Stojkovic, Miodrag; Sanchez-Puelles, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1333-1342</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The biol. of the α subunits of hypoxia-inducible factors (HIFα) has expanded from their role in angiogenesis to their current position in the self-renewal and differentiation of stem cells.  The results reported in this article show the discovery of FM19G11, a novel chem. entity that inhibits HIFα proteins that repress target genes of the two α subunits, in various tumor cell lines as well as in adult and embryonic stem cell models from rodents and humans, resp.  FM19G11 inhibits at nanomolar range the transcriptional and protein expression of Oct4, Sox2, Nanog, and Tgf-α undifferentiating factors, in adult rat and human embryonic stem cells, FM19G11 activity occurs in ependymal progenitor stem cells from rats (epSPC), a cell model reported for spinal cord regeneration, which allows the progression of oligodendrocyte cell differentiation in a hypoxic environment, has created interest in its characterization for pharmacol. research.  Expts. using small interfering RNA showed a significant depletion in Sox2 protein only in the case of HIF2α silencing, but not in HIF1α-mediated ablation.  Moreover, chromatin immunopptn. data, together with the significant presence of functional hypoxia response element consensus sequences in the promoter region of Sox2, strongly validated that this factor behaves as a target gene of HIF2α in epSPCs.  FM19G11 causes a redn. of overall histone acetylation with significant repression of p300, a histone acetyltransferase required as a co-factor for HIF-transcription activation.  Arrays carried out in the presence and absence of the inhibitor showed the predominant involvement of epigenetic-assocd. events mediated by the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc8a-2Ol7PIrVg90H21EOLACvtfcHk0lieu3Ej-OZxww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFar&md5=25b81c2bb65a53948bd1ea8fd89d15d9</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.008326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.008326%26sid%3Dliteratum%253Aachs%26aulast%3DMoreno-Manzano%26aufirst%3DV.%26aulast%3DRodriguez-Jimenez%26aufirst%3DF.%2BJ.%26aulast%3DAcena-Bonilla%26aufirst%3DJ.%2BL.%26aulast%3DFustero-Lardies%26aufirst%3DS.%26aulast%3DErceg%26aufirst%3DS.%26aulast%3DDopazo%26aufirst%3DJ.%26aulast%3DMontaner%26aufirst%3DD.%26aulast%3DStojkovic%26aufirst%3DM.%26aulast%3DSanchez-Puelles%26aufirst%3DJ.%2BM.%26atitle%3DFM19G11%252C%2520a%2520new%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%2520modulator%252C%2520affects%2520stem%2520cell%2520differentiation%2520status%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D2%26spage%3D1333%26epage%3D1342%26doi%3D10.1074%2Fjbc.M109.008326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thittai, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeure, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span> <span> </span><span class="NLM_article-title">Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2057</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1535-7163.MCT-09-0768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20587661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFertbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=2057-2067&issue=7&author=D.+L.+Schwartzauthor=J.+A.+Banksonauthor=R.+Lemosauthor=S.+Y.+Laiauthor=A.+K.+Thittaiauthor=Y.+Heauthor=G.+Hostetterauthor=M.+J.+Demeureauthor=D.+D.+Von+Hoffauthor=G.+Powis&title=Radiosensitization+and+stromal+imaging+response+correlates+for+the+HIF-1+inhibitor+PX-478+given+with+or+without+chemotherapy+in+pancreatic+cancer&doi=10.1158%2F1535-7163.MCT-09-0768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer</span></div><div class="casAuthors">Schwartz, David L.; Bankson, James A.; Lemos, Robert, Jr.; Lai, Stephen Y.; Thittai, Arun K.; He, Yi; Hostetter, Galen; Demeure, Michael J.; Von Hoff, Daniel D.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2057-2067</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Growing tumors are hypoxic and respond to microenvironmental stress through increased expression of the hypoxia inducible factor-1α (HIF-1α) transcription factor, resulting in an adaptive switch to glycolytic metab., angiogenic signaling, survival, and metastasis.  HIF-1α expression is assocd. with tumor resistance to cytotoxic therapy and inferior patient outcomes.  Pancreatic cancer is the most hypoxic of all solid tumors and remains refractory to current chemoradiotherapy.  The authors have seen nuclear HIF-1α in 88% of human pancreatic ductal carcinoma but in only 16% of normal pancreas.  Stroma adjacent to the pancreatic ductal carcinoma also showed HIF-1α in 43% of cases.  We investigated the novel selective HIF-1α inhibitor PX-478 on in vitro and in vivo radiation response of human pancreatic cancer models.  Inhibition of HIF-1α by PX-478 increased cell killing by radiation.  In mice with Panc-1, CF-PAC-1, or SU.86.86 pancreatic xenografts, concurrent administration of PX-478 potentiated the antitumor effects of fractionated radiation, with or without combined treatment with 5-fluorouracil or gemcitabine.  Alternative sequencing of PX-478 with fractionated radiotherapy suggests optimal radiosensitization with concurrent or neoadjuvant administration of drug.  Early tumor responses to combined PX-478/radiation treatment could be rapidly and repeatedly quantified by vascular imaging biomarkers.  Dual-tracer dynamic contrast enhanced-magnetic resonance imaging and ultrasound imaging discriminated response to combined treatment prior to detection of differences in anat. tumor size at 10 days posttreatment.  Therefore, PX-478 is a mechanistically appealing and potentially clin. relevant enhancer of pancreatic cancer radiosensitivity, inhibiting tumor and stromal HIF-1 proangiogenic signaling and reducing the innate radiation resistance of hypoxic tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Vh20CzG0KLVg90H21EOLACvtfcHk0lieu3Ej-OZxww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFertbbL&md5=ad248567a3b64c54ac9206ac171ed502</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0768%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BL.%26aulast%3DBankson%26aufirst%3DJ.%2BA.%26aulast%3DLemos%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DS.%2BY.%26aulast%3DThittai%26aufirst%3DA.%2BK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHostetter%26aufirst%3DG.%26aulast%3DDemeure%26aufirst%3DM.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DRadiosensitization%2520and%2520stromal%2520imaging%2520response%2520correlates%2520for%2520the%2520HIF-1%2520inhibitor%2520PX-478%2520given%2520with%2520or%2520without%2520chemotherapy%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D7%26spage%3D2057%26epage%3D2067%26doi%3D10.1158%2F1535-7163.MCT-09-0768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HIF-1alpha by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1198</span>– <span class="NLM_lpage">1212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28560067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1198-1212&issue=5&author=Y.+Zhuauthor=Y.+Zangauthor=F.+Zhaoauthor=Z.+Liauthor=J.+Zhangauthor=L.+Fangauthor=M.+Liauthor=L.+Xingauthor=Z.+Xuauthor=J.+Yu&title=Inhibition+of+HIF-1alpha+by+PX-478+suppresses+tumor+growth+of+esophageal+squamous+cell+cancer+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo</span></div><div class="casAuthors">Zhu, Yingming; Zang, Yuanwei; Zhao, Fen; Li, Zhenxiang; Zhang, Jianbo; Fang, Liang; Li, Minghuan; Xing, Ligang; Xu, Zhonghua; Yu, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1198-1212, S1</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">The aim of this study is to investigate the clin. significance of hypoxia inducible factor-1α (HIF-1α) expression in esophageal squamous cell cancer (ESCC) and clarify the effects of PX-478, a selective HIF-1α inhibitor, on ESCC both in vitro and in vivo.  HIF-1α, cyclooxygenase-2 (COX-2) and programmed death ligand-1 (PD-L1) were markedly overexpressed in ESCC tissue and assocd. with poorer survival.  In vitro, both COX-2 and PD-L1 expression of ESCC cells were significantly induced by CoCl2 treatment, but inhibited by HIF-1α knock-down or PX-478 treatment.  Furthermore, PX-478 significantly inhibited tumor cell proliferation by inhibiting the G2/M transition and promoting apoptosis of ESCC cells.  In addn., inhibited epithelial-mesenchymal transition was obsd. after PX-478 treatment.  In vivo, PX-478 significantly decreased tumor vol. following s.c. implantation.  Together, our results indicated that PX-478 had significant antitumor activity against HIF-1α over-expressing ESCC tumors in vitro and in vivo.  These results opened up the possibility of inhibiting HIF-1α for targeted therapy of ESCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgUxhTqFTJhLVg90H21EOLACvtfcHk0lifCqCplobPbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77O&md5=ec3eced62377c98ec9ffd67c154e18e3</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520HIF-1alpha%2520by%2520PX-478%2520suppresses%2520tumor%2520growth%2520of%2520esophageal%2520squamous%2520cell%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26issue%3D5%26spage%3D1198%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Min, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">5574</span>),  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1126/science.1073440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1073440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12004076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVWmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1886-1889&issue=5574&author=J.+H.+Minauthor=H.+Yangauthor=M.+Ivanauthor=F.+Gertlerauthor=W.+G.+Kaelinauthor=N.+P.+Pavletich&title=Structure+of+an+HIF-1%CE%B1-pVHL+complex%3A+hydroxyproline+recognition+in+signaling&doi=10.1126%2Fscience.1073440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling</span></div><div class="casAuthors">Min, Jung-Hyun; Yang, Haifeng; Ivan, Mircea; Gertler, Frank; Kaelin, William G., Jr.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5574</span>),
    <span class="NLM_cas:pages">1886-1889</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability.  PVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent.  The 1.85 Å structure of a 20-residue HIF-1α peptide-pVHL-Elongin B-Elongin C complex shows that HIF-1α binds to pVHL in an extended β strand-like conformation.  The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues.  Although the β sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-5OY8IZiA7Vg90H21EOLACvtfcHk0lifCqCplobPbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVWmsr8%253D&md5=c3ccb5f0a383257ae465cc1c5f7a189f</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1126%2Fscience.1073440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1073440%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DJ.%2BH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DIvan%26aufirst%3DM.%26aulast%3DGertler%26aufirst%3DF.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520an%2520HIF-1%25CE%25B1-pVHL%2520complex%253A%2520hydroxyproline%2520recognition%2520in%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D296%26issue%3D5574%26spage%3D1886%26epage%3D1889%26doi%3D10.1126%2Fscience.1073440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span> (<span class="NLM_issue">6892</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">978</span>, <span class="refDoi"> DOI: 10.1038/nature00767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature00767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12050673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVagsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=975-978&issue=6892&author=W.+C.+Honauthor=M.+I.+Wilsonauthor=K.+Harlosauthor=T.+D.+W.+Claridgeauthor=C.+J.+Schofieldauthor=C.+W.+Pughauthor=P.+H.+Maxwellauthor=P.+J.+Ratcliffeauthor=D.+I.+Stuartauthor=E.+Y.+Jones&title=Structural+basis+for+the+recognition+of+hydroxyproline+in+HIF-1%CE%B1+by+pVHL&doi=10.1038%2Fnature00767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL</span></div><div class="casAuthors">Hon, Wai-Ching; Wilson, Michael I.; Harlos, Karl; Claridge, Timothy D. W.; Schofield, Christopher J.; Pugh, Christopher W.; Maxwell, Patrick H.; Ratcliffe, Peter J.; Stuart, David I.; Jones, E. Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6892</span>),
    <span class="NLM_cas:pages">975-978</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability.  HIF-1α is the oxygen-regulated subunit of HIF-1, an αβ heterodimeric complex.  HIF-1α is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degrdn. by the ubiquitination complex pVHL, the protein of the von Hippel-Lindau (VHL) tumor suppressor gene and a component of an E3 ubiquitin ligase complex.  Capture of HIF-1α by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1α.  The crystal structure of a hydroxylated HIF-1α peptide bound to VCB (pVHL, elongins C and B) and soln. binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL.  Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues.  This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEVz7Ev-hoaLVg90H21EOLACvtfcHk0lifCqCplobPbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVagsLs%253D&md5=8f91f9a4bb0607152d1b9df2376c1a25</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnature00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature00767%26sid%3Dliteratum%253Aachs%26aulast%3DHon%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DM.%2BI.%26aulast%3DHarlos%26aufirst%3DK.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DJones%26aufirst%3DE.%2BY.%26atitle%3DStructural%2520basis%2520for%2520the%2520recognition%2520of%2520hydroxyproline%2520in%2520HIF-1%25CE%25B1%2520by%2520pVHL%26jtitle%3DNature%26date%3D2002%26volume%3D417%26issue%3D6892%26spage%3D975%26epage%3D978%26doi%3D10.1038%2Fnature00767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title">Signalling hypoxia by HIF hydroxylases</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.08.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2005.08.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16139242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=617-626&issue=1&author=C.+J.+Schofieldauthor=P.+J.+Ratcliffe&title=Signalling+hypoxia+by+HIF+hydroxylases&doi=10.1016%2Fj.bbrc.2005.08.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling hypoxia by HIF hydroxylases</span></div><div class="casAuthors">Schofield, Christopher J.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">617-626</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Anal. of oxygen sensitive pathways that regulate the hypoxia inducible factor (HIF) transcriptional system has revealed a novel role for oxygenases in signaling hypoxia.  The enzymes, which catalyze hydroxylation of specific prolyl and asparaginyl residues in the regulatory HIF-α subunits, belong to the superfamily of non-heme Fe(II)-dependent oxygenases that use the citric acid cycle intermediate 2-oxoglutarate (2OG) as a co-substrate.  We review biochem. and physiol. data that demonstrate a central role for these oxygenases in integrating multiple signals that coordinate cellular responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SZ4fXOuLVbVg90H21EOLACvtfcHk0lifCqCplobPbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrjM&md5=983faf06533620be97faa65bcc74471e</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.08.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.08.111%26sid%3Dliteratum%253Aachs%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DSignalling%2520hypoxia%2520by%2520HIF%2520hydroxylases%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D338%26issue%3D1%26spage%3D617%26epage%3D626%26doi%3D10.1016%2Fj.bbrc.2005.08.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, S. L.</span></span> <span> </span><span class="NLM_article-title">A conserved family of prolyl-4-hydroxylases that modify HIF</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">5545</span>),  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1126/science.1066373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1066373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11598268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1337-1340&issue=5545&author=R.+K.+Bruickauthor=S.+L.+McKnight&title=A+conserved+family+of+prolyl-4-hydroxylases+that+modify+HIF&doi=10.1126%2Fscience.1066373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved family of prolyl-4-hydroxylases that modify HIF</span></div><div class="casAuthors">Bruick, Richard K.; McKnight, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5545</span>),
    <span class="NLM_cas:pages">1337-1340</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF).  The alpha subunit of HIF is targeted for degrdn. under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF.  The authors identified a conserved family of HIF prolyl hydroxylase (HPH) enzymes that appear to be responsible for this posttranslational modification.  In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH.  Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene (LDH, encoding lactate dehydrogenase) under normoxic conditions.  These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH62syyo7QG7Vg90H21EOLACvtfcHk0lhZWZUKjTsm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D&md5=e17b5094d300fc6e292cd063d5633502</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1126%2Fscience.1066373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1066373%26sid%3Dliteratum%253Aachs%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DMcKnight%26aufirst%3DS.%2BL.%26atitle%3DA%2520conserved%2520family%2520of%2520prolyl-4-hydroxylases%2520that%2520modify%2520HIF%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5545%26spage%3D1337%26epage%3D1340%26doi%3D10.1126%2Fscience.1066373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehme, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellinghaus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolkhof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span> <span> </span><span class="NLM_article-title">Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(02)00862-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS0006-291X%2802%2900862-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12163023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2gsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=343-349&issue=2&author=F.+Oehmeauthor=P.+Ellinghausauthor=P.+Kolkhofauthor=T.+J.+Smithauthor=S.+Ramakrishnanauthor=J.+Hutterauthor=M.+Schrammauthor=I.+Flamme&title=Overexpression+of+PH-4%2C+a+novel+putative+proline+4-hydroxylase%2C+modulates+activity+of+hypoxia-inducible+transcription+factors&doi=10.1016%2FS0006-291X%2802%2900862-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors</span></div><div class="casAuthors">Oehme, Felix; Ellinghaus, Peter; Kolkhof, Peter; Smith, Timothy J.; Ramakrishnan, Shyam; Hutter, Joachim; Schramm, Matthias; Flamme, Ingo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Hypoxia-inducible transcription factors (HIFs) are important for transcriptional adaptation to hypoxia.  Availability of HIFs is regulated via posttranslational modification of their α subunits (HIF-1α and HIF-2α).  Under normoxia, two highly conserved proline residues within the oxygen-dependent degrdn. domain (ODDD) are hydroxylated by oxoglutarate-dependent proline 4-hydroxylases EGLN1-3.  Hydroxylated HIF-α interacts with the pVHL-E3 ubiquitin ligase complex and, subsequently, is degraded via the proteasomal pathway.  We identified a novel putative proline 4-hydroxylase, PH-4, with an amino-terminal EF-hand motif and a carboxy-terminal catalytic domain, which was highly expressed in most organs, and-unlike EGLNs which localize to the cytoplasm and nucleus-was assocd. with the endoplasmic reticulum.  Like EGLNs, PH-4 overexpressed in cellular reporter assays suppressed the HIF transactivation activity, dependent on the consensus ODDD proline residues.  Suppression of transactivation was correlated with decrease of cellular contents of HIF.  Thus, PH-4 might be related to cellular oxygen sensing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKk1JcgHlaULVg90H21EOLACvtfcHk0lhZWZUKjTsm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2gsb4%253D&md5=b40d00a31ddf342d4a602f286fa9ca59</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2900862-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252900862-8%26sid%3Dliteratum%253Aachs%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DEllinghaus%26aufirst%3DP.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DT.%2BJ.%26aulast%3DRamakrishnan%26aufirst%3DS.%26aulast%3DHutter%26aufirst%3DJ.%26aulast%3DSchramm%26aufirst%3DM.%26aulast%3DFlamme%26aufirst%3DI.%26atitle%3DOverexpression%2520of%2520PH-4%252C%2520a%2520novel%2520putative%2520proline%25204-hydroxylase%252C%2520modulates%2520activity%2520of%2520hypoxia-inducible%2520transcription%2520factors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D296%26issue%3D2%26spage%3D343%26epage%3D349%26doi%3D10.1016%2FS0006-291X%2802%2900862-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metzen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berchner-Pfannschmidt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marxsen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wotzlaw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellwig-Burgel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelkmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrey, J.</span></span> <span> </span><span class="NLM_article-title">Intracellular localization of human HIF-1α hydroxylases: Implications for oxygen sensing</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1326</span>, <span class="refDoi"> DOI: 10.1242/jcs.00318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1242%2Fjcs.00318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12615973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=1319-1326&issue=7&author=E.+Metzenauthor=U.+Berchner-Pfannschmidtauthor=P.+Stengelauthor=J.+H.+Marxsenauthor=I.+Stolzeauthor=M.+Klingerauthor=W.+Q.+Huangauthor=C.+Wotzlawauthor=T.+Hellwig-Burgelauthor=W.+Jelkmannauthor=H.+Ackerauthor=J.+Fandrey&title=Intracellular+localization+of+human+HIF-1%CE%B1+hydroxylases%3A+Implications+for+oxygen+sensing&doi=10.1242%2Fjcs.00318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular localization of human HIF-1α hydroxylases: Implications for oxygen sensing</span></div><div class="casAuthors">Metzen, Eric; Berchner-Pfannschmidt, Utta; Stengel, Petra; Marxsen, Jan H.; Stolze, Ineke; Klinger, Matthias; Huang, Wei Qi; Wotzlaw, Christoph; Hellwig-Burgel, Thomas; Jelkmann, Wolfgang; Acker, Helmut; Fandrey, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1319-1326</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is an essential transcription factor for cellular adaptation to decreased oxygen availability.  In normoxia the oxygen-sensitive α-subunit of HIF-1 is hydroxylated on Pro564 and Pro402 and thus targeted for proteasomal degrdn.  Three human oxygen-dependent HIF-1α prolyl hydroxylases (PHD1, PHD2, and PHD3) function as oxygen sensors in vivo.  Furthermore, the asparagine hydroxylase FIH-1 (factor inhibiting HIF) has been found to hydroxylate Asp803 of the HIF-1 C-terminal transactivation domain, which results in the decreased ability of HIF-1 to bind to the transcriptional coactivator p300/CBP.  We have fused these enzymes to the N-terminus of fluorescent proteins and transiently transfected the fusion proteins into human osteosarcoma cells (U2OS).  Three-dimensional 2-photon confocal fluorescence microscopy showed that PHD1 was exclusively present in the nucleus, PHD2 and FIH-1 were mainly located in the cytoplasm and PHD3 was homogeneously distributed in cytoplasm and nucleus.  Hypoxia did not influence the localization of any enzyme under investigation.  In contrast to FIH-1, each PHD inhibited nuclear HIF-1α accumulation in hypoxia.  All hydroxylases suppressed activation of a cotransfected hypoxia-responsive luciferase reporter gene.  Endogenous PHD2mRNA and PHD3mRNA were hypoxia-inducible, whereas expression of PHD1mRNA and FIH-1mRNA was oxygen independent.  We propose that PHDs and FIH-1 form an oxygen sensor cascade of distinct subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiwh7sGGnRw7Vg90H21EOLACvtfcHk0lhZWZUKjTsm7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFWhu78%253D&md5=45a5a4ea8f59fd74e0009efefff641d7</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00318%26sid%3Dliteratum%253Aachs%26aulast%3DMetzen%26aufirst%3DE.%26aulast%3DBerchner-Pfannschmidt%26aufirst%3DU.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DMarxsen%26aufirst%3DJ.%2BH.%26aulast%3DStolze%26aufirst%3DI.%26aulast%3DKlinger%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%2BQ.%26aulast%3DWotzlaw%26aufirst%3DC.%26aulast%3DHellwig-Burgel%26aufirst%3DT.%26aulast%3DJelkmann%26aufirst%3DW.%26aulast%3DAcker%26aufirst%3DH.%26aulast%3DFandrey%26aufirst%3DJ.%26atitle%3DIntracellular%2520localization%2520of%2520human%2520HIF-1%25CE%25B1%2520hydroxylases%253A%2520Implications%2520for%2520oxygen%2520sensing%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26issue%3D7%26spage%3D1319%26epage%3D1326%26doi%3D10.1242%2Fjcs.00318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appelhoff, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raval, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleadle, J. M.</span></span> <span> </span><span class="NLM_article-title">Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">38458</span>– <span class="NLM_lpage">38465</span>, <span class="refDoi"> DOI: 10.1074/jbc.M406026200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M406026200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15247232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1OqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=38458-38465&issue=37&author=R.+J.+Appelhoffauthor=Y.+M.+Tianauthor=R.+R.+Ravalauthor=H.+Turleyauthor=A.+L.+Harrisauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=J.+M.+Gleadle&title=Differential+function+of+the+prolyl+hydroxylases+PHD1%2C+PHD2%2C+and+PHD3+in+the+regulation+of+hypoxia-inducible+factor&doi=10.1074%2Fjbc.M406026200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor</span></div><div class="casAuthors">Appelhoff, Rebecca J.; Tian, Ya-Min; Raval, Raju R.; Turley, Helen; Harris, Adrian L.; Pugh, Christopher W.; Ratcliffe, Peter J.; Gleadle, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">38458-38465</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF) is a transcriptional regulator that plays a key role in many aspects of oxygen homeostasis.  The heterodimeric HIF complex is regulated by proteolysis of its α-subunits, following oxygen-dependent hydroxylation of specific prolyl residues.  Although three HIF prolyl hydroxylases, PHD1, PHD2, and PHD3, have been identified that have the potential to catalyze this reaction, the contribution of each isoform to the physiol. regulation of HIF remains uncertain.  Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1α and HIF-2α subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme.  Thus in different cell types, isoform-specific patterns of PHD induction by hypoxia and estrogen alter both the relative abundance of the PHDs and their relative contribution to the regulation of HIF.  In addn., the PHDs manifest specificity for different prolyl hydroxylation sites within each HIF-α subunit, and a degree of selectively between HIF-1α and HIF-2α isoforms, indicating that differential PHD inhibition has the potential to selectively alter the characteristics of HIF activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGFQdU0fEZP7Vg90H21EOLACvtfcHk0lgVX8wik5Trwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1OqtLs%253D&md5=bec1e6f72c7c062ccf09fd51ce65cd53</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M406026200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M406026200%26sid%3Dliteratum%253Aachs%26aulast%3DAppelhoff%26aufirst%3DR.%2BJ.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DRaval%26aufirst%3DR.%2BR.%26aulast%3DTurley%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DGleadle%26aufirst%3DJ.%2BM.%26atitle%3DDifferential%2520function%2520of%2520the%2520prolyl%2520hydroxylases%2520PHD1%252C%2520PHD2%252C%2520and%2520PHD3%2520in%2520the%2520regulation%2520of%2520hypoxia-inducible%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D37%26spage%3D38458%26epage%3D38465%26doi%3D10.1074%2Fjbc.M406026200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsilae, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivirikko, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myllyharju, J.</span></span> <span> </span><span class="NLM_article-title">Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">30772</span>– <span class="NLM_lpage">30780</span>, <span class="refDoi"> DOI: 10.1074/jbc.M304982200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M304982200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12788921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFeqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=30772-30780&issue=33&author=M.+Hirsilaeauthor=P.+Koivunenauthor=V.+Guenzlerauthor=K.+I.+Kivirikkoauthor=J.+Myllyharju&title=Characterization+of+the+human+prolyl+4-hydroxylases+that+modify+the+hypoxia-inducible+factor&doi=10.1074%2Fjbc.M304982200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor</span></div><div class="casAuthors">Hirsilae, Maija; Koivunen, Peppi; Guenzler, Volkmar; Kivirikko, Kari I.; Myllyharju, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">30772-30780</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hypoxia-inducible factors (HIFs) play a central role in oxygen homeostasis.  Hydroxylation of one or two crit. prolines by specific hydroxylases (P4Hs) targets their HIF-α subunits for proteasomal degrdn.  By studying the three human HIF-P4Hs, we found that the longest and shortest isoenzymes have major transcripts encoding inactive polypeptides, which suggest novel regulation by alternative splicing.  Recombinant HIF-P4Hs expressed in insect cells required peptides of more than 8 residues, distinct differences being found between isoenzymes.  All the HIF-P4Hs hydroxylated peptides corresponding to Pro564 in HIF-1α, whereas a Pro402 peptide had 20-50-fold Km values for two isoenzymes but was not hydroxylated by the shortest isoenzyme at all; this difference was not explained by the two prolines being in a -Pro402-Ala- and -Pro564-Tyr-sequence.  All the HIF-P4Hs-hydroxylated peptides corresponding to two of three potential sites in HIF-2α and one in HIF-3α.  The Km values for O2 were slightly above its atm. concn., indicating that the HIF-P4Hs are effective oxygen sensors.  Small mol. inhibitors of collagen P4Hs also inhibited the HIF-P4Hs, but with distinctly different Ki values, indicating that it should be possible to develop specific inhibitors for each class of P4Hs and possibly even for the individual HIF-P4Hs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKRUilSLTYhLVg90H21EOLACvtfcHk0lgVX8wik5Trwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFeqsb4%253D&md5=7f2d58fb0816f1dd9ee0fd1442c98b4f</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M304982200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M304982200%26sid%3Dliteratum%253Aachs%26aulast%3DHirsilae%26aufirst%3DM.%26aulast%3DKoivunen%26aufirst%3DP.%26aulast%3DGuenzler%26aufirst%3DV.%26aulast%3DKivirikko%26aufirst%3DK.%2BI.%26aulast%3DMyllyharju%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520human%2520prolyl%25204-hydroxylases%2520that%2520modify%2520the%2520hypoxia-inducible%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D33%26spage%3D30772%26epage%3D30780%26doi%3D10.1074%2Fjbc.M304982200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehrismann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genn, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathioudakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>401</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1042/BJ20061151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1042%2FBJ20061151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16952279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShsLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2007&pages=227-234&issue=2&author=D.+Ehrismannauthor=E.+Flashmanauthor=D.+N.+Gennauthor=N.+Mathioudakisauthor=K.+S.+Hewitsonauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Studies+on+the+activity+of+the+hypoxia-inducible-factor+hydroxylases+using+an+oxygen+consumption+assay&doi=10.1042%2FBJ20061151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay</span></div><div class="casAuthors">Ehrismann, Dominic; Flashman, Emily; Genn, David N.; Mathioudakis, Nicolas; Hewitson, Kirsty S.; Ratcliffe, Peter J.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">227-234</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The activity and levels of the metazoan HIF (hypoxia-inducible factor) are regulated by its hydroxylation, catalyzed by 2OG (2-oxoglutarate)- and Fe(II)-dependent dioxygenases.  An oxygen consumption assay was developed and used to study the relationship between HIF hydroxylase activity and oxygen concn. for recombinant forms of two human HIF hydroxylases, PHD2 (prolyl hydroxylase domain-contg. protein 2) and FIH (factor inhibiting HIF), and compared with two other 2OG-dependent dioxygenases.  Although there are caveats on the abs. values, the apparent Km (oxygen) values for PHD2 and FIH were within the range obsd. for other 2OG oxygenases.  Recombinant protein substrates were found to have lower apparent Km (oxygen) values compared with shorter synthetic peptides of HIF.  The analyses also suggest that human PHD2 is selective for fragments of the C-terminal over the N-terminal oxygen-dependent degrdn. domain of HIF-1α.  The present results, albeit obtained under non-physiol. conditions, imply that the apparent Km (oxygen) values of the HIF hydroxylases enable them to act as oxygen sensors providing their in vivo capacity is appropriately matched to a hydroxylation-sensitive signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAEtXBODUrK7Vg90H21EOLACvtfcHk0lgVX8wik5Trwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShsLfE&md5=99dfd44568845e9f3589ec31313cc0e6</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1042%2FBJ20061151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061151%26sid%3Dliteratum%253Aachs%26aulast%3DEhrismann%26aufirst%3DD.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DGenn%26aufirst%3DD.%2BN.%26aulast%3DMathioudakis%26aufirst%3DN.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStudies%2520on%2520the%2520activity%2520of%2520the%2520hypoxia-inducible-factor%2520hydroxylases%2520using%2520an%2520oxygen%2520consumption%2520assay%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D401%26issue%3D2%26spage%3D227%26epage%3D234%26doi%3D10.1042%2FBJ20061151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lygate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span> <span> </span><span class="NLM_article-title">HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2006.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.yjmcc.2006.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16765982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1antbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=68-77&issue=1&author=C.+Willamauthor=P.+H.+Maxwellauthor=L.+Nicholsauthor=C.+Lygateauthor=Y.+M.+Tianauthor=W.+Bernhardtauthor=M.+Wiesenerauthor=P.+J.+Ratcliffeauthor=K.+U.+Eckardtauthor=C.+W.+Pugh&title=HIF+prolyl+hydroxylases+in+the+rat%3B+organ+distribution+and+changes+in+expression+following+hypoxia+and+coronary+artery+ligation&doi=10.1016%2Fj.yjmcc.2006.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation</span></div><div class="casAuthors">Willam, Carsten; Maxwell, Patrick H.; Nichols, Lynn; Lygate, Craig; Tian, Ya Min; Bernhardt, Wanja; Wiesener, Michael; Ratcliffe, Peter J.; Eckardt, Kai-Uwe; Pugh, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF) regulates expression of genes involved in adaptation to hypoxia and ischemia.  Three prolyl hydroxylases (PHD1-3) underlie oxygen-regulated destruction of HIFalpha chains.  We have investigated the organ distribution of the PHDs in the rat, their regulation by hypoxia and changes in local expression after exptl. myocardial infarction using RNase protection assays, in situ hybridization and immunohistochem. mRNAs of all isoforms were detectable in heart, liver, kidney, brain, testis and lung.  In normal animals, highest levels for PHD2 mRNA and PHD3 mRNA were found in myocardium, whereas PHD1 mRNA was detected predominantly in the testis.  PHD1 mRNA was constitutively expressed.  PHD2 mRNA was induced by hypoxia in the liver and PHD3 mRNA in liver, testis and heart.  Overall our results show that PHD2 mRNA is ubiquitously expressed in normal animals, in keeping with a general role in oxygen sensing.  PHD1 and 3 mRNA distributions suggest particular roles in testis and heart, resp.  In a model of myocardial infarction, in situ hybridization showed periischemic enhancement for PHD2 mRNA and PHD3 mRNA, but not PHD1 mRNA.  Immunostaining of PHD2 and 3 in infarcted hearts showed enhanced protein expression, maximal 7 days after infarction.  Levels were strongest in regions neighboring areas of HIF staining but also partially overlapped with these zones.  Inducibility of PHD2 and 3 by hypoxia and ischemia in vivo has important implications both for the pathophysiol. of conditions where oxygen supply is deranged and for attempts to manipulate the HIF system therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJKeHSbhFBDbVg90H21EOLACvtfcHk0lgEdWSfSGJJgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1antbg%253D&md5=67c79d106beb6b6604d7c358dc8a0e78</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2006.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2006.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DWillam%26aufirst%3DC.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DNichols%26aufirst%3DL.%26aulast%3DLygate%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DBernhardt%26aufirst%3DW.%26aulast%3DWiesener%26aufirst%3DM.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26atitle%3DHIF%2520prolyl%2520hydroxylases%2520in%2520the%2520rat%253B%2520organ%2520distribution%2520and%2520changes%2520in%2520expression%2520following%2520hypoxia%2520and%2520coronary%2520artery%2520ligation%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2006%26volume%3D41%26issue%3D1%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.yjmcc.2006.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benizri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginouves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volmat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span> <span> </span><span class="NLM_article-title">HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4082</span>– <span class="NLM_lpage">4090</span>, <span class="refDoi"> DOI: 10.1093/emboj/cdg392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1093%2Femboj%2Fcdg392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12912907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=4082-4090&issue=16&author=E.+Berraauthor=E.+Benizriauthor=A.+Ginouvesauthor=V.+Volmatauthor=D.+Rouxauthor=J.+Pouyssegur&title=HIF+prolyl-hydroxylase+2+is+the+key+oxygen+sensor+setting+low+steady-state+levels+of+HIF-1%CE%B1+in+normoxia&doi=10.1093%2Femboj%2Fcdg392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia</span></div><div class="casAuthors">Berra, Edurne; Benizri, Emmanuel; Ginouves, Amandine; Volmat, Veronique; Roux, Daniele; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4082-4090</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF), a transcriptional complex conserved from Caenorhabditis elegans to vertebrates, plays a pivotal role in cellular adaptation to low oxygen availability.  In normoxia, the HIF-α subunits are targeted for destruction by prolyl hydroxylation, a specific modification that provides recognition for the E3 ubiquitin ligase complex contg. the von Hippel-Lindau tumor suppressor protein (pVHL).  Three HIF prolyl-hydroxylases (PHD1, 2 and 3) were identified recently in mammals and shown to hydroxylate HIF-α subunits.  Here we show that specific silencing' of PHD2 with short interfering RNAs is sufficient to stabilize and activate HIF-1α in normoxia in all the human cells investigated.  Silencing' of PHD1 and PHD3 has no effect on the stability of HIF-1α either in normoxia or upon re-oxygenation of cells briefly exposed to hypoxia.  We therefore conclude that, in vivo, PHDs have distinct assigned functions, PHD2 being the crit. oxygen sensor setting the low steady-state levels of HIF-1α in normoxia.  Interestingly, PHD2 is upregulated by hypoxia, providing an HIF-1-dependent auto-regulatory mechanism driven by the oxygen tension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZqlOv_GKAo7Vg90H21EOLACvtfcHk0lgEdWSfSGJJgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGgsLo%253D&md5=0664088d2f005bddec8f685f162201fd</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg392%26sid%3Dliteratum%253Aachs%26aulast%3DBerra%26aufirst%3DE.%26aulast%3DBenizri%26aufirst%3DE.%26aulast%3DGinouves%26aufirst%3DA.%26aulast%3DVolmat%26aufirst%3DV.%26aulast%3DRoux%26aufirst%3DD.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DHIF%2520prolyl-hydroxylase%25202%2520is%2520the%2520key%2520oxygen%2520sensor%2520setting%2520low%2520steady-state%2520levels%2520of%2520HIF-1%25CE%25B1%2520in%2520normoxia%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26issue%3D16%26spage%3D4082%26epage%3D4090%26doi%3D10.1093%2Femboj%2Fcdg392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. L.</span></span> <span> </span><span class="NLM_article-title">The molecular characterization, expression pattern and alternative initiation of Megalobrama amblycephala Hif prolyl hydroxylase Phd1</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>678</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2018.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.gene.2018.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=30086363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFWjsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=678&publication_year=2018&pages=219-225&author=N.+Chenauthor=C.+X.+Huangauthor=C.+H.+Huangauthor=Y.+Heauthor=T.+S.+Chenauthor=D.+M.+Zhuauthor=H.+Liuauthor=W.+M.+Wangauthor=H.+L.+Wang&title=The+molecular+characterization%2C+expression+pattern+and+alternative+initiation+of+Megalobrama+amblycephala+Hif+prolyl+hydroxylase+Phd1&doi=10.1016%2Fj.gene.2018.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular characterization, expression pattern and alternative initiation of Megalobrama amblycephala Hif prolyl hydroxylase Phd1</span></div><div class="casAuthors">Chen, Nan; Huang, Chun-Xiao; Huang, Cui-Hong; He, Yan; Chen, Tian-Sheng; Zhu, Dong-Mei; Liu, Hong; Wang, Wei-Min; Wang, Huan-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">678</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219-225</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HIF prolyl hydroxylase 1 (PHD1) functions in prolyl hydroxylation on mammal hypoxia-inducible factors (HIF), important transcription factors involved in hypoxia, however the roles of Phd1 in fish remain unclear.  In this study, the full-length cDNA and promoter sequences of blunt snout bream (Megalobrama amblycephala) phd1 gene were isolated by a modified RACE strategy.  The phd1 cDNA was 2672 bp for encoding 481 amino acid residues.  In silico assays indicated that phd1 had 5 exons, and a 348 bp CpG island in the exon1, and several transcription factor binding sites (CAAT box, HRE, ARNT, FOX, etc.) were also found on the promoter.  The quant. real-time PCR results suggested that phd1 mRNA was constitutively expressed in all detected tissues, and higher in the blood, brain and heart in normoxia, but significantly decreased after hypoxia in all detected tissues except for gill.  Western blot assays indicated that two Phd1 isoforms were generated by alternative translation initiation.  Moreover, these two isoforms were both localized in the nucleus, therein only the senior isoform promoted cell proliferation.  Taken together, the present study firstly describes the functions of M. amblycephala two Phd1 isoforms in hypoxia and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuugZG11fTkbVg90H21EOLACvtfcHk0lgEdWSfSGJJgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFWjsrzE&md5=7194067764baf61a5285bbababf47451</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2018.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2018.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DC.%2BX.%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DT.%2BS.%26aulast%3DZhu%26aufirst%3DD.%2BM.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%2BM.%26aulast%3DWang%26aufirst%3DH.%2BL.%26atitle%3DThe%2520molecular%2520characterization%252C%2520expression%2520pattern%2520and%2520alternative%2520initiation%2520of%2520Megalobrama%2520amblycephala%2520Hif%2520prolyl%2520hydroxylase%2520Phd1%26jtitle%3DGene%26date%3D2018%26volume%3D678%26spage%3D219%26epage%3D225%26doi%3D10.1016%2Fj.gene.2018.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loenarz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1016/j.str.2009.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.str.2009.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19604478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=981-989&issue=7&author=R.+Chowdhuryauthor=M.+A.+McDonoughauthor=J.+Mecinovicauthor=C.+Loenarzauthor=E.+Flashmanauthor=K.+S.+Hewitsonauthor=C.+Domeneauthor=C.+J.+Schofield&title=Structural+basis+for+binding+of+hypoxia-inducible+factor+to+the+oxygen-sensing+prolyl+hydroxylases&doi=10.1016%2Fj.str.2009.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; McDonough, Michael A.; Mecinovic, Jasmin; Loenarz, Christoph; Flashman, Emily; Hewitson, Kirsty S.; Domene, Carmen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">981-989</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The oxygen-dependent hydroxylation of proline residues in the α subunit of hypoxia-inducible transcription factor (HIFα) is central to the hypoxic response in animals.  Prolyl hydroxylation of HIFα increases its binding to the von Hippel-Lindau protein (pVHL), so signaling for degrdn. via the ubiquitin-proteasome system.  The HIF prolyl hydroxylases (PHDs, prolyl hydroxylase domain enzymes) are related to the collagen prolyl hydroxylases, but form unusually stable complexes with their Fe(II) cofactor and 2-oxoglutarate cosubstrate.  We report crystal structures of the catalytic domain of PHD2, the most important of the human PHDs, in complex with the C-terminal oxygen-dependent degrdn. domain of HIF-1α.  Together with biochem. analyses, the results reveal that PHD catalysis involves a mobile region that isolates the hydroxylation site and stabilizes the PHD2.Fe(II).2OG complex.  The results will be of use in the design of PHD inhibitors aimed at treating anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj4EIAtw-X1LVg90H21EOLACvtfcHk0lhI6YiTwDoEOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D&md5=c0e60731ac33bdbf947cd0227dc86244</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DLoenarz%26aufirst%3DC.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DDomene%26aufirst%3DC.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520hypoxia-inducible%2520factor%2520to%2520the%2520oxygen-sensing%2520prolyl%2520hydroxylases%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26issue%3D7%26spage%3D981%26epage%3D989%26doi%3D10.1016%2Fj.str.2009.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">3130</span>– <span class="NLM_lpage">3133</span>, <span class="refDoi"> DOI: 10.1039/C8CC00387D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2FC8CC00387D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29522057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFagsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=3130-3133&issue=25&author=M.+I.+Abboudauthor=T.+E.+McAllisterauthor=I.+K.+H.+Leungauthor=R.+Chowdhuryauthor=C.+Jorgensenauthor=C.+Domeneauthor=J.+Mecinovicauthor=K.+Lipplauthor=R.+L.+Hancockauthor=R.+J.+Hopkinsonauthor=A.+Kawamuraauthor=T.+D.+W.+Claridgeauthor=C.+J.+Schofield&title=2-Oxoglutarate+regulates+binding+of+hydroxylated+hypoxia-inducible+factor+to+prolyl+hydroxylase+domain+2&doi=10.1039%2FC8CC00387D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2</span></div><div class="casAuthors">Abboud, Martine I.; McAllister, Tom E.; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Jorgensen, Christian; Domene, Carmen; Mecinovic, Jasmin; Lippl, Kerstin; Hancock, Rebecca L.; Hopkinson, Richard J.; Kawamura, Akane; Claridge, Timothy D. W.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3130-3133</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Prolyl hydroxylation of hypoxia inducible factor (HIF)-α, as catalyzed by the Fe(II)/2-oxoglutarate (2OG)-dependent prolyl hydroxylase domain (PHD) enzymes, has a hypoxia sensing role in animals.  We report that binding of prolyl-hydroxylated HIF-α to PHD2 is ∼50 fold hindered by prior 2OG binding; thus, when 2OG is limiting, HIF-α degrdn. might be inhibited by PHD binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2mOvIMPzQ6LVg90H21EOLACvtfcHk0lhI6YiTwDoEOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFagsrw%253D&md5=f6275f3ba65d82a7bc14028dbd6f06f2</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2FC8CC00387D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC00387D%26sid%3Dliteratum%253Aachs%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DMcAllister%26aufirst%3DT.%2BE.%26aulast%3DLeung%26aufirst%3DI.%2BK.%2BH.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DJorgensen%26aufirst%3DC.%26aulast%3DDomene%26aufirst%3DC.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DLippl%26aufirst%3DK.%26aulast%3DHancock%26aufirst%3DR.%2BL.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3D2-Oxoglutarate%2520regulates%2520binding%2520of%2520hydroxylated%2520hypoxia-inducible%2520factor%2520to%2520prolyl%2520hydroxylase%2520domain%25202%26jtitle%3DChem.%2520Commun.%26date%3D2018%26volume%3D54%26issue%3D25%26spage%3D3130%26epage%3D3133%26doi%3D10.1039%2FC8CC00387D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3610</span>– <span class="NLM_lpage">3615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1182%2Fblood.V82.12.3610.3610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=8260699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK2cXhtlSlsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1993&pages=3610-3615&issue=12&author=G.+L.+Wangauthor=G.+L.+Semenza&title=Desferrioxamine+induces+erythropoietin+gene+expression+and+hypoxia-inducible+factor+1+DNA-binding+activity%3A+implications+for+models+of+hypoxia+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction</span></div><div class="casAuthors">Wang, Guang L.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3610-15</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">Erythropoietin (EPO) gene transcription is activated in kidney cells in vivo and in Hep3B cells exposed to hypoxia or cobalt chloride.  Hypoxia-inducible factor 1 (HIF-1) is a nuclear factor that binds to the hypoxia-inducible enhancer of the EPO gene at a site that is required for transcriptional activation.  HIF-1 DNA-binding activity is induced by hypoxia or cobalt chloride treatment of Hep3B cells.  The authors report that treatment of Hep3B cells with desferrioxamine (DFX) induced HIF-1 activity and EPO RNA expression with kinetics similar to the induction of HIF-1 by hypoxia or cobalt chloride.  Induction by each of these stimuli was inhibited by cycloheximide, indicating a requirement for de novo protein synthesis.  DFX appears to induce HIF-1 by chelating iron, as induction was inhibited by coadministration of ferrous ammonium sulfate.  DFX administration to mice transiently increased EPO RNA levels in the kidney.  As previously shown for hypoxia and cobalt treatment, DFX also induced HIF-1 activity in non-EPO-producing cells, suggesting the existence of a common hypoxia signal-transduction pathway leading to HIF-1 induction in different cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVrTxL6miJ0bVg90H21EOLACvtfcHk0lhI6YiTwDoEOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtlSlsLw%253D&md5=10d0007ff9fb27794d0001b7757c82d9</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1182%2Fblood.V82.12.3610.3610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V82.12.3610.3610%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BL.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDesferrioxamine%2520induces%2520erythropoietin%2520gene%2520expression%2520and%2520hypoxia-inducible%2520factor%25201%2520DNA-binding%2520activity%253A%2520implications%2520for%2520models%2520of%2520hypoxia%2520signal%2520transduction%26jtitle%3DBlood%26date%3D1993%26volume%3D82%26issue%3D12%26spage%3D3610%26epage%3D3615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span> <span> </span><span class="NLM_article-title">Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1124/mol.107.034041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1124%2Fmol.107.034041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17377063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1676-1684&issue=6&author=H.+Jeonauthor=H.+Kimauthor=D.+Choiauthor=D.+Kimauthor=S.+Y.+Parkauthor=Y.+J.+Kimauthor=Y.+M.+Kimauthor=Y.+Jung&title=Quercetin+activates+an+angiogenic+pathway%2C+hypoxia+inducible+factor+%28HIF%29-1-vascular+endothelial+growth+factor%2C+by+inhibiting+HIF-prolyl+hydroxylase%3A+a+structural+analysis+of+quercetin+for+inhibiting+HIF-prolyl+hydroxylase&doi=10.1124%2Fmol.107.034041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase</span></div><div class="casAuthors">Jeon, Hyunchu; Kim, Heejung; Choi, Daekyu; Kim, Duksoo; Park, Shi-Young; Kim, Yung-Jin; Kim, Young Mi; Jung, Yunjin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1676-1684</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We investigated a mol. mechanism underlying quercetin-mediated amelioration of colonic mucosal injury and analyzed chem. structure contributing to the quercetin's effect.  Quercetin up-regulated vascular endothelial growth factor (VEGF), an ulcer healing factor, not only in colon epithelial cell lines but also in the inflamed colonic tissue.  VEGF derived from quercetin-treated colon epithelial cells promoted tube formation.  The VEGF induction was dependent on quercetin-mediated hypoxia-inducible factor-1 (HIF-1) activation.  Quercetin delayed HIF-1α protein disappearance, which occurred by inhibiting HIF-prolyl hydroxylase (HPH), the key enzyme for HIF-1α hydroxylation and subsequent von Hippel Lindau-dependent HIF-1α degrdn.  HPH inhibition by quercetin was neutralized significantly by an elevated dose of iron.  Consistent with this, cellular induction of HIF-1α by quercetin was abolished by pretreatment with iron.  Two iron-chelating moieties in quercetin, -OH at position 3 of the C ring and/or -OH at positions 3' and 4' of the B ring, enabled the flavonoid to inhibit HPH and subsequently induce HIF-1α.  Our data suggest that the clin. effect of quercetin may be partly attributed to the activation of an angiogenic pathway HIF-1-VEGF via inhibiting HPH and the chelating moieties of quercetin were required for inhibiting HPH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcK39oTOUrSbVg90H21EOLACvtfcHk0lgpcoSiOoovSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqtbk%253D&md5=8d5147dfa2b36e05a88b5fbd4d1ac955</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.034041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.034041%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DJung%26aufirst%3DY.%26atitle%3DQuercetin%2520activates%2520an%2520angiogenic%2520pathway%252C%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529-1-vascular%2520endothelial%2520growth%2520factor%252C%2520by%2520inhibiting%2520HIF-prolyl%2520hydroxylase%253A%2520a%2520structural%2520analysis%2520of%2520quercetin%2520for%2520inhibiting%2520HIF-prolyl%2520hydroxylase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26issue%3D6%26spage%3D1676%26epage%3D1684%26doi%3D10.1124%2Fmol.107.034041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltier, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bembenek, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanelakis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocutt, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondstetter, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugh, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzadegan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankley, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole-2-pyrazole HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1021/ml100198y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100198y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cgs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=526-529&issue=9&author=M.+D.+Rosenauthor=H.+Venkatesanauthor=H.+M.+Peltierauthor=S.+D.+Bembenekauthor=K.+C.+Kanelakisauthor=L.+X.+Zhaoauthor=B.+E.+Leonardauthor=F.+M.+Hocuttauthor=X.+Wuauthor=H.+L.+Palominoauthor=T.+I.+Brondstetterauthor=P.+V.+Haughauthor=L.+Cagnonauthor=W.+Yanauthor=L.+A.+Liottaauthor=A.+Youngauthor=T.+Mirzadeganauthor=N.+P.+Shankleyauthor=T.+D.+Barrettauthor=M.+H.+Rabinowitz&title=Benzimidazole-2-pyrazole+HIF+prolyl+4-hydroxylase+inhibitors+as+oral+erythropoietin+secretagogues&doi=10.1021%2Fml100198y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues</span></div><div class="casAuthors">Rosen, Mark D.; Venkatesan, Hariharan; Peltier, Hillary M.; Bembenek, Scott D.; Kanelakis, Kimon C.; Zhao, Lucy X.; Leonard, Barry E.; Hocutt, Frances M.; Wu, Xiaodong; Palomino, Heather L.; Brondstetter, Theresa I.; Haugh, Peter V.; Cagnon, Laurence; Yan, Wen; Liotta, Lisa A.; Young, Andrew; Mirzadegan, Tara; Shankley, Nigel P.; Barrett, Terrance D.; Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">526-529</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiol. responses to hypoxia by modulating the levels of hypoxia inducible factor 1-α (HIF1α).  Certain benzimidazole-2-pyrazole carboxylates, e.g., I were discovered to be PHD2 inhibitors using ligand- and structure-based methods and found to be potent, orally efficacious stimulators of erythropoietin secretion in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJr3s7CR6lOLVg90H21EOLACvtfcHk0lgpcoSiOoovSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cgs7nI&md5=b60c31a48faf7fd9824e143287b685e3</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fml100198y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100198y%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DM.%2BD.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DPeltier%26aufirst%3DH.%2BM.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DKanelakis%26aufirst%3DK.%2BC.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26aulast%3DHocutt%26aufirst%3DF.%2BM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DPalomino%26aufirst%3DH.%2BL.%26aulast%3DBrondstetter%26aufirst%3DT.%2BI.%26aulast%3DHaugh%26aufirst%3DP.%2BV.%26aulast%3DCagnon%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DMirzadegan%26aufirst%3DT.%26aulast%3DShankley%26aufirst%3DN.%2BP.%26aulast%3DBarrett%26aufirst%3DT.%2BD.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DBenzimidazole-2-pyrazole%2520HIF%2520prolyl%25204-hydroxylase%2520inhibitors%2520as%2520oral%2520erythropoietin%2520secretagogues%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26issue%3D9%26spage%3D526%26epage%3D529%26doi%3D10.1021%2Fml100198y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candela-Lena, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenald, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conejo-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eeden, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1496</span>, <span class="refDoi"> DOI: 10.1021/cb400088q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400088q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1488-1496&issue=7&author=R.+Chowdhuryauthor=J.+I.+Candela-Lenaauthor=M.+C.+Chanauthor=D.+J.+Greenaldauthor=K.+K.+Yeohauthor=Y.+M.+Tianauthor=M.+A.+McDonoughauthor=A.+Tumberauthor=N.+R.+Roseauthor=A.+Conejo-Garciaauthor=M.+Demetriadesauthor=S.+Mathavanauthor=A.+Kawamuraauthor=M.+K.+Leeauthor=F.+van+Eedenauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Selective+small+molecule+probes+for+the+hypoxia+inducible+factor+%28HIF%29+prolyl+hydroxylases&doi=10.1021%2Fcb400088q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; Candela-Lena, Jose Ignacio; Chan, Mun Chiang; Greenald, David Jeremy; Yeoh, Kar Kheng; Tian, Ya-Min; McDonough, Michael A.; Tumber, Anthony; Rose, Nathan R.; Conejo-Garcia, Ana; Demetriades, Marina; Mathavan, Sinnakaruppan; Kawamura, Akane; Lee, Myung Kyu; van Eeden, Freek; Pugh, Christopher W.; Ratcliffe, Peter J.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1488-1496</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypoxia inducible factor (HIF) system is central to the signaling of low oxygen (hypoxia) in animals.  The levels of HIF-α isoforms are regulated in an oxygen-dependent manner by the activity of the HIF prolyl-hydroxylases (PHD or EGLN enzymes), which are Fe(II) and 2-oxoglutarate (2OG) dependent oxygenases.  Here, we describe biochem., crystallog., cellular profiling, and animal studies on PHD inhibitors including selectivity studies using a representative set of human 2OG oxygenases.  We identify suitable probe compds. for use in studies on the functional effects of PHD inhibition in cells and in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprl-2yCzTAKbVg90H21EOLACvtfcHk0lgpcoSiOoovSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGjtrs%253D&md5=c857df3bdae0b9b29760200cea91fce0</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fcb400088q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400088q%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DCandela-Lena%26aufirst%3DJ.%2BI.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DGreenald%26aufirst%3DD.%2BJ.%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DN.%2BR.%26aulast%3DConejo-Garcia%26aufirst%3DA.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DMathavan%26aufirst%3DS.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3Dvan%2BEeden%26aufirst%3DF.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520small%2520molecule%2520probes%2520for%2520the%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529%2520prolyl%2520hydroxylases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D7%26spage%3D1488%26epage%3D1496%26doi%3D10.1021%2Fcb400088q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienard, B. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zondlo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzeja, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9819</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601283103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0601283103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16782814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=9814-9819&issue=26&author=M.+A.+McDonoughauthor=V.+Liauthor=E.+Flashmanauthor=R.+Chowdhuryauthor=C.+Mohrauthor=B.+M.+R.+Lienardauthor=J.+Zondloauthor=N.+J.+Oldhamauthor=I.+J.+Cliftonauthor=J.+Lewisauthor=L.+A.+McNeillauthor=R.+J.+M.+Kurzejaauthor=K.+S.+Hewitsonauthor=E.+Yangauthor=S.+Jordanauthor=R.+S.+Syedauthor=C.+J.+Schofield&title=Cellular+oxygen+sensing%3A+crystal+structure+of+hypoxia-inducible+factor+prolyl+hydroxylase+%28PHD2%29&doi=10.1073%2Fpnas.0601283103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span></div><div class="casAuthors">McDonough, Michael A.; Li, Vivian; Flashman, Emily; Chowdhury, Rasheduzzaman; Mohr, Christopher; Lienard, Benoit M. R.; Zondlo, James; Oldham, Neil J.; Clifton, Ian J.; Lewis, Jeffrey; McNeill, Luke A.; Kurzeja, Robert J. M.; Hewitson, Kirsty S.; Yang, Evelyn; Jordan, Steven; Syed, Rashid S.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9814-9819</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cellular and physiol. responses to changes in dioxygen levels in metazoans are mediated via the posttranslational oxidn. of hypoxia-inducible transcription factor (HIF).  Hydroxylation of conserved prolyl residues in the HIF-α subunit, catalyzed by HIF prolyl-hydroxylases (PHDs), signals for its proteasomal degrdn.  The requirement of the PHDs for dioxygen links changes in dioxygen levels with the transcriptional regulation of the gene array that enables the cellular response to chronic hypoxia; the PHDs thus act as an oxygen-sensing component of the HIF system, and their inhibition mimics the hypoxic response.  We describe crystal structures of the catalytic domain of human PHD2, an important prolyl-4-hydroxylase in the human hypoxic response in normal cells, in complex with Fe(II) and an inhibitor to 1.7 Å resoln.  PHD2 crystallizes as a homotrimer and contains a double-stranded β-helix core fold common to the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, the residues of which are well conserved in the three human PHD enzymes (PHD 1-3).  The structure provides insights into the hypoxic response, helps to rationalize a clin. obsd. mutation leading to familial erythrocytosis, and will aid in the design of PHD selective inhibitors for the treatment of anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXKAbBi_2YrVg90H21EOLACvtfcHk0lg4jP9vYyKwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D&md5=2829121b3017e69b547b95ec5f28cd1b</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601283103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601283103%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DLienard%26aufirst%3DB.%2BM.%2BR.%26aulast%3DZondlo%26aufirst%3DJ.%26aulast%3DOldham%26aufirst%3DN.%2BJ.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DKurzeja%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DSyed%26aufirst%3DR.%2BS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DCellular%2520oxygen%2520sensing%253A%2520crystal%2520structure%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520%2528PHD2%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D26%26spage%3D9814%26epage%3D9819%26doi%3D10.1073%2Fpnas.0601283103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atasoylu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Perez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt-Martyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0132004</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0132004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1371%2Fjournal.pone.0132004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26147748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWjsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&issue=7&author=M.+C.+Chanauthor=O.+Atasoyluauthor=E.+Hodsonauthor=A.+Tumberauthor=I.+K.+Leungauthor=R.+Chowdhuryauthor=V.+Gomez-Perezauthor=M.+Demetriadesauthor=A.+M.+Rydzikauthor=J.+Holt-Martynauthor=Y.+M.+Tianauthor=T.+Bishopauthor=T.+D.+Claridgeauthor=A.+Kawamuraauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Potent+and+selective+triazole-based+inhibitors+of+the+hypoxia-inducible+factor+prolyl-hydroxylases+with+activity+in+the+murine+brain&doi=10.1371%2Fjournal.pone.0132004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain</span></div><div class="casAuthors">Chan, Mun Chiang; Atasoylu, Onur; Hodson, Emma; Tumber, Anthony; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Gomez-Perez, Veronica; Demetriades, Marina; Rydzik, Anna M.; Holt-Martyn, James; Tian, Ya-Min; Bishop, Tammie; Claridge, Timothy D. W.; Kawamura, Akane; Pugh, Christopher W.; Ratcliffe, Peter J.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0132004/1-e0132004/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs).  Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs).  Here, we report studies on tricyclic triazole-contg. compds. as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate.  One compd. (IOX4) induces HIFα in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtXPcYJjl7_bVg90H21EOLACvtfcHk0lg4jP9vYyKwgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWjsb%252FE&md5=2b95483f1984bfb745acf0fad2a902a3</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132004%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DAtasoylu%26aufirst%3DO.%26aulast%3DHodson%26aufirst%3DE.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DGomez-Perez%26aufirst%3DV.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DHolt-Martyn%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520triazole-based%2520inhibitors%2520of%2520the%2520hypoxia-inducible%2520factor%2520prolyl-hydroxylases%2520with%2520activity%2520in%2520the%2520murine%2520brain%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0132004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span> <span> </span><span class="NLM_article-title">Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6964</span>– <span class="NLM_lpage">6982</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Gmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6964-6982&issue=16&author=A.+A.+Joharapurkarauthor=V.+B.+Pandyaauthor=V.+J.+Patelauthor=R.+C.+Desaiauthor=M.+R.+Jain&title=Prolyl+hydroxylase+inhibitors%3A+a+breakthrough+in+the+therapy+of+anemia+associated+with+chronic+diseases&doi=10.1021%2Facs.jmedchem.7b01686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases</span></div><div class="casAuthors">Joharapurkar, Amit A.; Pandya, Vrajesh B.; Patel, Vishal J.; Desai, Ranjit C.; Jain, Mukul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6964-6982</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia.  Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates erythropoietin (EPO) synthesis.  Prolyl hydroxylase domain (PHD) enzyme inhibition can stabilize hypoxia-inducible factor (HIF).  HIF stabilization also decreases hepcidin, a hormone of hepatic origin, which regulates iron homeostasis.  PHD inhibitors represent a novel pharmacol. treatment of anemia assocd. with chronic diseases.  Many orally active PHD inhibitors like roxadustat, molidustat, vadadustat, and desidustat are in late phase clin. trials.  This review discusses the role of PHD inhibitors in the treatment of anemia assocd. with chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSEZtvGwIdjbVg90H21EOLACvtfcHk0lhms1BOFmJG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Gmurg%253D&md5=535ba40985e28405c250b40dc003ff6b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01686%26sid%3Dliteratum%253Aachs%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DPatel%26aufirst%3DV.%2BJ.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26aulast%3DJain%26aufirst%3DM.%2BR.%26atitle%3DProlyl%2520hydroxylase%2520inhibitors%253A%2520a%2520breakthrough%2520in%2520the%2520therapy%2520of%2520anemia%2520associated%2520with%2520chronic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D6964%26epage%3D6982%26doi%3D10.1021%2Facs.jmedchem.7b01686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thede, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbaba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ergueden, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keldenich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehme, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Militzer, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuss, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of Molidustat (BAY 85-3934): a small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the Treatment of renal anemia</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">988</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fcmdc.201700783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29485740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=988-1003&issue=10&author=H.+Beckauthor=M.+Jeskeauthor=K.+Thedeauthor=F.+Stollauthor=I.+Flammeauthor=M.+Akbabaauthor=J.+K.+Erguedenauthor=G.+Karigauthor=J.+Keldenichauthor=F.+Oehmeauthor=H.+C.+Militzerauthor=I.+V.+Hartungauthor=U.+Thuss&title=Discovery+of+Molidustat+%28BAY+85-3934%29%3A+a+small-molecule+oral+HIF-prolyl+hydroxylase+%28HIF-PH%29+inhibitor+for+the+Treatment+of+renal+anemia&doi=10.1002%2Fcmdc.201700783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia</span></div><div class="casAuthors">Beck, Hartmut; Jeske, Mario; Thede, Kai; Stoll, Friederike; Flamme, Ingo; Akbaba, Metin; Ergueden, Jens-Kerim; Karig, Gunter; Keldenich, Joerg; Oehme, Felix; Militzer, Hans-Christian; Hartung, Ingo V.; Thuss, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-1003</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) are currently under clin. development as novel treatment options for chronic kidney disease (CKD) assocd. anemia.  Inhibition of HIF-PH mimics hypoxia and leads to increased erythropoietin (EPO) expression and subsequently increased erythropoiesis.  Herein the authors describe the discovery, synthesis, structure-activity relationship (SAR), and proposed binding mode of novel 2,4-diheteroaryl-1,2-dihydro-3H-pyrazol-3-ones as orally bioavailable HIF-PH inhibitors for the treatment of anemia.  High-throughput screening of the authors' corporate compd. library identified BAY-908 as a promising hit.  The lead optimization program then resulted in the identification of molidustat (BAY 85-3934), a novel small-mol. oral HIF-PH inhibitor.  Molidustat is currently being investigated in clin. phase III trials as molidustat sodium for the treatment of anemia in patients with CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiZ1SDboNjPrVg90H21EOLACvtfcHk0lhms1BOFmJG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVKmtbk%253D&md5=9f2d758b31c41092e108d266a76ec451</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700783%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DJeske%26aufirst%3DM.%26aulast%3DThede%26aufirst%3DK.%26aulast%3DStoll%26aufirst%3DF.%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DAkbaba%26aufirst%3DM.%26aulast%3DErgueden%26aufirst%3DJ.%2BK.%26aulast%3DKarig%26aufirst%3DG.%26aulast%3DKeldenich%26aufirst%3DJ.%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DMilitzer%26aufirst%3DH.%2BC.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DThuss%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520Molidustat%2520%2528BAY%252085-3934%2529%253A%2520a%2520small-molecule%2520oral%2520HIF-prolyl%2520hydroxylase%2520%2528HIF-PH%2529%2520inhibitor%2520for%2520the%2520Treatment%2520of%2520renal%2520anemia%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26issue%3D10%26spage%3D988%26epage%3D1003%26doi%3D10.1002%2Fcmdc.201700783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiuchi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1320</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1320-1325&issue=12&author=Y.+Ogoshiauthor=T.+Matsuiauthor=I.+Mitaniauthor=M.+Yokotaauthor=M.+Terashitaauthor=D.+Motodaauthor=K.+Ueyamaauthor=T.+Hottaauthor=T.+Itoauthor=Y.+Haseauthor=K.+Fukuiauthor=K.+Deaiauthor=H.+S.+Yoshiuchiauthor=S.+Itoauthor=H.+Abe&title=Discovery+of+JTZ-951%3A+a+HIF+prolyl+hydroxylase+inhibitor+for+the+treatment+of+renal+anemia&doi=10.1021%2Facsmedchemlett.7b00404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia</span></div><div class="casAuthors">Ogoshi, Yosuke; Matsui, Takuya; Mitani, Ikuo; Yokota, Masahiro; Terashita, Masakazu; Motoda, Dai; Ueyama, Kazuhito; Hotta, Takahiro; Ito, Takashi; Hase, Yasunori; Fukui, Kenji; Deai, Katsuya; Yoshiuchi, Hiromi; Ito, Soichiro; Abe, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1320-1325</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of hypoxia inducible factor prolyl hydroxylase (PHD) represents a promising strategy for the discovery of a next generation treatment for renal anemia.  We identified several 5,6-fused ring systems as novel scaffolds of the PHD inhibitor on the basis of pharmacophore anal.  In particular, triazolopyridine derivs. showed potent PHD2 inhibitory activities.  Examn. of the predominance of the triazolopyridines in potency by electrostatic calcns. suggested favorable π-π stacking interactions with Tyr310.  Lead optimization to improve the efficacy of erythropoietin release in cells and in vivo by improving cell permeability led to the discovery of JTZ-951 (compd. 14), with a 5-phenethyl substituent on the triazolopyridine group, which increased Hb levels with daily oral dosing in rats.  Compd. 14 was rapidly absorbed after oral administration and disappeared shortly thereafter, which could be advantageous in terms of safety.  Compd. 14 was selected as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyv_5DiDhDq7Vg90H21EOLACvtfcHk0lhms1BOFmJG8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM&md5=f1fb9366a5c92eafabb512f2e2fecc23</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00404%26sid%3Dliteratum%253Aachs%26aulast%3DOgoshi%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DMitani%26aufirst%3DI.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DTerashita%26aufirst%3DM.%26aulast%3DMotoda%26aufirst%3DD.%26aulast%3DUeyama%26aufirst%3DK.%26aulast%3DHotta%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DFukui%26aufirst%3DK.%26aulast%3DDeai%26aufirst%3DK.%26aulast%3DYoshiuchi%26aufirst%3DH.%2BS.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520JTZ-951%253A%2520a%2520HIF%2520prolyl%2520hydroxylase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D12%26spage%3D1320%26epage%3D1325%26doi%3D10.1021%2Facsmedchemlett.7b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besarab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durham, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cangiano, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiello, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikali, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczech, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, T. B.</span></span> <span> </span><span class="NLM_article-title">Oral hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD</span>. <i>Clin. J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">991</span>, <span class="refDoi"> DOI: 10.2215/CJN.06890615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.2215%2FCJN.06890615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27094610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVSks7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=982-991&issue=6&author=R.+Provenzanoauthor=A.+Besarabauthor=C.+H.+Sunauthor=S.+A.+Diamondauthor=J.+H.+Durhamauthor=J.+L.+Cangianoauthor=J.+R.+Aielloauthor=J.+E.+Novakauthor=T.+Leeauthor=R.+Leongauthor=B.+K.+Robertsauthor=K.+G.+Saikaliauthor=S.+Hemmerichauthor=L.+A.+Szczechauthor=K.+H.+Yuauthor=T.+B.+Neff&title=Oral+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor+roxadustat+%28FG-4592%29+for+the+treatment+of+anemia+in+patients+with+CKD&doi=10.2215%2FCJN.06890615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Oral hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD</span></div><div class="casAuthors">Provenzano, Robert; Besarab, Anatole; Sun, Chao H.; Diamond, Susan A.; Durham, John H.; Cangiano, Jose L.; Aiello, Joseph R.; Novak, James E.; Lee, Tyson; Leong, Robert; Roberts, Brian K.; Saikali, Khalil G.; Hemmerich, Stefan; Szczech, Lynda A.; Yu, Kin-Hung Peony; Neff, Thomas B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-991</span>CODEN:
                <span class="NLM_cas:coden">CJASC7</span>;
        ISSN:<span class="NLM_cas:issn">1555-9041</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Background and objectives: Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, regulates iron metab., and reduces hepcidin, was evaluated in this phase 2b study for safety, efficacy, optimal dose, and dose frequency in patients with nondialysis CKD.  Design, setting, participants, & measurements: The 145 patients with nondialysis CKD and Hb ≤10.5 g/dL were randomized into one of six cohorts of approx. 24 patients each with varying roxadustat starting doses (tiered wt. and fixed amts.) and frequencies (two and three times weekly) followed by Hb maintenance with roxadustat one to three times weekly.  Treatment duration was 16 or 24 wk.  I.v. iron was prohibited.  The primary end point was the proportion of patients achieving Hb increase of ≥1.0 g/dL from baseline and Hb of ≥11.0 g/dL by week 17 (16 wk of treatment).  Secondary analyses included mean Hb change from baseline, iron utilization, and serum lipids.  Safety was evaluated by frequency/severity of adverse events.  Results: Of the 145 patients enrolled, 143 were evaluable for efficacy.  Overall, 92% of patients achieved Hb response.  Higher compared with lower starting doses led to earlier achievement of Hb response.  Roxadustat-induced Hb increases were independent of baseline C-reactive protein levels and iron repletion status.  Overall, over the first 16 treatment weeks, hepcidin levels decreased by 16.9% (P = 0.004), reticulocyte Hb content was maintained, and Hb increased by a mean (±SD) of 1.83 (±0.09) g/dL (P<0.001).  Overall mean total cholesterol level was reduced by a mean (±SD) of 26 (±30) mg/dL (P<0.001) after 8 wk of therapy, independent of the use of statins or other lipid-lowering agents.  No drug-related serious adverse events were reported.  Conclusions: In patients with nondialysis CKD who were anemic, various starting dose regimens of roxadustat were well tolerated and achieved anemia correction with reduced serum hepcidin levels.  After anemia correction, Hb was maintained by roxadustat at various dose frequencies without i.v. iron supplementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVZ7-oE2mfNrVg90H21EOLACvtfcHk0lj_CBGeDeIP5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVSks7bI&md5=710c58a01b4b7c6e2e610273ec82e26b</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2215%2FCJN.06890615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2215%252FCJN.06890615%26sid%3Dliteratum%253Aachs%26aulast%3DProvenzano%26aufirst%3DR.%26aulast%3DBesarab%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DC.%2BH.%26aulast%3DDiamond%26aufirst%3DS.%2BA.%26aulast%3DDurham%26aufirst%3DJ.%2BH.%26aulast%3DCangiano%26aufirst%3DJ.%2BL.%26aulast%3DAiello%26aufirst%3DJ.%2BR.%26aulast%3DNovak%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DLeong%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DB.%2BK.%26aulast%3DSaikali%26aufirst%3DK.%2BG.%26aulast%3DHemmerich%26aufirst%3DS.%26aulast%3DSzczech%26aufirst%3DL.%2BA.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DNeff%26aufirst%3DT.%2BB.%26atitle%3DOral%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%2520roxadustat%2520%2528FG-4592%2529%2520for%2520the%2520treatment%2520of%2520anemia%2520in%2520patients%2520with%2520CKD%26jtitle%3DClin.%2520J.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D982%26epage%3D991%26doi%3D10.2215%2FCJN.06890615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiadeen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colandrea, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyvratt, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keohane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhuebel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieczykowski, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleitz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athanasopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyuz, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">1,3,8-triazaspiro(4.5)decane-2,4-diones as efficacious pan-inhibitors of hypoxia-Inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2945</span>– <span class="NLM_lpage">2959</span>, <span class="refDoi"> DOI: 10.1021/jm201542d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201542d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2945-2959&issue=7&author=P.+Vachalauthor=S.+Miaoauthor=J.+M.+Pierceauthor=D.+Guiadeenauthor=V.+J.+Colandreaauthor=M.+J.+Wyvrattauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=J.+A.+Milliganauthor=R.+Hajduauthor=A.+Gollapudiauthor=C.+A.+Keohaneauthor=R.+B.+Linghamauthor=S.+M.+Mandalaauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=D.+Steinhuebelauthor=G.+R.+Kieczykowskiauthor=F.+J.+Fleitzauthor=K.+Chapmanauthor=J.+Athanasopoulosauthor=G.+Adamauthor=C.+D.+Akyuzauthor=D.+K.+Jenaauthor=J.+W.+Lusenauthor=J.+Mengauthor=B.+D.+Steinauthor=L.+Xiaauthor=E.+C.+Shererauthor=J.+J.+Hale&title=1%2C3%2C8-triazaspiro%284.5%29decane-2%2C4-diones+as+efficacious+pan-inhibitors+of+hypoxia-Inducible+factor+prolyl+hydroxylase+1-3+%28HIF+PHD1-3%29+for+the+treatment+of+anemia&doi=10.1021%2Fjm201542d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Vachal, Petr; Miao, Shouwu; Pierce, Joan M.; Guiadeen, Deodial; Colandrea, Vincent J.; Wyvratt, Matthew J.; Salowe, Scott P.; Sonatore, Lisa M.; Milligan, James A.; Hajdu, Richard; Gollapudi, Anantha; Keohane, Carol A.; Lingham, Russell B.; Mandala, Suzanne M.; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Steinhuebel, Dietrich; Kieczykowski, Gerard R.; Fleitz, Fred J.; Chapman, Kevin; Athanasopoulos, John; Adam, Gregory; Akyuz, Can D.; Jena, Dhirendra K.; Lusen, Jeffrey W.; Meng, Juncai; Stein, Benjamin D.; Xia, Lei; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2945-2959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 1,3,8-triazaspiro[4.5]decane-2,4-diones (spirohydantoins) as a structural class of pan-inhibitors of the prolyl hydroxylase (PHD) family of enzymes for the treatment of anemia is described.  The initial hit class, spirooxindoles, was identified through affinity selection mass spectrometry (AS-MS) and optimized for PHD2 inhibition and optimal PK/PD profile (short-acting PHDi inhibitors). 1,3,8-Triazaspiro[4.5]decane-2,4-diones (spirohydantoins) were optimized as an advanced lead class derived from the original spiroindole hit.  A new set of general conditions for C-N coupling, developed using a high-throughput experimentation (HTE) technique, enabled a full SAR anal. of the spirohydantoins.  This rapid and directed SAR exploration has resulted in the first reported examples of hydantoin derivs. with good PK in preclin. species.  Potassium channel off-target activity (hERG) was successfully eliminated through the systematic introduction of acidic functionality to the mol. structure.  Undesired upregulation of alanine aminotransferase (ALT) liver enzymes was mitigated and a robust on-/off-target margin was achieved.  Spirohydantoins represent a class of highly efficacious, short-acting PHD1-3 inhibitors causing a robust erythropoietin (EPO) upregulation in vivo in multiple preclin. species.  This profile deems spirohydantoins as attractive short-acting PHDi inhibitors with the potential for treatment of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMoX0fQFHBsLVg90H21EOLACvtfcHk0lj_CBGeDeIP5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D&md5=3d23fd3c5379c259eb556d1fac6133de</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm201542d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201542d%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DGuiadeen%26aufirst%3DD.%26aulast%3DColandrea%26aufirst%3DV.%2BJ.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DSteinhuebel%26aufirst%3DD.%26aulast%3DKieczykowski%26aufirst%3DG.%2BR.%26aulast%3DFleitz%26aufirst%3DF.%2BJ.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DAkyuz%26aufirst%3DC.%2BD.%26aulast%3DJena%26aufirst%3DD.%2BK.%26aulast%3DLusen%26aufirst%3DJ.%2BW.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DB.%2BD.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3D1%252C3%252C8-triazaspiro%25284.5%2529decane-2%252C4-diones%2520as%2520efficacious%2520pan-inhibitors%2520of%2520hypoxia-Inducible%2520factor%2520prolyl%2520hydroxylase%25201-3%2520%2528HIF%2520PHD1-3%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D7%26spage%3D2945%26epage%3D2959%26doi%3D10.1021%2Fjm201542d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Click chemistry-based discovery of (3-Hydroxy-5-(1H-1,2,3-triazol-4-yl) picolinoyl) glycines as orally active hypoxia-inducing factor prolyl hydroxylase inhibitors with favorable safety profiles for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5332</span>– <span class="NLM_lpage">5349</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00549</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00549" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5332-5349&issue=12&author=Y.+Wuauthor=Z.+Jiangauthor=Z.+Liauthor=J.+Guauthor=Q.+Youauthor=X.+Zhang&title=Click+chemistry-based+discovery+of+%283-Hydroxy-5-%281H-1%2C2%2C3-triazol-4-yl%29+picolinoyl%29+glycines+as+orally+active+hypoxia-inducing+factor+prolyl+hydroxylase+inhibitors+with+favorable+safety+profiles+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.8b00549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Click Chemistry-Based Discovery of [3-Hydroxy-5-(1H-1,2,3-triazol-4-yl)picolinoyl]glycines as Orally Active Hypoxia-Inducing Factor Prolyl Hydroxylase Inhibitors with Favorable Safety Profiles for the Treatment of Anemia</span></div><div class="casAuthors">Wu, Yue; Jiang, Zhensheng; Li, Zhihong; Gu, Jing; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5332-5349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a gene assocd. with anemia, the erythropoiesis gene is physiol. expressed under hypoxia regulated by †hypoxia-inducing factor-α (HIF-α).  Thus, stabilizing HIF-α is a potent strategy to stimulate the expression and secretion of erythropoiesis.  In this study, we applied click chem. to the discovery of HIF prolyl hydroxylase 2 (HIF-PHD2) inhibitors for the first time, and a series of triazole compds. showed preferable inhibitory activity in fluorescence polarization assays.  Of particular note was the orally active HIF-PHD inhibitor 15i (IC50 = 62.23 nM), which was almost ten times more active than the phase III drug FG-4592 (IC50 = 591.4 nM).  Furthermore, it can upregulate the Hb of cisplatin-induced anemia mice (120 g/L) to normal levels (160 g/L) with no apparent toxicity obsd. in vivo.  These results confirm that triazole compd. 15i is a promising candidate for the treatment of renal anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt3rmHNKrVXbVg90H21EOLACvtfcHk0lhKE590mwCuaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzL&md5=11a4b00f8d9a883a387acb553510ba2a</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00549%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DClick%2520chemistry-based%2520discovery%2520of%2520%25283-Hydroxy-5-%25281H-1%252C2%252C3-triazol-4-yl%2529%2520picolinoyl%2529%2520glycines%2520as%2520orally%2520active%2520hypoxia-inducing%2520factor%2520prolyl%2520hydroxylase%2520inhibitors%2520with%2520favorable%2520safety%2520profiles%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D12%26spage%3D5332%26epage%3D5349%26doi%3D10.1021%2Facs.jmedchem.8b00549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debenham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(Bis(4-methoxyphenyl)methyl)-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11049</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01242</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01242" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11039-11049&issue=24&author=J.+S.+Debenhamauthor=C.+Madsen-Dugganauthor=M.+J.+Clementsauthor=T.+F.+Walshauthor=J.+T.+Kuetheauthor=M.+Reibarkhauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=R.+Hajduauthor=J.+A.+Milliganauthor=D.+M.+Viscoauthor=D.+Zhouauthor=R.+B.+Linghamauthor=D.+Stickensauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=J.+Pangauthor=R.+R.+Millerauthor=E.+C.+Shererauthor=J.+J.+Hale&title=Discovery+of+N-%28Bis%284-methoxyphenyl%29methyl%29-4-hydroxy-2-%28pyridazin-3-yl%29pyrimidine-5-carboxamide+%28MK-8617%29%2C+an+orally+active+pan-inhibitor+of+hypoxia-inducible+factor+prolyl+hydroxylase+1-3+%28HIF+PHD1-3%29+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.6b01242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Debenham, John S.; Madsen-Duggan, Christina; Clements, Matthew J.; Walsh, Thomas F.; Kuethe, Jeffrey T.; Reibarkh, Mikhail; Salowe, Scott P.; Sonatore, Lisa M.; Hajdu, Richard; Milligan, James A.; Visco, Denise M.; Zhou, Dan; Lingham, Russell B.; Stickens, Dominique; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Pang, Jianmei; Miller, Randy R.; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11049</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) are described.  These are potent, selective, orally bioavailable across several species and are active in stimulating erythropoiesis.  Mouse and rat studies showed hematol. changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration while 4 wk QD po administration in rat elevated Hb levels.  A major focus of the optimization process was to decrease the long half-life obsd. in higher species with early compds.  These efforts led to the identification of 28 (MK-8617) which has advanced to human clin. trials for anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs63u66yCX7Vg90H21EOLACvtfcHk0lhKE590mwCuaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN&md5=7acb236af3ca035b010a203f7234a5b7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01242%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DClements%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DStickens%26aufirst%3DD.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%2528Bis%25284-methoxyphenyl%2529methyl%2529-4-hydroxy-2-%2528pyridazin-3-yl%2529pyrimidine-5-carboxamide%2520%2528MK-8617%2529%252C%2520an%2520orally%2520active%2520pan-inhibitor%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201-3%2520%2528HIF%2520PHD1-3%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D24%26spage%3D11039%26epage%3D11049%26doi%3D10.1021%2Facs.jmedchem.6b01242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayscough, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livermore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkens, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, A. G.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolo-(1,5-a)pyridine HIF prolylhydroxylase domain-1 (PHD-1) inhibitors with a novel monodentate binding interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5663</span>– <span class="NLM_lpage">5672</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5663-5672&issue=13&author=S.+Ahmedauthor=A.+Ayscoughauthor=G.+R.+Barkerauthor=H.+E.+Canningauthor=R.+Davenportauthor=R.+Downhamauthor=D.+Harrisonauthor=K.+Jenkinsauthor=N.+Kinsellaauthor=D.+G.+Livermoreauthor=S.+Wrightauthor=A.+D.+Ivetacauthor=R.+Skeneauthor=S.+J.+Wilkensauthor=N.+A.+Websterauthor=A.+G.+Hendrick&title=1%2C2%2C4-Triazolo-%281%2C5-a%29pyridine+HIF+prolylhydroxylase+domain-1+%28PHD-1%29+inhibitors+with+a+novel+monodentate+binding+interaction&doi=10.1021%2Facs.jmedchem.7b00352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction</span></div><div class="casAuthors">Ahmed, Saleh; Ayscough, Andrew; Barker, Greg R.; Canning, Hannah E.; Davenport, Richard; Downham, Robert; Harrison, David; Jenkins, Kerry; Kinsella, Natasha; Livermore, David G.; Wright, Susanne; Ivetac, Anthony D.; Skene, Robert; Wilkens, Steven J.; Webster, Natalie A.; Hendrick, Alan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5663-5672</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein the authors describe the identification of 4-{[1,2,4]triazolo[1,5-a]pyridin-5-yl}benzonitrile-based inhibitors of the hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme.  These inhibitors were shown to possess a novel binding mode by x-ray crystallog., in which the triazolo N1 atom coordinates in a hitherto unreported monodentate interaction with the active site Fe2+ ion, while the benzonitrile group accepts a hydrogen-bonding interaction from the side chain residue of Asn 315.  Further optimization led to potent PHD-1 inhibitors with good physicochem. and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGothtARENldnbVg90H21EOLACvtfcHk0lhKE590mwCuaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSktb8%253D&md5=765c5e0aa28f0677327046029414656f</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00352%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DAyscough%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DG.%2BR.%26aulast%3DCanning%26aufirst%3DH.%2BE.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DK.%26aulast%3DKinsella%26aufirst%3DN.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DIvetac%26aufirst%3DA.%2BD.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DWilkens%26aufirst%3DS.%2BJ.%26aulast%3DWebster%26aufirst%3DN.%2BA.%26aulast%3DHendrick%26aufirst%3DA.%2BG.%26atitle%3D1%252C2%252C4-Triazolo-%25281%252C5-a%2529pyridine%2520HIF%2520prolylhydroxylase%2520domain-1%2520%2528PHD-1%2529%2520inhibitors%2520with%2520a%2520novel%2520monodentate%2520binding%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5663%26epage%3D5672%26doi%3D10.1021%2Facs.jmedchem.7b00352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Geyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mairbaeurl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoung, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollenhauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2009.09.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1053%2Fj.gastro.2009.09.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19818783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVCrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&pages=1143-1154&issue=3&author=M.+Schneiderauthor=K.+Van+Geyteauthor=P.+Fraislauthor=J.+Kissauthor=J.+Aragonesauthor=M.+Mazzoneauthor=H.+Mairbaeurlauthor=K.+De+Bockauthor=N.+H.+Jeoungauthor=M.+Mollenhauerauthor=M.+Georgiadouauthor=T.+Bishopauthor=C.+Roncalauthor=A.+Sutherlandauthor=B.+Jordanauthor=B.+Gallezauthor=J.+Weitzauthor=R.+A.+Harrisauthor=P.+Maxwellauthor=M.+Baesauthor=P.+Ratcliffeauthor=P.+Carmeliet&title=Loss+or+silencing+of+the+PHD1+prolyl+hydroxylase+protects+livers+of+mice+against+ischemia%2Freperfusion+injury&doi=10.1053%2Fj.gastro.2009.09.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury</span></div><div class="casAuthors">Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Kiss, Judit; Aragones, Julian; Mazzone, Massimiliano; Mairbaeurl, Heimo; De Bock, Katrien; Jeoung, Nam Ho; Mollenhauer, Martin; Georgiadou, Maria; Bishop, Tammie; Roncal, Carmen; Sutherland, Andrew; Jordan, Benedicte; Gallez, Bernard; Weitz, Juergen; Harris, Robert A.; Maxwell, Patrick; Baes, Myriam; Ratcliffe, Peter; Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1143-1154</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">BACKGROUND & AIMS: Liver ischemia/reperfusion (I/R) injury is a frequent cause of organ dysfunction.  Loss of the oxygen sensor prolyl hydroxylase domain enzyme 1 (PHD1) causes tolerance of skeletal muscle to hypoxia.  We assessed whether loss or short-term silencing of PHD1 could likewise induce hypoxia tolerance in hepatocytes and protect them against hepatic I/R damage.  METHODS: Hepatic ischemia was induced in mice by clamping of the portal vessels of the left lateral liver lobe; 90 min later livers were reperfused for 8 h for I/R expts.  Hepatocyte damage following ischemia or I/R was investigated in PHD1-deficient (PHD1-/-) and wild-type mice or following short hairpin RNA-mediated short-term inhibition of PHD1 in vivo.  RESULTS: PHD1-/- livers were largely protected against acute ischemia or I/R injury.  Among mice subjected to hepatic I/R followed by surgical resection of all nonischemic liver lobes, more than half of wild-type mice succumbed, whereas all PHD1-/- mice survived.  Also, short-term inhibition of PHD1 through RNA interference-mediated silencing provided protection against I/R.  Knockdown of PHD1 also induced hypoxia tolerance of hepatocytes in vitro.  Mechanistically, loss of PHD1 decreased prodn. of oxidative stress, which likely relates to a decrease in oxygen consumption as a result of a reprogramming of hepatocellular metab.  CONCLUSIONS: Loss of PHD1 provided tolerance of hepatocytes to acute hypoxia and protected them against I/R-damage.  Short-term inhibition of PHD1 is a novel therapeutic approach to reducing or preventing I/R-induced liver injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv8nMbbqAwK7Vg90H21EOLACvtfcHk0lh111EPcDbZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVCrtbk%253D&md5=1622d350695c7d592012a1d9f4d76196</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2009.09.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2009.09.057%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVan%2BGeyte%26aufirst%3DK.%26aulast%3DFraisl%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DJ.%26aulast%3DAragones%26aufirst%3DJ.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DMairbaeurl%26aufirst%3DH.%26aulast%3DDe%2BBock%26aufirst%3DK.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DMollenhauer%26aufirst%3DM.%26aulast%3DGeorgiadou%26aufirst%3DM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DRoncal%26aufirst%3DC.%26aulast%3DSutherland%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DGallez%26aufirst%3DB.%26aulast%3DWeitz%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DMaxwell%26aufirst%3DP.%26aulast%3DBaes%26aufirst%3DM.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DLoss%2520or%2520silencing%2520of%2520the%2520PHD1%2520prolyl%2520hydroxylase%2520protects%2520livers%2520of%2520mice%2520against%2520ischemia%252Freperfusion%2520injury%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26issue%3D3%26spage%3D1143%26epage%3D1154%26doi%3D10.1053%2Fj.gastro.2009.09.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majmundar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors and the response to hypoxic stress</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.molcel.2010.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20965423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=294-309&issue=2&author=A.+J.+Majmundarauthor=W.+J.+Wongauthor=M.+C.+Simon&title=Hypoxia-inducible+factors+and+the+response+to+hypoxic+stress&doi=10.1016%2Fj.molcel.2010.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-Inducible Factors and the Response to Hypoxic Stress</span></div><div class="casAuthors">Majmundar, Amar J.; Wong, Waihay J.; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">294-309</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxygen (O2) is an essential nutrient that serves as a key substrate in cellular metab. and bioenergetics.  In a variety of physiol. and pathol. states, organisms encounter insufficient O2 availability, or hypoxia.  In order to cope with this stress, evolutionarily conserved responses are engaged.  In mammals, the primary transcriptional response to hypoxic stress is mediated by the hypoxia-inducible factors (HIFs).  While canonically regulated by prolyl hydroxylase domain-contg. enzymes (PHDs), the HIFα subunits are intricately responsive to numerous other factors, including factor-inhibiting HIF1α (FIH1), sirtuins, and metabolites.  These transcription factors function in normal tissue homeostasis and impinge on crit. aspects of disease progression and recovery.  Insights from basic HIF biol. are being translated into pharmaceuticals targeting the HIF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_qlyQh52bprVg90H21EOLACvtfcHk0lh111EPcDbZZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr%252FN&md5=7b9aa81ba8c838c0a9251d79736c10b3</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DMajmundar%26aufirst%3DA.%2BJ.%26aulast%3DWong%26aufirst%3DW.%2BJ.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DHypoxia-inducible%2520factors%2520and%2520the%2520response%2520to%2520hypoxic%2520stress%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D40%26issue%3D2%26spage%3D294%26epage%3D309%26doi%3D10.1016%2Fj.molcel.2010.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koepp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowyra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreland, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iliopoulos, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, J. W.</span></span> <span> </span><span class="NLM_article-title">Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">5414</span>),  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1126/science.284.5414.657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.284.5414.657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10213691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1MXislyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=657-661&issue=5414&author=T.+Kamuraauthor=D.+M.+Koeppauthor=M.+N.+Conradauthor=D.+Skowyraauthor=R.+J.+Morelandauthor=O.+Iliopoulosauthor=W.+S.+Laneauthor=W.+G.+Kaelinauthor=S.+J.+Elledgeauthor=R.+C.+Conawayauthor=J.+W.+Harperauthor=J.+W.+Conaway&title=Rbx1%2C+a+component+of+the+VHL+tumor+suppressor+complex+and+SCF+ubiquitin+ligase&doi=10.1126%2Fscience.284.5414.657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase</span></div><div class="casAuthors">Kamura, T.; Koepp, D. M.; Conrad, M. N.; Skowyra, D.; Moreland, R. J.; Iliopoulos, O.; Lane, W. S.; Kaelin, W. G., Jr.; Elledge, S. J.; Conaway, R. C.; Harper, J. W.; Conaway, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">5414</span>),
    <span class="NLM_cas:pages">657-661</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The von Hippel-Lindau (VHL) tumor suppressor gene is mutated in most human kidney cancers.  The VHL protein is part of a complex that includes Elongin B, Elongin C, and Cullin-2, proteins assocd. with transcriptional Elongation and ubiquitination.  Here it is shown that the endogenous VHL complex in rat liver also includes Rbx1, an evolutionarily conserved protein that contains a RING-HZ fingerlike motif and that interacts with Cullins.  The yeast homolog of Rbx1 is a subunit and potent activator of the Cdc53-contg. SCFCdc4 ubiquitin ligase required for ubiquitination of the cyclin-dependent kinase inhibitor Sic1 and for the G1 to S cell cycle transition.  These findings provide a further link between VHL and the cellular ubiquitination machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HMCtDCdH9LVg90H21EOLACvtfcHk0lisAjvpm6EOjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislyrur8%253D&md5=e6db9e408fa978fb4bab8e93b8d1accc</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1126%2Fscience.284.5414.657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.284.5414.657%26sid%3Dliteratum%253Aachs%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DKoepp%26aufirst%3DD.%2BM.%26aulast%3DConrad%26aufirst%3DM.%2BN.%26aulast%3DSkowyra%26aufirst%3DD.%26aulast%3DMoreland%26aufirst%3DR.%2BJ.%26aulast%3DIliopoulos%26aufirst%3DO.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26atitle%3DRbx1%252C%2520a%2520component%2520of%2520the%2520VHL%2520tumor%2520suppressor%2520complex%2520and%2520SCF%2520ubiquitin%2520ligase%26jtitle%3DScience%26date%3D1999%26volume%3D284%26issue%3D5414%26spage%3D657%26epage%3D661%26doi%3D10.1126%2Fscience.284.5414.657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesener, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wykoff, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title">The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">271</span>, <span class="refDoi"> DOI: 10.1038/20459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2F20459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10353251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1MXjsFyqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=271&author=P.+H.+Maxwellauthor=M.+S.+Wiesenerauthor=G.-W.+Changauthor=S.+C.+Cliffordauthor=E.+C.+Vauxauthor=M.+E.+Cockmanauthor=C.+C.+Wykoffauthor=C.+W.+Pughauthor=E.+R.+Maherauthor=P.+J.+Ratcliffe&title=The+tumour+suppressor+protein+VHL+targets+hypoxia-inducible+factors+for+oxygen-dependent+proteolysis&doi=10.1038%2F20459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis</span></div><div class="casAuthors">Maxwell, Patrick H.; Wiesener, Michael S.; Chang, Gin-Wen; Clifford, Steven C.; Vaux, Emma C.; Cockman, Matthew E.; Wykoff, Charles C.; Pugh, Christopher W.; Maher, Eamonn R.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6733</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) has a key role in cellular responses to hypoxia, including the regulation of genes involved in energy metab., angiogenesis and apoptosis.  The α subunits of HIF are rapidly degraded by the proteasome under normal conditions, but are stabilized by hypoxia.  Cobaltous ions or iron chelators mimic hypoxia, indicating that the stimuli may interact through effects on a ferroprotein oxygen sensor.  Here the authors demonstrate a crit. role for the von Hippel-Lindau (VHL) tumor suppressor gene product pVHL in HIF-1 regulation.  In VHL-defective cells, HIF α-subunits are constitutively stabilized and HIF-1 is activated.  Re-expression of pVHL restored oxygen-dependent instability.  PVHL and HIF α-subunits co-immunoppt., and pVHL is present in the hypoxic HIF-1 DNA-binding complex.  In cells exposed to iron chelation or cobaltous ions, HIF-1 is dissocd. from pVHL.  These findings indicate that the interaction between HIF-1 and pVHL is iron dependent, and that it is necessary for the oxygen-dependent degrdn. of HIF α-subunits.  Thus, constitutive HIF-1 activation may underlie the angiogenic phenotype of VHL-assocd. tumors.  The pVHL/HIF-1 interaction provides a new focus for understanding cellular oxygen sensing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk9Nt-50qJOrVg90H21EOLACvtfcHk0lisAjvpm6EOjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsFyqt74%253D&md5=10a50baefa94ba2bba0f97576f96197b</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2F20459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F20459%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DWiesener%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DG.-W.%26aulast%3DClifford%26aufirst%3DS.%2BC.%26aulast%3DVaux%26aufirst%3DE.%2BC.%26aulast%3DCockman%26aufirst%3DM.%2BE.%26aulast%3DWykoff%26aufirst%3DC.%2BC.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DMaher%26aufirst%3DE.%2BR.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520tumour%2520suppressor%2520protein%2520VHL%2520targets%2520hypoxia-inducible%2520factors%2520for%2520oxygen-dependent%2520proteolysis%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D271%26doi%3D10.1038%2F20459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brahimi-Horn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span> <span> </span><span class="NLM_article-title">Harnessing the hypoxia-inducible factor in cancer and ischemic disease</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2006.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bcp.2006.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17101119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Slsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=450-457&issue=3&author=M.+C.+Brahimi-Hornauthor=J.+Pouyssegur&title=Harnessing+the+hypoxia-inducible+factor+in+cancer+and+ischemic+disease&doi=10.1016%2Fj.bcp.2006.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the hypoxia-inducible factor in cancer and ischemic disease</span></div><div class="casAuthors">Brahimi-Horn, M. Christiane; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-457</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The α/β-heterodimeric transcription factor hypoxia-inducible factor (HIF) functions when the oxygen level in tissues is low, i.e. when the tissue microenvironment becomes hypoxic, and is non-functional when the level of oxygen is high.  Certain pathophysiol. conditions such as ischemic disorders and cancer encounter low levels of local tissue oxygenation due to a defective or insufficient vasculature.  Highly proliferating tumor cells rapidly form into a mass that becomes located too far from the vasculature to be nourished and oxygenated.  Under such conditions HIF activates or represses a vast array of genes that in particular, initiate the formation of new blood vessels and modify metab.  In this way the tumor mass re-establishes conditions favorable for further proliferation.  Interest is being expressed in the direct repression or stimulation of HIF activity, resp., in the treatment of cancer and of ischemic disorders.  The modulation of other HIF-target genes implicated, in particular, in tumor metab. and intracellular pH control may also prove to be useful in cancer therapy.  However, before going further a better understanding of the basics of the HIF signalling pathway is essential.  This review will introduce the reader to the mol. mechanisms that regulate HIF and some of the biol. consequences of its action, in particular in tumor metab., growth and invasion.  Approaches to either enforce tumor regression or increase blood vessel formation through the targeting of HIF or its downstream effectors will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXvhp8EEj_VLVg90H21EOLACvtfcHk0lisAjvpm6EOjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Slsw%253D%253D&md5=d54730d638d42e47c9087a630c1c9900</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi-Horn%26aufirst%3DM.%2BC.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DHarnessing%2520the%2520hypoxia-inducible%2520factor%2520in%2520cancer%2520and%2520ischemic%2520disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26issue%3D3%26spage%3D450%26epage%3D457%26doi%3D10.1016%2Fj.bcp.2006.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bicknell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span> <span> </span><span class="NLM_article-title">Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">10423</span>– <span class="NLM_lpage">10428</span>, <span class="refDoi"> DOI: 10.1073/pnas.162119399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.162119399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12149454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1Ciu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10423-10428&issue=16&author=C.+Willamauthor=N.+Massonauthor=Y.+M.+Tianauthor=S.+A.+Mahmoodauthor=M.+I.+Wilsonauthor=R.+Bicknellauthor=K.+U.+Eckardtauthor=P.+H.+Maxwellauthor=P.+J.+Ratcliffeauthor=C.+W.+Pugh&title=Peptide+blockade+of+HIFalpha+degradation+modulates+cellular+metabolism+and+angiogenesis&doi=10.1073%2Fpnas.162119399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis</span></div><div class="casAuthors">Willam, Carsten; Masson, Norma; Tian, Ya-Min; Mahmood, S. Aleema; Wilson, Michael I.; Bicknell, Roy; Eckardt, Kai-Uwe; Maxwell, Patrick H.; Ratcliffe, Peter J.; Pugh, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10423-10428</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF) is a transcription factor central to oxygen homeostasis.  It is regulated via its α isoforms.  In normoxia they are ubiquitinated by the von Hippel-Lindau E3 ligase complex and destroyed by the proteasome, thereby preventing the formation of an active transcriptional complex.  Oxygen-dependent enzymic hydroxylation of either of two crit. prolyl residues in each HIFα chain has recently been identified as the modification necessary for targeting by the von Hippel-Lindau E3 ligase complex.  Here we demonstrate that polypeptides bearing either of these prolyl residues interfere with the degradative pathway, resulting in stabilization of endogenous HIFα chains and consequent up-regulation of HIF target genes.  Similar peptides in which the prolyl residues are mutated are inactive.  Induction of peptide expression in cell cultures affects physiol. important functions such as glucose transport and leads cocultured endothelial cells to form tubules.  Coupling of these HIFα sequences to the HIV tat translocation domain allows delivery of recombinant peptide to cells with resultant induction of HIF-dependent genes.  Injection of tat-HIF polypeptides in a murine sponge angiogenesis assay causes a markedly accelerated local angiogenic response and induction of glucose transporter-1 gene expression.  These results demonstrate the feasibility of using these polypeptides to enhance HIF activity, opening addnl. therapeutic avenues for ischemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPVZbRexSyUrVg90H21EOLACvtfcHk0lisAjvpm6EOjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1Ciu7k%253D&md5=1933d3cc099645c5ca3dd5e09a2819a0</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1073%2Fpnas.162119399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.162119399%26sid%3Dliteratum%253Aachs%26aulast%3DWillam%26aufirst%3DC.%26aulast%3DMasson%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DMahmood%26aufirst%3DS.%2BA.%26aulast%3DWilson%26aufirst%3DM.%2BI.%26aulast%3DBicknell%26aufirst%3DR.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26atitle%3DPeptide%2520blockade%2520of%2520HIFalpha%2520degradation%2520modulates%2520cellular%2520metabolism%2520and%2520angiogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D16%26spage%3D10423%26epage%3D10428%26doi%3D10.1073%2Fpnas.162119399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loenarz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for a stereoelectronic effect in human oxygen sensing</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1784</span>– <span class="NLM_lpage">1787</span>, <span class="refDoi"> DOI: 10.1002/anie.200805427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fanie.200805427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Ojt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1784-1787&issue=10&author=C.+Loenarzauthor=J.+Mecinovicauthor=R.+Chowdhuryauthor=L.+A.+McNeillauthor=E.+Flashmanauthor=C.+J.+Schofield&title=Evidence+for+a+stereoelectronic+effect+in+human+oxygen+sensing&doi=10.1002%2Fanie.200805427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a stereoelectronic effect in human oxygen sensing</span></div><div class="casAuthors">Loenarz, Christoph; Mecinovic, Jasmin; Chowdhury, Rasheduzzaman; McNeill, Luke A.; Flashman, Emily; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1784-1787</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">How PHDs achieve specificity: trans-4-prolyl hydroxylation of the transcription factor HIF occurs with stereochem. retention.  Substrate-analog studies show how the von Hippel Lindau tumor suppressor protein (pVHL) and the oxygen-sensing hydroxylases (PHDs) achieve specificity for hydroxyprolyl/prolyl residues for the C4-exo/endo prolyl conformations, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzHXp367U3mLVg90H21EOLACvtfcHk0ljZxfapdYIifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Ojt7Y%253D&md5=3365a4a6c8ebbf7abc5e90df2cf82086</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805427%26sid%3Dliteratum%253Aachs%26aulast%3DLoenarz%26aufirst%3DC.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520stereoelectronic%2520effect%2520in%2520human%2520oxygen%2520sensing%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D10%26spage%3D1784%26epage%3D1787%26doi%3D10.1002%2Fanie.200805427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Efficient drug lead discovery and optimization</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1021/ar800236t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar800236t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFentr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=724-733&issue=6&author=W.+L.+Jorgensen&title=Efficient+drug+lead+discovery+and+optimization&doi=10.1021%2Far800236t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Drug Lead Discovery and Optimization</span></div><div class="casAuthors">Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">724-733</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  During the 1980s, advances in the abilities to perform computer simulations of chem. and biomol. systems and to calc. free energy changes led to the expectation that such methodol. would soon show great utility for guiding mol. design.  Important potential applications included design of selective receptors, catalysts, and regulators of biol. function including enzyme inhibitors.  This time also saw the rise of high-throughput screening and combinatorial chem. along with complementary computational methods for de novo design and virtual screening including docking.  These technologies appeared poised to deliver diverse lead compds. for any biol. target.  As with many technol. advances, realization of the expectations required significant addnl. effort and time.  However, as summarized here, striking success has now been achieved for computer-aided drug lead generation and optimization.  De novo design using both mol. growing and docking are illustrated for lead generation, and lead optimization features free energy perturbation calcns. in conjunction with Monte Carlo statistical mechanics simulations for protein-inhibitor complexes in aq. soln.  The specific applications are to the discovery of non-nucleoside inhibitors of HIV reverse transcriptase (HIV-RT) and inhibitors of the binding of the proinflammatory cytokine MIF to its receptor CD74.  A std. protocol is presented that includes scans for possible addns. of small substituents to a mol. core, interchange of heterocycles, and focused optimization of substituents at one site.  Initial leads with activities at low-micromolar concns. have been advanced rapidly to low-nanomolar inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn0YpWuo1jCLVg90H21EOLACvtfcHk0ljZxfapdYIifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFentr4%253D&md5=9641587769701c6541b38e18fa05538a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Far800236t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far800236t%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEfficient%2520drug%2520lead%2520discovery%2520and%2520optimization%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2009%26volume%3D42%26issue%3D6%26spage%3D724%26epage%3D733%26doi%3D10.1021%2Far800236t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noblin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Targeting the von hippel-lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4465</span>– <span class="NLM_lpage">4468</span>, <span class="refDoi"> DOI: 10.1021/ja209924v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja209924v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=4465-4468&issue=10&author=D.+L.+Buckleyauthor=I.+Van+Molleauthor=P.+C.+Gareissauthor=H.+S.+Taeauthor=J.+Michelauthor=D.+J.+Noblinauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Targeting+the+von+hippel-lindau+E3+ubiquitin+ligase+using+small+molecules+to+disrupt+the+VHL%2FHIF-1%CE%B1+interaction&doi=10.1021%2Fja209924v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction</span></div><div class="casAuthors">Buckley, Dennis L.; Van Molle, Inge; Gareiss, Peter C.; Tae, Hyun Seop; Michel, Julien; Noblin, Devin J.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4465-4468</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases, which bind protein targets, leading to their ubiquitination and subsequent degrdn., are attractive drug targets due to their exquisite substrate specificity.  However, the development of small-mol. inhibitors has proven extraordinarily challenging as modulation of E3 ligase activities requires the targeting of protein-protein interactions.  Using rational design, we have generated the first small mol. targeting the von Hippel-Lindau protein (VHL), the substrate recognition subunit of an E3 ligase, and an important target in cancer, chronic anemia, and ischemia.  We have also obtained the crystal structure of VHL bound to our most potent inhibitor, confirming that the compd. mimics the binding mode of the transcription factor HIF-1α, a substrate of VHL.  These results have the potential to guide future development of improved lead compds. as therapeutics for the treatment of chronic anemia and ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolmBVM_mfWzrVg90H21EOLACvtfcHk0ljZxfapdYIifQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D&md5=60f7384b6bc932c9828dc12999283a1e</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fja209924v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja209924v%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DMichel%26aufirst%3DJ.%26aulast%3DNoblin%26aufirst%3DD.%2BJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeting%2520the%2520von%2520hippel-lindau%2520E3%2520ubiquitin%2520ligase%2520using%2520small%2520molecules%2520to%2520disrupt%2520the%2520VHL%252FHIF-1%25CE%25B1%2520interaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D10%26spage%3D4465%26epage%3D4468%26doi%3D10.1021%2Fja209924v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1alpha protein-protein interface</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.chembiol.2012.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23102223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2hsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1300-1312&issue=10&author=I.+Van+Molleauthor=A.+Thomannauthor=D.+L.+Buckleyauthor=E.+C.+Soauthor=S.+Langauthor=C.+M.+Crewsauthor=A.+Ciulli&title=Dissecting+fragment-based+lead+discovery+at+the+von+Hippel-Lindau+protein%3Ahypoxia+inducible+factor+1alpha+protein-protein+interface&doi=10.1016%2Fj.chembiol.2012.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface</span></div><div class="casAuthors">Van Molle, Inge; Thomann, Andreas; Buckley, Dennis L.; So, Ernest C.; Lang, Steffen; Crews, Craig M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1300-1312</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fragment screening is widely used to identify attractive starting points for drug design.  However, its potential and limitations to assess the tractability of often challenging protein:protein interfaces have been underexplored.  Here, we address this question by means of a systematic deconstruction of lead-like inhibitors of the pVHL:HIF-1α interaction into their component fragments.  Using biophys. techniques commonly employed for screening, we could only detect binding of fragments that violate the Rule of Three, are more complex than those typically screened against classical druggable targets, and occupy two adjacent binding subsites at the interface rather than just one.  Analyses based on ligand and group lipophilicity efficiency of anchored fragments were applied to dissect the individual subsites and probe for binding hot spots.  The implications of our findings for targeting protein interfaces by fragment-based approaches are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRRhzUJQp0HrVg90H21EOLACvtfcHk0lgZygy2rSWgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2hsb3P&md5=b126164f72aa2fcdc3e9da2196aba442</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DThomann%26aufirst%3DA.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DSo%26aufirst%3DE.%2BC.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DDissecting%2520fragment-based%2520lead%2520discovery%2520at%2520the%2520von%2520Hippel-Lindau%2520protein%253Ahypoxia%2520inducible%2520factor%25201alpha%2520protein-protein%2520interface%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D10%26spage%3D1300%26epage%3D1312%26doi%3D10.1016%2Fj.chembiol.2012.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the interaction between the E3 Ligase VHL and HIF1α</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">11463</span>– <span class="NLM_lpage">11467</span>, <span class="refDoi"> DOI: 10.1002/anie.201206231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fanie.201206231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=11463-11467&issue=46&author=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=I.+Van+Molleauthor=A.+G.+Rothauthor=H.+S.+Taeauthor=P.+C.+Gareissauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Small-molecule+inhibitors+of+the+interaction+between+the+E3+Ligase+VHL+and+HIF1%CE%B1&doi=10.1002%2Fanie.201206231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α</span></div><div class="casAuthors">Buckley, Dennis L.; Gustafson, Jeffrey L.; Van Molle, Inge; Roth, Anke G.; Tae, Hyun Seop; Gareiss, Peter C.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">11463-11467</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This study reports the structure-based design and synthesis of novel VHL ligands, illustrating structure-activity relationships and improving potency.  Two fragments of the ligands were individually optimized, arriving at a new class of N-terminal benzamide fragments.  The interactions made by this new class were then elucidated through X-ray crystallog. of the protein-ligand complex.  Structural studies of this ligand class revealed both a new binding mode as well as a novel water-mediated' hydrogen bond.  Finally, using these optimized fragments, we assembled new VHL ligands in a combinatorial fashion, arriving at (I), the first small-mol. submicromolar inhibitor of the interaction between VHL and a peptide derived from HIF1α.  While no cell-based activity has yet been obsd.,we hope to take advantage of the interactions highlighted by the crystal structure of I to design more drug-like inhibitors of VHL with improved cell permeability.  These ligands and the novel interactions and binding modes highlighted have the potential to guide the development of future chem. probes that can target the E3 ligase VHL or stabilize HIF1α proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0HINAsXwwLVg90H21EOLACvtfcHk0lgZygy2rSWgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL&md5=eefeb63a3491737738e94c00be083cfd</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1002%2Fanie.201206231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201206231%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520interaction%2520between%2520the%2520E3%2520Ligase%2520VHL%2520and%2520HIF1%25CE%25B1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26issue%3D46%26spage%3D11463%26epage%3D11467%26doi%3D10.1002%2Fanie.201206231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaffidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birced, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel-Lindau (VHL) E3 ubiquitin ligase and the hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8657</span>– <span class="NLM_lpage">8663</span>, <span class="refDoi"> DOI: 10.1021/jm5011258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5011258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGhtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8657-8663&issue=20&author=C.+Galdeanoauthor=M.+S.+Gaddauthor=P.+Soaresauthor=S.+Scaffidiauthor=I.+Van+Molleauthor=I.+Bircedauthor=S.+Hewittauthor=D.+M.+Diasauthor=A.+Ciulli&title=Structure-guided+design+and+optimization+of+small+molecules+targeting+the+protein-protein+interaction+between+the+von+Hippel-Lindau+%28VHL%29+E3+ubiquitin+ligase+and+the+hypoxia+inducible+factor+%28HIF%29+alpha+subunit+with+in+vitro+nanomolar+affinities&doi=10.1021%2Fjm5011258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design and Optimization of Small Molecules Targeting the Protein-Protein Interaction between the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities</span></div><div class="casAuthors">Galdeano, Carles; Gadd, Morgan S.; Soares, Pedro; Scaffidi, Salvatore; Van Molle, Inge; Birced, Ipek; Hewitt, Sarah; Dias, David M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8657-8663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are attractive targets in the ubiquitin-proteasome system, however, the development of small-mol. ligands has been rewarded with limited success.  The von Hippel-Lindau protein (pVHL) is the substrate recognition subunit of the VHL E3 ligase that targets HIF-1α for degrdn.  The authors recently reported inhibitors of the pVHL:HIF-1α interaction, however they exhibited moderate potency.  Herein, the authors report the design and optimization, guided by x-ray crystal structures, of a ligand series with nanomolar binding affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpixK3qp1ctJrVg90H21EOLACvtfcHk0lgZygy2rSWgNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGhtb%252FP&md5=831aa2387d94cb03d735a4be7bdd2cdd</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm5011258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5011258%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DScaffidi%26aufirst%3DS.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DBirced%26aufirst%3DI.%26aulast%3DHewitt%26aufirst%3DS.%26aulast%3DDias%26aufirst%3DD.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DStructure-guided%2520design%2520and%2520optimization%2520of%2520small%2520molecules%2520targeting%2520the%2520protein-protein%2520interaction%2520between%2520the%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520E3%2520ubiquitin%2520ligase%2520and%2520the%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529%2520alpha%2520subunit%2520with%2520in%2520vitro%2520nanomolar%2520affinities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8657%26epage%3D8663%26doi%3D10.1021%2Fjm5011258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzes, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epemolu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantrell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13312</span>, <span class="refDoi"> DOI: 10.1038/ncomms13312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fncomms13312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27811928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSitLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13312&author=J.+Frostauthor=C.+Galdeanoauthor=P.+Soaresauthor=M.+S.+Gaddauthor=K.+M.+Grzesauthor=L.+Ellisauthor=O.+Epemoluauthor=S.+Shimamuraauthor=M.+Bantscheffauthor=P.+Grandiauthor=K.+D.+Readauthor=D.+A.+Cantrellauthor=S.+Rochaauthor=A.+Ciulli&title=Potent+and+selective+chemical+probe+of+hypoxic+signalling+downstream+of+HIF-alpha+hydroxylation+via+VHL+inhibition&doi=10.1038%2Fncomms13312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition</span></div><div class="casAuthors">Frost, Julianty; Galdeano, Carles; Soares, Pedro; Gadd, Morgan S.; Grzes, Katarzyna M.; Ellis, Lucy; Epemolu, Ola; Shimamura, Satoko; Bantscheff, Marcus; Grandi, Paola; Read, Kevin D.; Cantrell, Doreen A.; Rocha, Sonia; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13312</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. strategies to using small mols. to stimulate hypoxia inducible factors (HIFs) activity and trigger a hypoxic response under normoxic conditions, such as iron chelators and inhibitors of prolyl hydroxylase domain (PHD) enzymes, have broad-spectrum activities and off-target effects.  Here we disclose VH298, a potent VHL inhibitor that stabilizes HIF-α and elicits a hypoxic response via a different mechanism, that is the blockade of the VHL:HIF-α protein-protein interaction downstream of HIF-α hydroxylation by PHD enzymes.  We show that VH298 engages with high affinity and specificity with VHL as its only major cellular target, leading to selective on-target accumulation of hydroxylated HIF-α in a concn.- and time-dependent fashion in different cell lines, with subsequent upregulation of HIF-target genes at both mRNA and protein levels.  VH298 represents a high-quality chem. probe of the HIF signalling cascade and an attractive starting point to the development of potential new therapeutics targeting hypoxia signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLB1WvVF4EFLVg90H21EOLACvtfcHk0liLCIg3WfeCng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSitLfJ&md5=7a884b6193b3ca5e119fecea2eb31d3e</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1038%2Fncomms13312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13312%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DGrzes%26aufirst%3DK.%2BM.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DEpemolu%26aufirst%3DO.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DCantrell%26aufirst%3DD.%2BA.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DPotent%2520and%2520selective%2520chemical%2520probe%2520of%2520hypoxic%2520signalling%2520downstream%2520of%2520HIF-alpha%2520hydroxylation%2520via%2520VHL%2520inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13312%26doi%3D10.1038%2Fncomms13312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epemolu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Group-based optimization of potent and cell-active inhibitors of the von Hippel-Lindau (VHL) E3 ubiquitin ligase: structure-activity relationships leading to the chemical probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00675</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00675" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWms77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=599-618&issue=2&author=P.+Soaresauthor=M.+S.+Gaddauthor=J.+Frostauthor=C.+Galdeanoauthor=L.+Ellisauthor=O.+Epemoluauthor=S.+Rochaauthor=K.+D.+Readauthor=A.+Ciulli&title=Group-based+optimization+of+potent+and+cell-active+inhibitors+of+the+von+Hippel-Lindau+%28VHL%29+E3+ubiquitin+ligase%3A+structure-activity+relationships+leading+to+the+chemical+probe+%282S%2C4R%29-1-%28%28S%29-2-%281-Cyanocyclopropanecarboxamido%29-3%2C3-dimethylbutanoyl%29-4-hydroxy-N-%284-%284-methylthiazol-5-yl%29benzyl%29pyrrolidine-2-carboxamide+%28VH298%29&doi=10.1021%2Facs.jmedchem.7b00675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)</span></div><div class="casAuthors">Soares, Pedro; Gadd, Morgan S.; Frost, Julianty; Galdeano, Carles; Ellis, Lucy; Epemolu, Ola; Rocha, Sonia; Read, Kevin D.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">599-618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The von Hippel-Lindau tumor suppressor protein is the substrate binding subunit of the VHL E3 ubiquitin ligase, which targets hydroxylated α subunit of hypoxia inducible factors (HIFs) for ubiquitination and subsequent proteasomal degrdn.  VHL is a potential target for treating anemia and ischemic diseases, motivating the development of inhibitors of the VHL:HIF-α protein-protein interaction.  Addnl., bifunctional proteolysis targeting chimeras (PROTACs) contg. a VHL ligand can hijack the E3 ligase activity to induce degrdn. of target proteins.  We report the structure-guided design and group-based optimization of a series of VHL inhibitors with low nanomolar potencies and improved cellular permeability.  Structure-activity relationships led to the discovery of potent inhibitors 10 and chem. probe VH298, with dissocn. consts. <100 nM, which induced marked HIF-1α intracellular stabilization.  Our study provides new chem. tools to probe the VHL-HIF pathways and new VHL ligands for next-generation PROTACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQfJe2l2WgX7Vg90H21EOLACvtfcHk0liLCIg3WfeCng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWms77P&md5=1c1e7c976c2de9a9681773ff216fdfd7</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00675%26sid%3Dliteratum%253Aachs%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DFrost%26aufirst%3DJ.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DEpemolu%26aufirst%3DO.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DGroup-based%2520optimization%2520of%2520potent%2520and%2520cell-active%2520inhibitors%2520of%2520the%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520E3%2520ubiquitin%2520ligase%253A%2520structure-activity%2520relationships%2520leading%2520to%2520the%2520chemical%2520probe%2520%25282S%252C4R%2529-1-%2528%2528S%2529-2-%25281-Cyanocyclopropanecarboxamido%2529-3%252C3-dimethylbutanoyl%2529-4-hydroxy-N-%25284-%25284-methylthiazol-5-yl%2529benzyl%2529pyrrolidine-2-carboxamide%2520%2528VH298%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D2%26spage%3D599%26epage%3D618%26doi%3D10.1021%2Facs.jmedchem.7b00675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Surface probing by fragment-based screening and computational methods identifies ligandable pockets on the von Hippel-Lindau (VHL) E3 ubiquitin ligase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7387</span>– <span class="NLM_lpage">7393</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00842</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00842" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyktLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7387-7393&issue=16&author=X.+Lucasauthor=I.+Van+Molleauthor=A.+Ciulli&title=Surface+probing+by+fragment-based+screening+and+computational+methods+identifies+ligandable+pockets+on+the+von+Hippel-Lindau+%28VHL%29+E3+ubiquitin+ligase&doi=10.1021%2Facs.jmedchem.8b00842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Surface Probing by Fragment-Based Screening and Computational Methods Identifies Ligandable Pockets on the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase</span></div><div class="casAuthors">Lucas, Xavier; Van Molle, Inge; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7387-7393</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Beyond the targeting of E3 ubiquitin ligases to inhibit protein homeostasis, E3 ligase binders can be repurposed as targeted protein degraders (PROTACs or mol. glues).  The authors sought to identify new binders of the VHL E3 ligase by biophys. fragment-based screening followed by x-ray crystallog. soaking.  The authors identified fragments binding at the Elongin C:Cullin 2 interface and a new cryptic pocket in VHL, along with other potential ligandable sites predicted computationally and found to bind solvent mols. in crystal structures.  The elucidated interactions provide starting points for future ligand development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZdhy5IVXNgrVg90H21EOLACvtfcHk0ljWggYGva6Yzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyktLbE&md5=c081e7cf26807f59e646a60a0ec74361</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00842%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSurface%2520probing%2520by%2520fragment-based%2520screening%2520and%2520computational%2520methods%2520identifies%2520ligandable%2520pockets%2520on%2520the%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520E3%2520ubiquitin%2520ligase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D7387%26epage%3D7393%26doi%3D10.1021%2Facs.jmedchem.8b00842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zengerle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Structural basis of PROTAC cooperative recognition for selective protein degradation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnchembio.2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28288108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFahtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=514-521&issue=5&author=M.+S.+Gaddauthor=A.+Testaauthor=X.+Lucasauthor=K.+H.+Chanauthor=W.+Chenauthor=D.+J.+Lamontauthor=M.+Zengerleauthor=A.+Ciulli&title=Structural+basis+of+PROTAC+cooperative+recognition+for+selective+protein+degradation&doi=10.1038%2Fnchembio.2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of PROTAC cooperative recognition for selective protein degradation</span></div><div class="casAuthors">Gadd, Morgan S.; Testa, Andrea; Lucas, Xavier; Chan, Kwok-Ho; Chen, Wenzhang; Lamont, Douglas J.; Zengerle, Michael; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">514-521</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inducing macromol. interactions with small mols. to activate cellular signaling is a challenging goal.  PROTACs (proteolysis-targeting chimeras) are bifunctional mols. that recruit a target protein in proximity to an E3 ubiquitin ligase to trigger protein degrdn.  Structural elucidation of the key ternary ligase-PROTAC-target species and its impact on target degrdn. selectivity remain elusive.  Here, we solved the crystal structure of Brd4 degrader MZ1 in complex with human VHL and the Brd4 bromodomain (Brd4BD2).  The ligand folds into itself to allow formation of specific intermol. interactions in the ternary complex.  Isothermal titrn. calorimetry studies, supported by surface mutagenesis and proximity assays, were consistent with pronounced cooperative formation of ternary complexes with Brd4BD2.  Structure-based-designed compd. AT1 exhibited highly selective depletion of Brd4 in cells.  These results elucidate how PROTAC-induced de novo contacts dictate preferential recruitment of a target protein into a stable and cooperative complex with an E3 ligase for selective degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJri00jB5YJLVg90H21EOLACvtfcHk0ljWggYGva6Yzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFahtbg%253D&md5=dfee13913106d362d0972d7b1a62d700</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2329%26sid%3Dliteratum%253Aachs%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DTesta%26aufirst%3DA.%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLamont%26aufirst%3DD.%2BJ.%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520PROTAC%2520cooperative%2520recognition%2520for%2520selective%2520protein%2520degradation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26issue%3D5%26spage%3D514%26epage%3D521%26doi%3D10.1038%2Fnchembio.2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maniaci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">830</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00954-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fs41467-017-00954-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29018234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252Fptlaiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=830&author=C.+Maniaciauthor=S.+J.+Hughesauthor=A.+Testaauthor=W.+Chenauthor=D.+J.+Lamontauthor=S.+Rochaauthor=D.+R.+Alessiauthor=R.+Romeoauthor=A.+Ciulli&title=Homo-PROTACs%3A+bivalent+small-molecule+dimerizers+of+the+VHL+E3+ubiquitin+ligase+to+induce+self-degradation&doi=10.1038%2Fs41467-017-00954-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation</span></div><div class="casAuthors">Maniaci Chiara; Hughes Scott J; Testa Andrea; Chen Wenzhang; Lamont Douglas J; Ciulli Alessio; Maniaci Chiara; Alessi Dario R; Rocha Sonia; Romeo Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">830</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">E3 ubiquitin ligases are key enzymes within the ubiquitin proteasome system which catalyze the ubiquitination of proteins, targeting them for proteasomal degradation.  E3 ligases are gaining importance as targets to small molecules, both for direct inhibition and to be hijacked to induce the degradation of non-native neo-substrates using bivalent compounds known as PROTACs (for 'proteolysis-targeting chimeras').  We describe Homo-PROTACs as an approach to dimerize an E3 ligase to trigger its suicide-type chemical knockdown inside cells.  We provide proof-of-concept of Homo-PROTACs using diverse molecules composed of two instances of a ligand for the von Hippel-Lindau (VHL) E3 ligase.  The most active compound, CM11, dimerizes VHL with high avidity in vitro and induces potent, rapid and proteasome-dependent self-degradation of VHL in different cell lines, in a highly isoform-selective fashion and without triggering a hypoxic response.  This approach offers a novel chemical probe for selective VHL knockdown, and demonstrates the potential for a new modality of chemical intervention on E3 ligases.Targeting the ubiquitin proteasome system to modulate protein homeostasis using small molecules has promising therapeutic potential.  Here the authors describe Homo-PROTACS: small molecules that can induce the homo-dimerization of E3 ubiquitin ligases and cause their proteasome-dependent degradation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVJKELZUTFBpPq5LRczm8ffW6udTcc2eYfrrLeiF-66bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252Fptlaiuw%253D%253D&md5=0ed79d9ff14eb7b6132a152f0413c4ef</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00954-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00954-1%26sid%3Dliteratum%253Aachs%26aulast%3DManiaci%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DTesta%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLamont%26aufirst%3DD.%2BJ.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DRomeo%26aufirst%3DR.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DHomo-PROTACs%253A%2520bivalent%2520small-molecule%2520dimerizers%2520of%2520the%2520VHL%2520E3%2520ubiquitin%2520ligase%2520to%2520induce%2520self-degradation%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D830%26doi%3D10.1038%2Fs41467-017-00954-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hangasky, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. J.</span></span> <span> </span><span class="NLM_article-title">The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O<sub>2</sub> activation</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2016.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.jinorgbio.2016.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27815979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2017&pages=26-33&author=J.+A.+Hangaskyauthor=C.+Y.+Taabazuingauthor=C.+B.+Martinauthor=S.+J.+Eronauthor=M.+J.+Knapp&title=The+facial+triad+in+the+%CE%B1-ketoglutarate+dependent+oxygenase+FIH%3A+A+role+for+sterics+in+linking+substrate+binding+to+O2+activation&doi=10.1016%2Fj.jinorgbio.2016.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O2 activation</span></div><div class="casAuthors">Hangasky, John A.; Taabazuing, Cornelius Y.; Martin, Cristina B.; Eron, Scott J.; Knapp, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-33</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The factor inhibiting hypoxia inducible factor-1α (FIH) is a nonheme Fe(II)/αKG oxygenase using a 2-His-1-Asp facial triad.  FIH activates O2 via oxidative decarboxylation of α-ketoglutarate (αKG) to generate an enzyme-based oxidant which hydroxylates the Asn803 residue within the C-terminal transactivation domain (CTAD) of HIF-1α.  Tight coupling of these two sequential reactions requires a structural linkage between the Fe(II) and the substrate binding site to ensure that O2 activation occurs after substrate binds.  We tested the hypothesis that the facial triad carboxylate (Asp201) of FIH linked substrate binding and O2 binding sites.  Asp201 variants of FIH were constructed and thoroughly characterized in vitro using steady-state kinetics, crystallog., autohydroxylation, and coupling measurements.  Our studies revealed each variant activated O2 with a catalytic efficiency similar to that of wild-type (WT) FIH (kcataKM(O2) = 0.17 μM- 1min- 1), but led to defects in the coupling of O2 activation to substrate hydroxylation.  Steady-state kinetics showed similar catalytic efficiencies for hydroxylation by WT-FIH (kcat/KM(CTAD) = 0.42 μM- 1 min- 1) and D201G (kcat/KM(CTAD) = 0.34 μM- 1 min- 1); hydroxylation by D201E was greatly impaired, while hydroxylation by D201A was undetectable.  Anal. of the crystal structure of the D201E variant revealed steric crowding near the diffusible ligand site supporting a role for sterics from the facial triad carboxylate in the O2 binding order.  Our data support a model in which the facial triad carboxylate Asp201 provides both steric and polar contacts to favor O2 access to the Fe(II) only after substrate binds, leading to coupled turnover in FIH and other αKG oxygenases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRQ-vyH2GGbVg90H21EOLACvtfcHk0ljWggYGva6Yzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKksLrO&md5=6fef6dd964120cf683b98dcdfe97814b</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2016.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DHangasky%26aufirst%3DJ.%2BA.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DMartin%26aufirst%3DC.%2BB.%26aulast%3DEron%26aufirst%3DS.%2BJ.%26aulast%3DKnapp%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520facial%2520triad%2520in%2520the%2520%25CE%25B1-ketoglutarate%2520dependent%2520oxygenase%2520FIH%253A%2520A%2520role%2520for%2520sterics%2520in%2520linking%2520substrate%2520binding%2520to%2520O2%2520activation%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D166%26spage%3D26%26epage%3D33%26doi%3D10.1016%2Fj.jinorgbio.2016.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dann, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deisenhofer, J.</span></span> <span> </span><span class="NLM_article-title">Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">15351</span>– <span class="NLM_lpage">15356</span>, <span class="refDoi"> DOI: 10.1073/pnas.202614999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.202614999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12432100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVCl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15351-15356&issue=24&author=C.+E.+Dannauthor=R.+K.+Bruickauthor=J.+Deisenhofer&title=Structure+of+factor-inhibiting+hypoxia-inducible+factor+1%3A+an+asparaginyl+hydroxylase+involved+in+the+hypoxic+response+pathway&doi=10.1073%2Fpnas.202614999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway</span></div><div class="casAuthors">Dann, Charles E., III; Bruick, Richard K.; Deisenhofer, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15351-15356</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Precise regulation of the evolutionarily conserved hypoxia-inducible transcription factor (HIF) ensures proper adaptation to variations in oxygen availability throughout development and into adulthood.  Oxygen-dependent regulation of HIF stability and activity are mediated by hydroxylation of conserved proline and asparagine residues, resp.  Because the relevant prolyl and asparaginyl hydroxylases use O2 to effect these posttranslational modifications, these enzymes are implicated as direct oxygen sensors in the mammalian hypoxic response pathway.  Here we present the structure of factor-inhibiting HIF-1 (FIH-1), the pertinent asparaginyl hydroxylase involved in hypoxic signaling.  Hydroxylation of the C-terminal transactivation domain (CTAD) of HIF by FIH-1 prevents CTAD assocn. with transcriptional coactivators under normoxic conditions.  Consistent with other structurally known hydroxylases, FIH-1 is comprised of a β-strand jellyroll core with both Fe(II) and the cosubstrate 2-oxoglutarate bound in the active site.  Details of the mol. contacts at the active site of FIH-1 have been elucidated and provide a platform for future drug design.  Furthermore, the structure reveals the presence of a FIH-1 homodimer that forms in soln. and is essential for FIH activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqABqFMocA22rVg90H21EOLACvtfcHk0lgxUwqxXyNm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVCl&md5=a5ab9e5d6bae7344600a48f9e24ea472</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1073%2Fpnas.202614999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.202614999%26sid%3Dliteratum%253Aachs%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DDeisenhofer%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520factor-inhibiting%2520hypoxia-inducible%2520factor%25201%253A%2520an%2520asparaginyl%2520hydroxylase%2520involved%2520in%2520the%2520hypoxic%2520response%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D24%26spage%3D15351%26epage%3D15356%26doi%3D10.1073%2Fpnas.202614999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flagg, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. J.</span></span> <span> </span><span class="NLM_article-title">Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.jinorgbio.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22687491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2012&pages=25-30&issue=6&author=S.+C.+Flaggauthor=C.+B.+Martinauthor=C.+Y.+Taabazuingauthor=B.+E.+Holmesauthor=M.+J.+Knapp&title=Screening+chelating+inhibitors+of+HIF-prolyl+hydroxylase+domain+2+%28PHD2%29+and+factor+inhibiting+HIF+%28FIH%29&doi=10.1016%2Fj.jinorgbio.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)</span></div><div class="casAuthors">Flagg, Shannon C.; Martin, Cristina B.; Taabazuing, Cornelius Y.; Holmes, Breanne E.; Knapp, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Two primary O2-sensors for humans are the HIF-hydroxylases, enzymes that hydroxylate specific residues of the hypoxia inducible factor-α (HIF).  These enzymes are factor inhibiting HIF (FIH) and prolyl hydroxylase-2 (PHD2), each an α-ketoglutarate (αKG) dependent, non-heme Fe(II) dioxygenase.  Although the two enzymes have similar active sites, FIH hydroxylates Asn803 of HIF-1α while PHD2 hydroxylates Pro402 and/or Pro564 of HIF-1α.  The similar structures but unique functions of FIH and PHD2 make them prime targets for selective inhibition leading to regulatory control of diseases such as cancer and stroke.  Three classes of iron chelators were tested as inhibitors for FIH and PHD2: pyridines, hydroxypyrones/hydroxypyridinones and catechols.  An initial screen of the ten small mol. inhibitors at varied [αKG] revealed a non-overlapping set of inhibitors for PHD2 and FIH.  Dose response curves at moderate [αKG] ([αKG] ∼ K M) showed that the hydroxypyrones/hydroxypyridinones were selective inhibitors, with IC50 in the μM range, and that the catechols were generally strong inhibitors of both FIH and PHD2, with IC50 in the low μM range.  As support for binding at the active site of each enzyme as the mode of inhibition, ESR (EPR) spectroscopy were used to demonstrate inhibitor binding to the metal center of each enzyme.  This work shows some selective inhibition between FIH and PHD2, primarily through the use of simple arom. or pseudo-arom. chelators, and suggests that hydroxypyrones and hydroxypyridones may be promising chelates for FIH or PHD2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6PGia6AOpc7Vg90H21EOLACvtfcHk0lgxUwqxXyNm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7zE&md5=46a1e4d51db097d5ed5888b352a9f6cb</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DFlagg%26aufirst%3DS.%2BC.%26aulast%3DMartin%26aufirst%3DC.%2BB.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DHolmes%26aufirst%3DB.%2BE.%26aulast%3DKnapp%26aufirst%3DM.%2BJ.%26atitle%3DScreening%2520chelating%2520inhibitors%2520of%2520HIF-prolyl%2520hydroxylase%2520domain%25202%2520%2528PHD2%2529%2520and%2520factor%2520inhibiting%2520HIF%2520%2528FIH%2529%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D113%26issue%3D6%26spage%3D25%26epage%3D30%26doi%3D10.1016%2Fj.jinorgbio.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilliet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papamicael, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerji, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of factor inhibiting hypoxia-inducible factor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7680</span>– <span class="NLM_lpage">7681</span>, <span class="refDoi"> DOI: 10.1021/ja050841b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja050841b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFWgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=7680-7681&issue=21&author=M.+A.+McDonoughauthor=L.+A.+McNeillauthor=M.+Tillietauthor=C.+A.+Papamicaelauthor=Q.+Y.+Chenauthor=B.+Banerjiauthor=K.+S.+Hewitsonauthor=C.+J.+Schofield&title=Selective+inhibition+of+factor+inhibiting+hypoxia-inducible+factor&doi=10.1021%2Fja050841b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor</span></div><div class="casAuthors">McDonough, Michael A.; McNeill, Luke A.; Tilliet, Melanie; Papamicaeel, Cyril A.; Chen, Qiu-Yun; Banerji, Biswadip; Hewitson, Kirsty S.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7680-7681</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of four non-heme iron(II) and 2-oxoglutarate-dependent enzymes catalyze the post-translational modification of a transcription factor, hypoxia inducible factor (HIF), that mediates the hypoxic response in animals.  Hydroxylation of HIF both causes its degrdn. and limits its activity.  We describe how the use of structural data coupled to solid-phase synthesis led to the discovery of a selective inhibitor of one of the HIF hydroxylases.  The inhibitor N-oxalyl-D-phenylalanine was shown to inhibit the HIF asparaginyl hydroxylase (FIH) but not a HIF prolyl hydroxylase.  A crystal structure of the inhibitor complexed to FIH reveals that it binds in the 2OG and, likely, in the dioxygen binding site.  The results will help to enable the modulation of the hypoxic response for the up-regulation of specific genes of biomedical importance, such as erythropoietin and vascular endothelial growth factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO2W67f7IJI7Vg90H21EOLACvtfcHk0lgxUwqxXyNm7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFWgsro%253D&md5=28b1ee541b595e6a6a00eeca34c26639</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fja050841b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja050841b%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DTilliet%26aufirst%3DM.%26aulast%3DPapamicael%26aufirst%3DC.%2BA.%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DBanerji%26aufirst%3DB.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520inhibition%2520of%2520factor%2520inhibiting%2520hypoxia-inducible%2520factor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26issue%3D21%26spage%3D7680%26epage%3D7681%26doi%3D10.1021%2Fja050841b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochocki, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gade, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">Fructose-1,6-bisphosphatase opposes renal carcinoma progression</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span> (<span class="NLM_issue">7517</span>),  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1038/nature13557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature13557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25043030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOltrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=251-255&issue=7517&author=B.+Liauthor=B.+Qiuauthor=D.+S.+Leeauthor=Z.+E.+Waltonauthor=J.+D.+Ochockiauthor=L.+K.+Mathewauthor=A.+Mancusoauthor=T.+P.+Gadeauthor=B.+Keithauthor=I.+Nissimauthor=M.+C.+Simon&title=Fructose-1%2C6-bisphosphatase+opposes+renal+carcinoma+progression&doi=10.1038%2Fnature13557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose-1,6-bisphosphatase opposes renal carcinoma progression</span></div><div class="casAuthors">Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Gade, Terence P. F.; Keith, Brian; Nissim, Itzhak; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7517</span>),
    <span class="NLM_cas:pages">251-255</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, is characterized by elevated glycogen levels and fat deposition.  These consistent metabolic alterations are assocd. with normoxic stabilization of hypoxia-inducible factors (HIFs) secondary to von Hippel-Lindau (VHL) mutations that occur in over 90% of ccRCC tumors.  However, kidney-specific VHL deletion in mice fails to elicit ccRCC-specific metabolic phenotypes and tumor formation, suggesting that addnl. mechanisms are essential.  Recent large-scale sequencing analyses revealed the loss of several chromatin remodelling enzymes in a subset of ccRCC (these included polybromo-1, SET domain contg. 2 and BRCA1-assocd. protein-1, among others), indicating that epigenetic perturbations are probably important contributors to the natural history of this disease.  Here we used an integrative approach comprising pan-metabolomic profiling and metabolic gene set anal. and detd. that the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1) is uniformly depleted in over six hundred ccRCC tumors examd.  Notably, the human FBP1 locus resides on chromosome 9q22, the loss of which is assocd. with poor prognosis for ccRCC patients.  Our data further indicate that FBP1 inhibits ccRCC progression through two distinct mechanisms.  First, FBP1 antagonizes glycolytic flux in renal tubular epithelial cells, the presumptive ccRCC cell of origin, thereby inhibiting a potential Warburg effect.  Second, in pVHL (the protein encoded by the VHL gene)-deficient ccRCC cells, FBP1 restrains cell proliferation, glycolysis and the pentose phosphate pathway in a catalytic-activity-independent manner, by inhibiting nuclear HIF function via direct interaction with the HIF inhibitory domain.  This unique dual function of the FBP1 protein explains its ubiquitous loss in ccRCC, distinguishing FBP1 from previously identified tumor suppressors that are not consistently mutated in all tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTwq6rXdgYK7Vg90H21EOLACvtfcHk0ljMjrPJ7Is05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOltrjK&md5=1e0d6f2a5d7dc7fc058866b690feaa9b</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fnature13557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13557%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DWalton%26aufirst%3DZ.%2BE.%26aulast%3DOchocki%26aufirst%3DJ.%2BD.%26aulast%3DMathew%26aufirst%3DL.%2BK.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DGade%26aufirst%3DT.%2BP.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DNissim%26aufirst%3DI.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DFructose-1%252C6-bisphosphatase%2520opposes%2520renal%2520carcinoma%2520progression%26jtitle%3DNature%26date%3D2014%26volume%3D513%26issue%3D7517%26spage%3D251%26epage%3D255%26doi%3D10.1038%2Fnature13557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1042/CS20171625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1042%2FCS20171625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29581249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFamurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2018&pages=825-838&issue=7&author=Y.+Yangauthor=X.+Yuauthor=Y.+Zhangauthor=G.+Dingauthor=C.+Zhuauthor=S.+Huangauthor=Z.+Jiaauthor=A.+Zhang&title=Hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor+roxadustat+%28FG-4592%29+protects+against+cisplatin-induced+acute+kidney+injury&doi=10.1042%2FCS20171625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury</span></div><div class="casAuthors">Yang, Yunwen; Yu, Xiaowen; Zhang, Yue; Ding, Guixia; Zhu, Chunhua; Huang, Songming; Jia, Zhanjun; Zhang, Aihua</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">825-838</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Renal hypoxia occurs in acute kidney injury (AKI) of various etiologies.  Activation of hypoxia-inducible transcription factor (HIF) has been identified as an important mechanism of cellular adaptation to low oxygen.  Preconditional HIF activation protects against AKI, suggesting a new approach in AKI treatment.  HIF is degraded under normoxic conditions mediated by oxygen-dependent hydroxylation of specific prolyl residues of the regulative α-subunits by HIF prolyl hydroxylases (PHD).  FG-4592 is a novel, orally active, small-mol. HIF PHD inhibitor for the treatment of anemia in patients with chronic kidney disease (CKD).  The current study aimed to evaluate the effect of FG-4592 (Roxadustat) on cis-diamminedichloroplatinum (cisplatin)-induced kidney injury.  In mice, pretreatment with FG-4592 markedly ameliorated cisplatin-induced kidney injury as shown by the improved renal function (blood urea nitrogen (BUN), serum creatinine (Scr), and cystatin C) and kidney morphol. (periodic acid-Schiff (PAS) staining) in line with a robust blockade of renal tubular injury markers of kidney injury mol. 1 (KIM-1) and neutrophil gelatinase-assocd. lipocalin (NGAL).  Meanwhile, the renal apoptosis and inflammation induced by cisplatin were also strikingly attenuated in FG-4592-treated mice.  Along with the protective effects shown above, FG-4592 pretreatment strongly enhanced HIF-1α in tubular cells, as well as the expressions of HIF target genes.  FG-4592 alone did not affect the renal function and morphol. in mice.  In vitro, FG-4592 treatment significantly up-regulated HIF-1α and protected the tubular cells against cisplatin-induced apoptosis.  In summary, FG-4592 treatment remarkably ameliorated the cisplatin-induced kidney injury possibly through the stabilization of HIF.  Thus, besides the role in treating CKD anemia, the clin. use of FG-4592 also could be extended to AKI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKx-vnkcRmrVg90H21EOLACvtfcHk0ljMjrPJ7Is05w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFamurvE&md5=7232accbdd48f1d0186ee96ff512d94a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1042%2FCS20171625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20171625%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DHypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%2520roxadustat%2520%2528FG-4592%2529%2520protects%2520against%2520cisplatin-induced%2520acute%2520kidney%2520injury%26jtitle%3DClin.%2520Sci.%26date%3D2018%26volume%3D132%26issue%3D7%26spage%3D825%26epage%3D838%26doi%3D10.1042%2FCS20171625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson’s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">121</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2018.00121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.3389%2Ffnagi.2018.00121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29755339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=121&author=X.+Liauthor=X.+X.+Cuiauthor=Y.+J.+Chenauthor=T.+T.+Wuauthor=Y.+C.+Wuauthor=H.+Xuauthor=H.+Yin&title=Therapeutic+potential+of+a+prolyl+hydroxylase+inhibitor+FG-4592+for+Parkinson%E2%80%99s+diseases+in+vitro+and+in+vivo%3A+regulation+of+redox+biology+and+mitochondrial+function&doi=10.3389%2Ffnagi.2018.00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for parkinson's diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span></div><div class="casAuthors">Li, Xuan; Cui, Xin-Xin; Chen, Ya-Jing; Wu, Ting-Ting; Xu, Huaxi; Yin, Huiyong; Wu, Yun-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">121/1-121/16</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">As the main transcription factor that regulates the cellular responses to hypoxia, Hypoxia-inducible factor-1α (HIF-1α) plays an important role in the pathogenesis of Parkinson's disease (PD).  HIF-1α is normally degraded through ubiquitination after hydroxylation by prolyl hydroxylases (PHD).  Emerging evidence has suggested that HIF PHD inhibitors (HIF-PHI) may have neuroprotective effects on PD through increasing HIF-1α levels.  However, the therapeutic benefit of HIF-PHI for PD remains poorly explored due to the lack of proper clin. compds. and understanding of the underlying mol. mechanisms.  In this study, we examd. the therapeutic benefit of a new HIF-PHI, FG-4592, which is currently in phase 3 clin. trials to treat anemia in patients with chronic kidney diseases (CKD) in PD models.  FG-4592 attenuates MPP+-induced apoptosis and loss of tyrosine hydroxylase (TH) in SHSY5Y cells.  Pretreatment with FG-4592 mitigates MPP+-induced loss of mitochondrial membrane potential (MMP), mitochondrial oxygen consumption rate (OCR), prodn. of reactive oxygen species (ROS) and ATP.  Furthermore, FG-4592 counterbalances the oxidative stress through up-regulating nuclear factor erythroid 2 p45-related factor 2 (Nrf-2), heme oxygenase-1 (HO-1) and superoxide dismutase 2 (SOD2).  FG-4592 treatment also induces the expression of Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) through increasing the phosphorylation of AMP-activated protein kinase (AMPK).  In MPTP-treated mice, FG-4592 protects against MPTP-induced loss of TH-pos. neurons of substantia nigra and attenuates behavioral impairments.  Collectively, our study demonstrates that FG-4592 is a promising therapeutic strategy for PD through improving the mitochondrial function under oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQ__V5ZZmvrVg90H21EOLACvtfcHk0ljhDBKFnO202A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN&md5=6de27ad23eb1b16c4384ff23d385b38e</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2018.00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2018.00121%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DX.%2BX.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DWu%26aufirst%3DT.%2BT.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DTherapeutic%2520potential%2520of%2520a%2520prolyl%2520hydroxylase%2520inhibitor%2520FG-4592%2520for%2520Parkinson%25E2%2580%2599s%2520diseases%2520in%2520vitro%2520and%2520in%2520vivo%253A%2520regulation%2520of%2520redox%2520biology%2520and%2520mitochondrial%2520function%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2018%26volume%3D10%26spage%3D121%26doi%3D10.3389%2Ffnagi.2018.00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">FG-4592 accelerates cutaneous wound healing by epidermal stem cell activation via HIF-1alpha stabilization</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2460</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1159/000489652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1159%2F000489652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29742498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVajsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=2460-2470&issue=6&author=D.+Tangauthor=J.+Zhangauthor=T.+Yanauthor=J.+Weiauthor=X.+Jiangauthor=D.+Zhangauthor=Q.+Zhangauthor=J.+Jiaauthor=Y.+Huang&title=FG-4592+accelerates+cutaneous+wound+healing+by+epidermal+stem+cell+activation+via+HIF-1alpha+stabilization&doi=10.1159%2F000489652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">FG-4592 Accelerates Cutaneous Wound Healing by Epidermal Stem Cell Activation via HIF-1α Stabilization</span></div><div class="casAuthors">Tang, Di; Zhang, Junhui; Yan, Tiantian; Wei, Jingyu; Jiang, Xupin; Zhang, Dongxia; Zhang, Qiong; Jia, Jiezhi; Huang, Yuesheng</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2460-2470</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Regional hypoxia promptly develops after trauma because of microvascular injury and increased oxygen consumption.  This acute hypoxia plays a pos. role in early skin wound healing.  One of the mechanisms underlying the beneficial effects of acute hypoxia on wound healing may be increased hypoxia-inducible factor-1 (HIF-1α) expression.  HIF-1α may affect the wound-healing process through many aspects, including angiogenesis, metab., and extra-cellular matrix synthesis and remodelling.  Epidermal stem cells (EpSCs) are important participants in wound repair; however, whether these cells are regulated by hypoxia is unclear.  This study aimed to elucidate the regulatory mechanism by which hypoxia acts on EpSCs.  Methods: CCK8 assays, western blots and live cell station observation were employed to compare the viability, proliferation and motility of EpSCs cultured under normoxic conditions (21% O2) with those cultured under hypoxic conditions (2% O2).  Moreover, we used FG-4592 (a prolyl hydroxylase inhibitor that stabilizes HIF-1α in normoxia), KC7F2 (a selective inhibitor of HIF-1α transcription) and siRNA against HIF-1α to regulate HIF-1α expression.  Results: Acute hypoxia caused EpSCs to switch from a quiescent state to an activated state with higher viability and motility, as well as an earlier proliferation peak.  We demonstrated that the HIF-1 signalling pathway mediated hypoxia-induced activation of EpSCs.  Finally, the in vivo expts. showed that exogenous FG-4592 effectively accelerates wound healing, shortens healing times and even induces epidermal hyperplasia.  Conclusion: This study demonstrated that both hypoxia and exogenous FG-4592 improve EpSC proliferation and motility by stabilizing HIF-1α, and its results suggest that HIF-1α is an important target through which wound healing can be accelerated and that FG-4592 is a promising new drug for wound repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2_YG1WlcArVg90H21EOLACvtfcHk0ljhDBKFnO202A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVajsbvE&md5=c1bf51015825ece8805597c5358bb63a</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1159%2F000489652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000489652%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DFG-4592%2520accelerates%2520cutaneous%2520wound%2520healing%2520by%2520epidermal%2520stem%2520cell%2520activation%2520via%2520HIF-1alpha%2520stabilization%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D46%26issue%3D6%26spage%3D2460%26epage%3D2470%26doi%3D10.1159%2F000489652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, S. R.</span></span> <span> </span><span class="NLM_article-title">Inflammation and hypoxia: HIF and PHD isoform selectivity</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2018.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.molmed.2018.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=30442494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKhsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=33&author=E.+R.+Wattsauthor=S.+R.+Walmsley&title=Inflammation+and+hypoxia%3A+HIF+and+PHD+isoform+selectivity&doi=10.1016%2Fj.molmed.2018.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and Hypoxia: HIF and PHD Isoform Selectivity</span></div><div class="casAuthors">Watts, Emily R.; Walmsley, Sarah R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-46</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cells sense and respond to hypoxia through the activity of the transcription factor HIF (hypoxia-inducible factor) and its regulatory hydroxylases, the prolyl hydroxylase domain enzymes (PHDs).  Multiple isoforms of HIFs and PHDs exist, and isoform-selective roles have been identified in the context of the inflammatory environment, which is itself frequently hypoxic.  Recent advances in the field have highlighted the complexity of this system, particularly with regards to the cell and context-specific activity of HIFs and PHDs.  Because novel therapeutic agents which regulate this pathway are nearing the clinic, understanding the role of HIFs and PHDs in inflammation outcomes is an essential step in avoiding off-target effects and, crucially, in developing new anti-inflammatory strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwdsO08qRh_rVg90H21EOLACvtfcHk0ljhDBKFnO202A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKhsLrO&md5=4263636a9b4a5f4a8cb36a540aa5a62f</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2018.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DE.%2BR.%26aulast%3DWalmsley%26aufirst%3DS.%2BR.%26atitle%3DInflammation%2520and%2520hypoxia%253A%2520HIF%2520and%2520PHD%2520isoform%2520selectivity%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D33%26doi%3D10.1016%2Fj.molmed.2018.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuchnio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchnio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruys, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thienpont, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ungureanu, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyere, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manderveld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Fernaud, J.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanivan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foidart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinckier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewerchin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">The cancer cell oxygen sensor PHD2 promotes metastasis via activation of cancer-associated fibroblasts</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.celrep.2015.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26235614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Kmur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=992-1005&author=A.+Kuchnioauthor=S.+Moensauthor=U.+Bruningauthor=K.+Kuchnioauthor=B.+Cruysauthor=B.+Thienpontauthor=M.+Brouxauthor=A.+A.+Ungureanuauthor=R.+L.+de+Oliveiraauthor=F.+Bruyereauthor=H.+Cuervoauthor=A.+Manderveldauthor=A.+Cartonauthor=J.%0AR.+Hernandez-Fernaudauthor=S.+Zanivanauthor=C.+Barticauthor=J.+Foidartauthor=A.+Noelauthor=S.+Vinckierauthor=D.+Lambrechtsauthor=M.+Dewerchinauthor=M.+Mazzoneauthor=P.+Carmeliet&title=The+cancer+cell+oxygen+sensor+PHD2+promotes+metastasis+via+activation+of+cancer-associated+fibroblasts&doi=10.1016%2Fj.celrep.2015.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts</span></div><div class="casAuthors">Kuchnio, Anna; Moens, Stijn; Bruning, Ulrike; Kuchnio, Karol; Cruys, Bert; Thienpont, Bernard; Broux, Michael; Ungureanu, Andreea Alexandra; Leite de Oliveira, Rodrigo; Bruyere, Francoise; Cuervo, Henar; Manderveld, Ann; Carton, An; Hernandez-Fernaud, Juan Ramon; Zanivan, Sara; Bartic, Carmen; Foidart, Jean-Michel; Noel, Agnes; Vinckier, Stefan; Lambrechts, Diether; Dewerchin, Mieke; Mazzone, Massimiliano; Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">992-1005</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Several questions about the role of the oxygen sensor prolyl-hydroxylase 2 (PHD2) in cancer have not been addressed.  First, the role of PHD2 in metastasis has not been studied in a spontaneous tumor model.  Here, we show that global PHD2 haplodeficiency reduced metastasis without affecting tumor growth.  Second, it is unknown whether PHD2 regulates cancer by affecting cancer-assocd. fibroblasts (CAFs).  We show that PHD2 haplodeficiency reduced metastasis via two mechanisms: (1) by decreasing CAF activation, matrix prodn., and contraction by CAFs, an effect that surprisingly relied on PHD2 deletion in cancer cells, but not in CAFs; and (2) by improving tumor vessel normalization.  Third, the effect of concomitant PHD2 inhibition in malignant and stromal cells (mimicking PHD2 inhibitor treatment) is unknown.  We show that global PHD2 haplodeficiency, induced not only before but also after tumor onset, impaired metastasis.  These findings warrant investigation of PHD2's therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzRPAreNPyUrVg90H21EOLACvtfcHk0lig82wTZ016mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Kmur%252FO&md5=e65539ad69f1d3cda3910b5c26a8c65b</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DKuchnio%26aufirst%3DA.%26aulast%3DMoens%26aufirst%3DS.%26aulast%3DBruning%26aufirst%3DU.%26aulast%3DKuchnio%26aufirst%3DK.%26aulast%3DCruys%26aufirst%3DB.%26aulast%3DThienpont%26aufirst%3DB.%26aulast%3DBroux%26aufirst%3DM.%26aulast%3DUngureanu%26aufirst%3DA.%2BA.%26aulast%3Dde%2BOliveira%26aufirst%3DR.%2BL.%26aulast%3DBruyere%26aufirst%3DF.%26aulast%3DCuervo%26aufirst%3DH.%26aulast%3DManderveld%26aufirst%3DA.%26aulast%3DCarton%26aufirst%3DA.%26aulast%3DHernandez-Fernaud%26aufirst%3DJ.%2BR.%26aulast%3DZanivan%26aufirst%3DS.%26aulast%3DBartic%26aufirst%3DC.%26aulast%3DFoidart%26aufirst%3DJ.%26aulast%3DNoel%26aufirst%3DA.%26aulast%3DVinckier%26aufirst%3DS.%26aulast%3DLambrechts%26aufirst%3DD.%26aulast%3DDewerchin%26aufirst%3DM.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DThe%2520cancer%2520cell%2520oxygen%2520sensor%2520PHD2%2520promotes%2520metastasis%2520via%2520activation%2520of%2520cancer-associated%2520fibroblasts%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D992%26epage%3D1005%26doi%3D10.1016%2Fj.celrep.2015.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaGory, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span> <span> </span><span class="NLM_article-title">The ever expanding role of HIF in tumour and stromal biology</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1038/ncb3330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fncb3330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27027486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFKiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=356-365&issue=4&author=E.+L.+LaGoryauthor=A.+J.+Giaccia&title=The+ever+expanding+role+of+HIF+in+tumour+and+stromal+biology&doi=10.1038%2Fncb3330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The ever-expanding role of HIF in tumour and stromal biology</span></div><div class="casAuthors">LaGory, Edward L.; Giaccia, Amato J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-365</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Low oxygen tension (hypoxia) is a hallmark of cancer that influences cancer cell function, but is also an important component of the tumor microenvironment as it alters the extracellular matrix, modulates the tumor immune response and increases angiogenesis.  Here we discuss the regulation and role of hypoxia and its key transcriptional mediators, the hypoxia-inducible factor (HIF) family of transcription factors, in the tumor microenvironment and stromal compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD5HJxfRxES7Vg90H21EOLACvtfcHk0lig82wTZ016mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFKiur0%253D&md5=4434a6121f6499a7d5b1a92a402bdad4</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1038%2Fncb3330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3330%26sid%3Dliteratum%253Aachs%26aulast%3DLaGory%26aufirst%3DE.%2BL.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520ever%2520expanding%2520role%2520of%2520HIF%2520in%2520tumour%2520and%2520stromal%2520biology%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2016%26volume%3D18%26issue%3D4%26spage%3D356%26epage%3D365%26doi%3D10.1038%2Fncb3330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span> <span> </span><span class="NLM_article-title">Von Hippel-Lindau (VHL) protein antagonist, VH298, promotes functional activities of tendon-derived stem cells and accelerates healing of entheses in rats by inhibiting ubiquitination of hydroxy-HIF-1alpha</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>505</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1063</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.09.172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2018.09.172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=30314704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVyhu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2018&pages=1063-1069&issue=4&author=S.+Qiuauthor=Y.+Jiaauthor=J.+Tangauthor=X.+Liuauthor=H.+Huauthor=T.+Wuauthor=Y.+Chai&title=Von+Hippel-Lindau+%28VHL%29+protein+antagonist%2C+VH298%2C+promotes+functional+activities+of+tendon-derived+stem+cells+and+accelerates+healing+of+entheses+in+rats+by+inhibiting+ubiquitination+of+hydroxy-HIF-1alpha&doi=10.1016%2Fj.bbrc.2018.09.172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Von Hippel-Lindau (VHL) protein antagonist, VH298, promotes functional activities of tendon-derived stem cells and accelerates healing of entheses in rats by inhibiting ubiquitination of hydroxy-HIF-1α</span></div><div class="casAuthors">Qiu, Shuo; Jia, Yachao; Tang, Jin; Liu, Xuanzhe; Hu, Hai; Wu, Tianyi; Chai, Yimin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1063-1069</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enthesis is the region where a tendon attaches to a bone.  It is a relatively vulnerable position, and in most cases surgical treatment is required upon rupture.  The reconstructed enthesis is usually weaker compared to the original, and is prone to rupture again.  Hypoxia-inducible factor-1 α (HIF-1α) is known to be involved in extensive activities in cells.  It is inhibited under normoxic conditions, and undergoes two essential processes, hydroxylation and ubiquitination, the latter of which has been largely unexplored.  Herein, we measured the levels of HIF-1α and hydroxy-HIF-1α in VH298-treated rat tendon-derived stem cells (TDSCs) by immunoblotting.  We also detected the proliferation of TDSCs using CCK-8 assay and the mRNA levels of related genes by quant. RT-PCR.  The TDSCs were obsd. to be induced and the chondrogenic differentiation related genes were found to be enhanced.  We also simulated in-vitro wounding in a scratch test and reconstructed the enthesis in a rat model of Achilles tendon by classical surgery followed by administration of phosphate buffer saline (PBS) injection or VH298 injection.  We obsd. that HIF-1α and hydroxy-HIF-1α levels were increased in VH298-treated TDSCs in a dose- and time-dependent manner.  Thirty micromolar VH298 could significantly increase cell proliferation, migration, and expression of collagen-1α, collagen-3α, decorin, tenomodulin, tenascin C genes, and chondrogenic differentiation-related genes, collagen-2α, SRY-box9, aggrecan.  VH298-treated enthesis could tolerate more load-to-failure, had a better healing pattern, and activation of HIF signaling pathway.  VH298 can thus enhance the functional activities of TDSCs, enhance their chondrogenic differentiation potential, and accelerate enthesis healing by inhibiting the ubiquitination of hydroxy-HIF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xy_oOhp-5LVg90H21EOLACvtfcHk0lig82wTZ016mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVyhu7fJ&md5=cde6c8cf6d37d89bf27c89b0d383f444</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.09.172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.09.172%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DChai%26aufirst%3DY.%26atitle%3DVon%2520Hippel-Lindau%2520%2528VHL%2529%2520protein%2520antagonist%252C%2520VH298%252C%2520promotes%2520functional%2520activities%2520of%2520tendon-derived%2520stem%2520cells%2520and%2520accelerates%2520healing%2520of%2520entheses%2520in%2520rats%2520by%2520inhibiting%2520ubiquitination%2520of%2520hydroxy-HIF-1alpha%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D505%26issue%3D4%26spage%3D1063%26epage%3D1069%26doi%3D10.1016%2Fj.bbrc.2018.09.172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowburn, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrakis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macias, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bargiela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittipassorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chey, Y. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rundqvist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span> <span> </span><span class="NLM_article-title">The factor inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cmet.2018.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29617647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=898-913&issue=4&author=J.+Simauthor=A.+S.+Cowburnauthor=A.+Palazonauthor=B.+Madhuauthor=P.+A.+Tyrakisauthor=D.+Maciasauthor=D.+M.+Bargielaauthor=S.+Pietschauthor=M.+Grallaauthor=C.+E.+Evansauthor=T.+Kittipassornauthor=Y.+C.+J.+Cheyauthor=C.+M.+Brancoauthor=H.+Rundqvistauthor=D.+J.+Peetauthor=R.+S.+Johnson&title=The+factor+inhibiting+HIF+asparaginyl+hydroxylase+regulates+oxidative+metabolism+and+accelerates+metabolic+adaptation+to+hypoxia&doi=10.1016%2Fj.cmet.2018.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia</span></div><div class="casAuthors">Sim, Jingwei; Cowburn, Andrew S.; Palazon, Asis; Madhu, Basetti; Tyrakis, Petros A.; Macias, David; Bargiela, David M.; Pietsch, Sandra; Gralla, Michael; Evans, Colin E.; Kittipassorn, Thaksaon; Chey, Yu C. J.; Branco, Cristina M.; Rundqvist, Helene; Peet, Daniel J.; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">898-913.e7</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Animals require an immediate response to oxygen availability to allow rapid shifts between oxidative and glycolytic metab.  These metabolic shifts are highly regulated by the HIF transcription factor.  The factor inhibiting HIF (FIH) is an asparaginyl hydroxylase that controls HIF transcriptional activity in an oxygen-dependent manner.  We show here that FIH loss increases oxidative metab., while also increasing glycolytic capacity, and that this gives rise to an increase in oxygen consumption.  We further show that the loss of FIH acts to accelerate the cellular metabolic response to hypoxia.  Skeletal muscle expresses 50-fold higher levels of FIH than other tissues: we analyzed skeletal muscle FIH mutants and found a decreased metabolic efficiency, correlated with an increased oxidative rate and an increased rate of hypoxic response.  We find that FIH, through its regulation of oxidn., acts in concert with the PHD/vHL pathway to accelerate HIF-mediated metabolic responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr58Zs_Uji4UbVg90H21EOLACvtfcHk0lgDC1ngvpq1eQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVKqsL0%253D&md5=049720b4f4b7fc6cac59da1ec2829f45</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DCowburn%26aufirst%3DA.%2BS.%26aulast%3DPalazon%26aufirst%3DA.%26aulast%3DMadhu%26aufirst%3DB.%26aulast%3DTyrakis%26aufirst%3DP.%2BA.%26aulast%3DMacias%26aufirst%3DD.%26aulast%3DBargiela%26aufirst%3DD.%2BM.%26aulast%3DPietsch%26aufirst%3DS.%26aulast%3DGralla%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DC.%2BE.%26aulast%3DKittipassorn%26aufirst%3DT.%26aulast%3DChey%26aufirst%3DY.%2BC.%2BJ.%26aulast%3DBranco%26aufirst%3DC.%2BM.%26aulast%3DRundqvist%26aufirst%3DH.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DThe%2520factor%2520inhibiting%2520HIF%2520asparaginyl%2520hydroxylase%2520regulates%2520oxidative%2520metabolism%2520and%2520accelerates%2520metabolic%2520adaptation%2520to%2520hypoxia%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26issue%3D4%26spage%3D898%26epage%3D913%26doi%3D10.1016%2Fj.cmet.2018.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xiaojin Zhang, Yonghua Lei, Tianhan Hu, Yue Wu, Zhihong Li, Zhensheng Jiang, Changyong Yang, Lianshan Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Qidong You</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 10045-10060. <a href="https://doi.org/10.1021/acs.jmedchem.0c01161" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01161%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252B%2525285-%2525283-%2525284-Chlorophenoxy%252529prop-1-yn-1-yl%252529-3-hydroxypicolinoyl%252529glycine%25252C%252Ban%252BOrally%252BBioavailable%252BProlyl%252BHydroxylase%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAnemia%26aulast%3DZhang%26aufirst%3DXiaojin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06072020%26date%3D05082020%26date%3D28072020%26volume%3D63%26issue%3D17%26spage%3D10045%26epage%3D10060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingming Liu, Yuru Liang, Zhongzhen Zhu, Jin Wang, Xingxing Cheng, Jiayi Cheng, Binpeng Xu, Rong Li, Xinhua Liu, <span class="NLM_string-name hlFld-ContribAuthor">Yang Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Aryl Carboxamide Derivatives as Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 9299-9314. <a href="https://doi.org/10.1021/acs.jmedchem.9b01313" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01313%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BAryl%252BCarboxamide%252BDerivatives%252Bas%252BHypoxia-Inducible%252BFactor%252B1%2525CE%2525B1%252BSignaling%252BInhibitors%252Bwith%252BPotent%252BActivities%252Bof%252BAnticancer%252BMetastasis%26aulast%3DLiu%26aufirst%3DMingming%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D10082019%26date%3D04102019%26date%3D26092019%26volume%3D62%26issue%3D20%26spage%3D9299%26epage%3D9314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irma  Telarovic</span>, <span class="hlFld-ContribAuthor ">Roland H.  Wenger</span>, <span class="hlFld-ContribAuthor ">Martin  Pruschy</span>. </span><span class="cited-content_cbyCitation_article-title">Interfering with Tumor Hypoxia for Radiotherapy Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2021,</strong> <em>40 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-021-02000-x" title="DOI URL">https://doi.org/10.1186/s13046-021-02000-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-021-02000-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-021-02000-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DInterfering%252Bwith%252BTumor%252BHypoxia%252Bfor%252BRadiotherapy%252BOptimization%26aulast%3DTelarovic%26aufirst%3DIrma%26date%3D2021%26date%3D2021%26volume%3D40%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xusheng  Guo</span>, <span class="hlFld-ContribAuthor ">Xuwen  Da</span>, <span class="hlFld-ContribAuthor ">Yishan  Yao</span>, <span class="hlFld-ContribAuthor ">Haihua  Xiao</span>, <span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Qianxiong  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title"><a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="d88d9b9688989a8b99">[email protected]</a>@Ru nanoparticles with tumor-specific and NIR-triggered efficient PACT activity
              in vivo. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2021,</strong> <em>50 </em>
                                    (22)
                                     , 7715-7724. <a href="https://doi.org/10.1039/D1DT00777G" title="DOI URL">https://doi.org/10.1039/D1DT00777G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1DT00777G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1DT00777G%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DUCNP%252540BSA%252540Ru%252Bnanoparticles%252Bwith%252Btumor-specific%252Band%252BNIR-triggered%252Befficient%252BPACT%252Bactivity%252Bin%252Bvivo%26aulast%3DZhang%26aufirst%3DChao%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D22%26spage%3D7715%26epage%3D7724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">The Design and Application of Bioisosteres in Drug Design. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-81. <a href="https://doi.org/10.1002/0471266949.bmc259" title="DOI URL">https://doi.org/10.1002/0471266949.bmc259</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc259%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDesign%252Band%252BApplication%252Bof%252BBioisosteres%252Bin%252BDrug%252BDesign%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D81%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Li</span>, <span class="hlFld-ContribAuthor ">Song  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiankang  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">The study on the inhibitory mechanism of JTZ-951 and its analogue against prolyl hydroxylase-2 to mediate the response to hypoxia in the process of sports. </span><span class="cited-content_cbyCitation_journal-name">Molecular Physics</span><span> <strong>2021,</strong> <em>119 </em>
                                    (7)
                                     , e1853268. <a href="https://doi.org/10.1080/00268976.2020.1853268" title="DOI URL">https://doi.org/10.1080/00268976.2020.1853268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00268976.2020.1853268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00268976.2020.1853268%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Physics%26atitle%3DThe%252Bstudy%252Bon%252Bthe%252Binhibitory%252Bmechanism%252Bof%252BJTZ-951%252Band%252Bits%252Banalogue%252Bagainst%252Bprolyl%252Bhydroxylase-2%252Bto%252Bmediate%252Bthe%252Bresponse%252Bto%252Bhypoxia%252Bin%252Bthe%252Bprocess%252Bof%252Bsports%26aulast%3DLi%26aufirst%3DTao%26date%3D2021%26date%3D2021%26volume%3D119%26issue%3D7%26spage%3De1853268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Courtney E.  McAleese</span>, <span class="hlFld-ContribAuthor ">Chandra  Choudhury</span>, <span class="hlFld-ContribAuthor ">Neville J.  Butcher</span>, <span class="hlFld-ContribAuthor ">Rodney F.  Minchin</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-mediated drug resistance in breast cancers. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2021,</strong> <em>502 </em>, 189-199. <a href="https://doi.org/10.1016/j.canlet.2020.11.045" title="DOI URL">https://doi.org/10.1016/j.canlet.2020.11.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2020.11.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2020.11.045%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DHypoxia-mediated%252Bdrug%252Bresistance%252Bin%252Bbreast%252Bcancers%26aulast%3DMcAleese%26aufirst%3DCourtney%2BE.%26date%3D2021%26volume%3D502%26spage%3D189%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zuo-lin  Li</span>, <span class="hlFld-ContribAuthor ">Bin  Wang</span>, <span class="hlFld-ContribAuthor ">Lin-li  Lv</span>, <span class="hlFld-ContribAuthor ">Tao-tao  Tang</span>, <span class="hlFld-ContribAuthor ">Yi  Wen</span>, <span class="hlFld-ContribAuthor ">Jing-yuan  Cao</span>, <span class="hlFld-ContribAuthor ">Xiao-xiao  Zhu</span>, <span class="hlFld-ContribAuthor ">Song-tao  Feng</span>, <span class="hlFld-ContribAuthor ">Steven D.  Crowley</span>, <span class="hlFld-ContribAuthor ">Bi-cheng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">FIH-1-modulated HIF-1α C-TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>95 </em><a href="https://doi.org/10.1038/s41401-021-00617-4" title="DOI URL">https://doi.org/10.1038/s41401-021-00617-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-021-00617-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-021-00617-4%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DFIH-1-modulated%252BHIF-1%2525CE%2525B1%252BC-TAD%252Bpromotes%252Bacute%252Bkidney%252Binjury%252Bto%252Bchronic%252Bkidney%252Bdisease%252Bprogression%252Bvia%252Bregulating%252BKLF5%252Bsignaling%26aulast%3DLi%26aufirst%3DZuo-lin%26date%3D2021%26date%3D2021%26volume%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takahiro  Shimizu</span>, <span class="hlFld-ContribAuthor ">Norihito  Takahashi</span>, <span class="hlFld-ContribAuthor ">Vincent J.  Huber</span>, <span class="hlFld-ContribAuthor ">Yasunobu  Asawa</span>, <span class="hlFld-ContribAuthor ">Hiroki  Ueda</span>, <span class="hlFld-ContribAuthor ">Atsushi  Yoshimori</span>, <span class="hlFld-ContribAuthor ">Yukiko  Muramatsu</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Seimiya</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kouji</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Nakamura</span>, <span class="hlFld-ContribAuthor ">Hiroki  Oguri</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 14 and 15-membered macrocyclic scaffolds exhibiting inhibitory activities of hypoxia-inducible factor 1α. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>30 </em>, 115949. <a href="https://doi.org/10.1016/j.bmc.2020.115949" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115949</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115949&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115949%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B14%252Band%252B15-membered%252Bmacrocyclic%252Bscaffolds%252Bexhibiting%252Binhibitory%252Bactivities%252Bof%252Bhypoxia-inducible%252Bfactor%252B1%2525CE%2525B1%26aulast%3DShimizu%26aufirst%3DTakahiro%26date%3D2021%26volume%3D30%26spage%3D115949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita  Meleddu</span>, <span class="hlFld-ContribAuthor ">Serenella  Deplano</span>, <span class="hlFld-ContribAuthor ">Elias  Maccioni</span>, <span class="hlFld-ContribAuthor ">Francesco  Ortuso</span>, <span class="hlFld-ContribAuthor ">Filippo  Cottiglia</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>, <span class="hlFld-ContribAuthor ">Alessia  Onali</span>, <span class="hlFld-ContribAuthor ">Erica  Sanna</span>, <span class="hlFld-ContribAuthor ">Andrea  Angeli</span>, <span class="hlFld-ContribAuthor ">Rossella  Angius</span>, <span class="hlFld-ContribAuthor ">Stefano  Alcaro</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>, <span class="hlFld-ContribAuthor ">Simona  Distinto</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2021,</strong> <em>36 </em>
                                    (1)
                                     , 685-692. <a href="https://doi.org/10.1080/14756366.2021.1887171" title="DOI URL">https://doi.org/10.1080/14756366.2021.1887171</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2021.1887171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2021.1887171%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSelective%252Binhibition%252Bof%252Bcarbonic%252Banhydrase%252BIX%252Band%252BXII%252Bby%252Bcoumarin%252Band%252Bpsoralen%252Bderivatives%26aulast%3DMeleddu%26aufirst%3DRita%26date%3D2021%26date%3D2021%26volume%3D36%26issue%3D1%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Shuai  Zhen</span>, <span class="hlFld-ContribAuthor ">Kaijun  Su</span>, <span class="hlFld-ContribAuthor ">Anthony  Tumber</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Dong</span>, <span class="hlFld-ContribAuthor ">Michael  McDonough</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schofield</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (91)
                                     , 14199-14202. <a href="https://doi.org/10.1039/D0CC06353C" title="DOI URL">https://doi.org/10.1039/D0CC06353C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC06353C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC06353C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DA%252Bsmall-molecule%252Bprobe%252Bfor%252Bmonitoring%252Bbinding%252Bto%252Bprolyl%252Bhydroxylase%252Bdomain%252B2%252Bby%252Bfluorescence%252Bpolarisation%26aulast%3DLi%26aufirst%3DZhihong%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D91%26spage%3D14199%26epage%3D14202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yunyao  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Wang</span>, <span class="hlFld-ContribAuthor ">Wenshu  Li</span>, <span class="hlFld-ContribAuthor ">Yujiao  Xu</span>, <span class="hlFld-ContribAuthor ">Yating  Zhuo</span>, <span class="hlFld-ContribAuthor ">Mengyuan  Li</span>, <span class="hlFld-ContribAuthor ">Yuan  He</span>, <span class="hlFld-ContribAuthor ">Xiaosheng  Wang</span>, <span class="hlFld-ContribAuthor ">Qinglong  Guo</span>, <span class="hlFld-ContribAuthor ">Li  Zhao</span>, <span class="hlFld-ContribAuthor ">Lei  Qiang</span>. </span><span class="cited-content_cbyCitation_article-title">Oroxylin A reverses hypoxia-induced cisplatin resistance through inhibiting HIF-1α mediated XPC transcription. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2020,</strong> <em>39 </em>
                                    (45)
                                     , 6893-6905. <a href="https://doi.org/10.1038/s41388-020-01474-x" title="DOI URL">https://doi.org/10.1038/s41388-020-01474-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41388-020-01474-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41388-020-01474-x%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DOroxylin%252BA%252Breverses%252Bhypoxia-induced%252Bcisplatin%252Bresistance%252Bthrough%252Binhibiting%252BHIF-1%2525CE%2525B1%252Bmediated%252BXPC%252Btranscription%26aulast%3DLiu%26aufirst%3DYunyao%26date%3D2020%26date%3D2020%26volume%3D39%26issue%3D45%26spage%3D6893%26epage%3D6905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhan  Yu</span>, <span class="hlFld-ContribAuthor ">Zhihong  Li</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Huilin  Song</span>, <span class="hlFld-ContribAuthor ">Hanyu  Sun</span>, <span class="hlFld-ContribAuthor ">Rufeng  Fan</span>, <span class="hlFld-ContribAuthor ">Angzhi  Bi</span>, <span class="hlFld-ContribAuthor ">Jun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of prolyl hydroxylase 2 inhibitors with new chemical scaffolds as in vivo active erythropoietin inducers through a combined virtual screening strategy. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2020,</strong> <em>95 </em>
                                    (2)
                                     , 270-278. <a href="https://doi.org/10.1111/cbdd.13640" title="DOI URL">https://doi.org/10.1111/cbdd.13640</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13640%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDiscovery%252Bof%252Bprolyl%252Bhydroxylase%252B2%252Binhibitors%252Bwith%252Bnew%252Bchemical%252Bscaffolds%252Bas%252Bin%252Bvivo%252Bactive%252Berythropoietin%252Binducers%252Bthrough%252Ba%252Bcombined%252Bvirtual%252Bscreening%252Bstrategy%26aulast%3DYu%26aufirst%3DZhan%26date%3D2020%26date%3D2019%26volume%3D95%26issue%3D2%26spage%3D270%26epage%3D278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruo-Lan  Li</span>, <span class="hlFld-ContribAuthor ">Li-Ying  He</span>, <span class="hlFld-ContribAuthor ">Qing  Zhang</span>, <span class="hlFld-ContribAuthor ">Jia  Liu</span>, <span class="hlFld-ContribAuthor ">Feng  Lu</span>, <span class="hlFld-ContribAuthor ">Hu-Xin-Yue  Duan</span>, <span class="hlFld-ContribAuthor ">Lin-Hong  Fan</span>, <span class="hlFld-ContribAuthor ">Wei  Peng</span>, <span class="hlFld-ContribAuthor ">Yong-Liang  Huang</span>, <span class="hlFld-ContribAuthor ">Chun-Jie  Wu</span>. </span><span class="cited-content_cbyCitation_article-title"><p>HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases</p>. </span><span class="cited-content_cbyCitation_journal-name">Drug Design, Development and Therapy</span><span> <strong>2020,</strong> <em>Volume 14 </em>, 4915-4949. <a href="https://doi.org/10.2147/DDDT.S274980" title="DOI URL">https://doi.org/10.2147/DDDT.S274980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/DDDT.S274980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FDDDT.S274980%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Design%252C%2520Development%2520and%2520Therapy%26atitle%3D%25253Cp%25253EHIF-1%2525CE%2525B1%252Bis%252Ba%252BPotential%252BMolecular%252BTarget%252Bfor%252BHerbal%252BMedicine%252Bto%252BTreat%252BDiseases%25253C%25252Fp%25253E%26aulast%3DLi%26aufirst%3DRuo-Lan%26date%3D2020%26date%3D2020%26volume%3DVolume%252014%26spage%3D4915%26epage%3D4949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yancheng  Yu</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric inhibition of HIF-2α as a novel therapy for clear cell renal cell carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2332-2340. <a href="https://doi.org/10.1016/j.drudis.2019.09.008" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAllosteric%252Binhibition%252Bof%252BHIF-2%2525CE%2525B1%252Bas%252Ba%252Bnovel%252Btherapy%252Bfor%252Bclear%252Bcell%252Brenal%252Bcell%252Bcarcinoma%26aulast%3DYu%26aufirst%3DYancheng%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2332%26epage%3D2340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0026.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Functional domains of the HIF subunits. HIF-1α and HIF-2α share high amino acid sequence similarities, while C-TAD is missing in HIF-3α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Profile of the main findings related to the critical components of the HIF pathway and the major modeled behaviors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Small-molecule inhibitors of the HIF pathway targeting different sites.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. NMR structure of CH1domain of p300 (red) in complex with the HIF-1α CAD peptide (yellow) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L3E">1L3E</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Natural products as inhibitors of the HIF-1α/p300 protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Small-molecule inhibitors involved in the HIF-1α/p300 protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Representative peptoid inhibitors of the HIF-1α/p300 protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Small-molecule inhibitors interrupting HIF-α/HIF-β dimerization.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Binding of the HIF-2α PAS-B and HIF-β PAS-B domain (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TBM">5TBM</a>) and the binding mode of PT2385 (<b>30</b>) with HIF-2α.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Small-molecule inhibitors of HIF-1 DNA binding.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Architecture of HIF bHLH-PAS heterodimers: (A) X-ray crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPR">4ZPR</a>) of the HIF-1α/HIF-β bHLH-PAS heterodimer bound to DNA; (B) crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPK">4ZPK</a>) of the HIF-2α/HIF-β bHLH-PAS heterodimer bound to DNA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Small-molecule inhibitors that down-regulate HIF-1α mRNA expression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Representative small-molecules that suppress HIF-1α expression.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Representative small molecules that decrease the stability of the HIF-1α protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Representative small molecules that facilitate HIF-1α degradation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Small molecule that inhibits HIF at multiple pathways.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Oxygen-dependent regulation process of HIF-α and the potential strategies for activating the HIF pathway.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. (A) Crystal structures of the PHD2 (red) and HIF-1α peptide substrate (green) complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR">3HQR</a>). (B) Crystal structure of PHD2 and 2-OG complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ">3OUJ</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of representative small-molecule inhibitors of PHD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Crystal structure of the PHD2 and FG-2216 (<b>75</b>) complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT">2HBT</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Crystal structure of the PHD1 and <b>85</b> complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5%2520V1B">5 V1B</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Small-molecule inhibitors of the VHL:HIF-α protein–protein interaction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. (A) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LQB">1LQB</a>) of the pVHL and hydroxylated HIF-1α CODD peptide complex. (B) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LLI">5LLI</a>) of the VBC and VH298 (<b>89</b>) complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. (A) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JWP">5JWP</a>) of the FIH (yellow), HIF-1α peptide (green), and 2-OG complex. (B) Crystal structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MZF">1MZF</a>) of the FIH and 2-OG complex.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/medium/jm-2018-01596q_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Structures of small-molecule inhibitors of FIH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-12/acs.jmedchem.8b01596/20190621/images/large/jm-2018-01596q_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01596&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70187" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70187" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 165 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">The human oxygen sensing machinery and its manipulation</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>37</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1308</span>– <span class="NLM_lpage">1319</span>, <span class="refDoi"> DOI: 10.1039/b701676j</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2Fb701676j" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18568157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFejsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2008&pages=1308-1319&issue=7&author=R.+Chowdhuryauthor=A.+Hardyauthor=C.+J.+Schofield&title=The+human+oxygen+sensing+machinery+and+its+manipulation&doi=10.1039%2Fb701676j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The human oxygen sensing machinery and its manipulation</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; Hardy, Adam; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1308-1319</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Animals respond to the challenge of limited oxygen availability by a coordinated response that works to increase oxygen supply and minimize tissue damage.  The chronic hypoxic response is mediated by the α,β-hypoxia inducible transcription factor (HIF) that enables the expression of a gene array.  Because this array includes genes encoding for proteins that regulate processes including red blood cell and blood vessel formation, manipulation of the HIF system has potential for the treatment of ischemic diseases, anemia and tumors.  Hydroxylase enzymes act as oxygen sensors by regulating both the lifetime of HIF-α and its transcriptional activity.  This tutorial review aims to provide a non-expert introduction to the HIF field by providing a background to current work, summarizing mol. knowledge on the HIF system, and outlining opportunities for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8ryJk6Dq22LVg90H21EOLACvtfcHk0lgQ3lckpofU3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFejsLg%253D&md5=0065a2e7f0c71d834cda758fd6bb3437</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1039%2Fb701676j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb701676j%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DHardy%26aufirst%3DA.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520human%2520oxygen%2520sensing%2520machinery%2520and%2520its%2520manipulation%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2008%26volume%3D37%26issue%3D7%26spage%3D1308%26epage%3D1319%26doi%3D10.1039%2Fb701676j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B.Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klco, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickols, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervan, P. B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">16768</span>– <span class="NLM_lpage">16773</span>, <span class="refDoi"> DOI: 10.1073/pnas.0407617101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0407617101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15556999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16768-16773&issue=48&author=B.Z.+Olenyukauthor=G.+J.+Zhangauthor=J.+M.+Klcoauthor=N.+G.+Nickolsauthor=W.+G.+Kaelinauthor=P.+B.+Dervan&title=Inhibition+of+vascular+endothelial+growth+factor+with+a+sequence-specific+hypoxia+response+element+antagonist&doi=10.1073%2Fpnas.0407617101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist</span></div><div class="casAuthors">Olenyuk, Bogdan Z.; Zhang, Guo-Jun; Klco, Jeffery M.; Nickols, Nicholas G.; Kaelin, William G., Jr.; Dervan, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16768-16773</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) and its receptors have been implicated as key factors in tumor angiogenesis that are up-regulated by hypoxia.  We evaluated the effects of DNA-binding small mols. on hypoxia-inducible transcription of VEGF.  A synthetic pyrrole-imidazole polyamide designed to bind the hypoxia response element (HRE) was found to disrupt hypoxia-inducible factor (HIF) binding to HRE.  In cultured HeLa cells, this resulted in a redn. of VEGF mRNA and secreted protein levels.  The obsd. effects were polyamide-specific and dose-dependent.  Anal. of genome-wide effects of the HRE-specific polyamide revealed that a no. of hypoxia-inducible genes were downregulated.  Pathway-based regulation of hypoxia-inducible gene expression with DNA-binding small mols. may represent a new approach for targeting angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmHMJXCJLFfbVg90H21EOLACvtfcHk0lgQ3lckpofU3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansrzF&md5=771a32718ed7b951effab51bd04565b6</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407617101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407617101%26sid%3Dliteratum%253Aachs%26aulast%3DOlenyuk%26aufirst%3DB.Z.%26aulast%3DZhang%26aufirst%3DG.%2BJ.%26aulast%3DKlco%26aufirst%3DJ.%2BM.%26aulast%3DNickols%26aufirst%3DN.%2BG.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26aulast%3DDervan%26aufirst%3DP.%2BB.%26atitle%3DInhibition%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520with%2520a%2520sequence-specific%2520hypoxia%2520response%2520element%2520antagonist%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26issue%3D48%26spage%3D16768%26epage%3D16773%26doi%3D10.1073%2Fpnas.0407617101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Higashijima, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nangaku, M.</span></span> <span> </span><span class="NLM_article-title">Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1517/17460441.2013.796358</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1517%2F17460441.2013.796358" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23642028" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOitL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=965-976&issue=8&author=Y.+Higashijimaauthor=T.+Tanakaauthor=M.+Nangaku&title=Structure-based+drug+design+for+hypoxia-inducible+factor+prolyl-hydroxylase+inhibitors+and+its+therapeutic+potential+for+the+treatment+of+erythropoiesis-stimulating+agent-resistant+anemia%3A+raising+expectations+for+exploratory+clinical+trials&doi=10.1517%2F17460441.2013.796358"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design for hypoxia-inducible factor prolyl-hydroxylase inhibitors and its therapeutic potential for the treatment of erythropoiesis-stimulating agent-resistant anemia: raising expectations for exploratory clinical trials</span></div><div class="casAuthors">Higashijima, Yoshiki; Tanaka, Tetsuhiro; Nangaku, Masaomi</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">965-976</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Anemia occurs in various chronic diseases and its treatment is dramatically improved after the appearance of erythropoiesis-stimulating agents (ESA).  However, there are several problems regarding the use of ESA including: (i) invasiveness, (ii) high cost and (iii) ESA resistance.  Therefore, there is a need to develop small mol. drugs which can improve these problems.  Hypoxia-inducible factor (HIF) plays a key role in regulating erythropoietin prodn.  HIF stabilizers, particularly, prolyl hydroxylase domain-contg. protein (PHD) inhibitors, have emerged as small mol.-based anti-anemia medicine.  Areas covered: This article discusses the current status of PHD inhibitors and the pros and cons of currently tested methods.  Specifically, the article reviews the advantages of structure-based drug design in the development of PHD inhibitors and looks at future perspectives within the field.  Expert opinion: Despite the fact that structure-based drug design has dramatically improved drug discovery, testing on humans is still one of the most time-consuming parts of drug discovery and one that is not accelerated by structural approaches.  Exploratory clin. trials, first-in-man studies have emerged as a new strategy for preclin. and clin. development of drugs.  Exploratory clin. trials will not only reduce the time and cost in preclin. trials but also provide important information on candidate drug's pharmacol. effects in humans.  Exploratory clin. trials may be a potential alternative strategy for the drug discovery in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-cXHk00oTjLVg90H21EOLACvtfcHk0lgh3QYj1cNUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOitL7K&md5=e91fa9d462817c59affc775b48911b1b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F17460441.2013.796358&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17460441.2013.796358%26sid%3Dliteratum%253Aachs%26aulast%3DHigashijima%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DNangaku%26aufirst%3DM.%26atitle%3DStructure-based%2520drug%2520design%2520for%2520hypoxia-inducible%2520factor%2520prolyl-hydroxylase%2520inhibitors%2520and%2520its%2520therapeutic%2520potential%2520for%2520the%2520treatment%2520of%2520erythropoiesis-stimulating%2520agent-resistant%2520anemia%253A%2520raising%2520expectations%2520for%2520exploratory%2520clinical%2520trials%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2013%26volume%3D8%26issue%3D8%26spage%3D965%26epage%3D976%26doi%3D10.1517%2F17460441.2013.796358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jain, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolopoulou, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, A.</span></span> <span> </span><span class="NLM_article-title">Hypoxia inducible factor as a therapeutic target for atherosclerosis</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>183</i></span>,  <span class="NLM_fpage">22</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2017.09.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.pharmthera.2017.09.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28942242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOrt7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2018&pages=22-33&author=T.+Jainauthor=E.+A.+Nikolopoulouauthor=Q.+Xuauthor=A.+Qu&title=Hypoxia+inducible+factor+as+a+therapeutic+target+for+atherosclerosis&doi=10.1016%2Fj.pharmthera.2017.09.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia inducible factor as a therapeutic target for atherosclerosis</span></div><div class="casAuthors">Jain, Tanmay; Nikolopoulou, Eleni Aliki; Xu, Qingbo; Qu, Aijuan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22-33</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Atherosclerosis is a highly prevalent disease that can significantly increase the risk of major vascular events, such as myocardial or cerebral infarctions.  The anoxemia theory states that a disparity between oxygen supply and demand contributes to atherosclerosis.  Hypoxia inducible factor-1 (HIF-1) is a heterodimeric protein, part of the basic helix-loop-helix family and one of the main regulators of cellular responses in a low-oxygen environment.  It plays a key role in the development of atherosclerosis through cell-specific responses, acting on endothelial cells, vascular smooth muscle cells (SMCs) and macrophages.  Through the upregulation of VEGF, NO, ROS and PDGF, HIF-1 is able to cause endothelial cell dysfunction, proliferation, angiogenesis and inflammation.  Activation of the NF-kB pathway in endothelial cells is an important contributor to inflammation and pos. feedbacks to HIF-1.  HIF-1 also plays a significant role in both the proliferation and migration of smooth muscle cells - two important features of atherosclerosis, while the formation of foam cells (lipid-laden macrophages) is also a crit. step in atherosclerosis and mediated by HIF-1 through various mechanisms such as dysfunctional efflux pathways in macrophages.  Overall, HIF-1 exerts its effect on the pathogenesis of atherosclerosis via a variety of mol. and cellular events in the process.  In this review article, we examine the effects HIF-1 on vascular cells and macrophages in the development of atherosclerosis, highlighting the environmental cues and signalling pathways that control HIF-1 expression/activation within the vasculature.  We will highlight the potential of HIF-1 as a therapeutic target on the disease development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQEXMxI2rIlrVg90H21EOLACvtfcHk0lgh3QYj1cNUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOrt7%252FF&md5=8b320f6bbdee92a45abc7de260707810</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2017.09.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2017.09.003%26sid%3Dliteratum%253Aachs%26aulast%3DJain%26aufirst%3DT.%26aulast%3DNikolopoulou%26aufirst%3DE.%2BA.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DQu%26aufirst%3DA.%26atitle%3DHypoxia%2520inducible%2520factor%2520as%2520a%2520therapeutic%2520target%2520for%2520atherosclerosis%26jtitle%3DPharmacol.%2520Ther.%26date%3D2018%26volume%3D183%26spage%3D22%26epage%3D33%26doi%3D10.1016%2Fj.pharmthera.2017.09.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Warfel, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Deiry, W. S.</span></span> <span> </span><span class="NLM_article-title">HIF-1 signaling in drug resistance to chemotherapy</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">3021</span>– <span class="NLM_lpage">3028</span>, <span class="refDoi"> DOI: 10.2174/0929867321666140414101056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.2174%2F0929867321666140414101056" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24735366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKgsrnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=3021-3028&issue=26&author=N.+A.+Warfelauthor=W.+S.+El-Deiry&title=HIF-1+signaling+in+drug+resistance+to+chemotherapy&doi=10.2174%2F0929867321666140414101056"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 Signaling in Drug Resistance to Chemotherapy</span></div><div class="casAuthors">Warfel, N. A.; El-Deiry, W. S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">3021-3028</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Activation of hypoxia-inducible factor 1 (HIF-1) signaling is obsd. in a broad range of human cancers due to tumor hypoxia and epigenetic mechanisms.  HIF-1 activation leads to the transcription of a plethora of target genes that promote physiol. changes assocd. with therapeutic resistance, including the inhibition of apoptosis and senescence and the activation of drug efflux and cellular metab.  As a result, targeting HIF-1 represents an attractive strategy to enhance the efficacy of current therapies as well as reduce resistance to chemotherapy in tumors.  Approaches to inhibit HIF-1 signaling have primarily focused on reducing HIF-1α protein levels, by inducing its degrdn. or inhibiting its transcription, inhibiting HIF-1-mediated transcription, or disrupting the formation of the HIF-1 transcription factor complex.  To date, multiple preclin. and clin. agents have been identified that effectively inhibit HIF-1 activity through various mechanisms, likely accounting for a portion of their anti-tumor efficacy.  This review aims to provide an overview of our current understanding of the role of HIF-1 in therapeutic resistance and discuss the ongoing effort to develop HIF-1 inhibitors as an anti-cancer strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosCs3z--5GYLVg90H21EOLACvtfcHk0lgh3QYj1cNUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKgsrnN&md5=c8648648e198f8e4d880e455b706b41b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F0929867321666140414101056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666140414101056%26sid%3Dliteratum%253Aachs%26aulast%3DWarfel%26aufirst%3DN.%2BA.%26aulast%3DEl-Deiry%26aufirst%3DW.%2BS.%26atitle%3DHIF-1%2520signaling%2520in%2520drug%2520resistance%2520to%2520chemotherapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D21%26issue%3D26%26spage%3D3021%26epage%3D3028%26doi%3D10.2174%2F0929867321666140414101056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masoud, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span> <span> </span><span class="NLM_article-title">HIF-1α pathway: role, regulation and intervention for cancer therapy</span>. <i>Acta Pharm. Sin. B</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/j.apsb.2015.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.apsb.2015.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26579469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A280%3ADC%252BC28rgtlOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=378-389&issue=5&author=G.+N.+Masoudauthor=W.+Li&title=HIF-1%CE%B1+pathway%3A+role%2C+regulation+and+intervention+for+cancer+therapy&doi=10.1016%2Fj.apsb.2015.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1α pathway: role, regulation and intervention for cancer therapy</span></div><div class="casAuthors">Masoud Georgina N; Li Wei</div><div class="citationInfo"><span class="NLM_cas:title">Acta pharmaceutica Sinica. B</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">378-89</span>
        ISSN:<span class="NLM_cas:issn">2211-3835</span>.
    </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer drug target.  Many recent studies have provided convincing evidences of strong correlation between elevated levels of HIF-1 and tumor metastasis, angiogenesis, poor patient prognosis as well as tumor resistance therapy.  It was found that hypoxia (low O2 levels) is a common character in many types of solid tumors.  As an adaptive response to hypoxic stress, hypoxic tumor cells activate several survival pathways to carry out their essential biological processes in different ways compared with normal cells.  Recent advances in cancer biology at the cellular and molecular levels highlighted the HIF-1α pathway as a crucial survival pathway for which novel strategies of cancer therapy could be developed.  However, targeting the HIF-1α pathway has been a challenging but promising progresses have been made in the past twenty years.  This review summarizes the role and regulation of the HIF-1α in cancer, and recent therapeutic approaches targeting this important pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-qtzzXrDFl5ggzHGM8X5CfW6udTcc2ebT-BawkccU8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rgtlOqsg%253D%253D&md5=807f3c1d149d6f93137dac071e13d1d5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.apsb.2015.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apsb.2015.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DMasoud%26aufirst%3DG.%2BN.%26aulast%3DLi%26aufirst%3DW.%26atitle%3DHIF-1%25CE%25B1%2520pathway%253A%2520role%252C%2520regulation%2520and%2520intervention%2520for%2520cancer%2520therapy%26jtitle%3DActa%2520Pharm.%2520Sin.%2520B%26date%3D2015%26volume%3D5%26issue%3D5%26spage%3D378%26epage%3D389%26doi%3D10.1016%2Fj.apsb.2015.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the discovery of HIF-1alpha-p300/CBP inhibitors as anti-cancer agents</span>. <i>Mini-Rev. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.2174/1389557516666160630124938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.2174%2F1389557516666160630124938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27484627" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1amu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=296-309&issue=4&author=J.+Weiauthor=Y.+Yangauthor=M.+Luauthor=Y.+Leiauthor=L.+Xuauthor=Z.+Jiangauthor=X.+Xuauthor=X.+Guoauthor=X.+Zhangauthor=H.+Sunauthor=Q.+You&title=Recent+advances+in+the+discovery+of+HIF-1alpha-p300%2FCBP+inhibitors+as+anti-cancer+agents&doi=10.2174%2F1389557516666160630124938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents</span></div><div class="casAuthors">Wei, Jinlian; Yang, Yingrui; Lu, Mengchen; Lei, Yonghua; Xu, Lili; Jiang, Zhengyu; Xu, Xiaoli; Guo, Xiaoke; Zhang, Xiaojin; Sun, Haopeng; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">Mini-Reviews in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">296-309</span>CODEN:
                <span class="NLM_cas:coden">MMCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1389-5575</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1), a heterodimeric (contg. &#945; and &#946; subunits) transcription factor, is involved in hypoxia response pathway that regulates the expression of many tumorrelated genes.  The stabilized HIF-1 heterodimer couples to the general co-activators p300/CBP (CREB binding protein), forming an active transcription factor to initiate hypoxic responses.  Inhibiting the transcription factor-coactivator HIF-1&#945;-p300/CBP interaction represents an attractive approach for blocking hypoxia pathway in tumors.  Recently, diverse HIF-1&#945;-p300/CBP inhibitors have been designed and their anti-tumor activities have been evaluated.  The developments of inhibitors of HIF-1&#945;- p300/CBP are discussed in this review.  An outline of structures and biol. activities of these inhibitors can be traced, along with the approaches for inhibitors discovery.  The challenges in identifying novel and selective potent inhibitors of HIF-1&#945;-p300/CBP are also put forward.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEyyag59FsKLVg90H21EOLACvtfcHk0lgfYTQ6cUa_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1amu7w%253D&md5=b73708d2cc6a9cd34375efbbc6b60e66</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1389557516666160630124938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389557516666160630124938%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DRecent%2520advances%2520in%2520the%2520discovery%2520of%2520HIF-1alpha-p300%252FCBP%2520inhibitors%2520as%2520anti-cancer%2520agents%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2018%26volume%3D18%26issue%3D4%26spage%3D296%26epage%3D309%26doi%3D10.2174%2F1389557516666160630124938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson’s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">121</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2018.00121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.3389%2Ffnagi.2018.00121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29755339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=121&author=X.+Liauthor=X.+X.+Cuiauthor=Y.+J.+Chenauthor=T.+T.+Wuauthor=H.+Xuauthor=H.+Yinauthor=Y.+C.+Wu&title=Therapeutic+potential+of+a+prolyl+hydroxylase+inhibitor+FG-4592+for+Parkinson%E2%80%99s+diseases+in+vitro+and+in+vivo%3A+regulation+of+redox+biology+and+mitochondrial+function&doi=10.3389%2Ffnagi.2018.00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for parkinson's diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span></div><div class="casAuthors">Li, Xuan; Cui, Xin-Xin; Chen, Ya-Jing; Wu, Ting-Ting; Xu, Huaxi; Yin, Huiyong; Wu, Yun-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">121/1-121/16</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">As the main transcription factor that regulates the cellular responses to hypoxia, Hypoxia-inducible factor-1α (HIF-1α) plays an important role in the pathogenesis of Parkinson's disease (PD).  HIF-1α is normally degraded through ubiquitination after hydroxylation by prolyl hydroxylases (PHD).  Emerging evidence has suggested that HIF PHD inhibitors (HIF-PHI) may have neuroprotective effects on PD through increasing HIF-1α levels.  However, the therapeutic benefit of HIF-PHI for PD remains poorly explored due to the lack of proper clin. compds. and understanding of the underlying mol. mechanisms.  In this study, we examd. the therapeutic benefit of a new HIF-PHI, FG-4592, which is currently in phase 3 clin. trials to treat anemia in patients with chronic kidney diseases (CKD) in PD models.  FG-4592 attenuates MPP+-induced apoptosis and loss of tyrosine hydroxylase (TH) in SHSY5Y cells.  Pretreatment with FG-4592 mitigates MPP+-induced loss of mitochondrial membrane potential (MMP), mitochondrial oxygen consumption rate (OCR), prodn. of reactive oxygen species (ROS) and ATP.  Furthermore, FG-4592 counterbalances the oxidative stress through up-regulating nuclear factor erythroid 2 p45-related factor 2 (Nrf-2), heme oxygenase-1 (HO-1) and superoxide dismutase 2 (SOD2).  FG-4592 treatment also induces the expression of Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) through increasing the phosphorylation of AMP-activated protein kinase (AMPK).  In MPTP-treated mice, FG-4592 protects against MPTP-induced loss of TH-pos. neurons of substantia nigra and attenuates behavioral impairments.  Collectively, our study demonstrates that FG-4592 is a promising therapeutic strategy for PD through improving the mitochondrial function under oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQ__V5ZZmvrVg90H21EOLACvtfcHk0lgfYTQ6cUa_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN&md5=6de27ad23eb1b16c4384ff23d385b38e</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2018.00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2018.00121%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DX.%2BX.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DWu%26aufirst%3DT.%2BT.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%2BC.%26atitle%3DTherapeutic%2520potential%2520of%2520a%2520prolyl%2520hydroxylase%2520inhibitor%2520FG-4592%2520for%2520Parkinson%25E2%2580%2599s%2520diseases%2520in%2520vitro%2520and%2520in%2520vivo%253A%2520regulation%2520of%2520redox%2520biology%2520and%2520mitochondrial%2520function%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2018%26volume%3D10%26spage%3D121%26doi%3D10.3389%2Ffnagi.2018.00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eltzschig, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colgan, S. P.</span></span> <span> </span><span class="NLM_article-title">Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">852</span>– <span class="NLM_lpage">869</span>, <span class="refDoi"> DOI: 10.1038/nrd4422</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnrd4422" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25359381" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVCmsrrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=852-869&issue=11&author=H.+K.+Eltzschigauthor=D.+L.+Brattonauthor=S.+P.+Colgan&title=Targeting+hypoxia+signalling+for+the+treatment+of+ischaemic+and+inflammatory+diseases&doi=10.1038%2Fnrd4422"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting hypoxia signalling for the treatment of ischemic and inflammatory diseases</span></div><div class="casAuthors">Eltzschig, Holger K.; Bratton, Donna L.; Colgan, Sean P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">852-869</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIFs) are stabilized during adverse inflammatory processes assocd. with disorders such as inflammatory bowel disease, pathogen infection and acute lung injury, as well as during ischemia-reperfusion injury.  HIF stabilization and hypoxia-induced changes in gene expression have a profound impact on the inflamed tissue microenvironment and on disease outcomes.  Although the mechanism that initiates HIF stabilization may vary, the final mol. steps that control HIF stabilization converge on a set of oxygen-sensing prolyl hydroxylases (PHDs) that mark HIFs for proteasomal degrdn.  PHDs are therefore promising therapeutic targets.  In this Review, we discuss the emerging potential and assocd. challenges of targeting the PHD-HIF pathway for the treatment of inflammatory and ischemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx3QDAep7Kn7Vg90H21EOLACvtfcHk0lgfYTQ6cUa_1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVCmsrrP&md5=df291f8754ab0cb25ef5c9abdfb09c24</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrd4422&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4422%26sid%3Dliteratum%253Aachs%26aulast%3DEltzschig%26aufirst%3DH.%2BK.%26aulast%3DBratton%26aufirst%3DD.%2BL.%26aulast%3DColgan%26aufirst%3DS.%2BP.%26atitle%3DTargeting%2520hypoxia%2520signalling%2520for%2520the%2520treatment%2520of%2520ischaemic%2520and%2520inflammatory%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26issue%3D11%26spage%3D852%26epage%3D869%26doi%3D10.1038%2Fnrd4422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors in physiology and medicine</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">399</span>– <span class="NLM_lpage">408</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2012.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cell.2012.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22304911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFaqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2012&pages=399-408&issue=3&author=G.+L.+Semenza&title=Hypoxia-inducible+factors+in+physiology+and+medicine&doi=10.1016%2Fj.cell.2012.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factors in physiology and medicine</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">399-408</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxygen homeostasis represents an organizing principle for understanding metazoan evolution, development, physiol., and pathobiol.  The hypoxia-inducible factors (HIFs) are transcriptional activators that function as master regulators of oxygen homeostasis in all metazoan species.  Rapid progress is being made in elucidating homeostatic roles of HIFs in many physiol. systems, detg. pathol. consequences of HIF dysregulation in chronic diseases, and investigating potential targeting of HIFs for therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeggwDZ0i657Vg90H21EOLACvtfcHk0lhSgEyd84lBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFaqsrY%253D&md5=f43f8e5c556c8aa7a5596176ecf31af5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2012.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2012.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DHypoxia-inducible%2520factors%2520in%2520physiology%2520and%2520medicine%26jtitle%3DCell%26date%3D2012%26volume%3D148%26issue%3D3%26spage%3D399%26epage%3D408%26doi%3D10.1016%2Fj.cell.2012.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ema, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokotani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujii-Kuriyama, Y.</span></span> <span> </span><span class="NLM_article-title">A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">4273</span>– <span class="NLM_lpage">4278</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.9.4273</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.94.9.4273" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=9113979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK2sXjtVyitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=4273-4278&issue=9&author=M.+Emaauthor=S.+Tayaauthor=N.+Yokotaniauthor=K.+Sogawaauthor=Y.+Matsudaauthor=Y.+Fujii-Kuriyama&title=A+novel+bHLH-PAS+factor+with+close+sequence+similarity+to+hypoxia-inducible+factor+1alpha+regulates+the+VEGF+expression+and+is+potentially+involved+in+lung+and+vascular+development&doi=10.1073%2Fpnas.94.9.4273"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development</span></div><div class="casAuthors">Ema, Masatsugu; Taya, Shinichiro; Yokotani, Noboru; Sogawa, Kazuhiro; Matsuda, Youichi; Fujii-Kuriyama, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4273-4278</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The authors have isolated and characterized a cDNA for a novel Per-Arnt/AhR-Sim basic helix-loop-helix (bHLH-PAS) factor that interacts with the Ah receptor nuclear translocator (Arnt), and its predicted amino acid sequence exhibits significant similarity to the hypoxia-inducible factor 1α (HIF1α) and Drosophila trachealess (dTrh) gene product.  The HIF1α-like factor (HLF) encoded by the isolated cDNA bound the hypoxia-response element (HRE) found in enhancers of genes for erythropoietin, vascular endothelial growth factor (VEGF), and various glycolytic enzymes, and activated transcription of a reporter gene harboring the HRE.  Although transcription-activating properties of HLF were very similar to those reported for HIFA1α, their expression patterns were quite different between the two factors; HLF mRNA was most abundantly expressed in lung, followed by heart, liver, and other various organs under normoxic conditions, whereas HIF1α mRNA was ubiquitously expressed at much lower levels.  In lung development around parturition, HLF mRNA expression was markedly enhanced, whereas that of HIF1α mRNA remained apparently unchanged at a much lower level.  Moreover, HLF mRNA expression was closely correlated with that of VEGF mRNA.  Whole mount in situ hybridization expts. demonstrated that HLF mRNA was expressed in vascular endothelial cells at the middle stages (9.5 and 10.5 days postcoitus) of mouse embryo development, where HIF1α mRNA was almost undetectable.  The high expression level of HLF mRNA in the O2 delivery system of developing embryos and adult organs suggests that in a normoxic state, HLF regulates gene expression of VEGF, various glycolytic enzymes, and others driven by the HRE sequence, and may be involved in development of blood vessels and the tubular system of lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5Z3HBze-7drVg90H21EOLACvtfcHk0lhSgEyd84lBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjtVyitbY%253D&md5=b847e32f117f6adc37ec975252d64275</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.9.4273&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.9.4273%26sid%3Dliteratum%253Aachs%26aulast%3DEma%26aufirst%3DM.%26aulast%3DTaya%26aufirst%3DS.%26aulast%3DYokotani%26aufirst%3DN.%26aulast%3DSogawa%26aufirst%3DK.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DFujii-Kuriyama%26aufirst%3DY.%26atitle%3DA%2520novel%2520bHLH-PAS%2520factor%2520with%2520close%2520sequence%2520similarity%2520to%2520hypoxia-inducible%2520factor%25201alpha%2520regulates%2520the%2520VEGF%2520expression%2520and%2520is%2520potentially%2520involved%2520in%2520lung%2520and%2520vascular%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D9%26spage%3D4273%26epage%3D4278%26doi%3D10.1073%2Fpnas.94.9.4273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogenesch, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wartman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradfield, C. A.</span></span> <span> </span><span class="NLM_article-title">Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α</span>. <i>Gene Expression</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">213</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=9840812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1cXnslKhsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1998&pages=205-213&issue=3&author=Y.+Z.+Guauthor=S.+M.+Moranauthor=J.+B.+Hogeneschauthor=L.+Wartmanauthor=C.+A.+Bradfield&title=Molecular+characterization+and+chromosomal+localization+of+a+third+%CE%B1-class+hypoxia+inducible+factor+subunit%2C+HIF3%CE%B1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α</span></div><div class="casAuthors">Gu, Yi-Zhong; Moran, Susan M.; Hogenesch, John B.; Wartman, Lukas; Bradfield, Christopher A.</div><div class="citationInfo"><span class="NLM_cas:title">Gene Expression</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">205-213</span>CODEN:
                <span class="NLM_cas:coden">GEEXEJ</span>;
        ISSN:<span class="NLM_cas:issn">1052-2166</span>.
    
            (<span class="NLM_cas:orgname">Cognizant Communication Corp.</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors that regulate a no. of adaptive responses to low oxygen tension.  They are composed of α- and β-subunits that belong to the basic helix-loop-helix-PAS (bHLH-PAS) superfamily.  In these efforts to identify new bHLH-PAS proteins, the authors cloned a cDNA encoding a novel α-class hypoxia inducible factor, HIF3α.  The HIF3α open reading frame encodes a 662-amino acid protein with a predicted mol. wt. of 73 kDa and is expressed in adult thymus, lung, brain, heart, and kidney.  The N-terminal bHLH-PAS domain of this protein shares amino acid sequence identity with that of HIF1α and HIF2α (57% and 53% identity, resp.).  The C-terminus of HIF3α contains a 36-amino acid sequence that shares 61% identity with the hypoxia responsive domain-1 (HRD1) of HIF1α.  In transient transfections, this domain confers hypoxia responsiveness when linked to a heterologous transactivation domain.  In vitro studies reveal that HIF3α dimerizes with a prototype β-class subunit, ARNT, and that the resultant heterodimer recognizes the hypoxia responsive element (HRE) core sequence, TACGTG.  Transient transfection expts. demonstrate that the HIF3α-ARNT interaction can occur in vivo, and that the activity of HIF3α is upregulated in response to cobalt chloride or low oxygen tension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUZOh7jJT1eLVg90H21EOLACvtfcHk0lhSgEyd84lBfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslKhsLg%253D&md5=6f6f960ed1aa4bf35618b8a022791d1c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DY.%2BZ.%26aulast%3DMoran%26aufirst%3DS.%2BM.%26aulast%3DHogenesch%26aufirst%3DJ.%2BB.%26aulast%3DWartman%26aufirst%3DL.%26aulast%3DBradfield%26aufirst%3DC.%2BA.%26atitle%3DMolecular%2520characterization%2520and%2520chromosomal%2520localization%2520of%2520a%2520third%2520%25CE%25B1-class%2520hypoxia%2520inducible%2520factor%2520subunit%252C%2520HIF3%25CE%25B1%26jtitle%3DGene%2520Expression%26date%3D1998%26volume%3D7%26issue%3D3%26spage%3D205%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sander, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conley, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hankinson, O.</span></span> <span> </span><span class="NLM_article-title">Cloning of a factor required for activity of the Ah (dioxin) receptor</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>252</i></span> (<span class="NLM_issue">5008</span>),  <span class="NLM_fpage">954</span>– <span class="NLM_lpage">958</span>, <span class="refDoi"> DOI: 10.1126/science.1852076</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1852076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1852076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK38XjsFeitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1991&pages=954-958&issue=5008&author=E.+C.+Hoffmanauthor=H.+Reyesauthor=F.+F.+Chuauthor=F.+Sanderauthor=L.+H.+Conleyauthor=B.+A.+Brooksauthor=O.+Hankinson&title=Cloning+of+a+factor+required+for+activity+of+the+Ah+%28dioxin%29+receptor&doi=10.1126%2Fscience.1852076"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning of a factor required for activity of the Ah (dioxin) receptor</span></div><div class="casAuthors">Hoffman, Emily C.; Reyes, Herminio; Chu, Fong Fong; Sander, Fred; Conley, Linda H.; Brooks, Barbara A.; Hankinson, Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">5008</span>),
    <span class="NLM_cas:pages">954-8</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">The aryl hydrocarbon (Ah) receptor binds various environmental pollutants, such as polycyclic arom. hydrocarbons, heterocyclic amines, and polychlorinated arom. compds. (dioxins, dibenzofurans, and biphenyls), and mediates the carcinogenic effects of these agents.  The cDNA and part of the gene for an 87-kilodalton human protein that is necessary for Ah receptor function have been cloned.  The protein is not the ligand-binding subunit of the receptor but is a factor that is required for the ligand-binding subunit to translocate from the cytosol to the nucleus after binding ligand.  The requirement for this factor distinguishes the Ah receptor from the glucocorticoid receptor, to which the Ah receptor has been presumed to be similar.  Two portions of the 87-kilodalton protein share sequence similarities with 2 Drosophila proteins, Per and Sim.  Another segment of the protein shows conformity to the consensus sequence for the basic helix-loop-helix motif found in proteins that bind DNA as homodimers or heterodimers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1Y4LQODfhXrVg90H21EOLACvtfcHk0lhXhOhWZdUibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38XjsFeitQ%253D%253D&md5=9b50f6894e5bb7a148d6ed9f0e653ee3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1126%2Fscience.1852076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1852076%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DE.%2BC.%26aulast%3DReyes%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DF.%2BF.%26aulast%3DSander%26aufirst%3DF.%26aulast%3DConley%26aufirst%3DL.%2BH.%26aulast%3DBrooks%26aufirst%3DB.%2BA.%26aulast%3DHankinson%26aufirst%3DO.%26atitle%3DCloning%2520of%2520a%2520factor%2520required%2520for%2520activity%2520of%2520the%2520Ah%2520%2528dioxin%2529%2520receptor%26jtitle%3DScience%26date%3D1991%26volume%3D252%26issue%3D5008%26spage%3D954%26epage%3D958%26doi%3D10.1126%2Fscience.1852076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rue, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>271</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">17771</span>– <span class="NLM_lpage">17778</span>, <span class="refDoi"> DOI: 10.1074/jbc.271.30.17771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.271.30.17771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=8663540" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK28XksFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=17771-17778&issue=30&author=B.+H.+Jiangauthor=E.+G.+Rueauthor=L.+Wangauthor=R.+Roeauthor=G.+L.+Semenza&title=Dimerization%2C+DNA+binding%2C+and+transactivation+properties+of+hypoxia-inducible+factor+1&doi=10.1074%2Fjbc.271.30.17771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1</span></div><div class="casAuthors">Jiang, Bing-Hua; Rue, Elizabeth; Wang, Guang L.; Roe, Rick; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">271</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">17771-17778</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix transcription factor that regulates hypoxia-inducible genes including the human erythropoietin (EPO) gene.  This study reports structural features of the HIF-1α subunit that are required for heterodimerization, DNA binding, and transactivation.  The HIF-1α and HIF-1β (ARNT; aryl hydrocarbon receptor nuclear translocator) subunits were coimmunopptd. from nuclear exts., indicating that these proteins heterodimerize in the absence of DNA.  In vitro-translated HIF-1α and HIF-1β generated a HIF-1/DNA complex with similar electrophoretic mobility and sequence specificity as HIF-1 present in nuclear exts. from hypoxic cells.  Compared to 826-amino acid, full-length HIF-1α, amino acids 1-166 mediated heterodimerization with HIF-1β (ARNT), but amino acids 1-390 were required for optimal DNA binding.  A deletion involving the basic domain of HIF-1α eliminated DNA binding without affecting heterodimerization.  In cotransfection assays, forced expression of recombinant HIF-1α and HIF-1β (ARNT) activated transcription of reporter genes contg. EPO enhancer sequences with intact, but not mutant, HIF-1 binding sites.  Deletion of the C-terminus of HIF-1α (amino acids 391-826) markedly decreased the ability of recombinant HIF-1 to activate transcription.  Overexpression of a HIF-1α construct with deletions of the basic domain and C-terminus blocked reporter gene activation by endogenous HIF-1 in hypoxic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIAZXegFaPK7Vg90H21EOLACvtfcHk0lhXhOhWZdUibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XksFyit70%253D&md5=e97f21eebd815ff821bdfeda72b96c87</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.271.30.17771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.271.30.17771%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DRue%26aufirst%3DE.%2BG.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DRoe%26aufirst%3DR.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDimerization%252C%2520DNA%2520binding%252C%2520and%2520transactivation%2520properties%2520of%2520hypoxia-inducible%2520factor%25201%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26issue%3D30%26spage%3D17771%26epage%3D17778%26doi%3D10.1074%2Fjbc.271.30.17771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishopric, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, K. A.</span></span> <span> </span><span class="NLM_article-title">Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">12645</span>– <span class="NLM_lpage">12653</span>, <span class="refDoi"> DOI: 10.1074/jbc.M011344200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M011344200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11278891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtFynt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=12645-12653&issue=16&author=K.+D.+Yamashitaauthor=J.+Discherauthor=J.+Huauthor=N.+H.+Bishopricauthor=K.+A.+Webster&title=Molecular+regulation+of+the+endothelin-1+gene+by+hypoxia.+Contributions+of+hypoxia-inducible+factor-1%2C+activator+protein-1%2C+GATA-2%2C+and+p300%2FCBP&doi=10.1074%2Fjbc.M011344200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/CBP</span></div><div class="casAuthors">Yamashita, Kazuhito; Discher, Daryl J.; Hu, Jing; Bishopric, Nanette H.; Webster, Keith A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">12645-12653</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Endothelin-1 (ET-1) is a peptide hormone with potent vasoconstrictor properties which is synthesized and secreted predominantly by vascular endothelial cells.  Its prodn. is regulated by numerous stimuli including ischemia and hypoxia, and the enhanced levels that occur during myocardial ischemia may contribute to the progression of heart failure.  We reported previously a preliminary characterization of a hypoxia-inducible factor-1 (HIF-1) binding site in the human ET-1 promoter which contributed to the activation of ET-1 expression in endothelial cells.  We report here that the HIF-1 binding site alone is not sufficient for the response to hypoxia but requires an addnl. 50 base pairs of flanking sequence that includes binding sites for the factors activator protein-1 (AP-1), GATA-2, and CAAT-binding factor (NF-1).  Mutation of any one of these sites or the HIF-1 site eliminated induction by hypoxia.  Mutations of the AP-1 and GATA-2 sites, but not the HIF-1 site, were complemented by overexpressing AP-1, GATA-2, HIF-1α, or the activator protein p300/CBP, restoring the response to hypoxia.  Binding studies in vitro confirmed phys. assocns. among GATA-2, AP-1, and HIF-1 factors.  Overexpression or depletion of p300/CBP modulated the level of ET-1 promoter expression as well as the endogenous ET-1 transcript but did not change the fold induction by hypoxia in either case.  Regulation of the ET-1 promoter by hypoxia in non-endothelial cells required overexpression of GATA-2 and HIF-1α.  The results support essential roles for AP-1, GATA-2, and NF-1 in stabilizing the binding of HIF-1 and promoting recruitment of p300/CBP to the ET-1 hypoxia response complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx1xkLdtgQRrVg90H21EOLACvtfcHk0lhXhOhWZdUibA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtFynt7c%253D&md5=0306ca6413b77d0845bb7b2bdc3f71bc</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M011344200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M011344200%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DK.%2BD.%26aulast%3DDischer%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DBishopric%26aufirst%3DN.%2BH.%26aulast%3DWebster%26aufirst%3DK.%2BA.%26atitle%3DMolecular%2520regulation%2520of%2520the%2520endothelin-1%2520gene%2520by%2520hypoxia.%2520Contributions%2520of%2520hypoxia-inducible%2520factor-1%252C%2520activator%2520protein-1%252C%2520GATA-2%252C%2520and%2520p300%252FCBP%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D16%26spage%3D12645%26epage%3D12653%26doi%3D10.1074%2Fjbc.M011344200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hara, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imura, N.</span></span> <span> </span><span class="NLM_article-title">Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: suppression of HIF-mediated gene expression by HIF-3α</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>287</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1006/bbrc.2001.5659</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1006%2Fbbrc.2001.5659" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11573933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntV2gu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2001&pages=808-813&issue=4&author=S.+Haraauthor=J.+Hamadaauthor=C.+Kobayashiauthor=Y.+Kondoauthor=N.+Imura&title=Expression+and+characterization+of+hypoxia-inducible+factor+%28HIF%29-3%CE%B1+in+human+kidney%3A+suppression+of+HIF-mediated+gene+expression+by+HIF-3%CE%B1&doi=10.1006%2Fbbrc.2001.5659"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and characterization of hypoxia-inducible factor (HIF)-3α in human kidney: suppression of HIF-mediated gene expression by HIF-3α</span></div><div class="casAuthors">Hara, Shuntaro; Hamada, Junko; Kobayashi, Chie; Kondo, Yukihiro; Imura, Nobumasa</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">808-813</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors that regulate a no. of adaptive responses to low oxygen tension.  They are composed of α- and β-subunits that belong to the basic helix-loop-helix-PAS superfamily.  Here we examd. the expression of HIF-α subunit proteins in the human kidney and found that, in addn. to HIF-1α and -2α, HIF-3α was also expressed.  The sequence anal. revealed that, like mouse HIF-3α, human HIF-3α has high similarity with HIF-1α and -2α in the bHLH and PAS domains, but lacks structures for transactivation found in the C-terminus of HIF-1α and -2α.  Furthermore, we performed reporter gene anal. and showed that HIF-3α suppresses hypoxia-inducible HIF-mediated gene expression.  HIF-3α might be a neg. regulator of hypoxia-inducible gene expression in the human kidney.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-3L1bSRQlGLVg90H21EOLACvtfcHk0liUa25IaktjiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntV2gu7g%253D&md5=9f3175506948605be257f28c8a395527</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1006%2Fbbrc.2001.5659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fbbrc.2001.5659%26sid%3Dliteratum%253Aachs%26aulast%3DHara%26aufirst%3DS.%26aulast%3DHamada%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DC.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DImura%26aufirst%3DN.%26atitle%3DExpression%2520and%2520characterization%2520of%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-3%25CE%25B1%2520in%2520human%2520kidney%253A%2520suppression%2520of%2520HIF-mediated%2520gene%2520expression%2520by%2520HIF-3%25CE%25B1%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2001%26volume%3D287%26issue%3D4%26spage%3D808%26epage%3D813%26doi%3D10.1006%2Fbbrc.2001.5659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title">HIF-1 and HIF-2: working alone or together in hypoxia?</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">862</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.1172/JCI31750</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1172%2FJCI31750" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17404612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=862-865&issue=4&author=P.+J.+Ratcliffe&title=HIF-1+and+HIF-2%3A+working+alone+or+together+in+hypoxia%3F&doi=10.1172%2FJCI31750"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">HIF-1 and HIF-2: working alone or together in hypoxia?</span></div><div class="casAuthors">Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">862-865</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Erythropoietin (EPO) is the hormonal regulator of red cell prodn. and provided the paradigm for oxygen-regulated gene expression that led to the discovery of hypoxia-inducible factor (HIF).  In this issue of the JCI, Rankin and colleagues show, using targeted gene inactivation, that induction of Epo expression in murine liver is dependent on the integrity of HIF-2α, and not HIF-1α (see the related article beginning on page 1068).  These results demonstrate distinct functions for different HIF-α isoforms that could potentially be exploited in therapeutic approaches to anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpge5O8T1sFDbVg90H21EOLACvtfcHk0liUa25IaktjiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOisLc%253D&md5=729bd7e4db61a2d25a4245b2fc184482</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1172%2FJCI31750&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI31750%26sid%3Dliteratum%253Aachs%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DHIF-1%2520and%2520HIF-2%253A%2520working%2520alone%2520or%2520together%2520in%2520hypoxia%253F%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26issue%3D4%26spage%3D862%26epage%3D865%26doi%3D10.1172%2FJCI31750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rankin, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biju, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haase, V. H.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>117</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1068</span>– <span class="NLM_lpage">1077</span>, <span class="refDoi"> DOI: 10.1172/JCI30117</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1172%2FJCI30117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17404621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=1068-1077&issue=4&author=E.+B.+Rankinauthor=M.+P.+Bijuauthor=Q.+Liuauthor=T.+L.+Ungerauthor=J.+Rhaauthor=R.+S.+Johnsonauthor=M.+C.+Simonauthor=B.+Keithauthor=V.+H.+Haase&title=Hypoxia-inducible+factor-2+%28HIF-2%29+regulates+hepatic+erythropoietin+in+vivo&doi=10.1172%2FJCI30117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo</span></div><div class="casAuthors">Rankin, Erinn B.; Biju, Mangatt P.; Liu, Qingdu; Unger, Travis L.; Rha, Jennifer; Johnson, Randall S.; Simon, M. Celeste; Keith, Brian; Haase, Volker H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1068-1077</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Erythropoiesis is critically dependent on erythropoietin (EPO), a glycoprotein hormone that is regulated by hypoxia-inducible factor (HIF).  Hepatocytes are the primary source of extrarenal EPO in the adult and express HIF-1 and HIF-2, whose roles in the hypoxic induction of EPO remain controversial.  In order to define the role of HIF-1 and HIF-2 in the regulation of hepatic EPO expression, we have generated mice with conditional inactivation of Hif-1α and/or Hif-2α (Epas1) in hepatocytes.  We have previously shown that inactivation of the von Hippel-Lindau tumor suppressor pVHL, which targets both HIFs for proteasomal degrdn., results in increased hepatic Epo prodn. and polycythemia independent of Hif-1α.  Here we show that conditional inactivation of Hif-2α in pVHL-deficient mice suppressed hepatic Epo and the development of polycythemia.  Furthermore, we found that physiol. Epo expression in infant livers required Hif-2α but not Hif-1α and that the hypoxic induction of liver Epo in anemic adults was Hif-2α dependent.  Since other Hif target genes such phosphoglycerate kinase 1 (Pgk) were Hif-1α dependent, we provide genetic evidence that HIF-1 and HIF-2 have distinct roles in the regulation of hypoxia-inducible genes and that EPO is preferentially regulated by HIF-2 in the liver.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRmkJgWNuXdrVg90H21EOLACvtfcHk0liUa25IaktjiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOit70%253D&md5=8e741a8ead316dbc00dbf5da438f3440</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1172%2FJCI30117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI30117%26sid%3Dliteratum%253Aachs%26aulast%3DRankin%26aufirst%3DE.%2BB.%26aulast%3DBiju%26aufirst%3DM.%2BP.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DUnger%26aufirst%3DT.%2BL.%26aulast%3DRha%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DHaase%26aufirst%3DV.%2BH.%26atitle%3DHypoxia-inducible%2520factor-2%2520%2528HIF-2%2529%2520regulates%2520hepatic%2520erythropoietin%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26issue%3D4%26spage%3D1068%26epage%3D1077%26doi%3D10.1172%2FJCI30117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavia-Jimenez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homayoun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousuf, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyce, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedrosa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geiger, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeves, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zojwalla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKay, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugarolas, J.</span></span> <span> </span><span class="NLM_article-title">Targeting renal cell carcinoma with a HIF-2 antagonist</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>539</i></span> (<span class="NLM_issue">7627</span>),  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">117</span>, <span class="refDoi"> DOI: 10.1038/nature19796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature19796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27595394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslyis7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=539&publication_year=2016&pages=112-117&issue=7627&author=W.+Chenauthor=H.+Hillauthor=A.+Christieauthor=M.+S.+Kimauthor=E.+Hollomanauthor=A.+Pavia-Jimenezauthor=F.+Homayounauthor=Y.+Maauthor=N.+Patelauthor=P.+Yellauthor=G.+Haoauthor=Q.+Yousufauthor=A.+Joyceauthor=I.+Pedrosaauthor=H.+Geigerauthor=H.+Zhangauthor=J.+Changauthor=K.+H.+Gardnerauthor=R.+K.+Bruickauthor=C.+Reevesauthor=T.+H.+Hwangauthor=K.+Courtneyauthor=E.+Frenkelauthor=X.+Sunauthor=N.+Zojwallaauthor=T.+Wongauthor=J.+P.+Rizziauthor=E.+M.+Wallaceauthor=J.+A.+Joseyauthor=Y.+Xieauthor=X.+J.+Xieauthor=P.+Kapurauthor=R.+M.+McKayauthor=J.+Brugarolas&title=Targeting+renal+cell+carcinoma+with+a+HIF-2+antagonist&doi=10.1038%2Fnature19796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting renal cell carcinoma with a HIF-2 antagonist</span></div><div class="casAuthors">Chen, Wenfang; Hill, Haley; Christie, Alana; Kim, Min Soo; Holloman, Eboni; Pavia-Jimenez, Andrea; Homayoun, Farrah; Ma, Yuanqing; Patel, Nirav; Yell, Paul; Hao, Guiyang; Yousuf, Qurratulain; Joyce, Allison; Pedrosa, Ivan; Geiger, Heather; Zhang, He; Chang, Jenny; Gardner, Kevin H.; Bruick, Richard K.; Reeves, Catherine; Hwang, Tae Hyun; Courtney, Kevin; Frenkel, Eugene; Sun, Xiankai; Zojwalla, Naseem; Wong, Tai; Rizzi, James P.; Wallace, Eli M.; Josey, John A.; Xie, Yang; Xie, Xian-Jin; Kapur, Payal; McKay, Renee M.; Brugarolas, James</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">539</span>
        (<span class="NLM_cas:issue">7627</span>),
    <span class="NLM_cas:pages">112-117</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma (ccRCC) is characterized by inactivation of the von Hippel-Lindau tumor suppressor gene (VHL).  Because no other gene is mutated as frequently in ccRCC and VHL mutations are truncal, VHL inactivation is regarded as the governing event.  VHL loss activates the HIF-2 transcription factor, and constitutive HIF-2 activity restores tumorigenesis in VHL-reconstituted ccRCC cells.  HIF-2 has been implicated in angiogenesis and multiple other processes, but angiogenesis is the main target of drugs such as the tyrosine kinase inhibitor sunitinib.  HIF-2 has been regarded as undruggable.  Here we use a tumorgraft/patient-derived xenograft platform to evaluate PT2399, a selective HIF-2 antagonist that was identified using a structure-based design approach.  PT2399 dissocd. HIF-2 (an obligatory heterodimer of HIF-2α-HIF-1β) in human ccRCC cells and suppressed tumorigenesis in 56% (10 out of 18) of such lines.  PT2399 had greater activity than sunitinib, was active in sunitinib-progressing tumors, and was better tolerated.  Unexpectedly, some VHL-mutant ccRCCs were resistant to PT2399.  Resistance occurred despite HIF-2 dissocn. in tumors and evidence of Hif-2 inhibition in the mouse, as detd. by suppression of circulating erythropoietin, a HIF-2 target and possible pharmacodynamic marker.  We identified a HIF-2-dependent gene signature in sensitive tumors.  Gene expression was largely unaffected by PT2399 in resistant tumors, illustrating the specificity of the drug.  Sensitive tumors exhibited a distinguishing gene expression signature and generally higher levels of HIF-2α.  Prolonged PT2399 treatment led to resistance.  We identified binding site and second site suppressor mutations in HIF-2α and HIF-1β, resp.  Both mutations preserved HIF-2 dimers despite treatment with PT2399.  Finally, an extensively pretreated patient whose tumor had given rise to a sensitive tumorgraft showed disease control for more than 11 mo when treated with a close analog of PT2399, PT2385.  We validate HIF-2 as a target in ccRCC, show that some ccRCCs are HIF-2 independent, and set the stage for biomarker-driven clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnxhUY1OeFy7Vg90H21EOLACvtfcHk0lgAfpifnaVsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslyis7rL&md5=006f9c774419f6226e22681286f43b6e</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnature19796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19796%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHill%26aufirst%3DH.%26aulast%3DChristie%26aufirst%3DA.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DHolloman%26aufirst%3DE.%26aulast%3DPavia-Jimenez%26aufirst%3DA.%26aulast%3DHomayoun%26aufirst%3DF.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DYell%26aufirst%3DP.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DYousuf%26aufirst%3DQ.%26aulast%3DJoyce%26aufirst%3DA.%26aulast%3DPedrosa%26aufirst%3DI.%26aulast%3DGeiger%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DReeves%26aufirst%3DC.%26aulast%3DHwang%26aufirst%3DT.%2BH.%26aulast%3DCourtney%26aufirst%3DK.%26aulast%3DFrenkel%26aufirst%3DE.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZojwalla%26aufirst%3DN.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DKapur%26aufirst%3DP.%26aulast%3DMcKay%26aufirst%3DR.%2BM.%26aulast%3DBrugarolas%26aufirst%3DJ.%26atitle%3DTargeting%2520renal%2520cell%2520carcinoma%2520with%2520a%2520HIF-2%2520antagonist%26jtitle%3DNature%26date%3D2016%26volume%3D539%26issue%3D7627%26spage%3D112%26epage%3D117%26doi%3D10.1038%2Fnature19796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nordgren, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, A.</span></span> <span> </span><span class="NLM_article-title">Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">4307</span>– <span class="NLM_lpage">4317</span>, <span class="refDoi"> DOI: 10.1039/c1cs15032d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2Fc1cs15032d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=21483947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovVemurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2011&pages=4307-4317&issue=8&author=I.+K.+Nordgrenauthor=A.+Tavassoli&title=Targeting+tumour+angiogenesis+with+small+molecule+inhibitors+of+hypoxia+inducible+factor&doi=10.1039%2Fc1cs15032d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting tumour angiogenesis with small molecule inhibitors of hypoxia inducible factor</span></div><div class="casAuthors">Nordgren, Ida Karin; Tavassoli, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4307-4317</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The adaptation of tumors to hypoxia is crit. for their survival and growth.  The high proliferation rate of solid tumors causes the continuous outstripping of the oxygen supply provided by the local vasculature, resulting in hypoxic regions within the tumor.  Hypoxia inducible factor (HIF) is the key mediator of cellular response to hypoxia, activating the expression of multiple genes that participate in angiogenesis, iron metab., glycolysis, glucose transport and cell proliferation and survival.  The crit. role of the hypoxia response network and HIF in cancer has resulted in it being viewed as an ideal target for small mol. intervention.  In this tutorial review we discuss the central role of HIF in the adaptation of tumors to a hypoxic environment, going on to describe recent attempts at developing small mols. that disrupt this pathway and their potential for use as the next generation anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqss09KS6Sw3rVg90H21EOLACvtfcHk0lgAfpifnaVsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovVemurk%253D&md5=47759f99f7fe35b1d45748086c14d8bc</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1039%2Fc1cs15032d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cs15032d%26sid%3Dliteratum%253Aachs%26aulast%3DNordgren%26aufirst%3DI.%2BK.%26aulast%3DTavassoli%26aufirst%3DA.%26atitle%3DTargeting%2520tumour%2520angiogenesis%2520with%2520small%2520molecule%2520inhibitors%2520of%2520hypoxia%2520inducible%2520factor%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2011%26volume%3D40%26issue%3D8%26spage%3D4307%26epage%3D4317%26doi%3D10.1039%2Fc1cs15032d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1038/nrc3183</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnrc3183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aisbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=9-22&issue=1&author=B.+Keithauthor=R.+S.+Johnsonauthor=M.+C.+Simon&title=HIF1%CE%B1+and+HIF2%CE%B1%3A+sibling+rivalry+in+hypoxic+tumour+growth+and+progression&doi=10.1038%2Fnrc3183"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression</span></div><div class="casAuthors">Keith, Brian; Johnson, Randall S.; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-22</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Hypoxia-inducible factors (HIFs) are broadly expressed in human cancers, and HIF1α and HIF2α were previously suspected to promote tumor progression through largely overlapping functions.  However, this relatively simple model has now been challenged in light of recent data from various approaches that reveal unique and sometimes opposing activities of these HIFα isoforms in both normal physiol. and disease.  These effects are mediated in part through the regulation of unique target genes, as well as through direct and indirect interactions with important oncoproteins and tumor suppressors, including MYC and p53.  As HIF inhibitors are currently undergoing clin. evaluation as cancer therapeutics, a more thorough understanding of the unique roles performed by HIF1α and HIF2α in human neoplasia is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5DWqO5HSWFrVg90H21EOLACvtfcHk0lgAfpifnaVsjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aisbzM&md5=c306992e7ffe972c98a351a9b8217c57</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrc3183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc3183%26sid%3Dliteratum%253Aachs%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DHIF1%25CE%25B1%2520and%2520HIF2%25CE%25B1%253A%2520sibling%2520rivalry%2520in%2520hypoxic%2520tumour%2520growth%2520and%2520progression%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2012%26volume%3D12%26issue%3D1%26spage%3D9%26epage%3D22%26doi%3D10.1038%2Fnrc3183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleadle, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Rourke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mole, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukherji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaakkola, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barstead, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgkin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title"><i>C. elegans</i> EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>107</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(01)00507-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS0092-8674%2801%2900507-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11595184" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFOntL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2001&pages=43-54&issue=1&author=A.+C.+Epsteinauthor=R.+J.+M.+Gleadleauthor=L.+A.+McNeillauthor=K.+S.+Hewitsonauthor=J.+O%E2%80%99Rourkeauthor=D.+R.+Moleauthor=M.+Mukherjiauthor=E.+Metzenauthor=M.+I.+Wilsonauthor=A.+Dhandaauthor=Y.+M.+Tianauthor=N.+Massonauthor=D.+L.+Hamiltonauthor=P.+Jaakkolaauthor=R.+Barsteadauthor=J.+Hodgkinauthor=P.+H.+Maxwellauthor=C.+W.+Pughauthor=C.+J.+Schofieldauthor=P.+J.+Ratcliffe&title=C.+elegans+EGL-9+and+mammalian+homologs+define+a+family+of+dioxygenases+that+regulate+HIF+by+prolyl+hydroxylation&doi=10.1016%2FS0092-8674%2801%2900507-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation</span></div><div class="casAuthors">Epstein, Andrew C. R.; Gleadle, Jonathan M.; McNeill, Luke A.; Hewitson, Kirsty S.; O'Rourke, John; Mole, David R.; Mukherji, Mridul; Metzen, Eric; Wilson, Michael I.; Dhanda, Anu; Tian, Ya-Min; Masson, Norma; Hamilton, Donald L.; Jaakkola, Panu; Barstead, Robert; Hodgkin, Jonathan; Maxwell, Patrick H.; Pugh, Christopher W.; Schofield, Christopher J.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-54</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis.  Recent studies have defined posttranslational modification by prolyl hydroxylation as a key regulatory event that targets HIF-α subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex.  Here, we define a conserved HIF-VHL-prolyl hydroxylase pathway in C. elegans, and use a genetic approach to identify EGL-9 as a dioxygenase that regulates HIF by prolyl hydroxylation.  In mammalian cells, we show that the HIF-prolyl hydroxylases are represented by a series of isoforms bearing a conserved 2-histidine-1-carboxylate iron coordination motif at the catalytic site.  Direct modulation of recombinant enzyme activity by graded hypoxia, iron chelation, and cobaltous ions mirrors the characteristics of HIF induction in vivo, fulfilling requirements for these enzymes being oxygen sensors that regulate HIF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWz1IWEpVokbVg90H21EOLACvtfcHk0lgMS4YoNExA2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFOntL0%253D&md5=a23d16c40ee5b3fa12c8e616e85ce771</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900507-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900507-4%26sid%3Dliteratum%253Aachs%26aulast%3DEpstein%26aufirst%3DA.%2BC.%26aulast%3DGleadle%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DO%25E2%2580%2599Rourke%26aufirst%3DJ.%26aulast%3DMole%26aufirst%3DD.%2BR.%26aulast%3DMukherji%26aufirst%3DM.%26aulast%3DMetzen%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DM.%2BI.%26aulast%3DDhanda%26aufirst%3DA.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DMasson%26aufirst%3DN.%26aulast%3DHamilton%26aufirst%3DD.%2BL.%26aulast%3DJaakkola%26aufirst%3DP.%26aulast%3DBarstead%26aufirst%3DR.%26aulast%3DHodgkin%26aufirst%3DJ.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DC.%2520elegans%2520EGL-9%2520and%2520mammalian%2520homologs%2520define%2520a%2520family%2520of%2520dioxygenases%2520that%2520regulate%2520HIF%2520by%2520prolyl%2520hydroxylation%26jtitle%3DCell%26date%3D2001%26volume%3D107%26issue%3D1%26spage%3D43%26epage%3D54%26doi%3D10.1016%2FS0092-8674%2801%2900507-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czyzyk-Krzeska, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, J. W.</span></span> <span> </span><span class="NLM_article-title">Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">10430</span>– <span class="NLM_lpage">10435</span>, <span class="refDoi"> DOI: 10.1073/pnas.190332597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.190332597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10973499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=10430-10435&issue=19&author=T.+Kamuraauthor=S.+Satoauthor=K.+Iwaiauthor=M.+Czyzyk-Krzeskaauthor=R.+C.+Conawayauthor=J.+W.+Conaway&title=Activation+of+HIF1alpha+ubiquitination+by+a+reconstituted+von+Hippel-Lindau+%28VHL%29+tumor+suppressor+complex&doi=10.1073%2Fpnas.190332597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex</span></div><div class="casAuthors">Kamura, Takumi; Sato, Shigeo; Iwai, Kazuhiro; Czyzyk-Krzeska, Maria; Conaway, Ronald C.; Conaway, Joan Weliky</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">10430-10435</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mutations in the VHL tumor suppressor gene result in constitutive expression of many hypoxia-inducible genes, at least in part because of increases in the cellular level of hypoxia-inducible transcription factor HIF1α, which in normal cells is rapidly ubiquitinated and degraded by the proteasome under normoxic conditions.  The recent observation that the VHL protein is a subunit of an Skp1-Cul1/Cdc53-F-box (SCF)-like E3 ubiquitin ligase raised the possibility that VHL may be directly responsible for regulating cellular levels of HIF1α by targeting it for ubiquitination and proteolysis.  In this report, we test this hypothesis directly.  We report development of methods for prodn. of the purified recombinant VHL complex and present direct biochem. evidence that it can function with an E1 ubiquitin-activating enzyme and E2 ubiquitin-conjugating enzyme to activate HIF1α ubiquitination in vitro.  Our findings provide new insight into the function of the VHL tumor suppressor protein, and they provide a foundation for future investigations of the mechanisms underlying VHL regulation of oxygen-dependent gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjwQDn-YYjRLVg90H21EOLACvtfcHk0lgMS4YoNExA2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1Crsb4%253D&md5=5ba458b01d352b6350e61c2dbdc074ca</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1073%2Fpnas.190332597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.190332597%26sid%3Dliteratum%253Aachs%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DIwai%26aufirst%3DK.%26aulast%3DCzyzyk-Krzeska%26aufirst%3DM.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26atitle%3DActivation%2520of%2520HIF1alpha%2520ubiquitination%2520by%2520a%2520reconstituted%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520tumor%2520suppressor%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26issue%3D19%26spage%3D10430%26epage%3D10435%26doi%3D10.1073%2Fpnas.190332597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lando, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitelaw, M. L.</span></span> <span> </span><span class="NLM_article-title">Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>295</i></span> (<span class="NLM_issue">5556</span>),  <span class="NLM_fpage">858</span>– <span class="NLM_lpage">861</span>, <span class="refDoi"> DOI: 10.1126/science.1068592</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1068592" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11823643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFemtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2002&pages=858-861&issue=5556&author=D.+Landoauthor=D.+J.+Peetauthor=D.+A.+Whelanauthor=J.+J.+Gormanauthor=M.+L.+Whitelaw&title=Asparagine+hydroxylation+of+the+HIF+transactivation+domain%3A+A+hypoxic+switch&doi=10.1126%2Fscience.1068592"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch</span></div><div class="casAuthors">Lando, David; Peet, Daniel J.; Whelan, Dean A.; Gorman, Jeffrey J.; Whitelaw, Murray L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">5556</span>),
    <span class="NLM_cas:pages">858-861</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The hypoxia-inducible factors (HIFs) 1α and 2α are key mammalian transcription factors that exhibit dramatic increases in both protein stability and intrinsic transcriptional potency during low-oxygen stress.  This increased stability is due to the absence of proline hydroxylation, which in normoxia promotes binding of HIF to the von Hippel-Lindau (VHL tumor suppressor) ubiquitin ligase.  We now show that hypoxic induction of the C-terminal transactivation domain (CAD) of HIF occurs through abrogation of hydroxylation of a conserved asparagine in the CAD.  Inhibitors of Fe(II)- and 2-oxoglutarate-dependent dioxygenases prevented hydroxylation of the Asn, thus allowing the CAD to interact with the p300 transcription coactivator.  Replacement of the conserved Asn by Ala resulted in constitutive p300 interaction and strong transcriptional activity.  Full induction of HIF-1α and 2α, therefore, relies on the abrogation of both Pro and Asn hydroxylation, which during normoxia occur at the degrdn. and C-terminal transactivation domains, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSpfguxNUc4bVg90H21EOLACvtfcHk0lgMS4YoNExA2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFemtrs%253D&md5=45b32c44aa081c620c436ca246a640c9</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.1068592&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1068592%26sid%3Dliteratum%253Aachs%26aulast%3DLando%26aufirst%3DD.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26aulast%3DWhelan%26aufirst%3DD.%2BA.%26aulast%3DGorman%26aufirst%3DJ.%2BJ.%26aulast%3DWhitelaw%26aufirst%3DM.%2BL.%26atitle%3DAsparagine%2520hydroxylation%2520of%2520the%2520HIF%2520transactivation%2520domain%253A%2520A%2520hypoxic%2520switch%26jtitle%3DScience%26date%3D2002%26volume%3D295%26issue%3D5556%26spage%3D858%26epage%3D861%26doi%3D10.1126%2Fscience.1068592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Backus, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenchock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerfen, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witkiewicz, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clardy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>166</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.05.042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cell.2016.05.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27368101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFaitLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2016&pages=126-139&issue=1&author=K.+J.+Briggsauthor=P.+Koivunenauthor=S.+Caoauthor=K.+M.+Backusauthor=B.+A.+Olenchockauthor=H.+Patelauthor=Q.+Zhangauthor=S.+Signorettiauthor=G.+J.+Gerfenauthor=A.+L.+Richardsonauthor=A.+K.+Witkiewiczauthor=B.+F.+Cravattauthor=J.+Clardyauthor=W.+G.+Kaelin&title=Paracrine+induction+of+HIF+by+glutamate+in+breast+cancer%3A+EglN1+senses+cysteine&doi=10.1016%2Fj.cell.2016.05.042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine</span></div><div class="casAuthors">Briggs, Kimberly J.; Koivunen, Peppi; Cao, Shugeng; Backus, Keriann M.; Olenchock, Benjamin A.; Patel, Hetalben; Zhang, Qing; Signoretti, Sabina; Gerfen, Gary J.; Richardson, Andrea L.; Witkiewicz, Agnieszka K.; Cravatt, Benjamin F.; Clardy, Jon; Kaelin, William G. Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-139</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The HIF transcription factor promotes adaptation to hypoxia and stimulates the growth of certain cancers, including triple-neg. breast cancer (TNBC).  The HIFα subunit is usually prolyl-hydroxylated by EglN family members under normoxic conditions, causing its rapid degrdn.  We confirmed that TNBC cells secrete glutamate, which we found is both necessary and sufficient for the paracrine induction of HIF1α in such cells under normoxic conditions.  Glutamate inhibits the xCT glutamate-cystine antiporter, leading to intracellular cysteine depletion.  EglN1, the main HIFα prolyl-hydroxylase, undergoes oxidative self-inactivation in the absence of cysteine both in biochem. assays and in cells, resulting in HIF1α accumulation.  Therefore, EglN1 senses both oxygen and cysteine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpixbsM2Fx-erVg90H21EOLACvtfcHk0lj-625SPM45fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFaitLbJ&md5=c73e36d306dfb7bcebb3b897c79c94fa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.05.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.05.042%26sid%3Dliteratum%253Aachs%26aulast%3DBriggs%26aufirst%3DK.%2BJ.%26aulast%3DKoivunen%26aufirst%3DP.%26aulast%3DCao%26aufirst%3DS.%26aulast%3DBackus%26aufirst%3DK.%2BM.%26aulast%3DOlenchock%26aufirst%3DB.%2BA.%26aulast%3DPatel%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DGerfen%26aufirst%3DG.%2BJ.%26aulast%3DRichardson%26aufirst%3DA.%2BL.%26aulast%3DWitkiewicz%26aufirst%3DA.%2BK.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26aulast%3DClardy%26aufirst%3DJ.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DParacrine%2520induction%2520of%2520HIF%2520by%2520glutamate%2520in%2520breast%2520cancer%253A%2520EglN1%2520senses%2520cysteine%26jtitle%3DCell%26date%3D2016%26volume%3D166%26issue%3D1%26spage%3D126%26epage%3D139%26doi%3D10.1016%2Fj.cell.2016.05.042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Locatelli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fishbane, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Block, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall, I. C.</span></span> <span> </span><span class="NLM_article-title">Targeting hypoxia-inducible factors for the treatment of anemia in chronic kidney disease patients</span>. <i>Am. J. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">187</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1159/000455166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1159%2F000455166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28118622" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjvF2jsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2017&pages=187-199&issue=3&author=F.+Locatelliauthor=S.+Fishbaneauthor=G.+A.+Blockauthor=I.+C.+Macdougall&title=Targeting+hypoxia-inducible+factors+for+the+treatment+of+anemia+in+chronic+kidney+disease+patients&doi=10.1159%2F000455166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients</span></div><div class="casAuthors">Locatelli, Francesco; Fishbane, Steven; Block, Geoffrey A.; MacDougall, Iain C.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Nephrology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">187-199</span>CODEN:
                <span class="NLM_cas:coden">AJNED9</span>;
        ISSN:<span class="NLM_cas:issn">0250-8095</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: Anemia, a common complication of chronic kidney disease (CKD), has previously been attributed primarily to decreased prodn. of erythropoietin.  More recently, it has become apparent that the etiol. of anemia involves several other factors, most notably dysfunctional iron metab., mediated via increased hepcidin activity and reduced clearance.  Current management of anemia in patients with advanced CKD is based on erythropoiesis-stimulating agents and iron supplementation, along with red blood cell transfusions when necessary; however, safety considerations assocd. with these therapies highlight the need to pursue alternative treatment options targeting other mechanisms such as hypoxia-inducible factors (HIFs) that act as central regulators of erythropoiesis by coordinating a series of graded hypoxic responses.  Summary: This review discusses the discovery of the HIF pathway and its regulation via HIF prolyl hydroxylase enzymes in the context of erythropoiesis and iron metab.  The rationale for targeting this pathway and the clin. development of HIF prolyl hydroxylase inhibitors are reviewed, with a commentary on the potential implications of this class of agents in CKD anemia management.  Key Messages: Pharmacol. activation of the HIF pathway results in a transient pseudo-hypoxic state that stimulates erythropoiesis in CKD patients with anemia.  Results from clin. studies of a no. of HIF prolyl hydroxylase inhibitors are increasingly available and provide support for the continued evaluation of the risk-benefit ratio of this novel therapeutic approach to the treatment of anemia in CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjrGsm4Prr1LVg90H21EOLACvtfcHk0lj-625SPM45fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjvF2jsr8%253D&md5=1ebf14b1fea55a5ce5834517ef75ca69</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1159%2F000455166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000455166%26sid%3Dliteratum%253Aachs%26aulast%3DLocatelli%26aufirst%3DF.%26aulast%3DFishbane%26aufirst%3DS.%26aulast%3DBlock%26aufirst%3DG.%2BA.%26aulast%3DMacdougall%26aufirst%3DI.%2BC.%26atitle%3DTargeting%2520hypoxia-inducible%2520factors%2520for%2520the%2520treatment%2520of%2520anemia%2520in%2520chronic%2520kidney%2520disease%2520patients%26jtitle%3DAm.%2520J.%2520Nephrol.%26date%3D2017%26volume%3D45%26issue%3D3%26spage%3D187%26epage%3D199%26doi%3D10.1159%2F000455166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spivak-Kroizman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Posner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aziz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeure, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hingorani, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palculict, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izzo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiriakova, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelmelek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomeusz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span> <span> </span><span class="NLM_article-title">Hypoxia triggers hedgehog-mediated tumor-stromal interactions in pancreatic cancer</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3235</span>– <span class="NLM_lpage">3247</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-1433</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-11-1433" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23633488" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFSqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=3235-3247&issue=11&author=T.+R.+Spivak-Kroizmanauthor=G.+Hostetterauthor=R.+Posnerauthor=M.+Azizauthor=C.+Huauthor=M.+J.+Demeureauthor=D.+Von+Hoffauthor=S.+R.+Hingoraniauthor=T.+B.+Palculictauthor=J.+Izzoauthor=G.+M.+Kiriakovaauthor=M.+Abdelmelekauthor=G.+Bartholomeuszauthor=B.+P.+Jamesauthor=G.+Powis&title=Hypoxia+triggers+hedgehog-mediated+tumor-stromal+interactions+in+pancreatic+cancer&doi=10.1158%2F0008-5472.CAN-11-1433"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia Triggers Hedgehog-Mediated Tumor-Stromal Interactions in Pancreatic Cancer</span></div><div class="casAuthors">Spivak-Kroizman, Taly R.; Hostetter, Galen; Posner, Richard; Aziz, Meraj; Hu, Chengcheng; Demeure, Michael J.; Von Hoff, Daniel; Hingorani, Sunil R.; Palculict, Timothy B.; Izzo, Julie; Kiriakova, Galina M.; Abdelmelek, Mena; Bartholomeusz, Geoffrey; James, Brian P.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3235-3247</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Pancreatic cancer is characterized by a desmoplastic reaction that creates a dense fibroinflammatory microenvironment, promoting hypoxia and limiting cancer drug delivery due to decreased blood perfusion.  Here, we describe a novel tumor-stroma interaction that may help explain the prevalence of desmoplasia in this cancer.  Specifically, we found that activation of hypoxia-inducible factor-α (HIF-1α) by tumor hypoxia strongly activates secretion of the sonic hedgehog (SHH) ligand by cancer cells, which in turn causes stromal fibroblasts to increase fibrous tissue deposition.  In support of this finding, elevated levels of HIF-1α and SHH in pancreatic tumors were detd. to be markers of decreased patient survival.  Repeated cycles of hypoxia and desmoplasia amplified each other in a feed forward loop that made tumors more aggressive and resistant to therapy.  This loop could be blocked by HIF-1α inhibition, which was sufficient to block SHH prodn. and hedgehog signaling.  Taken together, our findings suggest that increased HIF-1α produced by hypoxic tumors triggers the desmoplasic reaction in pancreatic cancer, which is then amplified by a feed forward loop involving cycles of decreased blood flow and increased hypoxia.  Our findings strengthen the rationale for testing HIF inhibitors and may therefore represent a novel therapeutic option for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEC-EkRE3eA7Vg90H21EOLACvtfcHk0lj-625SPM45fA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFSqsrc%253D&md5=619e19ddd9ccfe02924ce2a65f6cbb82</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-1433&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-1433%26sid%3Dliteratum%253Aachs%26aulast%3DSpivak-Kroizman%26aufirst%3DT.%2BR.%26aulast%3DHostetter%26aufirst%3DG.%26aulast%3DPosner%26aufirst%3DR.%26aulast%3DAziz%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DDemeure%26aufirst%3DM.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%26aulast%3DHingorani%26aufirst%3DS.%2BR.%26aulast%3DPalculict%26aufirst%3DT.%2BB.%26aulast%3DIzzo%26aufirst%3DJ.%26aulast%3DKiriakova%26aufirst%3DG.%2BM.%26aulast%3DAbdelmelek%26aufirst%3DM.%26aulast%3DBartholomeusz%26aufirst%3DG.%26aulast%3DJames%26aufirst%3DB.%2BP.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DHypoxia%2520triggers%2520hedgehog-mediated%2520tumor-stromal%2520interactions%2520in%2520pancreatic%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2013%26volume%3D73%26issue%3D11%26spage%3D3235%26epage%3D3247%26doi%3D10.1158%2F0008-5472.CAN-11-1433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">11570</span>– <span class="NLM_lpage">11572</span>, <span class="refDoi"> DOI: 10.1073/pnas.192442299</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.192442299" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12186981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XntFWqs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11570-11572&issue=18&author=G.+L.+Semenza&title=Physiology+meets+biophysics%3A+visualizing+the+interaction+of+hypoxia-inducible+factor+1%CE%B1+with+p300+and+CBP&doi=10.1073%2Fpnas.192442299"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Physiology meets biophysics: visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP</span></div><div class="casAuthors">Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">11570-11572</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review on the mol. mechanism for the oxygen-dependent regulation of the expression and transcriptional activity of hypoxia-inducible factor 1α (HIF-1α).  The binding of the coactivators CBP (CREB-binding protein) and p300 to the carboxyl-terminal transactivation domain (TAD-C) is crit. for HIF-1 transcriptional activity.  Oxygen-dependent hydroxylation of Asn-803 in TAD-C domain of HIF-1 can disrupt this interaction.  HIF-1α TAD-C binds to a domain in p300 and CBP that is known as the cysteine/histidine-rich 1 (CH1) or transcriptional adapter zinc-binding 1 (TAZ1) domain.  The recent NMR spectroscopic analyses of the structural interaction of HIF-1α TAD-C with the CH1/TAZ1 domain of either p300 or CBP are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN2MSfZhL27LVg90H21EOLACvtfcHk0lhQhNfgpKdFXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XntFWqs7s%253D&md5=409271e316a744734f8272a771f9bcfd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1073%2Fpnas.192442299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.192442299%26sid%3Dliteratum%253Aachs%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DPhysiology%2520meets%2520biophysics%253A%2520visualizing%2520the%2520interaction%2520of%2520hypoxia-inducible%2520factor%25201%25CE%25B1%2520with%2520p300%2520and%2520CBP%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D18%26spage%3D11570%26epage%3D11572%26doi%3D10.1073%2Fpnas.192442299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srinivas, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leshchinsky, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caro, J.</span></span> <span> </span><span class="NLM_article-title">Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2984</span>– <span class="NLM_lpage">2992</span>, <span class="refDoi"> DOI: 10.1128/MCB.22.9.2984-2992.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1128%2FMCB.22.9.2984-2992.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11940656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFylsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=2984-2992&issue=9&author=N.+Sangauthor=J.+Fangauthor=V.+Srinivasauthor=I.+Leshchinskyauthor=J.+Caro&title=Carboxyl-terminal+transactivation+activity+of+hypoxia-inducible+factor+1+alpha+is+governed+by+a+von+Hippel-Lindau+protein-independent%2C+hydroxylation-regulated+association+with+p300%2FCBP&doi=10.1128%2FMCB.22.9.2984-2992.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1α is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP</span></div><div class="casAuthors">Sang, Nianli; Fang, Jie; Srinivas, Vickram; Leshchinsky, Irene; Caro, Jaime</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2984-2992</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 complex (HIF-1) plays a pivotal role in oxygen homeostasis and adaptation to hypoxia.  Its function is controlled by both the protein stability and the transactivation activity of its alpha subunit, HIF-1α.  Hydroxylation of at least two prolyl residues in the oxygen-dependent degrdn. domain of HIF-1α regulates its interaction with the von Hippel-Lindau protein (VHL) that targets HIF-1α for ubiquitination and proteasomal degrdn.  Several prolyl hydroxylases have been found to specifically hydroxylate HIF-1α.  In this report, we investigated possible roles of VHL and hydroxylases in the regulation of the transactivation activity of the C-terminal activating domain (CAD) of HIF-1α.  We demonstrate that regulation of the transactivation activity of HIF-1α CAD also involves hydroxylase activity but does not require functional VHL.  In addn., stimulation of the CAD activity by a hydroxylase inhibitor, hypoxia, and desferrioxamine was severely blocked by the adenoviral oncoprotein E1A but not by an E1A mutant defective in targeting p300/CBP.  We further demonstrate that a hydroxylase inhibitor, hypoxia, and desferrioxamine promote the functional and phys. interaction between HIF-1α CAD and p300/CBP in vivo.  Taken together, our data provide evidence that hypoxia-regulated stabilization and transcriptional stimulation of HIF-1α function are regulated through partially overlapping but distinguishable pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4aoLCyMGskLVg90H21EOLACvtfcHk0lhQhNfgpKdFXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFylsbw%253D&md5=46844a10eddfd9275179cbf646677d05</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.9.2984-2992.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.9.2984-2992.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSang%26aufirst%3DN.%26aulast%3DFang%26aufirst%3DJ.%26aulast%3DSrinivas%26aufirst%3DV.%26aulast%3DLeshchinsky%26aufirst%3DI.%26aulast%3DCaro%26aufirst%3DJ.%26atitle%3DCarboxyl-terminal%2520transactivation%2520activity%2520of%2520hypoxia-inducible%2520factor%25201%2520alpha%2520is%2520governed%2520by%2520a%2520von%2520Hippel-Lindau%2520protein-independent%252C%2520hydroxylation-regulated%2520association%2520with%2520p300%252FCBP%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26issue%3D9%26spage%3D2984%26epage%3D2992%26doi%3D10.1128%2FMCB.22.9.2984-2992.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poy, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5367</span>– <span class="NLM_lpage">5372</span>, <span class="refDoi"> DOI: 10.1073/pnas.082117899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.082117899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11959990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFKlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=5367-5372&issue=8&author=S.+J.+Freedmanauthor=Z.+Y.+Sunauthor=J.+F.+Poyauthor=A.+L.+Kungauthor=D.+M.+Livingstonauthor=G.+Wagnerauthor=M.+J.+Eck&title=Structural+basis+for+recruitment+of+CBP%2Fp300+by+hypoxia-inducible+factor-1%CE%B1&doi=10.1073%2Fpnas.082117899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α</span></div><div class="casAuthors">Freedman, Steven J.; Sun, Zhen-Yu J.; Poy, Florence; Kung, Andrew L.; Livingston, David M.; Wagner, Gerhard; Eck, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5367-5372</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Adaptation to hypoxia is mediated by transactivation of hypoxia-responsive genes by hypoxia-inducible factor-1 (HIF-1) in complex with the CBP and p300 transcriptional coactivators.  We report the soln. structure of the cysteine/histidine-rich 1 (CH1) domain of p300 bound to the C-terminal transactivation domain of HIF-1α.  CH1 has a triangular geometry composed of four α-helixes with three intervening Zn2+-coordinating centers.  CH1 serves as a scaffold for folding of the HIF-1α C-terminal transactivation domain, which forms a vise-like clamp on the CH1 domain that is stabilized by extensive hydrophobic and polar interactions.  The structure reveals the mechanism of specific recognition of p300 by HIF-1α, and shows how HIF-1α transactivation is regulated by asparagine hydroxylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrILX4VebplX7Vg90H21EOLACvtfcHk0lhQhNfgpKdFXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFKlsL4%253D&md5=89e6f7a3be011184c0d2fc7cd7c80d80</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.082117899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.082117899%26sid%3Dliteratum%253Aachs%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26aulast%3DSun%26aufirst%3DZ.%2BY.%26aulast%3DPoy%26aufirst%3DJ.%2BF.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26aulast%3DWagner%26aufirst%3DG.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520recruitment%2520of%2520CBP%252Fp300%2520by%2520hypoxia-inducible%2520factor-1%25CE%25B1%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D8%26spage%3D5367%26epage%3D5372%26doi%3D10.1073%2Fpnas.082117899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Henchey, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of hypoxia inducible factor 1 transcription coactivator interaction by a hydrogen bond surrogate α-helix</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">941</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1021/ja9082864</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9082864" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1alur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=941-943&issue=3&author=L.+K.+Hencheyauthor=S.+Kushalauthor=R.+Dubeyauthor=R.+N.+Chapmanauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=Inhibition+of+hypoxia+inducible+factor+1+transcription+coactivator+interaction+by+a+hydrogen+bond+surrogate+%CE%B1-helix&doi=10.1021%2Fja9082864"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxia Inducible Factor 1 - Transcription Coactivator Interaction by a Hydrogen Bond Surrogate α-Helix</span></div><div class="casAuthors">Henchey, Laura K.; Kushal, Swati; Dubey, Ramin; Chapman, Ross N.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">941-943</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers.  We report a stabilized α-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1α (HIF-1α) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300.  The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZknynNJEK87Vg90H21EOLACvtfcHk0ljCJjFi4RuHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1alur%252FF&md5=1914debf74c9001d2c0ed6087d7081ea</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fja9082864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9082864%26sid%3Dliteratum%253Aachs%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DChapman%26aufirst%3DR.%2BN.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DInhibition%2520of%2520hypoxia%2520inducible%2520factor%25201%2520transcription%2520coactivator%2520interaction%2520by%2520a%2520hydrogen%2520bond%2520surrogate%2520%25CE%25B1-helix%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26issue%3D3%26spage%3D941%26epage%3D943%26doi%3D10.1021%2Fja9082864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burslem, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kyle, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breeze, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warriner, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. J.</span></span> <span> </span><span class="NLM_article-title">Small-molecule proteomimetic inhibitors of the HIF-1α-p300 protein-protein interaction</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1083</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.1002/cbic.201400009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fcbic.201400009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24782431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXntVSntrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=1083-1087&issue=8&author=G.+M.+Burslemauthor=H.+F.+Kyleauthor=A.+L.+Breezeauthor=T.+A.+Edwardsauthor=A.+Nelsonauthor=S.+L.+Warrinerauthor=A.+J.+Wilson&title=Small-molecule+proteomimetic+inhibitors+of+the+HIF-1%CE%B1-p300+protein-protein+interaction&doi=10.1002%2Fcbic.201400009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Proteomimetic Inhibitors of the HIF-1α-p300 Protein-Protein Interaction</span></div><div class="casAuthors">Burslem, George M.; Kyle, Hannah F.; Breeze, Alexander L.; Edwards, Thomas A.; Nelson, Adam; Warriner, Stuart L.; Wilson, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1083-1087</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The therapeutically relevant hypoxia inducible factor HIF-1α-p300 protein-protein interaction can be orthosterically inhibited with α-helix mimetics based on an oligoamide scaffold that recapitulates essential features of the C-terminal helix of the HIF-1α C-TAD (C-terminal transactivation domain).  Preliminary SAR studies demonstrated the important role of side-chain size and hydrophobicity/hydrophilicity in detg. potency.  These small mols. represent the first biophys. characterized HIF-1α-p300 PPI inhibitors and the first examples of small-mol. arom. oligoamide helix mimetics to be shown to have a selective binding profile.  Although the compds. were less potent than HIF-1α, the result is still remarkable in that the mimetic reproduces only three residues from the 42-residue HIF-1α C-TAD from which it is derived.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPBNsroQkON7Vg90H21EOLACvtfcHk0ljCJjFi4RuHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXntVSntrg%253D&md5=b687264154fe266515f9400b21f1a391</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201400009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201400009%26sid%3Dliteratum%253Aachs%26aulast%3DBurslem%26aufirst%3DG.%2BM.%26aulast%3DKyle%26aufirst%3DH.%2BF.%26aulast%3DBreeze%26aufirst%3DA.%2BL.%26aulast%3DEdwards%26aufirst%3DT.%2BA.%26aulast%3DNelson%26aufirst%3DA.%26aulast%3DWarriner%26aufirst%3DS.%2BL.%26aulast%3DWilson%26aufirst%3DA.%2BJ.%26atitle%3DSmall-molecule%2520proteomimetic%2520inhibitors%2520of%2520the%2520HIF-1%25CE%25B1-p300%2520protein-protein%2520interaction%26jtitle%3DChemBioChem%26date%3D2014%26volume%3D15%26issue%3D8%26spage%3D1083%26epage%3D1087%26doi%3D10.1002%2Fcbic.201400009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dames, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Yamout, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De-Guzman, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for Hif-1 alpha /CBP recognition in the cellular hypoxic response</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">5271</span>– <span class="NLM_lpage">5276</span>, <span class="refDoi"> DOI: 10.1073/pnas.082121399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.082121399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11959977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtFKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=5271-5276&issue=8&author=S.+A.+Damesauthor=M.+Martinez-Yamoutauthor=R.+N.+De-Guzmanauthor=H.+J.+Dysonauthor=P.+E.+Wright&title=Structural+basis+for+Hif-1+alpha+%2FCBP+recognition+in+the+cellular+hypoxic+response&doi=10.1073%2Fpnas.082121399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for Hif-1α/CBP recognition in the cellular hypoxic response</span></div><div class="casAuthors">Dames, Sonja A.; Martinez-Yamout, Maria; De Guzman, Roberto N.; Dyson, H. Jane; Wright, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5271-5276</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The cellular response to low tissue oxygen concns. is mediated by the hypoxia-inducible transcription factor HIF-1.  Under hypoxic conditions, HIF-1 activates transcription of crit. adaptive genes by recruitment of the general coactivators CBP/p300 through interactions with its α-subunit (Hif-1α).  Disruption of the Hif-1α/p300 interaction has been linked to attenuation of tumor growth.  To delineate the structural basis for this interaction, we have detd. the soln. structure of the complex between the carboxy-terminal activation domain (CAD) of Hif-1α and the zinc-binding TAZ1 (CH1) motif of cAMP response element binding protein (CREB) binding protein (CBP).  Despite the overall similarity of the TAZ1 structure to that of the TAZ2 (part of the CH3) domain of CBP, differences occur in the packing of helixes that can account for differences in specificity.  The unbound CAD is intrinsically disordered and remains relatively extended upon binding, wrapping almost entirely around the TAZ1 domain in a groove through much of its surface.  Three short helixes are formed upon binding, stabilized by intermol. interactions.  The Asn-803 side chain, which functions as a hypoxic switch, is located on the second of these helixes and is buried in the mol. interface.  The third helix of the Hif-1α CAD docks in a deep hydrophobic groove in TAZ1, providing extensive intermol. hydrophobic interactions that contribute to the stability of the complex.  The structure of this complex provides new insights into the mechanism through which Hif-1α recruits CBP/p300 in response to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmGZTdgpkoWrVg90H21EOLACvtfcHk0ljCJjFi4RuHyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtFKlsro%253D&md5=acda89a699984ab91f03c0968c416f2a</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1073%2Fpnas.082121399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.082121399%26sid%3Dliteratum%253Aachs%26aulast%3DDames%26aufirst%3DS.%2BA.%26aulast%3DMartinez-Yamout%26aufirst%3DM.%26aulast%3DDe-Guzman%26aufirst%3DR.%2BN.%26aulast%3DDyson%26aufirst%3DH.%2BJ.%26aulast%3DWright%26aufirst%3DP.%2BE.%26atitle%3DStructural%2520basis%2520for%2520Hif-1%2520alpha%2520%252FCBP%2520recognition%2520in%2520the%2520cellular%2520hypoxic%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D8%26spage%3D5271%26epage%3D5276%26doi%3D10.1073%2Fpnas.082121399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, P. E.</span></span> <span> </span><span class="NLM_article-title">Role of intrinsic protein disorder in the function and interactions of the transcriptional coactivators CREB-binding Protein (CBP) and p300</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>291</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6714</span>– <span class="NLM_lpage">6122</span>, <span class="refDoi"> DOI: 10.1074/jbc.R115.692020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.R115.692020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26851278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvVyntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=291&publication_year=2016&pages=6714-6122&issue=13&author=H.+J.+Dysonauthor=P.+E.+Wright&title=Role+of+intrinsic+protein+disorder+in+the+function+and+interactions+of+the+transcriptional+coactivators+CREB-binding+Protein+%28CBP%29+and+p300&doi=10.1074%2Fjbc.R115.692020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Role of intrinsic protein disorder in the function and interactions of the transcriptional coactivators CREB-binding protein (CBP) and p300</span></div><div class="casAuthors">Dyson, H. Jane; Wright, Peter E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">291</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6714-6722</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Transcriptional coactivators CREB-binding protein (CBP) and p300 undergo a particularly rich set of interactions with disordered and partly ordered partners, as a part of their ubiquitous role in facilitating transcription of genes.  CBP and p300 contain a no. of small structured domains that provide scaffolds for the interaction of disordered transactivation domains from a wide variety of partners, including p53, hypoxia-inducible factor 1α (HIF-1α), NF-κB, and STAT proteins, and are the targets for the interactions of disordered viral proteins that compete with cellular factors to disrupt signaling and subvert the cell cycle.  The functional diversity of the CBP/p300 interactome provides an excellent example of the power of intrinsic disorder to facilitate the complexity of living systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6SVRTjy0OFbVg90H21EOLACvtfcHk0li8V6jMqHUZ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvVyntr4%253D&md5=b42a41e633abe38f5072d058fd946334</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1074%2Fjbc.R115.692020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.R115.692020%26sid%3Dliteratum%253Aachs%26aulast%3DDyson%26aufirst%3DH.%2BJ.%26aulast%3DWright%26aufirst%3DP.%2BE.%26atitle%3DRole%2520of%2520intrinsic%2520protein%2520disorder%2520in%2520the%2520function%2520and%2520interactions%2520of%2520the%2520transcriptional%2520coactivators%2520CREB-binding%2520Protein%2520%2528CBP%2529%2520and%2520p300%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2016%26volume%3D291%26issue%3D13%26spage%3D6714%26epage%3D6122%26doi%3D10.1074%2Fjbc.R115.692020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haddad, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poellinger, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span> <span> </span><span class="NLM_article-title">The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">364</span>– <span class="NLM_lpage">378</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cmet.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20399150" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtleis7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=364-378&issue=5&author=N.+Zhangauthor=Z.+Fuauthor=S.+Linkeauthor=J.+Chicherauthor=J.+J.+Gormanauthor=D.+Viskauthor=G.+G.+Haddadauthor=L.+Poellingerauthor=D.+J.+Peetauthor=F.+Powellauthor=R.+S.+Johnson&title=The+asparaginyl+hydroxylase+factor+inhibiting+HIF-1alpha+is+an+essential+regulator+of+metabolism&doi=10.1016%2Fj.cmet.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">The asparaginyl hydroxylase factor inhibiting HIF-1α is an essential regulator of metabolism</span></div><div class="casAuthors">Zhang, Na; Fu, Zhenxing; Linke, Sarah; Chicher, Johana; Gorman, Jeffrey J.; Visk, DeeAnn; Haddad, Gabriel G.; Poellinger, Lorenz; Peet, Daniel J.; Powell, Frank; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">364-378</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Factor inhibiting HIF-1α (FIH) is an asparaginyl hydroxylase.  Hydroxylation of HIF-α proteins by FIH blocks assocn. of HIFs with the transcriptional coactivators CBP/p300, thus inhibiting transcriptional activation.  We have created mice with a null mutation in the FIH gene and found that it has little or no discernable role in mice in altering classical aspects of HIF function, e.g., angiogenesis, erythropoiesis, or development.  Rather, it is an essential regulator of metab.: mice lacking FIH exhibit reduced body wt., elevated metabolic rate, hyperventilation, and improved glucose and lipid homeostasis and are resistant to high-fat-diet-induced wt. gain and hepatic steatosis.  Neuron-specific loss of FIH phenocopied some of the major metabolic phenotypes of the global null animals: those mice have reduced body wt., increased metabolic rate, and enhanced insulin sensitivity and are also protected against high-fat-diet-induced wt. gain.  These results demonstrate that FIH acts to a significant degree through the nervous system to regulate metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3n8qeyuQXk7Vg90H21EOLACvtfcHk0li8V6jMqHUZ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtleis7g%253D&md5=9a0248ccf3984d8d257e9e1bdae308b2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DLinke%26aufirst%3DS.%26aulast%3DChicher%26aufirst%3DJ.%26aulast%3DGorman%26aufirst%3DJ.%2BJ.%26aulast%3DVisk%26aufirst%3DD.%26aulast%3DHaddad%26aufirst%3DG.%2BG.%26aulast%3DPoellinger%26aufirst%3DL.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26aulast%3DPowell%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DThe%2520asparaginyl%2520hydroxylase%2520factor%2520inhibiting%2520HIF-1alpha%2520is%2520an%2520essential%2520regulator%2520of%2520metabolism%26jtitle%3DCell%2520Metab.%26date%3D2010%26volume%3D11%26issue%3D5%26spage%3D364%26epage%3D378%26doi%3D10.1016%2Fj.cmet.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span> <span> </span><span class="NLM_article-title">YC-1: A potential anticancer drug targeting hypoxia-inducible factor 1</span>. <i>J. Natl. Cancer Inst.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">525</span>, <span class="refDoi"> DOI: 10.1093/jnci/95.7.516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1093%2Fjnci%2F95.7.516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12671019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislyjs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=516-525&issue=7&author=E.+J.+Yeoauthor=Y.+S.+Chunauthor=Y.+S.+Choauthor=J.+Kimauthor=J.+C.+Leeauthor=M.+S.+Kimauthor=J.+W.+Park&title=YC-1%3A+A+potential+anticancer+drug+targeting+hypoxia-inducible+factor+1&doi=10.1093%2Fjnci%2F95.7.516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">YC-1: A Potential Anticancer Drug Targeting Hypoxia-Inducible Factor 1</span></div><div class="casAuthors">Yeo, Eun-Jin; Chun, Yang-Sook; Cho, Young-Suk; Kim, Jinho; Lee, June-Chul; Kim, Myung-Suk; Park, Jong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">516-525</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 alpha (HIF-1α), a component of HIF-1, is expressed in human tumors and renders cells able to survive and grow under hypoxic (low-oxygen) conditions.  YC-1, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole, an agent developed for circulatory disorders that inhibits platelet aggregation and vascular contraction, inhibits HIF-1 activity in vitro.  We tested whether YC-1 inhibits HIF-1 and tumor growth in vivo.  Hep3B hepatoma, NCI-H87 stomach carcinoma, Caki-1 renal carcinoma, SiHa cervical carcinoma, and SK-N-MC neuroblastoma cells were grown as xenografts in immunodeficient mice (69 mice total).  After the tumors were 100-150 mm3, mice received daily i.p. injections of vehicle or YC-1 (30 μg/g) for 2 wk.  HIF-1α protein levels and vascularity in tumors were assessed by immunohistochem., and the expression of HIF-1-inducible genes (vascular endothelial growth factor, aldolase, and enolase) was assessed by reverse transcription-polymerase chain reaction.  All statistical tests were two-sided.  Compared with tumors from vehicle-treated mice, tumors from YC-1-treated mice were statistically significantly smaller (P<.01 for all comparisons), expressed lower levels of HIF-1α (P<.01 for all comparisons), were less vascularized (P<.01 for all comparisons), and expressed lower levels of HIF-1-inducible genes, regardless of tumor type.  The inhibition of HIF-1α activity in tumors from YC-1-treated mice is assocd. with blocked angiogenesis and an inhibition of tumor growth.  YC-1 has the potential to become the first antiangiogenic anticancer agent to target HIF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-kqeoaq7INLVg90H21EOLACvtfcHk0li8V6jMqHUZ4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislyjs74%253D&md5=8b2370cf3dce9a7528cdcac7b2a93250</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F95.7.516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F95.7.516%26sid%3Dliteratum%253Aachs%26aulast%3DYeo%26aufirst%3DE.%2BJ.%26aulast%3DChun%26aufirst%3DY.%2BS.%26aulast%3DCho%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26aulast%3DKim%26aufirst%3DM.%2BS.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26atitle%3DYC-1%253A%2520A%2520potential%2520anticancer%2520drug%2520targeting%2520hypoxia-inducible%2520factor%25201%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D2003%26volume%3D95%26issue%3D7%26spage%3D516%26epage%3D525%26doi%3D10.1093%2Fjnci%2F95.7.516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ban, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchimaru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kizaka-Kondoh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1455</span>– <span class="NLM_lpage">1461</span>, <span class="refDoi"> DOI: 10.1039/c2md20134h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2Fc2md20134h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1455-1461&issue=11&author=A.+Takeuchiauthor=M.+Horiauthor=S.+Satoauthor=H.+S.+Banauthor=T.+Kuchimaruauthor=S.+Kizaka-Kondohauthor=T.+Yamoriauthor=H.+Nakamura&title=Synthesis+and+biological+activity+of+furanylindazoles+as+inhibitors+of+hypoxia+inducible+factor+%28HIF%29-1+transcriptional+activity&doi=10.1039%2Fc2md20134h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activity of furanylindazoles as inhibitors of hypoxia inducible factor (HIF)-1 transcriptional activity</span></div><div class="casAuthors">Takeuchi, Ayano; Hori, Makihito; Sato, Shinichi; Ban, Hyun Seung; Kuchimaru, Takahiro; Kizaka-Kondoh, Shinae; Yamori, Takao; Nakamura, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1455-1461</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">New YC-1 derivs. were synthesized and evaluated with HIF-1 transcriptional activity, and a potent deriv. shows activity in vivo.  Furthermore, for the mechanistic study of the YC-1 deriv., we evaluate the antiproliferative activity against 39 human cancer cell lines and the localization of active probes in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU6JkW56vrPLVg90H21EOLACvtfcHk0litIm_TkwFaSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKgsrnK&md5=acd688d8471a74a2a044a1957fb43e2d</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1039%2Fc2md20134h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20134h%26sid%3Dliteratum%253Aachs%26aulast%3DTakeuchi%26aufirst%3DA.%26aulast%3DHori%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DS.%26aulast%3DBan%26aufirst%3DH.%2BS.%26aulast%3DKuchimaru%26aufirst%3DT.%26aulast%3DKizaka-Kondoh%26aufirst%3DS.%26aulast%3DYamori%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520furanylindazoles%2520as%2520inhibitors%2520of%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529-1%2520transcriptional%2520activity%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26issue%3D11%26spage%3D1455%26epage%3D1461%26doi%3D10.1039%2Fc2md20134h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span> <span> </span><span class="NLM_article-title">Anti-angiogenesis Compounds</span>. <span class="NLM_patent">WO2007065010A2</span>, <span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=J.+W.+Park&title=Anti-angiogenesis+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DJ.%2BW.%26atitle%3DAnti-angiogenesis%2520Compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hay, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singleton, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tallant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picaud, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monteiro, O. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conway, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rooney, T. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yapp, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of small-molecule ligands for the CBP/p300 bromodomains</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9308</span>– <span class="NLM_lpage">9319</span>, <span class="refDoi"> DOI: 10.1021/ja412434f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja412434f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=9308-9319&issue=26&author=D.+A.+Hayauthor=O.+Fedorovauthor=S.+Martinauthor=D.+C.+Singletonauthor=C.+Tallantauthor=C.+Wellsauthor=S.+Picaudauthor=M.+Philpottauthor=O.+P.+Monteiroauthor=C.+M.+Rogersauthor=S.+J.+Conwayauthor=T.+P.+C.+Rooneyauthor=A.+Tumberauthor=C.+Yappauthor=P.+Filippakopoulosauthor=M.+E.+Bunnageauthor=S.+Mullerauthor=S.+Knappauthor=C.+J.+Schofieldauthor=P.+E.+Brennan&title=Discovery+and+optimization+of+small-molecule+ligands+for+the+CBP%2Fp300+bromodomains&doi=10.1021%2Fja412434f"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains</span></div><div class="casAuthors">Hay, Duncan A.; Fedorov, Oleg; Martin, Sarah; Singleton, Dean C.; Tallant, Cynthia; Wells, Christopher; Picaud, Sarah; Philpott, Martin; Monteiro, Octovia P.; Rogers, Catherine M.; Conway, Stuart J.; Rooney, Timothy P. C.; Tumber, Anthony; Yapp, Clarence; Filippakopoulos, Panagis; Bunnage, Mark E.; Muller, Susanne; Knapp, Stefan; Schofield, Christopher J.; Brennan, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9308-9319</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Small-mol. inhibitors that target bromodomains outside of the bromodomain and extra-terminal (BET) sub-family are lacking.  Here, the authors describe highly potent and selective ligands for the bromodomain module of the human lysine acetyl transferase CBP/p300, developed from a series of 5-isoxazolyl-benzimidazoles.  The starting point was a fragment hit, which was optimized into a more potent and selective lead using parallel synthesis employing Suzuki couplings, benzimidazole-forming reactions, and reductive aminations.  The selectivity of the lead compd. against other bromodomain family members was investigated using a thermal stability assay, which revealed some inhibition of the structurally related BET family members.  To address the BET selectivity issue, x-ray crystal structures of the lead compd. bound to the CREB binding protein (CBP) and the first bromodomain of BRD4 (BRD4(1)) were used to guide the design of more selective compds.  The crystal structures obtained revealed two distinct binding modes.  By varying the aryl substitution pattern and developing conformationally constrained analogs, selectivity for CBP over BRD4(1) was increased.  The optimized compd. is highly potent (Kd = 21 nM) and selective, displaying 40-fold selectivity over BRD4(1).  Cellular activity was demonstrated using fluorescence recovery after photo-bleaching (FRAP) and a p53 reporter assay.  The optimized compds. are cell-active and have nanomolar affinity for CBP/p300; therefore, they should be useful in studies investigating the biol. roles of CBP and p300 and to validate the CBP and p300 bromodomains as therapeutic targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFzgs1DD4QZLVg90H21EOLACvtfcHk0litIm_TkwFaSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVShsLvP&md5=e5da3e96a4d234453a481c7ee5e788f2</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fja412434f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja412434f%26sid%3Dliteratum%253Aachs%26aulast%3DHay%26aufirst%3DD.%2BA.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMartin%26aufirst%3DS.%26aulast%3DSingleton%26aufirst%3DD.%2BC.%26aulast%3DTallant%26aufirst%3DC.%26aulast%3DWells%26aufirst%3DC.%26aulast%3DPicaud%26aufirst%3DS.%26aulast%3DPhilpott%26aufirst%3DM.%26aulast%3DMonteiro%26aufirst%3DO.%2BP.%26aulast%3DRogers%26aufirst%3DC.%2BM.%26aulast%3DConway%26aufirst%3DS.%2BJ.%26aulast%3DRooney%26aufirst%3DT.%2BP.%2BC.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DYapp%26aufirst%3DC.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DMuller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520small-molecule%2520ligands%2520for%2520the%2520CBP%252Fp300%2520bromodomains%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26issue%3D26%26spage%3D9308%26epage%3D9319%26doi%3D10.1021%2Fja412434f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arany, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunn, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span> <span> </span><span class="NLM_article-title">An essential role for p300/CBP in the cellular response to hypoxia</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>93</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">12969</span>– <span class="NLM_lpage">12973</span>, <span class="refDoi"> DOI: 10.1073/pnas.93.23.12969</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.93.23.12969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=8917528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK28XmvV2ksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=12969-12973&issue=23&author=Z.+Aranyauthor=L.+E.+Huangauthor=R.+Ecknerauthor=S.+Bhattacharyaauthor=C.+Jiangauthor=M.+A.+Goldbergauthor=H.+F.+Bunnauthor=D.+M.+Livingston&title=An+essential+role+for+p300%2FCBP+in+the+cellular+response+to+hypoxia&doi=10.1073%2Fpnas.93.23.12969"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">An essential role for p300/CBP in the cellular response to hypoxia</span></div><div class="casAuthors">Arany, Zoltan; Huang, L. Eric; Eckner, Richard; Bhattacharya, Shoumo; Jiang, Chian; Goldberg, Mark A.; Bunn, H. Franklin; Livingston, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">12969-12973</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">P300 and CBP are homologous transcription adapters targeted by the E1A oncoprotein.  They participate in numerous biol. processes, including cell cycle arrest, differentiation, and transcription activation.  P300 and/or CBP (p300/CBP) also coactivate CREB.  How they participate in these processes is not yet known.  In a search for specific p300 binding proteins, the authors have cloned the intact cDNA for HIF-1α.  This transcription factor mediates hypoxic induction of genes encoding certain glycolytic enzymes, erythropoietin (Epo), and vascular endothelial growth factor.  Hypoxic conditions lead to the formation of a DNA binding complex contg. both HIF-1α and p300/CBP.  Hypoxia-induced transcription from the Epo promoter was specifically enhanced by ectopic p300 and inhibited by E1A binding to p300/CBP.  Hypoxia-induced VEGF and Epo mRNA synthesis were similarly inhibited by E1A.  Hence, p300/CBP-HIF complexes participate in the induction of hypoxia-responsive genes, including one (vascular endothelial growth factor) that plays a major role in tumor angiogenesis.  Paradoxically, these data, to the authors knowledge for the first time, suggest that p300/CBP are active in both transformation suppression and tumor development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM-e4qQzJO8LVg90H21EOLACvtfcHk0lg95XIoPeNtrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XmvV2ksL0%253D&md5=9e4664e6abbe36f1ab5112cd8601ceb5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.23.12969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.23.12969%26sid%3Dliteratum%253Aachs%26aulast%3DArany%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DL.%2BE.%26aulast%3DEckner%26aufirst%3DR.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DGoldberg%26aufirst%3DM.%2BA.%26aulast%3DBunn%26aufirst%3DH.%2BF.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DAn%2520essential%2520role%2520for%2520p300%252FCBP%2520in%2520the%2520cellular%2520response%2520to%2520hypoxia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26issue%3D23%26spage%3D12969%26epage%3D12973%26doi%3D10.1073%2Fpnas.93.23.12969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabludoff, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornell-Kennon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Memmert, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naegeli, H. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livingston, D. M.</span></span> <span> </span><span class="NLM_article-title">Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">33</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ccr.2004.06.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.ccr.2004.06.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15261140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlKnt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=33-43&issue=1&author=A.+L.+Kungauthor=S.+D.+Zabludoffauthor=D.+S.+Franceauthor=S.+J.+Freedmanauthor=E.+A.+Tannerauthor=A.+Vieiraauthor=S.+Cornell-Kennonauthor=J.+Leeauthor=B.+Wangauthor=J.+Wangauthor=K.+Memmertauthor=H.+U.+Naegeliauthor=F.+Petersenauthor=M.+J.+Eckauthor=K.+W.+Bairauthor=A.+W.+Woodauthor=D.+M.+Livingston&title=Small+molecule+blockade+of+transcriptional+coactivation+of+the+hypoxia-inducible+factor+pathway&doi=10.1016%2Fj.ccr.2004.06.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule blockade of transcriptional coactivation of the hypoxia-inducible factor pathway</span></div><div class="casAuthors">Kung, Andrew L.; Zabludoff, Sonya D.; France, Dennis S.; Freedman, Steven J.; Tanner, Elizabeth A.; Vieira, Annelisa; Cornell-Kennon, Susan; Lee, Jennifer; Wang, Beqing; Wang, Jamin; Memmert, Klaus; Naegeli, Hans-Ulrich; Petersen, Frank; Eck, Michael J.; Bair, Kenneth W.; Wood, Alexander W.; Livingston, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-43</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Homeostasis under hypoxic conditions is maintained through a coordinated transcriptional response mediated by the hypoxia-inducible factor (HIF) pathway and requires coactivation by the CBP and p300 transcriptional coactivators.  Through a target-based high-throughput screen, the authors identified chetomin as a disrupter of HIF binding to p300.  At a mol. level, chetomin disrupts the structure of the CH1 domain of p300 and precludes its interaction with HIF, thereby attenuating hypoxia-inducible transcription.  Systemic administration of chetomin inhibited hypoxia-inducible transcription within tumors and inhibited tumor growth.  These results demonstrate a therapeutic window for pharmacol. attenuation of HIF activity and further establish the feasibility of disrupting a signal transduction pathway by targeting the function of a transcriptional coactivator with a small mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKTy3mUgy2bbVg90H21EOLACvtfcHk0lg95XIoPeNtrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlKnt7s%253D&md5=3caa81703ea36d0be098ba295ade1748</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2004.06.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2004.06.009%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DFrance%26aufirst%3DD.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26aulast%3DTanner%26aufirst%3DE.%2BA.%26aulast%3DVieira%26aufirst%3DA.%26aulast%3DCornell-Kennon%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMemmert%26aufirst%3DK.%26aulast%3DNaegeli%26aufirst%3DH.%2BU.%26aulast%3DPetersen%26aufirst%3DF.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DBair%26aufirst%3DK.%2BW.%26aulast%3DWood%26aufirst%3DA.%2BW.%26aulast%3DLivingston%26aufirst%3DD.%2BM.%26atitle%3DSmall%2520molecule%2520blockade%2520of%2520transcriptional%2520coactivation%2520of%2520the%2520hypoxia-inducible%2520factor%2520pathway%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D6%26issue%3D1%26spage%3D33%26epage%3D43%26doi%3D10.1016%2Fj.ccr.2004.06.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De Munari, S.</span>; <span class="NLM_string-name">Grugni, M.</span>; <span class="NLM_string-name">Menta, E.</span>; <span class="NLM_string-name">Cassin, M.</span>; <span class="NLM_string-name">Colella, G.</span></span> <span> </span><span class="NLM_article-title">Use of diketodithiopiperazine Antibiotics for the Preparation of Antiangiogenic Pharmaceutical Compositions</span>. <span class="NLM_patent">WO2006066775A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+De+Munari&author=M.+Grugni&author=E.+Menta&author=M.+Cassin&author=G.+Colella&title=Use+of+diketodithiopiperazine+Antibiotics+for+the+Preparation+of+Antiangiogenic+Pharmaceutical+Compositions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BMunari%26aufirst%3DS.%26atitle%3DUse%2520of%2520diketodithiopiperazine%2520Antibiotics%2520for%2520the%2520Preparation%2520of%2520Antiangiogenic%2520Pharmaceutical%2520Compositions%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dial, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Z. Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freedman, S. J.</span></span> <span> </span><span class="NLM_article-title">Three conformational states of the p300 CH1 domain define its functional properties</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">9937</span>– <span class="NLM_lpage">9945</span>, <span class="refDoi"> DOI: 10.1021/bi034989o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi034989o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvVSjs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=9937-9945&issue=33&author=R.+Dialauthor=Z.+Y.+J.+Sunauthor=S.+J.+Freedman&title=Three+conformational+states+of+the+p300+CH1+domain+define+its+functional+properties&doi=10.1021%2Fbi034989o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Three Conformational States of the p300 CH1 Domain Define Its Functional Properties</span></div><div class="casAuthors">Dial, Ravina; Sun, Zhen-Yu J.; Freedman, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">9937-9945</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Numerous transcription factors interact with the basal transcriptional machinery through the transcriptional co-activators p300 and CREB-binding protein (CBP).  The Zn2+-binding cysteine/histidine-rich 1 (CH1) domain of p300/CBP binds many of these transcription factors, including hypoxia-inducible factor (HIF).  The authors studied the structural and biophys. properties of the p300 CH1 domain alone and bound to the HIF-1α C-terminal transactivation domain (TAD) to understand the diverse binding properties of CH1.  The Zn2+-bound CH1 domain (CH1-Zn2+) and the HIF-1α TAD-CH1 complex (CH1-Zn2+-HIF-1α) are similarly helical, whereas metal-free CH1 is mostly random coil.  CH1-Zn2+ undergoes noncooperative thermal denaturation, does not have a near-UV elliptical signal, and binds the hydrophobic fluorophore ANS.  In contrast, the CH1-Zn2+-HIF-1α complex undergoes cooperative thermal denaturation, does produce a near-UV signal, and does not bind ANS.  Addn. of Zn2+ ions to metal-free CH1 produced one conformational change, and subsequent addn. of a HIF-1α TAD peptide induced a second conformational change as detected by intrinsic tryptophan fluorescence spectroscopy.  The NMR 1H-15N HSQC spectrum of CH1-Zn2+ exhibits few poorly dispersed peaks with broad line widths.  Removal of metal ions produces more poorly dispersed peaks with sharper line widths.  Addn. of a HIF-1α TAD peptide to CH1-Zn2+ produces many well-dispersed peaks with sharp line widths.  Taken together, these data support three conformational states for CH1, including an unstructured metal-free domain, a partially structured Zn2+-bound domain with molten globule characteristics, and a stable, well-ordered HIF-1α TAD-CH1 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8FPKW355mwrVg90H21EOLACvtfcHk0lg95XIoPeNtrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvVSjs70%253D&md5=1ef2323f606e713aca4e1ef6dc6303e2</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi034989o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi034989o%26sid%3Dliteratum%253Aachs%26aulast%3DDial%26aufirst%3DR.%26aulast%3DSun%26aufirst%3DZ.%2BY.%2BJ.%26aulast%3DFreedman%26aufirst%3DS.%2BJ.%26atitle%3DThree%2520conformational%2520states%2520of%2520the%2520p300%2520CH1%2520domain%2520define%2520its%2520functional%2520properties%26jtitle%3DBiochemistry%26date%3D2003%26volume%3D42%26issue%3D33%26spage%3D9937%26epage%3D9945%26doi%3D10.1021%2Fbi034989o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goey, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnermann, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, K. R.</span></span> <span> </span><span class="NLM_article-title">Structural elucidation and synthesis of eudistidine A: an unusual polycyclic marine alkaloid that blocks interaction of the protein binding domains of p300 and HIF-1alpha</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>137</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5569</span>– <span class="NLM_lpage">5575</span>, <span class="refDoi"> DOI: 10.1021/jacs.5b02156</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jacs.5b02156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslOisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2015&pages=5569-5575&issue=16&author=S.+T.+Chanauthor=P.+R.+Patelauthor=T.+R.+Ransomauthor=C.+J.+Henrichauthor=T.+C.+McKeeauthor=A.+K.+Goeyauthor=K.+M.+Cookauthor=W.+D.+Figgauthor=J.+B.+McMahonauthor=M.+J.+Schnermannauthor=K.+R.+Gustafson&title=Structural+elucidation+and+synthesis+of+eudistidine+A%3A+an+unusual+polycyclic+marine+alkaloid+that+blocks+interaction+of+the+protein+binding+domains+of+p300+and+HIF-1alpha&doi=10.1021%2Fjacs.5b02156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Elucidation and Synthesis of Eudistidine A: An Unusual Polycyclic Marine Alkaloid that Blocks Interaction of the Protein Binding Domains of p300 and HIF-1α</span></div><div class="casAuthors">Chan, Susanna T. S.; Patel, Paresma R.; Ransom, Tanya R.; Henrich, Curtis J.; McKee, Tawnya C.; Goey, Andrew K. L.; Cook, Kristina M.; Figg, William D.; McMahon, James B.; Schnermann, Martin J.; Gustafson, Kirk R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5569-5575</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Low oxygen environments are a hallmark of solid tumors, and transcription of many hypoxia-responsive genes needed for survival under these conditions is regulated by the transcription factor HIF-1 (hypoxia-inducible factor 1).  Activation of HIF-1 requires binding of its α-subunit (HIF-1α) to the transcriptional coactivator protein p300.  Inhibition of the p300/HIF-1α interaction can suppress HIF-1 activity.  A screen for inhibitors of the protein binding domains of p300 (CH1) and HIF-1α (C-TAD) identified an ext. of the marine ascidian Eudistoma sp. as active.  Novel heterocyclic alkaloids eudistidines A (1, I) and B (2, II) were isolated from the ext., and their structures assigned by spectroscopic analyses.  They contain an unprecedented tetracyclic core composed of two pyrimidine rings fused with an imidazole ring.  Eudistidine A (1) was synthesized in a concise four-step sequence featuring a condensation/cyclization reaction cascade between 4-(2-aminophenyl)pyrimidin-2-amine and (4-methoxyphenyl)glyoxal, while eudistidine B (2) was synthesized in a similar fashion with glyoxylic acid in place of (4-methoxyphenyl)glyoxal.  Naturally occurring eudistidine A (1) effectively inhibited CH1/C-TAD binding with an IC50 of 75 μM, and synthetic 1 had similar activity.  The eudistidine A (1) scaffold, which can be synthesized in a concise, scalable manner, may provide potential therapeutic lead compds. or mol. probes to study p300/HIF-1α interactions and the role these proteins play in tumor response to low oxygen conditions.  The unique structural scaffolds and functional group arrays often found in natural products make these secondary metabolites a rich source of new compds. that can disrupt crit. protein-protein binding events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtuQlTDBBMprVg90H21EOLACvtfcHk0lgSdwaJYf5H-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslOisLw%253D&md5=6d8a4aa6c942772992b638c88f87702d</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjacs.5b02156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjacs.5b02156%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DS.%2BT.%26aulast%3DPatel%26aufirst%3DP.%2BR.%26aulast%3DRansom%26aufirst%3DT.%2BR.%26aulast%3DHenrich%26aufirst%3DC.%2BJ.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DGoey%26aufirst%3DA.%2BK.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DSchnermann%26aufirst%3DM.%2BJ.%26aulast%3DGustafson%26aufirst%3DK.%2BR.%26atitle%3DStructural%2520elucidation%2520and%2520synthesis%2520of%2520eudistidine%2520A%253A%2520an%2520unusual%2520polycyclic%2520marine%2520alkaloid%2520that%2520blocks%2520interaction%2520of%2520the%2520protein%2520binding%2520domains%2520of%2520p300%2520and%2520HIF-1alpha%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2015%26volume%3D137%26issue%3D16%26spage%3D5569%26epage%3D5575%26doi%3D10.1021%2Fjacs.5b02156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goey, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sissung, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venzon, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransom, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grkovic, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadelis, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copp, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span> <span> </span><span class="NLM_article-title">Screening and biological effects of marine pyrroloiminoquinone alkaloids:potential inhibitors of the HIF-1alpha/p300 interaction</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1267</span>– <span class="NLM_lpage">1275</span>, <span class="refDoi"> DOI: 10.1021/acs.jnatprod.5b00846</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jnatprod.5b00846" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVShsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2016&pages=1267-1275&issue=5&author=A.+K.+Goeyauthor=C.+H.+Chauauthor=T.+M.+Sissungauthor=K.+M.+Cookauthor=D.+J.+Venzonauthor=A.+Castroauthor=T.+R.+Ransomauthor=C.+J.+Henrichauthor=T.+C.+McKeeauthor=J.+B.+McMahonauthor=T.+Grkovicauthor=M.+M.+Cadelisauthor=B.+R.+Coppauthor=K.+R.+Gustafsonauthor=W.+D.+Figg&title=Screening+and+biological+effects+of+marine+pyrroloiminoquinone+alkaloids%3Apotential+inhibitors+of+the+HIF-1alpha%2Fp300+interaction&doi=10.1021%2Facs.jnatprod.5b00846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction</span></div><div class="casAuthors">Goey, Andrew K. L.; Chau, Cindy H.; Sissung, Tristan M.; Cook, Kristina M.; Venzon, David J.; Castro, Amaya; Ransom, Tanya R.; Henrich, Curtis J.; McKee, Tawnya C.; McMahon, James B.; Grkovic, Tanja; Cadelis, Melissa M.; Copp, Brent R.; Gustafson, Kirk R.; Figg, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1267-1275</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Inhibition of the hypoxia-inducible factor 1α (HIF-1α) pathway by disrupting its assocn. with the transcriptional coactivator p300 inhibits angiogenesis and tumor development.  Development of HIF-1α/p300 inhibitors has been hampered by preclin. toxicity; therefore, we aimed to identify novel HIF-1α/p300 inhibitors.  Using a cell-free assay designed to test compds. that block HIF-1α/p300 binding, 170,298 crude natural product exts. and prefractionated samples were screened, identifying 25 active exts.  One of these exts., originating from the marine sponge Latrunculia sp., afforded six pyrroloiminoquinone alkaloids that were identified as pos. hits (IC50 values: 1-35 μM).  Luciferase assays confirmed inhibition of HIF-1α transcriptional activity by discorhabdin B (1) and its dimer (2), 3-dihydrodiscorhabdin C (3), makaluvamine F (5), discorhabdin H (8), discorhabdin L (9), and discorhabdin W (11) in HCT 116 colon cancer cells (0.1-10 μM, p < 0.05).  Except for 11, all of these compds. also reduced HIF-1α transcriptional activity in LNCaP prostate cancer cells (0.1-10 μM, p < 0.05).  These effects occurred at noncytotoxic concns. (<50% cell death) under hypoxic conditions.  At the downstream HIF-1α target level, compd. 8 (0.5 μM) significantly decreased VEGF secretion in LNCaP cells (p < 0.05).  In COLO 205 colon cancer cells no activity was shown in the luciferase or cytotoxicity assays.  Pyrroloiminoquinone alkaloids are a novel class of HIF-1α inhibitors, which interrupt the protein-protein interaction between HIF-1α and p300 and consequently reduce HIF-related transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUXDw3T75ifrVg90H21EOLACvtfcHk0lgSdwaJYf5H-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVShsr0%253D&md5=e5a0fbd3511e8b5d47fc26d947e8beb4</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Facs.jnatprod.5b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jnatprod.5b00846%26sid%3Dliteratum%253Aachs%26aulast%3DGoey%26aufirst%3DA.%2BK.%26aulast%3DChau%26aufirst%3DC.%2BH.%26aulast%3DSissung%26aufirst%3DT.%2BM.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DVenzon%26aufirst%3DD.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DRansom%26aufirst%3DT.%2BR.%26aulast%3DHenrich%26aufirst%3DC.%2BJ.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DGrkovic%26aufirst%3DT.%26aulast%3DCadelis%26aufirst%3DM.%2BM.%26aulast%3DCopp%26aufirst%3DB.%2BR.%26aulast%3DGustafson%26aufirst%3DK.%2BR.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26atitle%3DScreening%2520and%2520biological%2520effects%2520of%2520marine%2520pyrroloiminoquinone%2520alkaloids%253Apotential%2520inhibitors%2520of%2520the%2520HIF-1alpha%252Fp300%2520interaction%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2016%26volume%3D79%26issue%3D5%26spage%3D1267%26epage%3D1275%26doi%3D10.1021%2Facs.jnatprod.5b00846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Block, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polaske, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henchey, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makhoul, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meuillet, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span> <span> </span><span class="NLM_article-title">Direct inhibition of hypoxia-inducible transcription factor complex with designed dimeric epidithiodiketopiperazine</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">50</span>),  <span class="NLM_fpage">18078</span>– <span class="NLM_lpage">18088</span>, <span class="refDoi"> DOI: 10.1021/ja807601b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja807601b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVWhuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=18078-18088&issue=50&author=K.+M.+Blockauthor=H.+Wangauthor=L.+Z.+Szaboauthor=N.+W.+Polaskeauthor=L.+K.+Hencheyauthor=R.+Dubeyauthor=S.+Kushalauthor=C.+F.+Laszloauthor=J.+Makhoulauthor=Z.+Songauthor=E.+J.+Meuilletauthor=B.+Z.+Olenyuk&title=Direct+inhibition+of+hypoxia-inducible+transcription+factor+complex+with+designed+dimeric+epidithiodiketopiperazine&doi=10.1021%2Fja807601b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Direct Inhibition of Hypoxia-Inducible Transcription Factor Complex with Designed Dimeric Epidithiodiketopiperazine</span></div><div class="casAuthors">Block, Katherine M.; Wang, Hui; Szabo, Lajos Z.; Polaske, Nathan W.; Henchey, Laura K.; Dubey, Ramin; Kushal, Swati; Laszlo, Csaba F.; Makhoul, Joshua; Song, Zuohe; Meuillet, Emmanuelle J.; Olenyuk, Bogdan Z.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">18078-18088</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective blockade of hypoxia-inducible gene expression by designed small mols. would prove valuable in suppressing tumor angiogenesis, metastasis and altered energy metab.  The design, synthesis, and biol. evaluation of a dimeric epidithiodiketopiperazine (ETP) small mol. transcriptional antagonist targeting the interaction of the p300/CBP coactivator with the transcription factor HIF-1α is reported.  The results indicate that disrupting this interaction results in rapid down-regulation of hypoxia-inducible genes crit. for cancer progression.  The obsd. effects are compd.-specific and dose-dependent.  Controlling gene expression with designed small mols. targeting the transcription factor-coactivator interface may represent a new approach for arresting tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCjFazOhjGcbVg90H21EOLACvtfcHk0li8kqz2kRK3Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVWhuro%253D&md5=426c5b85378abc54f86fbd31279fd21f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fja807601b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja807601b%26sid%3Dliteratum%253Aachs%26aulast%3DBlock%26aufirst%3DK.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DSzabo%26aufirst%3DL.%2BZ.%26aulast%3DPolaske%26aufirst%3DN.%2BW.%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DLaszlo%26aufirst%3DC.%2BF.%26aulast%3DMakhoul%26aufirst%3DJ.%26aulast%3DSong%26aufirst%3DZ.%26aulast%3DMeuillet%26aufirst%3DE.%2BJ.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26atitle%3DDirect%2520inhibition%2520of%2520hypoxia-inducible%2520transcription%2520factor%2520complex%2520with%2520designed%2520dimeric%2520epidithiodiketopiperazine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D50%26spage%3D18078%26epage%3D18088%26doi%3D10.1021%2Fja807601b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levin, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szabo, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laszlo, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnitzer, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span> <span> </span><span class="NLM_article-title">Suppression of tumor growth by designed dimeric epidithiodiketopiperazine targeting hypoxia-Inducible transcription factor complex</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">4537</span>– <span class="NLM_lpage">4549</span>, <span class="refDoi"> DOI: 10.1021/ja400805b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja400805b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=4537-4549&issue=11&author=R.+Dubeyauthor=M.+D.+Levinauthor=L.+Z.+Szaboauthor=C.+F.+Laszloauthor=S.+Kushalauthor=J.+B.+Singhauthor=P.+Ohauthor=J.+E.+Schnitzerauthor=B.+Z.+Olenyuk&title=Suppression+of+tumor+growth+by+designed+dimeric+epidithiodiketopiperazine+targeting+hypoxia-Inducible+transcription+factor+complex&doi=10.1021%2Fja400805b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of Tumor Growth by Designed Dimeric Epidithiodiketopiperazine Targeting Hypoxia-Inducible Transcription Factor Complex</span></div><div class="casAuthors">Dubey, Ramin; Levin, Michael D.; Szabo, Lajos Z.; Laszlo, Csaba F.; Kushal, Swati; Singh, Jason B.; Oh, Philip; Schnitzer, Jan E.; Olenyuk, Bogdan Z.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4537-4549</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia is a hallmark of solid tumors, is assocd. with local invasion, metastatic spread, resistance to chemo- and radiotherapy, and is an independent, neg. prognostic factor for a diverse range of malignant neoplasms.  The cellular response to hypoxia is primarily mediated by a family of transcription factors, among which hypoxia-inducible factor 1 (HIF1) plays a major role.  Under normoxia, the oxygen-sensitive α subunit of HIF1 is rapidly and constitutively degraded but is stabilized and accumulates under hypoxia.  Upon nuclear translocation, HIF1 controls the expression of over 100 genes involved in angiogenesis, altered energy metab., antiapoptotic, and pro-proliferative mechanisms that promote tumor growth.  A designed transcriptional antagonist, dimeric epidithiodiketopiperazine (ETP 2), selectively disrupts the interaction of HIF1α with p300/CBP coactivators and downregulates the expression of hypoxia-inducible genes.  ETP 2 was synthesized via a novel homo-oxidative coupling of the aliph. primary carbons of the dithioacetal precursor.  It effectively inhibits HIF1-induced activation of VEGFA, LOX, Glut1, and c-Met genes in a panel of cell lines representing breast and lung cancers.  We obsd. an outstanding antitumor efficacy of both (±)-ETP 2 and meso-ETP 2 in a fully established breast carcinoma model by intravital microscopy.  Treatment with either form of ETP 2 (1 mg/kg) resulted in a rapid regression of tumor growth that lasted for up to 14 days.  These results suggest that inhibition of HIF1 transcriptional activity by designed dimeric ETPs could offer an innovative approach to cancer therapy with the potential to overcome hypoxia-induced tumor growth and resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXlsOJ0fCSKLVg90H21EOLACvtfcHk0li8kqz2kRK3Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgtbs%253D&md5=c92889f1e42c63eb55680b9700fe327f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja400805b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja400805b%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DLevin%26aufirst%3DM.%2BD.%26aulast%3DSzabo%26aufirst%3DL.%2BZ.%26aulast%3DLaszlo%26aufirst%3DC.%2BF.%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DJ.%2BB.%26aulast%3DOh%26aufirst%3DP.%26aulast%3DSchnitzer%26aufirst%3DJ.%2BE.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26atitle%3DSuppression%2520of%2520tumor%2520growth%2520by%2520designed%2520dimeric%2520epidithiodiketopiperazine%2520targeting%2520hypoxia-Inducible%2520transcription%2520factor%2520complex%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D11%26spage%3D4537%26epage%3D4549%26doi%3D10.1021%2Fja400805b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jayatunga, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKee, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reece, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sekirnik, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seden, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figg, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, A. D.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">509</span>– <span class="NLM_lpage">516</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.ejmech.2014.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25023609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtLnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2015&pages=509-516&author=M.+K.+Jayatungaauthor=P.+S.+Thompsonauthor=T.+C.+McKeeauthor=M.+C.+Chanauthor=K.+M.+Reeceauthor=A.+P.+Hardyauthor=R.+Sekirnikauthor=P.+T.+Sedenauthor=K.+M.+Cookauthor=J.+B.+McMahonauthor=W.+D.+Figgauthor=C.+J.+Schofieldauthor=A.+D.+Hamilton&title=Inhibition+of+the+HIF1%CE%B1-p300+interaction+by+quinone-+and+indandione-mediated+ejection+of+structural+Zn%28II%29&doi=10.1016%2Fj.ejmech.2014.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the HIF1α-p300 interaction by quinone- and indandione-mediated ejection of structural Zn(II)</span></div><div class="casAuthors">Jayatunga, Madura K. P.; Thompson, Sam; McKee, Tawnya C.; Chan, Mun Chiang; Reece, Kelie M.; Hardy, Adam P.; Sekirnik, Rok; Seden, Peter T.; Cook, Kristina M.; McMahon, James B.; Figg, William D.; Schofield, Christopher J.; Hamilton, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">509-516</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Protein-protein interactions between the hypoxia inducible factor (HIF) and the transcriptional coactivators p300/CBP are potential cancer targets due to their role in the hypoxic response.  A natural product based screen led to the identification of indandione and benzoquinone derivs. that reduce the tight interaction between a HIF-1α fragment and the CH1 domain of p300.  The indandione derivs. were shown to fragment to give ninhydrin, which was identified as the active species.  Both the naphthoquinones and ninhydrin were obsd. to induce Zn(II) ejection from p300 and the catalytic domain of the histone demethylase KDM4A.  Together with previous reports on the effects of related compds. on HIF-1α and other systems, the results suggest that care should be taken in interpreting biol. results obtained with highly electrophilic/thiol modifying compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDr1pjG22OaLVg90H21EOLACvtfcHk0li8kqz2kRK3Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCgtLnF&md5=5e6b8137d90072e24936c1321d16995f</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DJayatunga%26aufirst%3DM.%2BK.%26aulast%3DThompson%26aufirst%3DP.%2BS.%26aulast%3DMcKee%26aufirst%3DT.%2BC.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DReece%26aufirst%3DK.%2BM.%26aulast%3DHardy%26aufirst%3DA.%2BP.%26aulast%3DSekirnik%26aufirst%3DR.%26aulast%3DSeden%26aufirst%3DP.%2BT.%26aulast%3DCook%26aufirst%3DK.%2BM.%26aulast%3DMcMahon%26aufirst%3DJ.%2BB.%26aulast%3DFigg%26aufirst%3DW.%2BD.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DHamilton%26aufirst%3DA.%2BD.%26atitle%3DInhibition%2520of%2520the%2520HIF1%25CE%25B1-p300%2520interaction%2520by%2520quinone-%2520and%2520indandione-mediated%2520ejection%2520of%2520structural%2520Zn%2528II%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D94%26spage%3D509%26epage%3D516%26doi%3D10.1016%2Fj.ejmech.2014.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cassin, M. M.</span>; <span class="NLM_string-name">Colella, G.</span>; <span class="NLM_string-name">De Munari, S. M.</span>; <span class="NLM_string-name">Grugni, M.</span></span> <span> </span><span class="NLM_article-title">Use of Thiazolidinone Derivatives as Antiangiogenic Agents</span>. <span class="NLM_patent">WO2006066846A1</span>, <span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+M.+Cassin&author=G.+Colella&author=S.+M.+De+Munari&author=M.+Grugni&title=Use+of+Thiazolidinone+Derivatives+as+Antiangiogenic+Agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCassin%26aufirst%3DM.%2BM.%26atitle%3DUse%2520of%2520Thiazolidinone%2520Derivatives%2520as%2520Antiangiogenic%2520Agents%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, D. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">5249</span>– <span class="NLM_lpage">5252</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.06.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bmcl.2012.06.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22789427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVamtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=5249-5252&issue=16&author=H.+S.+Kwonauthor=D.+R.+Kimauthor=E.+G.+Yangauthor=Y.+K.+Parkauthor=H.+C.+Ahnauthor=S.+J.+Minauthor=D.+R.+Ahn&title=Inhibition+of+VEGF+transcription+through+blockade+of+the+hypoxia+inducible+factor-1%CE%B1-p300+interaction+by+a+small+molecule&doi=10.1016%2Fj.bmcl.2012.06.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of VEGF transcription through blockade of the hypoxia inducible factor-1α-p300 interaction by a small molecule</span></div><div class="casAuthors">Kwon, Hyuk Sung; Kim, Da-Rae; Yang, Eun Gyeong; Park, Yong Keun; Ahn, Hee-Chul; Min, Sun-Joon; Ahn, Dae-Ro</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5249-5252</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Vascular endothelial growth factor (VEGF) plays a pro-angiogenic role in tumor progression.  Stabilization of a key regulator termed the hypoxia inducible factor (HIF)-1α under oxygen deficient environment around tumor is known to elicit expression of VEGF through binding to p300.  Thus, inhibition of the HIF-1α-p300 interaction would lead to down-regulation of VEGF expression, thereby providing potential cancer therapeutics.  Here, we have screened a chem. library against the interaction of the HIF-1α-derived peptide with p300 employing a fluorescence polarization-based assay.  We have identified a compd. as the most prominent inhibitor against the protein-protein interaction.  Further, we have obsd. suppression of the mRNA level of VEGF upon treatment of HeLa cells with the compd., demonstrating its inhibitory effect at the cellular level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-9yvc4cCB0rVg90H21EOLACvtfcHk0lho3XBlUqnUlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVamtbvE&md5=413fc3103d82c2a5c6f1ba5b4f918465</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DKwon%26aufirst%3DH.%2BS.%26aulast%3DKim%26aufirst%3DD.%2BR.%26aulast%3DYang%26aufirst%3DE.%2BG.%26aulast%3DPark%26aufirst%3DY.%2BK.%26aulast%3DAhn%26aufirst%3DH.%2BC.%26aulast%3DMin%26aufirst%3DS.%2BJ.%26aulast%3DAhn%26aufirst%3DD.%2BR.%26atitle%3DInhibition%2520of%2520VEGF%2520transcription%2520through%2520blockade%2520of%2520the%2520hypoxia%2520inducible%2520factor-1%25CE%25B1-p300%2520interaction%2520by%2520a%2520small%2520molecule%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D16%26spage%3D5249%26epage%3D5252%26doi%3D10.1016%2Fj.bmcl.2012.06.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Noronha, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boreddy, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruscato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolaou, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van-Meir, E. G.</span></span> <span> </span><span class="NLM_article-title">Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">6623</span>– <span class="NLM_lpage">6633</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-12-0861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1078-0432.CCR-12-0861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22923450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFSiurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=6623-6633&issue=24&author=S.+Yinauthor=S.+Kaluzauthor=N.+S.+Deviauthor=A.+A.+Jabbarauthor=R.+G.+de+Noronhaauthor=J.+Munauthor=Z.+Zhangauthor=P.+R.+Boreddyauthor=W.+Wangauthor=Z.+Wangauthor=T.+Abbruscatoauthor=Z.+Chenauthor=J.+J.+Olsonauthor=R.+Zhangauthor=M.+M.+Goodmanauthor=K.+C.+Nicolaouauthor=E.+G.+Van-Meir&title=Arylsulfonamide+KCN1+inhibits+in+vivo+glioma+growth+and+interferes+with+HIF+signaling+by+disrupting+HIF-1%CE%B1+interaction+with+cofactors+p300%2FCBP&doi=10.1158%2F1078-0432.CCR-12-0861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Arylsulfonamide KCN1 Inhibits In Vivo Glioma Growth and Interferes with HIF Signaling by Disrupting HIF-1α Interaction with Cofactors p300/CBP</span></div><div class="casAuthors">Yin, Shaoman; Kaluz, Stefan; Devi, Narra S.; Jabbar, Adnan A.; de Noronha, Rita G.; Mun, Jiyoung; Zhang, Zhaobin; Boreddy, Purushotham R.; Wang, Wei; Wang, Zhibo; Abbruscato, Thomas; Chen, Zhengjia; Olson, Jeffrey J.; Zhang, Ruiwen; Goodman, Mark M.; Nicolaou, K. C.; Van Meir, Erwin G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6623-6633</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The hypoxia-inducible factor-1 (HIF-1) plays a crit. role in tumor adaptation to hypoxia, and its elevated expression correlates with poor prognosis and treatment failure in patients with cancer.  In this study, we detd. whether 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide, KCN1, the lead inhibitor in a novel class of arylsulfonamide inhibitors of the HIF-1 pathway, had antitumorigenic properties in vivo and further defined its mechanism of action.  Exptl. Design: We studied the inhibitory effect of systemic KCN1 delivery on the growth of human brain tumors in mice.  To define mechanisms of KCN1 anti-HIF activities, we examd. its influence on the assembly of a functional HIF-1α/HIF-1β/p300 transcription complex.  Results: KCN1 specifically inhibited HIF reporter gene activity in several glioma cell lines at the nanomolar level.  KCN1 also downregulated transcription of endogenous HIF-1 target genes, such as VEGF, Glut-1, and carbonic anhydrase 9, in a hypoxia-responsive element (HRE)-dependent manner.  KCN1 potently inhibited the growth of s.c. malignant glioma tumor xenografts with minimal adverse effects on the host.  It also induced a temporary survival benefit in an intracranial model of glioma but had no effect in a model of melanoma metastasis to the brain.  Mechanistically, KCN1 did not downregulate the levels of HIF-1α or other components of the HIF transcriptional complex; rather, it antagonized hypoxia-inducible transcription by disrupting the interaction of HIF-1α with transcriptional coactivators p300/CBP.  Conclusions: Our results suggest that the new HIF pathway inhibitor KCN1 has antitumor activity in mouse models, supporting its further translation for the treatment of human tumors displaying hypoxia or HIF overexpression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjeEvHIu4G37Vg90H21EOLACvtfcHk0lho3XBlUqnUlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFSiurfN&md5=5c755fea0b065156cf5dd489b5014062</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-12-0861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-12-0861%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DS.%26aulast%3DKaluz%26aufirst%3DS.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3Dde%2BNoronha%26aufirst%3DR.%2BG.%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DBoreddy%26aufirst%3DP.%2BR.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DAbbruscato%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DOlson%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26aulast%3DVan-Meir%26aufirst%3DE.%2BG.%26atitle%3DArylsulfonamide%2520KCN1%2520inhibits%2520in%2520vivo%2520glioma%2520growth%2520and%2520interferes%2520with%2520HIF%2520signaling%2520by%2520disrupting%2520HIF-1%25CE%25B1%2520interaction%2520with%2520cofactors%2520p300%252FCBP%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2012%26volume%3D18%26issue%3D24%26spage%3D6623%26epage%3D6633%26doi%3D10.1158%2F1078-0432.CCR-12-0861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mooring, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaluz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van-Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">8471</span>– <span class="NLM_lpage">8489</span>, <span class="refDoi"> DOI: 10.1021/jm201018g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201018g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8471-8489&issue=24&author=S.+R.+Mooringauthor=H.+Jinauthor=N.+S.+Deviauthor=A.+A.+Jabbarauthor=S.+Kaluzauthor=Y.+Liuauthor=E.+G.+Van-Meirauthor=B.+Wang&title=Design+and+synthesis+of+novel+small-molecule+inhibitors+of+the+hypoxia+inducible+factor+pathway&doi=10.1021%2Fjm201018g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway</span></div><div class="casAuthors">Mooring, Suazette Reid; Jin, Hui; Devi, Narra S.; Jabbar, Adnan A.; Kaluz, Stefan; Liu, Yuan; Van Meir, Erwin G.; Wang, Binghe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8471-8489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia, a redn. in partial oxygen pressure, is a salient property of solid tumors.  Hypoxia drives malignant progression and metastasis in tumors and participates in tumor resistance to radio- and chemotherapies.  Hypoxia activates the hypoxia-inducible factor (HIF) family of transcription factors, which induce target genes that regulate adaptive biol. processes such as anaerobic metab., cell motility, and angiogenesis.  Clin. evidence has demonstrated that expression of HIF-1 is strongly assocd. with poor patient prognosis and activation of HIF-1 contributes to malignant behavior and therapeutic resistance.  Consequently, HIF-1 has become an important therapeutic target for inhibition by small mols.  Herein, we describe the design and synthesis of small mols. that inhibit the HIF-1 signaling pathway.  Many of these compds. exhibit inhibitory activity in the nanomolar range.  Sep. mechanistic studies indicate that these inhibitors do not alter HIF-1 levels but interfere with the ability of HIF-1α/HIF-1β to interact with cofactors p300/CBP to form an active transcriptional complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC3eSwxgvkCLVg90H21EOLACvtfcHk0li7nCyItLQIzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyjsrnO&md5=c21a16d41bf75cb886dc72753a880de9</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fjm201018g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201018g%26sid%3Dliteratum%253Aachs%26aulast%3DMooring%26aufirst%3DS.%2BR.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DKaluz%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DVan-Meir%26aufirst%3DE.%2BG.%26aulast%3DWang%26aufirst%3DB.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520the%2520hypoxia%2520inducible%2520factor%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D24%26spage%3D8471%26epage%3D8489%26doi%3D10.1021%2Fjm201018g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabbar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Meir, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodman, M. M.</span></span> <span> </span><span class="NLM_article-title">Design and in vitro activities of N-Alkyl-N-((8-R-2,2-dimethyl-2H-chromen-6-yl)methyl)heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">6738</span>– <span class="NLM_lpage">6750</span>, <span class="refDoi"> DOI: 10.1021/jm300752n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300752n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6738-6750&issue=15&author=J.+Munauthor=A.+A.+Jabbarauthor=N.+S.+Deviauthor=S.+Yinauthor=Y.+Wangauthor=C.+Tanauthor=D.+Culverauthor=J.+P.+Snyderauthor=E.+G.+Van+Meirauthor=M.+M.+Goodman&title=Design+and+in+vitro+activities+of+N-Alkyl-N-%28%288-R-2%2C2-dimethyl-2H-chromen-6-yl%29methyl%29heteroarylsulfonamides%2C+novel%2C+small-molecule+hypoxia+inducible+factor-1+pathway+inhibitors+and+anticancer+agents&doi=10.1021%2Fjm300752n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 Pathway Inhibitors and Anticancer Agents</span></div><div class="casAuthors">Mun, Jiyoung; Jabbar, Adnan Abdul; Devi, Narra Sarojini; Yin, Shaoman; Wang, Yingzhe; Tan, Chalet; Culver, Deborah; Snyder, James P.; Van Meir, Erwin G.; Goodman, Mark M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6738-6750</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypoxia inducible factor (HIF) pathway is an attractive target for cancer, as it controls tumor adaptation to growth under hypoxia and mediates chemotherapy and radiation resistance.  We previously discovered 3,4-dimethoxy-N-[(2,2-dimethyl-2H-chromen-6-yl)methyl]-N-phenylbenzenesulfonamide as a novel, small-mol. HIF-1 pathway inhibitor in a high-throughput cell-based assay, but its in vivo delivery is hampered by poor aq. soly. (0.009 μM in water; log P7.4 = 3.7).  Here we describe the synthesis of 12 N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, which were designed to possess optimal lipophilicities and aq. solubilities by in silico calcns.  Exptl. log P7.4 values of 8 of the 12 new analogs ranged from 1.2-3.1.  Aq. solubilities of three analogs were measured, among which the most sol. N-[(8-methoxy-2,2-dimethyl-2H-chromen-6-yl)methyl]-N-(propan-2-yl)pyridine-2-sulfonamide had an aq. soly. of 80 μM, e.g., a soly. improvement of ∼9000-fold.  The pharmacol. optimization had limited impact on drug efficacy as the compds. retained IC50 values at or below 5 μM in our HIF-dependent reporter assay.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVawJDxwPEs7Vg90H21EOLACvtfcHk0li7nCyItLQIzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsV2gtL0%253D&md5=8598c06dcaf2dfa4faec14fb3820299e</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjm300752n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300752n%26sid%3Dliteratum%253Aachs%26aulast%3DMun%26aufirst%3DJ.%26aulast%3DJabbar%26aufirst%3DA.%2BA.%26aulast%3DDevi%26aufirst%3DN.%2BS.%26aulast%3DYin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DVan%2BMeir%26aufirst%3DE.%2BG.%26aulast%3DGoodman%26aufirst%3DM.%2BM.%26atitle%3DDesign%2520and%2520in%2520vitro%2520activities%2520of%2520N-Alkyl-N-%2528%25288-R-2%252C2-dimethyl-2H-chromen-6-yl%2529methyl%2529heteroarylsulfonamides%252C%2520novel%252C%2520small-molecule%2520hypoxia%2520inducible%2520factor-1%2520pathway%2520inhibitors%2520and%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D15%26spage%3D6738%26epage%3D6750%26doi%3D10.1021%2Fjm300752n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J. W.</span></span> <span> </span><span class="NLM_article-title">Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3131</span>– <span class="NLM_lpage">3136</span>, <span class="refDoi"> DOI: 10.1182/blood-2007-11-120576</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1182%2Fblood-2007-11-120576" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18174379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjvVamtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=3131-3136&issue=6&author=D.+H.+Shinauthor=Y.+S.+Chunauthor=D.+S.+Leeauthor=L.+E.+Huangauthor=J.+W.+Park&title=Bortezomib+inhibits+tumor+adaptation+to+hypoxia+by+stimulating+the+FIH-mediated+repression+of+hypoxia-inducible+factor-1&doi=10.1182%2Fblood-2007-11-120576"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1</span></div><div class="casAuthors">Shin, Dong Hoon; Chun, Yang-Sook; Lee, Dong Soon; Huang, L. Eric; Park, Jong-Wan</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3131-3136</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">B ortezomib (PS-341), a proteasome inhibitor, was examd. clin. for the treatment of multiple myeloma and several solid tumors.  Bortezomib directly induces tumor cell death and was also reported to inhibit tumor adaptation to hypoxia by functionally inhibiting hypoxia-inducible factor-1α (HIF-1α).  However, the mechanism underlying HIF-1 inhibition by bortezomib remains obscure.  In the present study, we demonstrated that bortezomib attenuated the hypoxic induction of erythropoietin and vascular endothelial growth factor at subnanomolar concns. in multiple myeloma and liver cancer cell lines, regardless of cytotoxic concns. of bortezomib.  Bortezomib repressed HIF-1α activity by inhibiting the recruitment of p300 coactivator.  Specifically, bortezomib targeted HIF-1α C-terminal transactivation domain (CAD) but not the CAD lacking Asn803, which is a hydroxylation site by the factor inhibiting HIF-1 (FIH).  Accordingly, this effect of bortezomib on CAD was augmented by FIH expression and abolished by FIH knock-down.  Furthermore, bortezomib stimulated the interaction between CAD and FIH under hypoxic conditions, and FIH inhibition reversed the suppressions of erythropoietin and vascular endothelial growth factor by bortezomib.  We propose that the mechanism underlying the inhibitory effects of bortezomib on tumor angiogenesis and hypoxic adaptation involves the repression of HIF-1α transcriptional activity by reinforcing the FIH-mediated inhibition of p300 recruitment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoH9RkSejPUrVg90H21EOLACvtfcHk0li7nCyItLQIzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjvVamtbw%253D&md5=f24d6df8d498087281c30f8915d65347</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1182%2Fblood-2007-11-120576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2007-11-120576%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DD.%2BH.%26aulast%3DChun%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DHuang%26aufirst%3DL.%2BE.%26aulast%3DPark%26aufirst%3DJ.%2BW.%26atitle%3DBortezomib%2520inhibits%2520tumor%2520adaptation%2520to%2520hypoxia%2520by%2520stimulating%2520the%2520FIH-mediated%2520repression%2520of%2520hypoxia-inducible%2520factor-1%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26issue%3D6%26spage%3D3131%26epage%3D3136%26doi%3D10.1182%2Fblood-2007-11-120576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Na, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E. G.</span></span> <span> </span><span class="NLM_article-title">Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>434</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">879</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2013.04.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2013.04.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23618863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntlWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=434&publication_year=2013&pages=879-884&issue=4&author=Y.+R.+Naauthor=K.+C.+Hanauthor=H.+Parkauthor=E.+G.+Yang&title=Menadione+and+ethacrynic+acid+inhibit+the+hypoxia-inducible+factor+%28HIF%29+pathway+by+disrupting+HIF-1%CE%B1+interaction+with+p300&doi=10.1016%2Fj.bbrc.2013.04.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300</span></div><div class="casAuthors">Na, Yu-Ran; Han, Ki-Cheol; Park, Hyunsung; Yang, Eun Gyeong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">434</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">879-884</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia is a general characteristic of most solid malignancies and intimately related to neoplastic diseases and cancer progression.  Homeostatic response to hypoxia is primarily mediated by hypoxia inducible factor (HIF)-1α that elicits transcriptional activity through recruitment of the CREB binding protein (CBP)/p300 coactivator.  Targeted blockade of HIF-1α binding to CBP/p300 would thus constitute a novel approach for cancer treatment by suppressing tumor angiogenesis and metastasis.  Here, we identified inhibitors against the interaction between HIF-1α and p300 by a fluorescence polarization-based assay employing a fluorescently-labeled peptide contg. the C-terminal activation domain of HIF-1α.  Two small mol. inhibitors, menadione (MD) and ethacrynic acid (EA), were found to decrease expression of luciferase under the control of hypoxia-responsive elements in hypoxic cells as well as to efficiently block the interaction between the full-length HIF-1α and p300.  While these compds. did not alter the expression level of HIF-1α, they down-regulated expression of a HIF-1α target vascular endothelial growth factor (VEGF) gene.  Considering hypoxia-induced VEGF expression leading to highly aggressive tumor growth, MD and EA may provide new scaffolds for development of tumor therapeutic reagents as well as tools for a better understanding of HIF-1α-mediated hypoxic regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1Qy17dyErErVg90H21EOLACvtfcHk0lhOMhe_qtzfrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntlWjurk%253D&md5=db88e1fec232934d68dcc7587623b61e</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.04.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.04.044%26sid%3Dliteratum%253Aachs%26aulast%3DNa%26aufirst%3DY.%2BR.%26aulast%3DHan%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DE.%2BG.%26atitle%3DMenadione%2520and%2520ethacrynic%2520acid%2520inhibit%2520the%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%2520pathway%2520by%2520disrupting%2520HIF-1%25CE%25B1%2520interaction%2520with%2520p300%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D434%26issue%3D4%26spage%3D879%26epage%3D884%26doi%3D10.1016%2Fj.bbrc.2013.04.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span> <span> </span><span class="NLM_article-title">A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">5</span>), <span class="NLM_elocation-id">e62014</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0062014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1371%2Fjournal.pone.0062014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23671581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXns1Orsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=5&author=D.+Wuauthor=R.+Zhangauthor=R.+Zhaoauthor=G.+Chenauthor=Y.+Caiauthor=J.+Jin&title=A+novel+function+of+novobiocin%3A+disrupting+the+interaction+of+HIF+1%CE%B1+and+p300%2FCBP+through+direct+binding+to+the+HIF1%CE%B1+C-terminal+activation+domain&doi=10.1371%2Fjournal.pone.0062014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">A novel function of novobiocin: disrupting the interaction of HIF 1α and p300/CBP through direct binding to the HIF1α C-terminal activation domain</span></div><div class="casAuthors">Wu, Donglu; Zhang, Rui; Zhao, Rui; Chen, Guang; Cai, Yong; Jin, Jingji</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e62014</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1α (HIF1α) is an important cellular survival protein under hypoxic conditions, regulating the cellular response to low oxygen tension via recruitment of a transcriptional co-activator, p300/CBP.  P300/CBP induces expression of multiple genes involved in cell survival, proliferation, angiogenesis, and tumor development.  Thus, a strategy to inhibit hypoxic responses in tumors may be to target the protein-protein interaction between HIF1α and p300/CBP.  Here, we document, for the first time, that the aminocoumarin antibiotic, novobiocin, directly blocks the protein-protein interaction between the HIF1α C-terminal activation domain (CTAD) and the cysteine-histidine rich (CH1) region of p300/CBP.  Also, novobiocin down-regulated HIF1α-controlled gene expression, specifically CA9, which is related to tumorigenesis.  In a monolayer cell culture, novobiocin inhibited cell proliferation and colony formation in the MCF-7 human breast adenocarcinoma cell line and the A549 human lung cancer cell line.  Rescue expts. revealed that the recombinant CTAD fragment of HIF1α partially reversed novobiocin's inhibitory effects on cell proliferation and colony formation in MCF-7 cells.  These findings suggest a novel mechanism of action for novobiocin which has the potential for innovative therapeutic use in tumor treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqF65Ed7qzYbVg90H21EOLACvtfcHk0lhOMhe_qtzfrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXns1Orsbg%253D&md5=7173700dd540ccab47c71d5ab3974ef9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0062014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0062014%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DJ.%26atitle%3DA%2520novel%2520function%2520of%2520novobiocin%253A%2520disrupting%2520the%2520interaction%2520of%2520HIF%25201%25CE%25B1%2520and%2520p300%252FCBP%2520through%2520direct%2520binding%2520to%2520the%2520HIF1%25CE%25B1%2520C-terminal%2520activation%2520domain%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D5%26doi%3D10.1371%2Fjournal.pone.0062014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kushal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henchey, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesallati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traaseth, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">39</span>),  <span class="NLM_fpage">15602</span>– <span class="NLM_lpage">15607</span>, <span class="refDoi"> DOI: 10.1073/pnas.1312473110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.1312473110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24019500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=15602-15607&issue=39&author=S.+Kushalauthor=B.+B.+Laoauthor=L.+K.+Hencheyauthor=R.+Dubeyauthor=H.+Mesallatiauthor=N.+J.+Traasethauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=Protein+domain+mimetics+as+in+vivo+modulators+of+hypoxia-inducible+factor+signaling&doi=10.1073%2Fpnas.1312473110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Protein domain mimetics as in vivo modulators of hypoxia-inducible factor signaling</span></div><div class="casAuthors">Kushal, Swati; Lao, Brooke Bullock; Henchey, Laura K.; Dubey, Ramin; Mesallati, Hanah; Traaseth, Nathaniel J.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">15602-15607,S15602/1-S15602/29</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Selective blockade of gene expression by designed small mols. is a fundamental challenge at the interface of chem., biol., and medicine.  Transcription factors have been among the most elusive targets in genetics and drug discovery, but the fields of chem. biol. and genetics have evolved to a point where this task can be addressed.  Herein we report the design, synthesis, and in vivo efficacy evaluation of a protein domain mimetic targeting the interaction of the p300/CBP coactivator with the transcription factor hypoxia-inducible factor-1α.  Our results indicate that disrupting this interaction results in a rapid down-regulation of hypoxia-inducible genes crit. for cancer progression.  The obsd. effects were compd.-specific and dose-dependent.  Gene expression profiling with oligonucleotide microarrays revealed effective inhibition of hypoxia-inducible genes with relatively minimal perturbation of nontargeted signaling pathways.  We obsd. remarkable efficacy of the compd. HBS 1 in suppressing tumor growth in the fully established murine xenograft models of renal cell carcinoma of the clear cell type.  Our results suggest that rationally designed synthetic mimics of protein subdomains that target the transcription factor-coactivator interfaces represent a unique approach for in vivo modulation of oncogenic signaling and arresting tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM3XHm6lQqWrVg90H21EOLACvtfcHk0lhOMhe_qtzfrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1WlurrK&md5=230a70f6e32b3abc3c10abd7fb8df533</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1312473110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1312473110%26sid%3Dliteratum%253Aachs%26aulast%3DKushal%26aufirst%3DS.%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DHenchey%26aufirst%3DL.%2BK.%26aulast%3DDubey%26aufirst%3DR.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DTraaseth%26aufirst%3DN.%2BJ.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DProtein%2520domain%2520mimetics%2520as%2520in%2520vivo%2520modulators%2520of%2520hypoxia-inducible%2520factor%2520signaling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26issue%3D39%26spage%3D15602%26epage%3D15607%26doi%3D10.1073%2Fpnas.1312473110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lao, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grishagin, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesallati, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brewer, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olenyuk, B. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arora, P. S.</span></span> <span> </span><span class="NLM_article-title">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7531</span>– <span class="NLM_lpage">7536</span>, <span class="refDoi"> DOI: 10.1073/pnas.1402393111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.1402393111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24821806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=7531-7536&issue=21&author=B.+B.+Laoauthor=I.+Grishaginauthor=H.+Mesallatiauthor=T.+F.+Brewerauthor=B.+Z.+Olenyukauthor=P.+S.+Arora&title=In+vivo+modulation+of+hypoxia-inducible+signaling+by+topographical+helix+mimetics&doi=10.1073%2Fpnas.1402393111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo modulation of hypoxia-inducible signaling by topographical helix mimetics</span></div><div class="casAuthors">Lao, Brooke Bullock; Grishagin, Ivan; Mesallati, Hanah; Brewer, Thomas F.; Olenyuk, Bogdan Z.; Arora, Paramjit S.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7531-7536</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Development of small-mol. inhibitors of protein-protein interactions is a fundamental challenge at the interface of chem. and cancer biol.  Successful methods for design of protein-protein interaction inhibitors include computational and exptl. high-throughput and fragment-based screening strategies to locate small-mol. fragments that bind protein surfaces.  An alternative rational design approach seeks to mimic the orientation and disposition of crit. binding residues at protein interfaces.  The authors describe the design, synthesis, biochem., and in vivo evaluation of a small-mol. scaffold that captures the topog. of α-helixes.  The authors designed mimics of a key α-helical domain at the interface of hypoxia-inducible factor 1α and p300 to develop inhibitors of hypoxia-inducible signaling.  The hypoxia-inducible factor/p300 interaction regulates the transcription of key genes, whose expression contributes to angiogenesis, metastasis, and altered energy metab. in cancer.  The designed compds. target the desired protein with high affinity and in a predetd. manner, with the optimal ligand providing effective redn. of tumor burden in exptl. animal models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7DvqFbX-7prVg90H21EOLACvtfcHk0ljKJWlKuQK7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2nsbo%253D&md5=34b4289424a570528a22e6eca0fb502e</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1402393111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1402393111%26sid%3Dliteratum%253Aachs%26aulast%3DLao%26aufirst%3DB.%2BB.%26aulast%3DGrishagin%26aufirst%3DI.%26aulast%3DMesallati%26aufirst%3DH.%26aulast%3DBrewer%26aufirst%3DT.%2BF.%26aulast%3DOlenyuk%26aufirst%3DB.%2BZ.%26aulast%3DArora%26aufirst%3DP.%2BS.%26atitle%3DIn%2520vivo%2520modulation%2520of%2520hypoxia-inducible%2520signaling%2520by%2520topographical%2520helix%2520mimetics%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D21%26spage%3D7531%26epage%3D7536%26doi%3D10.1073%2Fpnas.1402393111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">42</span>),  <span class="NLM_fpage">17910</span>– <span class="NLM_lpage">17915</span>, <span class="refDoi"> DOI: 10.1073/pnas.0909353106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0909353106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19805192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtl2ru77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=17910-17915&issue=42&author=K.+Leeauthor=H.+Zhangauthor=D.+Z.+Qianauthor=S.+Reyauthor=J.+O.+Liuauthor=G.+L.+Semenza&title=Acriflavine+inhibits+HIF-1+dimerization%2C+tumor+growth%2C+and+vascularization&doi=10.1073%2Fpnas.0909353106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization</span></div><div class="casAuthors">Lee, KangAe; Zhang, Huafeng; Qian, David Z.; Rey, Sergio; Liu, Jun O.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">42</span>),
    <span class="NLM_cas:pages">17910-17915, S17910/1-S17910/32</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">HIF-1 is a heterodimeric transcription factor that mediates adaptive responses to hypoxia and plays crit. roles in cancer progression.  Using a cell-based screening assay we have identified acriflavine as a drug that binds directly to HIF-1α and HIF-2α and inhibits HIF-1 dimerization and transcriptional activity.  Pretreatment of mice bearing prostate cancer xenografts with acriflavine prevented tumor growth and treatment of mice bearing established tumors resulted in growth arrest.  Acriflavine treatment inhibited intratumoral expression of angiogenic cytokines, mobilization of angiogenic cells into peripheral blood, and tumor vascularization.  These results provide proof of principle that small mols. can inhibit dimerization of HIF-1 and have potent inhibitory effects on tumor growth and vascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpboBSToFYTvLVg90H21EOLACvtfcHk0ljKJWlKuQK7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtl2ru77O&md5=eab265a9166fff5d2a3fbf22fb0a7a41</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0909353106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0909353106%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DQian%26aufirst%3DD.%2BZ.%26aulast%3DRey%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DAcriflavine%2520inhibits%2520HIF-1%2520dimerization%252C%2520tumor%2520growth%252C%2520and%2520vascularization%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D42%26spage%3D17910%26epage%3D17915%26doi%3D10.1073%2Fpnas.0909353106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miranda, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordgren, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Male, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoakwie, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuda, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Court, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Packham, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavassoli, A.</span></span> <span> </span><span class="NLM_article-title">A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span> (<span class="NLM_issue">28</span>),  <span class="NLM_fpage">10418</span>– <span class="NLM_lpage">10425</span>, <span class="refDoi"> DOI: 10.1021/ja402993u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja402993u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvFaksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=10418-10425&issue=28&author=E.+Mirandaauthor=I.+K.+Nordgrenauthor=A.+L.+Maleauthor=C.+E.+Lawrenceauthor=F.+Hoakwieauthor=F.+Cudaauthor=W.+Courtauthor=K.+R.+Foxauthor=P.+A.+Townsendauthor=G.+K.+Packhamauthor=S.+A.+Ecclesauthor=A.+Tavassoli&title=A+cyclic+peptide+inhibitor+of+HIF-1+heterodimerization+that+inhibits+hypoxia+signaling+in+cancer+cells&doi=10.1021%2Fja402993u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">A Cyclic Peptide Inhibitor of HIF-1 Heterodimerization That Inhibits Hypoxia Signaling in Cancer Cells</span></div><div class="casAuthors">Miranda, Elena; Nordgren, Ida K.; Male, Abigail L.; Lawrence, Charlotte E.; Hoakwie, Franciane; Cuda, Francesco; Court, William; Fox, Keith R.; Townsend, Paul A.; Packham, Graham K.; Eccles, Suzanne A.; Tavassoli, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10418-10425</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia inducible factor-1 (HIF-1) is a heterodimeric transcription factor that acts as the master regulator of cellular response to reduced oxygen levels, thus playing a key role in the adaptation, survival, and progression of tumors.  Here we report cyclo-CLLFVY, identified from a library of 3.2 million cyclic hexapeptides using a genetically encoded high-throughput screening platform, as an inhibitor of the HIF-1α/HIF-1β protein-protein interaction in vitro and in cells.  The identified compd. inhibits HIF-1 dimerization and transcription activity by binding to the PAS-B domain of HIF-1α, reducing HIF-1-mediated hypoxia response signaling in a variety of cell lines, without affecting the function of the closely related HIF-2 isoform.  The reported cyclic peptide demonstrates the utility of our high-throughput screening platform for the identification of protein-protein interaction inhibitors, and forms the starting point for the development of HIF-1 targeted cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodwKA_rNEr2LVg90H21EOLACvtfcHk0ljKJWlKuQK7Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvFaksro%253D&md5=3f44683ebfa19a9dbb6f505d50bb6032</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fja402993u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja402993u%26sid%3Dliteratum%253Aachs%26aulast%3DMiranda%26aufirst%3DE.%26aulast%3DNordgren%26aufirst%3DI.%2BK.%26aulast%3DMale%26aufirst%3DA.%2BL.%26aulast%3DLawrence%26aufirst%3DC.%2BE.%26aulast%3DHoakwie%26aufirst%3DF.%26aulast%3DCuda%26aufirst%3DF.%26aulast%3DCourt%26aufirst%3DW.%26aulast%3DFox%26aufirst%3DK.%2BR.%26aulast%3DTownsend%26aufirst%3DP.%2BA.%26aulast%3DPackham%26aufirst%3DG.%2BK.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DTavassoli%26aufirst%3DA.%26atitle%3DA%2520cyclic%2520peptide%2520inhibitor%2520of%2520HIF-1%2520heterodimerization%2520that%2520inhibits%2520hypoxia%2520signaling%2520in%2520cancer%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26issue%3D28%26spage%3D10418%26epage%3D10425%26doi%3D10.1021%2Fja402993u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erbel, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Card, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakuzu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span> <span> </span><span class="NLM_article-title">Structural basis for PAS domain heterodimerization in the basic helix--loop--helix-PAS transcription factor hypoxia-inducible factor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">15504</span>– <span class="NLM_lpage">15509</span>, <span class="refDoi"> DOI: 10.1073/pnas.2533374100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.2533374100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=14668441" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=15504-15509&issue=26&author=P.+J.+Erbelauthor=P.+B.+Cardauthor=O.+Karakuzuauthor=R.+K.+Bruickauthor=K.+H.+Gardner&title=Structural+basis+for+PAS+domain+heterodimerization+in+the+basic+helix%2D%2Dloop%2D%2Dhelix-PAS+transcription+factor+hypoxia-inducible+factor&doi=10.1073%2Fpnas.2533374100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for PAS domain heterodimerization in the basic helix-loop-helix-PAS transcription factor hypoxia-inducible factor</span></div><div class="casAuthors">Erbel, Paul J. A.; Card, Paul B.; Karakuzu, Ozgur; Bruick, Richard K.; Gardner, Kevin H.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">15504-15509</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Biol. responses to oxygen availability play important roles in development, physiol. homeostasis, and many disease processes.  In mammalian cells, this adaptation is mediated in part by a conserved pathway centered on the hypoxia-inducible factor (HIF).  HIF is a heterodimeric protein complex composed of two members of the basic helix-loop-helix Per-ARNT-Sim (PAS) (ARNT, aryl hydrocarbon receptor nuclear translocator) domain family of transcriptional activators, HIFα and ARNT.  Although this complex involves protein-protein interactions mediated by basic helix-loop-helix and PAS domains in both proteins, the role played by the PAS domains is poorly understood.  To address this issue, we have studied the structure and interactions of the C-terminal PAS domain of human HIF-2α by NMR spectroscopy.  We demonstrate that HIF-2α PAS-B binds the analogous ARNT domain in vitro, showing that residues involved in this interaction are located on the solvent-exposed side of the HIF-2α central β-sheet.  Mutating residues at this surface not only disrupts the interaction between isolated PAS domains in vitro but also interferes with the ability of full-length HIF to respond to hypoxia in living cells.  Extending our findings to other PAS domains, we find that this β-sheet interface is widely used for both intra- and intermol. interactions, suggesting a basis of specificity and regulation of many types of PAS-contg. signaling proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokgBRHCUjRa7Vg90H21EOLACvtfcHk0lj9erGX3iSrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCjtA%253D%253D&md5=5c1a92df60db24fba6af0e4b50ca1540</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2533374100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2533374100%26sid%3Dliteratum%253Aachs%26aulast%3DErbel%26aufirst%3DP.%2BJ.%26aulast%3DCard%26aufirst%3DP.%2BB.%26aulast%3DKarakuzu%26aufirst%3DO.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26atitle%3DStructural%2520basis%2520for%2520PAS%2520domain%2520heterodimerization%2520in%2520the%2520basic%2520helix--loop--helix-PAS%2520transcription%2520factor%2520hypoxia-inducible%2520factor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D26%26spage%3D15504%26epage%3D15509%26doi%3D10.1073%2Fpnas.2533374100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Key, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naidoo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longgood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frantz, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambar, U. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of hypoxia inducible factor-2 with small molecules</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">271</span>– <span class="NLM_lpage">276</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnchembio.1185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23434853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFygtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=271-276&issue=4&author=T.+H.+Scheuermannauthor=Q.+Liauthor=H.+W.+Maauthor=J.+Keyauthor=L.+Zhangauthor=R.+Chenauthor=J.+A.+Garciaauthor=J.+Naidooauthor=J.+Longgoodauthor=D.+E.+Frantzauthor=U.+K.+Tambarauthor=K.+H.+Gardnerauthor=R.+K.+Bruick&title=Allosteric+inhibition+of+hypoxia+inducible+factor-2+with+small+molecules&doi=10.1038%2Fnchembio.1185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of hypoxia inducible factor-2 with small molecules</span></div><div class="casAuthors">Scheuermann, Thomas H.; Li, Qiming; Ma, He-Wen; Key, Jason; Zhang, Lei; Chen, Rui; Garcia, Joseph A.; Naidoo, Jacinth; Longgood, Jamie; Frantz, Doug E.; Tambar, Uttam K.; Gardner, Kevin H.; Bruick, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia inducible factors (HIFs) are heterodimeric transcription factors induced in many cancers where they frequently promote the expression of protumorigenic pathways.  Though transcription factors are typically considered 'undruggable', the PAS-B domain of the HIF-2α subunit contains a large cavity within its hydrophobic core that offers a unique foothold for small-mol. regulation.  Here we identify artificial ligands that bind within this pocket and characterize the resulting structural and functional changes caused by binding.  Notably, these ligands antagonize HIF-2 heterodimerization and DNA-binding activity in vitro and in cultured cells, reducing HIF-2 target gene expression.  Despite the high sequence identity between HIF-2α and HIF-1α, these ligands are highly selective and do not affect HIF-1 function.  These chem. tools establish the mol. basis for selective regulation of HIF-2, providing potential therapeutic opportunities to intervene in HIF-2-driven tumors, such as renal cell carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBimby6zSuR7Vg90H21EOLACvtfcHk0lj9erGX3iSrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFygtLc%253D&md5=e2e58842b3fe6472248c10012de365fb</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1185%26sid%3Dliteratum%253Aachs%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DMa%26aufirst%3DH.%2BW.%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DJ.%2BA.%26aulast%3DNaidoo%26aufirst%3DJ.%26aulast%3DLonggood%26aufirst%3DJ.%26aulast%3DFrantz%26aufirst%3DD.%2BE.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26atitle%3DAllosteric%2520inhibition%2520of%2520hypoxia%2520inducible%2520factor-2%2520with%2520small%2520molecules%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26issue%3D4%26spage%3D271%26epage%3D276%26doi%3D10.1038%2Fnchembio.1185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Key, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daggett, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span> <span> </span><span class="NLM_article-title">Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>131</i></span> (<span class="NLM_issue">48</span>),  <span class="NLM_fpage">17647</span>– <span class="NLM_lpage">17654</span>, <span class="refDoi"> DOI: 10.1021/ja9073062</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9073062" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2009&pages=17647-17654&issue=48&author=J.+Keyauthor=T.+H.+Scheuermannauthor=P.+C.+Andersonauthor=V.+Daggettauthor=K.+H.+Gardner&title=Principles+of+ligand+binding+within+a+completely+buried+cavity+in+HIF2alpha+PAS-B&doi=10.1021%2Fja9073062"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of Ligand Binding within a Completely Buried Cavity in HIF2α PAS-B</span></div><div class="casAuthors">Key, Jason; Scheuermann, Thomas H.; Anderson, Peter C.; Daggett, Valerie; Gardner, Kevin H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">17647-17654</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIFs) are heterodimeric transcription factors responsible for the metazoan hypoxia response and promote tumor growth, metastases, and resistance to cancer treatment.  The C-terminal Per-ARNT-Sim (PAS) domain of HIF2α (HIF2α PAS-B) contains a preformed solvent-inaccessible cavity that binds artificial ligands that allosterically perturb the formation of the HIF heterodimer.  To better understand how small mols. bind within this domain, we examd. the structures and equil. and transition-state thermodn. of HIF2α PAS-B with several artificial ligands using isothermal titrn. calorimetry, NMR exchange spectroscopy, and x-ray crystallog.  Rapid assocn. rates reveal that ligand binding is not dependent upon a slow conformational change in the protein to permit ligand access, despite the closed conformation obsd. in the NMR and crystal structures.  Compensating enthalpic and entropic contributions to the thermodn. barrier for ligand binding suggest a binding-competent transition state characterized by increased structural disorder.  Finally, mol. dynamics simulations reveal conversion between open and closed conformations of the protein and pathways of ligand entry into the binding pocket.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFEKzsVY8QgLVg90H21EOLACvtfcHk0lj9erGX3iSrrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSgtL%252FL&md5=d34456db2763c4e586844a7d5c04aa89</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fja9073062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9073062%26sid%3Dliteratum%253Aachs%26aulast%3DKey%26aufirst%3DJ.%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DDaggett%26aufirst%3DV.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26atitle%3DPrinciples%2520of%2520ligand%2520binding%2520within%2520a%2520completely%2520buried%2520cavity%2520in%2520HIF2alpha%2520PAS-B%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2009%26volume%3D131%26issue%3D48%26spage%3D17647%26epage%3D17654%26doi%3D10.1021%2Fja9073062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheuermann, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroud, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleet, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bayeh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Longgood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacMillan, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tambar, U. K.</span></span> <span> </span><span class="NLM_article-title">Isoform-selective and stereoselective inhibition of hypoxia inducible factor-2</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">5930</span>– <span class="NLM_lpage">5941</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00529</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00529" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1KmsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=5930-5941&issue=15&author=T.+H.+Scheuermannauthor=D.+Stroudauthor=C.+E.+Sleetauthor=L.+Bayehauthor=C.+Shokriauthor=H.+Wangauthor=C.+G.+Caldwellauthor=J.+Longgoodauthor=J.+B.+MacMillanauthor=R.+K.+Bruickauthor=K.+H.+Gardnerauthor=U.+K.+Tambar&title=Isoform-selective+and+stereoselective+inhibition+of+hypoxia+inducible+factor-2&doi=10.1021%2Facs.jmedchem.5b00529"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2</span></div><div class="casAuthors">Scheuermann, Thomas H.; Stroud, Daniel; Sleet, Christopher E.; Bayeh, Liela; Shokri, Cameron; Wang, Hanzhi; Caldwell, Charles G.; Longgood, Jamie; MacMillan, John B.; Bruick, Richard K.; Gardner, Kevin H.; Tambar, Uttam K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5930-5941</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxia inducible factor (HIF) transcription factors reside at the center of signaling pathways used by mammalian cells to sense and respond to low oxygen levels.  While essential to maintain oxygen homeostasis, misregulation of HIF protein activity correlates with tumor development and metastasis.  To provide artificial routes to target misregulated HIF activity, the authors identified small mol. antagonists of the HIF-2 transcription factor that bind an internal cavity within the C-terminal PAS domain of the HIF-2α subunit.  Here the authors describe a new class of chiral small mol. ligands that provide the highest affinity binding, the most effective, isoform-selective inhibition of HIF-2 in cells, and trigger the largest protein conformation changes reported to date.  The current results further illuminate the mol. mechanism of HIF-2 antagonism and suggest addnl. routes to develop higher affinity and potency HIF-2 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe0ABJGYcks7Vg90H21EOLACvtfcHk0lgIzLj0p1JYeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1KmsbnP&md5=495125fa479708ae2ae60e64b52eadc4</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00529%26sid%3Dliteratum%253Aachs%26aulast%3DScheuermann%26aufirst%3DT.%2BH.%26aulast%3DStroud%26aufirst%3DD.%26aulast%3DSleet%26aufirst%3DC.%2BE.%26aulast%3DBayeh%26aufirst%3DL.%26aulast%3DShokri%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCaldwell%26aufirst%3DC.%2BG.%26aulast%3DLonggood%26aufirst%3DJ.%26aulast%3DMacMillan%26aufirst%3DJ.%2BB.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DGardner%26aufirst%3DK.%2BH.%26aulast%3DTambar%26aufirst%3DU.%2BK.%26atitle%3DIsoform-selective%2520and%2520stereoselective%2520inhibition%2520of%2520hypoxia%2520inducible%2520factor-2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26issue%3D15%26spage%3D5930%26epage%3D5941%26doi%3D10.1021%2Facs.jmedchem.5b00529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wehn, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlachter, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halfmann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddie, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span> <span> </span><span class="NLM_article-title">Design and activity of specific hypoxia-inducible factor 2alpha (HIF-2alpha) inhibitors for the treatment of clear cell renal cell carcinoma: discovery of clinical candidate (S)-3-((2,2-difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">9691</span>– <span class="NLM_lpage">9721</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01196</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01196" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVKqt7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=9691-9721&issue=21&author=P.+M.+Wehnauthor=J.+P.+Rizziauthor=D.+D.+Dixonauthor=J.+Grinaauthor=S.+T.+Schlachterauthor=B.+Wangauthor=R.+Xuauthor=H.+Yangauthor=X.+Duauthor=G.+Hanauthor=K.+Wangauthor=Z.+Caoauthor=T.+Chengauthor=R.+M.+Czerwinskiauthor=B.+S.+Gogginauthor=H.+Huangauthor=M.+M.+Halfmannauthor=M.+A.+Maddieauthor=E.+L.+Mortonauthor=S.+R.+Oliveauthor=H.+Tanauthor=S.+Xieauthor=T.+Wongauthor=J.+A.+Joseyauthor=E.+M.+Wallace&title=Design+and+activity+of+specific+hypoxia-inducible+factor+2alpha+%28HIF-2alpha%29+inhibitors+for+the+treatment+of+clear+cell+renal+cell+carcinoma%3A+discovery+of+clinical+candidate+%28S%29-3-%28%282%2C2-difluoro-1-hydroxy-7-%28methylsulfonyl%29-2%2C3-dihydro-1H-inden-4-yl%29oxy%29-5-fluorobenzonitrile+%28PT2385%29&doi=10.1021%2Facs.jmedchem.8b01196"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)</span></div><div class="casAuthors">Wehn, Paul M.; Rizzi, James P.; Dixon, Darryl D.; Grina, Jonas A.; Schlachter, Stephen T.; Wang, Bin; Xu, Rui; Yang, Hanbiao; Du, Xinlin; Han, Guangzhou; Wang, Keshi; Cao, Zhaodan; Cheng, Tzuling; Czerwinski, Robert M.; Goggin, Barry S.; Huang, Heli; Halfmann, Megan M.; Maddie, Melissa A.; Morton, Emily L.; Olive, Sarah R.; Tan, Huiling; Xie, Shanhai; Wong, Tai; Josey, John A.; Wallace, Eli M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9691-9721</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIF-2α, a member of the HIF family of transcription factors, is a key oncogenic driver in cancers such as clear cell renal cell carcinoma (ccRCC).  A signature feature of these cancers is the overaccumulation of HIF-2α protein, often by inactivation of the E3 ligase VHL (von Hippel-Lindau).  Herein the authors disclose their structure based drug design (SBDD) approach that culminated in the identification of PT2385, the first HIF-2α antagonist to enter clin. trials.  Highlights include the use of a putative n → π*Ar interaction to guide early analog design, the conformational restriction of an essential hydroxyl moiety, and the remarkable impact of fluorination near the hydroxyl group.  Evaluation of select compds. from two structural classes in a sequence of PK/PD, efficacy, PK, and metabolite profiling identified I (PT2385, luciferase EC50 = 27 nM) as the clin. candidate.  Finally, a retrospective crystallog. anal. describes the structural perturbations necessary for efficient antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwG1t-5Van7rVg90H21EOLACvtfcHk0lgIzLj0p1JYeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVKqt7%252FN&md5=fcbb754286f47e1b1df3edb62bd2381e</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01196%26sid%3Dliteratum%253Aachs%26aulast%3DWehn%26aufirst%3DP.%2BM.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DDixon%26aufirst%3DD.%2BD.%26aulast%3DGrina%26aufirst%3DJ.%26aulast%3DSchlachter%26aufirst%3DS.%2BT.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DGoggin%26aufirst%3DB.%2BS.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DHalfmann%26aufirst%3DM.%2BM.%26aulast%3DMaddie%26aufirst%3DM.%2BA.%26aulast%3DMorton%26aufirst%3DE.%2BL.%26aulast%3DOlive%26aufirst%3DS.%2BR.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26atitle%3DDesign%2520and%2520activity%2520of%2520specific%2520hypoxia-inducible%2520factor%25202alpha%2520%2528HIF-2alpha%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520clear%2520cell%2520renal%2520cell%2520carcinoma%253A%2520discovery%2520of%2520clinical%2520candidate%2520%2528S%2529-3-%2528%25282%252C2-difluoro-1-hydroxy-7-%2528methylsulfonyl%2529-2%252C3-dihydro-1H-inden-4-yl%2529oxy%2529-5-fluorobenzonitrile%2520%2528PT2385%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D21%26spage%3D9691%26epage%3D9721%26doi%3D10.1021%2Facs.jmedchem.8b01196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liberzon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakraborty, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Signoretti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span> <span> </span><span class="NLM_article-title">On-target efficacy of a HIF-2alpha antagonist in preclinical kidney cancer models</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>539</i></span>,  <span class="NLM_fpage">107</span>– <span class="NLM_lpage">111</span>, <span class="refDoi"> DOI: 10.1038/nature19795</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature19795" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27595393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslyis73F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=539&publication_year=2016&pages=107-111&author=H.+Choauthor=X.+Duauthor=J.+P.+Rizziauthor=E.+Liberzonauthor=A.+A.+Chakrabortyauthor=W.+Gaoauthor=I.+Carvoauthor=S.+Signorettiauthor=R.+K.+Bruickauthor=J.+A.+Joseyauthor=E.+M.+Wallaceauthor=W.+G.+Kaelin&title=On-target+efficacy+of+a+HIF-2alpha+antagonist+in+preclinical+kidney+cancer+models&doi=10.1038%2Fnature19795"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models</span></div><div class="casAuthors">Cho, Hyejin; Du, Xinlin; Rizzi, James P.; Liberzon, Ella; Chakraborty, Abhishek A.; Gao, Wenhua; Carvo, Ingrid; Signoretti, Sabina; Bruick, Richard K.; Josey, John A.; Wallace, Eli M.; Kaelin, William G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">539</span>
        (<span class="NLM_cas:issue">7627</span>),
    <span class="NLM_cas:pages">107-111</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma, the most common form of kidney cancer, is usually linked to inactivation of the pVHL tumor suppressor protein and consequent accumulation of the HIF-2α transcription factor (also known as EPAS1).  Here we show that a small mol. (PT2399) (I) that directly inhibits HIF-2α causes tumor regression in preclin. mouse models of primary and metastatic pVHL-defective clear cell renal cell carcinoma in an on-target fashion. pVHL-defective clear cell renal cell carcinoma cell lines display unexpectedly variable sensitivity to PT2399, however, suggesting the need for predictive biomarkers to be developed to use this approach optimally in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXNjIx5YKNerVg90H21EOLACvtfcHk0ljRQ7gGhmWInA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslyis73F&md5=f8dc173e758b6a6a17630b791c0c318c</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1038%2Fnature19795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature19795%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DH.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DLiberzon%26aufirst%3DE.%26aulast%3DChakraborty%26aufirst%3DA.%2BA.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DCarvo%26aufirst%3DI.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26atitle%3DOn-target%2520efficacy%2520of%2520a%2520HIF-2alpha%2520antagonist%2520in%2520preclinical%2520kidney%2520cancer%2520models%26jtitle%3DNature%26date%3D2016%26volume%3D539%26spage%3D107%26epage%3D111%26doi%3D10.1038%2Fnature19795" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizzi, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wehn, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixon, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goggin, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grina, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halfmann, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maddie, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olive, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlachter, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span> <span> </span><span class="NLM_article-title">A small-molecule antagonist of HIF2alpha is efficacious in preclinical models of renal cell carcinoma</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5491</span>– <span class="NLM_lpage">5500</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-16-0473</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-16-0473" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27635045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2016&pages=5491-5500&issue=18&author=E.+M.+Wallaceauthor=J.+P.+Rizziauthor=G.+Hanauthor=P.+M.+Wehnauthor=Z.+Caoauthor=X.+Duauthor=T.+Chengauthor=R.+M.+Czerwinskiauthor=D.+D.+Dixonauthor=B.+S.+Gogginauthor=J.+A.+Grinaauthor=M.+M.+Halfmannauthor=M.+A.+Maddieauthor=S.+R.+Oliveauthor=S.+T.+Schlachterauthor=H.+Tanauthor=B.+Wangauthor=K.+Wangauthor=S.+Xieauthor=R.+Xuauthor=H.+Yangauthor=J.+A.+Josey&title=A+small-molecule+antagonist+of+HIF2alpha+is+efficacious+in+preclinical+models+of+renal+cell+carcinoma&doi=10.1158%2F0008-5472.CAN-16-0473"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma</span></div><div class="casAuthors">Wallace, Eli M.; Rizzi, James P.; Han, Guangzhou; Wehn, Paul M.; Cao, Zhaodan; Du, Xinlin; Cheng, Tzuling; Czerwinski, Robert M.; Dixon, Darryl D.; Goggin, Barry S.; Grina, Jonas A.; Halfmann, Megan M.; Maddie, Melissa A.; Olive, Sarah R.; Schlachter, Stephen T.; Tan, Huiling; Wang, Bin; Wang, Keshi; Xie, Shanhai; Xu, Rui; Yang, Hanbiao; Josey, John A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5491-5500</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">More than 90% of clear cell renal cell carcinomas (ccRCC) exhibit inactivation of the von Hippel-Lindau (pVHL) tumor suppressor, establishing it as the major underlying cause of this malignancy.  PVHL inactivation results in stabilization of the hypoxia-inducible transcription factors, HIF1α and HIF2α, leading to expression of a genetic program essential for the initiation and progression of ccRCC.  Herein, we describe the potent, selective, and orally active small-mol. inhibitor PT2385 as a specific antagonist of HIF2α that allosterically blocks its dimerization with the HIF1α/2α transcriptional dimerization partner ARNT/HIF1β.  PT2385 inhibited the expression of HIF2α-dependent genes, including VEGF-A, PAI-1, and cyclin D1 in ccRCC cell lines and tumor xenografts.  Treatment of tumor-bearing mice with PT2385 caused dramatic tumor regressions, validating HIF2α as a pivotal oncogenic driver in ccRCC.  Notably, unlike other anticancer agents that inhibit VEGF receptor signaling, PT2385 exhibited no adverse effect on cardiovascular performance.  Thus, PT2385 represents a novel class of therapeutics for the treatment of RCC with potent preclincal efficacy as well as improved tolerability relative to current agents that target the VEGF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCMg5jKD7j2bVg90H21EOLACvtfcHk0ljRQ7gGhmWInA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFWqsbjP&md5=502bf54f4767817787adc05471d631eb</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-16-0473&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-16-0473%26sid%3Dliteratum%253Aachs%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWehn%26aufirst%3DP.%2BM.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DDixon%26aufirst%3DD.%2BD.%26aulast%3DGoggin%26aufirst%3DB.%2BS.%26aulast%3DGrina%26aufirst%3DJ.%2BA.%26aulast%3DHalfmann%26aufirst%3DM.%2BM.%26aulast%3DMaddie%26aufirst%3DM.%2BA.%26aulast%3DOlive%26aufirst%3DS.%2BR.%26aulast%3DSchlachter%26aufirst%3DS.%2BT.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26atitle%3DA%2520small-molecule%2520antagonist%2520of%2520HIF2alpha%2520is%2520efficacious%2520in%2520preclinical%2520models%2520of%2520renal%2520cell%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2016%26volume%3D76%26issue%3D18%26spage%3D5491%26epage%3D5500%26doi%3D10.1158%2F0008-5472.CAN-16-0473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Courtney, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Infante, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figlin, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rini, B. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brugarolas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zojwalla, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallace, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Josey, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choueiri, T. K.</span></span> <span> </span><span class="NLM_article-title">Phase I dose-escalation trial of PT2385, a first-in-class hypoxia-inducible factor-2alpha antagonist in patients with previously treated advanced clear cell renal cell carcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">867</span>– <span class="NLM_lpage">874</span>, <span class="refDoi"> DOI: 10.1200/JCO.2017.74.2627</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1200%2FJCO.2017.74.2627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29257710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1amsbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2018&pages=867-874&issue=9&author=K.+D.+Courtneyauthor=J.+R.+Infanteauthor=E.+T.+Lamauthor=R.+A.+Figlinauthor=B.+I.+Riniauthor=J.+Brugarolasauthor=N.+J.+Zojwallaauthor=A.+M.+Loweauthor=K.+Wangauthor=E.+M.+Wallaceauthor=J.+A.+Joseyauthor=T.+K.+Choueiri&title=Phase+I+dose-escalation+trial+of+PT2385%2C+a+first-in-class+hypoxia-inducible+factor-2alpha+antagonist+in+patients+with+previously+treated+advanced+clear+cell+renal+cell+carcinoma&doi=10.1200%2FJCO.2017.74.2627"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Phase i dose-escalation trial of pt2385, a first-in-class hypoxia-inducible factor-2α antagonist in patients with previously treated advanced clear cell renal cell carcinoma</span></div><div class="casAuthors">Courtney, Kevin D.; Infante, Jeffrey R.; Lam, Elaine T.; Figlin, Robert A.; Rini, Brian I.; Brugarolas, James; Zojwalla, Naseem J.; Lowe, Ann M.; Wang, Keshi; Wallace, Eli M.; Josey, John A.; Choueiri, Toni K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">867-874,S1-S3</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">1527-7755</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">Purpose The von Hippel-Lindau tumor suppressor is inactivated in the majority of clear cell renal cell carcinomas (ccRCCs), leading to inappropriate stabilization of hypoxia-inducible factor-2α (HIF-2α).  PT2385 is a first-in-class HIF-2α antagonist.  Objectives of this first-in-human study were to characterize the safety, pharmacokinetics, pharmacodynamics, and efficacy, and to identify the recommended phase II dose (RP2D) of PT2385.  Patients and Methods Eligible patients had locally advanced or metastatic ccRCC that had progressed during one or more prior regimens that included a vascular endothelial growth factor inhibitor.  PT2385 was administered orally at twice-per-day doses of 100 to 1,800 mg, according to a 3 + 3 dose-escalation design, followed by an expansion phase at the RP2D.  Results The dose-escalation and expansion phases enrolled 26 and 25 patients, resp.  Patients were heavily pretreated, with a median of four (range, one to seven) prior therapies.  No dose-limiting toxicity was obsd. at any dose.  On the basis of safety, pharmacokinetic, and pharmacodynamic profiling, the RP2D was defined as 800 mg twice per day.  PT2385 was well tolerated, with anemia (grade 1 to 2, 35%; grade 3, 10%), peripheral edema (grade 1 to 2, 37%; grade 3, 2%), and fatigue (grade 1 to 2, 37%; no grade 3 or 4) being the most common treatment-emergent adverse events.  No patients discontinued treatment because of adverse events.  Complete response, partial response, and stable disease as best response were achieved by 2%, 12%, and 52% of patients, resp.  At data cutoff, eight patients remained in the study, with 13 patients in the study for ≥ 1 yr.  Conclusion PT2385 has a favorable safety profile and is active in patients with heavily pretreated ccRCC, validating direct HIF-2a antagonism for the treatment of patients with ccRCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgJGjefWSjx7Vg90H21EOLACvtfcHk0ljRQ7gGhmWInA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1amsbbL&md5=81997f4afc2c2f229cf057bbf3c94904</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1200%2FJCO.2017.74.2627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2017.74.2627%26sid%3Dliteratum%253Aachs%26aulast%3DCourtney%26aufirst%3DK.%2BD.%26aulast%3DInfante%26aufirst%3DJ.%2BR.%26aulast%3DLam%26aufirst%3DE.%2BT.%26aulast%3DFiglin%26aufirst%3DR.%2BA.%26aulast%3DRini%26aufirst%3DB.%2BI.%26aulast%3DBrugarolas%26aufirst%3DJ.%26aulast%3DZojwalla%26aufirst%3DN.%2BJ.%26aulast%3DLowe%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DWallace%26aufirst%3DE.%2BM.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DChoueiri%26aufirst%3DT.%2BK.%26atitle%3DPhase%2520I%2520dose-escalation%2520trial%2520of%2520PT2385%252C%2520a%2520first-in-class%2520hypoxia-inducible%2520factor-2alpha%2520antagonist%2520in%2520patients%2520with%2520previously%2520treated%2520advanced%2520clear%2520cell%2520renal%2520cell%2520carcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2018%26volume%3D36%26issue%3D9%26spage%3D867%26epage%3D874%26doi%3D10.1200%2FJCO.2017.74.2627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krausz, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patterson, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, F. J.</span></span> <span> </span><span class="NLM_article-title">Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1298</span>– <span class="NLM_lpage">1308</span>, <span class="refDoi"> DOI: 10.1038/nm.4412</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnm.4412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29035368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1aisrzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2017&pages=1298-1308&issue=11&author=C.+Xieauthor=T.+Yagaiauthor=Y.+Luoauthor=X.+Liangauthor=T.+Chenauthor=Q.+Wangauthor=D.+Sunauthor=J.+Zhaoauthor=S.+K.+Ramakrishnanauthor=L.+Sunauthor=C.+Jiangauthor=X.+Xueauthor=Y.+Tianauthor=K.+W.+Krauszauthor=A.+D.+Pattersonauthor=Y.+M.+Shahauthor=Y.+Wuauthor=C.+Jiangauthor=F.+J.+Gonzalez&title=Activation+of+intestinal+hypoxia-inducible+factor+2alpha+during+obesity+contributes+to+hepatic+steatosis&doi=10.1038%2Fnm.4412"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis</span></div><div class="casAuthors">Xie, Cen; Yagai, Tomoki; Luo, Yuhong; Liang, Xianyi; Chen, Tao; Wang, Qiong; Sun, Dongxue; Zhao, Jie; Ramakrishnan, Sadeesh K.; Sun, Lulu; Jiang, Chunmei; Xue, Xiang; Tian, Yuan; Krausz, Kristopher W.; Patterson, Andrew D.; Shah, Yatrik M.; Wu, Yue; Jiang, Changtao; Gonzalez, Frank J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1298-1308</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Nonalcoholic fatty liver disease is becoming the most common chronic liver disease in Western countries, and limited therapeutic options are available.  Here we uncovered a role for intestinal hypoxia-inducible factor (HIF) in hepatic steatosis.  Human-intestine biopsies from individuals with or without obesity revealed that intestinal HIF-2α signaling was pos. correlated with body-mass index and hepatic toxicity.  The causality of this correlation was verified in mice with an intestine-specific disruption of Hif2a, in which high-fat-diet-induced hepatic steatosis and obesity were substantially lower as compared to control mice.  PT2385, a HIF-2α-specific inhibitor, had preventive and therapeutic effects on metabolic disorders that were dependent on intestine HIF-2α.  Intestine HIF-2α inhibition markedly reduced intestine and serum ceramide levels.  Mechanistically, intestine HIF-2α regulates ceramide metab. mainly from the salvage pathway, by pos. regulating the expression of Neu3, the gene encoding neuraminidase 3.  These results suggest that intestinal HIF-2α could be a viable target for hepatic steatosis therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_IFx6kul697Vg90H21EOLACvtfcHk0lhRV042yGL91w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1aisrzP&md5=1fb1444f6f986d84bb5baf905664d95b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1038%2Fnm.4412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.4412%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DC.%26aulast%3DYagai%26aufirst%3DT.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DRamakrishnan%26aufirst%3DS.%2BK.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DXue%26aufirst%3DX.%26aulast%3DTian%26aufirst%3DY.%26aulast%3DKrausz%26aufirst%3DK.%2BW.%26aulast%3DPatterson%26aufirst%3DA.%2BD.%26aulast%3DShah%26aufirst%3DY.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DGonzalez%26aufirst%3DF.%2BJ.%26atitle%3DActivation%2520of%2520intestinal%2520hypoxia-inducible%2520factor%25202alpha%2520during%2520obesity%2520contributes%2520to%2520hepatic%2520steatosis%26jtitle%3DNat.%2520Med.%26date%3D2017%26volume%3D23%26issue%3D11%26spage%3D1298%26epage%3D1308%26doi%3D10.1038%2Fnm.4412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickols, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farkas, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dervan, P. B.</span></span> <span> </span><span class="NLM_article-title">Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">561</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1021/cb700110z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb700110z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVOht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=561-571&issue=8&author=N.+G.+Nickolsauthor=C.+S.+Jacobsauthor=M.+E.+Farkasauthor=P.+B.+Dervan&title=Modulating+hypoxia-inducible+transcription+by+disrupting+the+HIF-1-DNA+interface&doi=10.1021%2Fcb700110z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating hypoxia-inducible transcription by disrupting the HIF-1-DNA interface</span></div><div class="casAuthors">Nickols, Nicholas G.; Jacobs, Claire S.; Farkas, Michelle E.; Dervan, Peter B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-571</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Transcription mediated by hypoxia-inducible factor (HIF-1) contributes to tumor angiogenesis and metastasis but is also involved in activation of cell death pathways and normal physiol. processes.  Given the complexity of HIF-1 signaling, it could be advantageous to target a subset of HIF-1 effectors rather than the entire pathway.  We compare the genome-wide effects of three mols. that each interfere with the HIF-1-DNA interaction: a polyamide targeted to the hypoxia response element, small interfering RNA targeted to HIF-1α, and echinomycin, a DNA-binding natural product with a similar but less specific sequence preference than the polyamide.  The polyamide affects a subset of hypoxia induced genes consistent with its binding site preferences.  For comparison, HIF-1α siRNA and echinomycin each affect the expression of nearly every gene induced by hypoxia.  Remarkably, the total no. of genes affected by either polyamide or HIF-1α siRNA over a range of thresholds is comparable.  The data show that polyamides can be used to affect a subset of a pathway regulated by a transcription factor.  In addn., this study offers a unique comparison of three complementary approaches towards exogenous control of endogenous gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBCofzE4gRZLVg90H21EOLACvtfcHk0lhRV042yGL91w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVOht78%253D&md5=3494c59563db58e5a7ca26fac767c3e5</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fcb700110z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb700110z%26sid%3Dliteratum%253Aachs%26aulast%3DNickols%26aufirst%3DN.%2BG.%26aulast%3DJacobs%26aufirst%3DC.%2BS.%26aulast%3DFarkas%26aufirst%3DM.%2BE.%26aulast%3DDervan%26aufirst%3DP.%2BB.%26atitle%3DModulating%2520hypoxia-inducible%2520transcription%2520by%2520disrupting%2520the%2520HIF-1-DNA%2520interface%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2007%26volume%3D2%26issue%3D8%26spage%3D561%26epage%3D571%26doi%3D10.1021%2Fcb700110z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardellina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Targeting the PAS-A domain of HIF-1alpha for development of small molecule inhibitors of HIF-1</span>. <i>Cell Cycle</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">1847</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.4161/cc.5.16.3019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.4161%2Fcc.5.16.3019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16861921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1847-1853&issue=16&author=E.+J.+Parkauthor=D.+Kongauthor=R.+Fisherauthor=J.+Cardellinaauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Targeting+the+PAS-A+domain+of+HIF-1alpha+for+development+of+small+molecule+inhibitors+of+HIF-1&doi=10.4161%2Fcc.5.16.3019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the PAS-A domain of HIF-1α for development of small molecule inhibitors of HIF-1</span></div><div class="casAuthors">Park, Eun Jung; Kong, Dehe; Fisher, Robert; Cardellina, John; Shoemaker, Robert H.; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cell Cycle</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1847-1853</span>CODEN:
                <span class="NLM_cas:coden">CCEYAS</span>;
        ISSN:<span class="NLM_cas:issn">1538-4101</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">Hypoxia inducible factor-1 (HIF-1) is a master regulator of cellular adaptation to oxygen deprivation and activates transcription of genes involved in tumor metab., angiogenesis, invasion and metastasis, all of which are implicated in cancer progression.  Several domains of HIF-1α mediate protein-protein interaction, which is essential for the formation of the active heterodimer with HIF-1β.  Targeting specific domains of HIF-1α might lead to the identification of more selective inhibitors.  HIF-1α and HIF-1β contain two Per-Arnt-Sim (PAS) domains, A and B, both of which appear to be important for heterodimer formation.  In an attempt to identify small mol. inhibitors of the PAS-A domain of HIF-1 we expressed proteins contg. amino acids 86-165 of HIF-1α and amino acids 159-240 of HIF-1β fused to a His or FLAG tag, resp.  Expressed proteins retained functional activity as indicated by in vitro immunopptn. expts. and activation of luciferase expression in a mammalian two-hybrid system.  Interestingly, over-expression of HIF-1α-PAS-A domain was sufficient to abrogate hypoxic induction of HIF-1-dependent luciferase expression, supporting its potential role as drug target.  An ELISA based on the interaction between FLAG-HIF-1β-PAS-A and HIF-1α-PAS-A-His was developed and used to screen libraries of synthetic compds.  NSC 50352 specifically inhibited PAS-A-dependent interaction between HIF-1α and HIF-1β, but not the interaction mediated by unrelated domains.  However, NSC 50352 was devoid of activity in cell-based assays.  Our results provide proof-of-principle that the PAS-A domain of HIF-1α is a valid target for development of small mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0IlreWLKvPrVg90H21EOLACvtfcHk0ljgMxO4uwCrMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Gnt7vL&md5=82829de97c89d4149821338a16001f71</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.4161%2Fcc.5.16.3019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.5.16.3019%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DKong%26aufirst%3DD.%26aulast%3DFisher%26aufirst%3DR.%26aulast%3DCardellina%26aufirst%3DJ.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DTargeting%2520the%2520PAS-A%2520domain%2520of%2520HIF-1alpha%2520for%2520development%2520of%2520small%2520molecule%2520inhibitors%2520of%2520HIF-1%26jtitle%3DCell%2520Cycle%26date%3D2006%26volume%3D5%26issue%3D16%26spage%3D1847%26epage%3D1853%26doi%3D10.4161%2Fcc.5.16.3019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, D. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2353</span>– <span class="NLM_lpage">2358</span>, <span class="refDoi"> DOI: 10.1073/pnas.0812801106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0812801106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19168635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1yqtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=2353-2358&issue=7&author=K.+Leeauthor=D.+Z.+Qianauthor=S.+Reyauthor=H.+Weiauthor=J.+O.+Liuauthor=G.+L.+Semenza&title=Anthracycline+chemotherapy+inhibits+HIF-1+transcriptional+activity+and+tumor-induced+mobilization+of+circulating+angiogenic+cells&doi=10.1073%2Fpnas.0812801106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells</span></div><div class="casAuthors">Lee, KangAe; Qian, David Z.; Rey, Sergio; Wei, Hong; Liu, Jun O.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2353-2358</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Using a cell-based reporter gene assay, we screened a library of drugs in clin. use and identified the anthracycline chemotherapeutic agents doxorubicin and daunorubicin as potent inhibitors of hypoxia-inducible factor 1 (HIF-1)-mediated gene transcription.  These drugs inhibited HIF-1 by blocking its binding to DNA.  Daily administration of doxorubicin or daunorubicin potently inhibited the transcription of a HIF-1-dependent reporter gene as well as endogenous HIF-1 target genes encoding vascular endothelial growth factor, stromal-derived factor 1, and stem cell factor in tumor xenografts.  CXCR4+/sca1+, VEGFR2+/CD34+, and VEGFR2+/CD117+ bone-marrow derived cells were increased in the peripheral blood of SCID mice bearing prostate cancer xenografts but not in tumor-bearing mice treated for 5 days with doxorubicin or daunorubicin, which dramatically reduced tumor vascularization.  These results provide a mol. basis for the antiangiogenic effect of anthracycline therapy and have important implications for refining the use of these drugs to treat human cancer more effectively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowjoJ93KjlVrVg90H21EOLACvtfcHk0ljgMxO4uwCrMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1yqtLg%253D&md5=0cc1320e9fb96bf3b35e63b06a771e15</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0812801106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0812801106%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%26aulast%3DQian%26aufirst%3DD.%2BZ.%26aulast%3DRey%26aufirst%3DS.%26aulast%3DWei%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DJ.%2BO.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DAnthracycline%2520chemotherapy%2520inhibits%2520HIF-1%2520transcriptional%2520activity%2520and%2520tumor-induced%2520mobilization%2520of%2520circulating%2520angiogenic%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D7%26spage%3D2353%26epage%3D2358%26doi%3D10.1073%2Fpnas.0812801106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span> <span> </span><span class="NLM_article-title">Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">2193</span>– <span class="NLM_lpage">2202</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-05-0443</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1535-7163.MCT-05-0443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16985052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28Xps1yns7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=2193-2202&issue=9&author=D.+T.+Jonesauthor=A.+L.+Harris&title=Identification+of+novel+small-molecule+inhibitors+of+hypoxia-inducible+factor-1+transactivation+and+DNA+binding&doi=10.1158%2F1535-7163.MCT-05-0443"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of novel small-molecule inhibitors of hypoxia-inducible factor-1 transactivation and DNA binding</span></div><div class="casAuthors">Jones, Dylan T.; Harris, Adrian L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2193-2202</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-α (Hif-α) plays an important role in tumor growth by increasing resistance to apoptosis and the prodn. of angiogenic factors, such as vascular endothelial growth factor (VEGF).  Therefore, Hif-α is an attractive target for development of novel cancer therapeutics.  We have generated Chinese hamster ovary cells, which stably express luciferase reporter construct under the control of a hypoxia response element to screen 15,000 compds.  We identified 40 compds. that inhibited hypoxic up-regulation of luciferase, and the top 30 compds. were further screened in a secondary assay using MDA-468 breast cancer cell line.  Eight compds. were shown to inhibit VEGF expression in hypoxic cells at subtoxic concns.  Three top putative Hif inhibitors, DJ12, DJ15, and DJ30, were chosen for further anal.  Transient transfection of cells with hypoxia-regulated luciferase reporter plasmids further validated that these compds. inhibit hypoxia up-regulated genes.  All three compds. failed to inhibit Hif-1α protein levels but they did inhibit induction of downstream targets of Hif-α under hypoxia.  Two of the three compds. were cell type specific, whereas compd. DJ12 inhibited VEGF at subtoxic levels in breast cancer cell lines MDA-468 and ZR-75, melanoma cell line MDA-435, and pVHL mutant renal cancer cell lines RCC4 and 786-0.  Compd. DJ12 down-regulated mRNA of downstream targets of Hif-α, and significantly inhibited Hif-1α transactivation activity by blocking Hif-1α hypoxia response element-DNA binding.  Our cell-based approach and deconvolution of the inhibitory effect of DJ12 has identified a novel compd. that targets the hypoxia pathway by inhibiting Hif-α-inducible transcription.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC0jdC1W9Mx7Vg90H21EOLACvtfcHk0ljgMxO4uwCrMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xps1yns7o%253D&md5=c996f44eb74d9cad0e343089a81ae809</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-05-0443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-05-0443%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BT.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26atitle%3DIdentification%2520of%2520novel%2520small-molecule%2520inhibitors%2520of%2520hypoxia-inducible%2520factor-1%2520transactivation%2520and%2520DNA%2520binding%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26issue%3D9%26spage%3D2193%26epage%3D2202%26doi%3D10.1158%2F1535-7163.MCT-05-0443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potluri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rastinejad, F.</span></span> <span> </span><span class="NLM_article-title">Structural integration in hypoxia-inducible factors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>524</i></span> (<span class="NLM_issue">7565</span>),  <span class="NLM_fpage">303</span>– <span class="NLM_lpage">308</span>, <span class="refDoi"> DOI: 10.1038/nature14883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature14883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26245371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=524&publication_year=2015&pages=303-308&issue=7565&author=D.+Wuauthor=N.+Potluriauthor=J.+Luauthor=Y.+Kimauthor=F.+Rastinejad&title=Structural+integration+in+hypoxia-inducible+factors&doi=10.1038%2Fnature14883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Structural integration in hypoxia-inducible factors</span></div><div class="casAuthors">Wu, Dalei; Potluri, Nalini; Lu, Jingping; Kim, Youngchang; Rastinejad, Fraydoon</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">524</span>
        (<span class="NLM_cas:issue">7565</span>),
    <span class="NLM_cas:pages">303-308</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The hypoxia-inducible factors (HIFs) coordinate cellular adaptations to low oxygen stress by regulating transcriptional programs in erythropoiesis, angiogenesis and metab.  These programs promote the growth and progression of many tumors, making HIFs attractive anticancer targets.  Transcriptionally active HIFs consist of HIF-α and ARNT (also called HIF-1β) subunits.  Here we describe crystal structures for each of mouse HIF-2α-ARNT and HIF-1α-ARNT heterodimers in states that include bound small mols. and their hypoxia response element.  A highly integrated quaternary architecture is shared by HIF-2α-ARNT and HIF-1α-ARNT, wherein ARNT spirals around the outside of each HIF-α subunit.  Five distinct pockets are obsd. that permit small-mol. binding, including PAS domain encapsulated sites and an interfacial cavity formed through subunit heterodimerization.  The DNA-reading head rotates, extends and cooperates with a distal PAS domain to bind hypoxia response elements.  HIF-α mutations linked to human cancers map to sensitive sites that establish DNA binding and the stability of PAS domains and pockets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzlNDlRsluLVg90H21EOLACvtfcHk0lgI7S2ad6cSDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht12jtbzL&md5=6f61623f717e8344460b5e81e161c77c</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1038%2Fnature14883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14883%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DD.%26aulast%3DPotluri%26aufirst%3DN.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DRastinejad%26aufirst%3DF.%26atitle%3DStructural%2520integration%2520in%2520hypoxia-inducible%2520factors%26jtitle%3DNature%26date%3D2015%26volume%3D524%26issue%3D7565%26spage%3D303%26epage%3D308%26doi%3D10.1038%2Fnature14883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Terzuoli, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puppo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapisarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranchimeg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziche, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashion</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span> (<span class="NLM_issue">17</span>),  <span class="NLM_fpage">6837</span>– <span class="NLM_lpage">6848</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-10-1075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20736373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2rsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=6837-6848&issue=17&author=E.+Terzuoliauthor=M.+Puppoauthor=A.+Rapisardaauthor=B.+Uranchimegauthor=L.+Caoauthor=A.+M.+Burgerauthor=M.+Zicheauthor=G.+Melillo&title=Aminoflavone%2C+a+ligand+of+the+aryl+hydrocarbon+receptor%2C+inhibits+HIF-1alpha+expression+in+an+AhR-independent+fashion&doi=10.1158%2F0008-5472.CAN-10-1075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Aminoflavone, a Ligand of the Aryl Hydrocarbon Receptor, Inhibits HIF-1α Expression in an AhR-Independent Fashion</span></div><div class="casAuthors">Terzuoli, Erika; Puppo, Maura; Rapisarda, Annamaria; Uranchimeg, Badarch; Cao, Liang; Burger, Angelika M.; Ziche, Marina; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6837-6848</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Aminoflavone (AF), the active component of a novel anticancer agent (AFP464) in phase I clin. trials, is a ligand of the aryl hydrocarbon receptor (AhR).  AhR dimerizes with HIF-1β/AhR, which is shared with HIF-1α, a transcription factor crit. for the response of cells to oxygen deprivation.  To address whether pharmacol. activation of the AhR pathway might be a potential mechanism for inhibition of HIF-1, we tested the effects of AF on HIF-1 expression.  AF inhibited HIF-1α transcriptional activity and protein accumulation in MCF-7 cells.  However, inhibition of HIF-1α by AF was independent from a functional AhR pathway.  Indeed, AF inhibited HIF-1α expression in AhR100 cells, in which the AhR pathway is functionally impaired, yet did not induce cytotoxicity, providing evidence that these effects are mediated by distinct signaling pathways.  Moreover, AF was inactive in MDA-MB-231 cells, yet inhibited HIF-1α in MDA-MB-231 cells transfected with the SULT1A1 gene.  AF inhibited HIF-1α mRNA expression by ∼50%.  Notably, actinomycin-D completely abrogated the ability of AF to downregulate HIF-1α mRNA, indicating that active transcription was required for the inhibition of HIF-1α expression.  Finally, AF inhibited HIF-1α protein accumulation and the expression of HIF-1 target genes in MCF-7 xenografts.  These results show that AF inhibits HIF-1α in an AhR-independent fashion, and they unveil addnl. activities of AF that may be relevant for its further clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoheAp_548Yt7Vg90H21EOLACvtfcHk0lgI7S2ad6cSDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2rsLfN&md5=fe37237b3f1778a7916a32bc2ddde427</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1075%26sid%3Dliteratum%253Aachs%26aulast%3DTerzuoli%26aufirst%3DE.%26aulast%3DPuppo%26aufirst%3DM.%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DBurger%26aufirst%3DA.%2BM.%26aulast%3DZiche%26aufirst%3DM.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DAminoflavone%252C%2520a%2520ligand%2520of%2520the%2520aryl%2520hydrocarbon%2520receptor%252C%2520inhibits%2520HIF-1alpha%2520expression%2520in%2520an%2520AhR-independent%2520fashion%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26issue%3D17%26spage%3D6837%26epage%3D6848%26doi%3D10.1158%2F0008-5472.CAN-10-1075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shyu, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsien Lee, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S.</span></span> <span> </span><span class="NLM_article-title">GL331 inhibits HIF-1alpha expression in a lung cancer model</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(03)00111-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS0006-291X%2803%2900111-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12593853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Cqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=95-100&issue=1&author=H.+Changauthor=K.+G.+Shyuauthor=C.+C.+Leeauthor=S.+C.+Tsaiauthor=B.+W.+Wangauthor=Y.+Hsien+Leeauthor=S.+Lin&title=GL331+inhibits+HIF-1alpha+expression+in+a+lung+cancer+model&doi=10.1016%2FS0006-291X%2803%2900111-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">GL331 inhibits HIF-1α expression in a lung cancer model</span></div><div class="casAuthors">Chang, Hang; Shyu, Kou-Gi; Lee, Chun-Chung; Tsai, Shiow-Chwen; Wang, Bao-Wei; Lee, Yu Hsien; Lin, Shankung</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-100</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">We have studied GL331's anti-cancer mechanisms by studying their effect on the tumor-induced angiogenesis.  Human lung adenocarcinoma CL1-5 cells were treated with GL331 and then maintained in serum-reduced, GL331-free medium for the prepn. of condition media.  These condition media were tested for their capability to induce in vitro angiogenesis, i.e., HUVEC tube formation and migration.  We found that media generated from GL331-treated CL1-5 cells presented reduced ability of inducing in vitro angiogenesis.  Western blot analyses showed that both VEGF and HIF-1α were down-regulated in GL331-treated CL1-5 cells.  Northern blot and EMSA analyses showed that GL331 down-regulated HIF-1α expression without decreasing the stability of HIF-1α mRNA, and that GL331 decreased the binding of CL1-5-derived nuclear components to the promoter of HIF-1α gene.  Therefore, our data showed that GL331 is a potent inhibitor of tumor-induced angiogenesis.  The underlying mechanisms might involve at least the inhibition of HIF-1α expression, probably through transcriptional repression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLQ5c434gW2LVg90H21EOLACvtfcHk0lgI7S2ad6cSDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Cqt7s%253D&md5=fec10a894a4a3b90b15affc6a8518e50</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2900111-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252900111-6%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DH.%26aulast%3DShyu%26aufirst%3DK.%2BG.%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DTsai%26aufirst%3DS.%2BC.%26aulast%3DWang%26aufirst%3DB.%2BW.%26aulast%3DHsien%2BLee%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DS.%26atitle%3DGL331%2520inhibits%2520HIF-1alpha%2520expression%2520in%2520a%2520lung%2520cancer%2520model%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D302%26issue%3D1%26spage%3D95%26epage%3D100%26doi%3D10.1016%2FS0006-291X%2803%2900111-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Greenberger, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horak, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filpula, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapra, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westergaard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydenlund, H. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albaek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orum, H.</span></span> <span> </span><span class="NLM_article-title">A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">3598</span>– <span class="NLM_lpage">3608</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-08-0510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1535-7163.MCT-08-0510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18974394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGgs77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=3598-3608&issue=11&author=L.+M.+Greenbergerauthor=I.+D.+Horakauthor=D.+Filpulaauthor=P.+Sapraauthor=M.+Westergaardauthor=H.+F.+Frydenlundauthor=C.+Albaekauthor=H.+Schroderauthor=H.+Orum&title=A+RNA+antagonist+of+hypoxia-inducible+factor-1alpha%2C+EZN-2968%2C+inhibits+tumor+cell+growth&doi=10.1158%2F1535-7163.MCT-08-0510"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth</span></div><div class="casAuthors">Greenberger, Lee M.; Horak, Ivan D.; Filpula, David; Sapra, Puja; Westergaard, Majken; Frydenlund, Henrik F.; Albaek, Charlotte; Schroder, Henrik; Orum, Henrik</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3598-3608</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) is a transcription factor that plays a crit. role in angiogenesis, survival, metastasis, drug resistance, and glucose metab.  Elevated expression of the α-subunit of HIF-1 (HIF-1α), which occurs in response to hypoxia or activation of growth factor pathways, is assocd. with poor prognosis in many types of cancer.  Therefore, down-regulation of HIF-1α protein by RNA antagonists may control cancer growth.  EZN-2968 is a RNA antagonist composed of third-generation oligonucleotide, locked nucleic acid, technol. that specifically binds and inhibits the expression of HIF-1α mRNA.  In vitro, in human prostate (15PC3, PC3, and DU145) and glioblastoma (U373) cells, EZN-2968 induced a potent, selective, and durable antagonism of HIF-1 mRNA and protein expression (IC50, 1-5 nmol/L) under normoxic and hypoxic conditions assocd. with inhibition of tumor cell growth.  Addnl., down-regulation of HIF-1α protein by EZN-2968 led to redn. of its transcriptional targets and of human umbilical vein endothelial cell tube formation.  In vivo, administration of EZN-2968 to normal mice led to specific, dose-dependent, and highly potent down-regulation of endogenous HIF-1α and vascular endothelial growth factor in the liver.  The effect can last for days after administration of single dose of EZN-2968 and is assocd. with long residence time of locked nucleic acid in certain tissues.  In efficacy studies, tumor redn. was found in nude mice implanted with DU145 cells treated with EZN-2968.  Ongoing phase I studies of EZN-2968 in patients with advanced malignancies will det. optimal dose and schedule for the phase II program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXfvxx_ooHjrVg90H21EOLACvtfcHk0liZy4uoB5t4dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGgs77K&md5=4be42a347a2a1ff6873e610a7246f67c</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0510%26sid%3Dliteratum%253Aachs%26aulast%3DGreenberger%26aufirst%3DL.%2BM.%26aulast%3DHorak%26aufirst%3DI.%2BD.%26aulast%3DFilpula%26aufirst%3DD.%26aulast%3DSapra%26aufirst%3DP.%26aulast%3DWestergaard%26aufirst%3DM.%26aulast%3DFrydenlund%26aufirst%3DH.%2BF.%26aulast%3DAlbaek%26aufirst%3DC.%26aulast%3DSchroder%26aufirst%3DH.%26aulast%3DOrum%26aufirst%3DH.%26atitle%3DA%2520RNA%2520antagonist%2520of%2520hypoxia-inducible%2520factor-1alpha%252C%2520EZN-2968%252C%2520inhibits%2520tumor%2520cell%2520growth%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26issue%3D11%26spage%3D3598%26epage%3D3608%26doi%3D10.1158%2F1535-7163.MCT-08-0510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogt, P. K.</span></span> <span> </span><span class="NLM_article-title">Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1</span>. <i>Cell Growth Differ.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11457733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsVCgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=363-369&issue=7&author=B.+H.+Jiangauthor=G.+Jiangauthor=J.+Z.+Zhengauthor=Z.+Luauthor=T.+Hunterauthor=P.+K.+Vogt&title=Phosphatidylinositol+3-kinase+signaling+controls+levels+of+hypoxia-inducible+factor+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1</span></div><div class="casAuthors">Jiang, Bing-Hua; Jiang, Guoqiang; Zheng, Jenny Z.; Lu, Zhimin; Hunter, Tony; Vogt, Peter K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Growth & Differentiation</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">363-369</span>CODEN:
                <span class="NLM_cas:coden">CGDIE7</span>;
        ISSN:<span class="NLM_cas:issn">1044-9523</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI3K) signaling pathway has inherent oncogenic potential.  It is up-regulated in diverse human cancers by either a gain of function in PI3K itself or in its downstream target Akt or by a loss of function in the neg. regulator PTEN.  However, the complete consequences of this up-regulation are not known.  Here we show that insulin and epidermal growth factor or an inactivating mutation in the tumor suppressor PTEN specifically increase the protein levels of hypoxia-inducible factor (HIF) 1α but not of HIF-1β in human cancer cell lines.  This specific elevation of HIF-1α protein expression requires PI3K signaling.  In the prostate carcinoma-derived cell lines PC-3 and DU145, insulin- and epidermal growth factor-induced expression of HIF-1α was inhibited by the PI3K-specific inhibitors LY294002 and wortmannin in a dose-dependent manner.  HIF-1β expression was not affected by these inhibitors.  Introduction of wild-type PTEN into the PTEN-neg. PC-3 cell line specifically inhibited the expression of HIF-1α but not that of HIF-1β.  In contrast to the HIF-1α protein, the level of HIF-1α mRNA was not significantly affected by PI3K signaling.  Vascular endothelial growth factor reporter gene activity was induced by insulin in PC-3 cells and was inhibited by the PI3K inhibitor LY294002 and by the coexpression of a HIF-1 dominant neg. construct.  Vascular endothelial growth factor reporter gene activity was also inhibited by expression of a dominant neg. PI3K construct and by the tumor suppressor PTEN.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpL0uJULeOiwrVg90H21EOLACvtfcHk0liZy4uoB5t4dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsVCgur8%253D&md5=6bee4f00d84c646821d278bece852eac</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DB.%2BH.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DZheng%26aufirst%3DJ.%2BZ.%26aulast%3DLu%26aufirst%3DZ.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DVogt%26aufirst%3DP.%2BK.%26atitle%3DPhosphatidylinositol%25203-kinase%2520signaling%2520controls%2520levels%2520of%2520hypoxia-inducible%2520factor%25201%26jtitle%3DCell%2520Growth%2520Differ.%26date%3D2001%26volume%3D12%26issue%3D7%26spage%3D363%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span> <span> </span><span class="NLM_article-title">Downregulation of HIF-1α inhibits the proliferation, migration and invasion of gastric cancer by inhibiting PI3K/AKT pathway and VEGF expression</span>. <i>Biosci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">BSR20180741</span>, <span class="refDoi"> DOI: 10.1042/BSR20180741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1042%2FBSR20180741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29899167" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=BSR20180741&author=J.+Zhangauthor=J.+Xuauthor=Y.+Dongauthor=B.+Huang&title=Downregulation+of+HIF-1%CE%B1+inhibits+the+proliferation%2C+migration+and+invasion+of+gastric+cancer+by+inhibiting+PI3K%2FAKT+pathway+and+VEGF+expression&doi=10.1042%2FBSR20180741"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1042%2FBSR20180741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20180741%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DB.%26atitle%3DDownregulation%2520of%2520HIF-1%25CE%25B1%2520inhibits%2520the%2520proliferation%252C%2520migration%2520and%2520invasion%2520of%2520gastric%2520cancer%2520by%2520inhibiting%2520PI3K%252FAKT%2520pathway%2520and%2520VEGF%2520expression%26jtitle%3DBiosci.%2520Rep.%26date%3D2018%26volume%3D38%26spage%3DBSR20180741%26doi%3D10.1042%2FBSR20180741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiang, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otterness, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loomis, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaper, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, R. T.</span></span> <span> </span><span class="NLM_article-title">Regulation of hypoxia-inducible factor 1 expression and function by the mammalian target of rapamycin</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">7004</span>– <span class="NLM_lpage">7014</span>, <span class="refDoi"> DOI: 10.1128/MCB.22.20.7004-7014.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1128%2FMCB.22.20.7004-7014.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12242281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsFKitrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=7004-7014&issue=20&author=C.+C.+Hudsonauthor=M.+Liuauthor=G.+G.+Chiangauthor=D.+M.+Otternessauthor=D.+C.+Loomisauthor=F.+Kaperauthor=A.+J.+Giacciaauthor=R.+T.+Abraham&title=Regulation+of+hypoxia-inducible+factor+1+expression+and+function+by+the+mammalian+target+of+rapamycin&doi=10.1128%2FMCB.22.20.7004-7014.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of hypoxia-inducible factor 1α expression and function by the mammalian target of rapamycin</span></div><div class="casAuthors">Hudson, Christine C.; Liu, Mei; Chiang, Gary G.; Otterness, Diane M.; Loomis, Dawn C.; Kaper, Fiona; Giaccia, Amato J.; Abraham, Robert T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7004-7014</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric transcription factor contg. an inducibly expressed HIF-1α subunit and a constitutively expressed HIF-1β subunit.  Under hypoxic conditions, the HIF-1α subunit accumulates due to a decrease in the rate of proteolytic degrdn., and the resulting HIF-1α-HIF-1β heterodimers undergo posttranslational modifications that promote transactivation.  Recent studies suggest that amplified signaling through phosphoinositide 3-kinase, and its downstream target, mTOR, enhances HIF-1-dependent gene expression in certain cell types.  In the present study, we have explored further the linkage between mTOR and HIF-1 in PC-3 prostate cancer cells treated with hypoxia or the hypoxia mimetic agent, CoCl2.  Pretreatment of PC-3 cells with the mTOR inhibitor, rapamycin, inhibited both the accumulation of HIF-1α and HIF-1-dependent transcription induced by hypoxia or CoCl2.  Transfection of these cells with wild-type mTOR enhanced HIF-1 activation by hypoxia or CoCl2, while expression of a rapamycin-resistant mTOR mutant rendered both HIF-1α stabilization and HIF-1 transactivating function refractory to inhibition by rapamycin.  Studies with GAL4-HIF-1α fusion proteins pinpointed the oxygen-dependent degrdn. domain as a crit. target for the rapamycin-sensitive, mTOR-dependent signaling pathway leading to HIF-1α stabilization by CoCl2.  These studies position mTOR as an upstream activator of HIF-1 function in cancer cells and suggest that the antitumor activity of rapamycin is mediated, in part, through the inhibition of cellular responses to hypoxic stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrELk511LwaKLVg90H21EOLACvtfcHk0liZy4uoB5t4dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsFKitrk%253D&md5=7f74629f6aacee66bf4289fdd3f16b85</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.20.7004-7014.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.20.7004-7014.2002%26sid%3Dliteratum%253Aachs%26aulast%3DHudson%26aufirst%3DC.%2BC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DOtterness%26aufirst%3DD.%2BM.%26aulast%3DLoomis%26aufirst%3DD.%2BC.%26aulast%3DKaper%26aufirst%3DF.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DRegulation%2520of%2520hypoxia-inducible%2520factor%25201%2520expression%2520and%2520function%2520by%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26issue%3D20%26spage%3D7004%26epage%3D7014%26doi%3D10.1128%2FMCB.22.20.7004-7014.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koh, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spivak-Kroizman, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span> <span> </span><span class="NLM_article-title">Inhibiting the hypoxia response for cancer therapy: the new kid on the block</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">5945</span>– <span class="NLM_lpage">5946</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-1650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1078-0432.CCR-09-1650" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19789327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=5945-5946&issue=19&author=M.+Y.+Kohauthor=T.+R.+Spivak-Kroizmanauthor=G.+Powis&title=Inhibiting+the+hypoxia+response+for+cancer+therapy%3A+the+new+kid+on+the+block&doi=10.1158%2F1078-0432.CCR-09-1650"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block</span></div><div class="casAuthors">Koh, Mei Yee; Spivak-Kroizman, Taly R.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5945-5946</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The hypoxia-inducible transcription factor (HIF)-1α inhibitor KC7F2 described in this issue of Clin. Cancer Research is the newest addn. to an emerging class of antitumor agents targeting the hypoxia response.  Here, we discuss the proposed mechanism of action of KC7F2 and its potential strengths and limitations in comparison with other promising HIF-1α inhibitors. (Clin Cancer Res 2009;15(19):5945-6).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkhgl0HOsZ7Vg90H21EOLACvtfcHk0lgs3ZjEtoAXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtF2ltbjL&md5=0ab7dd009b91465b6c872b1df34f46a8</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1650%26sid%3Dliteratum%253Aachs%26aulast%3DKoh%26aufirst%3DM.%2BY.%26aulast%3DSpivak-Kroizman%26aufirst%3DT.%2BR.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DInhibiting%2520the%2520hypoxia%2520response%2520for%2520cancer%2520therapy%253A%2520the%2520new%2520kid%2520on%2520the%2520block%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26issue%3D19%26spage%3D5945%26epage%3D5946%26doi%3D10.1158%2F1078-0432.CCR-09-1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shackelford, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasquez, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbeil, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vera, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, R. J.</span></span> <span> </span><span class="NLM_article-title">mTOR and HIF-1alpha-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">27</span>),  <span class="NLM_fpage">11137</span>– <span class="NLM_lpage">11142</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900465106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0900465106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19541609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptVWgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=11137-11142&issue=27&author=D.+B.+Shackelfordauthor=D.+S.+Vasquezauthor=J.+Corbeilauthor=S.+Wuauthor=M.+Leblancauthor=C.+L.+Wuauthor=D.+R.+Veraauthor=R.+J.+Shaw&title=mTOR+and+HIF-1alpha-mediated+tumor+metabolism+in+an+LKB1+mouse+model+of+Peutz-Jeghers+syndrome&doi=10.1073%2Fpnas.0900465106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">mTOR and HIF-1α-mediated tumor metabolism in an LKB1 mouse model of Peutz-Jeghers syndrome</span></div><div class="casAuthors">Shackelford, David B.; Vasquez, Debbie S.; Corbeil, Jacqueline; Wu, Shulin; Leblanc, Mathias; Wu, Chin-Lee; Vera, David R.; Shaw, Reuben J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">11137-11142, S11137/1-S11137/6</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Peutz-Jeghers syndrome (PJS) is a familial cancer disorder due to inherited loss of function mutations in the LKB1/STK11 serine/threonine kinase.  PJS patients develop gastrointestinal hamartomas with 100% penetrance often in the second decade of life, and demonstrate an increased predisposition toward the development of a no. of addnl. malignancies.  Among mitogenic signaling pathways, the mammalian-target of rapamycin complex 1 (mTORC1) pathway is hyperactivated in tissues and tumors derived from LKB1-deficient mice.  Consistent with a central role for mTORC1 in these tumors, rapamycin as a single agent results in a dramatic suppression of preexisting GI polyps in LKB1+/- mice.  However, the key targets of mTORC1 in LKB1-deficient tumors remain unknown.  We demonstrate here that these polyps, and LKB1- and AMPK-deficient mouse embryonic fibroblasts, show dramatic up-regulation of the HIF-1α transcription factor and its downstream transcriptional targets in an rapamycin-suppressible manner.  The HIF-1α targets hexokinase II and Glut1 are up-regulated in these polyps, and using FDG-PET, we demonstrate that LKB1+/- mice show increased glucose utilization in focal regions of their GI tract corresponding to these gastrointestinal hamartomas.  Importantly, we demonstrate that polyps from human Peutz-Jeghers patients similarly exhibit up-regulated mTORC1 signaling, HIF-1α, and GLUT1 levels.  Furthermore, like HIF-1α and its target genes, the FDG-PET signal in the GI tract of these mice is abolished by rapamycin treatment.  These findings suggest a no. of therapeutic modalities for the treatment and detection of hamartomas in PJS patients, and potential for the screening and treatment of the 30% of sporadic human lung cancers bearing LKB1 mutations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ-GDKsOxgbbVg90H21EOLACvtfcHk0lgs3ZjEtoAXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptVWgu78%253D&md5=323798fa0e664b1022918aa5f8a9f256</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900465106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900465106%26sid%3Dliteratum%253Aachs%26aulast%3DShackelford%26aufirst%3DD.%2BB.%26aulast%3DVasquez%26aufirst%3DD.%2BS.%26aulast%3DCorbeil%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DLeblanc%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DC.%2BL.%26aulast%3DVera%26aufirst%3DD.%2BR.%26aulast%3DShaw%26aufirst%3DR.%2BJ.%26atitle%3DmTOR%2520and%2520HIF-1alpha-mediated%2520tumor%2520metabolism%2520in%2520an%2520LKB1%2520mouse%2520model%2520of%2520Peutz-Jeghers%2520syndrome%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26issue%3D27%26spage%3D11137%26epage%3D11142%26doi%3D10.1073%2Fpnas.0900465106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mayerhofer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valent, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sperr, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillaber, C.</span></span> <span> </span><span class="NLM_article-title">BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>100</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">3767</span>– <span class="NLM_lpage">3775</span>, <span class="refDoi"> DOI: 10.1182/blood-2002-01-0109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1182%2Fblood-2002-01-0109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12393646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XoslKlsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2002&pages=3767-3775&issue=10&author=M.+Mayerhoferauthor=P.+Valentauthor=W.+R.+Sperrauthor=J.+D.+Griffinauthor=C.+Sillaber&title=BCR%2FABL+induces+expression+of+vascular+endothelial+growth+factor+and+its+transcriptional+activator%2C+hypoxia+inducible+factor-1alpha%2C+through+a+pathway+involving+phosphoinositide+3-kinase+and+the+mammalian+target+of+rapamycin&doi=10.1182%2Fblood-2002-01-0109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1α, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin</span></div><div class="casAuthors">Mayerhofer, Matthias; Valent, Peter; Sperr, Wolfgang R.; Griffin, James D.; Sillaber, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3767-3775</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Recent data suggest that vascular endothelial growth factor (VEGF), a cytokine involved in autocrine growth of tumor cells and tumor angiogenesis, is up-regulated and plays a potential role in myelogenous leukemias.  In chronic myelogenous leukemia (CML), VEGF is expressed at high levels in the bone marrow and peripheral blood.  We show here that the CML-assocd. oncogene BCR/ABL induces VEGF gene expression in growth factor-dependent Ba/F3 cells.  Whereas starved cells were found to contain only baseline levels of VEGF mRNA, Ba/F3 cells induced to express BCR/ABL exhibited substantial amts. of VEGF mRNA.  BCR/ABL also induced VEGF promoter activity and increased VEGF protein levels in Ba/F3 cells.  Moreover, BCR/ABL was found to promote the expression of functionally active hypoxia-inducible factor-1 (HIF-1), a major transcriptional regulator of VEGF gene expression.  BCR/ABL-induced VEGF gene expression was counteracted by the phosphoinositide 3-kinase (PI3-kinase) inhibitor LY294002 and rapamycin, an antagonist of mammalian target of rapamycin (mTOR), but not by inhibition of the mitogen-activated protein kinase pathway.  Similarly, BCR/ABL-dependent HIF-1α expression was inhibited by the addn. of LY294002 and rapamycin.  Together, our data show that BCR/ABL induces VEGF- and HIF-1α gene expression through a pathway involving PI3-kinase and mTOR.  BCR/ABL-induced VEGF expression may contribute to the pathogenesis and increased angiogenesis in CML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNo-4bbqnn47Vg90H21EOLACvtfcHk0lgs3ZjEtoAXiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XoslKlsro%253D&md5=8a9f8bcb0781b7d12a401a64ebb2aa66</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1182%2Fblood-2002-01-0109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2002-01-0109%26sid%3Dliteratum%253Aachs%26aulast%3DMayerhofer%26aufirst%3DM.%26aulast%3DValent%26aufirst%3DP.%26aulast%3DSperr%26aufirst%3DW.%2BR.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DSillaber%26aufirst%3DC.%26atitle%3DBCR%252FABL%2520induces%2520expression%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520and%2520its%2520transcriptional%2520activator%252C%2520hypoxia%2520inducible%2520factor-1alpha%252C%2520through%2520a%2520pathway%2520involving%2520phosphoinositide%25203-kinase%2520and%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DBlood%26date%3D2002%26volume%3D100%26issue%3D10%26spage%3D3767%26epage%3D3775%26doi%3D10.1182%2Fblood-2002-01-0109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rho, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryoo, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Na,  II.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. C.</span></span> <span> </span><span class="NLM_article-title">Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">801</span>– <span class="NLM_lpage">807</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19212642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvVWhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2009&pages=801-807&issue=3&author=J.+K.+Rhoauthor=Y.+J.+Choiauthor=J.+K.+Leeauthor=B.+Y.+Ryooauthor=+Naauthor=S.+H.+Yangauthor=C.+H.+Kimauthor=Y.+D.+Yooauthor=J.+C.+Lee&title=Gefitinib+circumvents+hypoxia-induced+drug+resistance+by+the+modulation+of+HIF-1alpha"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1α</span></div><div class="casAuthors">Rho, Jin Kyung; Choi, Yun Jung; Lee, Jin Kyung; Ryoo, Baek-yeol; Na, Im Ii; Yang, Sung Hyun; Kim, Cheol Hyeon; Yoo, Young Do; Lee, Jae Cheol</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">801-807</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1α (HIF-1α) is a transcriptional factor which is activated by hypoxia and assocd. with cell survival, proliferation and drug resistance.  Recent studies have shown that the down-stream mols. of the epidermal growth factor receptor (EGFR) signal are involved in the hypoxia-dependent or -independent HIF-1α protein accumulation.  Thus, we hypothesized that an EGFR-TK inhibitor, gefitinib, might circumvent the hypoxia-induced drug resistance via the regulation of HIF-1α expression.  In our data, treatment of gefitinib suppressed induced HIF-1α by hypoxia.  This action of gefitinib was caused by reduced protein stability without any change in the level of HIF-1α mRNA.  The effect of gefitinib on downregulation of HIF-1α was reversed by transfection of constitutively active form of Akt.  The cellular response to gefitinib was similar in both normoxia and hypoxia condition.  However, the response to conventional chemotherapeutic drugs decreased >50% under hypoxia condition and they did not change HIF-1α expression.  In addn., the suppression of HIF-1α using siRNA overcame partially hypoxia-induced drug resistance.  In conclusion, gefitinib was able to circumvent hypoxia-induced drug resistance suggesting that the effective suppression of HIF-1α by the inhibition of EGFR-Akt pathway may overcome the hypoxia-induced drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnMtTuGdQTdrVg90H21EOLACvtfcHk0lhpc4jPcVL50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvVWhtLo%253D&md5=e906e5f8f24ad622937ab651a6db9278</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRho%26aufirst%3DJ.%2BK.%26aulast%3DChoi%26aufirst%3DY.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BK.%26aulast%3DRyoo%26aufirst%3DB.%2BY.%26aulast%3DNa%26aulast%3DYang%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DC.%2BH.%26aulast%3DYoo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DGefitinib%2520circumvents%2520hypoxia-induced%2520drug%2520resistance%2520by%2520the%2520modulation%2520of%2520HIF-1alpha%26jtitle%3DOncol.%2520Rep.%26date%3D2009%26volume%3D21%26issue%3D3%26spage%3D801%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span> <span> </span><span class="NLM_article-title">Genistein decreases A549 cell viability via inhibition of the PI3K/AKT/HIF1alpha/VEGF and NF-kB/COX-2 signaling pathways</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2302</span>, <span class="refDoi"> DOI: 10.3892/mmr.2017.6260</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.3892%2Fmmr.2017.6260" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28259980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFWkt7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2017&pages=2296-2302&issue=4&author=J.+Zhangauthor=H.+Suauthor=Q.+Liauthor=J.+Liauthor=Q.+Zhao&title=Genistein+decreases+A549+cell+viability+via+inhibition+of+the+PI3K%2FAKT%2FHIF1alpha%2FVEGF+and+NF-kB%2FCOX-2+signaling+pathways&doi=10.3892%2Fmmr.2017.6260"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Genistein decreases A549 cell viability via inhibition of the PI3K/AKT/HIF-1α/VEGF and NF-κB/COX-2 signaling pathways</span></div><div class="casAuthors">Zhang, Juan; Su, Hongzheng; Li, Qingfeng; Li, Jing; Zhao, Qianfeng</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2296-2302</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-3004</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">Genistein is an important chemopreventive agent against atherosclerosis and cancer.  However, whether genistein is effective in the treatment of lung cancer, and its underlying mechanism, remains to be detd.  The present study demonstrated that genistein treatment of A549 lung cancer cells decreased viability in a dose- and time-dependent manner, and induced apoptosis.  Addnl., A549 cells exhibited significantly increased reactive oxygen species formation and cytochrome-c leakage, and activated caspase-3, B-cell lymphoma 2-assocd. X protein and apoptosis inducing factor expression levels, which are involved in the mitochondrial apoptosis pathway.  Furthermore, the phosphatidylinositol-4,5-biphosphate 3-kinase (PI3K)/protein kinase B (AKT)/hypoxia-inducible factor-1α (HIF-1α) and nuclear factor-κB (NF-κB)/cyclooxygenase-2 (COX-2) signaling pathways were significantly downregulated by genistein treatment.  In conclusion, reduced proliferation and increased apoptosis in A549 lung cancer cells was assocd. with inhibition of the PI3K/AKT/HIF-1α/ and NF-κB/COX-2 signaling pathways, which implicates genistein as a potential chemotherapeutic agent for the treatment of lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqxBvC1gPhJrVg90H21EOLACvtfcHk0lhpc4jPcVL50Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFWkt7zJ&md5=0310a174a3b2bc38503079d0407a4f0c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2017.6260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2017.6260%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26atitle%3DGenistein%2520decreases%2520A549%2520cell%2520viability%2520via%2520inhibition%2520of%2520the%2520PI3K%252FAKT%252FHIF1alpha%252FVEGF%2520and%2520NF-kB%252FCOX-2%2520signaling%2520pathways%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2017%26volume%3D15%26issue%3D4%26spage%3D2296%26epage%3D2302%26doi%3D10.3892%2Fmmr.2017.6260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richard, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gothie, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span> <span> </span><span class="NLM_article-title">P42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">32631</span>– <span class="NLM_lpage">32637</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.46.32631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.274.46.32631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10551817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1MXntlygsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=32631-32637&issue=46&author=D.+E.+Richardauthor=E.+Berraauthor=E.+Gothieauthor=D.+Rouxauthor=J.+Pouyssegur&title=P42%2Fp44+mitogen-activated+protein+kinases+phosphorylate+hypoxia-inducible+factor+1alpha+%28HIF-1alpha%29+and+enhance+the+transcriptional+activity+of+HIF-1&doi=10.1074%2Fjbc.274.46.32631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1</span></div><div class="casAuthors">Richard, Darren E.; Berra, Edurne; Gothie, Emmanuel; Roux, Daniele; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">32631-32637</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) controls the expression of a no. of genes such as vascular endothelial growth factor and erythropoietin in low oxygen conditions.  However, the mol. mechanisms that underlie the activation of the limiting subunit, HIF-1α, are still poorly resolved.  Results showing that endogenous HIF-1α migrated 12 kDa higher than in vitro translated protein led the authors to evaluate the possible role of phosphorylation on this phenomenon.  The authors report that HIF-1α is strongly phosphorylated in vivo and that phosphorylation is responsible for the marked differences in the migration pattern of HIF-1α.  In vitro, HIF-1α is phosphorylated by p42 and p44 mitogen-activated protein kinases (MAPKs) and not by p38 MAPK or c-Jun N-terminal kinase.  Interestingly, p42/p44 MAPK stoichiometrically phosphorylate HIF-1α in vitro, as judged by a complete upper shift of HIF-1α.  More importantly, the authors demonstrate that activation of the p42/p44 MAPK pathway in quiescent cells induced the phosphorylation and shift of HIF-1α, which was abrogated in presence of the MEK inhibitor, PD 98059.  Finally, the authors found that in a vascular endothelial growth factor promoter mutated at sites previously shown to be MAPK-sensitive (SP1/AP2-88-66 site), p42/p44 MAPK activation is sufficient to promote the transcriptional activity of HIF-1.  This interaction between HIF-1α and p42/p44 MAPK suggests a cooperation between hypoxic and growth factor signals that ultimately leads to the increase in HIF-1-mediated gene expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKuwlVSit0_rVg90H21EOLACvtfcHk0lhPLqAPJy-0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlygsbs%253D&md5=c8509171d0c8a0493625b87277e87726</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.46.32631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.46.32631%26sid%3Dliteratum%253Aachs%26aulast%3DRichard%26aufirst%3DD.%2BE.%26aulast%3DBerra%26aufirst%3DE.%26aulast%3DGothie%26aufirst%3DE.%26aulast%3DRoux%26aufirst%3DD.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DP42%252Fp44%2520mitogen-activated%2520protein%2520kinases%2520phosphorylate%2520hypoxia-inducible%2520factor%25201alpha%2520%2528HIF-1alpha%2529%2520and%2520enhance%2520the%2520transcriptional%2520activity%2520of%2520HIF-1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D46%26spage%3D32631%26epage%3D32637%26doi%3D10.1074%2Fjbc.274.46.32631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, J.</span></span> <span> </span><span class="NLM_article-title">NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>112</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">585</span>– <span class="NLM_lpage">595</span>, <span class="refDoi"> DOI: 10.1002/ijc.20438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fijc.20438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15382039" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptlGjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2004&pages=585-595&issue=4&author=H.+Zhongauthor=M.+Willardauthor=J.+Simons&title=NS398+reduces+hypoxia-inducible+factor+%28HIF%29-1alpha+and+HIF-1+activity%3A+multiple-level+effects+involving+cyclooxygenase-2+dependent+and+independent+mechanisms&doi=10.1002%2Fijc.20438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">NS398 reduces hypoxia-inducible factor (HIF)-1α and HIF-1 activity: Multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms</span></div><div class="casAuthors">Zhong, Hua; Willard, Margaret; Simons, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">585-595</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Tissue hypoxia is a common feature in solid tumors.  Hypoxia-inducible factor 1 (HIF-1) is a crit. transcription factor that regulates the expression of genes encoding factors that influence tumor growth including vascular endothelial growth factor.  Previous studies have demonstrated that post-transcriptional modification events are important for regulation of HIF-1α protein expression and HIF-1 transcriptional activity.  Prostaglandin E2 (PGE2), a major end product of the cyclooxygenase-2 (COX-2) enzyme, induces the basal and hypoxia-induced nuclear relocalization of HIF-1α.  This is suppressed by NS398, a COX-2 selective inhibitor.  NS398 also inhibits hypoxia-induced angiogenesis, which may be mediated by the inhibition of HIF-1 function in a COX-2-dependent manner.  Here, we show that NS398 reduces HIF-1α and HIF-1 transcriptional function in both COX-2 pos. PC-3 cells and COX-2 neg. HCT116 cells under normoxic and hypoxic conditions.  On the one hand, NS398 decreases the expression of HIF-1α mRNA and reduces HIF-1α synthesis in a COX-2/PGE2 dependent way, which can be restored by addn. of exogenous PGE2 that activates the phosphatidylinositol 3-kinase/AKT/p7056k signaling pathway.  On the other hand, NS398 accelerates HIF-1α degrdn. by moderately increasing ubiquitination and remarkably promoting the clearance of ubiquitylated protein, an effect most likely independent of COX-2/PGE2 since exogenous PGE2 fails to reverse it.  Finally, NS398 decreases hypoxia-induced shifted form of HIF-1α and attenuates HIF-1 activation in greater extent under hypoxic than normoxic conditions.  These data not only confirm the inhibitory effect of NS398 on HIF-1α and HIF-1 transcriptional activity but also demonstrate that such an effect occurs at multiple levels involving both COX-2 dependent and independent mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJMAYISQ-cWrVg90H21EOLACvtfcHk0lhPLqAPJy-0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptlGjsbs%253D&md5=5f2ead5d9d5d0e40e08ae4bbc9fc2314</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1002%2Fijc.20438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.20438%26sid%3Dliteratum%253Aachs%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DWillard%26aufirst%3DM.%26aulast%3DSimons%26aufirst%3DJ.%26atitle%3DNS398%2520reduces%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1alpha%2520and%2520HIF-1%2520activity%253A%2520multiple-level%2520effects%2520involving%2520cyclooxygenase-2%2520dependent%2520and%2520independent%2520mechanisms%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2004%26volume%3D112%26issue%3D4%26spage%3D585%26epage%3D595%26doi%3D10.1002%2Fijc.20438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcomb, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schnee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukyanov, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fowkes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagzag, D.</span></span> <span> </span><span class="NLM_article-title">Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy</span>. <i>Neuro Oncol</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">235</span>, <span class="refDoi"> DOI: 10.1215/S1152851704000997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1215%2FS1152851704000997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16053697" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXos1Cmtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=225-235&issue=3&author=E.+W.+Newcombauthor=M.+A.+Aliauthor=T.+Schneeauthor=L.+Lanauthor=Y.+Lukyanovauthor=M.+Fowkesauthor=D.+C.+Millerauthor=D.+Zagzag&title=Flavopiridol+downregulates+hypoxia-mediated+hypoxia-inducible+factor-1alpha+expression+in+human+glioma+cells+by+a+proteasome-independent+pathway%3A+implications+for+in+vivo+therapy&doi=10.1215%2FS1152851704000997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1α expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy</span></div><div class="casAuthors">Newcomb, Elizabeth W.; Ali, M. Aktar; Schnee, Tona; Lan, Li; Lukyanov, Yevgeniy; Fowkes, Mary; Miller, Douglas C.; Zagzag, David</div><div class="citationInfo"><span class="NLM_cas:title">Neuro-Oncology (Durham, NC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-235</span>CODEN:
                <span class="NLM_cas:coden">NEURJR</span>;
        ISSN:<span class="NLM_cas:issn">1522-8517</span>.
    
            (<span class="NLM_cas:orgname">Duke University Press</span>)
        </div><div class="casAbstract">Angiogenesis is a crit. step required for sustained tumor growth and tumor progression.  The stimulation of endothelial cells by cytokines secreted by tumor cells such as vascular endothelial growth factor (VEGF) induces their proliferation and migration.  This is a prominent feature of high-grade gliomas.  The secretion of VEGF is greatly upregulated under conditions of hypoxia because of the transcription factor hypoxia-inducible factor (HIF)-1α, which controls the expression of many genes, allowing rapid adaptation of cells to their hypoxic microenvironment.  Flavopiridol, a novel cyclin-dependent kinase inhibitor, has been attributed with antiangiogenic properties in some cancer cell lines by its ability to inhibit VEGF prodn.  Here, we show that flavopiridol treatment of human U87MG and T98G glioma cell lines decreases hypoxia-mediated HIF-1α expression, VEGF secretion, and tumor cell migration.  These in vitro results correlate with reduced vascularity of intracranial syngeneic GL261 gliomas from animals treated with flavopiridol.  In addn., we show that flavopiridol downregulates HIF-1α expression in the presence of a proteasome inhibitor, an agent that normally results in the accumulation and overexpression of HIF-1α.  The potential to downregulate HIF-1α expression with flavopiridol treatment in combination with a proteasome inhibitor makes this an extremely attractive anticancer treatment strategy for tumors with high angiogenic activity, such as gliomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpKisEISOYnrVg90H21EOLACvtfcHk0lhPLqAPJy-0Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXos1Cmtr4%253D&md5=e7aa7442a4d1fd1ae3e403bee8d86892</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1215%2FS1152851704000997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1215%252FS1152851704000997%26sid%3Dliteratum%253Aachs%26aulast%3DNewcomb%26aufirst%3DE.%2BW.%26aulast%3DAli%26aufirst%3DM.%2BA.%26aulast%3DSchnee%26aufirst%3DT.%26aulast%3DLan%26aufirst%3DL.%26aulast%3DLukyanov%26aufirst%3DY.%26aulast%3DFowkes%26aufirst%3DM.%26aulast%3DMiller%26aufirst%3DD.%2BC.%26aulast%3DZagzag%26aufirst%3DD.%26atitle%3DFlavopiridol%2520downregulates%2520hypoxia-mediated%2520hypoxia-inducible%2520factor-1alpha%2520expression%2520in%2520human%2520glioma%2520cells%2520by%2520a%2520proteasome-independent%2520pathway%253A%2520implications%2520for%2520in%2520vivo%2520therapy%26jtitle%3DNeuro%2520Oncol%26date%3D2005%26volume%3D7%26issue%3D3%26spage%3D225%26epage%3D235%26doi%3D10.1215%2FS1152851704000997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carbonaro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Brate, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span> <span> </span><span class="NLM_article-title">Microtubule disruption targets HIF-1alpha mRNA to cytoplasmic P-bodies for translational repression</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>192</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1083/jcb.201004145</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1083%2Fjcb.201004145" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=21220510" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnsl2htQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2011&pages=83-99&issue=1&author=M.+Carbonaroauthor=A.+O%E2%80%99Brateauthor=P.+Giannakakou&title=Microtubule+disruption+targets+HIF-1alpha+mRNA+to+cytoplasmic+P-bodies+for+translational+repression&doi=10.1083%2Fjcb.201004145"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression</span></div><div class="casAuthors">Carbonaro, Marisa; O'Brate, Aurora; Giannakakou, Paraskevi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-99</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">The hypoxia inducible factor 1α (HIF-1α) is overexpressed in solid tumors, driving tumor angiogenesis and survival.  However, the mechanisms regulating HIF-1α expression in solid tumors are not fully understood.  In this study, we find that microtubule integrity and dynamics are intricately involved in orchestrating HIF-1α translation.  HIF-1α mRNA traffics on dynamic microtubules when it is actively translated.  Microtubule perturbation by taxol (TX) and other microtubule-targeting drugs stalls HIF-1α mRNA transport and releases it from polysomes, suppressing its translation.  Immunopptn. of the P-body component Argonaute 2 (Ago2) after microtubule disruption shows significant enrichment of HIF-1α mRNAs and HIF-targeting microRNAs (miRNAs).  Inhibition of HIF-repressing miRNAs or Ago2 knockdown abrogates TX's ability to suppress HIF-1α translation.  Interestingly, microtubule repolymn. after nocodazole washout allows HIF-1α mRNA to reenter active translation, suggesting that microtubule dynamics exert tight yet reversible control over HIF-1α translation.  Collectively, we provide evidence for a new mechanism of microtubule-dependent HIF-1α translation with important implications for cell biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMDT8LLNXs8bVg90H21EOLACvtfcHk0lgPXHfeaY4oFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnsl2htQ%253D%253D&md5=3297aa4f3a6b7ecf0b2ac5ba7d6e9748</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201004145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201004145%26sid%3Dliteratum%253Aachs%26aulast%3DCarbonaro%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Brate%26aufirst%3DA.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3DMicrotubule%2520disruption%2520targets%2520HIF-1alpha%2520mRNA%2520to%2520cytoplasmic%2520P-bodies%2520for%2520translational%2520repression%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2011%26volume%3D192%26issue%3D1%26spage%3D83%26epage%3D99%26doi%3D10.1083%2Fjcb.201004145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mabjeesh, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Escuin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaVallee, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pribluda, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willard, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simons, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannakakou, P.</span></span> <span> </span><span class="NLM_article-title">2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">375</span>, <span class="refDoi"> DOI: 10.1016/S1535-6108(03)00077-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS1535-6108%2803%2900077-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12726862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFGgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=363-375&issue=4&author=N.+J.+Mabjeeshauthor=D.+Escuinauthor=T.+M.+LaValleeauthor=V.+S.+Pribludaauthor=G.+M.+Swartzauthor=M.+S.+Johnsonauthor=M.+T.+Willardauthor=H.+Zhongauthor=J.+W.+Simonsauthor=P.+Giannakakou&title=2ME2+inhibits+tumor+growth+and+angiogenesis+by+disrupting+microtubules+and+dysregulating+HIF&doi=10.1016%2FS1535-6108%2803%2900077-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF</span></div><div class="casAuthors">Mabjeesh, Nicola J.; Escuin, Daniel; LaVallee, Theresa M.; Pribluda, Victor S.; Swartz, Glenn M.; Johnson, Michelle S.; Willard, Margaret T.; Zhong, Hua; Simons, Jonathan W.; Giannakakou, Paraskevi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">363-375</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">2-Methoxyestradiol (2ME2) is a novel antitumor and antiangiogenic agent, currently in clin. trials, whose mol. mechanism of action remains unclear.  It is reported here that 2ME2 inhibited the growth and angiogenesis of various tumors in vitro at concns. equiv. to those that efficiently disrupted tumor microtubules (MTs) in mice in vivo.  2ME2 downregulated hypoxia-inducible factor-1 (HIF) at the post-transcriptional level and inhibited HIF-1-induced transcriptional activation of vascular endothelial growth factor expression.  Inhibition of HIF-1 occurred downstream from the 2ME2/tubulin interaction, as disruption of interphase MTs is required for HIF-α downregulation.  These data establish 2ME2 as a low-mol.-wt. inhibitor of HIF-1 and provide a mechanistic link between the disruption of the MT cytoskeleton and inhibition of angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-DOdEq9rf-bVg90H21EOLACvtfcHk0lgPXHfeaY4oFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFGgsrY%253D&md5=6cf0acac54e7778ccb1f3fd72cf92831</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900077-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900077-1%26sid%3Dliteratum%253Aachs%26aulast%3DMabjeesh%26aufirst%3DN.%2BJ.%26aulast%3DEscuin%26aufirst%3DD.%26aulast%3DLaVallee%26aufirst%3DT.%2BM.%26aulast%3DPribluda%26aufirst%3DV.%2BS.%26aulast%3DSwartz%26aufirst%3DG.%2BM.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DWillard%26aufirst%3DM.%2BT.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DSimons%26aufirst%3DJ.%2BW.%26aulast%3DGiannakakou%26aufirst%3DP.%26atitle%3D2ME2%2520inhibits%2520tumor%2520growth%2520and%2520angiogenesis%2520by%2520disrupting%2520microtubules%2520and%2520dysregulating%2520HIF%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26issue%3D4%26spage%3D363%26epage%3D375%26doi%3D10.1016%2FS1535-6108%2803%2900077-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moser, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellerbrand, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlitt, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogler, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoeltzing, O.</span></span> <span> </span><span class="NLM_article-title">ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">206</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-8-206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1186%2F1471-2407-8-206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18651980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A280%3ADC%252BD1cvpvFaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=206&author=C.+Moserauthor=S.+A.+Langauthor=A.+Moriauthor=C.+Hellerbrandauthor=H.+J.+Schlittauthor=E.+K.+Geisslerauthor=W.+E.+Foglerauthor=O.+Stoeltzing&title=ENMD-1198%2C+a+novel+tubulin-binding+agent+reduces+HIF-1alpha+and+STAT3+activity+in+human+hepatocellular+carcinoma%28HCC%29+cells%2C+and+inhibits+growth+and+vascularization+in+vivo&doi=10.1186%2F1471-2407-8-206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo</span></div><div class="casAuthors">Moser Christian; Lang Sven A; Mori Akira; Hellerbrand Claus; Schlitt Hans J; Geissler Edward K; Fogler William E; Stoeltzing Oliver</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">206</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Hepatocellular carcinoma (HCC) represents a highly vascularized tumor entity and the process of angiogenesis is essential for the growth of HCC.  Importantly, the pro-angiogenic transcription factors HIF-1alpha and STAT3 have been implicated in HCC progression, thus representing interesting targets for molecular targeted therapy.  We hypothesized that therapeutic inhibition of HIF-1alpha could be achieved by using a novel tubulin-binding agent (ENMD-1198).  ENMD-1198 is an analog of 2-methoxyestradiol (2ME2) with antiproliferative and antiangiogenic activity.  METHODS:  The human HCC cell lines HUH-7 and HepG2 were used for experiments.  Effects of ENMD-1198 on constitutive and inducible (hypoxia, growth factors) activation of signaling cascades, including HIF-1alpha and STAT3, were investigated by Western blotting.  Changes in VEGF expression were determined by real-time PCR.  Effects of ENMD-1198 on cancer cell migration and invasion were evaluated in in vitro-assays.  The growth-inhibitory effects of ENMD-1198 (200 mg/kg/day) were determined in a subcutaneous tumor model (HUH-7).  RESULTS:  ENMD-1198 inhibited the phosphorylation of MAPK/Erk, PI-3K/Akt and FAK.  Moreover, activation of HIF-1alpha and STAT3 was dramatically reduced by ENMD-1198, which resulted in lower VEGF mRNA expression (P < 0.05).  In addition, tumor cell migratory and invasive properties were significantly inhibited (P < 0.05, for both).  In vivo, treatment with ENMD-1198 led to a significant reduction in tumor growth, tumor vascularization, and numbers of proliferating tumor cells (P < 0.05 for all).  CONCLUSION:  The novel microtubule destabilizing agent ENMD-1198 is suitable for inhibiting HIF-1alpha and STAT3 in human HCC cells and leads to reduced tumor growth and vascularization in vivo.  Hence, inhibition of HIF-1alpha and STAT3 could prove valuable for therapy of hepatocellular carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ66w6qDcPMQWGmni0r9GoKfW6udTcc2eblKdv1Iv5EGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1cvpvFaiug%253D%253D&md5=fdb3186794e06c9475b05c5a761f3577</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-8-206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-8-206%26sid%3Dliteratum%253Aachs%26aulast%3DMoser%26aufirst%3DC.%26aulast%3DLang%26aufirst%3DS.%2BA.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DHellerbrand%26aufirst%3DC.%26aulast%3DSchlitt%26aufirst%3DH.%2BJ.%26aulast%3DGeissler%26aufirst%3DE.%2BK.%26aulast%3DFogler%26aufirst%3DW.%2BE.%26aulast%3DStoeltzing%26aufirst%3DO.%26atitle%3DENMD-1198%252C%2520a%2520novel%2520tubulin-binding%2520agent%2520reduces%2520HIF-1alpha%2520and%2520STAT3%2520activity%2520in%2520human%2520hepatocellular%2520carcinoma%2528HCC%2529%2520cells%252C%2520and%2520inhibits%2520growth%2520and%2520vascularization%2520in%2520vivo%26jtitle%3DBMC%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D206%26doi%3D10.1186%2F1471-2407-8-206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rapisarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zalek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollingshead, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braunschweig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranchimeg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonomi, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgel, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span> (<span class="NLM_issue">19</span>),  <span class="NLM_fpage">6845</span>– <span class="NLM_lpage">6848</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-2116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F0008-5472.CAN-04-2116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15466170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotFalsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=6845-6848&issue=19&author=A.+Rapisardaauthor=J.+Zalekauthor=M.+Hollingsheadauthor=T.+Braunschweigauthor=B.+Uranchimegauthor=C.+A.+Bonomiauthor=S.+D.+Borgelauthor=J.+P.+Carterauthor=S.+M.+Hewittauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Schedule-dependent+inhibition+of+hypoxia-inducible+factor-1alpha+protein+accumulation%2C+angiogenesis%2C+and+tumor+growth+by+topotecan+in+U251-HRE+glioblastoma+xenografts&doi=10.1158%2F0008-5472.CAN-04-2116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Schedule-dependent inhibition of hypoxia-inducible factor-1α protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts</span></div><div class="casAuthors">Rapisarda, Annamaria; Zalek, Jessica; Hollingshead, Melinda; Braunschweig, Till; Uranchimeg, Badarch; Bonomi, Carrie A.; Borgel, Suzanne D.; Carter, John P.; Hewitt, Stephen M.; Shoemaker, Robert H.; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6845-6848</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have previously shown that topotecan, a topoisomerase I poison, inhibits hypoxia-inducible factor (HIF)-1α protein accumulation by a DNA damage-independent mechanism.  Here, we report that daily administration of topotecan inhibits HIF-1α protein expression in U251-HRE glioblastoma xenografts.  Concomitant with HIF-1α inhibition, topotecan caused a significant tumor growth inhibition assocd. with a marked decrease of angiogenesis and expression of HIF-1 target genes in tumor tissue.  These results provide a compelling rationale for testing topotecan in clin. trials to target HIF-1 in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0OgB-vdXGNLVg90H21EOLACvtfcHk0lgrwqKFQnpKfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotFalsr8%253D&md5=999f21239d31db046eff4f99b375bdfb</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-2116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-2116%26sid%3Dliteratum%253Aachs%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DZalek%26aufirst%3DJ.%26aulast%3DHollingshead%26aufirst%3DM.%26aulast%3DBraunschweig%26aufirst%3DT.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DBonomi%26aufirst%3DC.%2BA.%26aulast%3DBorgel%26aufirst%3DS.%2BD.%26aulast%3DCarter%26aufirst%3DJ.%2BP.%26aulast%3DHewitt%26aufirst%3DS.%2BM.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DSchedule-dependent%2520inhibition%2520of%2520hypoxia-inducible%2520factor-1alpha%2520protein%2520accumulation%252C%2520angiogenesis%252C%2520and%2520tumor%2520growth%2520by%2520topotecan%2520in%2520U251-HRE%2520glioblastoma%2520xenografts%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26issue%3D19%26spage%3D6845%26epage%3D6848%26doi%3D10.1158%2F0008-5472.CAN-04-2116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Creighton-Gutteridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardellina, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rapisarda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uranchimeg, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hite, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoemaker, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melillo, G.</span></span> <span> </span><span class="NLM_article-title">Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1010</span>– <span class="NLM_lpage">1018</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2301</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1078-0432.CCR-06-2301" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17289897" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=1010-1018&issue=3&author=M.+Creighton-Gutteridgeauthor=J.+H.+Cardellinaauthor=A.+G.+Stephenauthor=A.+Rapisardaauthor=B.+Uranchimegauthor=K.+Hiteauthor=W.+A.+Dennyauthor=R.+H.+Shoemakerauthor=G.+Melillo&title=Cell+type-specific%2C+topoisomerase+II-dependent+inhibition+of+hypoxia-inducible+factor-1alpha+protein+accumulation+by+NSC+644221&doi=10.1158%2F1078-0432.CCR-06-2301"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Cell Type-Specific, Topoisomerase II-Dependent Inhibition of Hypoxia-Inducible Factor-1α Protein Accumulation by NSC 644221</span></div><div class="casAuthors">Creighton-Gutteridge, Mark; Cardellina, John H., II; Stephen, Andrew G.; Rapisarda, Annamaria; Uranchimeg, Badarch; Hite, Karen; Denny, William A.; Shoemaker, Robert H.; Melillo, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1010-1018</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: The discovery and development of small-mol. inhibitors of hypoxia-inducible factor-1 (HIF-1) is an attractive, yet challenging, strategy for the development of new cancer therapeutic agents.  Here, we report on a novel tricyclic carboxamide inhibitor of HIF-1α, NSC 644221.  Exptl. Design: We investigated the mechanism by which the novel compd. NSC 644221 inhibited HIF-1α.  RESULTS: NSC 644221 inhibited HIF-1-dependent, but not constitutive, luciferase expression in U251-HRE and U251-pGL3 cells, resp., as well as hypoxic induction of vascular endothelial growth factor mRNA expression in U251 cells.  HIF-1α, but not HIF-1{szligbeta}, protein expression was inhibited by NSC 644221 in a time- and dose-dependent fashion.  Interestingly, NSC 644221 was unable to inhibit HIF-1α protein accumulation in the presence of the proteasome inhibitors MG132 or PS341, yet it did not directly affect the degrdn. of HIF-1α as shown by expts. done in the presence of cyclohexamide or pulse-chase labeling using [35S]methionine.  In contrast, NSC 644221 decreased the rate of HIF-1α translation relative to untreated controls.  Silencing of topoisomerase (topo) IIα, but not topo I, by specific small interfering RNA completely blocked the ability of NSC 644221 to inhibit HIF-1α.  The data presented show that topo II is required for the inhibition of HIF-1α by NSC 644221.  Furthermore, although NSC 644221 induced p21 expression, γH2A.X, and G2-M arrest in the majority of cell lines tested, it only inhibited HIF-1α in a distinct subset of cells, raising the possibility of pathway-specific "resistance" to HIF-1 inhibition in cancer cells.  CONCLUSIONS: NSC 644221 is a novel HIF-1 inhibitor with potential for use as both an analytic tool and a therapeutic agent.  Our data provide a strong rationale for pursuing the preclin. development of NSC 644221 as a HIF-1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRfBXMVRyUF7Vg90H21EOLACvtfcHk0lgrwqKFQnpKfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyku7Y%253D&md5=b593b6a25511f58ccb88404b0c583108</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2301%26sid%3Dliteratum%253Aachs%26aulast%3DCreighton-Gutteridge%26aufirst%3DM.%26aulast%3DCardellina%26aufirst%3DJ.%2BH.%26aulast%3DStephen%26aufirst%3DA.%2BG.%26aulast%3DRapisarda%26aufirst%3DA.%26aulast%3DUranchimeg%26aufirst%3DB.%26aulast%3DHite%26aufirst%3DK.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DShoemaker%26aufirst%3DR.%2BH.%26aulast%3DMelillo%26aufirst%3DG.%26atitle%3DCell%2520type-specific%252C%2520topoisomerase%2520II-dependent%2520inhibition%2520of%2520hypoxia-inducible%2520factor-1alpha%2520protein%2520accumulation%2520by%2520NSC%2520644221%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D3%26spage%3D1010%26epage%3D1018%26doi%3D10.1158%2F1078-0432.CCR-06-2301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Isaacs, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mimnaugh, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuttitta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L. M.</span></span> <span> </span><span class="NLM_article-title">Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1alpha degradative pathway</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">29936</span>– <span class="NLM_lpage">29944</span>, <span class="refDoi"> DOI: 10.1074/jbc.M204733200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M204733200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12052835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVKhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=29936-29944&issue=33&author=J.+S.+Isaacsauthor=Y.+J.+Jungauthor=E.+G.+Mimnaughauthor=A.+Martinezauthor=F.+Cuttittaauthor=L.+M.+Neckers&title=Hsp90+regulates+a+von+Hippel+Lindau-independent+hypoxia-inducible+factor-1alpha+degradative+pathway&doi=10.1074%2Fjbc.M204733200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway</span></div><div class="casAuthors">Isaacs, Jennifer S.; Jung, Yun-Jin; Mimnaugh, Edward G.; Martinez, Alfredo; Cuttitta, Frank; Neckers, Leonard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">29936-29944</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">HIF-1α is a normally labile proangiogenic transcription factor that is stabilized and activated in hypoxia.  Although the von Hippel Lindau (VHL) gene product, the ubiquitin ligase responsible for regulating HIF-1α protein levels, efficiently targets HIF-1α for rapid proteasome-dependent degrdn. under normoxia, HIF-1α is resistant to the destabilizing effects of VHL under hypoxia.  HIF-1α also assocs. with the mol. chaperone Hsp90.  To examine the role of Hsp90 in HIF-1α function, we used renal carcinoma cell (RCC) lines that lack functional VHL and express stable HIF-1α protein under normoxia.  Geldanamycin (GA), an Hsp90 antagonist, promoted efficient ubiquitination and proteasome-mediated degrdn. of HIF-1α in RCC in both normoxia and hypoxia.  Furthermore, HIF-1α point mutations that block VHL assocn. did not protect HIF-1α from GA-induced destabilization.  Hsp90 antagonists also inhibited HIF-1α transcriptional activity and dramatically reduced both hypoxia-induced accumulation of VEGF mRNA and hypoxia-dependent angiogenic activity.  These findings demonstrate that disruption of Hsp90 function (1) promotes HIF-1α degrdn. via a novel, oxygen-independent E3 ubiquitin ligase and (2) diminishes HIF-1α transcriptional activity.  Existence of an Hsp90-dependent pathway for elimination of HIF-1α predicts that Hsp90 antagonists may be hypoxic cell sensitizers and possess antiangiogenic activity in vivo, thus extending the utility of these drugs as therapeutic anticancer agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5TGTCyrzbcLVg90H21EOLACvtfcHk0lgrwqKFQnpKfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVKhsrg%253D&md5=6e9204fb56624b5b5904debc46797b5d</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M204733200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M204733200%26sid%3Dliteratum%253Aachs%26aulast%3DIsaacs%26aufirst%3DJ.%2BS.%26aulast%3DJung%26aufirst%3DY.%2BJ.%26aulast%3DMimnaugh%26aufirst%3DE.%2BG.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCuttitta%26aufirst%3DF.%26aulast%3DNeckers%26aufirst%3DL.%2BM.%26atitle%3DHsp90%2520regulates%2520a%2520von%2520Hippel%2520Lindau-independent%2520hypoxia-inducible%2520factor-1alpha%2520degradative%2520pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26issue%3D33%26spage%3D29936%26epage%3D29944%26doi%3D10.1074%2Fjbc.M204733200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilkes, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer</span>. <i>J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>92</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">164</span>, <span class="refDoi"> DOI: 10.1007/s00109-013-1102-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1007%2Fs00109-013-1102-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=24248265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2gs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2014&pages=151-164&issue=2&author=L.+Xiangauthor=D.+M.+Gilkesauthor=P.+Chaturvediauthor=W.+Luoauthor=H.+Huauthor=N.+Takanoauthor=H.+Liangauthor=G.+L.+Semenza&title=Ganetespib+blocks+HIF-1+activity+and+inhibits+tumor+growth%2C+vascularization%2C+stem+cell+maintenance%2C+invasion%2C+and+metastasis+in+orthotopic+mouse+models+of+triple-negative+breast+cancer&doi=10.1007%2Fs00109-013-1102-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer</span></div><div class="casAuthors">Xiang, Lisha; Gilkes, Daniele M.; Chaturvedi, Pallavi; Luo, Weibo; Hu, Hongxia; Takano, Naoharu; Liang, Houjie; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Medicine (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">151-164</span>CODEN:
                <span class="NLM_cas:coden">JMLME8</span>;
        ISSN:<span class="NLM_cas:issn">0946-2716</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Targeted therapy against triple-neg. breast cancers, which lack expression of the estrogen, progesterone, and HER2 receptors, is not available and the overall response to cytotoxic chemotherapy is poor.  One of the mol. hallmarks of triple-neg. breast cancers is increased expression of genes that are transcriptionally activated by hypoxia-inducible factors (HIFs), which are implicated in many crit. aspects of cancer progression including metab., angiogenesis, invasion, metastasis, and stem cell maintenance.  Ganetespib is a second-generation inhibitor of heat shock protein 90 (HSP90), a mol. chaperone that is essential for the stability and function of multiple client proteins in cancer cells including HIF-1α.  In this study, human MDA-MB-231 and MDA-MB-435 triple-neg. breast cancer cells were injected into the mammary fat pad of immunodeficient mice that received weekly i.v. injections of ganetespib or vehicle following the development of palpable tumors.  Ganetespib treatment markedly impaired primary tumor growth and vascularization, and eliminated local tissue invasion and distant metastasis to regional lymph nodes and lungs.  Ganetespib treatment also significantly reduced the no. of Aldefluor-pos. cancer stem cells in the primary tumor.  Primary tumors of ganetespib-treated mice had significantly reduced levels of HIF-1α (but not HIF-2α) protein and of HIF-1 target gene mRNAs encoding proteins that play key roles in angiogenesis, metab., invasion, and metastasis, thereby providing a mol. basis for obsd. effects of the drug on the growth and metastasis of triple-neg. breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdTtl_GUyxwLVg90H21EOLACvtfcHk0ljmyVFL1fFBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2gs7fI&md5=85da4e780ed43a1f8b0fa1a93ff1aeec</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1007%2Fs00109-013-1102-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00109-013-1102-5%26sid%3Dliteratum%253Aachs%26aulast%3DXiang%26aufirst%3DL.%26aulast%3DGilkes%26aufirst%3DD.%2BM.%26aulast%3DChaturvedi%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DTakano%26aufirst%3DN.%26aulast%3DLiang%26aufirst%3DH.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DGanetespib%2520blocks%2520HIF-1%2520activity%2520and%2520inhibits%2520tumor%2520growth%252C%2520vascularization%252C%2520stem%2520cell%2520maintenance%252C%2520invasion%252C%2520and%2520metastasis%2520in%2520orthotopic%2520mouse%2520models%2520of%2520triple-negative%2520breast%2520cancer%26jtitle%3DJ.%2520Mol.%2520Med.%26date%3D2014%26volume%3D92%26issue%3D2%26spage%3D151%26epage%3D164%26doi%3D10.1007%2Fs00109-013-1102-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perusinghe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Haven Brandon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Box, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eccles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouschop, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashcroft, M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule activation of p53 blocks hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">2243</span>– <span class="NLM_lpage">2253</span>, <span class="refDoi"> DOI: 10.1128/MCB.00959-08</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1128%2FMCB.00959-08" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19223463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1Srs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=2243-2253&issue=8&author=J.+Yangauthor=A.+Ahmedauthor=E.+Poonauthor=N.+Perusingheauthor=A.+de+Haven+Brandonauthor=G.+Boxauthor=M.+Valentiauthor=S.+Ecclesauthor=K.+Rouschopauthor=B.+Woutersauthor=M.+Ashcroft&title=Small-molecule+activation+of+p53+blocks+hypoxia-inducible+factor+1alpha+and+vascular+endothelial+growth+factor+expression+in+vivo+and+leads+to+tumor+cell+apoptosis+in+normoxia+and+hypoxia&doi=10.1128%2FMCB.00959-08"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule activation of p53 blocks hypoxia-inducible factor 1α and vascular endothelial growth factor expression in vivo and leads to tumor cell apoptosis in normoxia and hypoxia</span></div><div class="casAuthors">Yang, Jun; Ahmed, Afshan; Poon, Evon; Perusinghe, Nina; de Haven Brandon, Alexis; Box, Gary; Valenti, Melanie; Eccles, Suzanne; Rouschop, Kasper; Wouters, Brad; Ashcroft, Margaret</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2243-2253</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The p53 tumor suppressor protein neg. regulates hypoxia-inducible factor 1α (HIF-1α).  Here, we show that induction of p53 by the small-mol. RITA (reactivation of p53 and induction of tumor cell apoptosis) [2,5-bis(5-hydroxymethyl-2-thienyl) furan] (NSC-652287) inhibits HIF-1α and vascular endothelial growth factor expression in vivo and induces significant tumor cell apoptosis in normoxia and hypoxia in p53-pos. cells.  RITA has been proposed to stabilize p53 by inhibiting the p53-HDM2 interaction.  However, induction of p53 alone was insufficient to block HIF-1α induced in hypoxia and has previously been shown to require addnl. stimuli, such as DNA damage.  Here, we identify a new mechanism of action for RITA: RITA activates a DNA damage response, resulting in phosphorylation of p53 and γH2AX in vivo.  Unlike other DNA damage response-inducing agents, RITA treatment of cells induced a p53-dependent increase in phosphorylation of the α subunit of eukaryotic initiation factor 2, requiring PKR-like endoplasmic reticulum kinase activity, and led to the subsequent downregulation of HIF-1α and p53 target proteins, including HDM2 and p21.  Through the identification of a new mechanism of action for RITA, our study uncovers a novel link between the DNA damage response-p53 pathway and the protein translational machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmqQO2vitL1bVg90H21EOLACvtfcHk0ljmyVFL1fFBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1Srs7Y%253D&md5=e70685a058b8e9f4524ff8b8c7522222</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FMCB.00959-08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.00959-08%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DA.%26aulast%3DPoon%26aufirst%3DE.%26aulast%3DPerusinghe%26aufirst%3DN.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DRouschop%26aufirst%3DK.%26aulast%3DWouters%26aufirst%3DB.%26aulast%3DAshcroft%26aufirst%3DM.%26atitle%3DSmall-molecule%2520activation%2520of%2520p53%2520blocks%2520hypoxia-inducible%2520factor%25201alpha%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520expression%2520in%2520vivo%2520and%2520leads%2520to%2520tumor%2520cell%2520apoptosis%2520in%2520normoxia%2520and%2520hypoxia%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2009%26volume%3D29%26issue%3D8%26spage%3D2243%26epage%3D2253%26doi%3D10.1128%2FMCB.00959-08" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nepal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, Y.</span></span> <span> </span><span class="NLM_article-title">An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1alpha</span>. <i>Cell. Biochem. Funct.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>29</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">126</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.1002/cbf.1732</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fcbf.1732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=21287578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktl2hs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=126-134&issue=2&author=M.+Nepalauthor=Y.+D.+Gongauthor=Y.+R.+Parkauthor=Y.+Soh&title=An+activator+of+PHD2%2C+KRH102140%2C+decreases+angiogenesis+via+inhibition+of+HIF-1alpha&doi=10.1002%2Fcbf.1732"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF-1α</span></div><div class="casAuthors">Nepal, Manoj; Gong, Young-Dae; Park, Young Ran; Soh, Yunjo</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biochemistry and Function</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">126-134</span>CODEN:
                <span class="NLM_cas:coden">CBFUDH</span>;
        ISSN:<span class="NLM_cas:issn">1099-0844</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Hypoxia-inducible transcription factors (HIFs) play a pivotal role in the response of cells to hypoxia.  HIFs are dimers of an oxygen-sensitive α-subunit (HIF-1α or HIF-2α), and a constitutively expressed β-subunit.  In normoxia, HIF-1α is destabilized by post-translational hydroxylation of Pro-564 and Pro-402 by a family of oxygen-sensitive dioxygenases.  Prolyl hydroxylation leads to von Hippel-Lindau protein-dependent ubiquitination and rapid degrdn. of HIF-.perp.α.  We previously reported that KRH102053, an activator of PHD2, rapidly decreased HIF-1α and eventually inhibited angiogenesis.  Here, we report a potent activator of PHD2, KRH102140, which has a structure similar to KRH102053 KRH102140 more efficiently suppressed HIF-1α than KRH102053 in human osteosarcoma cells under hypoxia.  Furthermore, KRH102140 decreased the mRNA levels of HIF-regulated downstream target genes assocd. with angiogenesis and energy metab. such as vascular endothelial growth factor, adrenomedullin, Glut1, aldolase A, enolase 1 and monocarbosylate transporter 4.  KRH102140 also inhibited tube formation in human umbilical vein endothelium cells.  The results suggest that KRH102140 has potential therapeutic effects in alleviating various diseases assocd. with HIFs.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqADFjAMZmNULVg90H21EOLACvtfcHk0lgTNQOBLcGP-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktl2hs78%253D&md5=27fa7b29d4864654ce1e6b3c3af4a526</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1002%2Fcbf.1732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbf.1732%26sid%3Dliteratum%253Aachs%26aulast%3DNepal%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DY.%2BD.%26aulast%3DPark%26aufirst%3DY.%2BR.%26aulast%3DSoh%26aufirst%3DY.%26atitle%3DAn%2520activator%2520of%2520PHD2%252C%2520KRH102140%252C%2520decreases%2520angiogenesis%2520via%2520inhibition%2520of%2520HIF-1alpha%26jtitle%3DCell.%2520Biochem.%2520Funct.%26date%3D2011%26volume%3D29%26issue%3D2%26spage%3D126%26epage%3D134%26doi%3D10.1002%2Fcbf.1732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gwak, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soh, Y.</span></span> <span> </span><span class="NLM_article-title">Rapid degradation of hypoxia-inducible factor-1alpha by KRH102053, a new activator of prolyl hydroxylase 2</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>154</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">125</span>, <span class="refDoi"> DOI: 10.1038/bjp.2008.70</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fbjp.2008.70" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=18332861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFOqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2008&pages=114-125&issue=1&author=H.+J.+Choiauthor=B.+J.+Songauthor=Y.+D.+Gongauthor=W.+J.+Gwakauthor=Y.+Soh&title=Rapid+degradation+of+hypoxia-inducible+factor-1alpha+by+KRH102053%2C+a+new+activator+of+prolyl+hydroxylase+2&doi=10.1038%2Fbjp.2008.70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid degradation of hypoxia-inducible factor-1α by KRH102053, a new activator of prolyl hydroxylase 2</span></div><div class="casAuthors">Choi, H. J.; Song, B.-J.; Gong, Y.-D.; Gwak, W. J.; Soh, Y.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-125</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF) is a transcription factor induced by hypoxia and degraded by ubiquitin-dependent proteasomes in normoxic conditions.  Under hypoxic conditions, hydroxylation of HIF-1α subunit by prolyl hydroxylase (PHD) is suppressed, thus leading to increased levels of HIF.  Although PHD2 plays a key role in regulating the levels of HIF, chem. activators of PHD2 are relatively unknown.  The aim of this study was to identify small mol. activators of PHD2 that could be used, eventually, to suppress the level of HIF-1α.  By using the overproduced PHD2 as a target, a mol. library consisting of more than 600 small mols. with a benzopyran structure was screened with an HPLC assay method.  We found a potent activator of PHD2, KRH102053 (2-amino-4-methylsulphanyl-butylic acid-4-methoxy-6-(4-methoxy-benzylamino)-2,2-dimethyl-chroman-3-yl ester).  The effects of KRH102053 on controlling HIF were studied in human HOS osteosarcoma, rat PC12 phaeochromocytoma and human HepG2 hepatoma cells.  Under our exptl. conditions, KRH102053 decreased the protein level of HIF-1α and the mRNA levels of HIF-regulated downstream target genes, such as vascular endothelial growth factor, aldolase A, enolase 1 and monocarboxylate transporter 4.  Consistent with these results, KRH102053 also inhibited the rates of HIF-related migration and invasion of HOS cells as well as the degree of tube formation in human umbilical vein endothelium cells.  These results suggest that KRH102053 and its structural analogs have the potential for use as therapeutic agents against various diseases assocd. with HIF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2esLBTkfJBrVg90H21EOLACvtfcHk0lgTNQOBLcGP-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFOqsrg%253D&md5=973fdcb897eb5e04954693281f282ad3</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1038%2Fbjp.2008.70&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjp.2008.70%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BJ.%26aulast%3DSong%26aufirst%3DB.%2BJ.%26aulast%3DGong%26aufirst%3DY.%2BD.%26aulast%3DGwak%26aufirst%3DW.%2BJ.%26aulast%3DSoh%26aufirst%3DY.%26atitle%3DRapid%2520degradation%2520of%2520hypoxia-inducible%2520factor-1alpha%2520by%2520KRH102053%252C%2520a%2520new%2520activator%2520of%2520prolyl%2520hydroxylase%25202%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D154%26issue%3D1%26spage%3D114%26epage%3D125%26doi%3D10.1038%2Fbjp.2008.70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Temes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Puig, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta-Iborra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castellanos, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feijoo-Cuaresma, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landazuri, M. O.</span></span> <span> </span><span class="NLM_article-title">Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">24238</span>– <span class="NLM_lpage">24244</span>, <span class="refDoi"> DOI: 10.1074/jbc.M414694200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M414694200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15849364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXltlKgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=24238-24244&issue=25&author=E.+Temesauthor=S.+Martin-Puigauthor=B.+Acosta-Iborraauthor=M.+C.+Castellanosauthor=M.+Feijoo-Cuaresmaauthor=G.+Olmosauthor=J.+Aragonesauthor=M.+O.+Landazuri&title=Activation+of+HIF-prolyl+hydroxylases+by+R59949%2C+an+inhibitor+of+the+diacylglycerol+kinase&doi=10.1074%2Fjbc.M414694200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of HIF-prolyl Hydroxylases by R59949, an Inhibitor of the Diacylglycerol Kinase</span></div><div class="casAuthors">Temes, Elisa; Martin-Puig, Silvia; Acosta-Iborra, Barbara; Castellanos, Maria C.; Feijoo-Cuaresma, Monica; Olmos, Gemma; Aragones, Julian; Landazuri, Manuel O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">24238-24244</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIF) are heterodimeric (α/β) transcription factors that play a fundamental role in cellular adaptation to low oxygen tension.  In the presence of oxygen, the HIF-α subunit becomes hydroxylated at specific prolyl residues by prolyl hydroxylases.  This post-translational modification is recognized by the von Hippel-Lindau (VHL) protein, which targets HIF-α for degrdn.  In the absence of oxygen, HIF-α hydroxylation is compromised and this subunit is stabilized.  We have previously shown that the hypoxia-induced accumulation of HIF-α protein is strongly impaired by the inhibitor of diacylglycerol kinase, R59949.  Here, we have investigated the mechanisms through which this inhibitor exerts its effect.  We found that R59949 inhibits the accumulation of HIF-1/2α protein without affecting the expression of their mRNAs.  We also detd. that R59949 could only block the accumulation of HIF-α in the presence of VHL protein.  In agreement with this, the binding of VHL to endogenous HIF-α was significantly enhanced after R59949 treatment, even under hypoxic conditions.  In addn., we found that R59949 could stimulate prolyl hydroxylase both at 21% O2 as well as at 1% O2.  Taken together, these results reveal that R59949 is an activator of HIF prolyl hydroxylases.  This is of particular interest when we consider that to date mainly inhibitors of these enzymes have been described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0GtOs6umRbVg90H21EOLACvtfcHk0lgTNQOBLcGP-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXltlKgs7s%253D&md5=0b8ae54b1d0edb0607762461f1dbdc91</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M414694200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M414694200%26sid%3Dliteratum%253Aachs%26aulast%3DTemes%26aufirst%3DE.%26aulast%3DMartin-Puig%26aufirst%3DS.%26aulast%3DAcosta-Iborra%26aufirst%3DB.%26aulast%3DCastellanos%26aufirst%3DM.%2BC.%26aulast%3DFeijoo-Cuaresma%26aufirst%3DM.%26aulast%3DOlmos%26aufirst%3DG.%26aulast%3DAragones%26aufirst%3DJ.%26aulast%3DLandazuri%26aufirst%3DM.%2BO.%26atitle%3DActivation%2520of%2520HIF-prolyl%2520hydroxylases%2520by%2520R59949%252C%2520an%2520inhibitor%2520of%2520the%2520diacylglycerol%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26issue%3D25%26spage%3D24238%26epage%3D24244%26doi%3D10.1074%2Fjbc.M414694200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, X.</span></span> <span> </span><span class="NLM_article-title">Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model</span>. <i>J. Mol. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1007/s12031-014-0469-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1007%2Fs12031-014-0469-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25451596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWgtL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=78-88&issue=1&author=L.+Yangauthor=Y.+Xuauthor=W.+Liauthor=B.+Yangauthor=S.+Yuauthor=H.+Zhouauthor=C.+Yangauthor=F.+Xuauthor=J.+Wangauthor=Y.+Gaoauthor=Y.+Huangauthor=L.+Luauthor=X.+Liang&title=Diacylglycerol+kinase+%28DGK%29+inhibitor+II+%28R59949%29+could+suppress+retinal+neovascularization+and+protect+retinal+astrocytes+in+an+oxygen-induced+retinopathy+model&doi=10.1007%2Fs12031-014-0469-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Diacylglycerol Kinase (DGK) Inhibitor II (R59949) Could Suppress Retinal Neovascularization and Protect Retinal Astrocytes in an Oxygen-Induced Retinopathy Model</span></div><div class="casAuthors">Yang, Lu; Xu, Yue; Li, Weihua; Yang, Boyu; Yu, Shanshan; Zhou, Huanjiao; Yang, Cheng; Xu, Fan; Wang, Jun; Gao, Yi; Huang, Yongsheng; Lu, Lin; Liang, Xiaoling</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">78-88</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factors (HIF) play a fundamental role in retinal neovascularization (NV) induced by low oxygen tension.  In the presence of oxygen, the HIF-α subunit becomes hydroxylated at specific prolyl residues by prolyl hydroxylases (PHD), which triggers HIF-α for degrdn.  In our present study, we examd. the effect of R59949, the diacylglycerol kinase (DGK) inhibitor II, on the retinal NV and its potential mechanism in an oxygen-induced retinopathy (OIR) model.  OIR model was induced by exposure of hyperoxia (75 % oxygen) to C57BL/6J mice from postnatal day 7 (P7) to P12 and then returned to room air.  By i.p. injection once a day (10 μg/g/day) from P12 to P17, R59949 not only effectively prevented pathol. NV but also preserved the astrocyte morphol.  Furthermore, the expression of PHD-2 was upregulated and HIF-1α and vascular endothelial growth factor (VEGF) were downregulated in the retina of OIR mice following R59949 treatment.  These findings suggested a potential possibility that R59949 suppressed retinal neovascular pathophysiol. via PHD2/HIF-1α/VEGF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIVrvSo3P8s7Vg90H21EOLACvtfcHk0lgTgxspQYNr_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWgtL3O&md5=0c43efc88d787076b8b73fd4980c8fd9</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1007%2Fs12031-014-0469-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12031-014-0469-2%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DX.%26atitle%3DDiacylglycerol%2520kinase%2520%2528DGK%2529%2520inhibitor%2520II%2520%2528R59949%2529%2520could%2520suppress%2520retinal%2520neovascularization%2520and%2520protect%2520retinal%2520astrocytes%2520in%2520an%2520oxygen-induced%2520retinopathy%2520model%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2015%26volume%3D56%26issue%3D1%26spage%3D78%26epage%3D88%26doi%3D10.1007%2Fs12031-014-0469-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boovanahalli, S.K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dat, N. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1alpha inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">6305</span>– <span class="NLM_lpage">6310</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bmcl.2007.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17884495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7rJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6305-6310&issue=22&author=S.K.+Boovanahalliauthor=X.+Jinauthor=Y.+Jinauthor=J.+H.+Kimauthor=N.+T.+Datauthor=Y.+S.+Hongauthor=J.+H.+Leeauthor=S.+H.+Jungauthor=K.+Leeauthor=J.+J.+Lee&title=Synthesis+of+%28aryloxyacetylamino%29-isonicotinic%2Fnicotinic+acid+analogues+as+potent+hypoxia-inducible+factor+%28HIF%29-1alpha+inhibitors&doi=10.1016%2Fj.bmcl.2007.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (aryloxyacetylamino)-isonicotinic/nicotinic acid analogues as potent hypoxia-inducible factor (HIF)-1α inhibitors</span></div><div class="casAuthors">Boovanahalli, Shanthaveerappa K.; Jin, Xuejun; Jin, Yinglan; Kim, Jin Hwan; Dat, Nguyen Tien; Hong, Young-Soo; Lee, Jeong Hyung; Jung, Sang-Hun; Lee, Kyeong; Lee, Jung Joon</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6305-6310</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We report a new series of HIF-1α inhibitors which were obtained through structural modifications of previously reported lead compd. I.  The in vitro inhibitory potencies of newly synthesized compds. were evaluated against hypoxia-induced HIF-1 activation using cell-based reporter assay in three human cancer cell lines including SK-Hep-1, Hep3B, and AGS cells.  Several compds. displayed significant inhibitory activity in all the three tested cell lines.  In particular, analog II displayed potent inhibition of hypoxia-induced accumulation of HIF-1α protein in Hep3B cell line, in addn. to the dose-dependent inhibition of HIF-1 target genes VEGF and EPO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp19KpOefEl1bVg90H21EOLACvtfcHk0lgTgxspQYNr_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt7rJ&md5=d55848ea7e16ad40d25566ad9f0e3e4a</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DBoovanahalli%26aufirst%3DS.K.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DDat%26aufirst%3DN.%2BT.%26aulast%3DHong%26aufirst%3DY.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%2520%2528aryloxyacetylamino%2529-isonicotinic%252Fnicotinic%2520acid%2520analogues%2520as%2520potent%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1alpha%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D22%26spage%3D6305%26epage%3D6310%26doi%3D10.1016%2Fj.bmcl.2007.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naik, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship of (<i>E</i>)-phenoxyacrylic amide derivatives as hypoxia-inducible factor (HIF) 1alpha inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">10564</span>– <span class="NLM_lpage">10571</span>, <span class="refDoi"> DOI: 10.1021/jm301419d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301419d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=10564-10571&issue=23&author=R.+Naikauthor=M.+Wonauthor=B.+K.+Kimauthor=Y.+Xiaauthor=H.+K.+Choiauthor=G.+Jinauthor=Y.+Jungauthor=H.+M.+Kimauthor=K.+Lee&title=Synthesis+and+structure-activity+relationship+of+%28E%29-phenoxyacrylic+amide+derivatives+as+hypoxia-inducible+factor+%28HIF%29+1alpha+inhibitors&doi=10.1021%2Fjm301419d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship of (E)-Phenoxyacrylic Amide Derivatives as Hypoxia-Inducible Factor (HIF) 1α Inhibitors</span></div><div class="casAuthors">Naik, Ravi; Won, Misun; Kim, Bo-Kyung; Xia, Yan; Choi, Hyun Kyung; Jin, Guanghai; Jung, Youngjin; Kim, Hwan Mook; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10564-10571</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(E)-phenoxyacrylamides such as I were prepd. and tested as inhibitors of the transcription factor hypoxia inducible factor-1α (HIF-1α) for potential use as antitumor agents; their toxicities to human cells and the aq. solubilities of selected compds. were detd.  I was a potent inhibitor of HIF-1α under hypoxic conditions (IC50 = 0.12 μM) in HCT116 cells.  I suppressed both hypoxia-induced HIF-1α accumulation and the expression of mRNAs for the genes for vascular endothelial growth factor, erythropoietin, and matrix metalloproteinase-9 in a dose-dependent manner.  I also inhibited tube formation (angiogenesis) and cell migration in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzPCB8XH7HLrVg90H21EOLACvtfcHk0lgTgxspQYNr_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ohs7vI&md5=cc1c0da351a3e7d6b9ef0a97d8b2fcc6</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Fjm301419d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301419d%26sid%3Dliteratum%253Aachs%26aulast%3DNaik%26aufirst%3DR.%26aulast%3DWon%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DB.%2BK.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DH.%2BK.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DJung%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520of%2520%2528E%2529-phenoxyacrylic%2520amide%2520derivatives%2520as%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%25201alpha%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D23%26spage%3D10564%26epage%3D10571%26doi%3D10.1021%2Fjm301419d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Won, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boovanahalli, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span> <span> </span><span class="NLM_article-title">A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>385</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">16</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2009.05.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2009.05.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19433063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntVGnur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=385&publication_year=2009&pages=16-21&issue=1&author=M.+S.+Wonauthor=N.+Imauthor=S.+Parkauthor=S.+K.+Boovanahalliauthor=Y.+Jinauthor=X.+Jinauthor=K.+S.+Chungauthor=M.+Kangauthor=K.+Leeauthor=S.+K.+Parkauthor=H.+M.+Kimauthor=B.+M.+Kwonauthor=J.+J.+Leeauthor=K.+Lee&title=A+novel+benzimidazole+analogue+inhibits+the+hypoxia-inducible+factor+%28HIF%29-1+pathway&doi=10.1016%2Fj.bbrc.2009.05.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway</span></div><div class="casAuthors">Won, Mi-Sun; Im, Namhui; Park, Soohyun; Boovanahalli, Shanthaveerappa K.; Jin, Yinglan; Jin, Xuejun; Chung, Kyung-Sook; Kang, Moorim; Lee, Kiho; Park, Song-Kyu; Kim, Hwan Mook; Kwon, Byoung Mog; Lee, Jung Joon; Lee, Kyeong</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">385</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">16-21</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF)-1 is a therapeutic target in solid tumors.  We report the novel benzimidazole analog AC1-004, obtained from a chem. library using an HRE-dependent cell-based assay in colorectal carcinoma HCT-116 cells.  The accumulation of hypoxia-induced HIF-1α was inhibited by compd. AC1-004 in various cancer cells, including HCT-116, MDA-MB435, SK-HEP1, and Caki-1.  Further, AC1-004 down-regulated VEGF and EPO, target genes of HIF-1, and inhibited in vitro tube formation of HUVEC, suggesting its potential inhibitory activity on angiogenesis.  Importantly, AC1-004 was found to regulate the stability of HIF-1α through the Hsp90-Akt pathway, leading to the degrdn. of HIF-1α.  An in vivo antitumor study demonstrated that AC1-004 reduced tumor size significantly (i.e., by 58.6%), without severe side effects.  These results suggest the benzimidazole analog AC1-004 is a novel HIF inhibitor that targets HIF-1α via the Hsp90-Akt pathway, and that it can be used as a new lead in developing anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-ymiDLQODIbVg90H21EOLACvtfcHk0lirWLeykx_Ahw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntVGnur0%253D&md5=698a8dde07240e37a946e6db3d84129b</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2009.05.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2009.05.022%26sid%3Dliteratum%253Aachs%26aulast%3DWon%26aufirst%3DM.%2BS.%26aulast%3DIm%26aufirst%3DN.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DBoovanahalli%26aufirst%3DS.%2BK.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DChung%26aufirst%3DK.%2BS.%26aulast%3DKang%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DPark%26aufirst%3DS.%2BK.%26aulast%3DKim%26aufirst%3DH.%2BM.%26aulast%3DKwon%26aufirst%3DB.%2BM.%26aulast%3DLee%26aufirst%3DJ.%2BJ.%26aulast%3DLee%26aufirst%3DK.%26atitle%3DA%2520novel%2520benzimidazole%2520analogue%2520inhibits%2520the%2520hypoxia-inducible%2520factor%2520%2528HIF%2529-1%2520pathway%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D385%26issue%3D1%26spage%3D16%26epage%3D21%26doi%3D10.1016%2Fj.bbrc.2009.05.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1746</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.06.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bmc.2016.06.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28209257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis1Wgt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1737-1746&issue=6&author=J.+Weiauthor=Y.+Yangauthor=Y.+Liauthor=X.+Moauthor=X.+Guoauthor=X.+Zhangauthor=X.+Xuauthor=Z.+Jiangauthor=Q.+You&title=Synthesis+and+evaluation+of+N-%28benzofuran-5-yl%29aromaticsulfonamide+derivatives+as+novel+HIF-1+inhibitors+that+possess+anti-angiogenic+potential&doi=10.1016%2Fj.bmc.2016.06.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential</span></div><div class="casAuthors">Wei, Jinlian; Yang, Yingrui; Li, Yali; Mo, Xiaofei; Guo, Xiaoke; Zhang, Xiaojin; Xu, Xiaoli; Jiang, Zhengyu; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1737-1746</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) as a key mediator in tumor metastasis, angiogenesis, and poor patient prognosis has been recognized as an important cancer drug target.  A novel series of N-(benzofuran-5-yl)aromaticsulfonamide derivs. were synthesized and evaluated as HIF-1 inhibitor.  Among these compds., 7q exhibited specific inhibitory effects on HIF-1 by downregulating the expression of HIF-1α under hypoxic conditions.  It inhibited the HIF-1 transcriptional activity (IC50 = 12.5 ± 0.7 μM) and secretion of VEGF (IC50 = 18.8 μM) in MCF-7 cells.  Meanwhile, it also significantly suppressed hypoxia-induced migration of HUVEC cells in nontoxic concns.  Addnl., tube formation assay demonstrated its anti-angiogenesis activity.  Finally, the in vivo study indicated that compd. 7q could retard angiogenesis in CAM model.  These findings supported the HIF-1 inhibitory effect and anti-angiogenic potential of this class of compds. as HIF-1 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrg1WrIaxBW8bVg90H21EOLACvtfcHk0lirWLeykx_Ahw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis1Wgt7s%253D&md5=39ec1334c309af5bcce7cfad25e8943f</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.06.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.06.021%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMo%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520N-%2528benzofuran-5-yl%2529aromaticsulfonamide%2520derivatives%2520as%2520novel%2520HIF-1%2520inhibitors%2520that%2520possess%2520anti-angiogenic%2520potential%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26issue%3D6%26spage%3D1737%26epage%3D1746%26doi%3D10.1016%2Fj.bmc.2016.06.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moreno-Manzano, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Jimenez, F.
J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acena-Bonilla, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fustero-Lardies, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erceg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dopazo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montaner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojkovic, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Puelles, J. M.</span></span> <span> </span><span class="NLM_article-title">FM19G11, a new hypoxia-inducible factor (HIF) modulator, affects stem cell differentiation status</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">1333</span>– <span class="NLM_lpage">1342</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.008326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M109.008326" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19897487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkvFar" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=1333-1342&issue=2&author=V.+Moreno-Manzanoauthor=F.%0AJ.+Rodriguez-Jimenezauthor=J.+L.+Acena-Bonillaauthor=S.+Fustero-Lardiesauthor=S.+Ercegauthor=J.+Dopazoauthor=D.+Montanerauthor=M.+Stojkovicauthor=J.+M.+Sanchez-Puelles&title=FM19G11%2C+a+new+hypoxia-inducible+factor+%28HIF%29+modulator%2C+affects+stem+cell+differentiation+status&doi=10.1074%2Fjbc.M109.008326"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status</span></div><div class="casAuthors">Moreno-Manzano, Victoria; Rodriguez-Jimenez, Francisco J.; Acena-Bonilla, Jose L.; Fustero-Lardies, Santos; Erceg, Slaven; Dopazo, Joaquin; Montaner, David; Stojkovic, Miodrag; Sanchez-Puelles, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1333-1342</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The biol. of the α subunits of hypoxia-inducible factors (HIFα) has expanded from their role in angiogenesis to their current position in the self-renewal and differentiation of stem cells.  The results reported in this article show the discovery of FM19G11, a novel chem. entity that inhibits HIFα proteins that repress target genes of the two α subunits, in various tumor cell lines as well as in adult and embryonic stem cell models from rodents and humans, resp.  FM19G11 inhibits at nanomolar range the transcriptional and protein expression of Oct4, Sox2, Nanog, and Tgf-α undifferentiating factors, in adult rat and human embryonic stem cells, FM19G11 activity occurs in ependymal progenitor stem cells from rats (epSPC), a cell model reported for spinal cord regeneration, which allows the progression of oligodendrocyte cell differentiation in a hypoxic environment, has created interest in its characterization for pharmacol. research.  Expts. using small interfering RNA showed a significant depletion in Sox2 protein only in the case of HIF2α silencing, but not in HIF1α-mediated ablation.  Moreover, chromatin immunopptn. data, together with the significant presence of functional hypoxia response element consensus sequences in the promoter region of Sox2, strongly validated that this factor behaves as a target gene of HIF2α in epSPCs.  FM19G11 causes a redn. of overall histone acetylation with significant repression of p300, a histone acetyltransferase required as a co-factor for HIF-transcription activation.  Arrays carried out in the presence and absence of the inhibitor showed the predominant involvement of epigenetic-assocd. events mediated by the drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqc8a-2Ol7PIrVg90H21EOLACvtfcHk0lirWLeykx_Ahw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkvFar&md5=25b81c2bb65a53948bd1ea8fd89d15d9</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.008326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.008326%26sid%3Dliteratum%253Aachs%26aulast%3DMoreno-Manzano%26aufirst%3DV.%26aulast%3DRodriguez-Jimenez%26aufirst%3DF.%2BJ.%26aulast%3DAcena-Bonilla%26aufirst%3DJ.%2BL.%26aulast%3DFustero-Lardies%26aufirst%3DS.%26aulast%3DErceg%26aufirst%3DS.%26aulast%3DDopazo%26aufirst%3DJ.%26aulast%3DMontaner%26aufirst%3DD.%26aulast%3DStojkovic%26aufirst%3DM.%26aulast%3DSanchez-Puelles%26aufirst%3DJ.%2BM.%26atitle%3DFM19G11%252C%2520a%2520new%2520hypoxia-inducible%2520factor%2520%2528HIF%2529%2520modulator%252C%2520affects%2520stem%2520cell%2520differentiation%2520status%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26issue%3D2%26spage%3D1333%26epage%3D1342%26doi%3D10.1074%2Fjbc.M109.008326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bankson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thittai, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demeure, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Von Hoff, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powis, G.</span></span> <span> </span><span class="NLM_article-title">Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2057</span>– <span class="NLM_lpage">2067</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1158%2F1535-7163.MCT-09-0768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20587661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFertbbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=2057-2067&issue=7&author=D.+L.+Schwartzauthor=J.+A.+Banksonauthor=R.+Lemosauthor=S.+Y.+Laiauthor=A.+K.+Thittaiauthor=Y.+Heauthor=G.+Hostetterauthor=M.+J.+Demeureauthor=D.+D.+Von+Hoffauthor=G.+Powis&title=Radiosensitization+and+stromal+imaging+response+correlates+for+the+HIF-1+inhibitor+PX-478+given+with+or+without+chemotherapy+in+pancreatic+cancer&doi=10.1158%2F1535-7163.MCT-09-0768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer</span></div><div class="casAuthors">Schwartz, David L.; Bankson, James A.; Lemos, Robert, Jr.; Lai, Stephen Y.; Thittai, Arun K.; He, Yi; Hostetter, Galen; Demeure, Michael J.; Von Hoff, Daniel D.; Powis, Garth</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2057-2067</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Growing tumors are hypoxic and respond to microenvironmental stress through increased expression of the hypoxia inducible factor-1α (HIF-1α) transcription factor, resulting in an adaptive switch to glycolytic metab., angiogenic signaling, survival, and metastasis.  HIF-1α expression is assocd. with tumor resistance to cytotoxic therapy and inferior patient outcomes.  Pancreatic cancer is the most hypoxic of all solid tumors and remains refractory to current chemoradiotherapy.  The authors have seen nuclear HIF-1α in 88% of human pancreatic ductal carcinoma but in only 16% of normal pancreas.  Stroma adjacent to the pancreatic ductal carcinoma also showed HIF-1α in 43% of cases.  We investigated the novel selective HIF-1α inhibitor PX-478 on in vitro and in vivo radiation response of human pancreatic cancer models.  Inhibition of HIF-1α by PX-478 increased cell killing by radiation.  In mice with Panc-1, CF-PAC-1, or SU.86.86 pancreatic xenografts, concurrent administration of PX-478 potentiated the antitumor effects of fractionated radiation, with or without combined treatment with 5-fluorouracil or gemcitabine.  Alternative sequencing of PX-478 with fractionated radiotherapy suggests optimal radiosensitization with concurrent or neoadjuvant administration of drug.  Early tumor responses to combined PX-478/radiation treatment could be rapidly and repeatedly quantified by vascular imaging biomarkers.  Dual-tracer dynamic contrast enhanced-magnetic resonance imaging and ultrasound imaging discriminated response to combined treatment prior to detection of differences in anat. tumor size at 10 days posttreatment.  Therefore, PX-478 is a mechanistically appealing and potentially clin. relevant enhancer of pancreatic cancer radiosensitivity, inhibiting tumor and stromal HIF-1 proangiogenic signaling and reducing the innate radiation resistance of hypoxic tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5Vh20CzG0KLVg90H21EOLACvtfcHk0liq4JhIoO0VqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFertbbL&md5=ad248567a3b64c54ac9206ac171ed502</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0768%26sid%3Dliteratum%253Aachs%26aulast%3DSchwartz%26aufirst%3DD.%2BL.%26aulast%3DBankson%26aufirst%3DJ.%2BA.%26aulast%3DLemos%26aufirst%3DR.%26aulast%3DLai%26aufirst%3DS.%2BY.%26aulast%3DThittai%26aufirst%3DA.%2BK.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHostetter%26aufirst%3DG.%26aulast%3DDemeure%26aufirst%3DM.%2BJ.%26aulast%3DVon%2BHoff%26aufirst%3DD.%2BD.%26aulast%3DPowis%26aufirst%3DG.%26atitle%3DRadiosensitization%2520and%2520stromal%2520imaging%2520response%2520correlates%2520for%2520the%2520HIF-1%2520inhibitor%2520PX-478%2520given%2520with%2520or%2520without%2520chemotherapy%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26issue%3D7%26spage%3D2057%26epage%3D2067%26doi%3D10.1158%2F1535-7163.MCT-09-0768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, J.</span></span> <span> </span><span class="NLM_article-title">Inhibition of HIF-1alpha by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo</span>. <i>Am. J. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1198</span>– <span class="NLM_lpage">1212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28560067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=1198-1212&issue=5&author=Y.+Zhuauthor=Y.+Zangauthor=F.+Zhaoauthor=Z.+Liauthor=J.+Zhangauthor=L.+Fangauthor=M.+Liauthor=L.+Xingauthor=Z.+Xuauthor=J.+Yu&title=Inhibition+of+HIF-1alpha+by+PX-478+suppresses+tumor+growth+of+esophageal+squamous+cell+cancer+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of HIF-1α by PX-478 suppresses tumor growth of esophageal squamous cell cancer in vitro and in vivo</span></div><div class="casAuthors">Zhu, Yingming; Zang, Yuanwei; Zhao, Fen; Li, Zhenxiang; Zhang, Jianbo; Fang, Liang; Li, Minghuan; Xing, Ligang; Xu, Zhonghua; Yu, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Cancer Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1198-1212, S1</span>CODEN:
                <span class="NLM_cas:coden">AJCRFT</span>;
        ISSN:<span class="NLM_cas:issn">2156-6976</span>.
    
            (<span class="NLM_cas:orgname">e-Century Publishing Corp.</span>)
        </div><div class="casAbstract">The aim of this study is to investigate the clin. significance of hypoxia inducible factor-1α (HIF-1α) expression in esophageal squamous cell cancer (ESCC) and clarify the effects of PX-478, a selective HIF-1α inhibitor, on ESCC both in vitro and in vivo.  HIF-1α, cyclooxygenase-2 (COX-2) and programmed death ligand-1 (PD-L1) were markedly overexpressed in ESCC tissue and assocd. with poorer survival.  In vitro, both COX-2 and PD-L1 expression of ESCC cells were significantly induced by CoCl2 treatment, but inhibited by HIF-1α knock-down or PX-478 treatment.  Furthermore, PX-478 significantly inhibited tumor cell proliferation by inhibiting the G2/M transition and promoting apoptosis of ESCC cells.  In addn., inhibited epithelial-mesenchymal transition was obsd. after PX-478 treatment.  In vivo, PX-478 significantly decreased tumor vol. following s.c. implantation.  Together, our results indicated that PX-478 had significant antitumor activity against HIF-1α over-expressing ESCC tumors in vitro and in vivo.  These results opened up the possibility of inhibiting HIF-1α for targeted therapy of ESCC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgUxhTqFTJhLVg90H21EOLACvtfcHk0ljQl7WrrLQY9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFOju77O&md5=ec3eced62377c98ec9ffd67c154e18e3</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520HIF-1alpha%2520by%2520PX-478%2520suppresses%2520tumor%2520growth%2520of%2520esophageal%2520squamous%2520cell%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DAm.%2520J.%2520Cancer%2520Res.%26date%3D2017%26volume%3D7%26issue%3D5%26spage%3D1198%26epage%3D1212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Min, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertler, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavletich, N. P.</span></span> <span> </span><span class="NLM_article-title">Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">5574</span>),  <span class="NLM_fpage">1886</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.1126/science.1073440</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1073440" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12004076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XksVWmsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=1886-1889&issue=5574&author=J.+H.+Minauthor=H.+Yangauthor=M.+Ivanauthor=F.+Gertlerauthor=W.+G.+Kaelinauthor=N.+P.+Pavletich&title=Structure+of+an+HIF-1%CE%B1-pVHL+complex%3A+hydroxyproline+recognition+in+signaling&doi=10.1126%2Fscience.1073440"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of an HIF-1α-pVHL complex: hydroxyproline recognition in signaling</span></div><div class="casAuthors">Min, Jung-Hyun; Yang, Haifeng; Ivan, Mircea; Gertler, Frank; Kaelin, William G., Jr.; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5574</span>),
    <span class="NLM_cas:pages">1886-1889</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability.  PVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent.  The 1.85 Å structure of a 20-residue HIF-1α peptide-pVHL-Elongin B-Elongin C complex shows that HIF-1α binds to pVHL in an extended β strand-like conformation.  The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues.  Although the β sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-5OY8IZiA7Vg90H21EOLACvtfcHk0ljQl7WrrLQY9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksVWmsr8%253D&md5=c3ccb5f0a383257ae465cc1c5f7a189f</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1126%2Fscience.1073440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1073440%26sid%3Dliteratum%253Aachs%26aulast%3DMin%26aufirst%3DJ.%2BH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DIvan%26aufirst%3DM.%26aulast%3DGertler%26aufirst%3DF.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructure%2520of%2520an%2520HIF-1%25CE%25B1-pVHL%2520complex%253A%2520hydroxyproline%2520recognition%2520in%2520signaling%26jtitle%3DScience%26date%3D2002%26volume%3D296%26issue%3D5574%26spage%3D1886%26epage%3D1889%26doi%3D10.1126%2Fscience.1073440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hon, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harlos, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E. Y.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>417</i></span> (<span class="NLM_issue">6892</span>),  <span class="NLM_fpage">975</span>– <span class="NLM_lpage">978</span>, <span class="refDoi"> DOI: 10.1038/nature00767</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature00767" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12050673" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XkvVagsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=417&publication_year=2002&pages=975-978&issue=6892&author=W.+C.+Honauthor=M.+I.+Wilsonauthor=K.+Harlosauthor=T.+D.+W.+Claridgeauthor=C.+J.+Schofieldauthor=C.+W.+Pughauthor=P.+H.+Maxwellauthor=P.+J.+Ratcliffeauthor=D.+I.+Stuartauthor=E.+Y.+Jones&title=Structural+basis+for+the+recognition+of+hydroxyproline+in+HIF-1%CE%B1+by+pVHL&doi=10.1038%2Fnature00767"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL</span></div><div class="casAuthors">Hon, Wai-Ching; Wilson, Michael I.; Harlos, Karl; Claridge, Timothy D. W.; Schofield, Christopher J.; Pugh, Christopher W.; Maxwell, Patrick H.; Ratcliffe, Peter J.; Stuart, David I.; Jones, E. Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">417</span>
        (<span class="NLM_cas:issue">6892</span>),
    <span class="NLM_cas:pages">975-978</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) is a transcriptional complex that controls cellular and systemic homeostatic responses to oxygen availability.  HIF-1α is the oxygen-regulated subunit of HIF-1, an αβ heterodimeric complex.  HIF-1α is stable in hypoxia, but in the presence of oxygen it is targeted for proteasomal degrdn. by the ubiquitination complex pVHL, the protein of the von Hippel-Lindau (VHL) tumor suppressor gene and a component of an E3 ubiquitin ligase complex.  Capture of HIF-1α by pVHL is regulated by hydroxylation of specific prolyl residues in two functionally independent regions of HIF-1α.  The crystal structure of a hydroxylated HIF-1α peptide bound to VCB (pVHL, elongins C and B) and soln. binding assays reveal a single, conserved hydroxyproline-binding pocket in pVHL.  Optimized hydrogen bonding to the buried hydroxyprolyl group confers precise discrimination between hydroxylated and unmodified prolyl residues.  This mechanism provides a new focus for development of therapeutic agents to modulate cellular responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEVz7Ev-hoaLVg90H21EOLACvtfcHk0liUxrjPaKa2_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XkvVagsLs%253D&md5=8f91f9a4bb0607152d1b9df2376c1a25</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnature00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature00767%26sid%3Dliteratum%253Aachs%26aulast%3DHon%26aufirst%3DW.%2BC.%26aulast%3DWilson%26aufirst%3DM.%2BI.%26aulast%3DHarlos%26aufirst%3DK.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DJones%26aufirst%3DE.%2BY.%26atitle%3DStructural%2520basis%2520for%2520the%2520recognition%2520of%2520hydroxyproline%2520in%2520HIF-1%25CE%25B1%2520by%2520pVHL%26jtitle%3DNature%26date%3D2002%26volume%3D417%26issue%3D6892%26spage%3D975%26epage%3D978%26doi%3D10.1038%2Fnature00767" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title">Signalling hypoxia by HIF hydroxylases</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>338</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">617</span>– <span class="NLM_lpage">626</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2005.08.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2005.08.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16139242" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=2005&pages=617-626&issue=1&author=C.+J.+Schofieldauthor=P.+J.+Ratcliffe&title=Signalling+hypoxia+by+HIF+hydroxylases&doi=10.1016%2Fj.bbrc.2005.08.111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling hypoxia by HIF hydroxylases</span></div><div class="casAuthors">Schofield, Christopher J.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">617-626</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Anal. of oxygen sensitive pathways that regulate the hypoxia inducible factor (HIF) transcriptional system has revealed a novel role for oxygenases in signaling hypoxia.  The enzymes, which catalyze hydroxylation of specific prolyl and asparaginyl residues in the regulatory HIF-α subunits, belong to the superfamily of non-heme Fe(II)-dependent oxygenases that use the citric acid cycle intermediate 2-oxoglutarate (2OG) as a co-substrate.  We review biochem. and physiol. data that demonstrate a central role for these oxygenases in integrating multiple signals that coordinate cellular responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6SZ4fXOuLVbVg90H21EOLACvtfcHk0liUxrjPaKa2_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksrjM&md5=983faf06533620be97faa65bcc74471e</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2005.08.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2005.08.111%26sid%3Dliteratum%253Aachs%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DSignalling%2520hypoxia%2520by%2520HIF%2520hydroxylases%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D338%26issue%3D1%26spage%3D617%26epage%3D626%26doi%3D10.1016%2Fj.bbrc.2005.08.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKnight, S. L.</span></span> <span> </span><span class="NLM_article-title">A conserved family of prolyl-4-hydroxylases that modify HIF</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>294</i></span> (<span class="NLM_issue">5545</span>),  <span class="NLM_fpage">1337</span>– <span class="NLM_lpage">1340</span>, <span class="refDoi"> DOI: 10.1126/science.1066373</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.1066373" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=11598268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=1337-1340&issue=5545&author=R.+K.+Bruickauthor=S.+L.+McKnight&title=A+conserved+family+of+prolyl-4-hydroxylases+that+modify+HIF&doi=10.1126%2Fscience.1066373"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">A conserved family of prolyl-4-hydroxylases that modify HIF</span></div><div class="casAuthors">Bruick, Richard K.; McKnight, Steven L.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5545</span>),
    <span class="NLM_cas:pages">1337-1340</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Mammalian cells respond to changes in oxygen availability through a conserved pathway that is regulated by the hypoxia-inducible factor (HIF).  The alpha subunit of HIF is targeted for degrdn. under normoxic conditions by a ubiquitin-ligase complex that recognizes a hydroxylated proline residue in HIF.  The authors identified a conserved family of HIF prolyl hydroxylase (HPH) enzymes that appear to be responsible for this posttranslational modification.  In cultured mammalian cells, inappropriate accumulation of HIF caused by forced expression of the HIF-1α subunit under normoxic conditions was attenuated by coexpression of HPH.  Suppression of HPH in cultured Drosophila melanogaster cells by RNA interference resulted in elevated expression of a hypoxia-inducible gene (LDH, encoding lactate dehydrogenase) under normoxic conditions.  These findings indicate that HPH is an essential component of the pathway through which cells sense oxygen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH62syyo7QG7Vg90H21EOLACvtfcHk0liUxrjPaKa2_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXotlKmtbo%253D&md5=e17b5094d300fc6e292cd063d5633502</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1126%2Fscience.1066373&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1066373%26sid%3Dliteratum%253Aachs%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DMcKnight%26aufirst%3DS.%2BL.%26atitle%3DA%2520conserved%2520family%2520of%2520prolyl-4-hydroxylases%2520that%2520modify%2520HIF%26jtitle%3DScience%26date%3D2001%26volume%3D294%26issue%3D5545%26spage%3D1337%26epage%3D1340%26doi%3D10.1126%2Fscience.1066373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oehme, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellinghaus, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolkhof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramakrishnan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutter, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schramm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span> <span> </span><span class="NLM_article-title">Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>296</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/S0006-291X(02)00862-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2FS0006-291X%2802%2900862-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12163023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2gsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=343-349&issue=2&author=F.+Oehmeauthor=P.+Ellinghausauthor=P.+Kolkhofauthor=T.+J.+Smithauthor=S.+Ramakrishnanauthor=J.+Hutterauthor=M.+Schrammauthor=I.+Flamme&title=Overexpression+of+PH-4%2C+a+novel+putative+proline+4-hydroxylase%2C+modulates+activity+of+hypoxia-inducible+transcription+factors&doi=10.1016%2FS0006-291X%2802%2900862-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors</span></div><div class="casAuthors">Oehme, Felix; Ellinghaus, Peter; Kolkhof, Peter; Smith, Timothy J.; Ramakrishnan, Shyam; Hutter, Joachim; Schramm, Matthias; Flamme, Ingo</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Hypoxia-inducible transcription factors (HIFs) are important for transcriptional adaptation to hypoxia.  Availability of HIFs is regulated via posttranslational modification of their α subunits (HIF-1α and HIF-2α).  Under normoxia, two highly conserved proline residues within the oxygen-dependent degrdn. domain (ODDD) are hydroxylated by oxoglutarate-dependent proline 4-hydroxylases EGLN1-3.  Hydroxylated HIF-α interacts with the pVHL-E3 ubiquitin ligase complex and, subsequently, is degraded via the proteasomal pathway.  We identified a novel putative proline 4-hydroxylase, PH-4, with an amino-terminal EF-hand motif and a carboxy-terminal catalytic domain, which was highly expressed in most organs, and-unlike EGLNs which localize to the cytoplasm and nucleus-was assocd. with the endoplasmic reticulum.  Like EGLNs, PH-4 overexpressed in cellular reporter assays suppressed the HIF transactivation activity, dependent on the consensus ODDD proline residues.  Suppression of transactivation was correlated with decrease of cellular contents of HIF.  Thus, PH-4 might be related to cellular oxygen sensing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKk1JcgHlaULVg90H21EOLACvtfcHk0lidoxKfQ9IRBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2gsb4%253D&md5=b40d00a31ddf342d4a602f286fa9ca59</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2802%2900862-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252802%252900862-8%26sid%3Dliteratum%253Aachs%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DEllinghaus%26aufirst%3DP.%26aulast%3DKolkhof%26aufirst%3DP.%26aulast%3DSmith%26aufirst%3DT.%2BJ.%26aulast%3DRamakrishnan%26aufirst%3DS.%26aulast%3DHutter%26aufirst%3DJ.%26aulast%3DSchramm%26aufirst%3DM.%26aulast%3DFlamme%26aufirst%3DI.%26atitle%3DOverexpression%2520of%2520PH-4%252C%2520a%2520novel%2520putative%2520proline%25204-hydroxylase%252C%2520modulates%2520activity%2520of%2520hypoxia-inducible%2520transcription%2520factors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2002%26volume%3D296%26issue%3D2%26spage%3D343%26epage%3D349%26doi%3D10.1016%2FS0006-291X%2802%2900862-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Metzen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berchner-Pfannschmidt, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stengel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marxsen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stolze, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wotzlaw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellwig-Burgel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jelkmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandrey, J.</span></span> <span> </span><span class="NLM_article-title">Intracellular localization of human HIF-1α hydroxylases: Implications for oxygen sensing</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>116</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1319</span>– <span class="NLM_lpage">1326</span>, <span class="refDoi"> DOI: 10.1242/jcs.00318</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1242%2Fjcs.00318" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12615973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFWhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2003&pages=1319-1326&issue=7&author=E.+Metzenauthor=U.+Berchner-Pfannschmidtauthor=P.+Stengelauthor=J.+H.+Marxsenauthor=I.+Stolzeauthor=M.+Klingerauthor=W.+Q.+Huangauthor=C.+Wotzlawauthor=T.+Hellwig-Burgelauthor=W.+Jelkmannauthor=H.+Ackerauthor=J.+Fandrey&title=Intracellular+localization+of+human+HIF-1%CE%B1+hydroxylases%3A+Implications+for+oxygen+sensing&doi=10.1242%2Fjcs.00318"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Intracellular localization of human HIF-1α hydroxylases: Implications for oxygen sensing</span></div><div class="casAuthors">Metzen, Eric; Berchner-Pfannschmidt, Utta; Stengel, Petra; Marxsen, Jan H.; Stolze, Ineke; Klinger, Matthias; Huang, Wei Qi; Wotzlaw, Christoph; Hellwig-Burgel, Thomas; Jelkmann, Wolfgang; Acker, Helmut; Fandrey, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1319-1326</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor 1 (HIF-1) is an essential transcription factor for cellular adaptation to decreased oxygen availability.  In normoxia the oxygen-sensitive α-subunit of HIF-1 is hydroxylated on Pro564 and Pro402 and thus targeted for proteasomal degrdn.  Three human oxygen-dependent HIF-1α prolyl hydroxylases (PHD1, PHD2, and PHD3) function as oxygen sensors in vivo.  Furthermore, the asparagine hydroxylase FIH-1 (factor inhibiting HIF) has been found to hydroxylate Asp803 of the HIF-1 C-terminal transactivation domain, which results in the decreased ability of HIF-1 to bind to the transcriptional coactivator p300/CBP.  We have fused these enzymes to the N-terminus of fluorescent proteins and transiently transfected the fusion proteins into human osteosarcoma cells (U2OS).  Three-dimensional 2-photon confocal fluorescence microscopy showed that PHD1 was exclusively present in the nucleus, PHD2 and FIH-1 were mainly located in the cytoplasm and PHD3 was homogeneously distributed in cytoplasm and nucleus.  Hypoxia did not influence the localization of any enzyme under investigation.  In contrast to FIH-1, each PHD inhibited nuclear HIF-1α accumulation in hypoxia.  All hydroxylases suppressed activation of a cotransfected hypoxia-responsive luciferase reporter gene.  Endogenous PHD2mRNA and PHD3mRNA were hypoxia-inducible, whereas expression of PHD1mRNA and FIH-1mRNA was oxygen independent.  We propose that PHDs and FIH-1 form an oxygen sensor cascade of distinct subcellular localization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiwh7sGGnRw7Vg90H21EOLACvtfcHk0lidoxKfQ9IRBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFWhu78%253D&md5=45a5a4ea8f59fd74e0009efefff641d7</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1242%2Fjcs.00318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.00318%26sid%3Dliteratum%253Aachs%26aulast%3DMetzen%26aufirst%3DE.%26aulast%3DBerchner-Pfannschmidt%26aufirst%3DU.%26aulast%3DStengel%26aufirst%3DP.%26aulast%3DMarxsen%26aufirst%3DJ.%2BH.%26aulast%3DStolze%26aufirst%3DI.%26aulast%3DKlinger%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%2BQ.%26aulast%3DWotzlaw%26aufirst%3DC.%26aulast%3DHellwig-Burgel%26aufirst%3DT.%26aulast%3DJelkmann%26aufirst%3DW.%26aulast%3DAcker%26aufirst%3DH.%26aulast%3DFandrey%26aufirst%3DJ.%26atitle%3DIntracellular%2520localization%2520of%2520human%2520HIF-1%25CE%25B1%2520hydroxylases%253A%2520Implications%2520for%2520oxygen%2520sensing%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2003%26volume%3D116%26issue%3D7%26spage%3D1319%26epage%3D1326%26doi%3D10.1242%2Fjcs.00318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appelhoff, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raval, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turley, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gleadle, J. M.</span></span> <span> </span><span class="NLM_article-title">Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>279</i></span> (<span class="NLM_issue">37</span>),  <span class="NLM_fpage">38458</span>– <span class="NLM_lpage">38465</span>, <span class="refDoi"> DOI: 10.1074/jbc.M406026200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M406026200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=15247232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnt1OqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=38458-38465&issue=37&author=R.+J.+Appelhoffauthor=Y.+M.+Tianauthor=R.+R.+Ravalauthor=H.+Turleyauthor=A.+L.+Harrisauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=J.+M.+Gleadle&title=Differential+function+of+the+prolyl+hydroxylases+PHD1%2C+PHD2%2C+and+PHD3+in+the+regulation+of+hypoxia-inducible+factor&doi=10.1074%2Fjbc.M406026200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor</span></div><div class="casAuthors">Appelhoff, Rebecca J.; Tian, Ya-Min; Raval, Raju R.; Turley, Helen; Harris, Adrian L.; Pugh, Christopher W.; Ratcliffe, Peter J.; Gleadle, Jonathan M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">38458-38465</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF) is a transcriptional regulator that plays a key role in many aspects of oxygen homeostasis.  The heterodimeric HIF complex is regulated by proteolysis of its α-subunits, following oxygen-dependent hydroxylation of specific prolyl residues.  Although three HIF prolyl hydroxylases, PHD1, PHD2, and PHD3, have been identified that have the potential to catalyze this reaction, the contribution of each isoform to the physiol. regulation of HIF remains uncertain.  Here we show using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both HIF-1α and HIF-2α subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme.  Thus in different cell types, isoform-specific patterns of PHD induction by hypoxia and estrogen alter both the relative abundance of the PHDs and their relative contribution to the regulation of HIF.  In addn., the PHDs manifest specificity for different prolyl hydroxylation sites within each HIF-α subunit, and a degree of selectively between HIF-1α and HIF-2α isoforms, indicating that differential PHD inhibition has the potential to selectively alter the characteristics of HIF activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGFQdU0fEZP7Vg90H21EOLACvtfcHk0lhsLPkmg0gjiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnt1OqtLs%253D&md5=bec1e6f72c7c062ccf09fd51ce65cd53</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M406026200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M406026200%26sid%3Dliteratum%253Aachs%26aulast%3DAppelhoff%26aufirst%3DR.%2BJ.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DRaval%26aufirst%3DR.%2BR.%26aulast%3DTurley%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DA.%2BL.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DGleadle%26aufirst%3DJ.%2BM.%26atitle%3DDifferential%2520function%2520of%2520the%2520prolyl%2520hydroxylases%2520PHD1%252C%2520PHD2%252C%2520and%2520PHD3%2520in%2520the%2520regulation%2520of%2520hypoxia-inducible%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26issue%3D37%26spage%3D38458%26epage%3D38465%26doi%3D10.1074%2Fjbc.M406026200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hirsilae, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koivunen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guenzler, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kivirikko, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myllyharju, J.</span></span> <span> </span><span class="NLM_article-title">Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>278</i></span> (<span class="NLM_issue">33</span>),  <span class="NLM_fpage">30772</span>– <span class="NLM_lpage">30780</span>, <span class="refDoi"> DOI: 10.1074/jbc.M304982200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1074%2Fjbc.M304982200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12788921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmtFeqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=30772-30780&issue=33&author=M.+Hirsilaeauthor=P.+Koivunenauthor=V.+Guenzlerauthor=K.+I.+Kivirikkoauthor=J.+Myllyharju&title=Characterization+of+the+human+prolyl+4-hydroxylases+that+modify+the+hypoxia-inducible+factor&doi=10.1074%2Fjbc.M304982200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Human Prolyl 4-Hydroxylases That Modify the Hypoxia-inducible Factor</span></div><div class="casAuthors">Hirsilae, Maija; Koivunen, Peppi; Guenzler, Volkmar; Kivirikko, Kari I.; Myllyharju, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">30772-30780</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The hypoxia-inducible factors (HIFs) play a central role in oxygen homeostasis.  Hydroxylation of one or two crit. prolines by specific hydroxylases (P4Hs) targets their HIF-α subunits for proteasomal degrdn.  By studying the three human HIF-P4Hs, we found that the longest and shortest isoenzymes have major transcripts encoding inactive polypeptides, which suggest novel regulation by alternative splicing.  Recombinant HIF-P4Hs expressed in insect cells required peptides of more than 8 residues, distinct differences being found between isoenzymes.  All the HIF-P4Hs hydroxylated peptides corresponding to Pro564 in HIF-1α, whereas a Pro402 peptide had 20-50-fold Km values for two isoenzymes but was not hydroxylated by the shortest isoenzyme at all; this difference was not explained by the two prolines being in a -Pro402-Ala- and -Pro564-Tyr-sequence.  All the HIF-P4Hs-hydroxylated peptides corresponding to two of three potential sites in HIF-2α and one in HIF-3α.  The Km values for O2 were slightly above its atm. concn., indicating that the HIF-P4Hs are effective oxygen sensors.  Small mol. inhibitors of collagen P4Hs also inhibited the HIF-P4Hs, but with distinctly different Ki values, indicating that it should be possible to develop specific inhibitors for each class of P4Hs and possibly even for the individual HIF-P4Hs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKRUilSLTYhLVg90H21EOLACvtfcHk0lhsLPkmg0gjiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmtFeqsb4%253D&md5=7f2d58fb0816f1dd9ee0fd1442c98b4f</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M304982200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M304982200%26sid%3Dliteratum%253Aachs%26aulast%3DHirsilae%26aufirst%3DM.%26aulast%3DKoivunen%26aufirst%3DP.%26aulast%3DGuenzler%26aufirst%3DV.%26aulast%3DKivirikko%26aufirst%3DK.%2BI.%26aulast%3DMyllyharju%26aufirst%3DJ.%26atitle%3DCharacterization%2520of%2520the%2520human%2520prolyl%25204-hydroxylases%2520that%2520modify%2520the%2520hypoxia-inducible%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D33%26spage%3D30772%26epage%3D30780%26doi%3D10.1074%2Fjbc.M304982200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ehrismann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genn, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathioudakis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>401</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">234</span>, <span class="refDoi"> DOI: 10.1042/BJ20061151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1042%2FBJ20061151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16952279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlShsLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=2007&pages=227-234&issue=2&author=D.+Ehrismannauthor=E.+Flashmanauthor=D.+N.+Gennauthor=N.+Mathioudakisauthor=K.+S.+Hewitsonauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Studies+on+the+activity+of+the+hypoxia-inducible-factor+hydroxylases+using+an+oxygen+consumption+assay&doi=10.1042%2FBJ20061151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay</span></div><div class="casAuthors">Ehrismann, Dominic; Flashman, Emily; Genn, David N.; Mathioudakis, Nicolas; Hewitson, Kirsty S.; Ratcliffe, Peter J.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">227-234</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The activity and levels of the metazoan HIF (hypoxia-inducible factor) are regulated by its hydroxylation, catalyzed by 2OG (2-oxoglutarate)- and Fe(II)-dependent dioxygenases.  An oxygen consumption assay was developed and used to study the relationship between HIF hydroxylase activity and oxygen concn. for recombinant forms of two human HIF hydroxylases, PHD2 (prolyl hydroxylase domain-contg. protein 2) and FIH (factor inhibiting HIF), and compared with two other 2OG-dependent dioxygenases.  Although there are caveats on the abs. values, the apparent Km (oxygen) values for PHD2 and FIH were within the range obsd. for other 2OG oxygenases.  Recombinant protein substrates were found to have lower apparent Km (oxygen) values compared with shorter synthetic peptides of HIF.  The analyses also suggest that human PHD2 is selective for fragments of the C-terminal over the N-terminal oxygen-dependent degrdn. domain of HIF-1α.  The present results, albeit obtained under non-physiol. conditions, imply that the apparent Km (oxygen) values of the HIF hydroxylases enable them to act as oxygen sensors providing their in vivo capacity is appropriately matched to a hydroxylation-sensitive signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAEtXBODUrK7Vg90H21EOLACvtfcHk0liiGfamZJ3iiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlShsLfE&md5=99dfd44568845e9f3589ec31313cc0e6</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1042%2FBJ20061151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061151%26sid%3Dliteratum%253Aachs%26aulast%3DEhrismann%26aufirst%3DD.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DGenn%26aufirst%3DD.%2BN.%26aulast%3DMathioudakis%26aufirst%3DN.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStudies%2520on%2520the%2520activity%2520of%2520the%2520hypoxia-inducible-factor%2520hydroxylases%2520using%2520an%2520oxygen%2520consumption%2520assay%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D401%26issue%3D2%26spage%3D227%26epage%3D234%26doi%3D10.1042%2FBJ20061151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lygate, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernhardt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span> <span> </span><span class="NLM_article-title">HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation</span>. <i>J. Mol. Cell. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.yjmcc.2006.04.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.yjmcc.2006.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16765982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28Xms1antbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=68-77&issue=1&author=C.+Willamauthor=P.+H.+Maxwellauthor=L.+Nicholsauthor=C.+Lygateauthor=Y.+M.+Tianauthor=W.+Bernhardtauthor=M.+Wiesenerauthor=P.+J.+Ratcliffeauthor=K.+U.+Eckardtauthor=C.+W.+Pugh&title=HIF+prolyl+hydroxylases+in+the+rat%3B+organ+distribution+and+changes+in+expression+following+hypoxia+and+coronary+artery+ligation&doi=10.1016%2Fj.yjmcc.2006.04.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation</span></div><div class="casAuthors">Willam, Carsten; Maxwell, Patrick H.; Nichols, Lynn; Lygate, Craig; Tian, Ya Min; Bernhardt, Wanja; Wiesener, Michael; Ratcliffe, Peter J.; Eckardt, Kai-Uwe; Pugh, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular and Cellular Cardiology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">JMCDAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-2828</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF) regulates expression of genes involved in adaptation to hypoxia and ischemia.  Three prolyl hydroxylases (PHD1-3) underlie oxygen-regulated destruction of HIFalpha chains.  We have investigated the organ distribution of the PHDs in the rat, their regulation by hypoxia and changes in local expression after exptl. myocardial infarction using RNase protection assays, in situ hybridization and immunohistochem. mRNAs of all isoforms were detectable in heart, liver, kidney, brain, testis and lung.  In normal animals, highest levels for PHD2 mRNA and PHD3 mRNA were found in myocardium, whereas PHD1 mRNA was detected predominantly in the testis.  PHD1 mRNA was constitutively expressed.  PHD2 mRNA was induced by hypoxia in the liver and PHD3 mRNA in liver, testis and heart.  Overall our results show that PHD2 mRNA is ubiquitously expressed in normal animals, in keeping with a general role in oxygen sensing.  PHD1 and 3 mRNA distributions suggest particular roles in testis and heart, resp.  In a model of myocardial infarction, in situ hybridization showed periischemic enhancement for PHD2 mRNA and PHD3 mRNA, but not PHD1 mRNA.  Immunostaining of PHD2 and 3 in infarcted hearts showed enhanced protein expression, maximal 7 days after infarction.  Levels were strongest in regions neighboring areas of HIF staining but also partially overlapped with these zones.  Inducibility of PHD2 and 3 by hypoxia and ischemia in vivo has important implications both for the pathophysiol. of conditions where oxygen supply is deranged and for attempts to manipulate the HIF system therapeutically.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJKeHSbhFBDbVg90H21EOLACvtfcHk0liiGfamZJ3iiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xms1antbg%253D&md5=67c79d106beb6b6604d7c358dc8a0e78</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2Fj.yjmcc.2006.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yjmcc.2006.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DWillam%26aufirst%3DC.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DNichols%26aufirst%3DL.%26aulast%3DLygate%26aufirst%3DC.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DBernhardt%26aufirst%3DW.%26aulast%3DWiesener%26aufirst%3DM.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26atitle%3DHIF%2520prolyl%2520hydroxylases%2520in%2520the%2520rat%253B%2520organ%2520distribution%2520and%2520changes%2520in%2520expression%2520following%2520hypoxia%2520and%2520coronary%2520artery%2520ligation%26jtitle%3DJ.%2520Mol.%2520Cell.%2520Cardiol.%26date%3D2006%26volume%3D41%26issue%3D1%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.yjmcc.2006.04.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benizri, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ginouves, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volmat, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roux, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span> <span> </span><span class="NLM_article-title">HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">4082</span>– <span class="NLM_lpage">4090</span>, <span class="refDoi"> DOI: 10.1093/emboj/cdg392</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1093%2Femboj%2Fcdg392" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12912907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=4082-4090&issue=16&author=E.+Berraauthor=E.+Benizriauthor=A.+Ginouvesauthor=V.+Volmatauthor=D.+Rouxauthor=J.+Pouyssegur&title=HIF+prolyl-hydroxylase+2+is+the+key+oxygen+sensor+setting+low+steady-state+levels+of+HIF-1%CE%B1+in+normoxia&doi=10.1093%2Femboj%2Fcdg392"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia</span></div><div class="casAuthors">Berra, Edurne; Benizri, Emmanuel; Ginouves, Amandine; Volmat, Veronique; Roux, Daniele; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4082-4090</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor (HIF), a transcriptional complex conserved from Caenorhabditis elegans to vertebrates, plays a pivotal role in cellular adaptation to low oxygen availability.  In normoxia, the HIF-α subunits are targeted for destruction by prolyl hydroxylation, a specific modification that provides recognition for the E3 ubiquitin ligase complex contg. the von Hippel-Lindau tumor suppressor protein (pVHL).  Three HIF prolyl-hydroxylases (PHD1, 2 and 3) were identified recently in mammals and shown to hydroxylate HIF-α subunits.  Here we show that specific silencing' of PHD2 with short interfering RNAs is sufficient to stabilize and activate HIF-1α in normoxia in all the human cells investigated.  Silencing' of PHD1 and PHD3 has no effect on the stability of HIF-1α either in normoxia or upon re-oxygenation of cells briefly exposed to hypoxia.  We therefore conclude that, in vivo, PHDs have distinct assigned functions, PHD2 being the crit. oxygen sensor setting the low steady-state levels of HIF-1α in normoxia.  Interestingly, PHD2 is upregulated by hypoxia, providing an HIF-1-dependent auto-regulatory mechanism driven by the oxygen tension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZqlOv_GKAo7Vg90H21EOLACvtfcHk0lhrKxCISHM6Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGgsLo%253D&md5=0664088d2f005bddec8f685f162201fd</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1093%2Femboj%2Fcdg392&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252Fcdg392%26sid%3Dliteratum%253Aachs%26aulast%3DBerra%26aufirst%3DE.%26aulast%3DBenizri%26aufirst%3DE.%26aulast%3DGinouves%26aufirst%3DA.%26aulast%3DVolmat%26aufirst%3DV.%26aulast%3DRoux%26aufirst%3DD.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DHIF%2520prolyl-hydroxylase%25202%2520is%2520the%2520key%2520oxygen%2520sensor%2520setting%2520low%2520steady-state%2520levels%2520of%2520HIF-1%25CE%25B1%2520in%2520normoxia%26jtitle%3DEMBO%2520J.%26date%3D2003%26volume%3D22%26issue%3D16%26spage%3D4082%26epage%3D4090%26doi%3D10.1093%2Femboj%2Fcdg392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H. L.</span></span> <span> </span><span class="NLM_article-title">The molecular characterization, expression pattern and alternative initiation of Megalobrama amblycephala Hif prolyl hydroxylase Phd1</span>. <i>Gene</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>678</i></span>,  <span class="NLM_fpage">219</span>– <span class="NLM_lpage">225</span>, <span class="refDoi"> DOI: 10.1016/j.gene.2018.08.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.gene.2018.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=30086363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFWjsrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=678&publication_year=2018&pages=219-225&author=N.+Chenauthor=C.+X.+Huangauthor=C.+H.+Huangauthor=Y.+Heauthor=T.+S.+Chenauthor=D.+M.+Zhuauthor=H.+Liuauthor=W.+M.+Wangauthor=H.+L.+Wang&title=The+molecular+characterization%2C+expression+pattern+and+alternative+initiation+of+Megalobrama+amblycephala+Hif+prolyl+hydroxylase+Phd1&doi=10.1016%2Fj.gene.2018.08.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular characterization, expression pattern and alternative initiation of Megalobrama amblycephala Hif prolyl hydroxylase Phd1</span></div><div class="casAuthors">Chen, Nan; Huang, Chun-Xiao; Huang, Cui-Hong; He, Yan; Chen, Tian-Sheng; Zhu, Dong-Mei; Liu, Hong; Wang, Wei-Min; Wang, Huan-Ling</div><div class="citationInfo"><span class="NLM_cas:title">Gene</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">678</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">219-225</span>CODEN:
                <span class="NLM_cas:coden">GENED6</span>;
        ISSN:<span class="NLM_cas:issn">0378-1119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HIF prolyl hydroxylase 1 (PHD1) functions in prolyl hydroxylation on mammal hypoxia-inducible factors (HIF), important transcription factors involved in hypoxia, however the roles of Phd1 in fish remain unclear.  In this study, the full-length cDNA and promoter sequences of blunt snout bream (Megalobrama amblycephala) phd1 gene were isolated by a modified RACE strategy.  The phd1 cDNA was 2672 bp for encoding 481 amino acid residues.  In silico assays indicated that phd1 had 5 exons, and a 348 bp CpG island in the exon1, and several transcription factor binding sites (CAAT box, HRE, ARNT, FOX, etc.) were also found on the promoter.  The quant. real-time PCR results suggested that phd1 mRNA was constitutively expressed in all detected tissues, and higher in the blood, brain and heart in normoxia, but significantly decreased after hypoxia in all detected tissues except for gill.  Western blot assays indicated that two Phd1 isoforms were generated by alternative translation initiation.  Moreover, these two isoforms were both localized in the nucleus, therein only the senior isoform promoted cell proliferation.  Taken together, the present study firstly describes the functions of M. amblycephala two Phd1 isoforms in hypoxia and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuugZG11fTkbVg90H21EOLACvtfcHk0lhdtJYlWer0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFWjsrzE&md5=7194067764baf61a5285bbababf47451</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1016%2Fj.gene.2018.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gene.2018.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DC.%2BX.%26aulast%3DHuang%26aufirst%3DC.%2BH.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DT.%2BS.%26aulast%3DZhu%26aufirst%3DD.%2BM.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DW.%2BM.%26aulast%3DWang%26aufirst%3DH.%2BL.%26atitle%3DThe%2520molecular%2520characterization%252C%2520expression%2520pattern%2520and%2520alternative%2520initiation%2520of%2520Megalobrama%2520amblycephala%2520Hif%2520prolyl%2520hydroxylase%2520Phd1%26jtitle%3DGene%26date%3D2018%26volume%3D678%26spage%3D219%26epage%3D225%26doi%3D10.1016%2Fj.gene.2018.08.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loenarz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">981</span>– <span class="NLM_lpage">989</span>, <span class="refDoi"> DOI: 10.1016/j.str.2009.06.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.str.2009.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19604478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=981-989&issue=7&author=R.+Chowdhuryauthor=M.+A.+McDonoughauthor=J.+Mecinovicauthor=C.+Loenarzauthor=E.+Flashmanauthor=K.+S.+Hewitsonauthor=C.+Domeneauthor=C.+J.+Schofield&title=Structural+basis+for+binding+of+hypoxia-inducible+factor+to+the+oxygen-sensing+prolyl+hydroxylases&doi=10.1016%2Fj.str.2009.06.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Binding of Hypoxia-Inducible Factor to the Oxygen-Sensing Prolyl Hydroxylases</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; McDonough, Michael A.; Mecinovic, Jasmin; Loenarz, Christoph; Flashman, Emily; Hewitson, Kirsty S.; Domene, Carmen; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">981-989</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The oxygen-dependent hydroxylation of proline residues in the α subunit of hypoxia-inducible transcription factor (HIFα) is central to the hypoxic response in animals.  Prolyl hydroxylation of HIFα increases its binding to the von Hippel-Lindau protein (pVHL), so signaling for degrdn. via the ubiquitin-proteasome system.  The HIF prolyl hydroxylases (PHDs, prolyl hydroxylase domain enzymes) are related to the collagen prolyl hydroxylases, but form unusually stable complexes with their Fe(II) cofactor and 2-oxoglutarate cosubstrate.  We report crystal structures of the catalytic domain of PHD2, the most important of the human PHDs, in complex with the C-terminal oxygen-dependent degrdn. domain of HIF-1α.  Together with biochem. analyses, the results reveal that PHD catalysis involves a mobile region that isolates the hydroxylation site and stabilizes the PHD2.Fe(II).2OG complex.  The results will be of use in the design of PHD inhibitors aimed at treating anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqj4EIAtw-X1LVg90H21EOLACvtfcHk0lhdtJYlWer0Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosV2gsrY%253D&md5=c0e60731ac33bdbf947cd0227dc86244</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2009.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2009.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DLoenarz%26aufirst%3DC.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DDomene%26aufirst%3DC.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520hypoxia-inducible%2520factor%2520to%2520the%2520oxygen-sensing%2520prolyl%2520hydroxylases%26jtitle%3DStructure%26date%3D2009%26volume%3D17%26issue%3D7%26spage%3D981%26epage%3D989%26doi%3D10.1016%2Fj.str.2009.06.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abboud, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAllister, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domene, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkinson, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>54</i></span> (<span class="NLM_issue">25</span>),  <span class="NLM_fpage">3130</span>– <span class="NLM_lpage">3133</span>, <span class="refDoi"> DOI: 10.1039/C8CC00387D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1039%2FC8CC00387D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29522057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXksFagsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2018&pages=3130-3133&issue=25&author=M.+I.+Abboudauthor=T.+E.+McAllisterauthor=I.+K.+H.+Leungauthor=R.+Chowdhuryauthor=C.+Jorgensenauthor=C.+Domeneauthor=J.+Mecinovicauthor=K.+Lipplauthor=R.+L.+Hancockauthor=R.+J.+Hopkinsonauthor=A.+Kawamuraauthor=T.+D.+W.+Claridgeauthor=C.+J.+Schofield&title=2-Oxoglutarate+regulates+binding+of+hydroxylated+hypoxia-inducible+factor+to+prolyl+hydroxylase+domain+2&doi=10.1039%2FC8CC00387D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">2-Oxoglutarate regulates binding of hydroxylated hypoxia-inducible factor to prolyl hydroxylase domain 2</span></div><div class="casAuthors">Abboud, Martine I.; McAllister, Tom E.; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Jorgensen, Christian; Domene, Carmen; Mecinovic, Jasmin; Lippl, Kerstin; Hancock, Rebecca L.; Hopkinson, Richard J.; Kawamura, Akane; Claridge, Timothy D. W.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3130-3133</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Prolyl hydroxylation of hypoxia inducible factor (HIF)-α, as catalyzed by the Fe(II)/2-oxoglutarate (2OG)-dependent prolyl hydroxylase domain (PHD) enzymes, has a hypoxia sensing role in animals.  We report that binding of prolyl-hydroxylated HIF-α to PHD2 is ∼50 fold hindered by prior 2OG binding; thus, when 2OG is limiting, HIF-α degrdn. might be inhibited by PHD binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2mOvIMPzQ6LVg90H21EOLACvtfcHk0lioYYftFAx6RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXksFagsrw%253D&md5=f6275f3ba65d82a7bc14028dbd6f06f2</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1039%2FC8CC00387D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC8CC00387D%26sid%3Dliteratum%253Aachs%26aulast%3DAbboud%26aufirst%3DM.%2BI.%26aulast%3DMcAllister%26aufirst%3DT.%2BE.%26aulast%3DLeung%26aufirst%3DI.%2BK.%2BH.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DJorgensen%26aufirst%3DC.%26aulast%3DDomene%26aufirst%3DC.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DLippl%26aufirst%3DK.%26aulast%3DHancock%26aufirst%3DR.%2BL.%26aulast%3DHopkinson%26aufirst%3DR.%2BJ.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%2BW.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3D2-Oxoglutarate%2520regulates%2520binding%2520of%2520hydroxylated%2520hypoxia-inducible%2520factor%2520to%2520prolyl%2520hydroxylase%2520domain%25202%26jtitle%3DChem.%2520Commun.%26date%3D2018%26volume%3D54%26issue%3D25%26spage%3D3130%26epage%3D3133%26doi%3D10.1039%2FC8CC00387D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semenza, G. L.</span></span> <span> </span><span class="NLM_article-title">Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>82</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3610</span>– <span class="NLM_lpage">3615</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1182%2Fblood.V82.12.3610.3610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=8260699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK2cXhtlSlsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1993&pages=3610-3615&issue=12&author=G.+L.+Wangauthor=G.+L.+Semenza&title=Desferrioxamine+induces+erythropoietin+gene+expression+and+hypoxia-inducible+factor+1+DNA-binding+activity%3A+implications+for+models+of+hypoxia+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction</span></div><div class="casAuthors">Wang, Guang L.; Semenza, Gregg L.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3610-15</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">Erythropoietin (EPO) gene transcription is activated in kidney cells in vivo and in Hep3B cells exposed to hypoxia or cobalt chloride.  Hypoxia-inducible factor 1 (HIF-1) is a nuclear factor that binds to the hypoxia-inducible enhancer of the EPO gene at a site that is required for transcriptional activation.  HIF-1 DNA-binding activity is induced by hypoxia or cobalt chloride treatment of Hep3B cells.  The authors report that treatment of Hep3B cells with desferrioxamine (DFX) induced HIF-1 activity and EPO RNA expression with kinetics similar to the induction of HIF-1 by hypoxia or cobalt chloride.  Induction by each of these stimuli was inhibited by cycloheximide, indicating a requirement for de novo protein synthesis.  DFX appears to induce HIF-1 by chelating iron, as induction was inhibited by coadministration of ferrous ammonium sulfate.  DFX administration to mice transiently increased EPO RNA levels in the kidney.  As previously shown for hypoxia and cobalt treatment, DFX also induced HIF-1 activity in non-EPO-producing cells, suggesting the existence of a common hypoxia signal-transduction pathway leading to HIF-1 induction in different cell types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVrTxL6miJ0bVg90H21EOLACvtfcHk0lioYYftFAx6RA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhtlSlsLw%253D&md5=10d0007ff9fb27794d0001b7757c82d9</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1182%2Fblood.V82.12.3610.3610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood.V82.12.3610.3610%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BL.%26aulast%3DSemenza%26aufirst%3DG.%2BL.%26atitle%3DDesferrioxamine%2520induces%2520erythropoietin%2520gene%2520expression%2520and%2520hypoxia-inducible%2520factor%25201%2520DNA-binding%2520activity%253A%2520implications%2520for%2520models%2520of%2520hypoxia%2520signal%2520transduction%26jtitle%3DBlood%26date%3D1993%26volume%3D82%26issue%3D12%26spage%3D3610%26epage%3D3615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, Y.</span></span> <span> </span><span class="NLM_article-title">Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>71</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1676</span>– <span class="NLM_lpage">1684</span>, <span class="refDoi"> DOI: 10.1124/mol.107.034041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1124%2Fmol.107.034041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17377063" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2007&pages=1676-1684&issue=6&author=H.+Jeonauthor=H.+Kimauthor=D.+Choiauthor=D.+Kimauthor=S.+Y.+Parkauthor=Y.+J.+Kimauthor=Y.+M.+Kimauthor=Y.+Jung&title=Quercetin+activates+an+angiogenic+pathway%2C+hypoxia+inducible+factor+%28HIF%29-1-vascular+endothelial+growth+factor%2C+by+inhibiting+HIF-prolyl+hydroxylase%3A+a+structural+analysis+of+quercetin+for+inhibiting+HIF-prolyl+hydroxylase&doi=10.1124%2Fmol.107.034041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Quercetin activates an angiogenic pathway, hypoxia inducible factor (HIF)-1-vascular endothelial growth factor, by inhibiting HIF-prolyl hydroxylase: a structural analysis of quercetin for inhibiting HIF-prolyl hydroxylase</span></div><div class="casAuthors">Jeon, Hyunchu; Kim, Heejung; Choi, Daekyu; Kim, Duksoo; Park, Shi-Young; Kim, Yung-Jin; Kim, Young Mi; Jung, Yunjin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1676-1684</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">We investigated a mol. mechanism underlying quercetin-mediated amelioration of colonic mucosal injury and analyzed chem. structure contributing to the quercetin's effect.  Quercetin up-regulated vascular endothelial growth factor (VEGF), an ulcer healing factor, not only in colon epithelial cell lines but also in the inflamed colonic tissue.  VEGF derived from quercetin-treated colon epithelial cells promoted tube formation.  The VEGF induction was dependent on quercetin-mediated hypoxia-inducible factor-1 (HIF-1) activation.  Quercetin delayed HIF-1α protein disappearance, which occurred by inhibiting HIF-prolyl hydroxylase (HPH), the key enzyme for HIF-1α hydroxylation and subsequent von Hippel Lindau-dependent HIF-1α degrdn.  HPH inhibition by quercetin was neutralized significantly by an elevated dose of iron.  Consistent with this, cellular induction of HIF-1α by quercetin was abolished by pretreatment with iron.  Two iron-chelating moieties in quercetin, -OH at position 3 of the C ring and/or -OH at positions 3' and 4' of the B ring, enabled the flavonoid to inhibit HPH and subsequently induce HIF-1α.  Our data suggest that the clin. effect of quercetin may be partly attributed to the activation of an angiogenic pathway HIF-1-VEGF via inhibiting HPH and the chelating moieties of quercetin were required for inhibiting HPH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcK39oTOUrSbVg90H21EOLACvtfcHk0liJe25q6XxtfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Wqtbk%253D&md5=8d5147dfa2b36e05a88b5fbd4d1ac955</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.034041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.034041%26sid%3Dliteratum%253Aachs%26aulast%3DJeon%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DChoi%26aufirst%3DD.%26aulast%3DKim%26aufirst%3DD.%26aulast%3DPark%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DJung%26aufirst%3DY.%26atitle%3DQuercetin%2520activates%2520an%2520angiogenic%2520pathway%252C%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529-1-vascular%2520endothelial%2520growth%2520factor%252C%2520by%2520inhibiting%2520HIF-prolyl%2520hydroxylase%253A%2520a%2520structural%2520analysis%2520of%2520quercetin%2520for%2520inhibiting%2520HIF-prolyl%2520hydroxylase%26jtitle%3DMol.%2520Pharmacol.%26date%3D2007%26volume%3D71%26issue%3D6%26spage%3D1676%26epage%3D1684%26doi%3D10.1124%2Fmol.107.034041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltier, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bembenek, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanelakis, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonard, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocutt, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomino, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brondstetter, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haugh, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzadegan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shankley, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrett, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabinowitz, M. H.</span></span> <span> </span><span class="NLM_article-title">Benzimidazole-2-pyrazole HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">526</span>– <span class="NLM_lpage">529</span>, <span class="refDoi"> DOI: 10.1021/ml100198y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100198y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Cgs7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=526-529&issue=9&author=M.+D.+Rosenauthor=H.+Venkatesanauthor=H.+M.+Peltierauthor=S.+D.+Bembenekauthor=K.+C.+Kanelakisauthor=L.+X.+Zhaoauthor=B.+E.+Leonardauthor=F.+M.+Hocuttauthor=X.+Wuauthor=H.+L.+Palominoauthor=T.+I.+Brondstetterauthor=P.+V.+Haughauthor=L.+Cagnonauthor=W.+Yanauthor=L.+A.+Liottaauthor=A.+Youngauthor=T.+Mirzadeganauthor=N.+P.+Shankleyauthor=T.+D.+Barrettauthor=M.+H.+Rabinowitz&title=Benzimidazole-2-pyrazole+HIF+prolyl+4-hydroxylase+inhibitors+as+oral+erythropoietin+secretagogues&doi=10.1021%2Fml100198y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues</span></div><div class="casAuthors">Rosen, Mark D.; Venkatesan, Hariharan; Peltier, Hillary M.; Bembenek, Scott D.; Kanelakis, Kimon C.; Zhao, Lucy X.; Leonard, Barry E.; Hocutt, Frances M.; Wu, Xiaodong; Palomino, Heather L.; Brondstetter, Theresa I.; Haugh, Peter V.; Cagnon, Laurence; Yan, Wen; Liotta, Lisa A.; Young, Andrew; Mirzadegan, Tara; Shankley, Nigel P.; Barrett, Terrance D.; Rabinowitz, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">526-529</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIF prolyl 4-hydroxylases (PHD) are a family of enzymes that mediate key physiol. responses to hypoxia by modulating the levels of hypoxia inducible factor 1-α (HIF1α).  Certain benzimidazole-2-pyrazole carboxylates, e.g., I were discovered to be PHD2 inhibitors using ligand- and structure-based methods and found to be potent, orally efficacious stimulators of erythropoietin secretion in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJr3s7CR6lOLVg90H21EOLACvtfcHk0lgVv4d8IB33yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Cgs7nI&md5=b60c31a48faf7fd9824e143287b685e3</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fml100198y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100198y%26sid%3Dliteratum%253Aachs%26aulast%3DRosen%26aufirst%3DM.%2BD.%26aulast%3DVenkatesan%26aufirst%3DH.%26aulast%3DPeltier%26aufirst%3DH.%2BM.%26aulast%3DBembenek%26aufirst%3DS.%2BD.%26aulast%3DKanelakis%26aufirst%3DK.%2BC.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26aulast%3DHocutt%26aufirst%3DF.%2BM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DPalomino%26aufirst%3DH.%2BL.%26aulast%3DBrondstetter%26aufirst%3DT.%2BI.%26aulast%3DHaugh%26aufirst%3DP.%2BV.%26aulast%3DCagnon%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DW.%26aulast%3DLiotta%26aufirst%3DL.%2BA.%26aulast%3DYoung%26aufirst%3DA.%26aulast%3DMirzadegan%26aufirst%3DT.%26aulast%3DShankley%26aufirst%3DN.%2BP.%26aulast%3DBarrett%26aufirst%3DT.%2BD.%26aulast%3DRabinowitz%26aufirst%3DM.%2BH.%26atitle%3DBenzimidazole-2-pyrazole%2520HIF%2520prolyl%25204-hydroxylase%2520inhibitors%2520as%2520oral%2520erythropoietin%2520secretagogues%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26issue%3D9%26spage%3D526%26epage%3D529%26doi%3D10.1021%2Fml100198y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candela-Lena, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenald, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, N. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conejo-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathavan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Eeden, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1488</span>– <span class="NLM_lpage">1496</span>, <span class="refDoi"> DOI: 10.1021/cb400088q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb400088q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1488-1496&issue=7&author=R.+Chowdhuryauthor=J.+I.+Candela-Lenaauthor=M.+C.+Chanauthor=D.+J.+Greenaldauthor=K.+K.+Yeohauthor=Y.+M.+Tianauthor=M.+A.+McDonoughauthor=A.+Tumberauthor=N.+R.+Roseauthor=A.+Conejo-Garciaauthor=M.+Demetriadesauthor=S.+Mathavanauthor=A.+Kawamuraauthor=M.+K.+Leeauthor=F.+van+Eedenauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Selective+small+molecule+probes+for+the+hypoxia+inducible+factor+%28HIF%29+prolyl+hydroxylases&doi=10.1021%2Fcb400088q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Selective small molecule probes for the hypoxia inducible factor (HIF) prolyl hydroxylases</span></div><div class="casAuthors">Chowdhury, Rasheduzzaman; Candela-Lena, Jose Ignacio; Chan, Mun Chiang; Greenald, David Jeremy; Yeoh, Kar Kheng; Tian, Ya-Min; McDonough, Michael A.; Tumber, Anthony; Rose, Nathan R.; Conejo-Garcia, Ana; Demetriades, Marina; Mathavan, Sinnakaruppan; Kawamura, Akane; Lee, Myung Kyu; van Eeden, Freek; Pugh, Christopher W.; Ratcliffe, Peter J.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1488-1496</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hypoxia inducible factor (HIF) system is central to the signaling of low oxygen (hypoxia) in animals.  The levels of HIF-α isoforms are regulated in an oxygen-dependent manner by the activity of the HIF prolyl-hydroxylases (PHD or EGLN enzymes), which are Fe(II) and 2-oxoglutarate (2OG) dependent oxygenases.  Here, we describe biochem., crystallog., cellular profiling, and animal studies on PHD inhibitors including selectivity studies using a representative set of human 2OG oxygenases.  We identify suitable probe compds. for use in studies on the functional effects of PHD inhibition in cells and in animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprl-2yCzTAKbVg90H21EOLACvtfcHk0lgVv4d8IB33yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGjtrs%253D&md5=c857df3bdae0b9b29760200cea91fce0</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fcb400088q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb400088q%26sid%3Dliteratum%253Aachs%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DCandela-Lena%26aufirst%3DJ.%2BI.%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DGreenald%26aufirst%3DD.%2BJ.%26aulast%3DYeoh%26aufirst%3DK.%2BK.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DRose%26aufirst%3DN.%2BR.%26aulast%3DConejo-Garcia%26aufirst%3DA.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DMathavan%26aufirst%3DS.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3Dvan%2BEeden%26aufirst%3DF.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520small%2520molecule%2520probes%2520for%2520the%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529%2520prolyl%2520hydroxylases%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26issue%3D7%26spage%3D1488%26epage%3D1496%26doi%3D10.1021%2Fcb400088q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lienard, B. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zondlo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oldham, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifton, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurzeja, R. J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Syed, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span> (<span class="NLM_issue">26</span>),  <span class="NLM_fpage">9814</span>– <span class="NLM_lpage">9819</span>, <span class="refDoi"> DOI: 10.1073/pnas.0601283103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.0601283103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=16782814" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=9814-9819&issue=26&author=M.+A.+McDonoughauthor=V.+Liauthor=E.+Flashmanauthor=R.+Chowdhuryauthor=C.+Mohrauthor=B.+M.+R.+Lienardauthor=J.+Zondloauthor=N.+J.+Oldhamauthor=I.+J.+Cliftonauthor=J.+Lewisauthor=L.+A.+McNeillauthor=R.+J.+M.+Kurzejaauthor=K.+S.+Hewitsonauthor=E.+Yangauthor=S.+Jordanauthor=R.+S.+Syedauthor=C.+J.+Schofield&title=Cellular+oxygen+sensing%3A+crystal+structure+of+hypoxia-inducible+factor+prolyl+hydroxylase+%28PHD2%29&doi=10.1073%2Fpnas.0601283103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular oxygen sensing: crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)</span></div><div class="casAuthors">McDonough, Michael A.; Li, Vivian; Flashman, Emily; Chowdhury, Rasheduzzaman; Mohr, Christopher; Lienard, Benoit M. R.; Zondlo, James; Oldham, Neil J.; Clifton, Ian J.; Lewis, Jeffrey; McNeill, Luke A.; Kurzeja, Robert J. M.; Hewitson, Kirsty S.; Yang, Evelyn; Jordan, Steven; Syed, Rashid S.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">9814-9819</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cellular and physiol. responses to changes in dioxygen levels in metazoans are mediated via the posttranslational oxidn. of hypoxia-inducible transcription factor (HIF).  Hydroxylation of conserved prolyl residues in the HIF-α subunit, catalyzed by HIF prolyl-hydroxylases (PHDs), signals for its proteasomal degrdn.  The requirement of the PHDs for dioxygen links changes in dioxygen levels with the transcriptional regulation of the gene array that enables the cellular response to chronic hypoxia; the PHDs thus act as an oxygen-sensing component of the HIF system, and their inhibition mimics the hypoxic response.  We describe crystal structures of the catalytic domain of human PHD2, an important prolyl-4-hydroxylase in the human hypoxic response in normal cells, in complex with Fe(II) and an inhibitor to 1.7 Å resoln.  PHD2 crystallizes as a homotrimer and contains a double-stranded β-helix core fold common to the Fe(II) and 2-oxoglutarate-dependent dioxygenase family, the residues of which are well conserved in the three human PHD enzymes (PHD 1-3).  The structure provides insights into the hypoxic response, helps to rationalize a clin. obsd. mutation leading to familial erythrocytosis, and will aid in the design of PHD selective inhibitors for the treatment of anemia and ischemic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbXKAbBi_2YrVg90H21EOLACvtfcHk0lgWAvuPiQQNaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVajt78%253D&md5=2829121b3017e69b547b95ec5f28cd1b</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601283103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601283103%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMohr%26aufirst%3DC.%26aulast%3DLienard%26aufirst%3DB.%2BM.%2BR.%26aulast%3DZondlo%26aufirst%3DJ.%26aulast%3DOldham%26aufirst%3DN.%2BJ.%26aulast%3DClifton%26aufirst%3DI.%2BJ.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DKurzeja%26aufirst%3DR.%2BJ.%2BM.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DJordan%26aufirst%3DS.%26aulast%3DSyed%26aufirst%3DR.%2BS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DCellular%2520oxygen%2520sensing%253A%2520crystal%2520structure%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520%2528PHD2%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26issue%3D26%26spage%3D9814%26epage%3D9819%26doi%3D10.1073%2Fpnas.0601283103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atasoylu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumber, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Perez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demetriades, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rydzik, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt-Martyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claridge, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0132004</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0132004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1371%2Fjournal.pone.0132004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26147748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsVWjsb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&issue=7&author=M.+C.+Chanauthor=O.+Atasoyluauthor=E.+Hodsonauthor=A.+Tumberauthor=I.+K.+Leungauthor=R.+Chowdhuryauthor=V.+Gomez-Perezauthor=M.+Demetriadesauthor=A.+M.+Rydzikauthor=J.+Holt-Martynauthor=Y.+M.+Tianauthor=T.+Bishopauthor=T.+D.+Claridgeauthor=A.+Kawamuraauthor=C.+W.+Pughauthor=P.+J.+Ratcliffeauthor=C.+J.+Schofield&title=Potent+and+selective+triazole-based+inhibitors+of+the+hypoxia-inducible+factor+prolyl-hydroxylases+with+activity+in+the+murine+brain&doi=10.1371%2Fjournal.pone.0132004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain</span></div><div class="casAuthors">Chan, Mun Chiang; Atasoylu, Onur; Hodson, Emma; Tumber, Anthony; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Gomez-Perez, Veronica; Demetriades, Marina; Rydzik, Anna M.; Holt-Martyn, James; Tian, Ya-Min; Bishop, Tammie; Claridge, Timothy D. W.; Kawamura, Akane; Pugh, Christopher W.; Ratcliffe, Peter J.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">e0132004/1-e0132004/17</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs).  Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs).  Here, we report studies on tricyclic triazole-contg. compds. as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate.  One compd. (IOX4) induces HIFα in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtXPcYJjl7_bVg90H21EOLACvtfcHk0lhM21VU252Iyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsVWjsb%252FE&md5=2b95483f1984bfb745acf0fad2a902a3</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132004%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DM.%2BC.%26aulast%3DAtasoylu%26aufirst%3DO.%26aulast%3DHodson%26aufirst%3DE.%26aulast%3DTumber%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DGomez-Perez%26aufirst%3DV.%26aulast%3DDemetriades%26aufirst%3DM.%26aulast%3DRydzik%26aufirst%3DA.%2BM.%26aulast%3DHolt-Martyn%26aufirst%3DJ.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DClaridge%26aufirst%3DT.%2BD.%26aulast%3DKawamura%26aufirst%3DA.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DPotent%2520and%2520selective%2520triazole-based%2520inhibitors%2520of%2520the%2520hypoxia-inducible%2520factor%2520prolyl-hydroxylases%2520with%2520activity%2520in%2520the%2520murine%2520brain%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26issue%3D7%26doi%3D10.1371%2Fjournal.pone.0132004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joharapurkar, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandya, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M. R.</span></span> <span> </span><span class="NLM_article-title">Prolyl hydroxylase inhibitors: a breakthrough in the therapy of anemia associated with chronic diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">6964</span>– <span class="NLM_lpage">6982</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01686</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01686" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXos1Gmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6964-6982&issue=16&author=A.+A.+Joharapurkarauthor=V.+B.+Pandyaauthor=V.+J.+Patelauthor=R.+C.+Desaiauthor=M.+R.+Jain&title=Prolyl+hydroxylase+inhibitors%3A+a+breakthrough+in+the+therapy+of+anemia+associated+with+chronic+diseases&doi=10.1021%2Facs.jmedchem.7b01686"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases</span></div><div class="casAuthors">Joharapurkar, Amit A.; Pandya, Vrajesh B.; Patel, Vishal J.; Desai, Ranjit C.; Jain, Mukul R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6964-6982</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Chronic kidney disease, cancer, chronic inflammatory disorders, nutritional, and genetic deficiency can cause anemia.  Hypoxia causes induction of hypoxia-inducible factor (HIF), which stimulates erythropoietin (EPO) synthesis.  Prolyl hydroxylase domain (PHD) enzyme inhibition can stabilize hypoxia-inducible factor (HIF).  HIF stabilization also decreases hepcidin, a hormone of hepatic origin, which regulates iron homeostasis.  PHD inhibitors represent a novel pharmacol. treatment of anemia assocd. with chronic diseases.  Many orally active PHD inhibitors like roxadustat, molidustat, vadadustat, and desidustat are in late phase clin. trials.  This review discusses the role of PHD inhibitors in the treatment of anemia assocd. with chronic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSEZtvGwIdjbVg90H21EOLACvtfcHk0lhM21VU252Iyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXos1Gmurg%253D&md5=535ba40985e28405c250b40dc003ff6b</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01686%26sid%3Dliteratum%253Aachs%26aulast%3DJoharapurkar%26aufirst%3DA.%2BA.%26aulast%3DPandya%26aufirst%3DV.%2BB.%26aulast%3DPatel%26aufirst%3DV.%2BJ.%26aulast%3DDesai%26aufirst%3DR.%2BC.%26aulast%3DJain%26aufirst%3DM.%2BR.%26atitle%3DProlyl%2520hydroxylase%2520inhibitors%253A%2520a%2520breakthrough%2520in%2520the%2520therapy%2520of%2520anemia%2520associated%2520with%2520chronic%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D6964%26epage%3D6982%26doi%3D10.1021%2Facs.jmedchem.7b01686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeske, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thede, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stoll, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flamme, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akbaba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ergueden, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keldenich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oehme, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Militzer, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartung, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thuss, U.</span></span> <span> </span><span class="NLM_article-title">Discovery of Molidustat (BAY 85-3934): a small-molecule oral HIF-prolyl hydroxylase (HIF-PH) inhibitor for the Treatment of renal anemia</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">988</span>– <span class="NLM_lpage">1003</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700783</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fcmdc.201700783" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29485740" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXnsVKmtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=988-1003&issue=10&author=H.+Beckauthor=M.+Jeskeauthor=K.+Thedeauthor=F.+Stollauthor=I.+Flammeauthor=M.+Akbabaauthor=J.+K.+Erguedenauthor=G.+Karigauthor=J.+Keldenichauthor=F.+Oehmeauthor=H.+C.+Militzerauthor=I.+V.+Hartungauthor=U.+Thuss&title=Discovery+of+Molidustat+%28BAY+85-3934%29%3A+a+small-molecule+oral+HIF-prolyl+hydroxylase+%28HIF-PH%29+inhibitor+for+the+Treatment+of+renal+anemia&doi=10.1002%2Fcmdc.201700783"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia</span></div><div class="casAuthors">Beck, Hartmut; Jeske, Mario; Thede, Kai; Stoll, Friederike; Flamme, Ingo; Akbaba, Metin; Ergueden, Jens-Kerim; Karig, Gunter; Keldenich, Joerg; Oehme, Felix; Militzer, Hans-Christian; Hartung, Ingo V.; Thuss, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">988-1003</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Small-mol. inhibitors of hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) are currently under clin. development as novel treatment options for chronic kidney disease (CKD) assocd. anemia.  Inhibition of HIF-PH mimics hypoxia and leads to increased erythropoietin (EPO) expression and subsequently increased erythropoiesis.  Herein the authors describe the discovery, synthesis, structure-activity relationship (SAR), and proposed binding mode of novel 2,4-diheteroaryl-1,2-dihydro-3H-pyrazol-3-ones as orally bioavailable HIF-PH inhibitors for the treatment of anemia.  High-throughput screening of the authors' corporate compd. library identified BAY-908 as a promising hit.  The lead optimization program then resulted in the identification of molidustat (BAY 85-3934), a novel small-mol. oral HIF-PH inhibitor.  Molidustat is currently being investigated in clin. phase III trials as molidustat sodium for the treatment of anemia in patients with CKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiZ1SDboNjPrVg90H21EOLACvtfcHk0lhLZczlBmL8Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXnsVKmtbk%253D&md5=9f2d758b31c41092e108d266a76ec451</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700783&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700783%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%26aulast%3DJeske%26aufirst%3DM.%26aulast%3DThede%26aufirst%3DK.%26aulast%3DStoll%26aufirst%3DF.%26aulast%3DFlamme%26aufirst%3DI.%26aulast%3DAkbaba%26aufirst%3DM.%26aulast%3DErgueden%26aufirst%3DJ.%2BK.%26aulast%3DKarig%26aufirst%3DG.%26aulast%3DKeldenich%26aufirst%3DJ.%26aulast%3DOehme%26aufirst%3DF.%26aulast%3DMilitzer%26aufirst%3DH.%2BC.%26aulast%3DHartung%26aufirst%3DI.%2BV.%26aulast%3DThuss%26aufirst%3DU.%26atitle%3DDiscovery%2520of%2520Molidustat%2520%2528BAY%252085-3934%2529%253A%2520a%2520small-molecule%2520oral%2520HIF-prolyl%2520hydroxylase%2520%2528HIF-PH%2529%2520inhibitor%2520for%2520the%2520Treatment%2520of%2520renal%2520anemia%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26issue%3D10%26spage%3D988%26epage%3D1003%26doi%3D10.1002%2Fcmdc.201700783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogoshi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitani, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terashita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motoda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotta, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hase, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukui, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshiuchi, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abe, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1320</span>– <span class="NLM_lpage">1325</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.7b00404</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.7b00404" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1320-1325&issue=12&author=Y.+Ogoshiauthor=T.+Matsuiauthor=I.+Mitaniauthor=M.+Yokotaauthor=M.+Terashitaauthor=D.+Motodaauthor=K.+Ueyamaauthor=T.+Hottaauthor=T.+Itoauthor=Y.+Haseauthor=K.+Fukuiauthor=K.+Deaiauthor=H.+S.+Yoshiuchiauthor=S.+Itoauthor=H.+Abe&title=Discovery+of+JTZ-951%3A+a+HIF+prolyl+hydroxylase+inhibitor+for+the+treatment+of+renal+anemia&doi=10.1021%2Facsmedchemlett.7b00404"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia</span></div><div class="casAuthors">Ogoshi, Yosuke; Matsui, Takuya; Mitani, Ikuo; Yokota, Masahiro; Terashita, Masakazu; Motoda, Dai; Ueyama, Kazuhito; Hotta, Takahiro; Ito, Takashi; Hase, Yasunori; Fukui, Kenji; Deai, Katsuya; Yoshiuchi, Hiromi; Ito, Soichiro; Abe, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1320-1325</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of hypoxia inducible factor prolyl hydroxylase (PHD) represents a promising strategy for the discovery of a next generation treatment for renal anemia.  We identified several 5,6-fused ring systems as novel scaffolds of the PHD inhibitor on the basis of pharmacophore anal.  In particular, triazolopyridine derivs. showed potent PHD2 inhibitory activities.  Examn. of the predominance of the triazolopyridines in potency by electrostatic calcns. suggested favorable π-π stacking interactions with Tyr310.  Lead optimization to improve the efficacy of erythropoietin release in cells and in vivo by improving cell permeability led to the discovery of JTZ-951 (compd. 14), with a 5-phenethyl substituent on the triazolopyridine group, which increased Hb levels with daily oral dosing in rats.  Compd. 14 was rapidly absorbed after oral administration and disappeared shortly thereafter, which could be advantageous in terms of safety.  Compd. 14 was selected as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyv_5DiDhDq7Vg90H21EOLACvtfcHk0lhLZczlBmL8Cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVCksrbM&md5=f1fb9366a5c92eafabb512f2e2fecc23</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.7b00404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.7b00404%26sid%3Dliteratum%253Aachs%26aulast%3DOgoshi%26aufirst%3DY.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DMitani%26aufirst%3DI.%26aulast%3DYokota%26aufirst%3DM.%26aulast%3DTerashita%26aufirst%3DM.%26aulast%3DMotoda%26aufirst%3DD.%26aulast%3DUeyama%26aufirst%3DK.%26aulast%3DHotta%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DHase%26aufirst%3DY.%26aulast%3DFukui%26aufirst%3DK.%26aulast%3DDeai%26aufirst%3DK.%26aulast%3DYoshiuchi%26aufirst%3DH.%2BS.%26aulast%3DIto%26aufirst%3DS.%26aulast%3DAbe%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520JTZ-951%253A%2520a%2520HIF%2520prolyl%2520hydroxylase%2520inhibitor%2520for%2520the%2520treatment%2520of%2520renal%2520anemia%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26issue%3D12%26spage%3D1320%26epage%3D1325%26doi%3D10.1021%2Facsmedchemlett.7b00404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Provenzano, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besarab, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diamond, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durham, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cangiano, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiello, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikali, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemmerich, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczech, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neff, T. B.</span></span> <span> </span><span class="NLM_article-title">Oral hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD</span>. <i>Clin. J. Am. Soc. Nephrol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">982</span>– <span class="NLM_lpage">991</span>, <span class="refDoi"> DOI: 10.2215/CJN.06890615</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.2215%2FCJN.06890615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27094610" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVSks7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=982-991&issue=6&author=R.+Provenzanoauthor=A.+Besarabauthor=C.+H.+Sunauthor=S.+A.+Diamondauthor=J.+H.+Durhamauthor=J.+L.+Cangianoauthor=J.+R.+Aielloauthor=J.+E.+Novakauthor=T.+Leeauthor=R.+Leongauthor=B.+K.+Robertsauthor=K.+G.+Saikaliauthor=S.+Hemmerichauthor=L.+A.+Szczechauthor=K.+H.+Yuauthor=T.+B.+Neff&title=Oral+hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor+roxadustat+%28FG-4592%29+for+the+treatment+of+anemia+in+patients+with+CKD&doi=10.2215%2FCJN.06890615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Oral hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) for the treatment of anemia in patients with CKD</span></div><div class="casAuthors">Provenzano, Robert; Besarab, Anatole; Sun, Chao H.; Diamond, Susan A.; Durham, John H.; Cangiano, Jose L.; Aiello, Joseph R.; Novak, James E.; Lee, Tyson; Leong, Robert; Roberts, Brian K.; Saikali, Khalil G.; Hemmerich, Stefan; Szczech, Lynda A.; Yu, Kin-Hung Peony; Neff, Thomas B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">982-991</span>CODEN:
                <span class="NLM_cas:coden">CJASC7</span>;
        ISSN:<span class="NLM_cas:issn">1555-9041</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Background and objectives: Roxadustat (FG-4592), an oral hypoxia-inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, regulates iron metab., and reduces hepcidin, was evaluated in this phase 2b study for safety, efficacy, optimal dose, and dose frequency in patients with nondialysis CKD.  Design, setting, participants, & measurements: The 145 patients with nondialysis CKD and Hb ≤10.5 g/dL were randomized into one of six cohorts of approx. 24 patients each with varying roxadustat starting doses (tiered wt. and fixed amts.) and frequencies (two and three times weekly) followed by Hb maintenance with roxadustat one to three times weekly.  Treatment duration was 16 or 24 wk.  I.v. iron was prohibited.  The primary end point was the proportion of patients achieving Hb increase of ≥1.0 g/dL from baseline and Hb of ≥11.0 g/dL by week 17 (16 wk of treatment).  Secondary analyses included mean Hb change from baseline, iron utilization, and serum lipids.  Safety was evaluated by frequency/severity of adverse events.  Results: Of the 145 patients enrolled, 143 were evaluable for efficacy.  Overall, 92% of patients achieved Hb response.  Higher compared with lower starting doses led to earlier achievement of Hb response.  Roxadustat-induced Hb increases were independent of baseline C-reactive protein levels and iron repletion status.  Overall, over the first 16 treatment weeks, hepcidin levels decreased by 16.9% (P = 0.004), reticulocyte Hb content was maintained, and Hb increased by a mean (±SD) of 1.83 (±0.09) g/dL (P<0.001).  Overall mean total cholesterol level was reduced by a mean (±SD) of 26 (±30) mg/dL (P<0.001) after 8 wk of therapy, independent of the use of statins or other lipid-lowering agents.  No drug-related serious adverse events were reported.  Conclusions: In patients with nondialysis CKD who were anemic, various starting dose regimens of roxadustat were well tolerated and achieved anemia correction with reduced serum hepcidin levels.  After anemia correction, Hb was maintained by roxadustat at various dose frequencies without i.v. iron supplementation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVZ7-oE2mfNrVg90H21EOLACvtfcHk0lhs7eovrmLsyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVSks7bI&md5=710c58a01b4b7c6e2e610273ec82e26b</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2215%2FCJN.06890615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2215%252FCJN.06890615%26sid%3Dliteratum%253Aachs%26aulast%3DProvenzano%26aufirst%3DR.%26aulast%3DBesarab%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DC.%2BH.%26aulast%3DDiamond%26aufirst%3DS.%2BA.%26aulast%3DDurham%26aufirst%3DJ.%2BH.%26aulast%3DCangiano%26aufirst%3DJ.%2BL.%26aulast%3DAiello%26aufirst%3DJ.%2BR.%26aulast%3DNovak%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DT.%26aulast%3DLeong%26aufirst%3DR.%26aulast%3DRoberts%26aufirst%3DB.%2BK.%26aulast%3DSaikali%26aufirst%3DK.%2BG.%26aulast%3DHemmerich%26aufirst%3DS.%26aulast%3DSzczech%26aufirst%3DL.%2BA.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DNeff%26aufirst%3DT.%2BB.%26atitle%3DOral%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%2520roxadustat%2520%2528FG-4592%2529%2520for%2520the%2520treatment%2520of%2520anemia%2520in%2520patients%2520with%2520CKD%26jtitle%3DClin.%2520J.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D982%26epage%3D991%26doi%3D10.2215%2FCJN.06890615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vachal, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guiadeen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colandrea, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyvratt, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollapudi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keohane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandala, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhuebel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kieczykowski, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleitz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Athanasopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akyuz, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jena, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lusen, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stein, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">1,3,8-triazaspiro(4.5)decane-2,4-diones as efficacious pan-inhibitors of hypoxia-Inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2945</span>– <span class="NLM_lpage">2959</span>, <span class="refDoi"> DOI: 10.1021/jm201542d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201542d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=2945-2959&issue=7&author=P.+Vachalauthor=S.+Miaoauthor=J.+M.+Pierceauthor=D.+Guiadeenauthor=V.+J.+Colandreaauthor=M.+J.+Wyvrattauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=J.+A.+Milliganauthor=R.+Hajduauthor=A.+Gollapudiauthor=C.+A.+Keohaneauthor=R.+B.+Linghamauthor=S.+M.+Mandalaauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=D.+Steinhuebelauthor=G.+R.+Kieczykowskiauthor=F.+J.+Fleitzauthor=K.+Chapmanauthor=J.+Athanasopoulosauthor=G.+Adamauthor=C.+D.+Akyuzauthor=D.+K.+Jenaauthor=J.+W.+Lusenauthor=J.+Mengauthor=B.+D.+Steinauthor=L.+Xiaauthor=E.+C.+Shererauthor=J.+J.+Hale&title=1%2C3%2C8-triazaspiro%284.5%29decane-2%2C4-diones+as+efficacious+pan-inhibitors+of+hypoxia-Inducible+factor+prolyl+hydroxylase+1-3+%28HIF+PHD1-3%29+for+the+treatment+of+anemia&doi=10.1021%2Fjm201542d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Vachal, Petr; Miao, Shouwu; Pierce, Joan M.; Guiadeen, Deodial; Colandrea, Vincent J.; Wyvratt, Matthew J.; Salowe, Scott P.; Sonatore, Lisa M.; Milligan, James A.; Hajdu, Richard; Gollapudi, Anantha; Keohane, Carol A.; Lingham, Russell B.; Mandala, Suzanne M.; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Steinhuebel, Dietrich; Kieczykowski, Gerard R.; Fleitz, Fred J.; Chapman, Kevin; Athanasopoulos, John; Adam, Gregory; Akyuz, Can D.; Jena, Dhirendra K.; Lusen, Jeffrey W.; Meng, Juncai; Stein, Benjamin D.; Xia, Lei; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2945-2959</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of 1,3,8-triazaspiro[4.5]decane-2,4-diones (spirohydantoins) as a structural class of pan-inhibitors of the prolyl hydroxylase (PHD) family of enzymes for the treatment of anemia is described.  The initial hit class, spirooxindoles, was identified through affinity selection mass spectrometry (AS-MS) and optimized for PHD2 inhibition and optimal PK/PD profile (short-acting PHDi inhibitors). 1,3,8-Triazaspiro[4.5]decane-2,4-diones (spirohydantoins) were optimized as an advanced lead class derived from the original spiroindole hit.  A new set of general conditions for C-N coupling, developed using a high-throughput experimentation (HTE) technique, enabled a full SAR anal. of the spirohydantoins.  This rapid and directed SAR exploration has resulted in the first reported examples of hydantoin derivs. with good PK in preclin. species.  Potassium channel off-target activity (hERG) was successfully eliminated through the systematic introduction of acidic functionality to the mol. structure.  Undesired upregulation of alanine aminotransferase (ALT) liver enzymes was mitigated and a robust on-/off-target margin was achieved.  Spirohydantoins represent a class of highly efficacious, short-acting PHD1-3 inhibitors causing a robust erythropoietin (EPO) upregulation in vivo in multiple preclin. species.  This profile deems spirohydantoins as attractive short-acting PHDi inhibitors with the potential for treatment of anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMoX0fQFHBsLVg90H21EOLACvtfcHk0lhJ4atz3ItqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOhtLs%253D&md5=3d23fd3c5379c259eb556d1fac6133de</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm201542d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201542d%26sid%3Dliteratum%253Aachs%26aulast%3DVachal%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DS.%26aulast%3DPierce%26aufirst%3DJ.%2BM.%26aulast%3DGuiadeen%26aufirst%3DD.%26aulast%3DColandrea%26aufirst%3DV.%2BJ.%26aulast%3DWyvratt%26aufirst%3DM.%2BJ.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DGollapudi%26aufirst%3DA.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DMandala%26aufirst%3DS.%2BM.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DSteinhuebel%26aufirst%3DD.%26aulast%3DKieczykowski%26aufirst%3DG.%2BR.%26aulast%3DFleitz%26aufirst%3DF.%2BJ.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DAthanasopoulos%26aufirst%3DJ.%26aulast%3DAdam%26aufirst%3DG.%26aulast%3DAkyuz%26aufirst%3DC.%2BD.%26aulast%3DJena%26aufirst%3DD.%2BK.%26aulast%3DLusen%26aufirst%3DJ.%2BW.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DStein%26aufirst%3DB.%2BD.%26aulast%3DXia%26aufirst%3DL.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3D1%252C3%252C8-triazaspiro%25284.5%2529decane-2%252C4-diones%2520as%2520efficacious%2520pan-inhibitors%2520of%2520hypoxia-Inducible%2520factor%2520prolyl%2520hydroxylase%25201-3%2520%2528HIF%2520PHD1-3%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26issue%3D7%26spage%3D2945%26epage%3D2959%26doi%3D10.1021%2Fjm201542d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Click chemistry-based discovery of (3-Hydroxy-5-(1H-1,2,3-triazol-4-yl) picolinoyl) glycines as orally active hypoxia-inducing factor prolyl hydroxylase inhibitors with favorable safety profiles for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">5332</span>– <span class="NLM_lpage">5349</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00549</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00549" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5332-5349&issue=12&author=Y.+Wuauthor=Z.+Jiangauthor=Z.+Liauthor=J.+Guauthor=Q.+Youauthor=X.+Zhang&title=Click+chemistry-based+discovery+of+%283-Hydroxy-5-%281H-1%2C2%2C3-triazol-4-yl%29+picolinoyl%29+glycines+as+orally+active+hypoxia-inducing+factor+prolyl+hydroxylase+inhibitors+with+favorable+safety+profiles+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.8b00549"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Click Chemistry-Based Discovery of [3-Hydroxy-5-(1H-1,2,3-triazol-4-yl)picolinoyl]glycines as Orally Active Hypoxia-Inducing Factor Prolyl Hydroxylase Inhibitors with Favorable Safety Profiles for the Treatment of Anemia</span></div><div class="casAuthors">Wu, Yue; Jiang, Zhensheng; Li, Zhihong; Gu, Jing; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5332-5349</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As a gene assocd. with anemia, the erythropoiesis gene is physiol. expressed under hypoxia regulated by †hypoxia-inducing factor-α (HIF-α).  Thus, stabilizing HIF-α is a potent strategy to stimulate the expression and secretion of erythropoiesis.  In this study, we applied click chem. to the discovery of HIF prolyl hydroxylase 2 (HIF-PHD2) inhibitors for the first time, and a series of triazole compds. showed preferable inhibitory activity in fluorescence polarization assays.  Of particular note was the orally active HIF-PHD inhibitor 15i (IC50 = 62.23 nM), which was almost ten times more active than the phase III drug FG-4592 (IC50 = 591.4 nM).  Furthermore, it can upregulate the Hb of cisplatin-induced anemia mice (120 g/L) to normal levels (160 g/L) with no apparent toxicity obsd. in vivo.  These results confirm that triazole compd. 15i is a promising candidate for the treatment of renal anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt3rmHNKrVXbVg90H21EOLACvtfcHk0lhJ4atz3ItqoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVKktbzL&md5=11a4b00f8d9a883a387acb553510ba2a</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00549%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DClick%2520chemistry-based%2520discovery%2520of%2520%25283-Hydroxy-5-%25281H-1%252C2%252C3-triazol-4-yl%2529%2520picolinoyl%2529%2520glycines%2520as%2520orally%2520active%2520hypoxia-inducing%2520factor%2520prolyl%2520hydroxylase%2520inhibitors%2520with%2520favorable%2520safety%2520profiles%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D12%26spage%3D5332%26epage%3D5349%26doi%3D10.1021%2Facs.jmedchem.8b00549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debenham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(Bis(4-methoxyphenyl)methyl)-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11049</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01242</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01242" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11039-11049&issue=24&author=J.+S.+Debenhamauthor=C.+Madsen-Dugganauthor=M.+J.+Clementsauthor=T.+F.+Walshauthor=J.+T.+Kuetheauthor=M.+Reibarkhauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=R.+Hajduauthor=J.+A.+Milliganauthor=D.+M.+Viscoauthor=D.+Zhouauthor=R.+B.+Linghamauthor=D.+Stickensauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=J.+Pangauthor=R.+R.+Millerauthor=E.+C.+Shererauthor=J.+J.+Hale&title=Discovery+of+N-%28Bis%284-methoxyphenyl%29methyl%29-4-hydroxy-2-%28pyridazin-3-yl%29pyrimidine-5-carboxamide+%28MK-8617%29%2C+an+orally+active+pan-inhibitor+of+hypoxia-inducible+factor+prolyl+hydroxylase+1-3+%28HIF+PHD1-3%29+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.6b01242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Debenham, John S.; Madsen-Duggan, Christina; Clements, Matthew J.; Walsh, Thomas F.; Kuethe, Jeffrey T.; Reibarkh, Mikhail; Salowe, Scott P.; Sonatore, Lisa M.; Hajdu, Richard; Milligan, James A.; Visco, Denise M.; Zhou, Dan; Lingham, Russell B.; Stickens, Dominique; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Pang, Jianmei; Miller, Randy R.; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11049</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) are described.  These are potent, selective, orally bioavailable across several species and are active in stimulating erythropoiesis.  Mouse and rat studies showed hematol. changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration while 4 wk QD po administration in rat elevated Hb levels.  A major focus of the optimization process was to decrease the long half-life obsd. in higher species with early compds.  These efforts led to the identification of 28 (MK-8617) which has advanced to human clin. trials for anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs63u66yCX7Vg90H21EOLACvtfcHk0lg3sT4JYQWLhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN&md5=7acb236af3ca035b010a203f7234a5b7</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01242%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DClements%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DStickens%26aufirst%3DD.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%2528Bis%25284-methoxyphenyl%2529methyl%2529-4-hydroxy-2-%2528pyridazin-3-yl%2529pyrimidine-5-carboxamide%2520%2528MK-8617%2529%252C%2520an%2520orally%2520active%2520pan-inhibitor%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201-3%2520%2528HIF%2520PHD1-3%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D24%26spage%3D11039%26epage%3D11049%26doi%3D10.1021%2Facs.jmedchem.6b01242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayscough, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canning, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Downham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsella, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livermore, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skene, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkens, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, A. G.</span></span> <span> </span><span class="NLM_article-title">1,2,4-Triazolo-(1,5-a)pyridine HIF prolylhydroxylase domain-1 (PHD-1) inhibitors with a novel monodentate binding interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">5663</span>– <span class="NLM_lpage">5672</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00352</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXpslSktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5663-5672&issue=13&author=S.+Ahmedauthor=A.+Ayscoughauthor=G.+R.+Barkerauthor=H.+E.+Canningauthor=R.+Davenportauthor=R.+Downhamauthor=D.+Harrisonauthor=K.+Jenkinsauthor=N.+Kinsellaauthor=D.+G.+Livermoreauthor=S.+Wrightauthor=A.+D.+Ivetacauthor=R.+Skeneauthor=S.+J.+Wilkensauthor=N.+A.+Websterauthor=A.+G.+Hendrick&title=1%2C2%2C4-Triazolo-%281%2C5-a%29pyridine+HIF+prolylhydroxylase+domain-1+%28PHD-1%29+inhibitors+with+a+novel+monodentate+binding+interaction&doi=10.1021%2Facs.jmedchem.7b00352"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,4-Triazolo-[1,5-a]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction</span></div><div class="casAuthors">Ahmed, Saleh; Ayscough, Andrew; Barker, Greg R.; Canning, Hannah E.; Davenport, Richard; Downham, Robert; Harrison, David; Jenkins, Kerry; Kinsella, Natasha; Livermore, David G.; Wright, Susanne; Ivetac, Anthony D.; Skene, Robert; Wilkens, Steven J.; Webster, Natalie A.; Hendrick, Alan G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5663-5672</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein the authors describe the identification of 4-{[1,2,4]triazolo[1,5-a]pyridin-5-yl}benzonitrile-based inhibitors of the hypoxia-inducible factor prolylhydroxylase domain-1 (PHD-1) enzyme.  These inhibitors were shown to possess a novel binding mode by x-ray crystallog., in which the triazolo N1 atom coordinates in a hitherto unreported monodentate interaction with the active site Fe2+ ion, while the benzonitrile group accepts a hydrogen-bonding interaction from the side chain residue of Asn 315.  Further optimization led to potent PHD-1 inhibitors with good physicochem. and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGothtARENldnbVg90H21EOLACvtfcHk0liqA9VRjC1djA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXpslSktb8%253D&md5=765c5e0aa28f0677327046029414656f</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00352%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DAyscough%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DG.%2BR.%26aulast%3DCanning%26aufirst%3DH.%2BE.%26aulast%3DDavenport%26aufirst%3DR.%26aulast%3DDownham%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DK.%26aulast%3DKinsella%26aufirst%3DN.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DWright%26aufirst%3DS.%26aulast%3DIvetac%26aufirst%3DA.%2BD.%26aulast%3DSkene%26aufirst%3DR.%26aulast%3DWilkens%26aufirst%3DS.%2BJ.%26aulast%3DWebster%26aufirst%3DN.%2BA.%26aulast%3DHendrick%26aufirst%3DA.%2BG.%26atitle%3D1%252C2%252C4-Triazolo-%25281%252C5-a%2529pyridine%2520HIF%2520prolylhydroxylase%2520domain-1%2520%2528PHD-1%2529%2520inhibitors%2520with%2520a%2520novel%2520monodentate%2520binding%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26issue%3D13%26spage%3D5663%26epage%3D5672%26doi%3D10.1021%2Facs.jmedchem.7b00352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Geyte, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraisl, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aragones, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mairbaeurl, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Bock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeoung, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollenhauer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgiadou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutherland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>138</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1154</span>, <span class="refDoi"> DOI: 10.1053/j.gastro.2009.09.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1053%2Fj.gastro.2009.09.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=19818783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVCrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2010&pages=1143-1154&issue=3&author=M.+Schneiderauthor=K.+Van+Geyteauthor=P.+Fraislauthor=J.+Kissauthor=J.+Aragonesauthor=M.+Mazzoneauthor=H.+Mairbaeurlauthor=K.+De+Bockauthor=N.+H.+Jeoungauthor=M.+Mollenhauerauthor=M.+Georgiadouauthor=T.+Bishopauthor=C.+Roncalauthor=A.+Sutherlandauthor=B.+Jordanauthor=B.+Gallezauthor=J.+Weitzauthor=R.+A.+Harrisauthor=P.+Maxwellauthor=M.+Baesauthor=P.+Ratcliffeauthor=P.+Carmeliet&title=Loss+or+silencing+of+the+PHD1+prolyl+hydroxylase+protects+livers+of+mice+against+ischemia%2Freperfusion+injury&doi=10.1053%2Fj.gastro.2009.09.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury</span></div><div class="casAuthors">Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Kiss, Judit; Aragones, Julian; Mazzone, Massimiliano; Mairbaeurl, Heimo; De Bock, Katrien; Jeoung, Nam Ho; Mollenhauer, Martin; Georgiadou, Maria; Bishop, Tammie; Roncal, Carmen; Sutherland, Andrew; Jordan, Benedicte; Gallez, Bernard; Weitz, Juergen; Harris, Robert A.; Maxwell, Patrick; Baes, Myriam; Ratcliffe, Peter; Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1143-1154</span>CODEN:
                <span class="NLM_cas:coden">GASTAB</span>;
        ISSN:<span class="NLM_cas:issn">0016-5085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">BACKGROUND & AIMS: Liver ischemia/reperfusion (I/R) injury is a frequent cause of organ dysfunction.  Loss of the oxygen sensor prolyl hydroxylase domain enzyme 1 (PHD1) causes tolerance of skeletal muscle to hypoxia.  We assessed whether loss or short-term silencing of PHD1 could likewise induce hypoxia tolerance in hepatocytes and protect them against hepatic I/R damage.  METHODS: Hepatic ischemia was induced in mice by clamping of the portal vessels of the left lateral liver lobe; 90 min later livers were reperfused for 8 h for I/R expts.  Hepatocyte damage following ischemia or I/R was investigated in PHD1-deficient (PHD1-/-) and wild-type mice or following short hairpin RNA-mediated short-term inhibition of PHD1 in vivo.  RESULTS: PHD1-/- livers were largely protected against acute ischemia or I/R injury.  Among mice subjected to hepatic I/R followed by surgical resection of all nonischemic liver lobes, more than half of wild-type mice succumbed, whereas all PHD1-/- mice survived.  Also, short-term inhibition of PHD1 through RNA interference-mediated silencing provided protection against I/R.  Knockdown of PHD1 also induced hypoxia tolerance of hepatocytes in vitro.  Mechanistically, loss of PHD1 decreased prodn. of oxidative stress, which likely relates to a decrease in oxygen consumption as a result of a reprogramming of hepatocellular metab.  CONCLUSIONS: Loss of PHD1 provided tolerance of hepatocytes to acute hypoxia and protected them against I/R-damage.  Short-term inhibition of PHD1 is a novel therapeutic approach to reducing or preventing I/R-induced liver injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqv8nMbbqAwK7Vg90H21EOLACvtfcHk0liqA9VRjC1djA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVCrtbk%253D&md5=1622d350695c7d592012a1d9f4d76196</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1053%2Fj.gastro.2009.09.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.gastro.2009.09.057%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DVan%2BGeyte%26aufirst%3DK.%26aulast%3DFraisl%26aufirst%3DP.%26aulast%3DKiss%26aufirst%3DJ.%26aulast%3DAragones%26aufirst%3DJ.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DMairbaeurl%26aufirst%3DH.%26aulast%3DDe%2BBock%26aufirst%3DK.%26aulast%3DJeoung%26aufirst%3DN.%2BH.%26aulast%3DMollenhauer%26aufirst%3DM.%26aulast%3DGeorgiadou%26aufirst%3DM.%26aulast%3DBishop%26aufirst%3DT.%26aulast%3DRoncal%26aufirst%3DC.%26aulast%3DSutherland%26aufirst%3DA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DGallez%26aufirst%3DB.%26aulast%3DWeitz%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DR.%2BA.%26aulast%3DMaxwell%26aufirst%3DP.%26aulast%3DBaes%26aufirst%3DM.%26aulast%3DRatcliffe%26aufirst%3DP.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DLoss%2520or%2520silencing%2520of%2520the%2520PHD1%2520prolyl%2520hydroxylase%2520protects%2520livers%2520of%2520mice%2520against%2520ischemia%252Freperfusion%2520injury%26jtitle%3DGastroenterology%26date%3D2010%26volume%3D138%26issue%3D3%26spage%3D1143%26epage%3D1154%26doi%3D10.1053%2Fj.gastro.2009.09.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Majmundar, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factors and the response to hypoxic stress</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/j.molcel.2010.09.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.molcel.2010.09.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=20965423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=294-309&issue=2&author=A.+J.+Majmundarauthor=W.+J.+Wongauthor=M.+C.+Simon&title=Hypoxia-inducible+factors+and+the+response+to+hypoxic+stress&doi=10.1016%2Fj.molcel.2010.09.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-Inducible Factors and the Response to Hypoxic Stress</span></div><div class="casAuthors">Majmundar, Amar J.; Wong, Waihay J.; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">294-309</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Oxygen (O2) is an essential nutrient that serves as a key substrate in cellular metab. and bioenergetics.  In a variety of physiol. and pathol. states, organisms encounter insufficient O2 availability, or hypoxia.  In order to cope with this stress, evolutionarily conserved responses are engaged.  In mammals, the primary transcriptional response to hypoxic stress is mediated by the hypoxia-inducible factors (HIFs).  While canonically regulated by prolyl hydroxylase domain-contg. enzymes (PHDs), the HIFα subunits are intricately responsive to numerous other factors, including factor-inhibiting HIF1α (FIH1), sirtuins, and metabolites.  These transcription factors function in normal tissue homeostasis and impinge on crit. aspects of disease progression and recovery.  Insights from basic HIF biol. are being translated into pharmaceuticals targeting the HIF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_qlyQh52bprVg90H21EOLACvtfcHk0lhmC3lQ6sCDjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlCjtr%252FN&md5=7b9aa81ba8c838c0a9251d79736c10b3</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2010.09.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2010.09.022%26sid%3Dliteratum%253Aachs%26aulast%3DMajmundar%26aufirst%3DA.%2BJ.%26aulast%3DWong%26aufirst%3DW.%2BJ.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DHypoxia-inducible%2520factors%2520and%2520the%2520response%2520to%2520hypoxic%2520stress%26jtitle%3DMol.%2520Cell%26date%3D2010%26volume%3D40%26issue%3D2%26spage%3D294%26epage%3D309%26doi%3D10.1016%2Fj.molcel.2010.09.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koepp, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skowyra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreland, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iliopoulos, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaelin, W. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elledge, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conaway, J. W.</span></span> <span> </span><span class="NLM_article-title">Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>284</i></span> (<span class="NLM_issue">5414</span>),  <span class="NLM_fpage">657</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1126/science.284.5414.657</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1126%2Fscience.284.5414.657" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10213691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1MXislyrur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=1999&pages=657-661&issue=5414&author=T.+Kamuraauthor=D.+M.+Koeppauthor=M.+N.+Conradauthor=D.+Skowyraauthor=R.+J.+Morelandauthor=O.+Iliopoulosauthor=W.+S.+Laneauthor=W.+G.+Kaelinauthor=S.+J.+Elledgeauthor=R.+C.+Conawayauthor=J.+W.+Harperauthor=J.+W.+Conaway&title=Rbx1%2C+a+component+of+the+VHL+tumor+suppressor+complex+and+SCF+ubiquitin+ligase&doi=10.1126%2Fscience.284.5414.657"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase</span></div><div class="casAuthors">Kamura, T.; Koepp, D. M.; Conrad, M. N.; Skowyra, D.; Moreland, R. J.; Iliopoulos, O.; Lane, W. S.; Kaelin, W. G., Jr.; Elledge, S. J.; Conaway, R. C.; Harper, J. W.; Conaway, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">5414</span>),
    <span class="NLM_cas:pages">657-661</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The von Hippel-Lindau (VHL) tumor suppressor gene is mutated in most human kidney cancers.  The VHL protein is part of a complex that includes Elongin B, Elongin C, and Cullin-2, proteins assocd. with transcriptional Elongation and ubiquitination.  Here it is shown that the endogenous VHL complex in rat liver also includes Rbx1, an evolutionarily conserved protein that contains a RING-HZ fingerlike motif and that interacts with Cullins.  The yeast homolog of Rbx1 is a subunit and potent activator of the Cdc53-contg. SCFCdc4 ubiquitin ligase required for ubiquitination of the cyclin-dependent kinase inhibitor Sic1 and for the G1 to S cell cycle transition.  These findings provide a further link between VHL and the cellular ubiquitination machinery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0HMCtDCdH9LVg90H21EOLACvtfcHk0lhmC3lQ6sCDjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXislyrur8%253D&md5=e6db9e408fa978fb4bab8e93b8d1accc</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1126%2Fscience.284.5414.657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.284.5414.657%26sid%3Dliteratum%253Aachs%26aulast%3DKamura%26aufirst%3DT.%26aulast%3DKoepp%26aufirst%3DD.%2BM.%26aulast%3DConrad%26aufirst%3DM.%2BN.%26aulast%3DSkowyra%26aufirst%3DD.%26aulast%3DMoreland%26aufirst%3DR.%2BJ.%26aulast%3DIliopoulos%26aufirst%3DO.%26aulast%3DLane%26aufirst%3DW.%2BS.%26aulast%3DKaelin%26aufirst%3DW.%2BG.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26aulast%3DConaway%26aufirst%3DR.%2BC.%26aulast%3DHarper%26aufirst%3DJ.%2BW.%26aulast%3DConaway%26aufirst%3DJ.%2BW.%26atitle%3DRbx1%252C%2520a%2520component%2520of%2520the%2520VHL%2520tumor%2520suppressor%2520complex%2520and%2520SCF%2520ubiquitin%2520ligase%26jtitle%3DScience%26date%3D1999%26volume%3D284%26issue%3D5414%26spage%3D657%26epage%3D661%26doi%3D10.1126%2Fscience.284.5414.657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesener, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaux, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockman, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wykoff, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maher, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span> <span> </span><span class="NLM_article-title">The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>399</i></span>,  <span class="NLM_fpage">271</span>, <span class="refDoi"> DOI: 10.1038/20459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2F20459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10353251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADyaK1MXjsFyqt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=399&publication_year=1999&pages=271&author=P.+H.+Maxwellauthor=M.+S.+Wiesenerauthor=G.-W.+Changauthor=S.+C.+Cliffordauthor=E.+C.+Vauxauthor=M.+E.+Cockmanauthor=C.+C.+Wykoffauthor=C.+W.+Pughauthor=E.+R.+Maherauthor=P.+J.+Ratcliffe&title=The+tumour+suppressor+protein+VHL+targets+hypoxia-inducible+factors+for+oxygen-dependent+proteolysis&doi=10.1038%2F20459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis</span></div><div class="casAuthors">Maxwell, Patrick H.; Wiesener, Michael S.; Chang, Gin-Wen; Clifford, Steven C.; Vaux, Emma C.; Cockman, Matthew E.; Wykoff, Charles C.; Pugh, Christopher W.; Maher, Eamonn R.; Ratcliffe, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">399</span>
        (<span class="NLM_cas:issue">6733</span>),
    <span class="NLM_cas:pages">271-276</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF-1) has a key role in cellular responses to hypoxia, including the regulation of genes involved in energy metab., angiogenesis and apoptosis.  The α subunits of HIF are rapidly degraded by the proteasome under normal conditions, but are stabilized by hypoxia.  Cobaltous ions or iron chelators mimic hypoxia, indicating that the stimuli may interact through effects on a ferroprotein oxygen sensor.  Here the authors demonstrate a crit. role for the von Hippel-Lindau (VHL) tumor suppressor gene product pVHL in HIF-1 regulation.  In VHL-defective cells, HIF α-subunits are constitutively stabilized and HIF-1 is activated.  Re-expression of pVHL restored oxygen-dependent instability.  PVHL and HIF α-subunits co-immunoppt., and pVHL is present in the hypoxic HIF-1 DNA-binding complex.  In cells exposed to iron chelation or cobaltous ions, HIF-1 is dissocd. from pVHL.  These findings indicate that the interaction between HIF-1 and pVHL is iron dependent, and that it is necessary for the oxygen-dependent degrdn. of HIF α-subunits.  Thus, constitutive HIF-1 activation may underlie the angiogenic phenotype of VHL-assocd. tumors.  The pVHL/HIF-1 interaction provides a new focus for understanding cellular oxygen sensing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk9Nt-50qJOrVg90H21EOLACvtfcHk0lg3ylUbl7a3KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjsFyqt74%253D&md5=10a50baefa94ba2bba0f97576f96197b</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2F20459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F20459%26sid%3Dliteratum%253Aachs%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DWiesener%26aufirst%3DM.%2BS.%26aulast%3DChang%26aufirst%3DG.-W.%26aulast%3DClifford%26aufirst%3DS.%2BC.%26aulast%3DVaux%26aufirst%3DE.%2BC.%26aulast%3DCockman%26aufirst%3DM.%2BE.%26aulast%3DWykoff%26aufirst%3DC.%2BC.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26aulast%3DMaher%26aufirst%3DE.%2BR.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520tumour%2520suppressor%2520protein%2520VHL%2520targets%2520hypoxia-inducible%2520factors%2520for%2520oxygen-dependent%2520proteolysis%26jtitle%3DNature%26date%3D1999%26volume%3D399%26spage%3D271%26doi%3D10.1038%2F20459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brahimi-Horn, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pouyssegur, J.</span></span> <span> </span><span class="NLM_article-title">Harnessing the hypoxia-inducible factor in cancer and ischemic disease</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">450</span>– <span class="NLM_lpage">457</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2006.10.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bcp.2006.10.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=17101119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Slsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=450-457&issue=3&author=M.+C.+Brahimi-Hornauthor=J.+Pouyssegur&title=Harnessing+the+hypoxia-inducible+factor+in+cancer+and+ischemic+disease&doi=10.1016%2Fj.bcp.2006.10.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Harnessing the hypoxia-inducible factor in cancer and ischemic disease</span></div><div class="casAuthors">Brahimi-Horn, M. Christiane; Pouyssegur, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">450-457</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The α/β-heterodimeric transcription factor hypoxia-inducible factor (HIF) functions when the oxygen level in tissues is low, i.e. when the tissue microenvironment becomes hypoxic, and is non-functional when the level of oxygen is high.  Certain pathophysiol. conditions such as ischemic disorders and cancer encounter low levels of local tissue oxygenation due to a defective or insufficient vasculature.  Highly proliferating tumor cells rapidly form into a mass that becomes located too far from the vasculature to be nourished and oxygenated.  Under such conditions HIF activates or represses a vast array of genes that in particular, initiate the formation of new blood vessels and modify metab.  In this way the tumor mass re-establishes conditions favorable for further proliferation.  Interest is being expressed in the direct repression or stimulation of HIF activity, resp., in the treatment of cancer and of ischemic disorders.  The modulation of other HIF-target genes implicated, in particular, in tumor metab. and intracellular pH control may also prove to be useful in cancer therapy.  However, before going further a better understanding of the basics of the HIF signalling pathway is essential.  This review will introduce the reader to the mol. mechanisms that regulate HIF and some of the biol. consequences of its action, in particular in tumor metab., growth and invasion.  Approaches to either enforce tumor regression or increase blood vessel formation through the targeting of HIF or its downstream effectors will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXvhp8EEj_VLVg90H21EOLACvtfcHk0lg3ylUbl7a3KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Slsw%253D%253D&md5=d54730d638d42e47c9087a630c1c9900</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.10.013%26sid%3Dliteratum%253Aachs%26aulast%3DBrahimi-Horn%26aufirst%3DM.%2BC.%26aulast%3DPouyssegur%26aufirst%3DJ.%26atitle%3DHarnessing%2520the%2520hypoxia-inducible%2520factor%2520in%2520cancer%2520and%2520ischemic%2520disease%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2007%26volume%3D73%26issue%3D3%26spage%3D450%26epage%3D457%26doi%3D10.1016%2Fj.bcp.2006.10.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Willam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahmood, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bicknell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eckardt, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratcliffe, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugh, C. W.</span></span> <span> </span><span class="NLM_article-title">Peptide blockade of HIFalpha degradation modulates cellular metabolism and angiogenesis</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">10423</span>– <span class="NLM_lpage">10428</span>, <span class="refDoi"> DOI: 10.1073/pnas.162119399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.162119399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12149454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1Ciu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10423-10428&issue=16&author=C.+Willamauthor=N.+Massonauthor=Y.+M.+Tianauthor=S.+A.+Mahmoodauthor=M.+I.+Wilsonauthor=R.+Bicknellauthor=K.+U.+Eckardtauthor=P.+H.+Maxwellauthor=P.+J.+Ratcliffeauthor=C.+W.+Pugh&title=Peptide+blockade+of+HIFalpha+degradation+modulates+cellular+metabolism+and+angiogenesis&doi=10.1073%2Fpnas.162119399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis</span></div><div class="casAuthors">Willam, Carsten; Masson, Norma; Tian, Ya-Min; Mahmood, S. Aleema; Wilson, Michael I.; Bicknell, Roy; Eckardt, Kai-Uwe; Maxwell, Patrick H.; Ratcliffe, Peter J.; Pugh, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10423-10428</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Hypoxia-inducible factor-1 (HIF) is a transcription factor central to oxygen homeostasis.  It is regulated via its α isoforms.  In normoxia they are ubiquitinated by the von Hippel-Lindau E3 ligase complex and destroyed by the proteasome, thereby preventing the formation of an active transcriptional complex.  Oxygen-dependent enzymic hydroxylation of either of two crit. prolyl residues in each HIFα chain has recently been identified as the modification necessary for targeting by the von Hippel-Lindau E3 ligase complex.  Here we demonstrate that polypeptides bearing either of these prolyl residues interfere with the degradative pathway, resulting in stabilization of endogenous HIFα chains and consequent up-regulation of HIF target genes.  Similar peptides in which the prolyl residues are mutated are inactive.  Induction of peptide expression in cell cultures affects physiol. important functions such as glucose transport and leads cocultured endothelial cells to form tubules.  Coupling of these HIFα sequences to the HIV tat translocation domain allows delivery of recombinant peptide to cells with resultant induction of HIF-dependent genes.  Injection of tat-HIF polypeptides in a murine sponge angiogenesis assay causes a markedly accelerated local angiogenic response and induction of glucose transporter-1 gene expression.  These results demonstrate the feasibility of using these polypeptides to enhance HIF activity, opening addnl. therapeutic avenues for ischemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPVZbRexSyUrVg90H21EOLACvtfcHk0liM4eHDTVozbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1Ciu7k%253D&md5=1933d3cc099645c5ca3dd5e09a2819a0</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1073%2Fpnas.162119399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.162119399%26sid%3Dliteratum%253Aachs%26aulast%3DWillam%26aufirst%3DC.%26aulast%3DMasson%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DY.%2BM.%26aulast%3DMahmood%26aufirst%3DS.%2BA.%26aulast%3DWilson%26aufirst%3DM.%2BI.%26aulast%3DBicknell%26aufirst%3DR.%26aulast%3DEckardt%26aufirst%3DK.%2BU.%26aulast%3DMaxwell%26aufirst%3DP.%2BH.%26aulast%3DRatcliffe%26aufirst%3DP.%2BJ.%26aulast%3DPugh%26aufirst%3DC.%2BW.%26atitle%3DPeptide%2520blockade%2520of%2520HIFalpha%2520degradation%2520modulates%2520cellular%2520metabolism%2520and%2520angiogenesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D16%26spage%3D10423%26epage%3D10428%26doi%3D10.1073%2Fpnas.162119399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loenarz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mecinovic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhury, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flashman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Evidence for a stereoelectronic effect in human oxygen sensing</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1784</span>– <span class="NLM_lpage">1787</span>, <span class="refDoi"> DOI: 10.1002/anie.200805427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fanie.200805427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1Ojt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=1784-1787&issue=10&author=C.+Loenarzauthor=J.+Mecinovicauthor=R.+Chowdhuryauthor=L.+A.+McNeillauthor=E.+Flashmanauthor=C.+J.+Schofield&title=Evidence+for+a+stereoelectronic+effect+in+human+oxygen+sensing&doi=10.1002%2Fanie.200805427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for a stereoelectronic effect in human oxygen sensing</span></div><div class="casAuthors">Loenarz, Christoph; Mecinovic, Jasmin; Chowdhury, Rasheduzzaman; McNeill, Luke A.; Flashman, Emily; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1784-1787</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">How PHDs achieve specificity: trans-4-prolyl hydroxylation of the transcription factor HIF occurs with stereochem. retention.  Substrate-analog studies show how the von Hippel Lindau tumor suppressor protein (pVHL) and the oxygen-sensing hydroxylases (PHDs) achieve specificity for hydroxyprolyl/prolyl residues for the C4-exo/endo prolyl conformations, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzHXp367U3mLVg90H21EOLACvtfcHk0liM4eHDTVozbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1Ojt7Y%253D&md5=3365a4a6c8ebbf7abc5e90df2cf82086</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1002%2Fanie.200805427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200805427%26sid%3Dliteratum%253Aachs%26aulast%3DLoenarz%26aufirst%3DC.%26aulast%3DMecinovic%26aufirst%3DJ.%26aulast%3DChowdhury%26aufirst%3DR.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DFlashman%26aufirst%3DE.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DEvidence%2520for%2520a%2520stereoelectronic%2520effect%2520in%2520human%2520oxygen%2520sensing%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2009%26volume%3D48%26issue%3D10%26spage%3D1784%26epage%3D1787%26doi%3D10.1002%2Fanie.200805427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span> <span> </span><span class="NLM_article-title">Efficient drug lead discovery and optimization</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">724</span>– <span class="NLM_lpage">733</span>, <span class="refDoi"> DOI: 10.1021/ar800236t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ar800236t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsFentr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2009&pages=724-733&issue=6&author=W.+L.+Jorgensen&title=Efficient+drug+lead+discovery+and+optimization&doi=10.1021%2Far800236t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient Drug Lead Discovery and Optimization</span></div><div class="casAuthors">Jorgensen, William L.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">724-733</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  During the 1980s, advances in the abilities to perform computer simulations of chem. and biomol. systems and to calc. free energy changes led to the expectation that such methodol. would soon show great utility for guiding mol. design.  Important potential applications included design of selective receptors, catalysts, and regulators of biol. function including enzyme inhibitors.  This time also saw the rise of high-throughput screening and combinatorial chem. along with complementary computational methods for de novo design and virtual screening including docking.  These technologies appeared poised to deliver diverse lead compds. for any biol. target.  As with many technol. advances, realization of the expectations required significant addnl. effort and time.  However, as summarized here, striking success has now been achieved for computer-aided drug lead generation and optimization.  De novo design using both mol. growing and docking are illustrated for lead generation, and lead optimization features free energy perturbation calcns. in conjunction with Monte Carlo statistical mechanics simulations for protein-inhibitor complexes in aq. soln.  The specific applications are to the discovery of non-nucleoside inhibitors of HIV reverse transcriptase (HIV-RT) and inhibitors of the binding of the proinflammatory cytokine MIF to its receptor CD74.  A std. protocol is presented that includes scans for possible addns. of small substituents to a mol. core, interchange of heterocycles, and focused optimization of substituents at one site.  Initial leads with activities at low-micromolar concns. have been advanced rapidly to low-nanomolar inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrn0YpWuo1jCLVg90H21EOLACvtfcHk0ljD9I2THJUUlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsFentr4%253D&md5=9641587769701c6541b38e18fa05538a</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1021%2Far800236t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far800236t%26sid%3Dliteratum%253Aachs%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26atitle%3DEfficient%2520drug%2520lead%2520discovery%2520and%2520optimization%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2009%26volume%3D42%26issue%3D6%26spage%3D724%26epage%3D733%26doi%3D10.1021%2Far800236t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noblin, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Targeting the von hippel-lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>134</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">4465</span>– <span class="NLM_lpage">4468</span>, <span class="refDoi"> DOI: 10.1021/ja209924v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja209924v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=4465-4468&issue=10&author=D.+L.+Buckleyauthor=I.+Van+Molleauthor=P.+C.+Gareissauthor=H.+S.+Taeauthor=J.+Michelauthor=D.+J.+Noblinauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Targeting+the+von+hippel-lindau+E3+ubiquitin+ligase+using+small+molecules+to+disrupt+the+VHL%2FHIF-1%CE%B1+interaction&doi=10.1021%2Fja209924v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the von Hippel-Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α Interaction</span></div><div class="casAuthors">Buckley, Dennis L.; Van Molle, Inge; Gareiss, Peter C.; Tae, Hyun Seop; Michel, Julien; Noblin, Devin J.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4465-4468</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases, which bind protein targets, leading to their ubiquitination and subsequent degrdn., are attractive drug targets due to their exquisite substrate specificity.  However, the development of small-mol. inhibitors has proven extraordinarily challenging as modulation of E3 ligase activities requires the targeting of protein-protein interactions.  Using rational design, we have generated the first small mol. targeting the von Hippel-Lindau protein (VHL), the substrate recognition subunit of an E3 ligase, and an important target in cancer, chronic anemia, and ischemia.  We have also obtained the crystal structure of VHL bound to our most potent inhibitor, confirming that the compd. mimics the binding mode of the transcription factor HIF-1α, a substrate of VHL.  These results have the potential to guide future development of improved lead compds. as therapeutics for the treatment of chronic anemia and ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolmBVM_mfWzrVg90H21EOLACvtfcHk0ljD9I2THJUUlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVOgurw%253D&md5=60f7384b6bc932c9828dc12999283a1e</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fja209924v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja209924v%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DMichel%26aufirst%3DJ.%26aulast%3DNoblin%26aufirst%3DD.%2BJ.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeting%2520the%2520von%2520hippel-lindau%2520E3%2520ubiquitin%2520ligase%2520using%2520small%2520molecules%2520to%2520disrupt%2520the%2520VHL%252FHIF-1%25CE%25B1%2520interaction%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26issue%3D10%26spage%3D4465%26epage%3D4468%26doi%3D10.1021%2Fja209924v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">So, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1alpha protein-protein interface</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1300</span>– <span class="NLM_lpage">1312</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2012.08.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.chembiol.2012.08.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=23102223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsF2hsb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=1300-1312&issue=10&author=I.+Van+Molleauthor=A.+Thomannauthor=D.+L.+Buckleyauthor=E.+C.+Soauthor=S.+Langauthor=C.+M.+Crewsauthor=A.+Ciulli&title=Dissecting+fragment-based+lead+discovery+at+the+von+Hippel-Lindau+protein%3Ahypoxia+inducible+factor+1alpha+protein-protein+interface&doi=10.1016%2Fj.chembiol.2012.08.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface</span></div><div class="casAuthors">Van Molle, Inge; Thomann, Andreas; Buckley, Dennis L.; So, Ernest C.; Lang, Steffen; Crews, Craig M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1300-1312</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Fragment screening is widely used to identify attractive starting points for drug design.  However, its potential and limitations to assess the tractability of often challenging protein:protein interfaces have been underexplored.  Here, we address this question by means of a systematic deconstruction of lead-like inhibitors of the pVHL:HIF-1α interaction into their component fragments.  Using biophys. techniques commonly employed for screening, we could only detect binding of fragments that violate the Rule of Three, are more complex than those typically screened against classical druggable targets, and occupy two adjacent binding subsites at the interface rather than just one.  Analyses based on ligand and group lipophilicity efficiency of anchored fragments were applied to dissect the individual subsites and probe for binding hot spots.  The implications of our findings for targeting protein interfaces by fragment-based approaches are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRRhzUJQp0HrVg90H21EOLACvtfcHk0ljrPXCWT4ac7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsF2hsb3P&md5=b126164f72aa2fcdc3e9da2196aba442</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2012.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2012.08.015%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DThomann%26aufirst%3DA.%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DSo%26aufirst%3DE.%2BC.%26aulast%3DLang%26aufirst%3DS.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DDissecting%2520fragment-based%2520lead%2520discovery%2520at%2520the%2520von%2520Hippel-Lindau%2520protein%253Ahypoxia%2520inducible%2520factor%25201alpha%2520protein-protein%2520interface%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26issue%3D10%26spage%3D1300%26epage%3D1312%26doi%3D10.1016%2Fj.chembiol.2012.08.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tae, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gareiss, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of the interaction between the E3 Ligase VHL and HIF1α</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">46</span>),  <span class="NLM_fpage">11463</span>– <span class="NLM_lpage">11467</span>, <span class="refDoi"> DOI: 10.1002/anie.201206231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1002%2Fanie.201206231" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=11463-11467&issue=46&author=D.+L.+Buckleyauthor=J.+L.+Gustafsonauthor=I.+Van+Molleauthor=A.+G.+Rothauthor=H.+S.+Taeauthor=P.+C.+Gareissauthor=W.+L.+Jorgensenauthor=A.+Ciulliauthor=C.+M.+Crews&title=Small-molecule+inhibitors+of+the+interaction+between+the+E3+Ligase+VHL+and+HIF1%CE%B1&doi=10.1002%2Fanie.201206231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule Inhibitors of the Interaction between the E3 Ligase VHL and HIF1α</span></div><div class="casAuthors">Buckley, Dennis L.; Gustafson, Jeffrey L.; Van Molle, Inge; Roth, Anke G.; Tae, Hyun Seop; Gareiss, Peter C.; Jorgensen, William L.; Ciulli, Alessio; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">11463-11467</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">This study reports the structure-based design and synthesis of novel VHL ligands, illustrating structure-activity relationships and improving potency.  Two fragments of the ligands were individually optimized, arriving at a new class of N-terminal benzamide fragments.  The interactions made by this new class were then elucidated through X-ray crystallog. of the protein-ligand complex.  Structural studies of this ligand class revealed both a new binding mode as well as a novel water-mediated' hydrogen bond.  Finally, using these optimized fragments, we assembled new VHL ligands in a combinatorial fashion, arriving at (I), the first small-mol. submicromolar inhibitor of the interaction between VHL and a peptide derived from HIF1α.  While no cell-based activity has yet been obsd.,we hope to take advantage of the interactions highlighted by the crystal structure of I to design more drug-like inhibitors of VHL with improved cell permeability.  These ligands and the novel interactions and binding modes highlighted have the potential to guide the development of future chem. probes that can target the E3 ligase VHL or stabilize HIF1α proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqs0HINAsXwwLVg90H21EOLACvtfcHk0ljrPXCWT4ac7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsV2rs7nL&md5=eefeb63a3491737738e94c00be083cfd</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1002%2Fanie.201206231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201206231%26sid%3Dliteratum%253Aachs%26aulast%3DBuckley%26aufirst%3DD.%2BL.%26aulast%3DGustafson%26aufirst%3DJ.%2BL.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DRoth%26aufirst%3DA.%2BG.%26aulast%3DTae%26aufirst%3DH.%2BS.%26aulast%3DGareiss%26aufirst%3DP.%2BC.%26aulast%3DJorgensen%26aufirst%3DW.%2BL.%26aulast%3DCiulli%26aufirst%3DA.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520the%2520interaction%2520between%2520the%2520E3%2520Ligase%2520VHL%2520and%2520HIF1%25CE%25B1%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2012%26volume%3D51%26issue%3D46%26spage%3D11463%26epage%3D11467%26doi%3D10.1002%2Fanie.201206231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaffidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birced, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dias, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Structure-guided design and optimization of small molecules targeting the protein-protein interaction between the von Hippel-Lindau (VHL) E3 ubiquitin ligase and the hypoxia inducible factor (HIF) alpha subunit with in vitro nanomolar affinities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">20</span>),  <span class="NLM_fpage">8657</span>– <span class="NLM_lpage">8663</span>, <span class="refDoi"> DOI: 10.1021/jm5011258</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5011258" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGhtb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8657-8663&issue=20&author=C.+Galdeanoauthor=M.+S.+Gaddauthor=P.+Soaresauthor=S.+Scaffidiauthor=I.+Van+Molleauthor=I.+Bircedauthor=S.+Hewittauthor=D.+M.+Diasauthor=A.+Ciulli&title=Structure-guided+design+and+optimization+of+small+molecules+targeting+the+protein-protein+interaction+between+the+von+Hippel-Lindau+%28VHL%29+E3+ubiquitin+ligase+and+the+hypoxia+inducible+factor+%28HIF%29+alpha+subunit+with+in+vitro+nanomolar+affinities&doi=10.1021%2Fjm5011258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Guided Design and Optimization of Small Molecules Targeting the Protein-Protein Interaction between the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities</span></div><div class="casAuthors">Galdeano, Carles; Gadd, Morgan S.; Soares, Pedro; Scaffidi, Salvatore; Van Molle, Inge; Birced, Ipek; Hewitt, Sarah; Dias, David M.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8657-8663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">E3 ubiquitin ligases are attractive targets in the ubiquitin-proteasome system, however, the development of small-mol. ligands has been rewarded with limited success.  The von Hippel-Lindau protein (pVHL) is the substrate recognition subunit of the VHL E3 ligase that targets HIF-1α for degrdn.  The authors recently reported inhibitors of the pVHL:HIF-1α interaction, however they exhibited moderate potency.  Herein, the authors report the design and optimization, guided by x-ray crystal structures, of a ligand series with nanomolar binding affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpixK3qp1ctJrVg90H21EOLACvtfcHk0lgRA68vv3AjRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGhtb%252FP&md5=831aa2387d94cb03d735a4be7bdd2cdd</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Fjm5011258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5011258%26sid%3Dliteratum%253Aachs%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DScaffidi%26aufirst%3DS.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DBirced%26aufirst%3DI.%26aulast%3DHewitt%26aufirst%3DS.%26aulast%3DDias%26aufirst%3DD.%2BM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DStructure-guided%2520design%2520and%2520optimization%2520of%2520small%2520molecules%2520targeting%2520the%2520protein-protein%2520interaction%2520between%2520the%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520E3%2520ubiquitin%2520ligase%2520and%2520the%2520hypoxia%2520inducible%2520factor%2520%2528HIF%2529%2520alpha%2520subunit%2520with%2520in%2520vitro%2520nanomolar%2520affinities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26issue%3D20%26spage%3D8657%26epage%3D8663%26doi%3D10.1021%2Fjm5011258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grzes, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epemolu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grandi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantrell, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Potent and selective chemical probe of hypoxic signalling downstream of HIF-alpha hydroxylation via VHL inhibition</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13312</span>, <span class="refDoi"> DOI: 10.1038/ncomms13312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fncomms13312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27811928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVSitLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13312&author=J.+Frostauthor=C.+Galdeanoauthor=P.+Soaresauthor=M.+S.+Gaddauthor=K.+M.+Grzesauthor=L.+Ellisauthor=O.+Epemoluauthor=S.+Shimamuraauthor=M.+Bantscheffauthor=P.+Grandiauthor=K.+D.+Readauthor=D.+A.+Cantrellauthor=S.+Rochaauthor=A.+Ciulli&title=Potent+and+selective+chemical+probe+of+hypoxic+signalling+downstream+of+HIF-alpha+hydroxylation+via+VHL+inhibition&doi=10.1038%2Fncomms13312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Potent and selective chemical probe of hypoxic signalling downstream of HIF-α hydroxylation via VHL inhibition</span></div><div class="casAuthors">Frost, Julianty; Galdeano, Carles; Soares, Pedro; Gadd, Morgan S.; Grzes, Katarzyna M.; Ellis, Lucy; Epemolu, Ola; Shimamura, Satoko; Bantscheff, Marcus; Grandi, Paola; Read, Kevin D.; Cantrell, Doreen A.; Rocha, Sonia; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13312</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. strategies to using small mols. to stimulate hypoxia inducible factors (HIFs) activity and trigger a hypoxic response under normoxic conditions, such as iron chelators and inhibitors of prolyl hydroxylase domain (PHD) enzymes, have broad-spectrum activities and off-target effects.  Here we disclose VH298, a potent VHL inhibitor that stabilizes HIF-α and elicits a hypoxic response via a different mechanism, that is the blockade of the VHL:HIF-α protein-protein interaction downstream of HIF-α hydroxylation by PHD enzymes.  We show that VH298 engages with high affinity and specificity with VHL as its only major cellular target, leading to selective on-target accumulation of hydroxylated HIF-α in a concn.- and time-dependent fashion in different cell lines, with subsequent upregulation of HIF-target genes at both mRNA and protein levels.  VH298 represents a high-quality chem. probe of the HIF signalling cascade and an attractive starting point to the development of potential new therapeutics targeting hypoxia signalling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLB1WvVF4EFLVg90H21EOLACvtfcHk0lgRA68vv3AjRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVSitLfJ&md5=7a884b6193b3ca5e119fecea2eb31d3e</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1038%2Fncomms13312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13312%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DJ.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DGrzes%26aufirst%3DK.%2BM.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DEpemolu%26aufirst%3DO.%26aulast%3DShimamura%26aufirst%3DS.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DCantrell%26aufirst%3DD.%2BA.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DPotent%2520and%2520selective%2520chemical%2520probe%2520of%2520hypoxic%2520signalling%2520downstream%2520of%2520HIF-alpha%2520hydroxylation%2520via%2520VHL%2520inhibition%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13312%26doi%3D10.1038%2Fncomms13312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Soares, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galdeano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epemolu, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Group-based optimization of potent and cell-active inhibitors of the von Hippel-Lindau (VHL) E3 ubiquitin ligase: structure-activity relationships leading to the chemical probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">599</span>– <span class="NLM_lpage">618</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00675</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00675" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVWms77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=599-618&issue=2&author=P.+Soaresauthor=M.+S.+Gaddauthor=J.+Frostauthor=C.+Galdeanoauthor=L.+Ellisauthor=O.+Epemoluauthor=S.+Rochaauthor=K.+D.+Readauthor=A.+Ciulli&title=Group-based+optimization+of+potent+and+cell-active+inhibitors+of+the+von+Hippel-Lindau+%28VHL%29+E3+ubiquitin+ligase%3A+structure-activity+relationships+leading+to+the+chemical+probe+%282S%2C4R%29-1-%28%28S%29-2-%281-Cyanocyclopropanecarboxamido%29-3%2C3-dimethylbutanoyl%29-4-hydroxy-N-%284-%284-methylthiazol-5-yl%29benzyl%29pyrrolidine-2-carboxamide+%28VH298%29&doi=10.1021%2Facs.jmedchem.7b00675"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase: Structure-Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)</span></div><div class="casAuthors">Soares, Pedro; Gadd, Morgan S.; Frost, Julianty; Galdeano, Carles; Ellis, Lucy; Epemolu, Ola; Rocha, Sonia; Read, Kevin D.; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">599-618</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The von Hippel-Lindau tumor suppressor protein is the substrate binding subunit of the VHL E3 ubiquitin ligase, which targets hydroxylated α subunit of hypoxia inducible factors (HIFs) for ubiquitination and subsequent proteasomal degrdn.  VHL is a potential target for treating anemia and ischemic diseases, motivating the development of inhibitors of the VHL:HIF-α protein-protein interaction.  Addnl., bifunctional proteolysis targeting chimeras (PROTACs) contg. a VHL ligand can hijack the E3 ligase activity to induce degrdn. of target proteins.  We report the structure-guided design and group-based optimization of a series of VHL inhibitors with low nanomolar potencies and improved cellular permeability.  Structure-activity relationships led to the discovery of potent inhibitors 10 and chem. probe VH298, with dissocn. consts. <100 nM, which induced marked HIF-1α intracellular stabilization.  Our study provides new chem. tools to probe the VHL-HIF pathways and new VHL ligands for next-generation PROTACs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQfJe2l2WgX7Vg90H21EOLACvtfcHk0lgyiDD45W1lHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVWms77P&md5=1c1e7c976c2de9a9681773ff216fdfd7</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00675%26sid%3Dliteratum%253Aachs%26aulast%3DSoares%26aufirst%3DP.%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DFrost%26aufirst%3DJ.%26aulast%3DGaldeano%26aufirst%3DC.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DEpemolu%26aufirst%3DO.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DGroup-based%2520optimization%2520of%2520potent%2520and%2520cell-active%2520inhibitors%2520of%2520the%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520E3%2520ubiquitin%2520ligase%253A%2520structure-activity%2520relationships%2520leading%2520to%2520the%2520chemical%2520probe%2520%25282S%252C4R%2529-1-%2528%2528S%2529-2-%25281-Cyanocyclopropanecarboxamido%2529-3%252C3-dimethylbutanoyl%2529-4-hydroxy-N-%25284-%25284-methylthiazol-5-yl%2529benzyl%2529pyrrolidine-2-carboxamide%2520%2528VH298%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D2%26spage%3D599%26epage%3D618%26doi%3D10.1021%2Facs.jmedchem.7b00675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Molle, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Surface probing by fragment-based screening and computational methods identifies ligandable pockets on the von Hippel-Lindau (VHL) E3 ubiquitin ligase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">7387</span>– <span class="NLM_lpage">7393</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00842</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00842" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtlyktLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=7387-7393&issue=16&author=X.+Lucasauthor=I.+Van+Molleauthor=A.+Ciulli&title=Surface+probing+by+fragment-based+screening+and+computational+methods+identifies+ligandable+pockets+on+the+von+Hippel-Lindau+%28VHL%29+E3+ubiquitin+ligase&doi=10.1021%2Facs.jmedchem.8b00842"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Surface Probing by Fragment-Based Screening and Computational Methods Identifies Ligandable Pockets on the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase</span></div><div class="casAuthors">Lucas, Xavier; Van Molle, Inge; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7387-7393</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Beyond the targeting of E3 ubiquitin ligases to inhibit protein homeostasis, E3 ligase binders can be repurposed as targeted protein degraders (PROTACs or mol. glues).  The authors sought to identify new binders of the VHL E3 ligase by biophys. fragment-based screening followed by x-ray crystallog. soaking.  The authors identified fragments binding at the Elongin C:Cullin 2 interface and a new cryptic pocket in VHL, along with other potential ligandable sites predicted computationally and found to bind solvent mols. in crystal structures.  The elucidated interactions provide starting points for future ligand development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZdhy5IVXNgrVg90H21EOLACvtfcHk0lhhctJOO9FAsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtlyktLbE&md5=c081e7cf26807f59e646a60a0ec74361</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00842%26sid%3Dliteratum%253Aachs%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DVan%2BMolle%26aufirst%3DI.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DSurface%2520probing%2520by%2520fragment-based%2520screening%2520and%2520computational%2520methods%2520identifies%2520ligandable%2520pockets%2520on%2520the%2520von%2520Hippel-Lindau%2520%2528VHL%2529%2520E3%2520ubiquitin%2520ligase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D16%26spage%3D7387%26epage%3D7393%26doi%3D10.1021%2Facs.jmedchem.8b00842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gadd, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zengerle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Structural basis of PROTAC cooperative recognition for selective protein degradation</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">514</span>– <span class="NLM_lpage">521</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnchembio.2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=28288108" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFahtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=514-521&issue=5&author=M.+S.+Gaddauthor=A.+Testaauthor=X.+Lucasauthor=K.+H.+Chanauthor=W.+Chenauthor=D.+J.+Lamontauthor=M.+Zengerleauthor=A.+Ciulli&title=Structural+basis+of+PROTAC+cooperative+recognition+for+selective+protein+degradation&doi=10.1038%2Fnchembio.2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of PROTAC cooperative recognition for selective protein degradation</span></div><div class="casAuthors">Gadd, Morgan S.; Testa, Andrea; Lucas, Xavier; Chan, Kwok-Ho; Chen, Wenzhang; Lamont, Douglas J.; Zengerle, Michael; Ciulli, Alessio</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">514-521</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Inducing macromol. interactions with small mols. to activate cellular signaling is a challenging goal.  PROTACs (proteolysis-targeting chimeras) are bifunctional mols. that recruit a target protein in proximity to an E3 ubiquitin ligase to trigger protein degrdn.  Structural elucidation of the key ternary ligase-PROTAC-target species and its impact on target degrdn. selectivity remain elusive.  Here, we solved the crystal structure of Brd4 degrader MZ1 in complex with human VHL and the Brd4 bromodomain (Brd4BD2).  The ligand folds into itself to allow formation of specific intermol. interactions in the ternary complex.  Isothermal titrn. calorimetry studies, supported by surface mutagenesis and proximity assays, were consistent with pronounced cooperative formation of ternary complexes with Brd4BD2.  Structure-based-designed compd. AT1 exhibited highly selective depletion of Brd4 in cells.  These results elucidate how PROTAC-induced de novo contacts dictate preferential recruitment of a target protein into a stable and cooperative complex with an E3 ligase for selective degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJri00jB5YJLVg90H21EOLACvtfcHk0lhhctJOO9FAsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFahtbg%253D&md5=dfee13913106d362d0972d7b1a62d700</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2329%26sid%3Dliteratum%253Aachs%26aulast%3DGadd%26aufirst%3DM.%2BS.%26aulast%3DTesta%26aufirst%3DA.%26aulast%3DLucas%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DK.%2BH.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLamont%26aufirst%3DD.%2BJ.%26aulast%3DZengerle%26aufirst%3DM.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DStructural%2520basis%2520of%2520PROTAC%2520cooperative%2520recognition%2520for%2520selective%2520protein%2520degradation%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2017%26volume%3D13%26issue%3D5%26spage%3D514%26epage%3D521%26doi%3D10.1038%2Fnchembio.2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maniaci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romeo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciulli, A.</span></span> <span> </span><span class="NLM_article-title">Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">830</span>, <span class="refDoi"> DOI: 10.1038/s41467-017-00954-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fs41467-017-00954-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29018234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A280%3ADC%252BC1M%252Fptlaiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=830&author=C.+Maniaciauthor=S.+J.+Hughesauthor=A.+Testaauthor=W.+Chenauthor=D.+J.+Lamontauthor=S.+Rochaauthor=D.+R.+Alessiauthor=R.+Romeoauthor=A.+Ciulli&title=Homo-PROTACs%3A+bivalent+small-molecule+dimerizers+of+the+VHL+E3+ubiquitin+ligase+to+induce+self-degradation&doi=10.1038%2Fs41467-017-00954-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Homo-PROTACs: bivalent small-molecule dimerizers of the VHL E3 ubiquitin ligase to induce self-degradation</span></div><div class="casAuthors">Maniaci Chiara; Hughes Scott J; Testa Andrea; Chen Wenzhang; Lamont Douglas J; Ciulli Alessio; Maniaci Chiara; Alessi Dario R; Rocha Sonia; Romeo Roberto</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">830</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">E3 ubiquitin ligases are key enzymes within the ubiquitin proteasome system which catalyze the ubiquitination of proteins, targeting them for proteasomal degradation.  E3 ligases are gaining importance as targets to small molecules, both for direct inhibition and to be hijacked to induce the degradation of non-native neo-substrates using bivalent compounds known as PROTACs (for 'proteolysis-targeting chimeras').  We describe Homo-PROTACs as an approach to dimerize an E3 ligase to trigger its suicide-type chemical knockdown inside cells.  We provide proof-of-concept of Homo-PROTACs using diverse molecules composed of two instances of a ligand for the von Hippel-Lindau (VHL) E3 ligase.  The most active compound, CM11, dimerizes VHL with high avidity in vitro and induces potent, rapid and proteasome-dependent self-degradation of VHL in different cell lines, in a highly isoform-selective fashion and without triggering a hypoxic response.  This approach offers a novel chemical probe for selective VHL knockdown, and demonstrates the potential for a new modality of chemical intervention on E3 ligases.Targeting the ubiquitin proteasome system to modulate protein homeostasis using small molecules has promising therapeutic potential.  Here the authors describe Homo-PROTACS: small molecules that can induce the homo-dimerization of E3 ubiquitin ligases and cause their proteasome-dependent degradation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVJKELZUTFBpPq5LRczm8ffW6udTcc2eZa6HH3r659YLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M%252Fptlaiuw%253D%253D&md5=0ed79d9ff14eb7b6132a152f0413c4ef</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1038%2Fs41467-017-00954-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-017-00954-1%26sid%3Dliteratum%253Aachs%26aulast%3DManiaci%26aufirst%3DC.%26aulast%3DHughes%26aufirst%3DS.%2BJ.%26aulast%3DTesta%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLamont%26aufirst%3DD.%2BJ.%26aulast%3DRocha%26aufirst%3DS.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DRomeo%26aufirst%3DR.%26aulast%3DCiulli%26aufirst%3DA.%26atitle%3DHomo-PROTACs%253A%2520bivalent%2520small-molecule%2520dimerizers%2520of%2520the%2520VHL%2520E3%2520ubiquitin%2520ligase%2520to%2520induce%2520self-degradation%26jtitle%3DNat.%2520Commun.%26date%3D2017%26volume%3D8%26spage%3D830%26doi%3D10.1038%2Fs41467-017-00954-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hangasky, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eron, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. J.</span></span> <span> </span><span class="NLM_article-title">The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O<sub>2</sub> activation</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>166</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2016.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.jinorgbio.2016.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27815979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslKksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=166&publication_year=2017&pages=26-33&author=J.+A.+Hangaskyauthor=C.+Y.+Taabazuingauthor=C.+B.+Martinauthor=S.+J.+Eronauthor=M.+J.+Knapp&title=The+facial+triad+in+the+%CE%B1-ketoglutarate+dependent+oxygenase+FIH%3A+A+role+for+sterics+in+linking+substrate+binding+to+O2+activation&doi=10.1016%2Fj.jinorgbio.2016.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The facial triad in the α-ketoglutarate dependent oxygenase FIH: A role for sterics in linking substrate binding to O2 activation</span></div><div class="casAuthors">Hangasky, John A.; Taabazuing, Cornelius Y.; Martin, Cristina B.; Eron, Scott J.; Knapp, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">166</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26-33</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The factor inhibiting hypoxia inducible factor-1α (FIH) is a nonheme Fe(II)/αKG oxygenase using a 2-His-1-Asp facial triad.  FIH activates O2 via oxidative decarboxylation of α-ketoglutarate (αKG) to generate an enzyme-based oxidant which hydroxylates the Asn803 residue within the C-terminal transactivation domain (CTAD) of HIF-1α.  Tight coupling of these two sequential reactions requires a structural linkage between the Fe(II) and the substrate binding site to ensure that O2 activation occurs after substrate binds.  We tested the hypothesis that the facial triad carboxylate (Asp201) of FIH linked substrate binding and O2 binding sites.  Asp201 variants of FIH were constructed and thoroughly characterized in vitro using steady-state kinetics, crystallog., autohydroxylation, and coupling measurements.  Our studies revealed each variant activated O2 with a catalytic efficiency similar to that of wild-type (WT) FIH (kcataKM(O2) = 0.17 μM- 1min- 1), but led to defects in the coupling of O2 activation to substrate hydroxylation.  Steady-state kinetics showed similar catalytic efficiencies for hydroxylation by WT-FIH (kcat/KM(CTAD) = 0.42 μM- 1 min- 1) and D201G (kcat/KM(CTAD) = 0.34 μM- 1 min- 1); hydroxylation by D201E was greatly impaired, while hydroxylation by D201A was undetectable.  Anal. of the crystal structure of the D201E variant revealed steric crowding near the diffusible ligand site supporting a role for sterics from the facial triad carboxylate in the O2 binding order.  Our data support a model in which the facial triad carboxylate Asp201 provides both steric and polar contacts to favor O2 access to the Fe(II) only after substrate binds, leading to coupled turnover in FIH and other αKG oxygenases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGRQ-vyH2GGbVg90H21EOLACvtfcHk0ljgvEZnD-xy9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslKksLrO&md5=6fef6dd964120cf683b98dcdfe97814b</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2016.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2016.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DHangasky%26aufirst%3DJ.%2BA.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DMartin%26aufirst%3DC.%2BB.%26aulast%3DEron%26aufirst%3DS.%2BJ.%26aulast%3DKnapp%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520facial%2520triad%2520in%2520the%2520%25CE%25B1-ketoglutarate%2520dependent%2520oxygenase%2520FIH%253A%2520A%2520role%2520for%2520sterics%2520in%2520linking%2520substrate%2520binding%2520to%2520O2%2520activation%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2017%26volume%3D166%26spage%3D26%26epage%3D33%26doi%3D10.1016%2Fj.jinorgbio.2016.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dann, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruick, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deisenhofer, J.</span></span> <span> </span><span class="NLM_article-title">Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">15351</span>– <span class="NLM_lpage">15356</span>, <span class="refDoi"> DOI: 10.1073/pnas.202614999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1073%2Fpnas.202614999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=12432100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjvVCl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=15351-15356&issue=24&author=C.+E.+Dannauthor=R.+K.+Bruickauthor=J.+Deisenhofer&title=Structure+of+factor-inhibiting+hypoxia-inducible+factor+1%3A+an+asparaginyl+hydroxylase+involved+in+the+hypoxic+response+pathway&doi=10.1073%2Fpnas.202614999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of factor-inhibiting hypoxia-inducible factor 1: an asparaginyl hydroxylase involved in the hypoxic response pathway</span></div><div class="casAuthors">Dann, Charles E., III; Bruick, Richard K.; Deisenhofer, Johann</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">15351-15356</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Precise regulation of the evolutionarily conserved hypoxia-inducible transcription factor (HIF) ensures proper adaptation to variations in oxygen availability throughout development and into adulthood.  Oxygen-dependent regulation of HIF stability and activity are mediated by hydroxylation of conserved proline and asparagine residues, resp.  Because the relevant prolyl and asparaginyl hydroxylases use O2 to effect these posttranslational modifications, these enzymes are implicated as direct oxygen sensors in the mammalian hypoxic response pathway.  Here we present the structure of factor-inhibiting HIF-1 (FIH-1), the pertinent asparaginyl hydroxylase involved in hypoxic signaling.  Hydroxylation of the C-terminal transactivation domain (CTAD) of HIF by FIH-1 prevents CTAD assocn. with transcriptional coactivators under normoxic conditions.  Consistent with other structurally known hydroxylases, FIH-1 is comprised of a β-strand jellyroll core with both Fe(II) and the cosubstrate 2-oxoglutarate bound in the active site.  Details of the mol. contacts at the active site of FIH-1 have been elucidated and provide a platform for future drug design.  Furthermore, the structure reveals the presence of a FIH-1 homodimer that forms in soln. and is essential for FIH activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqABqFMocA22rVg90H21EOLACvtfcHk0lhcdhI0p-5AXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjvVCl&md5=a5ab9e5d6bae7344600a48f9e24ea472</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1073%2Fpnas.202614999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.202614999%26sid%3Dliteratum%253Aachs%26aulast%3DDann%26aufirst%3DC.%2BE.%26aulast%3DBruick%26aufirst%3DR.%2BK.%26aulast%3DDeisenhofer%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520factor-inhibiting%2520hypoxia-inducible%2520factor%25201%253A%2520an%2520asparaginyl%2520hydroxylase%2520involved%2520in%2520the%2520hypoxic%2520response%2520pathway%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26issue%3D24%26spage%3D15351%26epage%3D15356%26doi%3D10.1073%2Fpnas.202614999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Flagg, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taabazuing, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, M. J.</span></span> <span> </span><span class="NLM_article-title">Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)</span>. <i>J. Inorg. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>113</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">25</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.jinorgbio.2012.03.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.jinorgbio.2012.03.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=22687491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2012&pages=25-30&issue=6&author=S.+C.+Flaggauthor=C.+B.+Martinauthor=C.+Y.+Taabazuingauthor=B.+E.+Holmesauthor=M.+J.+Knapp&title=Screening+chelating+inhibitors+of+HIF-prolyl+hydroxylase+domain+2+%28PHD2%29+and+factor+inhibiting+HIF+%28FIH%29&doi=10.1016%2Fj.jinorgbio.2012.03.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)</span></div><div class="casAuthors">Flagg, Shannon C.; Martin, Cristina B.; Taabazuing, Cornelius Y.; Holmes, Breanne E.; Knapp, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Inorganic Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">JIBIDJ</span>;
        ISSN:<span class="NLM_cas:issn">0162-0134</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Two primary O2-sensors for humans are the HIF-hydroxylases, enzymes that hydroxylate specific residues of the hypoxia inducible factor-α (HIF).  These enzymes are factor inhibiting HIF (FIH) and prolyl hydroxylase-2 (PHD2), each an α-ketoglutarate (αKG) dependent, non-heme Fe(II) dioxygenase.  Although the two enzymes have similar active sites, FIH hydroxylates Asn803 of HIF-1α while PHD2 hydroxylates Pro402 and/or Pro564 of HIF-1α.  The similar structures but unique functions of FIH and PHD2 make them prime targets for selective inhibition leading to regulatory control of diseases such as cancer and stroke.  Three classes of iron chelators were tested as inhibitors for FIH and PHD2: pyridines, hydroxypyrones/hydroxypyridinones and catechols.  An initial screen of the ten small mol. inhibitors at varied [αKG] revealed a non-overlapping set of inhibitors for PHD2 and FIH.  Dose response curves at moderate [αKG] ([αKG] ∼ K M) showed that the hydroxypyrones/hydroxypyridinones were selective inhibitors, with IC50 in the μM range, and that the catechols were generally strong inhibitors of both FIH and PHD2, with IC50 in the low μM range.  As support for binding at the active site of each enzyme as the mode of inhibition, ESR (EPR) spectroscopy were used to demonstrate inhibitor binding to the metal center of each enzyme.  This work shows some selective inhibition between FIH and PHD2, primarily through the use of simple arom. or pseudo-arom. chelators, and suggests that hydroxypyrones and hydroxypyridones may be promising chelates for FIH or PHD2 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6PGia6AOpc7Vg90H21EOLACvtfcHk0lhcdhI0p-5AXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSmu7zE&md5=46a1e4d51db097d5ed5888b352a9f6cb</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.jinorgbio.2012.03.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jinorgbio.2012.03.002%26sid%3Dliteratum%253Aachs%26aulast%3DFlagg%26aufirst%3DS.%2BC.%26aulast%3DMartin%26aufirst%3DC.%2BB.%26aulast%3DTaabazuing%26aufirst%3DC.%2BY.%26aulast%3DHolmes%26aufirst%3DB.%2BE.%26aulast%3DKnapp%26aufirst%3DM.%2BJ.%26atitle%3DScreening%2520chelating%2520inhibitors%2520of%2520HIF-prolyl%2520hydroxylase%2520domain%25202%2520%2528PHD2%2529%2520and%2520factor%2520inhibiting%2520HIF%2520%2528FIH%2529%26jtitle%3DJ.%2520Inorg.%2520Biochem.%26date%3D2012%26volume%3D113%26issue%3D6%26spage%3D25%26epage%3D30%26doi%3D10.1016%2Fj.jinorgbio.2012.03.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDonough, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilliet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papamicael, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerji, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitson, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schofield, C. J.</span></span> <span> </span><span class="NLM_article-title">Selective inhibition of factor inhibiting hypoxia-inducible factor</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>127</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7680</span>– <span class="NLM_lpage">7681</span>, <span class="refDoi"> DOI: 10.1021/ja050841b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja050841b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvFWgsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2005&pages=7680-7681&issue=21&author=M.+A.+McDonoughauthor=L.+A.+McNeillauthor=M.+Tillietauthor=C.+A.+Papamicaelauthor=Q.+Y.+Chenauthor=B.+Banerjiauthor=K.+S.+Hewitsonauthor=C.+J.+Schofield&title=Selective+inhibition+of+factor+inhibiting+hypoxia-inducible+factor&doi=10.1021%2Fja050841b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Inhibition of Factor Inhibiting Hypoxia-Inducible Factor</span></div><div class="casAuthors">McDonough, Michael A.; McNeill, Luke A.; Tilliet, Melanie; Papamicaeel, Cyril A.; Chen, Qiu-Yun; Banerji, Biswadip; Hewitson, Kirsty S.; Schofield, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7680-7681</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of four non-heme iron(II) and 2-oxoglutarate-dependent enzymes catalyze the post-translational modification of a transcription factor, hypoxia inducible factor (HIF), that mediates the hypoxic response in animals.  Hydroxylation of HIF both causes its degrdn. and limits its activity.  We describe how the use of structural data coupled to solid-phase synthesis led to the discovery of a selective inhibitor of one of the HIF hydroxylases.  The inhibitor N-oxalyl-D-phenylalanine was shown to inhibit the HIF asparaginyl hydroxylase (FIH) but not a HIF prolyl hydroxylase.  A crystal structure of the inhibitor complexed to FIH reveals that it binds in the 2OG and, likely, in the dioxygen binding site.  The results will help to enable the modulation of the hypoxic response for the up-regulation of specific genes of biomedical importance, such as erythropoietin and vascular endothelial growth factor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO2W67f7IJI7Vg90H21EOLACvtfcHk0lj2_5KSAuvlvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvFWgsro%253D&md5=28b1ee541b595e6a6a00eeca34c26639</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fja050841b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja050841b%26sid%3Dliteratum%253Aachs%26aulast%3DMcDonough%26aufirst%3DM.%2BA.%26aulast%3DMcNeill%26aufirst%3DL.%2BA.%26aulast%3DTilliet%26aufirst%3DM.%26aulast%3DPapamicael%26aufirst%3DC.%2BA.%26aulast%3DChen%26aufirst%3DQ.%2BY.%26aulast%3DBanerji%26aufirst%3DB.%26aulast%3DHewitson%26aufirst%3DK.%2BS.%26aulast%3DSchofield%26aufirst%3DC.%2BJ.%26atitle%3DSelective%2520inhibition%2520of%2520factor%2520inhibiting%2520hypoxia-inducible%2520factor%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2005%26volume%3D127%26issue%3D21%26spage%3D7680%26epage%3D7681%26doi%3D10.1021%2Fja050841b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walton, Z. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ochocki, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gade, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissim, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simon, M. C.</span></span> <span> </span><span class="NLM_article-title">Fructose-1,6-bisphosphatase opposes renal carcinoma progression</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>513</i></span> (<span class="NLM_issue">7517</span>),  <span class="NLM_fpage">251</span>– <span class="NLM_lpage">255</span>, <span class="refDoi"> DOI: 10.1038/nature13557</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fnature13557" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=25043030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOltrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=513&publication_year=2014&pages=251-255&issue=7517&author=B.+Liauthor=B.+Qiuauthor=D.+S.+Leeauthor=Z.+E.+Waltonauthor=J.+D.+Ochockiauthor=L.+K.+Mathewauthor=A.+Mancusoauthor=T.+P.+Gadeauthor=B.+Keithauthor=I.+Nissimauthor=M.+C.+Simon&title=Fructose-1%2C6-bisphosphatase+opposes+renal+carcinoma+progression&doi=10.1038%2Fnature13557"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Fructose-1,6-bisphosphatase opposes renal carcinoma progression</span></div><div class="casAuthors">Li, Bo; Qiu, Bo; Lee, David S. M.; Walton, Zandra E.; Ochocki, Joshua D.; Mathew, Lijoy K.; Mancuso, Anthony; Gade, Terence P. F.; Keith, Brian; Nissim, Itzhak; Simon, M. Celeste</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">513</span>
        (<span class="NLM_cas:issue">7517</span>),
    <span class="NLM_cas:pages">251-255</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, is characterized by elevated glycogen levels and fat deposition.  These consistent metabolic alterations are assocd. with normoxic stabilization of hypoxia-inducible factors (HIFs) secondary to von Hippel-Lindau (VHL) mutations that occur in over 90% of ccRCC tumors.  However, kidney-specific VHL deletion in mice fails to elicit ccRCC-specific metabolic phenotypes and tumor formation, suggesting that addnl. mechanisms are essential.  Recent large-scale sequencing analyses revealed the loss of several chromatin remodelling enzymes in a subset of ccRCC (these included polybromo-1, SET domain contg. 2 and BRCA1-assocd. protein-1, among others), indicating that epigenetic perturbations are probably important contributors to the natural history of this disease.  Here we used an integrative approach comprising pan-metabolomic profiling and metabolic gene set anal. and detd. that the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1) is uniformly depleted in over six hundred ccRCC tumors examd.  Notably, the human FBP1 locus resides on chromosome 9q22, the loss of which is assocd. with poor prognosis for ccRCC patients.  Our data further indicate that FBP1 inhibits ccRCC progression through two distinct mechanisms.  First, FBP1 antagonizes glycolytic flux in renal tubular epithelial cells, the presumptive ccRCC cell of origin, thereby inhibiting a potential Warburg effect.  Second, in pVHL (the protein encoded by the VHL gene)-deficient ccRCC cells, FBP1 restrains cell proliferation, glycolysis and the pentose phosphate pathway in a catalytic-activity-independent manner, by inhibiting nuclear HIF function via direct interaction with the HIF inhibitory domain.  This unique dual function of the FBP1 protein explains its ubiquitous loss in ccRCC, distinguishing FBP1 from previously identified tumor suppressors that are not consistently mutated in all tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTwq6rXdgYK7Vg90H21EOLACvtfcHk0lj2_5KSAuvlvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOltrjK&md5=1e0d6f2a5d7dc7fc058866b690feaa9b</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1038%2Fnature13557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature13557%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DB.%26aulast%3DQiu%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DWalton%26aufirst%3DZ.%2BE.%26aulast%3DOchocki%26aufirst%3DJ.%2BD.%26aulast%3DMathew%26aufirst%3DL.%2BK.%26aulast%3DMancuso%26aufirst%3DA.%26aulast%3DGade%26aufirst%3DT.%2BP.%26aulast%3DKeith%26aufirst%3DB.%26aulast%3DNissim%26aufirst%3DI.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26atitle%3DFructose-1%252C6-bisphosphatase%2520opposes%2520renal%2520carcinoma%2520progression%26jtitle%3DNature%26date%3D2014%26volume%3D513%26issue%3D7517%26spage%3D251%26epage%3D255%26doi%3D10.1038%2Fnature13557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, A.</span></span> <span> </span><span class="NLM_article-title">Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>132</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">825</span>– <span class="NLM_lpage">838</span>, <span class="refDoi"> DOI: 10.1042/CS20171625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1042%2FCS20171625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29581249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFamurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2018&pages=825-838&issue=7&author=Y.+Yangauthor=X.+Yuauthor=Y.+Zhangauthor=G.+Dingauthor=C.+Zhuauthor=S.+Huangauthor=Z.+Jiaauthor=A.+Zhang&title=Hypoxia-inducible+factor+prolyl+hydroxylase+inhibitor+roxadustat+%28FG-4592%29+protects+against+cisplatin-induced+acute+kidney+injury&doi=10.1042%2FCS20171625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against cisplatin-induced acute kidney injury</span></div><div class="casAuthors">Yang, Yunwen; Yu, Xiaowen; Zhang, Yue; Ding, Guixia; Zhu, Chunhua; Huang, Songming; Jia, Zhanjun; Zhang, Aihua</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">825-838</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Renal hypoxia occurs in acute kidney injury (AKI) of various etiologies.  Activation of hypoxia-inducible transcription factor (HIF) has been identified as an important mechanism of cellular adaptation to low oxygen.  Preconditional HIF activation protects against AKI, suggesting a new approach in AKI treatment.  HIF is degraded under normoxic conditions mediated by oxygen-dependent hydroxylation of specific prolyl residues of the regulative α-subunits by HIF prolyl hydroxylases (PHD).  FG-4592 is a novel, orally active, small-mol. HIF PHD inhibitor for the treatment of anemia in patients with chronic kidney disease (CKD).  The current study aimed to evaluate the effect of FG-4592 (Roxadustat) on cis-diamminedichloroplatinum (cisplatin)-induced kidney injury.  In mice, pretreatment with FG-4592 markedly ameliorated cisplatin-induced kidney injury as shown by the improved renal function (blood urea nitrogen (BUN), serum creatinine (Scr), and cystatin C) and kidney morphol. (periodic acid-Schiff (PAS) staining) in line with a robust blockade of renal tubular injury markers of kidney injury mol. 1 (KIM-1) and neutrophil gelatinase-assocd. lipocalin (NGAL).  Meanwhile, the renal apoptosis and inflammation induced by cisplatin were also strikingly attenuated in FG-4592-treated mice.  Along with the protective effects shown above, FG-4592 pretreatment strongly enhanced HIF-1α in tubular cells, as well as the expressions of HIF target genes.  FG-4592 alone did not affect the renal function and morphol. in mice.  In vitro, FG-4592 treatment significantly up-regulated HIF-1α and protected the tubular cells against cisplatin-induced apoptosis.  In summary, FG-4592 treatment remarkably ameliorated the cisplatin-induced kidney injury possibly through the stabilization of HIF.  Thus, besides the role in treating CKD anemia, the clin. use of FG-4592 also could be extended to AKI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcKx-vnkcRmrVg90H21EOLACvtfcHk0lg_aTD2AEL80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFamurvE&md5=7232accbdd48f1d0186ee96ff512d94a</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1042%2FCS20171625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20171625%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DA.%26atitle%3DHypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%2520inhibitor%2520roxadustat%2520%2528FG-4592%2529%2520protects%2520against%2520cisplatin-induced%2520acute%2520kidney%2520injury%26jtitle%3DClin.%2520Sci.%26date%3D2018%26volume%3D132%26issue%3D7%26spage%3D825%26epage%3D838%26doi%3D10.1042%2FCS20171625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for Parkinson’s diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">121</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2018.00121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.3389%2Ffnagi.2018.00121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29755339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=121&author=X.+Liauthor=X.+X.+Cuiauthor=Y.+J.+Chenauthor=T.+T.+Wuauthor=Y.+C.+Wuauthor=H.+Xuauthor=H.+Yin&title=Therapeutic+potential+of+a+prolyl+hydroxylase+inhibitor+FG-4592+for+Parkinson%E2%80%99s+diseases+in+vitro+and+in+vivo%3A+regulation+of+redox+biology+and+mitochondrial+function&doi=10.3389%2Ffnagi.2018.00121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of a prolyl hydroxylase inhibitor FG-4592 for parkinson's diseases in vitro and in vivo: regulation of redox biology and mitochondrial function</span></div><div class="casAuthors">Li, Xuan; Cui, Xin-Xin; Chen, Ya-Jing; Wu, Ting-Ting; Xu, Huaxi; Yin, Huiyong; Wu, Yun-Cheng</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">121/1-121/16</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">As the main transcription factor that regulates the cellular responses to hypoxia, Hypoxia-inducible factor-1α (HIF-1α) plays an important role in the pathogenesis of Parkinson's disease (PD).  HIF-1α is normally degraded through ubiquitination after hydroxylation by prolyl hydroxylases (PHD).  Emerging evidence has suggested that HIF PHD inhibitors (HIF-PHI) may have neuroprotective effects on PD through increasing HIF-1α levels.  However, the therapeutic benefit of HIF-PHI for PD remains poorly explored due to the lack of proper clin. compds. and understanding of the underlying mol. mechanisms.  In this study, we examd. the therapeutic benefit of a new HIF-PHI, FG-4592, which is currently in phase 3 clin. trials to treat anemia in patients with chronic kidney diseases (CKD) in PD models.  FG-4592 attenuates MPP+-induced apoptosis and loss of tyrosine hydroxylase (TH) in SHSY5Y cells.  Pretreatment with FG-4592 mitigates MPP+-induced loss of mitochondrial membrane potential (MMP), mitochondrial oxygen consumption rate (OCR), prodn. of reactive oxygen species (ROS) and ATP.  Furthermore, FG-4592 counterbalances the oxidative stress through up-regulating nuclear factor erythroid 2 p45-related factor 2 (Nrf-2), heme oxygenase-1 (HO-1) and superoxide dismutase 2 (SOD2).  FG-4592 treatment also induces the expression of Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) through increasing the phosphorylation of AMP-activated protein kinase (AMPK).  In MPTP-treated mice, FG-4592 protects against MPTP-induced loss of TH-pos. neurons of substantia nigra and attenuates behavioral impairments.  Collectively, our study demonstrates that FG-4592 is a promising therapeutic strategy for PD through improving the mitochondrial function under oxidative stress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSQ__V5ZZmvrVg90H21EOLACvtfcHk0lhhMirZVJSw_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKisrzN&md5=6de27ad23eb1b16c4384ff23d385b38e</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2018.00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2018.00121%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DX.%2BX.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DWu%26aufirst%3DT.%2BT.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DTherapeutic%2520potential%2520of%2520a%2520prolyl%2520hydroxylase%2520inhibitor%2520FG-4592%2520for%2520Parkinson%25E2%2580%2599s%2520diseases%2520in%2520vitro%2520and%2520in%2520vivo%253A%2520regulation%2520of%2520redox%2520biology%2520and%2520mitochondrial%2520function%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2018%26volume%3D10%26spage%3D121%26doi%3D10.3389%2Ffnagi.2018.00121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">FG-4592 accelerates cutaneous wound healing by epidermal stem cell activation via HIF-1alpha stabilization</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">2460</span>– <span class="NLM_lpage">2470</span>, <span class="refDoi"> DOI: 10.1159/000489652</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1159%2F000489652" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29742498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVajsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2018&pages=2460-2470&issue=6&author=D.+Tangauthor=J.+Zhangauthor=T.+Yanauthor=J.+Weiauthor=X.+Jiangauthor=D.+Zhangauthor=Q.+Zhangauthor=J.+Jiaauthor=Y.+Huang&title=FG-4592+accelerates+cutaneous+wound+healing+by+epidermal+stem+cell+activation+via+HIF-1alpha+stabilization&doi=10.1159%2F000489652"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">FG-4592 Accelerates Cutaneous Wound Healing by Epidermal Stem Cell Activation via HIF-1α Stabilization</span></div><div class="casAuthors">Tang, Di; Zhang, Junhui; Yan, Tiantian; Wei, Jingyu; Jiang, Xupin; Zhang, Dongxia; Zhang, Qiong; Jia, Jiezhi; Huang, Yuesheng</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2460-2470</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Regional hypoxia promptly develops after trauma because of microvascular injury and increased oxygen consumption.  This acute hypoxia plays a pos. role in early skin wound healing.  One of the mechanisms underlying the beneficial effects of acute hypoxia on wound healing may be increased hypoxia-inducible factor-1 (HIF-1α) expression.  HIF-1α may affect the wound-healing process through many aspects, including angiogenesis, metab., and extra-cellular matrix synthesis and remodelling.  Epidermal stem cells (EpSCs) are important participants in wound repair; however, whether these cells are regulated by hypoxia is unclear.  This study aimed to elucidate the regulatory mechanism by which hypoxia acts on EpSCs.  Methods: CCK8 assays, western blots and live cell station observation were employed to compare the viability, proliferation and motility of EpSCs cultured under normoxic conditions (21% O2) with those cultured under hypoxic conditions (2% O2).  Moreover, we used FG-4592 (a prolyl hydroxylase inhibitor that stabilizes HIF-1α in normoxia), KC7F2 (a selective inhibitor of HIF-1α transcription) and siRNA against HIF-1α to regulate HIF-1α expression.  Results: Acute hypoxia caused EpSCs to switch from a quiescent state to an activated state with higher viability and motility, as well as an earlier proliferation peak.  We demonstrated that the HIF-1 signalling pathway mediated hypoxia-induced activation of EpSCs.  Finally, the in vivo expts. showed that exogenous FG-4592 effectively accelerates wound healing, shortens healing times and even induces epidermal hyperplasia.  Conclusion: This study demonstrated that both hypoxia and exogenous FG-4592 improve EpSC proliferation and motility by stabilizing HIF-1α, and its results suggest that HIF-1α is an important target through which wound healing can be accelerated and that FG-4592 is a promising new drug for wound repair.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2_YG1WlcArVg90H21EOLACvtfcHk0lgjG2sakmvS0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVajsbvE&md5=c1bf51015825ece8805597c5358bb63a</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1159%2F000489652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000489652%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DJia%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DFG-4592%2520accelerates%2520cutaneous%2520wound%2520healing%2520by%2520epidermal%2520stem%2520cell%2520activation%2520via%2520HIF-1alpha%2520stabilization%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2018%26volume%3D46%26issue%3D6%26spage%3D2460%26epage%3D2470%26doi%3D10.1159%2F000489652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watts, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walmsley, S. R.</span></span> <span> </span><span class="NLM_article-title">Inflammation and hypoxia: HIF and PHD isoform selectivity</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2018.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.molmed.2018.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=30442494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKhsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2019&pages=33&author=E.+R.+Wattsauthor=S.+R.+Walmsley&title=Inflammation+and+hypoxia%3A+HIF+and+PHD+isoform+selectivity&doi=10.1016%2Fj.molmed.2018.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and Hypoxia: HIF and PHD Isoform Selectivity</span></div><div class="casAuthors">Watts, Emily R.; Walmsley, Sarah R.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33-46</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Cells sense and respond to hypoxia through the activity of the transcription factor HIF (hypoxia-inducible factor) and its regulatory hydroxylases, the prolyl hydroxylase domain enzymes (PHDs).  Multiple isoforms of HIFs and PHDs exist, and isoform-selective roles have been identified in the context of the inflammatory environment, which is itself frequently hypoxic.  Recent advances in the field have highlighted the complexity of this system, particularly with regards to the cell and context-specific activity of HIFs and PHDs.  Because novel therapeutic agents which regulate this pathway are nearing the clinic, understanding the role of HIFs and PHDs in inflammation outcomes is an essential step in avoiding off-target effects and, crucially, in developing new anti-inflammatory strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwdsO08qRh_rVg90H21EOLACvtfcHk0lgjG2sakmvS0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKhsLrO&md5=4263636a9b4a5f4a8cb36a540aa5a62f</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2018.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2018.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DWatts%26aufirst%3DE.%2BR.%26aulast%3DWalmsley%26aufirst%3DS.%2BR.%26atitle%3DInflammation%2520and%2520hypoxia%253A%2520HIF%2520and%2520PHD%2520isoform%2520selectivity%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2019%26volume%3D25%26spage%3D33%26doi%3D10.1016%2Fj.molmed.2018.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuchnio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruning, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuchnio, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruys, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thienpont, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ungureanu, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyere, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manderveld, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Fernaud, J.
R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zanivan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foidart, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinckier, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambrechts, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dewerchin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzone, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carmeliet, P.</span></span> <span> </span><span class="NLM_article-title">The cancer cell oxygen sensor PHD2 promotes metastasis via activation of cancer-associated fibroblasts</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">1005</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2015.07.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.celrep.2015.07.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=26235614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Kmur%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=992-1005&author=A.+Kuchnioauthor=S.+Moensauthor=U.+Bruningauthor=K.+Kuchnioauthor=B.+Cruysauthor=B.+Thienpontauthor=M.+Brouxauthor=A.+A.+Ungureanuauthor=R.+L.+de+Oliveiraauthor=F.+Bruyereauthor=H.+Cuervoauthor=A.+Manderveldauthor=A.+Cartonauthor=J.%0AR.+Hernandez-Fernaudauthor=S.+Zanivanauthor=C.+Barticauthor=J.+Foidartauthor=A.+Noelauthor=S.+Vinckierauthor=D.+Lambrechtsauthor=M.+Dewerchinauthor=M.+Mazzoneauthor=P.+Carmeliet&title=The+cancer+cell+oxygen+sensor+PHD2+promotes+metastasis+via+activation+of+cancer-associated+fibroblasts&doi=10.1016%2Fj.celrep.2015.07.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts</span></div><div class="casAuthors">Kuchnio, Anna; Moens, Stijn; Bruning, Ulrike; Kuchnio, Karol; Cruys, Bert; Thienpont, Bernard; Broux, Michael; Ungureanu, Andreea Alexandra; Leite de Oliveira, Rodrigo; Bruyere, Francoise; Cuervo, Henar; Manderveld, Ann; Carton, An; Hernandez-Fernaud, Juan Ramon; Zanivan, Sara; Bartic, Carmen; Foidart, Jean-Michel; Noel, Agnes; Vinckier, Stefan; Lambrechts, Diether; Dewerchin, Mieke; Mazzone, Massimiliano; Carmeliet, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">992-1005</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Several questions about the role of the oxygen sensor prolyl-hydroxylase 2 (PHD2) in cancer have not been addressed.  First, the role of PHD2 in metastasis has not been studied in a spontaneous tumor model.  Here, we show that global PHD2 haplodeficiency reduced metastasis without affecting tumor growth.  Second, it is unknown whether PHD2 regulates cancer by affecting cancer-assocd. fibroblasts (CAFs).  We show that PHD2 haplodeficiency reduced metastasis via two mechanisms: (1) by decreasing CAF activation, matrix prodn., and contraction by CAFs, an effect that surprisingly relied on PHD2 deletion in cancer cells, but not in CAFs; and (2) by improving tumor vessel normalization.  Third, the effect of concomitant PHD2 inhibition in malignant and stromal cells (mimicking PHD2 inhibitor treatment) is unknown.  We show that global PHD2 haplodeficiency, induced not only before but also after tumor onset, impaired metastasis.  These findings warrant investigation of PHD2's therapeutic potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzRPAreNPyUrVg90H21EOLACvtfcHk0lg19Ynm0CqRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Kmur%252FO&md5=e65539ad69f1d3cda3910b5c26a8c65b</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.07.010%26sid%3Dliteratum%253Aachs%26aulast%3DKuchnio%26aufirst%3DA.%26aulast%3DMoens%26aufirst%3DS.%26aulast%3DBruning%26aufirst%3DU.%26aulast%3DKuchnio%26aufirst%3DK.%26aulast%3DCruys%26aufirst%3DB.%26aulast%3DThienpont%26aufirst%3DB.%26aulast%3DBroux%26aufirst%3DM.%26aulast%3DUngureanu%26aufirst%3DA.%2BA.%26aulast%3Dde%2BOliveira%26aufirst%3DR.%2BL.%26aulast%3DBruyere%26aufirst%3DF.%26aulast%3DCuervo%26aufirst%3DH.%26aulast%3DManderveld%26aufirst%3DA.%26aulast%3DCarton%26aufirst%3DA.%26aulast%3DHernandez-Fernaud%26aufirst%3DJ.%2BR.%26aulast%3DZanivan%26aufirst%3DS.%26aulast%3DBartic%26aufirst%3DC.%26aulast%3DFoidart%26aufirst%3DJ.%26aulast%3DNoel%26aufirst%3DA.%26aulast%3DVinckier%26aufirst%3DS.%26aulast%3DLambrechts%26aufirst%3DD.%26aulast%3DDewerchin%26aufirst%3DM.%26aulast%3DMazzone%26aufirst%3DM.%26aulast%3DCarmeliet%26aufirst%3DP.%26atitle%3DThe%2520cancer%2520cell%2520oxygen%2520sensor%2520PHD2%2520promotes%2520metastasis%2520via%2520activation%2520of%2520cancer-associated%2520fibroblasts%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D992%26epage%3D1005%26doi%3D10.1016%2Fj.celrep.2015.07.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaGory, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccia, A. J.</span></span> <span> </span><span class="NLM_article-title">The ever expanding role of HIF in tumour and stromal biology</span>. <i>Nat. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">365</span>, <span class="refDoi"> DOI: 10.1038/ncb3330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1038%2Fncb3330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=27027486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFKiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=356-365&issue=4&author=E.+L.+LaGoryauthor=A.+J.+Giaccia&title=The+ever+expanding+role+of+HIF+in+tumour+and+stromal+biology&doi=10.1038%2Fncb3330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The ever-expanding role of HIF in tumour and stromal biology</span></div><div class="casAuthors">LaGory, Edward L.; Giaccia, Amato J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-365</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Low oxygen tension (hypoxia) is a hallmark of cancer that influences cancer cell function, but is also an important component of the tumor microenvironment as it alters the extracellular matrix, modulates the tumor immune response and increases angiogenesis.  Here we discuss the regulation and role of hypoxia and its key transcriptional mediators, the hypoxia-inducible factor (HIF) family of transcription factors, in the tumor microenvironment and stromal compartments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD5HJxfRxES7Vg90H21EOLACvtfcHk0lg19Ynm0CqRKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFKiur0%253D&md5=4434a6121f6499a7d5b1a92a402bdad4</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1038%2Fncb3330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb3330%26sid%3Dliteratum%253Aachs%26aulast%3DLaGory%26aufirst%3DE.%2BL.%26aulast%3DGiaccia%26aufirst%3DA.%2BJ.%26atitle%3DThe%2520ever%2520expanding%2520role%2520of%2520HIF%2520in%2520tumour%2520and%2520stromal%2520biology%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2016%26volume%3D18%26issue%3D4%26spage%3D356%26epage%3D365%26doi%3D10.1038%2Fncb3330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chai, Y.</span></span> <span> </span><span class="NLM_article-title">Von Hippel-Lindau (VHL) protein antagonist, VH298, promotes functional activities of tendon-derived stem cells and accelerates healing of entheses in rats by inhibiting ubiquitination of hydroxy-HIF-1alpha</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>505</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1063</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2018.09.172</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.bbrc.2018.09.172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=30314704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvVyhu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2018&pages=1063-1069&issue=4&author=S.+Qiuauthor=Y.+Jiaauthor=J.+Tangauthor=X.+Liuauthor=H.+Huauthor=T.+Wuauthor=Y.+Chai&title=Von+Hippel-Lindau+%28VHL%29+protein+antagonist%2C+VH298%2C+promotes+functional+activities+of+tendon-derived+stem+cells+and+accelerates+healing+of+entheses+in+rats+by+inhibiting+ubiquitination+of+hydroxy-HIF-1alpha&doi=10.1016%2Fj.bbrc.2018.09.172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Von Hippel-Lindau (VHL) protein antagonist, VH298, promotes functional activities of tendon-derived stem cells and accelerates healing of entheses in rats by inhibiting ubiquitination of hydroxy-HIF-1α</span></div><div class="casAuthors">Qiu, Shuo; Jia, Yachao; Tang, Jin; Liu, Xuanzhe; Hu, Hai; Wu, Tianyi; Chai, Yimin</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1063-1069</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enthesis is the region where a tendon attaches to a bone.  It is a relatively vulnerable position, and in most cases surgical treatment is required upon rupture.  The reconstructed enthesis is usually weaker compared to the original, and is prone to rupture again.  Hypoxia-inducible factor-1 α (HIF-1α) is known to be involved in extensive activities in cells.  It is inhibited under normoxic conditions, and undergoes two essential processes, hydroxylation and ubiquitination, the latter of which has been largely unexplored.  Herein, we measured the levels of HIF-1α and hydroxy-HIF-1α in VH298-treated rat tendon-derived stem cells (TDSCs) by immunoblotting.  We also detected the proliferation of TDSCs using CCK-8 assay and the mRNA levels of related genes by quant. RT-PCR.  The TDSCs were obsd. to be induced and the chondrogenic differentiation related genes were found to be enhanced.  We also simulated in-vitro wounding in a scratch test and reconstructed the enthesis in a rat model of Achilles tendon by classical surgery followed by administration of phosphate buffer saline (PBS) injection or VH298 injection.  We obsd. that HIF-1α and hydroxy-HIF-1α levels were increased in VH298-treated TDSCs in a dose- and time-dependent manner.  Thirty micromolar VH298 could significantly increase cell proliferation, migration, and expression of collagen-1α, collagen-3α, decorin, tenomodulin, tenascin C genes, and chondrogenic differentiation-related genes, collagen-2α, SRY-box9, aggrecan.  VH298-treated enthesis could tolerate more load-to-failure, had a better healing pattern, and activation of HIF signaling pathway.  VH298 can thus enhance the functional activities of TDSCs, enhance their chondrogenic differentiation potential, and accelerate enthesis healing by inhibiting the ubiquitination of hydroxy-HIF-1α.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4xy_oOhp-5LVg90H21EOLACvtfcHk0lgSVNlr9sk89g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvVyhu7fJ&md5=cde6c8cf6d37d89bf27c89b0d383f444</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2018.09.172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2018.09.172%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DChai%26aufirst%3DY.%26atitle%3DVon%2520Hippel-Lindau%2520%2528VHL%2529%2520protein%2520antagonist%252C%2520VH298%252C%2520promotes%2520functional%2520activities%2520of%2520tendon-derived%2520stem%2520cells%2520and%2520accelerates%2520healing%2520of%2520entheses%2520in%2520rats%2520by%2520inhibiting%2520ubiquitination%2520of%2520hydroxy-HIF-1alpha%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2018%26volume%3D505%26issue%3D4%26spage%3D1063%26epage%3D1069%26doi%3D10.1016%2Fj.bbrc.2018.09.172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowburn, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palazon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrakis, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macias, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bargiela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pietsch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gralla, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kittipassorn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chey, Y. C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rundqvist, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peet, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, R. S.</span></span> <span> </span><span class="NLM_article-title">The factor inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia</span>. <i>Cell Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">913</span>, <span class="refDoi"> DOI: 10.1016/j.cmet.2018.02.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=10.1016%2Fj.cmet.2018.02.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=29617647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;key=1%3ACAS%3A528%3ADC%252BC1cXntVKqsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2018&pages=898-913&issue=4&author=J.+Simauthor=A.+S.+Cowburnauthor=A.+Palazonauthor=B.+Madhuauthor=P.+A.+Tyrakisauthor=D.+Maciasauthor=D.+M.+Bargielaauthor=S.+Pietschauthor=M.+Grallaauthor=C.+E.+Evansauthor=T.+Kittipassornauthor=Y.+C.+J.+Cheyauthor=C.+M.+Brancoauthor=H.+Rundqvistauthor=D.+J.+Peetauthor=R.+S.+Johnson&title=The+factor+inhibiting+HIF+asparaginyl+hydroxylase+regulates+oxidative+metabolism+and+accelerates+metabolic+adaptation+to+hypoxia&doi=10.1016%2Fj.cmet.2018.02.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia</span></div><div class="casAuthors">Sim, Jingwei; Cowburn, Andrew S.; Palazon, Asis; Madhu, Basetti; Tyrakis, Petros A.; Macias, David; Bargiela, David M.; Pietsch, Sandra; Gralla, Michael; Evans, Colin E.; Kittipassorn, Thaksaon; Chey, Yu C. J.; Branco, Cristina M.; Rundqvist, Helene; Peet, Daniel J.; Johnson, Randall S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">898-913.e7</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Animals require an immediate response to oxygen availability to allow rapid shifts between oxidative and glycolytic metab.  These metabolic shifts are highly regulated by the HIF transcription factor.  The factor inhibiting HIF (FIH) is an asparaginyl hydroxylase that controls HIF transcriptional activity in an oxygen-dependent manner.  We show here that FIH loss increases oxidative metab., while also increasing glycolytic capacity, and that this gives rise to an increase in oxygen consumption.  We further show that the loss of FIH acts to accelerate the cellular metabolic response to hypoxia.  Skeletal muscle expresses 50-fold higher levels of FIH than other tissues: we analyzed skeletal muscle FIH mutants and found a decreased metabolic efficiency, correlated with an increased oxidative rate and an increased rate of hypoxic response.  We find that FIH, through its regulation of oxidn., acts in concert with the PHD/vHL pathway to accelerate HIF-mediated metabolic responses to hypoxia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr58Zs_Uji4UbVg90H21EOLACvtfcHk0lgSVNlr9sk89g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXntVKqsL0%253D&md5=049720b4f4b7fc6cac59da1ec2829f45</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2018.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2018.02.020%26sid%3Dliteratum%253Aachs%26aulast%3DSim%26aufirst%3DJ.%26aulast%3DCowburn%26aufirst%3DA.%2BS.%26aulast%3DPalazon%26aufirst%3DA.%26aulast%3DMadhu%26aufirst%3DB.%26aulast%3DTyrakis%26aufirst%3DP.%2BA.%26aulast%3DMacias%26aufirst%3DD.%26aulast%3DBargiela%26aufirst%3DD.%2BM.%26aulast%3DPietsch%26aufirst%3DS.%26aulast%3DGralla%26aufirst%3DM.%26aulast%3DEvans%26aufirst%3DC.%2BE.%26aulast%3DKittipassorn%26aufirst%3DT.%26aulast%3DChey%26aufirst%3DY.%2BC.%2BJ.%26aulast%3DBranco%26aufirst%3DC.%2BM.%26aulast%3DRundqvist%26aufirst%3DH.%26aulast%3DPeet%26aufirst%3DD.%2BJ.%26aulast%3DJohnson%26aufirst%3DR.%2BS.%26atitle%3DThe%2520factor%2520inhibiting%2520HIF%2520asparaginyl%2520hydroxylase%2520regulates%2520oxidative%2520metabolism%2520and%2520accelerates%2520metabolic%2520adaptation%2520to%2520hypoxia%26jtitle%3DCell%2520Metab.%26date%3D2018%26volume%3D27%26issue%3D4%26spage%3D898%26epage%3D913%26doi%3D10.1016%2Fj.cmet.2018.02.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L3E" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1L3E','PDB','1L3E'); return false;">PDB: 1L3E</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TBM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5TBM','PDB','5TBM'); return false;">PDB: 5TBM</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPR','PDB','4ZPR'); return false;">PDB: 4ZPR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4ZPK','PDB','4ZPK'); return false;">PDB: 4ZPK</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HQR','PDB','3HQR'); return false;">PDB: 3HQR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3OUJ','PDB','3OUJ'); return false;">PDB: 3OUJ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2HBT','PDB','2HBT'); return false;">PDB: 2HBT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5%2520V1B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5%2520V1B','PDB','5%20V1B'); return false;">PDB: 5 V1B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LQB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LQB','PDB','1LQB'); return false;">PDB: 1LQB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LLI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LLI','PDB','5LLI'); return false;">PDB: 5LLI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JWP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5JWP','PDB','5JWP'); return false;">PDB: 5JWP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MZF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1MZF','PDB','1MZF'); return false;">PDB: 1MZF</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01596&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01596%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-12" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01596" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                14MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679966aebfaf3d30","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
